1. health and fitness
2. disease
3. heart disease

Final Programme
World Congress of Cardiology
Buenos Aires, Argentina
18 - 21 May, 2008
congress FLOOR PLAN
CONtent
Welcome address 3
Committees 4
Hosting organizations
6
World Heart Federation
Argentine Society of Cardiology
Argentine Federation of Cardiology
Congress schedule 21
Congress information 24
How to get to the congress venue
About the congress venue La Rural
Registration
Media and press
Visual reproduction policy
Congress material
WCC on-site services
Social programme 34
WCC 2008 Community activities 35
About Argentina 36
Argentina
Buenos Aires
Climate
Language
Time difference
Banks, currency, credit cards and VAT
Electrical power
Security
Making phone calls
Useful phone numbers
Opening hours
Leaving Argentina
Tours Sponsorship and exhibition 41
Acknowledgements
Exhibition opening hours
List of exhibitors
Exhibition map
Sponsors’ and Exhibitors’ editorial listing
Scientific programme 38
60
Formats
CME Accreditation
Technical information for sessions
Posters & abstracts
Acknowledgements
Programme-at-a-glance
By day and by time
Author and FACULTY index
290
Content / 1
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
Do they know their risk?
Join the global effort to prevent and control cardiovascular disease, the world’s number one killer.
Support World Heart Day by giving heart health checks to your patients and their families to make
them aware of their risk of cardiovascular disease. Help spread the message: ‘Know Your Risk!’ and
have a heart for life. www.world-heart-federation.org
World Heart Day
Sunday, 28 September, 2008
WELCOME ADDRESS
A warm welcome to the World Congress of Cardiology 2008.
It is our pleasure, speaking on behalf of the joint organizers
of the World Heart Federation, the Argentine Society of
Cardiology and the Argentine Federation of Cardiology, to
welcome delegates from the furthest corners of the globe
to Buenos Aires.
We strongly believe that it is only with each and every
one of us working together that we will make a significant
difference – and that is what the World Congress of
Cardiology seeks to achieve. Our joint focus is on individual,
community and patient care interventions and the growing
epidemic of cardiovascular disease that could and can be
prevented and managed more effectively.
We all know the statistics, or a version of it – that
cardiovascular disease, primarily heart disease and stroke, is
known to be responsible for a staggering 17.5 million deaths
a year. A total, 80% of these deaths are in low- and middleincome countries, and we all have a role to play in changing
this trend, be it through prevention, education or the sharing
of knowledge. These are three key themes that unite the
approach of your World Congress Organizers, not to mention
many thousands of our participants.
And for now – WCC 2008 welcomes world class speakers
with topical and wide-ranging sessions under the theme of
“From patients to populations” – a theme that offers a rich,
diverse and rewarding opportunity to share new and exciting
advances in the fields of prevention and management of
heart disease and all its inter-related factors. Whether it
be part of the official scientific programme, a commercial
satellite symposium or a workshop or taking the time to
discover the wealth of new devices and pharmaceutical
products present in the exhibition hall – the World Congress
of Cardiology offers a wide and rich breadth of educational
material to enhance your personal learning and career. You
will see that the WCC 2008 also offers Continuing Medical
Education Credits (CME) – be sure to benefit from this
internationally recognized programme. Full details may be
found on page 60 of this WCC Final Programme.
As previously communicated, one key objective of
the scientific programme is to feature globally relevant
topics in the diagnosis, management and treatment
of cardiovascular disease, which includes basic clinical
and population research and another is to address public
policy and advocacy topics related to cardiovascular
disease. Whilst these objectives are shared by all three
joint organizers, it is of particular importance for the
World Heart Federation in its continuing relationships
with changing partners to construct your future World
Congresses of Cardiology. It is your participation that
makes the World Congress of Cardiology what it is and
it is your input and feedback that creates an environment
in which to exchange science and build stronger and better
working practices and procedures for the future.
The World Congress of Cardiology, the official congress
of the World Heart Federation, is delighted to be back in
Argentina for a second time. We encourage you to take
the opportunity post congress to visit this beautiful country
and experience the famous warmth of the Argentine people.
Welcome – we look forward to meeting you over the next
few days. Enjoy your World Congress of Cardiology and
Buenos Aires.
Horacio Faella, MD
Shahryar Sheikh, MD
President of the WCC 2008
President of the World Heart Federation
Welcome address / 3
CONGRESS MANAGEMENT COMMITTEE (CMC)
Presidents:
Horacio Faella (Argentina) – Shahryar Sheikh (Pakistan)
International Relationships:
Luis María Amuchástegui (Argentina)
Vice-Presidents:
Néstor Vita (Argentina) – Trevor Hassell (Barbados)
Valentin Fuster (US)
Pekka Puska (Finland)
General Secretary:
Juan Krauss (Argentina)
National Organizing Committee President:
Jorge Lerman (Argentina)
Director Congress Division, World Heart Federation:
Adrian Ott (Switzerland)
National Organizing Committee Vice-President:
Juan Carlos Linares-Casas (Argentina)
Managing Director, ICS Congresos Internacionales:
Mariano Castex (Argentina)
Chief Executive Officer, World Heart Federation:
Janet Voûte (Switzerland)
Scientific Committee:
Arturo Cagide (Argentina)
Felipe Martínez (Argentina)
Sidney C. Smith (US)
SCIENTIFIC PROGRAMME COMMITTEE (SPC)
Co-Chairmen:
Arturo Cagide (Argentina)
Felipe Martínez (Argentina)
Sidney C. Smith (US)
Scientific Advisory Board Council Chairs / Advisers:
Jonathan Carapetis (Australia)
Edgardo Escobar (Chile)
Dong Zhao (People’s Republic of China)
National Advisers: (Argentina)
Luis Alday
Hugo Grancelli
Liliana Grinfeld
Néstor Pérez Baliño
Juan A. Plastino
Ricardo Ronderos
International Advisers:
Mónica Acevedo (Chile)
Ayrton Brandão (Brazil)
Günter Breithardt (Germany)
Valentin Fuster (US)
Runlin Gao (China)
Trevor Hassell (Barbados)
José López-Sendón (Spain)
Mário Maranhão (Brazil)
Marco Martínez-Ríos (Mexico)
Akira Matsumori (Japan)
Bongani Mayosi (South Africa)
Sania Nishtar (Pakistan)
Churchill Onen (Botswana)
Dev Pahlajani (India)
Pekka Puska (Finland)
Srinath Reddy (India)
Carlos Romero (Uruguay)
Nizal Sarraf-Zadegan (Iran)
Sergio Timerman (Brazil)
Tak Fu Tse (China)
Andrew Tonkin (Australia)
William Wijns (Belgium)
Salim Yusuf (Canada)
Director Science Operations, World Heart Federation:
Marilyn Hunn (US)
SPONSORSHIP COMMITTEE
Horacio Faella (Argentina)
Shahryar Sheikh (Pakistan)
Jorge Lerman (Argentina)
PRESS COMMITTEE
Hugo Lastiri (Argentina)
Álvaro Sosa-Liprandi (Argentina)
Janet Voûte (Switzerland)
Janet Voûte (Switzerland)
Helen Alderson (Switzerland)
Adrian Ott (Switzerland)
Mariano Castex (Argentina)
Victoria Dix (Switzerland)
Patricia Blanco (Argentina)
Laura Torres (Argentina)
Eugenia De la Fuente (Argentina)
IT’S A RED ALERT
Heart disease & stroke is the No.1 killer of women worldwide. Most
heart disease & stroke is preventable. Spread the word. Go Red today.
www.worldheart.org/grfw
Hosting OrganiZations
World Heart Federation
Improving lives by preventing heart disease and stroke
The World Heart Federation is a non-governmental
organization committed to helping the global population
achieve a longer and better life through prevention and
control of heart disease and stroke, with a focus on lowand middle-income countries.
The World Heart Federation is comprised of 196 medical
societies and heart foundations from more than 100
countries, as well as continental members covering the
regions of Africa, the Americas, Asia-Pacific and Europe.
Recognized by the World Health Organization, the World
Heart Federation is its leading non-governmental partner
in cardiovascular disease prevention and control.
Our four pillars of activity include: awareness building,
advocacy, demonstration projects and sharing science/
building capacity. Together with its members, the World
Heart Federation raises awareness of heart disease and
stroke, advocates for policy changes, develops projects to
educate communities and patients about reducing the risk
of cardiovascular disease and shares medical and population
health science to build sustainable capabilities at national
and regional levels.
www.worldheart.org
AWARENESS BUILDING
To raise public awareness of heart disease and stroke,
the World Heart Federation develops campaigns and
events. With its members and other partners, it encourages
individuals and institutions to adopt heart-healthy habits
and plays a major role in ensuring that governments
implement policies for cardiovascular disease prevention.
World Heart Day is our most important awareness building
event. It promotes preventive measures to reduce the
incidence of cardiovascular disease worldwide. Today,
World Heart Day is actively celebrated in more than 100
countries and on all continents. This global event, which
takes place on the last Sunday of September and focuses
on a specific theme each year, involves a wide range of
activities, including physical exercise sessions, lectures,
shows, walking tours, healthy cooking competitions,
and health risk assessments including the testing of
cholesterol, blood pressure and glucose levels, along
with BMI and waist circumference measurement.
The Go Red for Women campaign raises awareness
of heart disease and stroke as the number one cause of
death of women worldwide. It encourages the medical
profession to include heart disease and stroke prevention
as a core component of women’s health and urges women
to recognize their risks and to reduce them by adopting
appropriate lifestyle changes.
Hosting OrganiZations
World Heart Federation
ADVOCACY
Tobacco use kills 5.4 million people a year - an average of
one person every six seconds - and accounts for one in
10 adult deaths worldwide. The World Heart Federation
and its member organizations are intensively involved in
advocating for tobacco control and, notably, the ratification
and implementation at the national level of the Framework
Convention on Tobacco Control, which has been signed by
168 countries and entered into force in 2005. 153 countries
have ratified the FCTC and thus become Parties. Our specific
focus includes active involvement in the Global Smokefree
Partnership and the development of a Youth Advocacy
Network in Latin America. The World Heart Federation also
focuses on the current overweight/obesity epidemic. It
is playing a lead role in campaigning for the need to protect
public health against the hazards associated with unhealthy
nutrition habits and physical inactivity.
In partnership with the World Economic Forum and the
World Health Organization, the World Heart Federation is
also leading the movement to improve employee health
through working toward wellness in the workplace.
DEMONSTRATION PROJECTS
The World Heart Federation aims to measurably impact
cardiovascular disease risk, using resource-appropriate
demonstration projects implemented at both population
and high-risk individual levels.
Demonstration projects are a part of the World Heart
Federation’s efforts to achieve measurable impact on
cardiovascular disease risk levels in low-income countries.
Projects are specifically geared towards demonstrating best
practice in areas of cardiovascular disease prevention and
control and span several continents. For example, the World
Heart Federation is leading the field of secondary prevention
for children with rheumatic fever/rheumatic heart disease in
Africa and the Asia-Pacific region. A partnership with Sesame
Workshop in Colombia is working to instill healthy habits
in young viewers and their families. The Grenada Heart
Project, implemented in collaboration with the Government
of Grenada, uses the World Health Organization STEPwise
approach to surveillance of CVD risk factors in order to help
communities to tailor prevention programmes to their needs.
Hosting organizations / 7
Hosting OrganiZations
World Heart Federation
sharing science/building capacity
World Congresses of Cardiology are held every two years
during which thousands of cardiologists and other healthcare
professionals from all over the world gather to share the
latest science on the treatment of patients and the latest
thinking in population-based prevention.
World Heart Federation Scientific Councils, composed
of experts from around the world, carry out international
training seminars, research and demonstration projects.
Through its Twin Centres programme, the organization
sponsors fellowships for young cardiologists and scientists
from less advantaged countries to undergo postgraduate
training in world-class cardiology centres.
CVD Prevention and Control is a quarterly journal of
the World Heart Federation, which focuses especially
on cardiovascular disease prevention in low- and middleincome countries. Nature Clinical Practice Cardiovascular
Medicine is a monthly publication of the World Heart
Federation, which provides physicians with the latest
science of patient care. Further information on the World
Heart Federation Journals can be found on page 16.
For more information about the World Heart Federation,
please visit www.worldheart.org
World Heart Federation Board
President
Shahryar SHEIKH (Pakistan)
Secretary
Akira MATSUMORI (Japan)
Vice-President
Trevor HASSELL (Barbados)
Treasurer
Craig T BEAM (United States)
President Elect
Pekka PUSKA (Finland)
Chief Executive Officer
Janet VOÛTE (Switzerland)
Vice-President Elect
Lyn ROBERTS (Australia)
Chairman, Foundations' Advisory Board
Srinath REDDY (India)
Past President
Valentin FUSTER (United States)
Chairman, Scientific Advisory Board
Sidney SMITH Jr. (USA)
Past Vice-President
Laksmiati A. HANAFIAH (Indonesia)
Editor-in-Chief, CVD Prevention & Control Journal
Andy WIELGOSZ (Canada)
Continental Representatives
Asia-Pacific
Tsui-Lieh HSU (Taiwan)
Anil Kumar D.M. (India)
Africa
Robert de SOUZA (South Africa)
Albert AMOAH (Ghana)
Europe
Peter HOLLINS (United Kingdom)
William WIJNS (Belgium)
Inter-America
Oscar Alvarado (Peru)
Rafael Shuchleib (Mexico)
World Heart Federation Meetings
World Heart Federation Foundations’ Advisory Board (FAB) Meeting
Saturday, 17 May, 2008
08.30 –12.30Room Martin Fierro, Sheraton San Martin, Buenos-Aires
World Heart Federation Board Meeting
Saturday, 17 May, 2008
13.30 –18.00Room Martin Fierro, Sheraton San Martin, Buenos-Aires
World Heart Federation Members' Workshop
Monday, 19 May, 2008
08.30 - 17.30 Sheraton, San Martin, Buenos-Aires
World Heart Federation Writers’ Workshop
Monday, 19 May, 2008
09.30 –12.30WHF Meeting Room, La Rural Congress Centre
OTHER MEETINGS
ISACCD (International Society Adults Congenital Heart Disease) Meeting
Wednesday, 21 May, 2008
12.30 - 13.30Ganges Room, La Rural Congress Centre
Argentine Foundation of Cardiology Meeting
Wednesday, 21 May, 2008
12.30 - 13.30Tiber Room, La Rural Congress Centre
Workshop: Medical and social issues about women's CV health.
Chairperson: Salvatti Ana (ARGENTINA)
Speakers:
Nanette Wenger (UNITED STATES), Grinfeld Liliana (ARGENTINA)
Book Presentation - "Fisiopatología Cardiovascular, bases racionales para la terapéutica"
Wednesday, 21 May, 2008
12.30 - 13.30Tigris Room, La Rural Congress Centre
World Heart Federation 10th General Assembly
Sunday, 18 May, 2008
11.30 –13.30 Room Piso 24, Sheraton San Martin, Buenos-Aires
Agenda
1. Introduction of Members of BoardShahryar Sheikh
2*. Adoption of Minutes of last General AssemblyShahryar Sheikh
3. President’s ReportShahryar Sheikh
4*. Report of the TreasurerCraig T BEAM
(including approval by General Assembly
of 2006 & 2007 audited reports)
5. Report of the Foundations’ Advisory BoardTrevor Hassell (for Srinath Reddy)
6. Report of the Scientific Advisory Board/DemonstrationSidney Smith
Project Reviews
7. Report of the Secretary Akira Matsumori
8*. Report of the Nominating Committee & ElectionsValentin Fuster
9. AwardsShahryar Sheikh
10. Future Priorities for ActionPekka Puska
11. Any Other Business
*Requires approval by General Assembly
Hosting organizations / 9
Accepted abstracts
are published in the
Circulation supplement.
Circulation – the journal of choice in
the cardiology community,
with an impact factor of 10.940.
Submitting
Your Research
To The
American
Heart
Association
Is The Right
Choice.
Global leaders in
cardiovascular research
and instruction will see
your science.
Discuss your work with the world’s
foremost leaders in your field.
Over 450 media attend; their articles
create 200 million impressions.
Opportunities exist for Early Career
Awards and Travel Stipends.
Featured research can have an immediate global impact.
Awards are available for qualified healthcare professionals.
Submit Your Best Science Today For Sessions
In New Orleans, November 8 – 12
The American Heart Association’s Scientific Sessions is the world’s premier cardiovascular conference,
with unmatched scientific scope, authority and prestige.
Abstract submissions
April 15 to June 6
Late-breaking abstract
submission deadline
June 30
O N E W O R L D . O N E M I S S I O N . Y O U R S P E C I A LT Y.
scientificsessions.org
©2008, American Heart Association. 4/08LS1704
World Heart Federation Members
CONTINENTAL MEMBERS
A continental society or foundation which is a group of societies or foundations from one of the continental groupings
of countries comprising Europe, North/Central/South America, Asia Pacific, and Africa.
Organization name
President/Chairman
Country
African Heart Network (AHN)
Robert de Souza
South Africa
Asia Pacific Heart Network (APHN)
Hsu Tsui-Lieh
China, Taiwan
Asian-Pacific Society of Cardiology (APSC)
Anil Kumar
India
European Heart Network (EHN)
Peter Hollins
United Kingdom
European Society of Cardiology (ESC)
Kim Fox
United Kingdom
InterAmerican Heart Foundation (IAHF)
Rafael Shuchleib
Mexico
Interamerican Society of Cardiology (IASC)
Oscar Alvarado
Peru
Pan-African Society of Cardiology (PASCAR)
Albert Amoah
Ghana
NATIONAL MEMBERS
A national society of cardiology or a national heart foundation.
Organization name
President/Chairman
Country
Algerian Society of Cardiology
Djamaleddine Nibouche
Algeria
Argentine Heart Foundation
Liliana Grinfeld
Argentina
Argentine Society of Cardiology
Eduardio Mele
Argentina
National Heart Foundation of Australia
Bruce Carter
Australia
The Cardiac Society of Australia & New Zealand
Michael Feneley
Australia
Austrian Heart Foundation
Konrad Steinbach
Austria
Austrian Society of Cardiology
Kurt Huber
Austria
Bangladesh Cardiac Society
Sirajul Haque
Bangladesh
National Heart Foundation of Bangladesh
Justice Chowdury ATM Masud
Bangladesh
Heart and Stroke Foundation of Barbados Inc
Dru Symmonds
Barbados
Belarusian Scientific Society of Cardiologists
N. Manak
Belarus
Belgian Heart League
Jean-Pierre Willaert
Belgium
Belgian Society of Cardiology
Guy Berkenboom
Belgium
Bolivian Society of Cardiology
Edgar Pozo Valdivia
Bolivia
Association of Cardiologists of Bosnia and Herzegovina
Enver Raljevíc
Bosnia and Herzegovina
Foundation of Health and Heart
Slobodan Cvjetic
Bosnia and Herzegovina
Brazilian Society of Cardiology
Antonio Palandri Chagas
Brazil
Funcor – Brazilian Heart Foundation
Alvaro Avezum
Brazil
Bulgarian Society of Cardiology
Tzvetana Katova
Bulgaria
Canadian Cardiovascular Society
Denis Roy
Canada
Heart and Stroke Foundation of Canada
Carol Jillings
Canada
Chilean Heart Foundation
Mario Alvo
Chile
Chilean Society of Cardiology & Cardiovascular Surgery
René Asenjo González
Chile
Hong Kong College of Cardiology
Chu-Pak Lau
China, Hong Kong
The Hong Kong Heart Foundation, Ltd.
Patrick Wu
China, Hong Kong
Macau Association of Cardiology
Mario Lima Evora
China, Macao
Macau Heart Foundation
Jimmy Chac Lam Chu
China, Macao
Chinese Society of Cardiology
Runlin Gao
People’s Republic of China
Taiwan Heart Foundation
Hung-Chi Lue
China, Taiwan
Taiwan Society of Cardiology
Fui-Tien Chiang
China, Taiwan
Colombian Society of Cardiology
Fernando Manzur Jattin
Colombia
World Heart Federation members / 11
World Heart Federation Members
Organization name
President/Chairman
Country
A Heart for Life
Nathalie Kaky-Ndembe
Congo
Croatian Cardiac Society
Davor Milicic
Croatia
Cuban Society of Cardiology
Lorenzo Llerena Rojas
Cuba
Cyprus Heart Foundation
Christos Mavrellis
Cyprus
Cyprus Society of Cardiology
Pambis Nicolaides
Cyprus
Czech Society of Cardiology
Michael Aschermann
Czech Republic
Healthy Nutrition Forum
Rudolf Poledne
Czech Republic
Danish Heart Foundation
Henrik Sillesen
Denmark
Danish Society of Cardiology
Henrik Steen Hansen
Denmark
Dominican Heart Foundation
Hector Mateo
Dominican Republic
Dominican Society of Cardiology
Frank Valdez Báez
Dominican Republic
Ecuadorian Foundation of Cardiology
Ernesto Fuentes
Ecuador
Ecuadorian Society of Cardiology
Santiago García Eguez
Ecuador
Egyptian Society of Cardiology
Aly Ramsy
Egypt
Society of Cardiology of El Salvador
Dagoberto Pereira
El Salvador
Estonian Heart Association
Maarit Vaikmaa
Estonia
Finnish Cardiac Society
Saila Vikman
Finland
Finnish Heart Association
Pekka Puska
Finland
French Society of Cardiology
Nicolas Danchin
France
Georgian Association of Cardiology
V. B. Tchumburidze
Georgia
Georgian Heart Foundation
Merab Mamatsashvili
Georgia
German Cardiac Society
Gerd Heusch
Germany
German Heart Foundation
Hans-Jürgen Becker
Germany
Ghana Heart Foundation
Kwabena Frimpong-Boateng
Ghana
Ghana Society of Hypertension and Cardiology
Albert Amoah
Ghana
Hellenic Cardiological Society
Dimitris Kremastinos
Greece
Hellenic Heart Foundation
Metropolitan of Thebes and Levadia Ieronymos
Greece
Guatemala Association of Cardiology
Pablo Montenegro Valdovinos
Guatemala
Honduras Society of Cardiology
Mauricio Varela
Honduras
Hungarian National Heart Foundation
András Nagy
Hungary
Hungarian Society of Cardiology
Tamás Forster
Hungary
Icelandic Heart Association
Gunnar Sigurdsson
Iceland
All India Heart Foundation
Sivaramakrishna Padmavati
India
Cardiological Society of India
S. S. Chatterje
India
Heart Foundation of Indonesia
Firdanerry A. Sani
Indonesia
Indonesian Heart Association
Muhammad Munawar
Indonesia
Iranian Heart Association
Feridoun Noohi
Islamic Republic of Iran
Iraqi Cardio-Thoracic Society
Adil S. Abdul-Ghafour
Iraq
Irish Cardiac Society
David Higginson
Ireland
Irish Heart Foundation
Eoin O'Brien
Ireland
Israel Heart Society
Basil Lewis
Israel
Italian Federation of Cardiology
Giuseppe Di Pasquale
Italy
Italian Heart Foundation
Rodolfo Paoletti
Italy
The Heart Foundation of Jamaica
Knox Hagley
Jamaica
Japan Heart Foundation
Takuji Shidachi
Japan
Japanese Circulation Society
Tetsu Yamaguchi
Japan
Jordan Cardiac Society
M. Al-Naser
Jordan
Association of Cardiologists of Kazakhstan
Alikham K. Jussipov
Kazakhstan
World Heart Federation Members
Organization name
President/Chairman
Country
Kenya Cardiac Society
Stephen Ogendo
Kenya
Kenyan-Heart National Foundation
David Githii
Kenya
The Korean Society of Cardiology
Woo Hyung Lee
Republic of Korea
Kuwait Heart Foundation
Jassim M Al-Bahar
Kuwait
Scientific Society of Cardiologists of the Kyrgyz Republic
Mirrachimov Mirhamidovich
Kyrgyzstan
Latvian Society of Cardiology
Andrejs Erglis
Latvia
Lebanese Society of Cardiology
Fouad Farhat
Lebanon
Libyan Cardiac Society
Omar Msalam
Libya
Lithuanian Heart Association
Pranas Serpytis
Lithuania
Lithuanian Society of Cardiology
Remigijus Zaliunas
Lithuania
Macedonia Society of Cardiology
Sasko Kedev
Macedonia
National Heart Association of Malaysia
Hendrick Chia
Malaysia
The Heart Foundation of Malaysia
Tun Omar Ong Yoke Lin
Malaysia
The Heart Foundation
T. K. Gunness
Mauritius
Mexican Society of Cardiology
Jorge Gaspar Hernandez
Mexico
Moldavian Society of Cardiology
Mihai Popovici
Republic of Moldavia
Moroccan Society of Cardiology
Mohamed Saadaoui
Morocco
Cardiac Society of Myanmar Medical Association
May San Khin
Myanmar
Cardiac Society of Nepal
Abani Upadhyaya
Nepal
Nepal Heart Foundation
Abani Upadhyaya
Nepal
Netherlands Heart Foundation
L. E. H. Vredevoogd
The Netherlands
The Netherlands Society of Cardiology
H. J. G. M. Crijns
The Netherlands
Cardiac Society of Australia and New Zealand
Robert Donaldson
New Zealand
The National Heart Foundation of New Zealand
Robert Donaldson
New Zealand
Nicaraguan Society of Cardiology
Daniel Rivas
Nicaragua
Nigerian Cardiac Society
Martin Aghaji
Nigeria
Nigerian Heart Foundation
A. V. M. Mouktar Mohammed
Nigeria
Norwegian Council On Cardiovascular Disease
Mons Lie
Norway
Norwegian Society of Cardiology
Cecilie Risøe
Norway
Pakistan Cardiac Society
Azhar Masood Faruqui
Pakistan
Pakistan Heart Foundation
Muhammad Ilyas
Pakistan
Cardiological Foundation of Panama
Alfredo L. Maduro
Panama
Society of Cardiology of Panama
Baldomero González
Panama
National Heart Foundation of Papua New Guinea Inc.
David Guinn
Papua New Guinea
Paraguayan Heart Foundation
Abdón Villamayor
Paraguay
Paraguayan Society of Cardiology
Maria Paniagua de Decoud
Paraguay
Peruvian Society of Cardiology
Jaime Espinoza S.
Peru
Heart Foundation of the Philippines
Francisco G. Dizon
Philippines
Philippine Heart Association Inc.
Efren Vicaldo
Philippines
Polish Cardiac Society
Andrzej Rynkiewicz
Poland
Portuguese Heart Foundation
Manuel Oliveira Carrageta
Portugal
Portuguese Society of Cardiology
Hugo Madeira
Portugal
Puerto Rican Society of Cardiology
Luis Molinary
Puerto Rico
Foundation for Cardiac Assistance (Ascar)
Costin Carp
Romania
Romanian Society of Cardiology
Radu Capalneanu
Romania
Society of Cardiology of Russian Federation
Rafael G. Oganov
Russian Federation
San Marino Society of Cardiology
Liano Marinelli
San Marino
Saudi Heart Association
Mohammed Arafah
Saudi Arabia
World Heart Federation members / 13
World Heart Federation Members
Organization name
President/Chairman
Country
Serbian Heart Foundation
Miodrag Ostojic
Republic of Serbia
Society of Cardiology of Serbia and Montenegro
Miodrag Ostijic
Republic of Serbia
Seychelles Heart and Stroke Foundation
Dolores Pool
Seychelles
Singapore Cardiac Society
Richard Ng
Singapore
Singapore Heart Foundation
Lip-Ping Low
Singapore
Slovak League Heart to Heart
Ján Slezák
Slovak Republic
Slovak Society of Cardiology
Róbert Hatala
Slovak Republic
Slovenian Heart Foundation
Danica Rotar Pavlic
Slovenia
Slovenian Society of Cardiology
Miran Kenda
Slovenia
Heart and Stroke Foundation South Africa
Richard Cramer
South Africa
The South African Heart Association
Bongani Mayosi
South Africa
Spanish Heart Foundation
Eduardo de Teresa Galván
Spain
Spanish Society of Cardiology
Maria Jesús Salvador Taboada
Spain
Sri Lanka Heart Association
S. J. Stephan
Sri Lanka
Swedish Heart Lung Foundation
Anna-Karin Lundin
Sweden
Swedish Society of Cardiology
Anna Engström-Laurent
Sweden
Swiss Heart Foundation
Ludwig von Segesser
Switzerland
Swiss Society of Cardiology
Andres Jaussi
Switzerland
Syrian Cardiovascular Association
Moufid Jokhadar
Syria
The Heart Association of Thailand
Pradistchai Chaiseri
Thailand
The Heart Foundation of Thailand
HRH Princess Maha Chakri Sirindhorn
Thailand
Turkish Heart Foundation
Cetin Yildirimakin
Turkey
Turkish Society of Cardiology
Cetin Erol
Turkey
Ukrainian Society of Cardiology
Volodymir Kovalenko
Ukraine
Emirates Cardiac Society
Wael Almahmeed
United Arab Emirates
British Cardiovascular Society
Nicholas Boon
United Kingdom
British Heart Foundation
Sir Peter Morris
United Kingdom
American College of Cardiology
James T. Dove
United States
American Heart Association
Daniel W. Jones
United States
Uruguayan Society of Cardiology
Alvaro Báez
Uruguay
Venezuelan Heart Foundation
Igor Morr García
Venezuela
Venezuelan Society of Cardiology
Bartolomé Finizola Celli
Venezuela
Vietnam National Heart Association
Pham Gia Khai
Vietnam
World Heart Federation Members
ASSOCIATE INTERNATIONAL MEMBER
An independent incorporated organization active in some aspect of the prevention and control of heart disease and stroke.
Organization name
President/Chairman
Country
Association of Black Cardiologists, Inc
Gerald DeVaughn
United States
Association of Thoracic and Cardiovascular Surgeons of Asia (ATCSA)
Avenilo P. Aventura
Philippines
Children's HeartLink
Elizabeth Bickel
United States
Eastern Mediterranean Network on Heart Health
Nizal Sarraf-Zadegan
Islamic Republic of Iran
Heart Friends Around the World
Alessandro Scalzini
Italy
Heartfile
Sania Nishtar
Pakistan
International Chinese Heart Health Network
Tan-Hoong Chu Eng
China, Hong Kong
International Council of Nurses
Hiroko Minami
Japan
International Forum for Hypertension Control and CVD Prevention in Africa
Daniel Lemogoum
Cameroon
International Heart Health Society (IHHS)
David MacLean
Canada
International Self-Monitoring Association of Oral Anticoagulated Patients (ISMAAP)
Christian Schaefer
Germany
International Society for Heart Research
J. M. Downey
United States
International Society for Holter & Non-Invasive Electrocardiology
Sergio Dubner
Argentina
International Society of Cardiomyopathy and Heart Failure
Akira Matsumori
Japan
International Society of Cardiovascular Pharmacotherapy
Antonio Bayés de Luna
Spain
International Society of Cardiovascular Ultrasound
Navin Nanda
United States
International Stroke Society
Geoffrey A. Donnan
Switzerland
Latin Society of Pediatric Cardiology and Cardiovascular Surgery
Pedro L. Ferrer
Panama
ProCOR/Lown Cardiovascular Research Foundation
Bernard Lown
United States
The International Society on Hypertension in Blacks (ISHIB)
Charles L. Curry
United States
The Society of Chest Pain Centers and Providers
J. Lee Garvey
United States
The World Heart Failure Society
Willem J. Remme
The Netherland
ASSOCIATE NATIONAL
A national society devoted to aspects of the prevention and control of heart disease and stroke or with aims similar
to those of the World Heart Federation.
Organization name
President/Chairman
Country
Academy of Cardiology at Mumbai
Dev. B. Phalajani
India
Cardiovascular Society of India
A. B. Mehta
India
Foundation for Lay Education on Heart Diseases
Adolfo B. Bellosillo
Philippines
Heart Care Foundation Comilla
Abu Hamid
Bangladesh
Heart Research UK
David Watson
United Kingdom
Indonesian Cardiocerebrovascular Society
Lukman Makmun
Indonesia
Norwegian Heart and Lung Patient Organization (LHL)
Svein Erik Myrseth
Norway
World Heart Federation members / 15
WORLD HEART FEDERATION JOURNALS
Nature Clinical Practice Cardiovascular Medicine, a peerreviewed journal for cardiologists, is an official publication of
the World Heart Federation. It delivers timely interpretations
of key research developments, translating the latest findings
into clinical practice. Our Editor-in-Chief, Valentin Fuster,
MD, PhD, and the journal’s international Advisory Board
ensure comprehensive coverage of topical issues throughout
the year, with the highest standards of editorial quality and
integrity that are hallmarks of the Nature Publishing Group.
Published monthly in print and online, Nature Clinical
Practice Cardiovascular Medicine features unique content
designed to be of real, practical value in making diagnosis
and treatment decisions. Content includes editorial and
opinion pieces, highlights from the current literature,
commentaries on the application of recent research to
practical patient care, comprehensive reviews, original
clinical research and in-depth case studies. Content is
subject to rigorous peer-review.
For more information about the journal, its Advisory Board
and its aims and scope, visit www.nature.com/ncpcardio
Visit the World Heart Federation booth to collect your free
copy of Nature Clinical Practice Cardiovascular Medicine.
­
Valentin Fuster, MD, PhD
Editor-in-Chief
As the official journal of the World Heart Federation, CVD
Prevention and Control (formerly “Prevention and Control”,
now re-launched under a new title) continues to provide
a forum for dialogue and education on matters relating to
the prevention and control of cardiovascular diseases
worldwide, with a special focus on countries with middle
and lower economies.
Now in its fourth year of publication, the response to this
new niche journal has been very encouraging. In line with
the mission of the World Heart Federation, CVD Prevention
and Control has become a priority journal for all who
wish to contribute to the advancement of knowledge
in cardiovascular diseases and to help halt the spread
of this epidemic worldwide.
CVD
Prevention
and
Control
CVD Prevention and Control
is organizing a Writers’
Workshop during the World Congress of Cardiology 2008 in
Buenos Aires, Argentina. This half day workshop is primarily
intended for those from developing countries who want
to publish in scientific journals. Participants will receive
information on how to organize and write a manuscript for
publication as well as information on how manuscripts are
processed through the Elsevier Electronic system. The aim
and scope of the journal will be discussed and a part of the
session will be focused on interactions with a successful
writer. This workshop is being held on Monday, May 19,
2008 from 9.30 –12.30. The number of participants is
limited to 40.
On Monday, 19 May at 13.30, Andy Wielgosz, the Editorin-Chief of CVD Prevention and Control will be holding a
“Meet the Editor” session at the World Heart Federation
booth. This is an opportunity for you to discuss the journal
and find out how you can submit a paper to the journal.
Andy Wielgosz, MSC, MD, PhD
Editor-in-Chief
For further details, please visit: www.precon-journal.com
CLINICAL PRACTICE
Calling now for original research submissions
Maximise the visibility and impact of your research by submitting to
Nature Clinical Practice Cardiovascular Medicine and be one of the first to be
published in our new Clinical Research section.
www.nature.com/ncpcardio/originalresearch
13409-12_WCC final programme ad.indd 1
18/3/08 17:09:55
The Argentine Society of Cardiology (SAC)
General information
The Argentine Society of Cardiology (SAC), founded in
1937, is a member of the World Heart Federation, the
Interamerican Society of Cardiology, the South American
Society of Cardiology and is affiliated to the European Society
of Cardiology. It is one of the world's oldest cardiology
societies. Its members include many prestigious historical
figures internationally recognized for their contributions
to science, such as the Nobel Prize winner Dr. Bernardo
Houssay and Drs Eduardo Braun Menéndez, Pedro Cossio,
Alberto Taquini, Mauricio Rosenbaum and Rene Favaloro.
Over its 70-year history, it has been responsible for a rich
history of scientific achievements – both educational and
within the community. Each year, the Argentine Society of
Cardiology organizes the Argentine Congress of Cardiology.
10,500 participants attended the 34th meeting in October
2007, including some of the most important international
figures in the world of cardiology. In 1974 the SAC jointly
hosted the 7th World Congress of Cardiology and in 1999
the 17th International Congress of Cardiology – setting the
scene for the partnership this May, once again playing an
active role in the World Congress of Cardiology.
The Argentine Society of Cardiology has more than 6,500
members in various categories including doctors, nurses and
technicians. It has 36 Regional Districts spread over the entire
national territory and 17 scientific councils representing all
the subspecialties of cardiology. It conducts continuous
and intensive teaching with courses in all subspecialties,
grants the certification of “University of Cardiology“
with various universities and conducts a programme
of recertification training.
Other important areas of its role include research, with
epidemiological surveys, clinical research studies and
the Consensus which sets standards for diagnosis and
treatment of major cardiovascular diseases. The society
acts as advisor to both legislative chambers of the national
parliament and also established a community programme
for the general population, the Argentine Foundation
of Cardiology, to educate and prevent cardiovascular
disease as well as running and dictating courses on
cardiopulmonary resuscitation.
Argentine Society of Cardiology Board
President
Eduardo Mele, MD
1st Vice-President Ricardo Iglesias, MD
2nd Vice-President Walter Santander, MD
Secretary
Fernando Sokn, MD
Vice Secretary
Antonio Pocoví, MD
Treasurer
Víctor Mauro, MD
Vice Treasurer
Rodolfo La Greca, MD
Members at Large Horacio Pomés Iparraguirre, MD
C. Sara Berensztein, MD
María Inés Sosa Liprandi, MD
Carlos Farinelli, MD
Andrés Mulassi, MD
Héctor Sequeira, MD
Mirta Diez, MD
Enrique Pautasso, MD
Past President
Osvaldo Masoli, MD
Revista Argentina de Cardiología (RAC)
(Argentine Journal of Cardiology)
The journal was created in 1934, and as of 1937, when
the Argentine Society of Cardiology was founded, it became
its official publication.
Argentine Society of Cardiology Projects
Medical continuous education and investigation are the
chief advocacies of the Argentine Society of Cardiology.
Current projects include: the organization of the next
Argentine Congress of Cardiology and Meeting of the
Regional Districts in 2009, the interactive programme for
continuous training, PROSAC, and the promotion of clinical
investigation, teaching and counselling on different aspects
of methodology and biostatistics, among others.
For more information about the Argentine Society
of Cardiology, please visit www.sac.org.ar
Many original scientific papers from different specialities,
editorials, clinical cases, review articles, controversies,
articles of opinion and images in cardiology are published
in the Journal. There is also a section devoted to letters
from the readers.
In the RAC´s web page (www.revista.sac.org.ar ) all editions
from 1993 onwards can be found, with all articles available at
full free access. It includes English versions of original papers
and the English version of the whole Journal will be available
soon. It is indexed in SciELO, LILACS, Latindex and DOAJ.
The Argentine Federation of Cardiology (FAC)
The Argentine Federation of Cardiology (FAC) is a scientific
institution comprised of 37 cardiology organizations and
11 delegations from the Republic of Argentina and currently
reaches more than 6’000 members. Its mission is to
promote the harmonious and integrated development of
Argentine cardiology to promote cardiovascular health.
The FAC was founded in 1965 by a group of prominent
cardiologists from the following Argentine northeast
provinces representing the six cardiology organizations
existing at the time: Córdoba, Rosario, Mendoza, San
Juan, Tucumán and La Plata. A Society of Societies was
formed, structured as a federation, in which every federate
society kept their autonomy and independence, with equal
representation and decision among the Federal National
Council, its leadership body.
Its first president and "alma mater" was Prof, Dr, Ricardo
Podio from Cordoba, who was then succeeded by members
of the Society of Cardiology from Rosario, Mendoza,
Córdoba, La Plata, Tucumán, Salta, Buenos Aires and
Neuquén. In over 40 years, the organization has carried out
intensive work to accomplish its goals in the development
and progress of cardiology throughout the country. Since
its foundation, many prestigious scientists such as Dr. René
Favaloro and others, have joined FAC, thus contributing
to its mission.
In this field, FAC has signed several arrangements
with different universities and ministers of health across
the country, in order to develop a proper process of
specialty certification.
Annually, FAC organizes the National Cardiology Congress
in different provinces, through a predefined rotation system,
and the mentioned congress has become one of the most
important cardiology events. The next FAC Congress will
take place in May 2009, and the usual attendance is about
to 7’000 cardiologists, technicians and nurses.
Its Center for Teleinformática (CETIFAC) was established in
1995 to develop communication between different federate
societies, as well as with several cardiologic centers from
abroad. Its achievements include the 5th Congress of Virtual
Cardiology, a pioneer activity on the Internet. It also works
closely with the CARDIO Foundation dealing with subjects
related to the prevention of cardiovascular diseases and
health education in the community.
Recognized in several worldwide scientific fora, with many
of its members participating in international scientific
meetings, FAC continues working in pursuit of a range
of goals and always under the ideals set by its founders.
For more information about the Argentine Federation
of Cardiology, please visit www.fac.org.ar
Currently FAC has a total of 22 scientific committees with
subspecialties devoted to research and scientific output.
It publishes a hierarchical Scientific Magazine, in which
prestigious national and foreign authors contribute. Through
its educational programmes, it develops regular activity
focusing on immediate postgraduate education.
Argentine FEDERATION of Cardiology BOARD
President
Luis Alberto Guzmán, MD
1st Vice-President
Héctor Luciardi, MD
2nd Vice-President
Domingo Pozzer, MD
Secretary
Guillermo Azize, MD
Treasurer
Miguel Chiappe, MD
Vice Secretary
Juan Muntaner, MD
Vice Treasurer
Sergio Chain, MD
Members at large Carlos Volonté, MD
Eduardo Conci, MD
Rodolfo Sarjanovich, MD
Graciela Scaro, MD
Horacio Sismondi, MD
Hosting organizations / 19
World
The World Heart Federation is committed to helping the global population achieve
Heart
a longer and better life through prevention and control of heart disease and stroke,
Federation
with a particular focus on low and middle-income countries.
Come and visit us at our booth
www.worldheart.org
CONGRESS SCHEDULE
TIMESat. 17 May, 2008Sun. 18 May, 2008 Mon. 19 May, 2008Tues. 20 May, 2008 Wed. 21 May, 2008TIME
6:30
6:45
6:30
6:45
7:30
INDUSTRY
INDUSTRY
INDUSTRY
7:45
7:15
7:30
7:45
7:00
7:15
CLOSED
CLOSED
CLOSED
8:00
8:15
8:30
8:45
Oral
Oral
Oral
9:00
Abstract
Abstract
Abstract
9:15
Sessions
Sessions
Sessions
9:30
9:45
R
R E
P
R E P P
R E P
10:00
E
E X O
E X O U
E X O
10:15
PUBLIC
G
G H S
G H S B
G H S
10:30
EVENT
I
I
I
T
I I T L
I
T
I
10:45
10km run & S B E
S
S B E I
S B E
11:00
SESSIONS T I R C SESSIONS
SESSIONS
3km walk
T
T I
R
I
R
T
11:15
R
R T S
R T S
R T S
11:30
E
A
A I
A I
I
A
11:45
V
T
T O
T O
T O
12:00
E
I
I N
I N
I N
12:15
N SATELLITE
O
O
O
SATELLITE O
SATELLITE
12:30
T SCIENTIFIC
N
N
N
SCIENTIFIC N
SCIENTIFIC
12:45
ACTIVITIES
ACTIVITIES
ACTIVITIES
T
PUBLIC
13:00
(INTER(INTER(INTERH
EVENT
13:15
SESSIONS)
SESSIONS)
SESSIONS)
E
CPR
13:30
M
COURSES
13:45
A
14:00
T
14:15
I
14:30
SESSIONS
SESSIONS
C SESSIONS
14:45
15:00
R
E
7:00
8:00
8:15
8:30
8:45
9:00
9:15
9:30
9:45
10:00
10:15
10:30
10:45
11:00
11:15
11:30
11:45
12:00
12:15
12:30
12:45
13:00
13:15
13:30
13:45
14:00
14:15
14:30
14:45
15:00
15:15
E
V
15:30
G
E
15:45
I
N
S
16:00
T
T
16:15
R
SESSIONS
SESSIONS
SESSIONS
16:30
A
16:45
T
17:00
I
17:15
O
17:30
N
17:45
15:15
15:30
15:45
X
18:15
OPENING
H EXHIBITION
SATELLITE SCIENTIFIC
SATELLITE SCIENTIFIC
18:30
OPENING
CEREMONY
I
ACTIVITIES
ACTIVITIES
18:45
B
(EVENING SESSIONS)
(EVENING SESSIONS)
I
19:00
18:15
18:30
18:45
20:00
20:00
E
18:00
T
16:00
16:15
16:30
16:45
17:00
17:15
17:30
17:45
18:00
19:00
19:15
I
19:30
O
N
19:45
19:15
19:30
19:45
20:15
20:30
20:45
20:15
20:30
20:45
21:15
GALA DINNER
21:30
(BY PAYMENT OR
21:45
INVITATION ONLY)
21:15
21:30
21:45
22:15
22:30
22:45
21:00
OFF-SITE
22:00
22:15
22:30
22:45
23:00
21:00
22:00
23:00
Congress schedule / 21
Building New Strategies in Acute
Tuesday, May 20, 2008
17:30 – 18:00 Reception
18:00 – 19:30 Symposium
Ganges Room
La Rural Convention &
Exhibition Centre
Av. Sarmiento 2704
Palermo
Buenos Aires,
Argentina
Organized by
Decompensated Heart Failure
Faculty
Nadine Clausell, MD, PhD (Co-Chair)
Associate Professor of Medicine
Federal University of Rio Grande do Sul
Porto Alegre, RS, Brazil
Sergio V. Perrone, MD (Co-Chair)
Medical Director —
Intrathoracic Transplant & Heart Failure Division
FLENI Institute
Buenos Aires, Argentina
Uri Elkayam, MD
Professor of Medicine
University of Southern California,
Keck School of Medicine
Los Angeles, California
J. Thomas Heywood, MD, FACC
Clinical Professor of Medicine
Loma Linda University School of Medicine
Loma Linda, California
Fábio Vilas-Boas, MD, PhD
Chief Cardiology Division
Hospital Espanhol
Salvador, BA, Brazil
Programme Overview
Acute decompensated heart failure (ADHF) is associated with
prolonged in-hospital lengths of stay, high rates of hospital
readmission, and substantial rates of inpatient and outpatient
morbidity and mortality. In Latin American countries, the incidence of
heart failure is rising, and ADHF has not been as well characterized as
chronic heart failure. An awareness of unmet needs in ADHF
management is therefore useful to improve the process of care in this
patient population. Goals of therapy for ADHF include relieving
symptoms, reversing acute hemodynamic abnormalities, initiating
evidence-based therapy, reducing length of stay, and preventing
rehospitalization. Treatment recommendations are generally based on
the patient’s fluid volume status and cardiac output. It is therefore
critical for cardiologists to be aware of when to use various intravenous
therapies for improving hemodynamics and acute heart failure signs
and symptoms. One such agent is the vasodilator nesiritide, a purified
preparation of human B-type natriuretic peptide (hBNP), which
reduces pulmonary capillary wedge pressure and improves dyspnea in
patients with ADHF who have dyspnea at rest or with minimal activity.
This program will help Latin American cardiologists understand the
challenges in managing ADHF and effective therapeutic strategies for
treating patients with different hemodynamic and clinical profiles. In
addition, faculty members will describe and demonstrate through case
presentation the appropriate use of nesiritide in patients with ADHF.
Agenda
17:30 – 18:00
18:00 – 18:05
18:05 – 18:15
Reception
Introduction (Co-chairs)
Nadine Clausell, MD, PhD
Sergio Perrone, MD
Focus on Latin America:
Unmet Needs in Acute Decompensated Heart Failure Management
Nadine Clausell, MD, PhD
18:15 – 18:35
Current Treatment Options for Acute Decompensated Heart Failure
18:35 – 18:55
Nesiritide Therapy for the ADHF Patient
18:55 – 19:15
Case Presentation and Panel Discussion
19:15 – 19:30
Question and Answer
Uri Elkayam, MD
J. Thomas Heywood, MD
Moderator: Uri Elkayam, MD
Panelists: Nadine Clausell, MD, PhD, Sergio Perrone, MD, Fábio Vilas-Boas, MD, PhD,
J. Thomas Heywood, MD
CONGRESS INFORMATION
How to get to the congress venue
By shuttle service
A shuttle service running every 15 minutes, will be available between
the congress venue and the main hotel area at key times.
Date
Hours of service
Sunday, 18 May
16.30 – 21.30
Monday, 19 May
07.00 – 10.00
17.00 – 20.00
Tuesday, 20 May
07.00 – 10.00
17.00 – 20.00
Wednesday, 21 May
07.00 – 10.00
16.00 – 18.00
There are four different routes. Please see below the shuttle bus map
and the schedule for each route.
Please be aware of
the following:
••When returning from the La Rural
Convention Centre buses will stop
on the opposite side of the Avenue
due to traffic regulations
••Frequency may vary during
rush hour
How to get to the congress venue
ROUTE 1 – YELLOW
34
Hotel InterContiental **
35
Reino Del Plata Hotel
37
NH City
38
562 Nogaró Hotel
44
Gran Boulevard Hotel
45
Hotel de las Luces
72
Argentino Hotel **
36
Imperial Park
39
Tribeca
40
Amerian Congreso
41
Apart Hotel & Spa Congreso
42
Castelar
43
Golden Tulip Savoy
48
Sarmiento Palace
67
Hotel Salles
12
Pestana **
7
Sheraton Libertador
8
Regente Palace Hotel
13
El Conquistador
14
Presidente
27
Shuttle service starts
Sunday
Mon, Tue & Wed
16.30
7.00
16.35 – 16.40
07.05 – 07.10
16.45 – 16.50
07.15 – 07.20
17.30
7.40
Loi Suites Esmeralda
Arrival at La Rural Congress Centre
** Indicates official shuttle pick-up and drop-off location
ROUTE 2 – ORANGE
15
Panamericano **
10
Hostería Posta Carretas
16
Argentina Tango Hotel
17
Art Deco Suites
18
725 Continental Hotel
19
Broadway All Suites
20
NH Latino
21
Obelisco Center
22
Park Central Kempinski
23
Mayflower Suites
46
Intersur Suites
24
Hotel Embajador **
25
Bel Air
26
Carlton
30
Argenta Tower
31
Loi Suites Arenales
33
Impala
47
Design Suites
Lenguas Vivas School – Carlos Pellegrini 1515 **
29
62
Shuttle service starts
Sunday
Mon, Tue & Wed
16.30
7.00
16.35 – 16.40
07.05 – 07.10
16.45 – 16.50
07.15 – 07.20
17.30
7.40
Four Seasons
Emperador
Arrival at La Rural Congress Centre
** Indicates official shuttle pick-up and drop-off location
Congress information / 25
How to get to the congress venue
ROUTE 3 – BLUE
51
Madero By Sofitel **
52
Faena Hotel
50
Hilton Buenos Aires **
Plaza Roma – Leandro N Alem & Lavalle **
3
Meliá Buenos Aires
4
Holiday Inn Express Puerto Madero
9
Regal Pacific
53
NH Jousten
54
Lafayette
55
Liberty
56
Claridge
57
Amerian Buenos Aires Park
58
NH Lancaster
60
Tryp Buenos Aires
61
Gran Hotel Buenos Aires
Arrival at La Rural Congress Centre
Shuttle service starts
Sunday
Mon, Tue & Wed
16.30
07.00
16.35 – 16.40
07.05 – 07.10
16.45 – 16.50
07.15 – 07.20
17.30
07.40
** Indicates official shuttle pick-up and drop-off location
ROUTE 4 – RED
1
Sheraton Buenos Aires **
2
Marriott Plaza
5
Howard Johnson Plaza
6
Waldorf
11
Sheltown
28
NH Crillon
59
NH Florida
68
Hotel Promenade
74
Meliá Buenos Aires Hotel
71
Caesar Park **
32
Howard Johnson Recoleta
63
Plaza Francia
64
Alvear Palace
65
Melia Recoleta
66
Ulises Recoleta
70
Shuttle service starts
Sunday
Mon, Tue & Wed
16.30
07.00
16.40 – 16.45
07.10 – 07.15
17.30
7.40
Temporary Apartments
Arrival at La Rural Congress Centre
** Indicates official shuttle pick-up and drop-off location
How to get to the congress venue
By subway
There are five “subtes” lines (abbreviated name for
subterraneo/subway). Subway lines are connected with
the main avenues, railway and bus stations. Each ticket
may be used on all the subway lines.
By taxi
Taxis can be called by phone or hailed directly in the street.
Radio taxis are considered the best option. Taxis can be
easily recognized by their colours, black and yellow, and a
red light on the taximeter indicates that they are available.
The main subway line from the hotel area to La Rural
Convention & Exhibition Centre is the “Subte Linea D”
with “Plaza Italia” as the stop. Delegates can buy discounted
metro tickets (MONEDERO) at the registration area.
Please see below the recommended radio taxi companies
that major hotels work with:
EL PORTEÑO: +54 11 4566 5777
PREMIUM: +54 11 4374 6666
SU TAXI: +54 11 4635 6089
It is highly recommended that you use only black and yellow taxis or taxi companies that work with leading hotels.
Congress information / 27
About the congress Centre La Rural
Address
La Rural Convention & Exhibition Centre
Av. Sarmiento 2704
Palermo
Buenos Aires, Argentina
Exhibition opening hours
Sunday, 18 May, 2008 Monday, 19 May, 2008 Tuesday, 20 May, 2008 Wednesday, 21 May, 2008 18.00 – 20.00
09.00 – 18.00
09.00 – 18.00
09.00 – 18.00
Session rooms
To highlight the international nature of the World Congress
of Cardiology all session rooms have been named after
rivers. Session rooms are shown on the WCC 2008 Floor
Plan on the inside front cover. Please note that seating in
the session rooms is on a first-come, first-served basis.
We recommend therefore that you go to the session room
well before your session begins. Due to safety policies of
La Rural, the access to the session rooms will be denied
once the room is filled to its maximum capacity.
Language
English is the official language of the congress. However,
a track line presented during the South American Congress
of Cardiology will be held in Spanish. Simultaneous
translation (English-Spanish and Spanish-English) will,
however, be provided in the following rooms: Main
Auditorium “Rio de la Plata”, Danube and Thames.
Tobacco Free Policy
Tobacco smoking is a major cause of preventable early death
throughout the world. Cigarette smokers have almost double
the risk of dying from coronary heart disease compared with
non-smokers. Exposure of non-smokers to environmental
tobacco smoke is increasingly suspected as being a cause
of coronary heart disease.
The World Heart Federation aims to promote the reduction in
the prevalence of smoking globally. Workplaces, community,
health care, educational institutions, food industry, health
professionals and governments are important settings for
implementing this policy.
All premises occupied by the World Heart Federation,
including those that are used temporarily by the World
Heart Federation, shall be smoke-free.
The WCC Congress Committees thank all participants and
exhibitors for not smoking in the Congress Centre “La Rural”
and its immediate surroundings at all times.
Disclaimer
The Congress organizers will accept no liability for personal
injuries sustained by, or for loss or damage to property
belonging to Congress participants, or other unforeseen
circumstances either during or as a result of the Congress or
during all tours and activities. It is therefore recommended
that participants, as well as companies, arrange their own
personal health, accident and travel insurance property loss,
damage insurance or any other necessary insurance. ICS
Congresos Internacionales S.A. and Bounty Travel Service
act as agents and cannot be held responsible for any loss,
injury or damage to any person or property whatever the
cause may be. The liability of persons and companies
providing means of transportation or other services,
however, remains unaffected.
Registration
Registration opening hours
To collect your badge in the registration area, please bring
a copy of your letter of confirmation, in order to facilitate the
process. Participants can register on-site during the following
opening hours:
On-site registration opening hours:
Saturday, May 17, 2008
15.00 – 18.00
Sunday, May 18, 2008
09.00 – 18.00
Monday, May 19, 2008
08.00 – 18.00
Tuesday, May 20, 2008
08.00 – 18.00
Wednesday, May 21, 2008
08.00 – 18.00
Fees
Registration fees are payable in US Dollars and are inclusive of VAT.
FEE CATEGORY
On-sitE REGISTRATION FEE
Standard Fee
USD 790
Technician/Nurse/Trainee USD 400
Latin-American and Caribbean Delegate
USD 790
Latin-American and Caribbean Technician/Nurse/Traineea
USD 400
Argentine Delegate
USD 790 a
Argentine Technician/Nurse/Trainee USD 400 Heart Foundation Professional USD 400 Accompanying Person’s Programmme
USD 345c a
b
a. With a letter of approval from your university or hospital. IMPORTANT
FOR TRAINEES: Registration will be processed only upon presentation
of a copy of your degree/licence sent with the registration form
(5 years maximum since graduation)
b. With a letter of approval from the World Heart Federation
c. According to availability
Delegate registration fees include:
••Congress badge
••Congress bag with the WCC 2008 Final Programme
••Full access to the exhibition and scientific sessions
••Access to the opening ceremony (limited seats available)
ATTENTION ITALIAN DELEGATES
Please note that Alijet & Fargo International has been
authorized to collect and deliver to the department
of Public Health in Rome, Italy, all application forms
from these delegates who will attend the WCC 2008.
Accompanying person fees include:
••Access to the exhibition
••Access to the opening ceremony (limited seats available)
••Half day city tour, Tigre Delta Cruise and Cultural tour
••Scientific sessions are not open to accompanying persons.
Contact: Alijet & Fargo International S.r.l.
Via Petro Maroncelli 44/46
50137 Firenze – Italy
Tel. +39 055 600555
Fax +39 055 609078
Contact person: Fawn Sarkisian
f.sarkisian@fargointernational.it
Registration / 29
Registration
Badges
Participants and accompanying persons are kindly asked to
wear their badge during all congress activities. Entry will not
be permitted without a badge. Replacement of lost badges
incurs an administrative charge of USD 100 (+VAT).
Name changes
Participant names may be changed with a handling fee of
USD 50 (+VAT) along with a newly completed registration
form for the replacement participant and with a written
permission from the original participant that the name
change has been approved.
Colour code of badges:
Delegate – White
Accompanying person – Grey
WCC Exhibitor – Green
WCC Staff – Red
WCC Faculty – Orange
Press – Purple
Visitor tracking system
All active delegate badges contain a bar code, which
acts as an electronic business card. Participants are
therefore able to leave their contact details for exhibitors
very quickly and easily. Please note that group registration
data is subject to corporate companies completing the
details of their delegates and whilst WCC encourage this,
we cannot guarantee the quality of group registrations
provided by industry.
Cancellation and refunds
For cancellations received in writing prior to 15 April,
2008 the paid registration fee will be reimbursed, less
a 25% administration fee. No refunds will be issued after
that date. Reimbursements will be forwarded 60 days
after the Congress ends.
Choice of journals
All delegates of the World Congress of Cardiology 2008 are
eligible to receive a special subscription rate to the following
journals. Fees stated in USD (US Dollars).
••Nature
Clinical Practice Cardiovascular Medicine Journal
at USD 50 for a one-year subscription
••CVD
Prevention and Control Journal at USD 50 for
a one-year subscription
••Revista
Argentina de Cardiologia Journal at USD 50 for
a one-year subscription
••Revista de la Federacion Cardiologica Argentina Journal
at USD 50 for a one-year subscription
Please find more information on Nature Clinical Practice
Cardiovascular Medicine and CVD Prevention and Control
on page 16.
Certificate of attendance
Attendance certificates for delegates can be found in
each congress bag.
Media and press
The WCC Press Centre is located in the Ocre Pavillion. It will
be open from 15.00 – 18.00 on 17 May, 08.00 – 20.00 on
18 May and on the 19, 20 and 21 May, from 08.00 – 18.00,
or later. A press badge is required to enter this facility. This
badge also gives access to the scientific sessions. In order to
be granted a complimentary press badge for the WCC 2008,
journalists have to register beforehand. Your press badge will
be available for you to collect on-site at the press registration
area. To collect your badge you will be asked to show photo
identification such as a passport, so please have this with you.
During the Congress you will have the opportunity to learn
about the latest science advances on the management of
cardiovascular diseases and to review effective approaches
to tackling the rising burden of cardiovascular disease
globally. These include, for example public policy and
advocacy, the development of the polypill, a focus
on women and CVD and youth tobacco advocacy.
The scientific programme will feature globally relevant
topics in the diagnosis, management and treatment of
cardiovascular disease, including basic clinical and population
research. The Scientific Programme includes Symposia,
Debates How to & Workshop Sessions and Clinical
Seminars. Around 250 scientific sessions will be presented in
the main programme, abstract based programme, or
in one of the special sessions. Another important feature
of the WCC programme is the Spanish Sessions track.
Press enquiries should be directed to Victoria Dix
(victoria.dix@cohnwolfe.com)
Visual reproduction policy
The WCC organizers reserve the right to film all
presentations during the WCC 2008. Photographing or
videotaping scientific sessions is not allowed on the WCC
congress site, except with specific prior permission
of the WCC organizers.
Congress material
WCC Final Programme
Each delegate will receive one copy of the WCC Final
Programme with their congress bag. Additional copies can
be purchased in the registration area on the final day of the
congress, subject to availability, for USD 10 per copy. The
WCC Final Programme is also available on the WCC 2008
Website www.worldcardiocongress.org
WCC Programme at a Glance
Your copy of the WCC Programme at a Glance is given
to you with your congress badge. It is your easy instant
summary of the key scientific programme activities. Once
you have located a session in the WCC Programme at
a Glance, refer to the WCC Final Programme for more
detailed information.
WEBCASTS
Certain official WCC 2008 Scientific Sessions will
be webcasted by Prous Science. These sessions
will be accessible on the WCC Congress website
www.worldcardiocongress.org approximately one
week after the congress.
WCC 2010 FIRST Announcement
Please come and see the World Heart Federation booth
on Wednesday, 21 May in order to retrieve the First
Announcement for the next WCC in 2010.
WCC Abstracts
All abstracts have been published in the online version of
the official American Heart Association Journal “Circulation”.
For more information, please visit www.circ.ahajournals.org.
In addition, all delegates may collect their personal electronic
copy of these abstracts on CD Rom from the Boehringer
Ingelheim booth in the exhibition hall. To collect your free
copy, please go to their booth with your voucher which you
will find in your congress bag.
The WCC would like to thank Boehringer Ingelheim for their
financial support towards the production and distribution of
the abstract CD Rom.
Farbe/colour:
PANTONE 288 CV
Congress information / 31
WCC on-site services
Cyber corner
Internet access will be provided at selected locations
throughout the congress venue. They can be used by all
delegates free of charge for a limited time period to access
the internet.
Business centre
Printing, copying and other office requirements can be handled
at the business centre located within the exhibition area.
Mobile phones
For mobile phone rentals, please visit www.phonerental.com.ar
or refer to page 33.
First aid
Delegates in need of medical treatment should contact
the First Aid Point located near the registration area.
Cloakrooms
Cloakroom service for clothing and reasonable-sized items
is available during the opening hours of the congress in the
exhibition hall. There will be a daily charge of ARS 5 or USD
2 for each item left in the cloakroom. Valuable items should
not be left in the cloakroom. Please ensure to collect all your
belongings at the end of the day.
Food and beverage outlets
Please refer to the map to locate different food and beverage
points throughout the congress venue. All food and beverage
facilities will be open during the day to serve drinks, snacks
and lunch. Payments can be made by cash (in ARS and USD)
or credit card.
Hotel information desk/Gala dinner
and tours desk
Desks for information about hotels, Gala dinner ticket sales
and tours will be located in the registration area.
Message centre
A message centre will be located behind the Amazon Room.
It can be used by all delegates free of charge for leaving
messages for other delegates.
Info points
WCC info points are located throughout the congress
centre. Please refer to the WCC 2008 Floor Plan on the
inside front cover for their exact location.
Parking
Underground parking can be accessed 24 hours from two
different entrances: via the Sarmiento Avenue and via the
Cerviño Street. Approximately 1,000 cars can be parked
at the La Rural Congress Venue.
The following rates will apply: 1 hour – USD 2.50,
12 hours – USD 12, 24 hours – USD 15.
Future events booth
In order to share knowledge and make you aware of other
national and international cardiology congresses, please
make sure to drop by the future events booth in the
exhibition hall.
Transport for disabled persons
Special transport facilities within La Rural will be provided
for disabled persons.
Lost and Found
A lost and found office will be available for delegates.
CONTACT INFORMATION
Registration, Accommodation, Sponsorship
(local and logistics), Tourism and Social Events
ICS Congresos Internacionales S.A.
C. C. (P. O. Box) 73, C1084ZAA, Buenos Aires, Argentina Phone: +54 11 4812 3444
Fax: +54 11 4813 0073
E-mail: wcc2008@congresosint.com.ar
Registration
wcc2008registration@congresosint.com.ar
Accommodation
wcc2008accommodation@congresosint.com.ar
Scientific Programme
World Heart Federation
7 Rue des Battoirs, CP 155­­
1211 Geneva 4, Switzerland
Phone: + 41 22 807 0320
Fax: + 41 22 807 0337
science@worldheart.org
www.worldcardiocongress.org
Social programme
WCC 2008 Opening Ceremony
Sunday, 18 May, 2008 – 18.00 – 20.00 – Rio de la Plata,
Red Pavillion, La Rural Congress – Exhibition Centre
(Overflow in meeting rooms of the Yellow Pavillion)
Also enjoy a unique Argentine tango performance!
Opening speeches by:
Horacio Faella, Shahryar Sheikh, Sidney Smith,
Felipe Martínez, Arturo Cagide, Eduardo Mele, Luiz Guzman
and Argentine authorities
WCC 2008 Opening Reception
Sunday, 18 May, 2008 at 20.30 – Room Libertador,
Sheraton Buenos Aires Hotel, San Martin 1225/1275,
Retiro, Buenos Aires
Buses will depart from the La Rural main entrance
(Sarmiento Avenue) immediately after the
Opening Ceremony
Entrance by invitation only
Dress code: Smart casual, please wear something red
WCC 2008 Gala dinner
Tuesday, 20 May, 2008 at 20.00 – Hilton Buenos Aires,
Macacha Guemes 351, Puerto Madero, Buenos Aires
Buses will depart from the Sheraton Buenos Aires Hotel
(San Martin Avenue) as of 19.00 up to 19.30
Access to the WCC 2008 Gala Dinner requires an invitation
or a pre-purchased ticket. Your tickets can be collected from
the registration area from Sunday, 18 May, 2008 from 10.00.
Dress code: Business attire
WCC 2008 Community activities
In celebration of the World Congress of Cardiology,
there are several public events that will run in parallel
to the Congress.
These will be coordinated by the Argentine Foundation of
Cardiology and the CARDIO Foundation who are pleased
to propose the following activity programme. All of the
activities are intended for the community and you are
invited to join in.
On Saturday, May 17, 2008 between 9.00 and 18.00
mass group CPR courses are planned in the park located
on Av. Sarmiento and Av. Del Libertador, close to
“Monumento a los Españoles”.
There will be 40-minute courses running throughout the day
– allowing attendees to be trained in Basic Cardiopulmonary
Resuscitation procedures. The activity will be carried out in
a 200m2 tent and the aim is to make people aware of the
importance of knowing the proper basic Cardiopulmonary
Resuscitation procedures in case of an emergency situation.
(Registration: Argentine Foundation of Cardiology
info@fundacioncariologica.org - +54 11 4961 6520 / 9388)
On Sunday, May 18, 2008 the Argentine Foundation of
Cardiology and the Cardio Foundation are organizing a 10 km
competitive run and 3 km aerobic walk at the Bosques de
Palermo. These activities will take place from 9.00 – 13.00.
The run is expected to gather approximately 3,000
professional runners and the walk about 7,000 people.
The aim is to promote the importance of physical exercise
in order to prevent cardiovascular disease and to improve
the quality of life whilst developing healthy habits from an
early age and maintaining them throughout your life.
The general goal of these activities is to spread the
importance of preventing cardiovascular diseases to
the Argentine community, as prevention is one of the
major topics being discussed during the World Congress
of Cardiology.
On Tuesday, May 20, 2008 visit the Thematic tent at Plaza
de la República (Obelisco) from 09.00 – 18.00. There will
be arterial pressure, waistline, cholesterol and glycemia
measurements, with leaflets and brochures containing
general tips.
There will also be a press area, with armchairs and a backpanel with logos of the societies involved. The media
are invited to cover the activity so as to get a strong
understanding of the themed agenda.
Material for this activity has included donations from
laboratories: lancets and reagents for cholesterol control,
stethoscopes, tape measure and scales for determining BMI.
Media: Press releases, information and invitations for all
means of communication: press, radio and television.
Publicity, promotional material and flyers have been sent
by e-mail to both foundations’ data bases.
WCC 2008 Community Activities / 35
ABOUT ARGENTINA & BUENOS AIRES
About Argentina
Argentina has a wealth of natural beauty and immensely
varied scenery. It covers an area of over 1 million square
miles and is the second largest country in South America.
In the north there are the hot Chaco grasslands and tropical
jungle and in the south the Antarctic ice of Tierra del Fuego.
A visit to Iguazu Falls, the largest and most extensive in
the world, can be combined with a horseback ride on
the Pampas, whale watching in the south, a visit to the
amazing Moreno glacier and the capital, Buenos Aires.
VISITING BUENOS AIRES
The cultural capital of South America, Buenos Aires, is
located on the eastern banks of the River Plate, the largest
river in the world. The city has a cosmopolitan atmosphere,
although being a modern city; it includes turn-of-thetwentieth-century European style buildings. It also has
some well preserved districts of typical colonial architecture.
Buenos Aires inhabitants are called “porteños” which
makes reference to the fact that the city is a port.
Buenos Aires has everything to transform your visit
into a wonderful experience.
We strongly recommend that you make reservations
in advance with Bounty Travel, as availability for tours is
limited. Further information about Bounty Travel Tours
and reservations can be found either at www.bts.com.ar
or at the tours information desk in the registration area.
CLIMATE
The climate of Buenos Aires is mild all year round.
The mean annual temperature is 18ºC. Visitors can enjoy
walking around the city in any season. On a sunny day
in autumn, mornings are chilly; the temperature rises at
mid-day and drops again at night. The average temperature
for May is 12°C.
LANGUAGE
The official language in Argentina is Spanish and many locals
also easily understand Italian and Portuguese. However,
most people involved in tourist activities speak English.
TIME DIFFERENCE
The time zone corresponds to GMT-3.
BANKS, CURRENCY AND CREDIT CARDS
Banks open at 10.00 and close at 15.00 (some banks
extend their closing time to 16.00). Cash withdrawals and
other transactions may be made at ATMs, 24 hours a day.
The tourist subsidiary of Banco Ciudad offers this service
to visitors. You can buy and sell US dollars, Euros and
travellers’ cheques:
Tuesdays to Fridays from 10.00 – 17.00;
Saturdays and Sundays from 11.00 – 16.00;
Mondays from 10.00 – 18.00.
Cashiers are tourist exclusive.
The Argentine currency is the peso ($). There are $ 100,
$ 50, $ 20, $ 10, $ 5 and $ 2 notes, and 1 peso, 50, 25,
10 and 5 cent coins.
The U.S. dollar (USD) is the most common foreign currency.
Banks and currency exchange offices (casas de cambio),
where you must present your passport, exchange foreign
currency. Most of the shops accept credit cards and
dollars but it is more convenient to pay by cash with pesos
exchanged in casas de cambio or banks.
ELECTRICAL POWER
Electric power in Argentina is 220 volt, 50-cycle alternating
current. Power outlets have two cylindrical holes or two flat
holes with ground connection.
SECURITY
Buenos Aires has the reputation of being a safe city but,
as in any other large cities in the world, tourists should
take sensible precautions.
TOURISM POLICE DEPARTMENT
In case of an emergency please call 0800 999 5000 or
+54 11 4346 5748 or contact turista@policiafederal.gov.ar
English, Italian, French, Portuguese, Ukrainian, Japanese
and Spanish are the available languages.
ABOUT ARGENTINA & BUENOS AIRES
MAKING PHONES CALLS
Buenos Aires has many public telephone booths. Public
phones operate with 5, 10, 25, 50-cent and 1-peso coins.
Phone cards can be bought at any sweet or tobacco
stalls (quiosco). These phones allow local, national and
international calls.
For international calls, dial 00 + country code + area code
+ local number.
The country code for Argentina is 54, and the area code for
Buenos Aires is 11. For example, to call to 4333-6666 from
outside the country, you should dial +54 11 4333 6666.
USEFUL PHONE NUMBERS
••Police: 101
••Fire: 100
••Medical assistance/Emergencies: 107
••Telephone enquiries: 110
••Ezeiza International Airport and Jorge Newbery Airport:
+54 11 5480 6111
OPENING HOURS
Shops are open from Monday through Fridays from 9.00 –
20.00, and Saturdays from 9.00 –13.00; however, shops in
main locations are also open on Saturday afternoons.
In shopping centres, hours usually extend until 20.00,
including Saturdays and Sundays.
LEAVING ARGENTINA
The VAT rate in Argentina is 21%. As a foreign visitor, you
have the right to a refund of the value-added tax included in
the price of the articles you export to your country. At the
airport you may obtain a VAT reimbursement corresponding
to any purchases made within the country for an amount
over $70 (per invoice) and in shops operating with the Global
Refund system.
Please note that your airport tax which is often
included in your booking fee may not be included
because of Argentinean regulations. You may be
asked to pay this in cash at the airport as you are
passing through security.
About Argentina & Buenos Aires / 37
TOURS
HALF DAY CITY TOUR
Half day tour around South America’s most elegant capital,
Buenos Aires. On the way you will see Plaza de Mayo and
the buildings that surround it: Casa Rosada (Government
House), Cabildo Old City Hall, the bustling banking and
business district. Then on to see the monumental Congress
Building and its square and along 9 de Julio Ave., the widest
in the world, the Colon Theatre, the famous Opera House
where the most important artists and musicians from all over
the world perform. You will also visit San Telmo, la Boca, and
its picturesque street “Caminito”, Puerto Madero, Palermo
Park with Jacaranda and Palo borracho trees which flower in
spring and late summer, the polo field and the race track and
the historical Recoleta Cementery with its ornate memorials.
Price per person USD 22*
TIGRE & DELTA CRUISE
Drive through the fashionable riverside suburbs of Olivos,
San Isidro, San Fernando to the Tigre district, with its
gracious homes, weeping willows, open air restaurants and
cafes. With its assorted food vendors and soap-box politics,
this is the preferred “playground of the porteños”. Board
the ‘Tren de la Costa’ – the Coastal Train – modern train on
the old suburban railway line which runs along the coast of
the Rio de la Plata towards the delta of the river. All stations
have been renovated, keeping the original buildings built
by the British. Drive then to San Isidro where a stop will be
arranged. Cruise along the waterways and islands of the
delta and past "turn-of-the century" stone mansions, English
cottages, Italian villas, little wooden shacks painted bright
blue and green, ferries, crews practicing in outriggers, lonely
canoeists, rowing and yacht clubs. You will enjoy a cruise
along innumerable channels before returning to town.
Price per person USD 45*
CULTURAL TOUR – MUSEUMS
The cultural heritage in Buenos Aires is ever increasing. This
tour is a selection of the best art collections of the city. First
you will go to the institutional centre, the Fine Arts National
Museum. Once you have visited the new and magnificent
museum of Latin American modern and contemporary art
(MALBA, Costantini Collection), you will go to the tiny and
excellent Xul Solar Museum that holds the best works
of some of the most prestigious Argentinean artists.
Price per person USD 55*
FULL DAY FIESTA GAUCHA
This tour is the ideal opportunity to absorb the atmosphere
of country life at a really colourful Argentine feast in the
Pampas. Lunch with renowned Argentine beef and live
entertainment by “Gauchos” in their typical dress, dancing
to folklore music, will make this a memorable day.
Price per person USD 112
*The accompanying person’s programme includes the
following local tours:
– Half day City Tour
– Tigre & Delta Cruise
– Cultural Tour
Please note that the Fiesta Gaucha Tour is not included.
People not participating in the accompanying persons programme
will have to pay for all tours.
Tour schedule for Monday, Tuesday and Wednesday
TOURTime
COST PER PERSON
Half day city tour
10.30 – 14.30
USD 22
Tigre and Delta Cruise
10.30 – 15.30
USD 45
Cultural tour
10.30 – 14.30
USD 55
Fiesta Gaucha (Full Day)
09.00 – 17.00
USD 112
We strongly recommend that you make reservations in
advance as availability for tours is limited. Further information
about the Bounty Travel Tours and their reservation can be
found either at www.bts.com.ar or at the tours information
desk in the registration area.
SIZING UP THE
H E A RT-H E A LT H Y FA C T S
The case for 23 almonds a day.
W E ’ R E T H E S N A C K T H AT
LO VES HEARTS BACK
should develop.
width: 10mm
height: 20mm
It may be news to some, but we’ve known
for a long time what a huge
difference a handful of
California Almonds can
make. From being
good for your heart
to staving off hunger
to getting a nutrientrich boost, eating
23 almonds every
day (an ounce to
be exact) is a hearthealthy habit everyone
O U R G O O D FAT S
RUN DEEP
Good things happen when you get
good fats. And with 9 grams of
monounsaturated fat per
serving, we’re full
of it. In fact, nearly
70 percent of the
fat in almonds is
monounsaturated,
making us one of
the leading sources
among nuts.
NUTRIENT
RICH & EXTRA
C R U N C H Y:
A TEMPTING
C O M B I N AT I O N
WE’RE
CHOLESTEROLFIGHTING DYNAMOS
Ounce for ounce almonds are one
of the most nutrient-rich nuts around.
All nine clinical studies conducted
We’d list them all if we had more room.
to date indicate that almonds lower
But if you’re looking for a tasty snack
cholesterol. These groundbreaking
{ Fig. 1a: Prunus dulcis }
that’s
an excellent source of three dietary
weight: 1/23 oz
studies show how a handful of almonds a day
nutrients, a good source of three and has
consistently lowered LDL cholesterol levels.*
3 grams of fiber, 6 grams of protein per serving while
And because people love eating them, almonds
packing a heck of a crunch, then we’re your nut.
are an ideal way for cholesterol-conscious patients to
maintain healthy numbers. If you’ve got time, these
clinical studies make fascinating reading. In fact,
when the FDA read the research,
it influenced their first Qualified
COME VISIT
To learn more about almond
nutrition research and taste the appeal
of almonds, visit the Almond Board
of California at booth number 271.
Health Claim for nuts:
“Scientific evidence suggests but does not prove
that eating 1.5 ounces per day of most nuts, such
as almonds, as part of a diet low in saturated fat
and cholesterol may reduce the
risk of heart disease.”
AlmondsAreIn.com
*Find more information at
www.AlmondsAreIn.com/9studies
CZlIgZcYh^c8Vi]ZiZg
6WaVi^dcd[6ig^Va;^Wg^aaVi^dc
Workshop Sess�on
Objectives
Speakers
To understand today’s role of catheter ablation in
patients with atrial fibrillation
Sergio Dubner, MD Professor
Buenos Aires, Argentina
To realize the benefit of continuous remote monitoring
in these patients
Johannes Brachmann, MD Professor
Coburg, Germany
To be familiar with the design of the CASTLE-AF trial
for heart failure patients with atrial fibrillation
Location
Date
Tuesday, May 20th, 12:45 – 13:30
Room Niger
La Rural Convention Center
Av. Sarmiento 2704
Buenos Aires
Sponsorship and exhibition
Acknowledgements
Exhibition opening hours
The World Congress of Cardiology Buenos Aires 2008
organizers, the World Heart Federation, the Argentine
Society of Cardiology and the Argentine Federation of
Cardiology, would like to thank all participating organizations
for their commitment to the World Congress of Cardiology
2008. This summary overview is correct at time of going to
press (17 April, 2008).
Please come and visit the WCC Exhibition in the Blue/Green
Pavillion during the following opening hours and discover the
wealth of new devices and pharmaceutical products present:
Sunday, 18 May, 2008 Monday, 19 May, 2008 Tuesday, 20 May, 2008 Wednesday, 21 May, 2008 18.00 – 20.00
09.00 – 18.00
09.00 – 18.00
09.00 – 18.00
Sponsorship and exhibition information / 41
List of exhibitors in alphabetical order
3M
221
Abbott Laboratories
229
Aché Laboratorios Farmaceuticos S.A
210
Almond Board of California
271
Aloka Co. Ltda. (represented in Argentina by
Hittec)
American College of Cardiology
American Heart Association
ANMAT (Dirección Nacional de
Medicamentos, Alimentos y Tecnología
Médica)
Aplicaciones Médicas
CVD Prevention and Control Journal
(Elsevier)
186+188 + 215
Daichii Sankyo Brazil Farmaceutica Ltda
307
Dasani
217
Diagnóstico Maipú por Imágenes S.A.
101
270
Digimed S.A.
105
121
Distribuna Editorial y Libreria Medica
162
Driplan
103
123A+123B+
124A
138B
113
Ecuadorian Foundation of Cardiology
108A
Ecuadorian Society of Cardiology
108A
Edan Instruments, Inc.
236
Argentine Federation of Cardiology (FAC)
313A
Ediciones Journal
194A
Argentine Society of Cardiology (SAC)
315A
Editorial Médica Panamericana
142A
Editorial Mediterráneo Argentina
195B
Astra Zeneca
Baptist Health International Center of Miami
309 and 181
108B
Ekosur S.A.
200
Bayer Schering Pharma AG
302
Esaote Latinoamérica S.A.
211
Biolab Farmaceutica Ltda
254
European Society of Cardiology
119
Biosite - an Inverness Medical Company
257
Feas Electrónica
160
Biotronik
301
Fundación Favaloro
Boehringer Ingelheim GmbH
306
Fundación Rusculleda / DAMIC SRL
163
Bolivian Society of Cardiology
136B
Future events
199
Bonus Comunicaciones S.R.L
177
Galix Biomedical Instrumentation
204
Boston Scientific
212+214+252
GE Healthcare
134B
219+243+244
Brazilian Society of Cardiology
128
Gedic - Grupo de Estudio, Docencia e
Investigacion Clinica
205
C2C -The eHealth Company
102
GlaxoSmithKline
230
Granix
110
Cambridge Theranostics Ltd.
137B
Cardiology Management
164
Griensu S.A.
207
Cardiotek Bv.
255
Hittec Medical S.A.
270
Hospital Alemán
238
Instramed
161
Chinese Society of Cardiology
Colegio Argentino de Cardiologos
Intervencionistas
114B
140
Colgate
194B
InterAmerican Society of Cardiology
124B
Colombian Society of Cardiology
138A
International Federation of Pharmaceutical
Manufacturers & Associations (IFPMA)
141A
Congreso Internacional de Medicina Interna
del Hospital de Clínicas
Content Ed Net Communications
106
139A
Cortex Biophysik GmbH
206
CSL Behring S.A.
183
Iroko Cardio, LLC
ISCP (International Society on Cardiovascular
Pharmacotherapy)
ISHNE (International Society of Holter and
Noninvasive Electrocardiology)
179
107B
126
List of exhibitors in alphabetical order
IVAX Argentina
201
Paraguay Society of Cardiology
136A
Janssen-Cilag Farmaceutica
197
PCNA (Preventive Cardiovascular Nurses
Association)
107A
Japanese Circulation Society
130B
Jota Tec S.A.
Karger AG
262
141B
Laboratorio Baliarda S.A.
265
Laboratorios Bagó S.A.
316
Laboratorios Bernabó S.A.
272
Laboratorios Casasco S.A.I.C.
269
Laboratorios Elea S.A.
242
Laboratorios Gador S.A.
317
Laboratorios Lazar
237
Laboratorios Phoenix S.A.I.C.F.
203
Laboratorios Roemmers S.A.I.C.F.
318
Pfizer
148+189
Pfm Medical
159
Philips Healthcare
266+267+268
Polymer Technology Systems, Inc
263
Productos Roche S.A.
180
Prous Science
260
Quaker – a PepsiCo Group Company
145
Raffo S.A.
253
Rozinn by Scottcare
116
Sanofi-aventis
157+182
Schiller
218+220
Siemens
198
Latin American Society of Interventional
Cardiology (SOLACI)
114A
Slovenian Society of Cardiology
112B
Libreria AKADIA Editorial
143A
Solvay Pharmaceuticals GmbH
153+ 185+ 151+
187
Libyan Cardiac Society
134A
Lilis S.A.
McGraw-Hill Education
259
143B
Medispec
104
Medley S.A Ind. Farmaceutica
250
South American Society of Cardiology
Spacelabs Healthcare
130A
103
Spanish Society of Cardiology
118+115
St Jude Medical
310
Taiwan Society of Cardiology
132
Menarini International Operations
Luxembourg S.A.
216+249
Tecnoimagen-Sonosite
Merck KGaA
247+248
Unilever
150
Merck Sharp & Dohme
245+246
UpTo Date
144
Veccsa
231
Vitaphone GmbH
184
Methabolic Syndrome Institute
264
Mexican Society of Cardiology
112A
233+239
Microlife USA
232
V-Patch Medical Systems
Micromed
206
Welch Allyn, Inc.
117
Ministerio de Turismo de la Prov. de Salta
167
Wiley-Blackwell
137A
Molinos Rio de la Plata S.A.
175
Wolters Kluwer
139B
Nature Clinical Practice Cardiovascular
Medicine (Nature publishing Group)
186+188+ 215
Novartis Pharma
303
Numed (Omnimédica Argentina)
202
Omron Healthcare, Inc
222
Oxford Journals | Oxford University Press
World Heart Federation
195A
186+188+ 215
World Point
111
Youth for Smoke Free Environments
258
142B
Sponsorship and exhibition information / 43
List of exhibitors by booth number
101
Diagnóstico Maipú por Imágenes S.A.
175
Molinos Rio de la Plata S.A.
102
C2C -The eHealth Company
177
Bonus Comunicaciones S.R.L
103
Driplan
179
Iroko Cardio, LLC
103
Spacelabs Healthcare
180
Productos Roche S.A.
104
Medispec
181
Astra Zeneca
105
Digimed S.A.
182
Sanofi-aventis
106
Congreso Internacional de Medicina Interna del Hospital
de Clínicas
183
CSL Behring S.A.
110
Granix
184
Vitaphone GmbH
111
World Point
185
Solvay Pharmaceuticals GmbH
113
Aplicaciones Médicas
186
CVD Prevention and Control Journal (Elsevier)
115
Spanish Society of Cardiology
186
Nature Clinical Practice Cardiovascular Medicine
(Nature publishing Group)
116
Rozinn by Scottcare
186
World Heart Federation
117
Welch Allyn, Inc.
187
Solvay Pharmaceuticals GmbH
118
Spanish Society of Cardiology
188
CVD Prevention and Control Journal (Elsevier)
119
European Society of Cardiology
188
Nature Clinical Practice Cardiovascular Medicine
(Nature publishing Group)
121
American College of Cardiology
188
World Heart Federation
126
ISHNE (International Society of Holter and Noninvasive
Electrocardiology)
189
Pfizer
128
Brazilian Society of Cardiology
197
Janssen-Cilag Farmaceutica
132
Taiwan Society of Cardiology
198
Siemens
140
Colegio Argentino de Cardiologos Intervencionistas
199
Future Events
144
UpTo Date
200
Ekosur S.A.
145
Quaker – a PepsiCo Group Company
201
IVAX Argentina
148
Pfizer
202
Numed (Omnimédica Argentina)
150
Unilever
203
Laboratorios Phoenix S.A.I.C.F.
151
Solvay Pharmaceuticals GmbH
204
Galix Biomedical Instrumentation
153
Solvay Pharmaceuticals GmbH
205
Gedic - Grupo de Estudio, Docencia e Investigacion
Clinica
157
Sanofi-aventis
206
Cortex Biophysik GmbH
159
Pfm Medical
206
Micromed
160
Feas Electrónica
207
Griensu S.A.
161
Instramed
210
Aché Laboratorios Farmaceuticos S.A
162
Distribuna Editorial y Libreria Medica
211
Esaote Latinoamérica S.A.
163
Fundación Rusculleda / DAMIC SRL
212
Boston Scientific
164
Cardiology Management
214
Boston Scientific
167
Ministerio de Turismo de la Prov. de Salta
215
CVD Prevention and Control Journal (Elsevier)
List of exhibitors by booth number
215
Nature Clinical Practice Cardiovascular Medicine
(Nature publishing Group)
215
World Heart Federation
216
Menarini International Operations Luxembourg S.A.
217
Dasani
218
Schiller
219
GE Healthcare
220
Schiller
221
3M
222
Omron Healthcare, Inc
229
Abbott Laboratories
230
GlaxoSmithKline
231
Veccsa
232
Microlife USA
233
Tecnoimagen-Sonosite
236
Edan Instruments, Inc.
237
Laboratorios Lazar
238
Hospital Alemán
239
Tecnoimagen-Sonosite
242
Laboratorios Elea S.A.
243
GE Healthcare
244
GE Healthcare
245
Merck Sharp & Dohme
246
Merck Sharp & Dohme
247
Merck KGaA
248
260
Prous Science
262
Jota Tec S.A.
263
Polymer Technology Systems, Inc
264
Methabolic Syndrome Institute
265
Laboratorio Baliarda S.A.
266
Philips Healthcare
267
Philips Healthcare
268
Philips Healthcare
269
Laboratorios Casasco S.A.I.C.
270
Aloka Co. Ltda. (represented in Argentina by Hittec)
270
Hittec Medical S.A.
271
Almond Board of California
272
Laboratorios Bernabó S.A.
301
Biotronik
302
Bayer Schering Pharma AG
303
Novartis Pharma
306
Boehringer Ingelheim GmbH
307
Daichii Sankyo Brazil Farmaceutica Ltda
309
Astra Zeneca
310
St Jude Medical
316
Laboratorios Bagó S.A.
317
Laboratorios Gador S.A.
318
Laboratorios Roemmers S.A.I.C.F.
107A
PCNA (Preventive Cardiovascular Nurses Association)
Merck KGaA
107B
ISCP (International Society on Cardiovascular
Pharmacotherapy)
249
Menarini International Operations Luxembourg S.A.
108A
Ecuadorian Foundation of Cardiology
250
Medley S.A Ind. Farmaceutica
108A
Ecuadorian Society of Cardiology
252
Boston Scientific
108B
Baptist Health International Center of Miami
253
Raffo S.A.
112A
Mexican Society of Cardiology
254
Biolab Farmaceutica Ltda
112B
Slovenian Society of Cardiology
255
Cardiotek Bv.
114A
Latin American Society of Interventional Cardiology
(SOLACI)
257
Biosite - an Inverness Medical Company
114B
Chinese Society of Cardiology
258
Youth for Smoke Free Environments
123A
American Heart Association
259
Lilis S.A.
123B
American Heart Association
Sponsorship and exhibition information / 45
List of exhibitors by booth number
124A
American Heart Association
124B
InterAmerican Society of Cardiology
130A
South American Society of Cardiology
130B
Japanese Circulation Society
134A
Libyan Cardiac Society
134B
Fundación Favaloro
136A
Paraguay Society of Cardiology
136B
Bolivian Society of Cardiology
137A
Wiley-Blackwell
137B
Cambridge Theranostics Ltd.
138A
Colombian Society of Cardiology
138B
ANMAT (Dirección Nacional de Medicamentos,
Alimentos y Tecnología Médica)
139A
Content Ed Net Communications
139B
Wolters Kluwer
141A
International Federation of Pharmaceutical
Manufacturers & Associations (IFPMA)
141B
Karger AG
142A
Editorial Médica Panamericana
142B
Oxford Journals | Oxford University Press
143A
Libreria AKADIA Editorial
143B
McGraw-Hill Education
313A
Argentine Federation of Cardiology
315A
Argentine Society of Cardiology
Exhibition floor plan
MAIN ENTRANCE FROM
PUBLIC TRANSPORT AND SHUTTLE BUS
A
B
104
103
102
CLOAK
ROOMS
101
HOSPITALITY
SUITES
C
106
D
107
A
107
B
108
A
108
B
112
A
112
B
114
A
114
B
115
105
REGISTRATION
110 167
229
LOST
AND
FOUND
230
111 165
113 163
@
231
164 175
164 177
B B
162 177
160
117
232
225
236
238
237
180
222
MAIN ENTRANCE FROM THE PARKING
263
233 239
179
159
118
228
161 116
264
242
266
265
221
267
268
269
270
271
272
119
157
182
181
220
219
243
244
245
121
155
184
183
218
217
248
247
246
123
A
123
B
124
A
124
B
153
185
151
187
186
216
249
214
252
250 262
188
@
303
302
301
306
307
309
310
253
215
212
150
126
128
130
A
130
B
132
134
A
134
B
136
A
136
B
138
A
138
B
140
148
145
189
192
210
211
207
206
215
257
197
255
260
258
259
315
A
313
A
316
141
137
A
A
139
B
137
B 139
A
141 144
B
142 143
A A
142 143
B B
194 195
A A
194 195
B B
205 204
MEETING POINT
317
ENTRANCE FROM SESSIONS, WORKSHOPS
AND SYMPOSIA ROOMS
POSTER AREA
POSTER HELP DESK
318
203 202 201
200
198
FUTURE
EVENTS
BUSINESS CENTER
Exhibition floorplan / 47
Exhibitors’ and sponsors’ editorial listing
3M
Olga Cossettini 1031
Buenos Aires C1107CEA
ARGENTINA
www.3m.com
Booth 221
Abbott Laboratories
200 Abbott Park Road
Abbott Park, IL 60064
UNITED STATES
Abbott is a global, broad-based healthcare company devoted
to the discovery, development, manufacture and marketing
of pharmaceuticals and medical products.
www.abbott.com
Booth 229
Aché Laboratorios Farmaceuticos S.A
BRAZIL
www.ache.com.br
Booth 210
Almond Board of California
1150 9th Street
Suite 1500
Modesto, CA 95354
UNITED STATES
www.almondsarein.com
The Almond Board of California, a Federal Marketing
Order under the United States Department of Agriculture,
promotes the best quality almonds.
Booth 271
Aloka Co. Ltda. (represented in Argentina by Hittec)
JAPAN
www.aloka.com
See Hittec
Booth 270
American College of Cardiology
2400 N Street NW
Washington DC, VA
UNITED STATES
www.acc.org
ACC will launch Cardiosource en Espanol, an
online cardiovascular information resource, and offer
information about ACC membership opportunities and
educational products.
Booth 121
American Heart Association
7272 Greenville Avenue
Dallas, TX 75231-4596
UNITED STATES
www.heart.org
The American Heart Association offers the latest information
on cardiovascular and stroke research. Pick up free
CD-ROMs: Core Collection 2008 & Scientific Sessions
Abstracts. Receive information on Emergency Cardiovascular
Care, Professional Membership, Scientific Publications,
Get With the Guidelines, Patient Education and more.
Booth 123A+123B+124A
ANMAT (Dirección Nacional de Medicamentos,
Alimentos y Tecnología Médica)
ARGENTINA
www.anmat.gov.ar
Booth 138B
Aplicaciones Médicas
Cnel Rosetti 2264
Olivos
Buenos Aires
ARGENTINA
www.aplimed.com.ar
Booth 113
Argentine Federation of Cardiology (FAC)
Bulnes 1004
C1176ABT
Buenos Aires
ARGENTINA
www.fac.org.ar
Booth 313 A
Argentine Society of Cardiology (SAC)
Azcuenaga 980 (C1115AAD)
Buenos Aires
ARGENTINA
www.sac.org.ar
Booth 315 A
Astra Zeneca
R&D MöIndal
SE 43183 MöIndal
SWEDEN
www.astrazeneca.com
Tel: +46 31 7761000 - Fax: +46 31 7763806
Web sites: www.incirculation.net www.astrazeneca.com
AstraZeneca is one of the world’s leading research-based
pharmaceutical companies. Our mission is to develop
innovative and effective new medicines that fulfil unmet
medical needs in important areas of healthcare.
Booth 309 and 181
Exhibitors’ and sponsors’ editorial listing
Baptist Health International Center of Miami
Miami, FL
UNITED STATES
Booth 108B
Bayer Schering Pharma AG
BU Primary Care
S101,9,120
Muellerstrasse 179
13353 Berlin
GERMANY
www.bayerhealthcare.com
Booth 302
Biolab Farmaceutica Ltda
Av Do cafe, 277
7 Andar
Torre B (04311-900)
Sao Paolo
BRAZIL
www.biolabfarma.com
Booth 254
Biosite - an Inverness Medical Company
21 Rue Albert Calmette
78350 Jouy en Josas
FRANCE
www.biosite.com
Inverness Medical is a world leader in diagnostic products
to assist laboratory and healthcare professionals in both
preventative and interventional medicine, providing
qualitative and quantitative results. Our focus is in the broad
clinical fields of Women’s Health, Blood Born Pathogens,
Oncology, Drugs of Abuse, Respiratory-Infectious Disease
and Cardiology. Visit us Booth 257 to discover our product
portfolio.
Booth 257
Biotronik
Woermannkehre 1
12359 Berlin
GERMANY
www.biotronik.com
BIOTRONIK® is a leading European company in the
field of biomedical technology. We focus on devices for
electrotherapy of the heart and for vascular intervention.
Our products help physicians to save lives and to improve
their patients’ quality of life. For further information, please
visit our booth 301 in the main exhibition hall.
Booth 301
Boehringer Ingelheim GmbH
Binger Strasse 173
55216 Ingelheim am Rhein
GERMANY
www.boehringeringelheim.com
Booth 306
Bolivian Society of Cardiology
Avenida Saavedra 1983
edificio Italia (Mezaninne)
Barrio Miraflores
La Paz
BOLIVIA
www.bago.com.bo
Booth 136B
Bonus Comunicaciones S.R.L
Fonrouge 1561
c1440CYO
Buenos Aires
ARGENTINA
Booth 177
Boston Scientific
One Boston Scientific Place
Natick, MA 1760
UNITED STATES
www.bsci.com
Taxus™ Liberté™, the only one that has CE mark for use
in Diabetic Patients. The proven one.
Booth 212+214+252
Brazilian Society of Cardiology
Booth 128
C2C -The eHealth Company
Republica dominicana 3, bajos local 1
07014 Palma de Mallorca
SPAIN
www.c2ctsis.com
Company specialized in developing Healthcare IT integration
solutions, focused mainly on imaging integration solutions.
Booth 102
Cambridge Theranostics Ltd.
7 Hills Avenue
Cambridge CB1 7UY
UNITED KINGDOM
CTL has developed AterononR/T, the first clinically proven
neutraceutical product able to inhibit the process responsible
for atherosclerotic plaque growth.
Booth 137B
Exhibitors’ and sponsors’ editorial listing / 49
Exhibitors’ and sponsors’ editorial listing
Cardiology Management
28 Rue de la Loi
1040 Brussels
BELGIUM
www.cardiologymanagement.eu
Booth 164
Cardiotek Bv.
Amerikalaan 70 (6199AE)
Maastricht Airport
Maastricht
THE NETHERLANDS
www.cardiotek.com
Amplifier /Stimulator for Electrophysiologic Procedures
Booth 255
Chinese Society of Cardiology
www.heart.org.cn
Booth 114B
Colegio Argentino de Cardiologos Intervencionistas
Booth 140
Colgate
300 Park Avenue
PK 12
New York, NY 10022
UNITED STATES
Colgate Total
Booth 194B
Cortex Biophysik GmbH
Nonnenstrabe 39
04229 Leipzig
GERMANY
www.cortex-medical.com
See Micromed
Booth 206
CSL Behring S.A.
Fray Justo Sarmiento 2350
Olivos (B1036AKJ)
Buenos Aires
ARGENTINA
www.cslbehring.com
Booth 183
CVD Prevention and Control Journal (Elsevier)
Radarweg 29
Amsterdam NX 1043
THE NETHERLANDS
www.elsevier.com
Elsevier publishes leading international medical journals,
including Prevention and Control, the official journal of
the World Heart Federation. Visit us and collect your free
sample copy.
Booth 186+188+215
Colombian Society of Cardiology
www.scc.org.co
Booth 138A
Daichii Sankyo Brazil Farmaceutica LTDA
Almeda Xingu, 766
Barueri
Sao Paul
BRAZIL
www.daiichisankyo.com
Booth 307
Congreso Internacional de Medicina Interna del Hospital
de Clínicas
Booth 106
Dasani
www.dasani.com
Booth 217
Content Ed Net Communications
Maetro Lasalle 36
28016 Madrid
SPAIN
Content Ed Net is a Global Medical Publishing Specialist with
10 offices in Argentina, Brazil, France, Italy, Japan, Mexico,
New Zealand, Spain & UK.
Booth 139 A
Diagnóstico Maipú por Imágenes S.A.
Av Maipu 1668 (1602)
Buenos Aires
ARGENTINA
Booth 101
Digimed S.A
Giribone 1002 (C1427CAN)
Buenos Aires
ARGENTINA
www.digimed.com
Booth 105
Exhibitors’ and sponsors’ editorial listing
Distribuna Editorial y Libreria Medica
Booth 162
Eli Lilly
www.lilly.com
Driplan
Catalina de Boyle 3340 (calle 28)
Gral. San Martin (B1650IMD)
Buenos Aires
ARGENTINA
www.driplan.com
Booth 103
Esaote Latinoamérica S.A.
Buenos Aires
ARGENTINA
Booth 211
Ecuadorian Foundation of Cardiology
Booth 108A
Ecuadorian Society of Cardiology
www.sec-np.org
Booth 108A
Edan Instruments, Inc.
3/F-B Nanshan Medical Equipments Park,Nanhai Rd.1019#
Shekou, Nanshan Shenzhen
Guangdong Province 518067
CHINA
www.edaninstruments.com
Edan Instruments, Inc. is one of the leading medical
equipments manufacturers in China.
Booth 236
Ediciones Journal
Junin 873 - Piso 4
Depto H
Buenos Aires
ARGENTINA
www.journal.com.ar
Publisher and distributor of medical books in both Spanish
and English language. Great exhibition and sale of books in
the field of cardiology of main US and European publishers:
Elsevier, Lippincott Williams & Wilkins and Springer Verlag.
Booth 194A
Editorial Médica Panamericana
Booth 142A
Editorial Mediterráneo Argentina
Paraguay 2028 4 Piso ofc. 21
Buenos Aires
ARGENTINA
Booth 195B
Ekosur S.A.
Buenos Aires
ARGENTINA
Booth 200
European Society of Cardiology
2035 Route des Colles
Les Templiers
BP 179
06903 Sophia Antipolis
FRANCE
www.escardio.org
Booth 119
Feas Electrónica
Colon 5760
(X5003DFP)
Cordoba
ARGENTINA
Booth 160
Fundación Favaloro
Booth 134B
Fundación Rusculleda / DAMIC SRL
Asistencia, docencia e investigación en Medicina.
Independencia 387. Cordoba Argentina
Booth 163
Future Events
Learn what's happening world wide in the field of cardiology
and heart disease.
Booth 199
Galix Biomedical Instrumentation
Rocamora 4029
Buenos Aires
ARGENTINA
www.galix-gbi.com
Cardiac External Pacemaker, Computerized ECG and
Stress Test Systems, ECG Holter Recorders and Analyzers.
Simulators for Polygraph and Electrophysiology.
Booth 204
GE Healthcare
Bouchard 710
3 piso
Buenos Aires
ARGENTINA
Booth 219+243+244
Exhibitors’ and sponsors’ editorial listing / 51
Exhibitors’ and sponsors’ editorial listing
GlaxoSmithKline
980 Great West Road
Brentford, Middlesex, TW8 9GS
UNITED KINGDOM
www.gsk.com
GlaxoSmithKline – one of the world’s leading research-based
pharmaceutical and healthcare companies, committed to
improve the quality of human life.ww.gsk.com
Booth 230
International Federation of Pharmaceutical
Manufacturers & Associations (IFPMA)
Ch Louis-Dunant 15
PO Box 195
1211 Geneva 20
SWITZERLAND
www.ifpma.org
IFPMA is the global non-profit NGO representing the
research-based pharmaceutical, biotech and vaccine sectors.
Its members comprise 26 leading international companies
and 46 national and regional industry associations covering
developed and developing countries. The IFPMA Clinical
Trials Portal (www.ifpma.org/clinicaltrials), the IFPMA’s
Ethical Promotion and its Health Partnerships information
help make the industry’s activities more transparent.
Booth 141 A
Granix
Buenos Aires
ARGENTINA
Booth 110
Iroko Cardio, LLC
Philadelphia
UNITED STATES
Booth 179
Griensu S.A.
Av.Julio A.Roca 636, Pisos 10O.
Buenos Aires
ARGENTINA
www.griensu.com
Booth 207
ISCP (International Society on Cardiovascular
Pharmacotherapy)
A. Bayés de Luna
ICCC - Hospital Sant Pau
Avda. Sant Antoni Mª Claret, 167
08025 Barcelona
SPAIN
www.iscpcardio.org
Booth 107B
Gedic - Grupo de Estudio, Docencia e Investigacion
Clinica
Av Rivadavia 2358 PB4
Buenos Aires
ARGENTINA
Booth 205
Hittec Medical S.A.
Mexico 3100
C1223ABL
Buenos Aires
ARGENTINA
Booth 270
Hospital Alemán
Buenos Aires
ARGENTINA
Booth 238
Instramed
Av. Protásio Alves, 3371
Porto Alegre 90410-003
BRAZIL
www.instramed.com.br
Booth 161
InterAmerican Society of Cardiology
Juan Badiano No. 1, Edificio Galas, P. B
Mexico D.F.
MEXICO
www.soinca.org
Booth 124B
ISHNE (International Society of Holter and Noninvasive
Electrocardiology)
Monroe County
Rochester, NY
UNITED STATES
www.ishne.org
Booth 126
IVAX Argentina
JJ Castelli 6701
Munro prov
Buenos Aires
ARGENTINA
www.ivax.com
Cardiovascular line of pharmaceutical products,
antihypertensives, lipid regulators, platelet
aggregation inhibitors.
Booth 201
Exhibitors’ and sponsors’ editorial listing
Janssen-Cilag Farmaceutica
1900 Charleston Road
M10-3111
Mountain View, CA 94043
UNITED STATES
NATRECOR® (nesiritide): A recombinant version of human
B-type natriuretic peptide, for I.V. treatment of acute
congestive heart failure.
Booth 197
Japanese Circulation Society
8th Floor, CUBE OIKE Bldg.
599 Bano-cho Karasuma Aneyakoji
Nakagyo-ku
Kyoto 604-8172
JAPAN
www.j-circ.or.jp
Booth 130B
Jota Tec S.A.
Maipu 231 3p of 40
Buenos Aires 1084
ARGENTINA
www.jotatec.com
We are leaders producing ABPM, Holter, ECG and
ergometry equipment. We are certified under ISO 13485,
CE mark and ANVISA.
Booth 262
Karger AG
Allschwilerstrasse 10
4009 Basel
SWITZERLAND
www.karger.com
We are pleased to present the latest publications in
Cardiology at the Karger booth including the book
‘Cardiovascular Diabetology’. Pick up a sample copy
of the journal CARDIOLOGY.
Booth 141B
Laboratorio Baliarda S.A.
Alberti 1283
Buenos Aires
ARGENTINA
Booth 265
Laboratorios Bagó S.A.
Bernardo de Irigoyen 248
Buenos Aires
ARGENTINA
www.bago.com.ar
Booth 316
Laboratorios Bernabó S.A.
Terrada 2346
Buenos Aires
ARGENTINA
www.laboratoriosbernabo.com
Booth 272
Laboratorios Casasco S.A.I.C.
Av. Carabobo 22
Buenos Aires
ARGENTINA
www.casasco.com.ar
Booth 269
Laboratorios Elea S.A.
Sanabria 2353 - C1417AZE
Buenos Aires
ARGENTINA
www.laboratorioelea.com.ar
Booth 242
Laboratorios Gador S.A.
Darwin 429
Buenos Aires
ARGENTINA
www.gador.com.ar
Booth 317
Laboratorios Lazar
Av. Vélez Sársfield 5855 - B1606ARI
Buenos Aires
ARGENTINA
www.lazar.com.ar
Since 1934 manufactoring top quality pharmaceutical
products under strict CMP standards.
LAZAR, a trustful symbol in the Medical Field.
Booth 237
Laboratorios Phoenix S.A.I.C.F.
Humahuaca 4065
Buenos Aires
ARGENTINA
www.phoenix.com.ar
Booth 203
Laboratorios Roemmers S.A.I.C.F.
Fray Justo Sarmiento 2350
Buenos Aires
ARGENTINA
www.roemmers.com.ar
Booth 318
Exhibitors’ and sponsors’ editorial listing / 53
Exhibitors’ and sponsors’ editorial listing
Latin American Society of Interventional Cardiology
(SOLACI)
Adolfo Alsina 2653 piso 2 departamento H
Buenos Aires
ARGENTINA
www.solaci.org
Booth 114A
Medley S.A Ind. Farmaceutica
Rua Macedo Costa 55
13080-180 Campinas
Sao Paulo
BRAZIL
www.medley.com.br
Booth 250
Libreria AKADIA Editorial
Paraguay 2078
Buenos Aires
ARGENTINA
www.editorialakadia.com.ar
Software and medical books in Spanish
Booth 143A
Menarini International Operations Luxembourg S.A.
Via Sette Santi 1
50131 Firenze
ITALY
www.menarini.com
Booth 216+249
Libyan Cardiac Society
Tajura Cardiac Center
P.O.Box: 82251
Tripoli
LIBYA
www.lcs.org.ly
Booth 134A
Lilis S.A.
Pasteur 798
Buenos Aires
ARGENTINA
www.lilis.com.ar
Littmann - Stethocopes - Medical supplies - ECG Electrocardiographs - Patient monitoring - Diagnostic
imaging - Blood pressure monitors - Oximeters - Head lights
- Binocular loupes heine - Accessories
Booth 259
McGraw-Hill Education
148 Princeton-Hightstown Road, N-1
Hightstown, NJ 08520
UNITED STATES
www.mheducation.com
Booth 143B
Medispec
2041 Observation Drive
Suite # 102
Germantown, MD 20876
UNITED STATES
www.medispec.com
Booth 104
Merck KGaA
Frankfurter Strasse 250
64293 Darmstadt
GERMANY
www.merck.de
Booth 247+248
Merck Sharp & Dohme
One Merck Drive, WS2C-36A
Whitehouse Station, NJ 08889
UNITED STATES
www.msd.com
Merck Sharp & Dohme is a global reseach-driven
pharmaceutical company dedicated to putting patients
first. Established in 1891, MSD discovers, develops,
manufactures and markets vaccines and medicines to
address unmet medical needs. The company also devotes
extensive efforts to increase access to medicines through
far-reaching programs that not only donate MSD medicines
but help deliver them to the people who need them.
MSD also publishes unbiased health information as a
not-for-profit service.
Booth 245+246
Methabolic Syndrome Institute
Booth 264
Mexican Society of Cardiology
Juan Badiano #1
Col. Sección XVI, Tlalpan C.P. 14080
C.P. 14080
Mexico D.F.
MEXICO
www.smcardiologia.org.mx
Booth 112A
Exhibitors’ and sponsors’ editorial listing
Microlife US
424 Skinner Boulevard
Suite B
Dunedin, FL 34698
UNITED STATES
www.microlifeusa.com
Booth 232
Micromed
Rua 3 Lotes 15/17 - Polo de Modas
Guara II
Brasilia DF 71070503
BRAZIL
Booth 206
Ministerio de Turismo de la Prov.de Salta
Booth 167
Molinos Rio de la Plata S.A
Booth 175
Nature Clinical Practice Cariovascular Medicine (Nature
publishing Group)
The Macmillan Building
4 Crinan Street
London N19XW
UNITED KINGDOM
www.nature.com
Booth 186+188+215
Novartis Pharma
5200 Blue Lagoon Drive
Suite 690
Miami, FL 33126
UNITED STATES
www.novartis.com
The Pharmaceuticals Division of Novartis is recognized
worldwide for the innovative medicines provided to patients,
physicians and healthcare organizations. Our current product
portfolio includes more than 45 key marketed products,
many of which are leaders in their respective therapeutic
areas. The product development pipeline involves nearly
140 projects – including potential new products as well
as potential new indications or formulations for existing
products in various stages of clinical development.
Booth 303
Numed (Omnimédica Argentina)
Buenos Aires
ARGENTINA
Booth 202
Omron Healthcare, Inc
1200 Lakeside Drive
Bannockburn, IL 60015 1243
UNITED STATES
www.omronhealthcare.com
Booth 222
Oxford Journals | Oxford University Press
Great Clarendon Street
Oxford OX2 6DP
UNITED KINGDOM
www.oup.co.uk
Booth 142B
Paraguay Society of Cardiology
www.spc.org.py
Booth 136A
PCNA (Preventive Cardiovascular Nurses Association)
613 Williamson Street
Suite 205
Madison, WI 53703
UNITED STATES
www.pcna.net
PCNA is the leading nursing organization dedicated to
preventing cardiovascular disease through assessing risk,
facilitating lifestyle changes, and guiding individuals to
achieve treatment goals.
Booth 107A
Pfizer
235 East 42nd Street
New York, NY 10017
UNITED STATES
www.pfizer.com
Booth 148+189
Pfm Medical
2605 Temple Heights Drive
Suite A
Oceanside, CA 92056
UNITED STATES
www.pfm-ag.com
Pfm Ag, Cologne, Germany and it affiliates world wide
provide innovative products to the medical community.
The Nit-Occlud® spiral coil system is designed for
transcatheter occlusion of Patent Ductus Arteriosus (PDA)
of all shapes. Safety and reliability of this system are the
result of a continuous further improvement of the proven
Duct-Occlud® system.
Booth 159
Exhibitors’ and sponsors’ editorial listing / 55
Exhibitors’ and sponsors’ editorial listing
Philips Healthcare
Vedia 3892
Buenos Aires
ARGENTINA
www.medical.philips.com
Royal Philips Electronics of the Netherlands is a global leader
in healthcare, lighting and consumer lifestyle, delivering
people-centric, innovative products, services and solutions
through the brand promise of “sense and simplicity”.
With sales of EUR 2007, the company is a market leader in
medical diagnostic imaging and patient monitoring systems,
energy efficient lighting solutions, as well as lifestyle
solutions for personal wellbeing.
Booth 266+267+268
Polymer Technology Systems, Inc
7736 Zionsville Road
Indianapolis, IN 46268
UNITED STATES
www.cardiochek.com
Booth 263
Productos Roche S.A.
Productos Roche S.A.Q.e I., Rawson 3150
B1610BAL Ricard Rojas, Tigre
Buenos Aires
ARGENTINA
Booth 180
Prous Science
Provenza 388
08025 Barcelona
SPAIN
www.prous.com
Prous Science, a Thomson Scientific business, provides
information and communication services on drug R&D,
pharmacology, medicine and medicinal chemistry.
Booth 260
Quaker – a PepsiCo Group Company
R&D Quaker Lar
Poneiente 116 No 659
Col. Industrial Vallejo
Mexico D.F 02300
MEXICO
www.pepsico.com
Booth 145
Raffo S.A.
Av. Cabildo 86
Buenos Aires
ARGENTINA
www.raffo.com.ar
Leaders in the treament of dsylipemias and cholesterol
lowering drugs.
Booth 253
Rozinn by Scottcare
4791 West 150th Street
Cleveland, OH 44135
UNITED STATES
www.scottcare.com
Rozinn by Scottcare offers holter, pacemaker follow-up,
cardiac evnt, ambulatory BP and Telerehab monitoring
systems, plus external counterpulsation (ECP)beds.
Booth 116
Sanofi-aventis
174, avenue de France
75013 Paris
FRANCE
www.sanofi-aventis.com
Sanofi-aventis is one of the leading pharmaceutical company
in the world, ranking number one in Europe. Backed by a
world-class R&D organization, sanofi-aventis is developing
leading positions in seven major therapeutic areas:
cardiovascular, thrombosis, oncology, metabolic diseases,
central nervous system, internal medicine and vaccines.
The Group is inspired by a powerful vision:
- to find new compounds to prevent, combat and eradicate
diseases around the world,
- to provide therapeutic and preventive solutions geared to
populations in both industrialized and developing countries,
- to support innovative medicines and vaccines, mature
products, OTC medicines and generics.
Every day, everywhere sanofi-aventis is working for what
really matters: Patients HEALTH.
Booth 157+182
Schiller
Altgasse 68
6341 Baar
SWITZERLAND
www.schiller.ch
SCHILLER specailizes in cardio-therapy equipment, focusing
on resting & exercise ecg, spirometry, patient monitoring
and cardiac defibrillation.
Booth 218+220
Exhibitors’ and sponsors’ editorial listing
Servier
192 Avenue Charles de Gaulle
92578 Neuilly-sur-Seine Cedex
FRANCE
www.servier.com
Siemens
Wittelsbacherplatz 2
80333 Munich
GERMANY
www.siemens.com
Booth 198
Slovenian Society of Cardiology
Slovenska hiša srca
Ulica stare pravde 6
1000 Ljubljana
SLOVENIA
www.sicardio.org
Booth 112B
Solvay Pharmaceuticals GmbH
Global Product Strategy Department
PO Box 220
30002 Hannover
GERMANY
Solvay Pharmaceuticals Cardiometabolic portfolio includes:
Lipanthyl®/Tricor® indicated for the treatment of lipid
disorders, Teveten® controlling high blood pressure
and Omacor® for the adjuvant treatment in secondary
prevention after myocardial infarction.
Booth 153+ 185+ 151+ 187
South American Society of Cardiology
Booth 130A
Spacelabs Healthcare
5150 220th AVE SE
Issaquah, WA
UNITED STATES
Booth 103
Spanish Society of Cardiology
Booth 118+115
St Jude Medical
One Lillehei Plaza
St. Paul, MN 55117
UNITED STATES
www.sjm.com
Booth 310
Taiwan Scociety of Cardiology
7, Chung-Shan S. Road
National Taiwan University Hospital
Taipei 100
TAIWAN, ROC
www.tsoc.org.tw
Booth 132
Tecnoimagen-Sonosite
Buenos Aires
ARGENTINA
Booth 233+239
Unilever
Olivier van Noortlaan 120
P.O.Box 114
Vlaardingen 3130 AC
THE NETHERLANDS
www.unilever.com
Unilever is the global food industry leader in heart health
nutrition via its products and education services.
Booth 150
UpTo Date
Boerhaavelaan 24
Zoetermeer 2713 HX
THE NETHERLANDS
www.uptodate.com
Booth 144
Veccsa
Juramento 5841
Buenos Aires C1431CLA
ARGENTINA
Booth 231
Vifor International Inc.
P.O.Box, Rechenstrasse 37
9001 St. Gallen
SWITZERLAND
Vitaphone GmbH
Markirchener Strasse 22
68229 Mannheim
GERMANY
With advanced telemedicine monitoring and care systems,
Vitaphone not only provides comprehensive patient care
solutions to care suppliers but also to healthcare insurers.
Booth 184
Exhibitors’ and sponsors’ editorial listing / 57
Exhibitors’ and sponsors’ editorial listing
V-Patch Medical Systems
Chemin Long 259
1310 La Hulpe
BELGIUM
Wireless, waterproof, body worn EVENT/HOLTER device
& patch, program to continuously monitor critical events,
data automatically sent to WWW.
Booth 195A
Welch Allyn, Inc.
4341 State Street Rd.
PO Box 220
Skaneateles Falls, NY 13153- 0220
UNITED STATES
www.welchallyn.com
Booth 117
Wiley-Blackwell
350 Main Street
Malden, MA 02148
UNITED STATES
www.wiley.com
Booth 137A
Wolters Kluwer
Philadelphia, PA 60090
UNITED STATES
www.wolterskluwer.com
Booth 139B
Unrestricted educational grants
In addition to the welcome participation and support from all
exhibitors and sponsors listed elsewhere in this programme,
the WCC 2008 would like to thank the following companies
for their contribution to WCC 2008 with an unrestricted
educational grant.
•• Otsuka Pharmaceuticals
•• St. Jude Medical
A special thanks also to the following societies for their support of
the WCC 2008:
Lawyers Bustamante, Cavallero, Bolo, Tomeo y Asociados
25 de Mayo 267 5º 512 (C 1002 ABE) - Buenos Aires - Argentina
Tel./Fax: +54 11 4343 4861 - bcbt@bcbt.com.ar - www.bcbt.com.ar
Counter Santiago Sáenz Valiente SSV
Paraná 754 Piso 8 Capital (Entre Córdoba y Viamonte) . 4816-6996
World Heart Federation
7 Rue des Battoirs
Case postale 155
1211 Geneva 4
SWITZERLAND
The World Heart Federation is committed to helping the
global population achieve a longer and better life through
prevention and control of heart disease and stroke, with
a particular focus on low and middle-income countries.
www.worldheart.org
Booth 186+188+215
World Point
1326 S. Wolf Rd.
Wheeling, IL 60090
UNITED STATES
www.worldpoint-ecc.com
Booth 111
Youth for Smoke Free Environments
A display on youth-led activities promoting smoke-free
environments, supported by networks linked to the World
Heart Federation and its members.
Booth 258
Session:
Rheumatic Fever/Rheumatic Heart Disease
Tuesday, 20 May, 2008 – 16.00-17.30 - Pilcomayo
Demonstration:
World Heart Federation booth
Wednesday, 21 May, 2008 – 10.00-10.30
Scientific Programme
Formats
Over 250 sessions will be presented in the following formats:
Symposia (SYMP) include a maximum of five presentations
on the latest developments in fields such as basic science,
clinical cardiology and epidemiology.
Debates (DEB) provide a discussion on controversial issues
with two statements that will be debated, each with a pro
and contra presentation followed by a discussion at the end
of each statement.
Clinical Seminars (CS) will highlight various specific
subspecialty topics. The sessions do not target exclusively
specialists but also a general audience.
The South American Congress of Cardiology (SACC)
will be held in conjunction with the World Congress of
Cardiology and presented in a series of eleven sessions in
Spanish. (Session rooms: Amazon, Tigris).
Special Featured Joint Sessions (SP) are held by
cardiology societies and organizations.
How-to & Workshop Sessions (HTS) will give the
opportunity to interact between a limited audience and
experts in various fields of clinical cardiology.
Continuing Medical Education (CME)
The World Congress of Cardiology is
accredited by the European Board for
Accreditation in Cardiology (EBAC) for
18 hours of External CME credits.
Each participant should claim only
those hours of credit that have actually
been spent in the educational activity.
One credit may be claimed for each hour of participation in
WCC scientific sessions.
EBAC works according to the quality standards of the
European Accreditation Council for Continuing Medical
Education (EACCME), which is an institution of the European
Union of Medical Specialists (UEMS).
In compliance with the EBAC guidelines, all speakers
and chair persons who are participating in this scientific
programme have disclosed or indicated potential conflicts of
interest which might case a bias in the presentations.
The Organizers are responsible for ensuring that all potential
conflicts of interest relevant to the congress are declared to
the audience prior to the CME activities.
The American Medical Association (AMA) has an
agreement of mutual recognition of continuing medical
education (CME) credit with the European Union of Medical
Specialties (UEMS). Under the terms of this agreement,
the AMA will convert CME credit certified by the European
Accreditation Council for Continuing Medical Education
(EACCME), the accrediting arm of the UEMS, to AMA PRA
Category 1 Credit™.
How do I receive credits?
Credits can be received after the congress via our online
system. Please make sure to keep a record of the session
titles / numbers and save your registration confirmation
number and/or access code. After completing the EBAC
evaluation you will be taken to the website to input your
information for EBAC CME credits. The site is accessible via
a direct link you will be provided within due course.
ATTENTION: It will take approximately 6-8 weeks to process
your enquiry and before you receive confirmation of your
accreditation. Please note that no certificates will be given
on-site.
Technical information for sessions
Speakers preview CENTRE
The speakers preview centre is located in the Green Pavilion
behind the Seine and the Niger rooms.
opening hours:
Saturday, 17 May, 2008: 15.00 – 18.00
Sunday, 18 May, 2008: 09.00 – 19.00
Monday, 19 May, 2008
07.00 – 19.00
Tuesday, 20 May, 2008: 07.00 – 19.00
Wednesday, 21 May, 2008: 07.00 – 16.00
IMPORTANT NOTE: CHECK-IN TO THE SPEAKERS PREVIEW CENTRE IS
MANDATORY FOR ALL PRESENTERS!
Plan to check-in the day before or no later than 4 hours
before your presentation time. Presenters who do not checkin sufficiently in advance of their presentation may give the
scheduled talk, but may not have visuals. Speakers who
have submitted their presentations in advance via the online
website are advised to visit the speakers preview room for a
final check. PowerPoint presentations
All presentations are downloaded on to a single server
before the session and sent through a network to the correct
session room.
Only MS-PowerPoint (2003 and XP) presentations with
video formats should be used for this conference. However,
technical assistance will be provided in case you are using a
MAC computer.
You will have NO possibility to upload/change your presentation(s)
to/on the computer in the session room. Therefore you must go
to the speakers preview room before your presentation starts.
Technicians will be available in case you may need assistance.
Time limit
All speakers are requested to adhere strictly to the time limit
indicated in the programme. The indicated lecture times include
time for discussions. Overrunning by even a few minutes may
impact on the smooth running of the following sessions, so
please respect your colleagues and the time slots. All session
rooms will be equipped with video projection. Overhead
projection and standard 35mm slide projection is not available.
Posters & abstracts
The Scientific Programme Committee (SPC) gratefully
acknowledges the submission of over 2000 abstracts from
all over the world. All abstracts have been graded and
reviewed by the Scientific Programme Committee.
All accepted abstracts have been published in the online
version of the official American Heart Association Journal
“Circulation” For more information, please visit
www.circ.ahajournals.org.
In addition to that, all delegates may collect their personal
abstract CD Rom from the Boehringer Ingelheim booth in
the exhibition hall. To collect your free copy, please go to
their booth with your voucher which you will find in your
congress bag.
The WCC would like to thank Boehringer Ingelheim for their
financial support towards the production and distribution of
the abstract CD Rom.
Abstracts will be presented in the following formats:
•• Poster
•• Oral abstract presentation
Farbe/colour:
PANTONE 288 CV
Poster presentations
•• Dimensions: 1.8 meters (max) to 1.5 meters (min) high by
0.9 meters wide (70.80 inches by 35.40 inches).
••The title, authors’ detail(s) and affiliation(s) should be
printed at the top of the poster. The chosen font should not
be smaller than 5 cm (1.95 inches).
•• Even at a distance of 1 meter from the poster board, the
poster should be easily readable.
••Posters must be placed on the boards (provided by the
organizers) with double sided tape (not provided by the
organizers).
••Regarding the content structure of the poster, the sections
outlined below should be observed:
– Introduction
– Materials and Methods
– Results
– Conclusion(s)
– Wherever possible, results can be illustrated with
picture(s) and chart(s)
••Posters must be put up and dismantled according to the
time slots given by the organizers.
••Should you not dismantle your poster at the appropriate
time the staff will take the liberty to remove it. The
Congress Organizers will accept no liability for your
material and poster.
Authors will be present at their posters during the coffee
breaks either from 10:00-10:30 or 15:30-16:00.
Scientific Programme / 61
Posters & abstracts
A poster help-desk is located within the poster area. Please
do not hesitate to contact one of the staff members at the
poster help desk for any further assistance.
••Pharmacology
••Basic Science
••Cardiac Imaging/Computers
Poster topics
Posters will be presented in the following scientific topics:
••Acute Cardiac Care
••Arrhythmias
••Nursing/Technician/Miscellaneous
••Heart Failure/Left Ventricular Function
••Public Policy / Advocacy initiatives
••Valvular Disease/Pulmonary Circulation/Myocardialpericardial
••Ischemia/Coronary Artery Disease
••Interventions/Peripheral Circulation/Stroke
••Paediatric/Congenital Heart Disease
Oral abstract presentations
Oral abstract sessions have a dedicated time slot from 8.30
to 10.00 in the morning. All details for oral abstract session
can be found in the detailed scientific programme.
••Hypertension
••Exercise/Epidemiology/Prevention
Special featured joint sessions
The World Congress of Cardiology 2008 organizers; the
World Heart Federation, the Argentine Society of Cardiology
and the Argentine Federation of Cardiology, would like to
thank the following societies and organizations that have
committed to the World Congress of Cardiology 2008.
••Interamerican Society of Cardiology (IASC)
••American College of Cardiology (ACC)
••Metabolic Syndrome Institute (MSI)
••American Heart Association (AHA)
••Mexican Society of Cardiology (SMC)
••American Society of Echocardiography (ASE) and
International Society for Cardiovascular Ultrasound (ISCU)
••Pan African Society of Cardiology (PASCAR)
••American Society of Nuclear Cardiology (ASNC)
••Argentine Ministry of Health
••Asian-Pacific Society of Cardiology (APSC)
••International Society of Hypertension (ISH)
••Latin American Society of Interventional Cardiology
(SOLACI) and Society for Cardiovascular Angiography and
Interventions (SCAI)
••Preventive Cardiovascular Nurses Association (PCNA)
••World Heart Failure Society (WHFS)
••International Society of Cardiovascular & Pharmacotherapy
(ISCP)
••Brazilian Society of Cardiology (SBC)
••Heart Rhythm Society (HRS) and International Society for
Holter and Noninvasive Electrocardiology (ISHNE)
For further information about these Special Featured Joint
Sessions, kindly refer to the detailed scientific programme
which follows.
South American Congress of Cardiology
The South American Congress of Cardiology will be held
in conjunction with the World Congress of Cardiology and
presented in Spanish in a series of eleven sessions
(Session rooms: Amazon, Tigris).
••Tratamiento actual de la enfermedad coronaria crónica
••Opening Ceremony-XXIII Congreso Sudamericano
de Cardiología
••Avances en la insuficiencia cardiaca aguda descompensada
••Factores de riesgo y aterosclerosis subclínica
••Toma de decisiones en valvulopatías
••Fibrilación auricular. Lo viejo y lo nuevo.
••Nuevas fronteras en la hipertensión arterial
••Desafíos actuales de la cardiología sudamericana
••Cómo optimizar el tratamiento de la insuficiencia
cardiaca crónica
••Manejo del paciente con síndrome coronario agudo
For further detailed information about the Spanish
sessions, please refer to the detailed scientific programme
which follows.
••Conferencias :
- De los ensayos clínicos a la práctica asistencial
- Avances en el manejo de la enfermedad aórtica
Webcasts
Certain official WCC 2008 Scientific Sessions will
be webcasted by Prous Science. These sessions
will be accessible on the WCC Congress website
www.worldcardiocongress.org after the congress.
Industry satellite symposia and workshop activities
Industry Satellite Symposia and Workshop activities as well as
Non-commercial symposia have dedicated time slots:
••before the congress opens in the afternoons
(Pre-Congress activities)
••in the middle of the day during the congress (Inter-Sessions)
••at the end of the afternoon (Evening Sessions)
••Non-commercial Symposia tailor-made for institutions
such as hospitals, universities and not-for-profit
organizations.
For further information about these Industry satellite symposia
and workshop activities, kindly refer to the detailed scientific
programme which follows.
These sessions include:
••Symposia specifically designed for any company active in
the field of cardiology as an opportunity to showcase the
latest developments and scientific information.
••Workshops
designed for medical device companies,
biotechnology companies and the distribution sector
related to cardiovascular medicine.
Scientific Programme / 63
Acknowledgements
The scientific programme has been prepared in close
collaboration with the Scientific Programme Committee
(SPC), local advisers and topic group leaders.
The WCC 2008 organizers would like to thank everybody
for their commitment and contribution to the WCC 2008
Scientific Programme.
Basic science
Luis Alday (Argentina)
Valentin Fuster (United States)
Cardiac imaging/Computers
Moníca Acevedo (Chile)
Néstor Pérez Baliño (Argentina)
Topic group leaders:
Arrhythmias
Günter Breithardt (Germany)
Alvaro Sosa Liprandi (Argentina)
Heart failure/Left ventricular function
Hugo Grancelli (Argentina)
Akira Matsumori (Japan)
Valvular disease/Pulmonary circulation/Myocardialpericardial
Edgardo Escobar (Chile)
Ricardo Ronderos (Argentina)
Ischemia/Coronary artery disease
Juan Krauss (Argentina)
Dev Pahlajani (India)
Interventions/Peripheral circulation/Stroke
Liliana Grinfeld (Argentina)
William Wijns (Belgium)
Hypertension
Luis Maria Amuchástegui (Argentina)
Ayrton Brandão (Brazil)
Churchill Onen (Botswana)
Exercise/Epidemiology/Prevention
Nizal Sarrafzadegan (Iran)
Néstor Vita (Argentina)
Pharmacology
Jorge Lerman (Argentina)
Andrew Tonkin (Australia)
Acute cardiac care
Juan Carlos Linares-Casas (Argentina)
Marco Martínez-Ríos (Mexico)
Paediatric/Congenital heart disease
Horacio Faella (Argentina)
Trevor Hassell (Barbados)
Nursing/Technician
Sania Nishtar (Pakistan)
Juan Plastino (Argentina)
Local advisers (Argentina)
Carla Agatiello
Carlos Barrero
Horacio Capelli
Sergio Dubner
Irene Ennis
Guillermo Fábregues
Mariano Falconi
Paola Kuschnir
Emilio Kuschnir
Pedro Lylyk
Osvaldo Masoli
Eduardo Mele
José Moltedo
Oscar Oseroff
Diego Pérez de Arenaza
Daniel Piñeiro
María Laura Plastino
Fernán Quiroz
José Luis Ramos
Rodolfo Rothlin
Scientific programme at a glance
Room
8.30-10.00
Rio de la Plata
Vulnerable plaque
and registries
HTS
Interpretation of the difficult
ECG: Practical approach Thames
Coronary and non-coronary
endovascular treatment I
CS
Novel concepts in
hypertension treatment Danube
Acute and chronic
Heart Failure
SYMP
Cardiac resynchronisation
therapy (CRT) - Part One
Amazon
South American
Congress of Cardiology
Opening Ceremony XXIII Congreso
Sudamericano de Cardiología
Rhine
Arrhythmias I
Missouri
SP
ACC: Regional challenges to
the prevention and treatment
of CVD in the U.S.
Research in Heart Failure
DEB
Treatment of Chagas disease
Huang He
3D Echocardiography
CS
Common challenges in the
everyday practice of nuclear
cardiology Nile
Lipids, obesity and
metabolic syndrome
SYMP
Cardiac rehabilitation
programmes Pilcomayo
Diet, drugs and
cardiovascular disease
CS
Pharmacotherapy in heart
failure: New drugs or new
benefits? Mississippi
Green
Volga
Clinical and experimental
atherosclerosis
General Cardiology I
Pediatric cardiology: From
neonates to grown-ups
Scientific sessions
Desafíos actuales de la
cardiología sudamericana
Tiber
Ochre
10.30-12.00
SACC
Oral abstract sessions
Yellow
Pavillion
Red
Monday, 19 May 2008
DEB
SP
SACC
CS
SP
CS
SYMP
SYMP
Advances in genetics SYMP
Severe pulmonary
insufficiency after
congenital heart surgery
SYMP
DEB
CS
Advances in cardiopulmonary
resuscitation Niger
Hypertrophy and dysfunction
of cardiac cells
CS
Acute coronary syndrome in
the elderly Ganges
Stroke and carotid artery
stenting
CS
Unresolved issues on coronary
interventions Seine
Myocardial infarction
SYMP
Yang Tze
Cardiovascular risk factors
in different populations
SYMP
Paraná
Diabetes and
cardiovascular risk
Euphrates
Innovations in surgical
and percutaneous valvular
treatments
Orinoco
Research in hypertension
SYMP
Mekong
Coronary and non-coronary
interventions
SYMP
SP
Drugs vs. electrical devices SCAI-SOLACI:
What we know and what we
don’t know about DES
The polypill SP
WHFS: The failing heart
around the world Cardiac resynchronisation therapy
(CRT) - Part Two
Cómo optimizar el tratamiento
de la insuficiencia cardiaca
SACC
crónica
Manejo del paciente con
síndrome coronario agudo
Non-invasive risk stratification
SYMP
for sudden cardiac death Management of arrhythmias in
genetically based diseases APSC: Global burden of heart
failure
SYMP
Heart failure with normal ejection
fraction All a cardiologist needs to know
Delayed enhancement imaging for
SYMP
about cardiac MSCT & MRI evaluation of cardiomyopathies Use of 3D echo in clinical
day-to-day practice Optimum treatment
for heart failure HTS
New trends in the management
HTS of cardiovascular risk: The role of SYMP
heart rate
Cellular regenerative therapy
in cardiology Interventional cardiology in
congenital heart disease SYMP
Fetal cardiology Cardiopulmonary resuscitation SYMP Resuscitation science and survival ISCU: Update in 3D
echocardiography
SP
Endovascular heart valve
CS interventions: The end of valvular
open-heart surgery? - Part One Acute decompensated heart
SYMP
failure Advanced heart failure
Atrial fibrillation: Nonpharmacologic treatment MSI: The Metabolic
Syndrome: Growing
prevalence in Latin America
and treatment needs
SYMP
Are comorbidities a limit
Primary and secondary prevention
SYMP to cardiovascular prevention in SYMP in atherosclerosis: From theory
the elderly? to daily practice SP
Experience with ST and
non ST elevation infarction
16.00-17.30
SYMP Electrical therapy in heart failure SYMP
PASCAR - Health Transitions
and CVD in Africa: Implications
for the 21st Century
Tigris
Arrhythmias
14.00-15.30
CS
All you need to know about
carotid stenting CS
Surgical treatment for
congestive heart failure SYMP
Health promotion for children
DEB
The polypill is an effective
strategy for reduction of
cardiovascular diseases SYMP
Cardiovascular risk and human
immunodeficiency virus (HIV)
infection in Africa CS
Anemia and heart failure SYMP
Management of asymptomatic
valve disease
Treatment of hypertension in
SYMP
special situations Update of treatment of
hypertension SP
Current treatment of
myocardial infarction: From SYMP
evidence to clinical practice Antithrombotic treatment
in non-ST-acute coronary
syndrome SYMP
ISH: Hot topics in hypertension:
An update
Revascularization of patients with
stable coronary artery disease Pharmacology
Heart failure / Left ventricular function
Basic science
SYMP
Symposium
Valvular disease / Pulmonary circulation / Myocardial-pericardial
Cardiac imaging / Computers
DEB
Debate
Ischemia/ Coronary artery disease
Acute cardiac care
HTS
How-to and Workshop session
Interventions / Peripheral circulation / Stroke
Paediatric / Congenital heart disease
Hypertension
Nursing / Technician
SP
Exercise / Epidemiology / Prevention
Public policy / Advocacy initiatives
SACC
CS
Clinical seminar
Special featured joint session
South American Congress of Cardiology
Scientific Programme / 65
Scientific programme at a glance
Tuesday, 20 May 2008
Red
Pavillion
Room
8.30-10.00
10.30-12.00
Rio de la Plata
Atrial flutter and fibrilation
DEB
Controversial issues regarding
management and treatment
of systolic heart failure
DEB
Thames
Experiences with high risk
patients I
SP
IASC: Heart failure with
preserved systolic function
SYMP
Danube
Chronic heart failure
CS
ECG, atrial fibrilation
and ablation
CS
Missouri
Cardiac transplantation
Huang He
Conferencias
Tratamiento actual de la
SACC enfermedad coronaria crónica SACC
AHA: Critical issues and new
strategies to manage patients SYMP
SP with cardiovascular disease
Echo stress II
SYMP
Nuclear cardiology 2008
Nile
Exercise, lifestyle and
ischemic heart disease
SYMP
Women and coronary heart
disease
Pilcomayo
Primary and secondary
prevention II
SYMP
The class effect dilemma are all drugs within a class
created equal?
Volga
Echo stress I
Fetal cardiology
SYMP
SP
Percutaneous pulmonary valve
SYMP
replacement
Tigris
Acute myocardial infarction
SYMP
Acute heart failure in the
emergency department
SYMP
Niger
Research on pharmacology
SYMP
Acute coronary syndrome in
diabetes
SYMP
Ganges
Drug eluting stent:
Early and late outcomes
CS
Percutaneous heart valve
interventions:The end of valvular CS
open heart surgery? - Part two
Seine
Acute coronary events
CS
BMS and DES restenosis: How
do we treat them in 2008?
Yang Tze
Primary and secondary
prevention I
SP
Paraná
Long QT syndrome,
heart failure and diabetes
SYMP
Euphrates
Mitral valve disease and
pulmonary hypertension
Orinoco
Drugs, diabetes and
hypertension
Mekong
Markers in acute syndromes
Arrhythmias
Risk stratification in genetic
Health from a gender perspective:
SYMP
disorders: ICD or not?
Implications for CVD
SYMP
SP
SYMP
Factores de riesgo y
aterosclerosis subclínica
Adequate management of
chronic heart failure
Endothelial dysfunction
SYMP detection with cold pressor SYMP
test and myocardial perfusion
The global nutrition challenge
SP
Coronary bypass surgery:
Contemporary issues
DEB
What is new in heart failure?
Novel treatments for
lipids disorders
PCNA: The role of the nurse
in preventive cardiology:
An area of leadership
SP
SYMP
Mississippi
Green
Promoting smoke-free
environments
SYMP Go Red for Women: Going global
CS
Tiber
Ochre
Guiding and optimizing
treatment of heart failure
Management of patients
with syncope
Scientific sessions
Rhine
16.00-17.30
Late results in cardiovascular
Mitral valve repair: What is
SYMP
interventions
the best option?
SACC
Oral abstract sessions
Yellow
Amazon
South American
Congress of Cardiology
14.00-15.30
Cardiovascular drug therapy
in women
Viability imaging
Stress and depression: New risk
factors for coronary heart disease
Rheumatic Fever/Rheumatic
Heart Disease
SP
Inflammation and
Cardiovascular Disease:
Multi-marker approach
Políticas de Salud
Congenital heart disease
in countries with limited
resources
SYMP
Prevention of cardiac disease
in childhood
Acute coronary syndrome
from pre-hospital to the
emergency room
SYMP
Reperfusion in the elderly:
Evidence vs. real life
An international look at care for
patients with acute coronary
syndrome
Acute coronary events during
SYMP
non-cardiac surgery
Complex patients and
complex decisions - Part one
CS
How to deal with PCI
complications?
Lower limb interventions:
Stand up and walk
SYMP
Stroke above the carotids
ASNC: The big trials on
nuclear cardiology
CS
Understanding hypertrophic
cardiomyopathy
Why are we not better in
preventing cardiovascular
diseases?
SYMP
Diabetes prevention
SYMP Update on mitral regurgitation SYMP
Current topics in infective
endocarditis
CS
Exercise in valvular heart disease
SYMP
Hypertension and target
organ damage
What are the strategies in
the management of mild
hypertension?
SYMP
Management of patients with
hypertension and comorbidities
CS
Interventional treatment of
acute myocardial infarction
CS
HRS & ISHNE:
Sudden cardiac death
Cardiovascular disease
prevention in children
SP
DEB
SYMP
Non-invasive imaging for
What should be the antithrombotic
SYMP the diagnosis of myocardial SYMP
therapy in acute coronary
ischemia: Which method?
syndrome?
Pharmacology
Heart failure / Left ventricular function
Basic science
SYMP
Symposium
Valvular disease / Pulmonary circulation / Myocardial-pericardial
Cardiac imaging / Computers
DEB
Debate
Ischemia/ Coronary artery disease
Acute cardiac care
HTS
How-to and Workshop session
Interventions / Peripheral circulation / Stroke
Paediatric / Congenital heart disease
Hypertension
Nursing / Technician
SP
Exercise / Epidemiology / Prevention
Public policy / Advocacy initiatives
SACC
CS
Clinical seminar
Special featured joint session
South American Congress of Cardiology
Scientific programme at a glance
ROOM
8.30-10.00
Rio de la Plata
Prognosis, myocardial
infarction and stents
Thames
Experiences with high
risk patients II
SYMP
Danube
Experimental and clinical
interventions with
cardiovascular cells
SYMP
Amazon
South American
Congress of Cardiology
Prevention of cardiovascular
disease
SACC
Rhine
ICD and pacemakers
SYMP
Missouri
Kidney and heart failure
Huang He
16.00-17.30
SYMP
Post-graduate cardiology
training and recertification
Advanced concepts in
critical care nursing
SYMP
Relevant nursing topics
Cardiology in middle- and
low-income countries
SYMP
To ablate or not to ablate?
Controversial issues
Update in ablation of
ventricular arrhythmias
CS
Sudden death
SYMP
Sudden death in heart failure
SYMP
The cardiorenal syndrome
in heart failure
CS
Prognostic factors for heart failure
in the betablocker era: Who must
be listed for heart transplant?
MRI and CT scan
SYMP
How to use CT multislice
and magnetic resonance
in clinical practice?
SYMP
Tissue doppler imaging:
Present and future
SYMP
Echo doppler in r
esynchronisation era
Nile
Hypertension and subclinical
atherosclerosis
SYMP
Global risk factors for the
development of coronary artery
disease and stroke
How to reach and
HTS maintain LDL below 70 in very SYMP
high risk patients
Nutrition, diet and C
VD prevention
Pilcomayo
Interventions and cardiac
ultrasound
SYMP
Cardiovascular safety of
non-cardiovascular drugs
Medical informatics:
Applications in cardiology
ISCP: Update on current
cardiovascular research in USA
and Europe
Volga
Exercise and autonomic
nervous system
Coronary and non coronary
endovascular treatment II
Tigris
Acute coronary syndromes
and PTCA
Niger
TC Scan, arrhytmias and
orthostatic hypotension
Ganges
Inside the artery,
inside the plaque
Seine
Women and
coronary disease
Yang Tze
Social and emotional factors
in heart disease
Paraná
Scientific sessions
SYMP
Cell therapy
Toma de decisiones en
valvulopatías
SYMP Nursing in cardiovascular disease
Atrial fibrillation: From
pathogenesis to practice
Mississippi
GREEN
14.00-15.30
Fibrilación auricular.
Lo viejo y lo nuevo.
Tiber
OCHRE
10.30-12.00
SACC
Oral abstract sessions
YELLOW
PAVILLION
RED
Wednesday, 21 May 2008
SYMP
SP
MSC: Interventional cardiology
in adults with congenital
heart disease
HTS
BSC: Coronary artery
disease 2008
SP
SYMP
Novel cellular mechanisms in
cardiac hypertrophy and ischemia
CS
Contemporary factors
in cardiology
SYMP
Prevention of cardiovascular
disease in asymptomatic patients
SYMP
Adult congenital heart
disease: Hot issues
SYMP
Management of
obesity today
CS
The cardiovascular hazards
of air pollution
SYMP
The chest pain centre:
Evolving concept
SP
DEB
SACC
Avances en la insuficiencia
cardiaca aguda
descompensada
Cardiovascular disease in diabetes:
Controversies and opportunities
CS
Women and
cardiovascular disease
CS
The high-risk asymptomatic
patient with coronary
artery disease
PCI in chronic CHD has no proven
long-term safety and benefit
CS
New Strategies for PCI
CS
Complex patients and complex
decisions - Part two
Metabolic syndrome in youth: Is it
SYMP the beginning of the cardiovascular SYMP
disease continuum?
Haemodynamics,
heart and hypertension
SYMP
Endothelial function and
dysfunction: Assessment,
therapy and outcome
SYMP
Stress echocardiography in
difficult patients
Advances in nursing topics
HTS
How to assess ventricular
dysynchrony for RCT?
CS
Euphrates
Cardiomyopathies
SYMP
Orinoco
Hypertension and other risk
factors
DEB
Mekong
Antiplatelets in PTCA
CS
Arrhythmias
Nuevas fronteras en la
hipertensión arterial
SACC
Management of acute pulmonary
embolism and pulmonary
SYMP
hypertension
Echodoppler as the main tool
in assessing left ventricular SYMP
function
Growing practice of nonpharmacological treatment in
congestive heart failure
Myocarditis and dilated
cardiomyopathies: How are
they related?
CS
Chagas disease
Management of pre-hypertension
SYMP Management of hypertension SYMP
and metabolic syndrome
Management of acute myocardial
SYMP
infarction in the 21st century
Scaling-up secondary
prevention
Hot topics in hypertension
Hyperglycemia, inflammation
and coronary artery disease:
New relationships?
CS
Pharmacology
Heart failure / Left ventricular function
Basic science
SYMP
Symposium
Valvular disease / Pulmonary circulation / Myocardial-pericardial
Cardiac imaging / Computers
DEB
Debate
Ischemia/ Coronary artery disease
Acute cardiac care
HTS
How-to and Workshop session
Interventions / Peripheral circulation / Stroke
Paediatric / Congenital heart disease
Hypertension
Nursing / Technician
SP
Exercise / Epidemiology / Prevention
Public policy / Advocacy initiatives
SACC
CS
Clinical seminar
Special featured joint session
South American Congress of Cardiology
Scientific Programme / 67
Scientific programme by day and by time
Sunday, 18 May 2008
R io de la P lat a - R e d P avillion - 1 8 .0 0 - 20. 00
Overflow in meeting rooms of the Yellow Pavillion
Op e n i n g Ce re mony
W o r l d C o ngre s s of C ardi o lo g y 2008
We l c o m e A d dr es s
by Argentinean Authorities
Ope n i n g A d dr e s s
Horacio Faella (ARGENTINA)
President of the World Congress of Cardiology 2008
Shahryar Sheikh (PAKISTAN)
President of the World Heart Federation
Sidney Smith (UNITED STATES), Felipe Martínez (ARGENTINA), Arturo Cagide (ARGENTINA)
Co-Chairmen of Scientific Programme Committee of the World Congress of Cardiology 2008
Eduardo Mele (ARGENTINA)
President of the Argentine Society of Cardiology
Luíz Guzman (ARGENTINA)
President of the Argentine Federation of Cardiology
Hugo Grancelli (ARGENTINA)
President of the XXIII Congress of the South American Society of Cardiology
The Opening Address is followed by
T h e I g n a c i o Cháve z L e c tur e
Fuster Valentin (UNITED STATES)
Simultaneous translation Spanish-English / English-Spanish provided in Rio de la Plata – Thames – Danube
Monday, 19 May 2008
Se ine - Gr e e n P avillion - 0 8 :3 0 - 10: 00
Oral abstract session
M yo card i a l In f arc t i o n
Chairs: Eduardo Morales Briceño (VENEZUELA), Carlos Boissonet (ARGENTINA)
08:30Are clinical characteristics, therapeutic interventions and in hospital outcome different in women with
non ST-segment elevation acute coronary syndromes?
H. Pomés Iparraguirre, P. Santander, G. Calderón, W. Santander, G. Andersen, O. Paredes, L. Ferrer, R. Aguero,
G. Guthman, J. C. Olmos
08:43
Early and late cardiogenic shock during acute myocardial infarction
A. Charask, V. Mauro, L. Rodriguez, J. Zimmermann, M. Ferrer, E. Fairman, Y. Castillo Costa, H. Gomez Santamaria,
J. Leguizamon, C. Barrero
08:56Role of embolic protection devices in acute myocardial infarction. Is their routine use of clinical benefit
at 6 months?
M. Masotti, H. Salazar, X. Freixa, N. Bellera, R. Kiamco, C. Fernández, M. Jiménez, S. Argiró, A. Betriu
09:09Late Recovery of Myocardial Blush 24 Hours After a Primary PCI Predicts Long Term Left Ventricular Function
(LVF) Improvement.
M.A. Riccitelli, J. Szarfer, P. Arce, A. García Escudero, G. Gigena, F. Blanco, R. Neme, R. Sarmiento, M. Gaito, L. Vidal
09:22Genetic Variability Of Platelet Glycoprotein Ia Regulates The Release Of Soluble CD40-Ligand And P Selectin
During Acute ST-Elevated Myocardial Infarction
C. Antoniades, D. Tousoulis, C. Vasiliadou, K. Marinou, N. Koumallos, E. Stefanadi, A. Antonopoulos, C. Tentolouris,
K. Bakoyiannis, C. Stefanadis
09:35
ST-T Elevation Myocardial Infarction Called By The Emergency Department: How Often Is It True?
T. Vagaonescu, A. Hussain, A. Mehra, J. Plate, G. Batsides, A. Wilson, A. Moreyra
09:48Are women at risk for poor outcomes after percutaneous coronary intervention for acute myocardial infarction?
M. Masotti, X. Freixa, N. Bellera, M. Jiménez, R. Kiamco, S. Argiró, C. Fernández, A. Betriu.
Scientific Programme / 69
Monday, 19 May 2008
R io de la P lat a - R e d P avillion - 0 8 :3 0- 10: 00
Oral abstract session
Vu l n e r a bl e p l a q u e a n d r egis tr i e s
Chairs: Conci Eduardo (ARGENTINA), Romero Carlos (URUGUAY)
08:30 Managing ACS patients in 2004 and 2007: does practice makes perfection?
C. Lourenço, R. Teixeira, S. Monteiro, N. António, S. Costa, F. Goncalves, P. Monteiro, L. Gonçalves, M. Freitas,
L. Providência
08:43Vulnerable Plaque: Presence and characteristics in patients who died because of an acute stroke
or cerebral trauma
M. J. Vera Janavel, C. Vigliano, E. Gurfinkel
08:56
Multicentric inflammation in coronary arteries in ischemic acute syndromes
R. A. Sarmiento, C. Parisi, F. Blanco, R. Blanco, L. Romeo, S. Fandiño, E. Bit Chacock, M. Riccitelli, L. Vidal
09:09
High Molecular Weight Adiponectin Is a Good Predictor for the Coronary Artery Soft Plaque
R. Nakazato, M. Moroi, T. Furuhashi, H. Fukuda, K. Sugi
09:22Importance of the magnitude of cardiac troponin T and natriuretic peptide release for long-term riskstratification in decompensated heart failure. A report from the CIAST-HF (Collaborative Italo
- Argentinean Study On Troponin-T In Heart Failure) Studies
E. Perna, N. Aspromonte, J. P. Cimbaro Canella, G. Di Tano, S. M. Macin, L. Milani, M. L. Coronel, M. Milli,
J. Parra Moreno, R. Valle
09:35Computed discharge report (Epi-Cardio) as a tool for a prospective multicenter registry of in-hospital
cardiology activity. A GEDIC-ARIAM collaboration
M. De Abreu, Horacio Pomes Iparraguirre, J. Benitez, S. Salzberg, A. Reina, I. Slimobich, P. Gitelman, J. Gagliardi,
H. Doval, C. Tajer
09:48Clinical profiles and outcomes of Acute Aortic Dissection from 2000 to 2006, “Instituto Nacional del Corazón”
ESSALUD, Lima – Peru.
Gálvez Caballero, David Germán, Rosales Vidal, Maritza, Franco Escobar, David Lenin, Rodriguez Villegas,
Jorge Morales Azcona, Rosa Maria, Zelaya Castro, Pio Daniel, Chacon Diaz, Manuel
Monday, 19 May 2008
Me kong - Ochre P avillion - 0 8 :3 0- 10: 00
Oral abstract session
Cor o n ary a n d n o n c o r o n a r y i n t erventions
Chairs: Raúl Bretal (ARGENTINA), Roxana Mehran (UNITED STATES )
08:30Which is the best strategy to treat patients with concomitant hypertrophic obstructive cardiomyopathy
and coronary artery disease?
SILVIA Judith Fortunato De Cano, MANUEL Nicolas Cano, ADRIANA C. Moreira, JAIRO Alves Pinheiro Jr.,
RICARDO Pavanello, VERA Marcia Lopes Gimenes, AMANDA Moraes R. Sousa, JOSE Eduardo Mr Sousa,
ADIB Domingos Jatene
08:43
The microvascular rheology of ultrasound contrast in ischemia-reperfusion injury, diabetes and sepsis
A. Camarozano, F. Cyrino, E. Bouskela, A. Siqueira-Filho, K. Camarozano, R. Noe
08:56Multiple Coronary-Left Ventricle Communications: angiographic and clinical characteristics in 20 patients
A. Dini, G. Tamashiro, C. Rando, M. Villegas, J. Diaz, J. Gomez, A. E. Ballestrini, A. Tamashiro
09:09A retrospective analysis of Contrast Induced Nephropathy (CIN) in 501 consecutive patients undergoing
coronary angiograms done in a secondary centre
I. Ternouth, C. Tibbatts, J. Sleigh
09:22StentBoost-A Novel Angiographic Technique to Evaluate Stent Expansion: Validation with Caliper Measurement
M. Albertal, A. Candiello, F. Cura, L. T. Padilla, P. Perez Balino, S. Jozami, J. A. Belardi
09:35Extent and Patterns of Neointimal Hyperplasia Distribution after Drug-Eluting Stent Implantation in Diabetic
Patients assessed by Intravascular Ultrasound
L. O. Jensen, M. Maeng, P. Thayssen, E. H. Christiansen, K. N. Hansen, A. Galloe, H. Kelbaek, J. F. Lassen,
L. Thuesen
09:48Evaluation of Collateral Circulation by Fractional Flow Reserve in Patients with Previous Myocardial
Infarction: Relation to Chest Pain and ECG Changes
B. Beleslin, M. Ostojic, S. Stojkovic, V. Vukcevic, G. Stankovic, D. Orlic, M. Nedeljkovic, A. Arandjelovic, J. Kostic,
M. Dikic
Scientific Programme / 71
Monday, 19 May 2008
Tigris - Ye llow P avillion - 0 8 :3 0- 10: 00
Oral abstract session
Exp e r i e n c e w it h ST and n o n ST ele vat ion infarc t ion
Chairs: Mònica Masotti (SPAIN), Juan Gagliardi (ARGENTINA)
08:30Significant decline in the age adjusted mortality rate from acute ST elevation myocardial infarction (STEMI)
in the United States
M. R. Movahed, M. Hashemzadeh, M. M. Jamal
08:43Impact of Combination Evidence-Based Medical Therapy Used at Admission on In-Hospital Mortality in
Patients With Non-ST-Elevation Myocardial Infarction
Z. Monhart, V. Faltus, H. Grunfeldova, P. Jansky
08:56HDL-Cholesterol Improves Prediction of In-hospital Events in Individuals with Unstable Angina or
Non-ST-Elevation Acute Myocardial Infarction
L. C. L. Correia, M. S. Rocha, J. P. Esteves
09:09Correlation between serum markers of inflammation, myocardial injury and thrombosis with coronary
angiographic findings in patients with non-ST elevation acute coronary syndromes.
Cyntia Karla Magalhães, Jose Geraldo Castro Amino, Aristarco Gonçalves Siqueira, Bernardo Rangel Tura,
Vitor Manuel Pereira Azevedo, Marco Aurelio Santos, Rogerio Brant Martins Chaves, Regina Maria Aquino Xavier
09:22
Nationwide trends in the incidence of non ST elevation myocardial infarction (NSTEMI) in the United States
M. R. Movahed, M. Hashemzadeh, M. M. Jamal
09:35Heart-kidney connection: Renal fibrosis and activation of renal molecular remodeling after myocardial
infarction in the absence of heart failure
F. L. Martin, A. Cataliotti, B. K. Huntley, G. E. Harders, H. H. Chen, J. C. Burnett
09:48Bisoprolol and standard therapy combination in patients with ischemic cardiomyopathy on long-term outcome
K. G. Adamyan, A. V. Astvatsatryan, A. L. Chilingaryan
R hine - Ye llow P avillion - 0 8 :3 0- 10: 00
Oral abstract session
Arr h y t m i a s I
Chairs: Ivan Mendoza (VENEZUELA), Alberto Giniger (ARGENTINA)
08:30Reperfusion arrhythmias: Are they only a marker of epicardial reperfusion or continuing myocardial ischemia
after acute myocardial infarction?
G. Heper, M. E. Korkmaz
08:43
Cardiac palpitations in menopausal women due to non-sustained right atrial tachycardia (NSRAT)
E. Sclarovsky
08:56
The left-middle (septal) fascicular block
P. Sanches, P. Moffa, A. Riera
09:09
Clinical use of microvolt T wave alternans test in risk stratification of dilated cardiomyopathy
G. Molon, A. Costa, T. De Santo, G. Ligorio, E. Barbieri
09:22NT-Pro-BNP decreases rapidly following cardioversion in patients with persistent atrial fibrillation and
preserved ventricular function.
C. Higa, J. Gambarte, G. Ciambrone, S. Donato, A. Escobar, P. D. Comignani, F. Novo, A. Macchia
09:35
Therapeutic limitations conducts in octogenarians in Intensive Care Unit
J. Silva, M. Fervenza, T. Asmann, R. Azevedo, R. Della Pasqua, L. Peixoto, A. Tors, E. Marques, J. Freitas, A. Macedo
09:48
Intravenous digoxin for the cardioversion of recent-onset atrial fibrillation: meta-analysis of randomized studies
H. H. Veloso, A. V. De Paola
Monday, 19 May 2008
Euphrat e s - Ochre P avillion - 0 8 :3 0 - 10: 00
Oral abstract session
Inno v a t i o n s i n s u r g i c a l a n d p ercutaneous valvula r tr eatments
Chairs: Agatiello Carla (ARGENTINA), Borracci Raúl (ARGENTINA)
08:30
Repair of anomalous left coronary artery from pulmonary artery. Early survival, outcomes and follow up.
M. Pilan 08:43
First UK experience of percutaneous aortic valve replacement
H. Jilaihawi, T. Spyt, E. Logtens, J. C. Laborde, D. Chin, J. Kovac
08:56
Percutaneous aortic valve replacement for severe aortic stenosis by core valve bioprosthesis
G. Schuler, A. Linke, S. Möbius-Winkler, F. Mohr, T. Walther, J. Fassl
09:09Minimally invasive mitral valve surgery without aortic cross-clamping: An excellent solution for re-operative
cardiac surgery
S. S. Eagle, R. Umakanthan, M. Leacche, M. R. Petracek, R. M. Ahmad, J. M. Balaguer, J. P. Greelish, S. K. Ball,
S. J. Hoff, J. G. Byrne
09:22
Aortic root surgery: Ten-Year experience at the Favaloro Foundation
R. Favaloro, P. Roura, C. Salvatori, J. Diaz, H. Raffaelli, E. Dulbecco, J. Abud, C. Lopez, H. Casabe, E. Guevara
09:35The Ross procedure for the treatment of aortic valve disease in adult patients: mid and long term results
at a single referral surgical center
R. Favaloro, P. Roura, C. Salvatori, J. Diaz, E. Guevara, F. Vaisbuj, C. Rodriguez Correa, F. Salmo, C. Gomez,
M. Bustamante Labarta
09:48
Atherosclerotic burden among patients with acute aortic artery syndrome
M. J. Fosco, M. P. Marturano, G. Procopio, R. Merbilháa, L. Cicco, R. Favaloro, F. Klein
Yangt z e - Ochre P avillion - 0 8 :3 0 - 10: 00
Oral abstract session
Card i o v a scu l ar r i s k f ac t or s i n diffe r ent p op ulations
Chairs: Jorge Vilarino (ARGENTINA), Fernando Manzur Jattin (COLOMBIA)
08:30
An assessment of cardiovascular disease risk factors and behavior in Pakistani adolescents
S. I. Hassan, K. Kazmi, F. Jahan, S. H. Badruddin, S. Ahmed
08:43Impact of cardiovascular risk factors on the relationship between education and mortality.
A Chilean prospective cohort study: the San Francisco Project.
E. Koch, T. Romero, C. Akel, C. Diaz, L. Manriquez, M. Paredes, A. Taylor, C. Roman
08:56
Factors associated with the cord blood lipid profile: Baseline data of a birth cohort study
R. Kelishadi, Z Badiei
09:09EUROACTION: Do couples attending a hospital based multidisciplinary family cardiovascular prevention and
rehabilitation programme share the same risk factors? Do they change together?
C. Jennings, T. Collier, A. Mead, J. Jones, A. Holden, S. Connolly, K. Kotseva, D. De Bacquer, G. De Backer, D. Wood
09:22
Development of a valid cardiovascular risk model that aims to stimulate lifestyle changes in the population
M.R. Cobain, P. Murray, J. Massaro, R. B. D'Agostino
09:35
National Keshan Disease Surveillance 2007
T. Wang, J. Hou, L. Zhang, J. Pei, H. Feng, Q. Li, B. Xu
09:48Prevalence and distribution of sub-clinical atherosclerosis by screening vascular ultrasound in a low and
intermediate Framingham risk cohort
J. Postley, A. Perez, N. D. Wong, M. Chan, J. Gardin
Scientific Programme / 73
Monday, 19 May 2008
Mis s ouri - Ye llow P avillion - 0 8 :3 0- 10: 00
Oral abstract session
Res e a rch i n H e a r t F ail ur e
Chairs: Marcelo Montera (BRAZIL), Gimeno Graciela (ARGENTINA)
08:30Assessment of contractility and afterload mismatch as determinants of reduced ejection fraction in severe
aortic stenosis with heart failure
R. Migliore, M. Adaniya, M. Bruzzece, F. Saliva, M. Barranco, G. Miramont, F. Guerrero, H. Tamagusuku, A. Sinisi
08:43Invasive and non-invasive evidences of cardiac function and morphology improvement in trained infarcted rats
L. Jorge, B. Rodrigues, J. Paulini, K. Rosa, K. De Angelis, M. C. Irigoyen
08:56Inspiratory muscle training improves distribution of blood flow to resting and exercising limbs in heart failure
(WITHDRAWN)
G. R. Chiappa, B. T. Roseguini, P. J. C. Vieira, C. N. Alves, A. Tavares, E. R. Winkelmann, E. L. Ferlin, R. Stein, J. P. Ribeiro
09:09Physical training improves haemodynamic function, muscle oxidative stress and plasmatic levels
of IL-10 in chronic heart failure rats
P. Dall'Ago, R. B. Nunes, M. Tonetto, N. McHado, M. Chazan, T. G. Heck, A. B. G. Veiga
09:22
Association of oxygen uptake efficiency slope with other prognostic variables in heart failure
S. Miriuka, D. Delgado, M. Walker, S. Carson, H. Ross
09:35Changes of endogenic intoxication during ivabradin and beta blockers therapy at patients with
decompensated CHF
N. A. Bylova, G. P. Arutyunov, A. G. Arutyunov, A. L. Volkova
09:48
Assessment of cardiotoxicity of imatinib mesylate in chronic myeloid leukemia patients - a cross-sectional study
M. S. Marcolino, H. N. S. Bittencourt, N. C. D. Clementino, M. M. Barbosa, M. C. P. Nunes, V. F. Xavier, A. L. P. Ribeiro
Acu t e a n d c hr o n ic H e a rt F a i l ur e
Chairs: Roberto Ricca (URUGUAY), Eduardo Sampo (ARGENTINA)
Danub e - Gr e e n P avillion - 0 8 :3 0- 10: 00
Oral abstract session
08:30 Immediate reversion of myocardial ischemic dysfunction after coronary angioplasty.
Jose Geraldo Castro Amino, Aristarco Gonçalves Siqueira, Bernardo Rangel Tura, Vitor Manuel Pereira Azevedo,
Marco Aurelio Santos, Rogerio Brant Martins Chaves, Regina Maria Aquino Xavier
08:43
Metabolic syndrome does not imply worse prognosis in systolic heart failure (WITHDRAWN)
J. Thierer, N. Vainstein, A. Acosta, J. Marino, D. Ametrano, A. Francesia, V. Mezzalira, M. Trivi, M. Sutton, F. Brites
08:56 Acute myocardial infarction in patients with prior coronary artery bypass surgery; 19-year experience
P. Mitrovic, B. Stefanovic, V. Vukcevic, N. Radovanovic, M. Radovanovic, D. Rajic, G. Matic, P. Erceg, Z. Vasiljevic,
M. Ostojic
09:09Safety and efficacy of the utilization of continuous I.V. infusion of Levosimendan out of the Coronary
Care Unit setting.
L. A. Guzman, G. Moré, R. Sarjanovich, G. B. Scaro, A. Vanella
09:22
Comparison of the effects on plasma neutrophils count of two ARBs in hypertensive patients
J. Said Nisi, M. Benderski, J. Martinez, F. Martinez
09:35Thrombolysis in patients with myocardial infarction after previous coronary artery bypass surgery;
19-year experience
P. Mitrovic, B. Stefanovic, V. Vukcevic, N. Radovanovic, M. Radovanovic, D. Rajic, G. Matic, P. Erceg, Z. Vasiljevic,
M. Ostojic
09:48 Structural alterations of large intestinal wall role in development of chronic heart failure
N. A. Bylova, G. P. Arutyunov, L. I. Kafarskaya, N. A. Savelov, Y. A. Pokrovskiy, N. V. Kokosadze, A. V. Risnenko,
Z. A. Chernaya, T. K. Chernyavskaya, M. I. Korsunskaya
Monday, 19 May 2008
Lip i d s , o b e s i t y a n d m e t a b o l i c s y ndrome
Chairs: Carlos Cuneo (ARGENTINA), Masao Sano (PARAGUAY)
08:30
Nile - Ye llow P avillion - 0 8 :3 0 - 10: 00
Oral abstract session
Significant differential metabolic effects of lipophilic and hydrophilic statins in hypercholesterolemic patients
K. Koh, M. Quon, S. Han, W. J. Chung, B. Oh, E. Shin
08:43Prevalence of metabolic syndrome and associated risk factors and the impact of acculturation among
multiethnic U.S adolescents
S. L. Bassin, A. Perez, V. Lopez, N. D. Wong
08:56Relationship between race/ethnicity, education and household income, and the prevalence of metabolic
syndrome: impact of education in the burden of cardiovascular disease in women
S. Yala, E. Fleck, R. Sciacca, D. Castro, E. Giardina
09:09Spleen derived vascular progenitor cell transfer restores metabolic and vascular insulin sensitivity in high-fat
diet insulin resistant mice
J. Bloch, M. Schwab, P. Dessen, C. Mathieu, A. Monney, H. Duplain, P. Nicod, C. Sartori, U. Scherrer
09:22
Waist circumference and its association with classic cardiovascular risk factors in healthy women.
Maria Teresa Lira, S. Kunstmann, E. Caballero, D. Gainza, J. C. Molina
09:35Prevalence of metabolic syndrome at age 16 using the International Diabetes Federation paediatric definition
(WITHDRAWN)
A. Pouta, J. Pirkola, T. Tammelin, A. Bloigu, J. Laitinen, A. Ruokonen, P. Tapanainen, M. R. Järvelin, M. Vääräsmäki
09:48Accuracy of anthropometric measures of adiposity to predict cardiovascular risk factors in Chilean men and
women. The San Francisco Project.
E. Koch, T. Romero, C. Diaz, L. Manriquez, M. Paredes, C. Roman, A. Taylor
P ilcomayo - Ye llow P avillion - 0 8 :3 0 - 10: 00
Oral abstract session
Diet , d r u g s and c a r diovas c u l a r dis e as e
Chairs: J Fernandes (BRAZIL), Ricardo Esper (ARGENTINA)
08:30
ipid-altering efficacy and safety profile of co-administered extended release Niacin/Laropiprant and
L
Simvastatin in patients with dyslipidemia
L. Ose, M. Farnier, G. Gleim, N. Liu, S. Thompson-Bell, K. Beckey, A. O. Johnson-Levonas, C. Ballantyne, J. F. Paolini
08:43
two-year study to assess the efficacy, safety, and tolerability of Taranabant in obese patients: 52 week results
A
M. Moreno, I. Gantz, N. Erondu, S. Suryawanshi, B. Musser, J. Nayee, A. O. Johnson-Levonas, S. Heymsfield, J. Amatruda
08:56
omparison of the omega-3 index in the acute coronary syndromes in a beef-eating population in Argentina
C
as compared to a fish-eating population in Norway.
R. Leòn De La Fuente, H. Aarsetoey, S. Kiserud, H. Grundt, E. Lovaglio, S. T. Nilsen, L. Woie, H. Staines, W. S. Harris,
D. W. T. Nilsen
09:09
lant sterol-enriched spread enhances the cholesterol-lowering potential of ezetimibe in coronary patients
P
already taking statins but not reaching lipid goals
G. B. Gomes, A. D. Zazula, L. S. Shigueoka, R. A. Fedato, J. R. Faria Neto
09:22
Low levels of antibodies against phosphorylcholine predict development of atherosclerosis
J. Frostegård, B. Sjöberg, J. Su, H. Grönlund, I. Dahlbom, B. Hedblad, G. Berglund, U. De Faire
09:35Green and black tea are equally potent stimuli of NO production and vasodilation: New insights into tea
ingredients involved
V. Stangl, N. Jochmann, M. Lorenz, J. Urban, G. Baumann, M. Laule, K. Stangl
09:48
Development of atherosclerosis: role of systemic inflammation and endotoxin
N. A. Bylova, G. P. Arutyunov, L. I. Kafarskaya
Scientific Programme / 75
Monday, 19 May 2008
R es e a rch i n hyp er te n s ion
Chairs: Brandão Ayrton (BRAZIL), Cristina Arranz(ARGENTINA)
Or inoco - Ochre P avillion - 0 8 :3 0- 10: 00
Oral abstract session
08:30
omparison of abdominal obesity and total obesity in predicting risk of prehypertension status
C
with reference to economic development in the south-west of Congo Kinshasa
B. Longo-Mbenza, J. B. Kasiam Lasi On’kin, A. Nge Okwe, D. Vangu Ngoma, S. Mbungu Fuele, G. Milongo Dipa
08:43
Left ventricular mass and diastolic function in patients undergoing renal artery stenting
T. Przewlocki, D. Rzeznik, A. Kablak-Ziembicka, M. Kostkiewicz, A. Roslawiecka, A. Kozanecki, W. Tracz
08:56
Baroreflex dysfunction by sinoaortic denervation increases cardiac damage in hypertension
K. Flues, I. C. M. Silva, J. Paulini, R. N. De La Fuente, E. D. Moreira, C. Mostarda, K. De Angelis, M. C. Irigoyen
09:09
holinergic stimulation with Pyridostigmine improves the chronotropic response during exercise
C
and heart rate recovery in heart failure patients
A. Nobrega, S. Serra, R. Vivacqua, S. Xavier
09:22
Association between Consumption of a DASH-type diet and blood pressure in adults from southern Brazil
S. C. Fuchs, A. Celestini, L. B. Moreira, R. L. Henn, F. C. Fuchs, F. D. Fuchs
09:35
Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs
K. Koh, M. Quon, S. Han, W. J. Chung, B. Oh, E. Shin
09:48The presence of nitric oxide synthase genetic polymorphism decreases arterial baroreflex sensitivity
after maximal exercise
F. Neves, B. Silva, A. Sales, N. Rocha, T. Barbosa, V. Stelet, R. Gonçalves, P. Soares, A. Nobrega
Volga - Yello w Pavillion - 08:30-10:00
Oral abstract session
Ped i a t r i c C a r d io l o g y: Fr om ne o n at e s t o grown-up
Chairs: Alberto Sciegata (ARGENTINA), John Cheatham (UNITED STATES )
08:30Levosimendan for cardiac failure in postoperative management of cardiac surgery for congenital
heart disease in neonates
C. R. Ferreiro, M. A. O. Barbosa, M. B. Jatene, I. Jatene, L. C. B. Souza, E. R. Romano, E. T. Egito, S. F. Pedra,
V. Fontes, J. E. Sousa
08:43Outcomes of 124 consecutive congenital heart surgical procedures. Analysis through a variable
life adjusted display.
E. Juaneda, B. Vega, R. De Rossi, O. Lazzarín, E. Banille, I. Azar, L. Alday
08:56
Anomalous origin of left coronary artery from pulmonary artery: outcome after surgical repair.
I. Lugones, M. Cazalas, A. Sardella, M. I. Roman, C. Kreutzer, J. L. Simon, A.J. Schlichter
09:09
Spectrum of conotruncal congenital heart malformations in patients with 22q11.2 chromosome microdeletion
E. Juaneda, N. Rossi, A. Sturich, C. Montes, R. Schumiachkin, A. Chávez, B. Vega, L. Alday
09:22
Stenting coarctation of the aorta with Cheatham platinum stent: initial results
R. Gamboa, F. P. Mollon, R. E. Rios Mendez, D. Antoni, G. M. Arro
09:35
Optimal programming of the ICD in children and young adults on the basis of long term follow-up.
M. Lewandowski, A. Przybylski, P. Syska, M. Sterlinski, A. Maciag, H. Szwed
09:48 Grown-up congenital heart disease treated in pediatric catheterization laboratory
R. E. Rios Mendez, R. Gamboa, F. P. Mollon, G. M. Arroyo, D. F. Gutierrez, H. Mon, H. E. Montero Monar,
L. R. Valdivieso Cedeño, O. A. Mendiz, A. Fogel
Monday, 19 May 2008
Nige r - Gr e e n P avillion - 0 8 :3 0 - 10: 00
Oral abstract session
Hype r tro p h y a n d d y s f u n ct i o n o f car diac cells
Chairs: Horacio F. Cingolani F (ARGENTINA), Kelly David T (AUSTRALIA)
08:30Ovarian hormones deprivation induces cardiovascular autonomic dysfunction associated with cholesterol
levels in LDL knockout mice
J. Paulini, K. Flues, M. Heeren, C. Mostarda, E. D. Moreira, K. De Angelis, M. C. Irigoyen
08:43
Endothelial function in healthy subjects exposes to hypobaric hypoxia
D. Iglesias, N. Vainstein, F. Brites, L. Rosso, C. Pesce, C. Lezon
08:56
Functional role of the arginase II in modulating cardiac contractility in mice with and without pressure overload
C. H. M. Azevedo, D. Gonzales, G. Joseph, A. M. Benjo, H. C. Champion, D. Nyhan, A. A. Shoukas, J. M Hare, D. Berkowitz
09:09Diagnosis of acute cellular cardiac allograft rejection by endomyocardial biopsy performed in a teaching
hospital from 1984 to 2007
S. Bordignon, E. Horowitz, M. Barra, L. Lima, J. Vieira, P. Ruschell, P. Cordeiro, V. Porto, S. Fonseca, I. Nesralla
09:22
Angiotensin AT2 receptor mediates cardiac c-kit+ cell proliferation and supports survival of cardiomyocyte
W. Altarche-Xifró, C. Birka, E. Kaschina, M. Timm, A. Grzesiak, C. Curato, M. Brinckmann, T. Unger, J. Li
09:35
enome-wide linkage analysis of electrocardiographic and echocardiographic left ventricular hypertrophy
G
in families with hypertension
B. M. Mayosi, P. J. Avery, M. Farrall, B. Keavney, H. Watkins
09:48
Echocardiographic study of left ventricular geometry in spontaneously hypertensive rats
O. A. Pinilla, V. B. Carranza, E. M. Escudero
Tib e r - Ye llow P avillion - 0 8 :3 0- 10: 00
Oral abstract session
Clin i c a l a n d exp er im e n tal a the r os cle ros is
Chairs: Luis De La Fuente (ARGENTINA), Zeljko Reiner (CROATIA)
08:30Simvastatin improves flow-mediated dilation, but reduces adiponectin levels and insulin sensitivity
in overweight hypercholesterolemic patients independent of doses
K. Koh, M. Quon, S. Han, W. J. Chung, B. Oh, E. Shin
08:43Effects of Peroxisome Proliferator Activated Receptor gamma (PPAR gamma) stimulation
in hypercholesterolemic rabbits with induced vascular lesion
A. Alessi, L. Baroncini, O. França, C. Prim, D. Précoma
08:56
Is hereditary thrombophilia a contributing factor in premature myocard infarction?
M. Kayikcioglu, C. Hasdemir, M. Ildizli, L. Can, S. Payzin, Z. Eroglu, E. Y. Sozmen, B. Saygi, H. Kultursay
09:09
EP2300 compounds, novel squalene synthase inhibitors, reduce atherosclerosis in vivo
A. Tavridou, L. Kaklamanis, A. P. Kourounakis, P. N. Kourounakis, A. Charalambous, V. G. Manolopoulos
09:22Aatorvastatin inhibits the RHO A/RHO kinase pathway and, reduces blood pressure and the expression
of vascular remodeling genes in rats with genetically high levels of angiotensin II
P. Rivera, M. Ocaranza, J. Jalil
09:35
Overall atherosclerosis burden in patients with end-stage renal disease who are receiving hemodialysis.
W. Masson Juarez, I. Bluro, R. Ricardo, G. Rosadiez, V. Aliperti, A. Elizalde, J. Krauss, A. Cagide
09:48 Rosiglitazone effects on counterlateral iliac artery after vascular injury in hypercholesterolemic rabbits
O. R. França Neto, A. Alessi, C.R. Prim, R. F. K. Caetano Da Silva, L. De Noronha, A. Caporal, L. A. V. Baroncini,
D. B. Precoma
Scientific Programme / 77
Monday, 19 May 2008
G ange s - Gr e e n P avillion - 0 8 :3 0- 10: 00
Oral abstract session
Str o k e a n d c ar o tid a r t er y s te n t ing
Chairs: Fernando Vinuela (UNITED STATES ), Jorge Bluguerman (ARGENTINA)
08:30
ENERI experience in carotid artery stenting. Lesson learned and current practice in 1013 patients.
P. Lylyk, A. Musacchio, A. Ferrario, C. Miranda, R. Ceratto, J. Vila, P. Angelani, J. Manterola, C. Ingino
08:43
Siriraj subtypes stroke and validation study in Kinshasa
B. Longo-Mbenza, J. C. Mbete Tsasa, M. Lelo Tshikwela, P. Mbuilu, D. Vangu Ngoma, S. Mbungu Fuele
08:56
ong-term survival after ‘tailored’ carotid artery stenting: Results from an academic registry
L
of 555 consecutive procedures
P. Pieniazek, L. Tekieli, P. Musialek, A. Kablak-Ziembicka, T. Przewlocki, A. Lesniak-Sobelga, B. Biernacka, K. Zmudka,
W. Tracz
09:09
Initial experience and mid term follow up with intracranial endovascular reconstruction aneurysm treatment
with a new stent pipeline
P. Lylyk, C. Miranda, A. Berez, K. Nelson, E. Scrivano, R. Romero, C. Ingino
09:22Percutaneous closure of patent foramen ovale with Amplatzer® device for secondary cryptogenic stroke
prevention. immediate results and middle term follow-up analysis
M. Borges, P. Machado, E. Horowitz, L. François, J. Silva, R. Rossi
09:35
Risk factors of stroke among Congolese black hypertensive diabetics
B. Longo-Mbenza, R. Mombo Ngimbi, D. Vangu Ngoma, S. Mbungu Fuele, B. Buassa-Bu-Tsumbu
09:48
Quality of stroke care in Argentina. Insights from The Argentinian National Stroke Registry (ReNACer)
L. A. Sposato, M. M. Esnaola, M. C. Zurru, R. Zamora, O. Fustoni, G. Saposnik
Thame s - Ye llow P avillion - 0 8 :3 0- 10: 00
Oral abstract session
Co r o n a r y a n d n o n c or o n a r y endovas cular t re at me nt I
Chairs: Deborah Nercolini (BRAZIL), Fernando Cura (ARGENTINA)
08:30Revival of percutaneous balloon aortic valvuloplasty in non surgical patients with degenerative aortic
stenosis as bridge for percutaneous aortic valve replacement
C. Agatiello, H. Eltchaninoff, C .Tron, D. Nercolini, C. Rojas Matas, D. Berrocal, A. Cribier, L. Grinfeld
08:43
Abdominal Aortic Aneurysm Evolution after Endovascular Repair.
G. Lev, O. Mendiz, L. Valdivieso, F. Carlos, L. Villagra, J. Scaglia, P. Mollon
08:56
Descending aorta endovascular repair: Dissection vs. non dissection disease
G. Lev, O. Mendiz, L. Valdivieso, C. Fava, L. Villagra, J. Scaglia, P. Mollon
09:09 Contribution to the clinical recognition of severe coronary disease in women
C. Serra MD, P. H. M. Del Sueldo, MD, S. Joekes, Magister, G. Pacheco, MD, J. Floridia, MD, H. Cuezo, MD,
P. Grosse, MD, A. Righetti, Magister, J. Sala, MD, C. Balestrini, MD
09:22
Therapeutic interventions based on findings in stored electrographs of patients with definitive pacemakers.
G. M. M. Pellegrino, D. F. Ortega, L. D. Barja, N. Mangani, L. Mari
09:35Effects of the late reperfusion of the infarct-related artery on mortality, morbidity and left ventricular
remodelling. A metaanalysis of randomised controlled trials.
J. Mariani, H. Cohen Arazi, C. Tajer
09:48 Are we treating the right non-ST acute coronary syndrome patients with an invasive strategy?
R. Teixeira, C. Lourenço, S. Monteiro, N. Antonio, S. Costa, F. Gonçalves, P. Monteiro, L. Gonçalves, M. Freitas,
L. A. Providencia
Monday, 19 May 2008
Huang He - Ye llow P avillion - 0 8 :3 0 - 10: 00
Oral abstract session
3D Ec h o c a r d i o g r ap hy
Chairs: Eduardo Guevara (ARGENTINA), Jose Fernando Guadalajara (MEXICO)
08:30Utility of the real time 3D echocardiography for assessment of left ventricular mass in patients with
hypertrophic cardiomyopathy. Comparison with cardiac magnetic resonance
G. Avegliano, M. Huguet, P. Kuschnir, J. Thierer, C. Tobon, D. Capdeferro, C. Burnikoff, A. Frangi, M. Petit,
R. Ronderos
08:43
on invasive estimation of end-diastolic pressure in patients with preserved and reduced ejection fraction.
N
A new single method using stroke volume and deceleration time.
R. Migliore, M. Adaniya, D. Duarte, M. Barranco, J. Poch, J. Lloveras, A. Greco, D Pisano, H. Tamagusuku, A. Sinisi
08:56
Left ventricular systolic performance, function and contractility in patients with severe sepsis or septic shock
D. Chejtman, A. Hita, S. Baratta, P. Pratesi, J. Bilbao, H. Fernandez, D. Bernardez, D. Turri
09:09
eal-time three dimensional echocardiographic left ventricular systolic evaluation: comparison between
R
dyssynchrony indexes and ejection fraction
M. L. C. Vieira, V. M. L. Gimenes, W. A. Oliveira, G. Naccarato, A. Cury, J. Pinheiro Jr, M. M. Andrade, S. F. P Pedra,
C. H. Fischer, S. S. Morhy
09:22
Epicardial fat as a contributing factor to diastolic dysfunction
S. B. Yoon, S. J. Eum, E. J. Lee, P. K. Min, Y. W. Yoon, B. K. Hong, H. M. Kwon, H. S. Kim, S. J. Rim
09:35
Systolic aortic regurgitation: Pathogenesis, doppler hemodynamic mechanisms and natural history
J. Mohan, D. Tomar, C. Shekhar
09:48Value of contrast echocardiography for the diagnosis of hepatopulmonary syndrome: prevalence in patients
with liver transplantation indication
F. L. Weich Glogier, T. F. Cianciulli, J. Vilkas Anzorena, F. Spernanzoni, M. C. Saccheri, J. A. Lax, A. N. Dorelle,
H. A. Prezioso, L. A . Vidal, O. C. Imventarza
Diabe t e s a n d c ar d io va s c ul ar r is k
Chairs: Guzman L (ARGENTINA), Raul Pisabarro (URUGUAY)
P araná - Ochr e Pavillion - 08:30-10:00
Oral abstract session
08:30
Type 2 Diabetes mellitus is strongly associated with third degree AV-block
M. R. Movahed, M. Hashemzadeh, M. M. Jamal
08:48
Relationship between Acute Myocardial Infarction and Glycemic Status
L. Ribeiro, P. Nogueira, R. Berber, R. Ramos, A. Timerman, C. Gun, L. Piegas
09:06The impact of diabetes mellitus on outcomes in patients undergoing primary percutaneous coronary
intervention for ST segment elevation myocardial infarction.
L. O. Jensen, M. Maeng, P. Thayssen, A. Kaltoft, H. Tilsted, M. Bottcher, J. F. Lassen, L. Pedersen, S. P. Johnsen,
L. Thuesen
09:24 Are all forms of pre-diabetes born equal regarding acute coronary syndromes outcome?
N. Antonio, C. Lourenco, P. Monteiro, S. Monteiro, S. Costa, R. Teixeira, F. Goncalves, L. Goncalves, M. Freitas,
L. A. Providencia
09:42Multiethnic prevalence of abdominal obesity and associated cardiometabolic risk factor burden
in U.S. adults 2003-2004
H. Ghandehari, V. Le, S. Kamal-Bahl, S. L. Bassin, N. D. Wong
Scientific Programme / 79
Monday, 19 May 2008
Mis s is s ippi - Ye llow P avillion - 0 8 :3 0- 10: 00
Oral abstract session
GENERAL C A RDIOLOGY I
Chairs: Victor Sinisi (ARGENTINA), Eduardo Roura (ECUADOR)
08:30
Fuzzy logic. A new internet tool for heart rhythm classification.
M. Lewandowski, A. Przybylski, W. Kuzmicz, J. Ollitrault, A. Blinowska, H. Szwed
08:43
Different methods for mechanical dyssynchrony assessment and prognosis in heart failure M. Trivi, J. Thierer, R. Ronderos, P. Kuschnir, R. Guglielmone, A. Acosta, A. Hirshon Prado, V. Mezzalira, M. Sultán, J. Marino
08:56Preliminary evaluation of the safety and effect of pancreatic adult stem cell implantation
in Diabetes Mellitus type 1 patients.
A. Mesples, B. Pertiné, R. Bellomo
09:09
Is fibrinogen a predictive factor for albuminuria in type 2 diabetes ?
A. C. Cordeiro, C. C. Gonzaga, M. G. Sousa, F. O. Borelli, O. Passarelli Jr, L. Lotaif, L. S. Piegas, C. Amodeo
09:22Left and right atrial appendage function after percutaneous mitral valvuloplasty in mitral stenosis
and sinus rhythm.
T. F. Cianciulli, M. C. Saccheri, J. A. Lax, R. A. Sarmiento, A. M. Bermann, J. E. Guerra, J. A. Gagliardi, A. N. Dorelle,
H. A. Prezioso, L. A. Vidal
09:35
Carotid intima-media thickness predicts cardiovascular events in patients with atherosclerosis
A. Kablak-Ziembicka, T. Przewlocki, W. Tracz, I. Stopa, P. Pieniazek, P. Musialek, A. Kozanecki
09:48
Age evaluation with cardiac doppler of the heart in young sportsmen category amateur soccer
D. Avayu, D. Morisse, J. Goral, J. Fuse, C. Seidler, C. Froimovich, L. Rodas, I. Diaz, L. Cimerman
Amaz on - Ye llow P avillion - 0 8 :3 0- 10: 00
South American Congress of Cardiology
Op e n i n g C ere m o n y
XXIII C o n g r e s o S u d a m e r ic ano d e Cardiología
08:30
Opening Ceremony - XXIII Congreso Sudamericano de Cardiología Co n f e r e n c i a :
Presidente: Sergio Varini (ARGENTINA)
09:00
Imagen y genoma como estrategias de prevención en el futuro. The HRP Study.
Fuster Valentin (UNITED STATES )
R io de la P lat a - R e d P avillion - 1 0 :3 0- 12: 00
How-to & Workshop Session
Int e rpre t a t i on o f t he d if f ic u l t ECG: P ract ical appr oach
Chairs: Alberto Giniger (ARGENTINA), Dario Sobral (BRAZIL)
10:30
Supraventricular tachycardia
Ivan Mendoza (VENEZUELA)
11:15
Ventricular tachycardia
Günter Breithardt (GERMANY)
Monday, 19 May 2008
Yangt z e - Och r e Pavillion - 10:30 -12:00
Symposium
Atr i a l f i br i l l a t i o n : N o n - p h ar m acologi cal tr eatment
Chairs: Carlos Labadet (ARGENTINA), Galvao Silas (BRAZIL)
10:30
Management of atrial fibrillation in patients with heart failure: From drug therapy to ablation
Shih-Ann Chen (CHINA, TAIWAN)
10:52
Catheter ablation of atrial fibrillation in brady-tachy syndrome
Yunlong Xia (CHINA, PEOPLE'S REPUBLIC OF)
11:14
Strategies and results of catheter ablation of atrial fibrillation
Andrea Natale (UNITED STATES )
11:36
Where are we going with management of atrial fibrillation
Adrian Baranchuk(CANADA)
Danub e - Gr e e n P avillion - 1 0 :3 0 - 12: 00
Symposium
Card i ac re s y nc hr o n i s a t i o n t h era py (CR T) - Pa r t One
Chairs: Ramos José Luis (ARGENTINA), Ricardo Miglino (BRAZIL)
10:30
Left ventricular dyssynchrony: Impact on function and structure
John Gorcsan III (UNITED STATES )
10:52
Right ventricular pacing: The unwanted model of dyssynchrony?
Jose Carlos Pachon Mateos (BRAZIL)
11:14
How to assess left ventricular dyssynchrony?
Cheuk-Man Yu (CHINA, PEOPLE'S REPUBLIC OF)
11:36
Impact of CRT on atrial fibrillation and atrial function
Michael Gold (UNITED STATES )
Se ine - Gr e e n P avillion - 1 0 :3 0 - 12: 00
Symposium
Acu t e d ec o mp e n s a t e d h e art f a i l ur e
Chairs: John Cleland (UNITED KINGDOM), Carlos García (COLOMBIA)
10:30
Neurohumoral aspect of acute heart failure
Mihai Gheorghiade (UNITED STATES )
10:52
Clinical aspect of acute heart failure: The ADHERE registry
Guillermo Torre Amione (UNITED STATES )
11:14
When to use inotropic therapy
Fabio Vilas-Boas (BRAZIL)
11:36
New perspectives in the treatment of acute heart failure
Faiez Zannad (FRANCE)
Scientific Programme / 81
Monday, 19 May 2008
Mis s is s ippi - Ye llow P avillion - 1 0 :3 0- 12: 00
Symposium
Ad v a nc e s i n g e n e t i cs
Chairs: Alicia MattiazzI (ARGENTINA), Walter Reyes Caorsi (URUGUAY)
10:30
The genetics of atrial fibrillation
Johannes Brachmann (GERMANY)
11:00
Clinical correlates of long QT syndrome mutations
Christian Wolpert (GERMANY)
11:30
Role of obesity and adiponectin in heart disease
Kwang Koh (KOREA, REPUBLIC OF)
Volga - Ye llow P avillion - 1 0 :3 0- 12: 00
Symposium
Severe pulmonary insufficiency after congenital heart surgery
Chairs: Ademar Atik(BRAZIL), Pilar Arnaiz (CHILE)
10:30
The impact of pulmonary insufficiency on GUCHS patients
Alex Javois (UNITED STATES )
10:48
Evaluation of right ventricular function
David Sahn (UNITED STATES )
11:06
Timing of pulmonary valve replacement
Miguel L Barbero Marcial (BRAZIL)
11:24
Transcatheter pulmonary valve insertion
Ziyad Hijazi (UNITED STATES )
11:42
Surgeon's perpsective
Christian Kreutzer (ARGENTINA)
Thame s - Yello w Pavillion - 10:30-12:00
Clinical Seminar
No v e l c o nc e p t s i n h y p e rt e n s i o n t reatment
Chairs: Carlos Ferrario (UNITED STATES ), Oscar Carretero (UNITED STATES )
10:30
The Renin Inhibition in hypertension?
Alberto Villamil (ARGENTINA)
10:52
Betablockers in Hypertension today
Lars Lindholm (SWEDEN)
11:14
Which combination of anti-hypertensive drugs is the most effective to reduce blood pressure?
Marcelo Orias (ARGENTINA)
11:36Gap between patients and physicians attitudes and awareness toward hypertension and its complication
in cardiovascular diseases
Luis Ruilope (SPAIN)
Monday, 19 May 2008
Nile - Ye llow P avillion - 1 0 :3 0 - 12: 00
Symposium
Card i a c re h a b i l i t a t i o n pr o gr a m mes
Chairs: Erika S Froelicher (UNITED STATES ), Puska Pekka (FINLAND)
10:30
Cardiac Rehabilitation in Latin America: Survey results
Hermes Ilarraza-Lomeli(MEXICO)
10:48
Simplified Methods of cardiac rehabilitation programs
Marian Worcester (AUSTRALIA)
11:06
Risk benefits of exercise
Alan Goble (AUSTRALIA)
11:24
Models of cardiac rehabilitation programs for low and middel income countries
Sarraf-Zadegan Nizal (IRAN, ISLAMIC REPUBLIC OF)
11:42
Cardiac Rehabilitation: the Cuban Model
Eduardo Rivas Estany (CUBA)
P ilcomayo - Ye llow P avillion - 1 0 :3 0 - 12: 00
Clinical Seminar
Pharmacotherapy in heart failure: New drugs or new benefits?
Chairs: Kelly David T (AUSTRALIA), Cesare Orlandi (UNITED STATES )
10:30
What is new in aldosterone blockage?
Willem Remme (NETHERLANDS)
10:52
Vasopressin receptor antagonists in heart failure
Marvin Konstam (UNITED STATES )
11:14
New beta blockers: New actions?
Juan Gonzalez Juanatey (SPAIN)
11:36
New drugs in heart failure: What is really new?
Philip A Poole-Wilson (UNITED KINGDOM)
Huang He - Ye llow P avillion - 1 0 :3 0- 12: 00
Clinical Seminar
Common challenges in the everyday practice of nuclear cardiology
Chairs: Claudio Meneghetti (BRAZIL), Adel Allam (EGYPT)
10:30
How to study obese patients?
Joao Vitola (BRAZIL)
10:48
Patients referred for viability assessment
Erick Alexanderson (MEXICO)
11:06
Patients with 50% stenosis in multi-slide computed tomography studies
Marcelo Goldstein (BELGIUM)
11:24
Patients with chest pain and negative ECG
Anibal Mele (ARGENTINA)
11:42
Clinical use of cardiac PET
Barry Zaret (UNITED STATES )
Scientific Programme / 83
Monday, 19 May 2008
Mis s ouri - Ye llow P avillion - 1 0 :3 0- 12: 00
Debate
Tr e a t m e n t o f Cha g a s d is e a s e
Chairs: Roberto Blandon Calderon (PANAMA), Fernando Aguirre (ECUADOR)
10:30
Statement 1:
Treatment of chronic Chagas disease with current anti-parasitic drugs
Pro: Rosalia Morais Torres (BRAZIL)
Contra: Jose Milei (ARGENTINA)
11:15
Statement 2:
Treatment of asymptomatic ventricular arrhythmias
Pro: Jorge Mitelman (ARGENTINA)
Contra: Juan Justiniano Encina (BOLIVIA)
Me kong - Ochre P avillion - 1 0 :3 0- 12: 00
Symposium
Cu rr e n t t r e a t m e n t o f m yo c a r dial infarc t ion:
Fr o m e v i d e n c e to c l inic al prac t ice
Chair: Fuster Valentin (UNITED STATES )
10:30
Un-treated patients: How to reduce lost opportunities?
Faiez Zannad (FRANCE)
10:52
Reperfusion strategies in the emergency treatment of ST-segment elevation myocardial infarction
Oscar Bazzino (ARGENTINA)
11:14
Predictors of one year mortality in high risk patients
Frans Van De Werf (BELGIUM)
11:36
Guidelines revised
Rafael Diaz (ARGENTINA)
Gange s - Gr e e n P avillion - 1 0 :3 0- 12: 00
Clinical Seminar
Unr e so l v e d is s ue s o n c or o n a r y int e rve nt ions
Chairs: Raúl Bretal (ARGENTINA), Gao Runlin (CHINA, PEOPLE'S REPUBLIC OF)
10:30
Late and very late stent thrombosis: New classification and outcomes
Donald Cutlip (UNITED STATES )
10:52
Clinical trials: Long-term follow-up regarding DES safety
Bonnie Weiner (UNITED STATES )
11:14
LIMA showed 30 years effectiveness: What happened with stent PCI in the last 30 years?
Julio Palmaz (UNITED STATES )
11:36
Which benefits does DES have shown in comparison with BMS at long-term follow-up?
Carlos Macaya (SPAIN)
Monday, 19 May 2008
Nige r - Gr e e n P avillion - 1 0 :3 0 - 12: 00
Clinical Seminar
Acu t e c o r o n a r y s yndr o m e in the e lde rly
Chairs: Jose Antonio Francisco Ramires (BRAZIL), Eduardo Roura (ECUADOR)
10:30
Risk stratification and management strategy in the elderly with non-ST ACS
Mauricio Cohen (UNITED STATES )
10:52
Is the aggressive medical treatment beneficial in the elderly?
Rodolfo Pizarro (ARGENTINA)
11:14
Antithrombotic treatment in St. miocardial infarction
Acevedo Monica (CHILE)
11:36
Prognosis and presictors of survival in St. miocardial infarction
Satyavan Sharma (INDIA)
Tigris - Y ellow Pavillion - 10:30 -12:00
Clinical Seminar
Adva n c e s i n c a r diop u l m onar y r es us cit at ion
Chairs: Alejandro Barbagelata (UNITED STATES ), Eduardo Hasbani (ARGENTINA)
10:30
Pathophysiology evolution of the RCP in the last 10 years
Kern Karl B (UNITED STATES )
10:52
Vasopressin: Is it an alternative or a better option than ephinefrine?
Ari Timerman (BRAZIL)
11:14
Post-resuscitation care: Induced hypothermia to whom, how and when?
Jorge Neira (ARGENTINA)
11:36
In hospital resuscitation: Outcomes and prediction of survival
Timerman Sergio (BRAZIL)
Or inoco - Ochr e Pavillion - 10:30-12:00
Symposium
Tr ea t m e n t o f h y p er t e n s i o n i n s p ecial situations
Chairs: Hugo Baglivo (ARGENTINA), Sokn Fernando (ARGENTINA)
10:30
Hypertension in pregnancy
Gloria S. Valdes (CHILE)
10:52
Pediatric and adolescent hypertension
Andrea Brandão (BRAZIL)
11:14
In elderly, 80 years and above
Kjeldsen Sverre E (NORWAY)
11:36
In resistant hypertension
Antonio Coca (SPAIN)
Scientific Programme / 85
Monday, 19 May 2008
P araná - Ochre P avillion - 1 0 :3 0- 12: 00
Special Featured Joint Session
MSI: T h e M e t a b o l ic S y n dro m e :
Gr ow i n g prev a l e nce i n La t i n A m er ica and t reatment needs
Chairs: Romero Carlos (URUGUAY), Piñeiro Daniel (ARGENTINA)
10:30
The emerging obesity problem in Latin America
Ada Cuevas (CHILE)
10:52
Drug therapy for the dyslipidemia of the Metabolic Syndrome
Jean Charles Fruchart (FRANCE)
11:14
The Metabolic Syndrome as a risk factor for diabetes
Pablo Aschner (COLOMBIA)
11:36
The Metabolic Syndrome as a risk factor for cardiovascular disease
Scott Grundy (UNITED STATES )
R hine - Ye llow P avillion - 1 0 :3 0- 12: 00
Special Featured Joint Session
ACC : Re g i o n a l Cha l l enge s to
the pr e v e n t i on a n d t r e a tm ent of CVD in t he U.S.
Chairs: W. Douglas Weaver (UNITED STATES ), Mele Eduardo (ARGENTINA)
10:30
Cardiovascular imaging for prevention and treatment of CV disease in the U.S.: Challenges and opportunities
George Beller (UNITED STATES )
10:52
The quality - first vision: building a learning health care system
Jack Lewin (UNITED STATES )
11:14
Challenges in maximizing functional capacity in elderly patients with valvular heart disease
Navin Nanda (UNITED STATES )
11:36
State of the art perspectives in heart failure: A Fantastic Voyage
Hector Ventura (UNITED STATES )
Tib e r - Ye llow P avillion - 1 0 :3 0- 12: 00
Special Featured Joint Session
PAS C A R - H e al t h Trans itions and CVD in Africa:
Imp l ica t i o n s f or t h e 2 1 s t C e n t u ry
Chairs: Robert Fagard (BELGIUM), Amoah Albert (GHANA)
10:30Epidemiologic and Nutritional Transitions in Africa - The Evidence from Obesity, Diabetes,
and the Metabolic Syndrome.
Krisela Steyn (SOUTH AFRICA)
10:52
Spectrum of CVD and risk factors in Africa today - The Heart of Soweto Study
Karen Sliwa (SOUTH AFRICA)
11:14
Addressing Rheumatic Fever and CVD in children and young adults - beyond the Drakensberg Declaration
Mayosi Bongani (SOUTH AFRICA)
11:36
Health Transitions in Africa: Policy and Resource Implications for International Health Organizations
George A. Mensah (UNITED STATES )
Monday, 19 May 2008
Amaz on - Ye llow P avillion - 1 0 :3 0 - 12: 00
South American Congress of Cardiology
Desafíos actuales de la cardiología sudamericana
Coordinadores: Gilson Feitosa(BRAZIL), Grancelli Hugo (ARGENTINA)
10:30
Epidemiología de las enfermedades cardiovasculares en sudamérica
Bartolome Finizola (VENEZUELA)
10:45
¿ Las guías internacionales son aplicables en nuestra realidad sanitaria?
Edgardo Sandoya (URUGUAY)
11:00
Tecnología y alta complejidad cardiovascular. Limitaciones e inequidades en la región
Jaime Goich (CHILE)
11:15
¿Cómo desarrollar investigación independiente en nuestros países?
Hernan Doval (ARGENTINA)
R hine - Ye llow P avillion - 1 4 :0 0- 15: 30
Clinical Seminar
Non-invasive risk stratification for sudden cardiac death
Chairs: Luis Alcocer (MEXICO), Martinelli Martino (BRAZIL)
14:00
Microvolt t-wave alternants
Gioia Turitto (UNITED STATES )
14:22
ECG and heart rate variability and turbulence
Dubner Sergio (ARGENTINA)
14:44
Signal average electrocardiogram
Nabil El-Sheriff(UNITED STATES )
15:06
Putting this all together: Is an individualized decision possible?
John Camm (UNITED KINGDOM)
R io de la P lat a - R e d P avillion - 1 4 :0 0 - 15: 30
Debate
Dr u g s v s . e l e c tr ic a l d e v ice s
Chairs: Günter Breithardt (GERMANY), Oseroff Oscar (ARGENTINA)
14:00
Statement 1:
Atrial fibrillation: Catheter ablation as first line treatment?
Pro: Andrea Natale ( UNITED STATES )
Contra: Shih-Ann Chen (CHINA, TAIWAN)
14:45
Statement 2:
All patients with cardiomyopathy and an ejection fraction below 35% should receive an ICD
Pro: Sergio Pinski (UNITED STATES )
Contra: José Luis López-Sendón (SPAIN)
Scientific Programme / 87
Monday, 19 May 2008
Danub e - Gr een Pavillion - 14:00-15:30
Symposium
Ele c t ric a l t h er a py i n h e a r t f a i lure
Chairs: Aleksandras Laucevicius (LITHUANIA), Diego Vanegas (COLOMBIA)
14:00
Cardiac contractility modulation to improve left ventricular function
María José Sancho Tello (SPAIN)
14:30
How to prevent pacing in pacemakers: Role of new algorithms
Jorge Gonzalez ZUelgaray (ARGENTINA)
15:00
Monitoring of heart failure by implanted devices
Michael Gold (UNITED STATES )
Ane m i a a n d h ear t f a il u r e
Chairs: Miguel Adorno (PARAGUAY), Bocchi E.A (BRAZIL)
Euphrat e s - Ochre P avillion - 1 4 :0 0- 15: 30
Clinical Seminar
14:00
Heart failure and anemia: Mechanisms and pathophysiology
Alejandro Macchia (ARGENTINA)
14:30
Prevalence of anemia in heart failure and its effects on prognosis
Cesar Belziti (ARGENTINA)
15:00
Use of EPO and Iron in the Treatment of Anemia in Heart Failure
Philip A Poole-Wilson (UNITED KINGDOM)
Se ine - Gr een Pavillion - 14:00-15:30
Symposium
Ad v a n c e d h ear t f a il u r e
Chairs: Norberto Vulcano (ARGENTINA), Ricardo Levin (UNITED STATES )
14:00
Advanced dysfunction without advanced symptoms: Pathophysiology and clinical profile
Santiago Miriuka (ARGENTINA)
14:18
The time for assistance: Clinical decisions for VAD implantation
Hector Ventura (UNITED STATES )
14:36
The future is here: New devices for the failing heart
Diego Delgado (CANADA)
14:54
Heart transplantation in 2008
Guillermo Torre Amione (UNITED STATES )
Monday, 19 May 2008
Gange s - Gr e e n P avillion - 1 4 :0 0- 15: 30
Clinical Seminar
Endo v a sc u l ar he a r t val ve int er v e nt ions :
The e n d o f v a l v u l a r op e n h e ar t surge ry? - Pa r t one
Chairs: Rubén Piraino (ARGENTINA), Ramón Quesada (UNITED STATES )
14:00
Results with a new valve
Alexander Abizaid (BRAZIL)
14:18
How to select patients for endovascular balloon expandable aortic bioprosthesis?
Agatiello Carla (ARGENTINA)
14:36
Innnovative approaches in surgical valve replacement
Timothy Gardner (UNITED STATES )
14:54
Further applications for percutaneous aortic valve biosprosthesisr: For all patients?
Deborah Nercolini (BRAZIL)
15:12
South American experience
Jose Condado (VENEZUELA)
P araná - Ochre P avillion - 1 4 :0 0 - 15: 30
Debate
The p o l y p i l l i s an ef f e c tive s tr a te gy
fo r re d uct i o n o f ca r d i o v a sc u l ar diseases
Chairs: Fuster Valentin (UNITED STATES ), Ricardo Esper (ARGENTINA)
14:00
Statement 1:
The polypill is an effective strategy for reduction of cardiovascular diseases
Pro: Gines Sanz (SPAIN)
Contra: Satyavan Sharma (INDIA)
14:45
Statement 2:
The statin pleotrophic effect is very important
Pro: Nanette Wenger (UNITED STATES )
Contra: TBD
Mis s is s ippi - Ye llow P avillion - 1 4 :0 0- 15: 30
How-to & Workshop Session
New trends in the management of cardiovascular risk:
The r o l e o f h e a r t r at e
Chairs: Kumar Anil (INDIA), Jose Luis Vukasovic (CHILE)
14:00
Heart rate and prognosis in cardiovascular diseases
José Luis López-Sendón (SPAIN)
14:30
Heart rate reduction: Evidence of clinical benefit
Sheikh Shahryar A (PAKISTAN)
15:00
Heart rate and heart failure: Partners or enemies?
Willem Remme (NETHERLANDS)
Scientific Programme / 89
Monday, 19 May 2008
Fet a l c ard i o l o g y
Chairs: Miguel Granja (ARGENTINA), Loreta Jara (CHILE)
14:00
Interventional cardiology in newborns
John Cheatham (UNITED STATES )
14:22
Management outcome of congenital AV block
Paulo Zielinsky (BRAZIL)
14:44
Advances in fetal diagnosis, including MRI
David Sahn (UNITED STATES )
15:06
Aortic valvuloplasty in HLHS
Pablo Marantz (ARGENTINA)
Volga - Ye llow P avillion - 1 4 :0 0- 15: 30
Symposium
Me kong - Ochre P avillion - 1 4 :0 0- 15: 30
Symposium
Antithrombotic treatment in non-ST-acute coronary syndrome
Chairs: Mònica Masotti (SPAIN), Barrero Carlos (ARGENTINA)
14:00
Usefulness of antithrombin agents in non-ST-acute coronary syndrome
Jose Nicolau (BRAZIL)
14:22Contemporary issues in clopidogreltherapy for non-ST segment elevation infarction:
New evidence for clinical practice
I. Coma-Canella (SPAIN)
14:44
Optimal pharmacological treatment of non-ST -elevation acute coronary syndrome without PTCA
Radke P (GERMANY)
15:06
Rate of complications and management of antithrombotic treatment in non-ST -acute coronary syndrome
Jose Navarro Estrada (ARGENTINA)
Or inoco - Ochre P avillion - 1 4 :0 0- 15: 30
Symposium
Up - d a t e o f t r e a t m e n t o f h y p e r t ension
Chairs: Alberto Re (ARGENTINA), Oscar Carretero (UNITED STATES )
14:00
Polypill: Which component and to whom?
Nicholas Wald (UNITED KINGDOM)
14:22
Meta-analysis in hypertension
Carlos Ferrario (UNITED STATES )
14:44
Clinical trials for hypertension: Expectation fulfilled and unfulfilled
Alberto Zanchetti (ITALY)
15:06How strong is the evidence for the use of beta-blockers as a first-line therapy for hypertension?
Systematic review and meta-analysis
Giuseppe Mancia (ITALY)
Monday, 19 May 2008
Huang He - Ye llow P avillion - 1 4 :0 0 - 15: 30
Clinical Seminar
All a c a r d i o logis t n ee d s to kn o w ab out cardiac MSCT& MR I
Chairs: Horacio Dinunzio (ARGENTINA), David Vetcher (ARGENTINA)
14:00
Actual role of cardiac MSCT: Where are we?
Marcelo Goldstein (BELGIUM)
14:22
Coronary calcium score: Applications in clinical practice
(UNITED STATES )
14:44Non-invasive coronary computed tomographic angiography for patients with low and high pre-test
probability for having coronary artery disease: Is it still an indication?
Anibal Damonte (ARGENTINA)
15:06
Dual source computed tomography: Is it the real advantage in MSCT?
Ernest Garcia (UNITED STATES )
Nile - Ye llow P avillion - 1 4 :0 0 - 15: 30
Symposium
Are comorbidities a limit to cardiovascular prevention in the elderly?
Chairs: Pasquale Abete (ITALY), Mariano Giorgi (ARGENTINA)
14:00
Cardiovascular Prevention in the Elderly
Mario Garcia-Palmieri (PUERTO RICO)
14:22
Acute coronary syndromes/myocardial infarction at advanced age
Faiez Zannad (FRANCE)
14:44
Polypharmacy in the elderly
Nedina Mendez (VENEZUELA)
15:06
Cardiac rehabilitation and its limits
Mauricio Wajngarten (BRAZIL)
Tigris - Ye llow P avillion - 1 4 :0 0 - 15: 30
Debate
Car d i o p u l m o n ar y r es u s c it a tion
Chairs: T. P. Aufderheide (UNITED STATES ), Ari Timerman (BRAZIL)
14:00
Statement 1:
Cardiocerebral resuscitation: Is ventilation not necessary in cardiac arrest?
Pro: Karl B. Kern (UNITED STATES )
Contra: Timerman Sergio (BRAZIL)
14:45
Statement 2:
Metabolic Resuscitation: Hibernation or hypothermia in CPR?
Pro: Soon Joo Wang(Seoul, KOREA, REPUBLIC OF)
Contra: Flavio Marques (BRAZIL)
Scientific Programme / 91
Monday, 19 May 2008
P ilcomayo - Ye llow P avillion - 1 4 :0 0- 15: 30
Symposium
U se o f 3 D ec h o i n c l i n ica l d a y - t o-day pr acti ce
Chairs: Mario Garcia (UNITED STATES ), Fernando Manzur Jattin (COLOMBIA)
14:00
Quantitation of valvar heart disease
Navin Nanda (UNITED STATES )
14:22
Differentiation of cardiac masses
Juan Carlos Plana (UNITED STATES )
14:44
Assessment of adult congenital heart disease
Mani Vannan (UNITED STATES )
15:06
Assesment of LV ejection fraction, volume and mass
Marcelo Trivi (ARGENTINA)
Thame s - Ye llow P avillion - 1 4 :0 0- 15: 30
Special Featured Joint Session
S C AI-SOLACI:
Wh a t w e k n o w a n d w h a t w e d o n 't kno w about DES
Chairs: Carlos Mendiz (ARGENTINA), Ziyad Hijazi (UNITED STATES )
14:00
Interventional cardiologist institute
Manish Parikh (UNITED STATES )
14:14
Worldwide impact of DES and worldwide impact of late sten thrombosis
Christopher Cates (UNITED STATES )
14:28
Is late stent thrombosis a main concern?
Bonnie Weiner (UNITED STATES )
14:42
What do we know and what we don't know about DES in off label indications
Daniel Berrocal(ARGENTINA)
14:56
The future of DES
Alexander Abizaid (BRAZIL)
15:10 Panel:
D. Echeverri (Columbia), F. Brito (Brazil), C. Cates (UNITED STATES), B. Weiner (UNITED STATES),
A. Abizaid (Brazil)
Mis s ouri - Ye llow P avillion - 1 4 :0 0- 15: 30
Special Featured Joint Session
A P S C : Gl o b a l b urd e n o f h e a r t f ailu re
Chairs: Hisayoshi Suma (JAPAN), Takeshi Nakatani (JAPAN)
14:00
Idiopathic Heart Failure: Contribution of cardiomyopathy and the global alert and response network
Matsumori Akira (JAPAN)
14:22
Etiological diagnosis of Heart Failure
Cheuk-Man Yu (CHINA, PEOPLE'S REPUBLIC OF)
14:44
Heart Failure: Epidemiology, pathophysiology and treatment worldwide
David T. Kelly(AUSTRALIA)
15:06
Valvular heart diseases in developed and undeveloped countries
Robert Bonow (UNITED STATES )
Monday, 19 May 2008
Amaz on - Ye llow P avillion - 1 4 :0 0- 15: 30
South American Congress of Cardiology
Cómo optimizar el tratamiento de la insuficiencia cardiaca crónica
Coordinadores: Graciela González Bogado (PARAGUAY), José Luis Barisani (ARGENTINA)
14:00 Tratamiento farmacológico actual. Interrogantes no resueltos
Miguel Gonzalez (ARGENTINA)
14:15
¿Cómo adecuar el tratamiento en el paciente con comorbilidades?
Waldo Fernández Durand (PERU)
14:30
¿Cómo seleccionar a los candidatos para resincronización ventricular?
Walter Reyes Caorsi (URUGUAY)
14:45
Estrategias de manejo en el paciente chagásico. ¿Son diferentes?
Harry Acquatella (VENEZUELA)
15:00
Alternativas terapéuticas en la IC refractaria
Fernando Bacal (BRAZIL)
R hine - Ye llow P avillion - 1 6 :0 0 - 17: 30
Symposium
M an a g e m e n t o f a rr h y t h m i a s i n geneti cally based diseases
Chairs: Walter Reyes Caorsi (URUGUAY), Pablo ChiAle (ARGENTINA)
16:00
Brugada syndrome
Marcelo Elizari (ARGENTINA)
16:22
Short and long QT syndrome
Christian Wolpert (GERMANY)
16:49
Right ventricular dysplasia
Nestor Galizio (ARGENTINA)
17:11
Catecholamine-induced polymorphic ventricular tachycardia
Riccardo Cappato (ITALY)
Danub e - Gr e e n P avillion - 1 6 :0 0 - 17: 30
Symposium
Car d i a c r e sy nc hr o n is at io n t her apy (CR T) - P art Two
Chair: Saúl Drajer (ARGENTINA)
16:00
Reasons for failure of CRT
Luis Molina (MEXICO)
16:22
Emerging indications for CRT
Michael Gold (UNITED STATES )
16:44
Should all patients with an indication for CRT also receive an ICD?
John Camm (UNITED KINGDOM)
17:06
Cost-effectiveness of CRT: Implications for developing countries
John Gorcsan III (UNITED STATES )
Scientific Programme / 93
Monday, 19 May 2008
P ilcomayo - Ye llow P avillion - 1 6 :0 0- 17: 30
How-to & Workshop Session
Op t i m u m tr e a t m e n t f or h e ar t f ailur e
Chairs: Krauss Juan (ARGENTINA), Roberto Ricca (URUGUAY)
16:00
How to prevent heart failure?
Jay Cohn (UNITED STATES )
16:45
How to achieve guidelines recommendations in patients with heart failure?
Philip A Poole-Wilson. (UNITED KINGDOM)
Se ine - Gr een Pavillion - 16:00-17:30
Clinical Seminar
S u r g ica l t r e a t m e n t f or c o n g e s tive hea rt failu r e
Chairs: Hector Ventura (UNITED STATES ), Ernesto Weinschelbaum (ARGENTINA)
16:00
Surgical correction of mitral regurgitation in end stage cardiomyopathy
Enio Buffolo (BRAZIL)
16:22
Surgical strategy for non-ischaemic cardiomyopathy
Hisayoshi Suma (JAPAN)
16:44
Ventricular restoration for ischaemic heart failure
Noedir Groppo Stolf (BRAZIL)
17:06
Left ventricular assist device
José Luis Navia (UNITED STATES )
Mis s ouri - Ye llow P avillion - 1 6 :0 0- 17: 30
Symposium
Hea r t f a i l u r e w ith n o r m a l e j ec t ion fract ion
Chairs: Mihai Gheorghiade (UNITED STATES ), Miguel Gonzalez(ARGENTINA)
16:00
Diastolic heart failure: Is it a disease?
Marvin Konstam (UNITED STATES )
16:22
Prevalence and etiologies 16:44
How to diagnose in clinical practice
Jorge Thierer (ARGENTINA)
17:06
How to treat
John Cleland (UNITED KINGDOM)
Thame s - Yello w Pavillion - 16:00-17:30
Special Featured Joint Session
WHFS : T h e f a i l ing hear t a r ound the world
Chairs: Shahryar A. Sheikh (PAKISTAN), Grancelli Hugo (ARGENTINA)
16:00
Chagas' disease, or hypertension and IHD: Which are the driving factors of heart failure in Latin America?
Bocchi E. A. (BRAZIL)
16:22
HIV-related heart failure in Africa
Mayosi Bongani (SOUTH AFRICA)
16:44
Heart failure due to virus infection in Asia
Matsumori Akira (JAPAN)
17:06
What we have learned from heart failure registries in Europe
Willem Remme (NETHERLANDS)
Monday, 19 May 2008
Huang He - Ye llow P avillion - 1 6 :0 0 - 17: 30
Symposium
Delayed enhancement imaging for evaluation of cardiomyopathies
Chairs: Wilson Mathias (BRAZIL), Lorenzo Montserrat (SPAIN)
16:00
Currents status, indications and limitations of MSCT angiography
Marcelo Goldstein (BELGIUM)
16:18
Myocardial perfusion imaging by MSCT: Is it possible to use in clinical practice?
Joanne D. Schuijf (NETHERLANDS)
16:36
MSCT and molecular imaging: New advances
Milind Desai (UNITED STATES )
16:54
Non-invasive diagnostic of vulnerable plaque: the eternal challenge
Mario Garcia (UNITED STATES )
17:12
Relationships between CT, PET, SPECT and MR
Daniel Berman (UNITED STATES )
Or inoco - Och r e Pavillion - 16:00 -17:30
Special Featured Joint Session
ISH : Ho t t op ics i n h y p er t e n s i o n : an u p date
Chairs: Gilson Feitosa(BRAZIL)
16:00
Is time to say good-bye to beta-blockers as first line treatment for primary hypertension?
Lars Lindholm (SWEDEN)
16:22
Ambulatory blood pressure and prediction of risk: do we need the night?
Robert Fagard (BELGIUM)
16:44
Heart remodelling in hypertension
Daniel Piskorz (ARGENTINA)
17:06
Salt sensitive hypertension: genetics pathophysiology and management
Ramiro Sánchez (ARGENTINA)
Euphrat e s - Ochre P avillion - 1 6 :0 0- 17: 30
Symposium
Man a g e m e n t o f a s y m p t o m a t ic v alve disease
Chairs: Jose Antonio Francisco Ramires (BRAZIL), Jorge Lopez Sosa (ARGENTINA)
16:00
Aortic regurgitation
Escobar Edgardo (CHILE)
16:22
Aortic stenosis
Jeffrey Borer (UNITED STATES )
16:44
Mitral valve prolapse
Tomás Cianciulli (ARGENTINA)
17:06
Criteria for early intervention in asymptomatic patients
Robert Bonow (UNITED STATES )
Scientific Programme / 95
Monday, 19 May 2008
Me kong - Ochre P avillion - 1 6 :0 0- 17: 30
Symposium
Revascularization of patients with stable coronary artery disease
Chairs: Cossio Pedro (ARGENTINA), Shirish Hiremath (INDIA)
16:00
Optimal medical treatment in patients with stable coronary artery disease
Karina Rey García (CUBA)
16:22
Is ischemia enough to select patients for PCI?
Gao Runlin (CHINA, PEOPLE'S REPUBLIC OF)
16:44
PCI outcomes with drug eluting stents
Jose Alejandro Martinez Sepulveda (CHILE)
17:06
How to select the best strategy for managing patients with stable coronary artery disease?
Volga - Ye llow P avillion - 1 6 :0 0- 17: 30
Symposium
Int e r v e n t i o n al c a r diol ogy in c onge nit al he art dis e as e
Chairs: Zabal Carlos (MEXICO), Mariano Ithuralde (ARGENTINA)
16:00
ASD Closure
Ziyad Hijazi (UNITED STATES )
16:18
VSD Closure new developments
Trong Phi Le (GERMANY)
16:36
Hybrid procedures
John Cheatham (UNITED STATES )
16:54
Use of stents
Carlos Pedra (BRAZIL)
17:12
Cutting balloon results
Neil Wilson (UNITED KINGDOM)
Mis s is s ippi - Ye llow P avillion - 1 6 :0 0- 17: 30
Symposium
Cell u l a r r e g e n er a tive t her a p y in cardiology
Chairs: Jorge Trainini (ARGENTINA), David T. Kelly(AUSTRALIA)
16:00
Role of stem- and progenitor cells in coronary artery disease
Luis De La Fuente (ARGENTINA)
16:22
Which cells and which route of administration?
Julio Argentieri(ARGENTINA)
16:44
For which patients?
Juan Carlos Chachques (FRANCE)
Monday, 19 May 2008
P araná - Ochre P avillion - 1 6 :0 0 - 17: 30
Symposium
Cardiovascular risk and human immunodeficiency virus (HIV) infection in Africa
Chairs: Jean-Rene M’buyamba (CONGO, THE DEMOCRATIC REPUBLIC OF THE), Karen Sliwa (SOUTH AFRICA)
16:00
Cardiovascular risk in HIV-infected patients: Global overview and implication for action
Sergio Lupo (ARGENTINA)
16:22
Cardiovascular risk in African HIV patients: Situation analysis and implication for action
Onen Churchill (BOTSWANA)
16:44
Cost-effective approaches for management and prevention of HIV infection induced cardiomyopathie in Africa
Amoah Albert (GHANA)
17:06
Mechanisms of cardiovascular diseases in HIV-infected patients: Is there an ethnic difference?
Daniel Lemogoum (CAMEROON)
Yangt z e - Ochre P avillion - 1 6 :0 0- 17: 30
Symposium
Hea l t h pr o m o t io n f or c hil d r e n
Chair: Diego Esandi (ARGENTINA), Volqvartz Susanne (DENMARK)
16:00
Relation between CVD risk factors in children and their parents: Smoking and Rayuela Project
Maria Ines Sosa Liprandi (ARGENTINA)
16:22
The role of the paediatrician in school-based health education programmes
Soon Joo Wang Ernesto Juaneda (ARGENTINA)
16:44
Protecting children from marketing
Anita Saxena (INDIA)
17:06
The Colombia experience
Beatriz Londoño (COLOMBIA)
R io de la P lat a - R e d P avillion - 1 6 :0 0- 17: 30
Symposium
The po l y pi l l
Chairs: Angeles Alonso Garcia (SPAIN), Alfonso Perez (UNITED STATES )
16:00
Why a polypill?
Nicholas Wald (UNITED KINGDOM)
16:22
Clinical considerations
Fuster Valentin (UNITED STATES )
16:44
Regulatory issues
Martin Seoane (ARGENTINA)
17:06
Cost benefit considerations
Gianni Tognoni (ITALY)
Scientific Programme / 97
Monday, 19 May 2008
R es u sc i t a t i o n s c ie n c e a n d s u r vival
Chairs: Timerman Sergio (BRAZIL), Ana Salvati (ARGENTINA)
Tigris - Ye llow P avillion - 1 6 :0 0- 17: 30
Symposium
16:00
International collaboration on resuscitation guidelines
Soon Joo Wang (KOREA, REPUBLIC OF)
16:22
Quality CPR
Manoel Fernandes Canesin (BRAZIL)
16:44
The history of how resuscitation techniques have been developed
Fabián Gelpi (ARGENTINA)
17:06
Public access to defibrillation: Why, when and where?
Alessandro Capucci (ITALY)
Nile - Yello w Pavillion - 16:00-17:30
Symposium
Pri m a r y a n d s e c o n d a r y preve n tion in at he ros cle ros is :
Fro m t h e o r y t o dail y prac t ic e
Chairs: Masao Sano (PARAGUAY), Guzman L. (ARGENTINA)
16:00
International guidelines: Can they be extrapolated and implemented in our countries?
Gianni Tognoni (ITALY)
16:22
Control and prevention of cardiovascular disease around the world
Ponte N Carlos I. (VENEZUELA)
16:44
Statins and other cardiovascular drugs in developing countries: Are the usual doses useful?
Carlos Cuneo (ARGENTINA)
17:06
Cardio-protection through promotion of physical activity in mega cities
Mario Garcia-Palmieri (PUERTO RICO)
Gange s - Gr e e n P avillion - 1 6 :0 0- 17: 30
Clinical Seminar
All y o u n e e d to kn o w a b out c arot id s t e nt ing
Chairs: Martínez Rios Marco A (MEXICO), Roxana Mehran (UNITED STATES )
16:00
Current practice and multicentric trial with the "TwinOne" cerebral protection system
Jacques Theron (FRANCE)
16:22
Protection devices: Are all the same?
José Gabay (ARGENTINA)
16:44
Why should we treat asymptomatic patients with severe carotid stenosis?
Lylyk Pedro (ARGENTINA)
17:06
Carotid stenting: Level of evidence: Where are we? Where are we going?
Hugo Londero (ARGENTINA)
Monday, 19 May 2008
Nige r - Gr e e n P avillion - 1 6 :0 0 - 17: 30
Special Featured Joint Session
IS CU: Up d a t e i n 3 D Ec h o c ar d i o gr ap hy
Chairs: Nelson Pizzano (URUGUAY), Amuchástegui Luis Maria (ARGENTINA)
16:00
Basics of 3-D echocardiography
Ronderos Ricardo (ARGENTINA)
16:22
3-D TTE /TEE in the evaluation of valvular heart disease
Juan Carlos Plana (UNITED STATES )
16:44
3-D transesophageal echocardiography
Mani Vannan (UNITED STATES )
17:06
3-D echocardiography in the assessment of intracardiac masses and adult congenital heart disease
Navin Nanda (UNITED STATES )
Amaz on - Ye llow P avillion - 1 6 :0 0 - 17: 30
South American Congress of Cardiology
Manejo del paciente con síndrome coronario agudo
Coordinadores: Gabriel D’empaire Yanes (VENEZUELA), Daniel Isaza (COLOMBIA)
16:00
SCA sin supra ST: ¿Cómo identificar al paciente de alto riesgo clínico?
Miguel Quintana (PARAGUAY)
16:15
SCA sin supra ST: Estrategia invasiva ¿Sistemática o electiva?
Carlos Tajer (ARGENTINA)
16:30
SCA con supra ST: ¿Cómo lograr la reperfusión óptima?
Francisco Benítez (ECUADOR)
16:45
Terapia antiplaquetaria combinada post SCA ¿A quién, cómo y durante cuánto tiempo?
Jose Nicolau (BRAZIL)
Scientific Programme / 99
Scientific programme by day and by time
Tuesday, 20 May 2008
Acu t e c o ro n ar y e v e n t s
Chairs: Manuel IrarrazAbal (CHILE), Ernesto Ferreiro (ARGENTINA)
Se ine - Gr een Pavillion - 08:30-10:00
Oral abstract Session
08:30Differences in mobilization of mesenchymal and endothelial progenitors cells by early ischemic
preconditioning in porcine myocardial ischemia-reperfusion
M. Gyongyosi, N. Pavo, A. Posa, R. Hemetsberger, S. Steiner-Boker, C. Kopp, I. Pavo Jr., Z. Petrasi, Ö. Petnehazy,
D. Glogar
08:43Effect of dietary restriction in the mitochondrial function in an EX-VIVO animal model of diabetes submitted
to global myocardial ischemia-reperfusion
P. Monteiro, P. Matafome, A. Reis, S. Monteiro, R. Seiça, L. Goncalves, L. A. Providencia
08:56Recurrent angina after admission may partially explain some discrepancies between initial risk stratification
and the selection for invasive evaluation in Non ST elevation Acute Coronary Syndromes. Results of the
multicentre registry Epi-Cardio
M. De Abreu, J. Mariani, A. Charask, E. Zuanich, C. Pellegrini, M. Trevisan, E. Forte, J. Gagliardi, C. Tajer, H. Doval
09:09Long-term prognosis of patients with acute chest pain, normal electrocardiogram, and non detectable
cardiac troponin
R. Merbilháa, M. P. Marturano, G. F. Procopio, L. Pfister, M. Piraino, G. A. Ontiveros, M. J. Fosco
09:22Utility of the Global Registry of Acute Coronary Events Risk Score in Mild or Severe Obstructive Coronary
Artery Disease in Non-ST-segment Elevation Acute Coronary Syndromes
E. Gurfinkel, E. Duronto, F. Guerloy, B. M. Kennelly, J. López-Sendón, Á. Avezum, E. Beck, K. A. Eagle, G. Fitzgerald,
J. M. Gore
09:35White Blood Cell Subtypes Predicting Diagnosis in a Chest Pain Unit: Diagnostic Value of an Elevated
Neutrophil to Lymphocyte Ratio in Patients with Suspected Acute Coronary Syndrome
D. Precoma Neto, A. D. Zazula, G. F. Barbieri, A. M. Gomes, H. Kruklis, M. Conforto, G. Facin, R. Y. Forte, J.R. Faria Neto
09:48Distinguishing Features of Mild vs Severe Coronary Artery Disease in Patients With Acute Coronary
Syndromes. The Global Registry of Acute Coronary Events
E. Duronto, E. P. Gurfinkel, K. A. Eagle, R. J. Goldberg, D. Brieger, B. Freedman, M. Jelinek, G. Fitzgerald, J. M. Gore
Tuesday, 20 May 2008
Me kong - Och r e Pavillion - 08:30 -10:00
Oral abstract Session
Ma r k ers i n a c u t e s y n dr o m e s
Chairs: Sokn Fernando (ARGENTINA), Luis Molinary (PUERTO RICO)
08:30Clinical correlates of acute myocardial infarction recurrence in patients presenting at a tertiary care
hospital in the US.
I. Singla, A. Sunil, H. Hreybe, S. Samir
08:43Creatinine Level or Estimated Creatinine Clearance as Predictors of Cardiovascular Mortality in Patients
Undergoing CABG – Do We Really Need the Math?
L. H. W. Gowdak, J. J. G. De Lima, J. A. F. Ramires, L. A. M. Cesar
08:56Cystatin c plasma concentration in patients with multivessel coronary artery disease and hypertension
predicts cardiovascular events during the follow-up observation
Z. Dzielinska, A. Januszewicz, A. Prejbisz, J. Chudek, M. Makowiecka-Ciesla, M. Demkow, P. Tyczynski, A. Wiecek,
W. Ruzyllo
09:09Reviewing the American Society of Transplantation Guidelines for Cardiovascular Risk Stratification in Renal
Transplant Candidates
L. H. W. Gowdak, R. L. Arantes, F.J. De Paula, L. A. M. Cesar, L. E. Ianhez, E. M. Krieger, J. J. G. De Lima
09:22
Prognostic value of the QTc prolongation in patients with Acute Coronary Syndrome
J. Siccha Martinez, M. Carrion Chambilla
09:35 Can the creatinine clearance predict bleeding complications in acute coronary syndrome patients?
N. Antonio, S. Monteiro, C. Lourenco, R. Teixeira, S. Costa, F. Goncalves, P. Monteiro, L. Goncalves, M. Freitas,
L. A. Providencia
09:48 Prediction of renal artery stenosis in patients with coronary and supraaortic artery atherosclerotic disease
T. Przewlocki, A. Kablak-Ziembicka, W. Tracz, G. Kopec, P. Rubis, A. Kozanecki, T. Stompor, M. Kostkiewicz,
A. Sokolowski, M. Pasowicz
Scientific Programme / 101
Tuesday, 20 May 2008
Tigris - Yello w Pavillion - 08:30-10:00
Oral abstract Session
Acu t e m y o c a r dial in f a rc t io n
Chairs: Jorge Leguizamon (ARGENTINA), Sismondi Horacio (ARGENTINA)
08:30Direct Transport of MI Patients to Interventional Cardiology Centre Following ECG Teletransmission Increases
Percentage of Patients Treated within the Timeframe Set by Guidelines
M. Karcz, P. Bekta, M. Skwarek, M. Dabrowski, K. Kukula, J. Kadziela, M. Ciszewski, A. Debski, M. Demkow, W. Ruzyllo
08:43Outcomes in ST Elevation Acute Myocardial Infarction patients poorly included in randomized controlled
clinical trials
C. Higa, F. Botto, J. Fuselli, P. Blanco, E. Fairman, A. Fernandez, H. Cohen Arazi, R. Merbilhaa, R. Sarmiento, J. Gagliardi
08:56The Chilean Health Reform and its impact in the Management and Mortality of ST Segment Elevation
Myocardial Infarction (STEMI) in Chilean Hospitals.
C. N. Carolina Nazzal, P. C. Pabla Campos, R. C. Ramon Corbalan, J. B. Jorge Bartolucci, P. S. Patricio Sanhueza,
J. C. P. Juan Carlos Prieto, F. L. Fernando Lanas
09:09
Nationwide trends in the incidence of acute ST elevation myocardial infarction (STEMI) in the United States
M. R. Movahed, M. Hashemzadeh, M. M. Jamal
09:22
Acute Myocardial Infarction With ST-Segment Elevation
W. Quiroga Castro, E. Conci, F. Zelaya, M. Isa, J. Sala, G. Pacheco, C. Balestrini, C. Serra, C. Quiroga, A. Bossi
09:35
Contribution of each subinterval to door-to-balloon time in primary angioplasty.
I. Gomes, A. Correa, M. Makdisse, M. Perin, S. F. Brito Jr., A. Abizaid, B. Almeida, M. A. Magalhães, T. C. Nascimento
09:48 Women with acute myocardial infarction are more likely than men to have delayed door-to-ECG time
M. Makdisse, A. G. Correa, A. Pfeferman, L. M. A. Forlenza, M. Knobel, V. Oliveira, S. Ellovitch, C. O. Berlowitz Fo,
M. Vaidotas, E. Knobel
R hine - Ye llow P avillion - 0 8 :3 0- 10: 00
Oral abstract Session
ECG , a tr i a l f i br i l a t i o n a n d a b l ation
Chairs: Carlos Labadet (ARGENTINA), Adrian Baranchuk(CANADA)
08:30
Isolated areas of electrical remodeling: electrocardiographic characteristics and clinical aspects.
S. Sclarovsky
08:43Electro-vectorcardiographic patterns in patients with severely symptomatic hypertrophic obstructive
cardiomyopathy submitted to percutaneous ethanol septal ablation: immediate and late follow up
Silvia Judith Fortunato De Cano, Manuel Nicolas Cano, Andrés Ricardo Pérez Riera, Jairo Alves Pinheiro Jr.,
Ricardo Pavanello, Amanda Moraes R. Sousa, Jose Eduardo Mr Sousa, Adib Domingos Jatene
08:56
Symptomatic repetitive monomorphic premature ventricular ectopy. Results of radiofrequency ablation.
A. Bochoeyer, R. Rabinovich, L. Enciso, R. Costello, R. Ferreyra
09:09Radiofrequency catheter ablation of incessant ventricular tachycardia in a patient with isolated noncompaction of the left ventricle.
L. Citta, E. Sosa, M. Scanavacca, N. Citta
09:22Findings of sustained ventricular tachycardia in stored electrograms and their correlation with syncope in
patients with definitive pacemakers
G. M. M. Pellegrino, D. Ortega, L. Barja, N. Mangani, L. Mari
09:35
MUSAFTA : MUlticenter Study Atrial Fibrillation Transcatheter Ablation ) – Ablation Characteristics. Follow-up
L. Barja, D. Ortega, N. Mangani, M. Kenar, A. Hita, F. Ditomaso, S. Baratta, J. Bilbao, H. Fernadez, D. Turri
09:48
Advantages of the catheter ablation of nodal slow pathway during atrioventricular nodal tachycardia
R. Speranza, G. Costa, O. Perez Mayo, A. Stefani, D. Deluso, A. Alfie, A. Balestrini, C. De Zuloaga
Tuesday, 20 May 2008
R io de la P lat a - R e d P avillion - 0 8 :3 0- 10: 00
Oral abstract Session
At ri a l f l u t t er a n d f i b r i l a t i o n
Chairs: Oseroff Oscar (ARGENTINA), Jose Carlos Pachon Mateos (BRAZIL)
08:30 D
oes Timing of Atrial Fibrillation Onset or Ventricular Rate Relate to the Development of In-Hospital
Ventricular Fibrillation in Patients with Acute Myocardial Infarction
R. Sankaranarayanan, H. Gonna, B. Nuta, S. Burtchaell, R. Holloway, M. A. James
08:43
Feasibility of Common Atrial Flutter Radiofrequency Catheter Ablation in Outpatients
E. Marijon, S. Boveda, N. Combes, A. Bortone, J. Najjar, J. P. Donzeau, S. Jacob, J. P. Albenque
08:56Omega 3 Fatty Acid Supplementation reduces One-Year Risk of Atrial Fibrillation in Patients Hospitalized with
Myocardial Infarction
A. Macchia, S. Monte, M. Romero, F. Pellegrini, A. P. Maggioni, A. Dettorre, G. Tognoni
09:09
ifferent medical pretreatment strategies in persistent atrial fibrillation after successful cardioversion.
D
From Bisoprolol to Ivabradin?
K. G. Adamyan, A. V. Astvatsatryan, A. L. Chilingaryan
09:22New insights of segmental pulmonary vein isolation by irrigated catheter ablation and the mesh
mapper technique
A. Meissner, M. Christ, M. Von Bracht, P. Maagh, C. A. Perings, H. J. Trappe, G. Plehn
09:35
CaMKII-dependent phosphorylation of defective RyR2 predisposes to atrial fibrillation (WITHDRAWN)
X. H. Wehrens, M.G. Chelu, S. Sood, R. Van Oort, D. Skapura, D. Dobrev
09:48 Predictive factors of atrial systole recovery after left MAZE III surgery by radiofrequency ablation
MD Tinetti Matias, MD Lescano Adrian, MD Costello Ramiro, MD Daru Victor, MD Cardenas Cesar,
MD Piazza Antonio, MD Iglesias Ricardo
Euphrat e s - Ochre P avillion - 0 8 :3 0- 10: 00
Oral abstract Session
Mitr a l v a l v e dis eas e a n d p u l m onary hype rt e ns ion
Chairs: Ricardo Migliore (ARGENTINA), Jane Somerville (UNITED KINGDOM)
08:30
Changes of myocardial function after mitral valve downsizing in patients with ischemic mitral regurgitation
J. Ostermeyer, S. Geidel, M. Lass, K. H. Kuck
08:43
Mechanisms underlying dyspnea in patients with Rheumatic Mitral Stenosis
C. Palaniswamy, R. Guleria, R. Narang, S. Ramamurthy, A. Mohan
08:56
Rheumatic heart disease prevalence in Fiji
A. C. Steer, J. Kado, N. Wilson, L. Waqatakirewa, T. Tuiketei, E. K. Mulholland, M. Good, A. J. W. Jenney, J. R. Carapetis
09:09
Pulmonary hypertension in patients with ankylosing spondylitis
D. A. Poddubnyy, N. A. Karoli, A. P. Rebrov
09:22
Oxidative stress-induced fetal programming of hypoxic pulmonary hypertension
J. Bloch, P. Y. Jayet, C. Mathieu, P. Dessen, A. Monney, M. Schwab, H. Duplain, J. F. Tolsa, C. Sartori, U. Scherrer
09:35Demographic, clinical and functional characteristics of outpatients with different stages of Chagas´disease
in a prospective registry
R. Agüero, L. Ferrer, V. Volberg, M. Leonardi, M. Sancineti, A. Sancineti, Horacio Pomes Iparraguirre, G. Calderon
09:48
xercise-induced abnormal pulmonary arterial pressure response in adolescents and adults with atrial
E
or ventricular septal defect
T. Möller, E. Pettersen, K. Peersen, P. M. Fredriksen, H. Holmstrøm, E. Thaulow
Scientific Programme / 103
Tuesday, 20 May 2008
Mis s ouri - Ye llow P avillion - 0 8 :3 0- 10: 00
Oral abstract Session
Card i ac tra n s p l a n t a t i o n
Chairs: Diez Mirta (ARGENTINA), Hector Ventura (UNITED STATES)
08:30Influence of regeneration of heart muscle on mobilization of BM-CPCs by intracoronary autologous bone
marrow cell transplantation in patients with AMI as well as with Chronic Myocardial Infarction
R. G. Turan, M. Brehm, S. Yokus, M. Koestering, S. Steiner, T. Zeus, T. Bartsch, C. M. Schannwell, B. E. Strauer
08:43Phenotype Characterization Through Cellular Network Reconstruction. A Systems Biology Approach to the
Discovery of Candidate Molecular Targets for Phenotype Characterization and Compound Discovery in Heart
Transplantation
M. Cadeiras, A. Sinha, M. Bayern, F. Latiff, W. K. Lim, R. Dedrick, T. Palomero, C. C. Marboe, A. Califano, M. C. Deng
08:56
NT-proBNP is not useful in early follow up of heart transplant patients
D. Milicic, J. Ljubas, B. Pezo-Nikolic, B. Skoric
09:09Improving Diagnostic Accuracy of Acute Cellular Cardiac Allograft Rejection Applying Non-Linear Algorithms
to Whole Genome Microarrays in Peripheral Blood Mononuclear Cells of Heart Transplant Recipients
E. Tabak, M. Cadeiras, C. Turner, F. Latif, P. Lal, C. C. Marboe, A. Califano, M. C. Deng
09:22Temporal trends of sex disparity in the referral of patients to heart function clinic, transplant listing, and
cardiac transplantation.
V. Micevski, F. Gustafsson, D. H. Delgado, H. J. Ross
09:35
Role of probiotics in multimodality therapy of chronic heart failure
N. A. Bylova, G.P. Arutyunov, L. I. Kafarskaya, T. K. Chernyavskaya, Z. A. Chernaya
09:48Outcomes in Patients with Advanced Heart Failure and Left Ventricular Ejection Fraction 30% or Less Referred
for Orthotopic Heart Transplantation: The Gender Paradox.
S. M. Yala, M. Cadeiras, R. Henquin, D. M. Mancini, Y. Naka, E. V. Giardina, M. C. Deng
Tuesday, 20 May 2008
Danub e - Gr e e n P avillion - 0 8 :3 0- 10: 00
Oral abstract Session
Chr o n ic h e a rt f a i l ur e
Chairs: Rafael Porcile (ARGENTINA), Ileana Piña (UNITED STATES)
08:30Location of Wall Motion Abnormality as a Determinant of Rapid Diastolic Filling: Role of Left Ventricular
Ejection Fraction
I. P. Clements, D. O. Hodge, C. G. Scott
08:43
Progression of chronic heart failure possible role of gram-negative flora
N. A. Bylova, G. P. Arutyunov, L. I. Kafarskaya, Y. A. Pocrovskiy, T. K. Chernyavskaya, Z. A. Chernaya
08:56Do Cholesterol Levels Influence Long-Term Heart Failure Outcome in Post-Infarct Patients with Moderate
to Severe Left Ventricular Systolic Dysfunction?
R. Sankaranarayanan, M. A. James, H. Gonna, S. Burtchaell, R. Holloway
09:09The Heart Failure Survival Score is a Useful Method in Predicting Cardiovascular Mortality in Severe Heart
Failure Patients
E. Acarturk, M. Koc, T. Yildiran, O. Sen, D. Y. Sahin
09:22Influence of cardiologist and non-cardiologist in the management of outpatients with chronic heart failure
in Argentina. Preliminary results from Argentinean HOSPICAL II Registry
E. Perna, J. P. Cimbaro Canella, C. Poy, F. Diez, R. Colque, L. Lobo Marquez, M. L. Coronel, P. Barrios, S. Perrone
09:35In-hospital and Long-Term Prognosis of Women Compared with Men with Heart Failure and Acute Myocardial
Infarction after Previous Coronary Artery Bypass Surgery; 19-Year Experience
P. Mitrovic, B. Stefanovic, V. Vukcevic, N. Radovanovic, M. Radovanovic, D. Rajic, G. Matic, P. Erceg, Z. Vasiljevic,
M. Ostojic
09:48Non-transplant surgical treatment of primary dilated cardiomyopathy and congestive heart failure RADO operation
N. Radovanovic, S. Popovic, M. Radovanovic, M. Cenanovic, M. Ignjatovic, S. Potic, N. Pejcic, S. Grujic, M. Zorc
Scientific Programme / 105
Tuesday, 20 May 2008
Or inoco - Ochre P avillion - 0 8 :3 0- 10: 00
Oral abstract Session
Dr u g s, d i a be te s a n d hyp er te n s ion
Chairs: Dagnovar Aristizabal (COLOMBIA), Jorge Resk (ARGENTINA)
08:30Blood pressure-lowering efficacy of amiloride versus enalapril as add-on drugs in patients with uncontrolled
blood pressure receiving hydrochlorothiazide: a double-blinded randomized trial with ambulatory blood
pressure measurement
P. Guerrero, F. D. Fuchs, L. B. Moreira, V. M. Martins, C. Bertoluci, S. C. Fuchs, M. Gus
08:43The combination of Amlodipine 5 mg and Valsartan 160 mg lowers blood pressure effectively and safely in
hypertensive patients not controlled by monotherapy with calcium channel blockers
J. Brachmann, R. Handrock, S. Klebs
08:56Anti-hypertensive drug treatment and the effect over different variability indexes of systolic blood pressure
measured by 24-hour Ambulatory Blood Pressure Monitoring
M. Gus, F. F. Vianna, A. L. Ferreira, F. C. Fuchs, J. L. Neyeloff, C. Schneider, M. B. Moreira, L. B. Moreira, S. C. Fuchs,
F. D. Fuchs
09:09Inverse association between ankle-brachial index and blood pressure variability estimated by the rate of
systolic blood pressure variation derived from 24-hour Ambulatory Blood Pressure Monitoring (ABPM)
L. B. Moreira, E. Wittke, F. T. Cichelero, C. M. Moreira, R. Picon, J. S. Varela, T. Bassani, S. C. Fuchs, F. D. Fuchs, M. Gus
09:22Depressive syndrome prevalence in hypertensives patients and its association with higher pulse pressure and
nondipping pattern
S. Obregon, C. Kotliar, P. Forcada, G. Iacometti, D. Chejtman, G. Vallejos, C. Bellido, A. Hita, D. Turri
09:35
Type 1 Diabetes mellitus is strongly and independently associated with essential hypertension
M. R. Movahed, M. Hashemzadeh, M. M. Jamal
09:48Cardiovascular risk assessment by SCORE System in Romania and Poland. Data from two National studies:
SEPHAR and NATPOL III PLUS
M. Dorobantu, T. Zdrojewski, E. Badila, S. Ghiorghe, P. Bandosz, R. O. Darabont, M. Olteanu, P. Flondor
P araná - Oc hr e Pavillion - 08:30-10:00
Oral abstract Session
Lon g QT s y n dr o m e , h e art f a i l ur e and diabetes
Chairs: Manuel Vazquez-Blanco (ARGENTINA), Miguel Adorno (PARAGUAY)
08:30
The Long QT syndrome in pediatric age: prognosis and risk factor
G. Fazio, S. Pipitone, L. D'Angelo, P. Palazzolo, G. Di Gesaro, L. Sutera, G. Novo, S. Novo
08:43
Exercise training in patients with left ventricular systolic dysfunction
G. Brion, R. Peidro, A. Angelino, D. Motta, E. Navia, P. Diaz Uberti, L. Favaloro, M. Diez, R. Favaloro
08:56A Single Submaximal Exercise Session Enhances Systemic Endothelial Function Independently of
Changes in Blood Flow in Patients with Chronic Heart Failure
D. Umpierre, J. P. Ribeiro, P. J. C. Vieira, R. S. Moraes, E. L. Ferlin, R. Stein
09:09
Heart failure mortality in three Brazilian states from 1999 to 2004: an analyis of death certification
E. Gaui, G. Oliveira, C. Klein
09:22
Age related renine and aldosterone status in 430 essential hypertensives
C. Kotliar, P. Forcada, S. Obregon, E. Arcani, J. Bustamante, A. Hita, S. Baratta, D. Turri
09:35Early detection of right ventricular systolic dysfunction by tissue Doppler derived isovolumic myocardial
acceleration (IVA) in Type II diabetes mellitus
Y. Tayyareci, Z. Bugra, Y. Nisanci, B. Umman, A. Oncul, I. Altun, S. Yurdakul, N. Polat, K. Adalet
09:48
Pancreatic islets xenotransplantation in dogs with diabetes type 1
A. Abalovich, M. A. Müller, V. Castillo, A. Pisarevsky, G. Ottaviano, R. Gomez Figueroa, D. R. Grana, J. Milei
Tuesday, 20 May 2008
Yangt z e - Ochre P avillion - 0 8 :3 0- 10: 00
Oral abstract Session
P rim a r y a n d s ec ondar y pre vent i on I
Chairs: Rodolfo Daniel La Greca (ARGENTINA), Mario Bey Lombana (PANAMA)
08:30
Cardiovascular rehabilitation in patients with peripheral artery disease
G. Brion, R. Peidro, A. Angelino, D. Motta, E. Navia, P. Diaz Uberti, C. Capano, M. Cisterna, R. Favaloro
08:43EUROACTION: Changes in smoking, diet and physical activity over one-year in a family based preventive
cardiology programme in hospital and general practice.
J. L. Jones, A. Mead, C. S. Jennings, A. Holden, S. B. Connolly, K. Kotseva, T. Collier, D. De Bacquer, G. De Backer,
D. A. Wood
08:56EUROACTION: Achieving Blood Pressure, Lipid and Glucose targets in a 16 week Multidisciplinary
Cardiovascular Prevention and Rehabilitation Hospital Programme – One Year Results
K. Kotseva, S. Connolly, C. Jennings, A. Mead, J. Jones, A. Holden, D. De Bacquer, G. De Backer, T. Collier, D Wood
09:09EUROACTION: The Achievement of Blood Pressure, Lipid and Glucose Targets in a Cardiovascular Prevention
Programme in General Practice – One Year Results
S. Connolly, K. Kotseva, C. Jennings, A. Mead, J. Jones, A. Holden, T. Collier, D. De Backer, G. De Bacquer, D. Wood
09:22
Cardiovascular Risk in Women: The Link Between Framingham Risk Score and Education Inequalities
S. Yala, E. Fleck, R. Sciacca, D. Castro, E. Giardina
09:35
Follow up of patients undergoing cardiovascular surgery, compliance with secondary prevention measures
S. Kerbage, E. Gallucci, G. Giunta, R. Bianco, J. Figal, J. Abud, E. Dulbecco, H. Raffaelli, R. Favaloro, B. Mautner
09:48 Lack of Cardiac Rehabilitation Programs in Latin America and the Caribbean
A. Montero-Gómez, C. Terzic, C. Mendoza, L. Saavedra, F. Kuniyoshi, R. Thomas, S. Kopecky, R. Squires, J. Vallejos,
F. López-Jiménez
P ilcomayo - Ye llow P avillion - 0 8 :3 0- 10: 00
Oral abstract Session
P rim ary a n d s e co n d a r y pr e v e n t ion II
Chairs: Palmira Pramparo (ARGENTINA), Mauricio Wajngarten (BRAZIL)
08:30 Dance-Hall dancing in patients with cardiovascular disease: Experience of 2 years
P. Quiroga, MD Rius Suárez, Hermes Ilarraza-Lomel, Y. Prior, MA Viveros, I. Montero, M. Chen, A. Halabe, A. López,
D. Flores
08:43EUROACTION: Achieving lifestyle targets in a hospital and primary care multidisiplinary cardiovascular
prevention and rehabilitation programme. Results at 1 year.
A. Mead, J. Jones, C. Jennings, A. Holden, S. Connolly, K. Kotseva, T. Collier, D. De Bacquer, G. De Backer, D. Wood
08:56Global mortality and relationship with cardiovascular risk factors in a cohort of public employees medical
service mendoza argentina. Optimal Systematic Evaluation Program (OSEP STUDY) in Cardiovascular Risk
O. Arrieta, S. Mortaloni, S. Zizzias, A. Añó, J. Alvarez, L. Cammi, S. Depine, S. Gimenez
09:09
Clinical reality of coronary prevention in Europe: a comparison of Euroaspire I, II and III surveys
K. Kotseva, C. Jennings, D. De Bacquer, G. De Backer, D. Wood
09:22
Profile and High Prevalence of Cardiovascular Risk Factors in an Urban Black African Population
K. Tibazarwa, L. Ntyintyane, K. Sliwa, T. Gerntholtz, D. Wilkinson, S. Stewart
09:35
High Prevalence of Cardiovascular Risk Factors Among Brazilian Cardiologists
M. S. Rocha, L. C. L. Correia, J. P. Esteves
09:48Cardiovascular disease prevention and risk factors control: Evaluation of educational community level
intervention and communicational strategies for primary prevention
S. Kunstmann, Maria Teresa Lira, D. Gainza, J. A. Degrazia, J. C. Molina
Scientific Programme / 107
Tuesday, 20 May 2008
Nige r - Gr een Pavillion - 08:30-10:00
Oral abstract Session
R es e a rch o n p har m ac ol ogy
Chairs: Lerman Jorge (ARGENTINA), Angeles Alonso Garcia (SPAIN)
08:30A novel orally active BNP possesses chronic natriuretic actions and decreases mean arterial pressure and
activates cGMP in a model of acute hypertension
A. Cataliotti, H. H. Chen, J. A. Schirger, F. L. Martin, G. Boerrigter, L. C. Costello-Boerrigter, K. D. James, J. C. Burnett
08:48Clinical Utility of Single-Pill Amlodipine Besylate/Atorvastatin Calcium to Reduce Predicted 10-Year Coronary
Heart Disease Risk by Lowering Blood Pressure and Lipids to Meet Therapeutic Goals in Latin American
Patients with Hypertension/Dyslipidemia
H. Chaves, Y. Ro, H. F. Tse, L. Howes, C. Aguilar-Salinas, S. Erdine, R. Guindy, P. Chopra, R. A. Moller, I. M. Schou
09:06Enoxaparin and unfractionated heparin for inpatient initial treatment of venous thromboembolism: an
utilization study and cost-minimization analysis
L. Moreira, C. Argenta, M. A. P. Ferreira
09:24Correlation Between Plasma Concentration Of Aldosterone And Neutrophils And The Effect With Aldosterone
Blockade In Patients With Heart Failure Following Ami
J. Martinez, J. Said Nisi, F. Martinez, M. Bendersky, F. Zaanad, B. Pitt
09:42Correlation of highly sensitive C reactive protein with Acute Coronary Syndromes and effects of Statin therapy
Y. Varma, R. Gupta, A. Kuchwaha, B. S. Yadav, G. Singh, R. K. Shrivastava, V. K. Sharma, T. N. Dube, R. K. Jain, R. S. Meena
Nile - Ye llow P avillion - 0 8 :3 0- 10: 00
Oral abstract Session
Exe rci s e , l i fe s t y l e a n d i s ch e m ic hea rt disease
Chairs: Hermes Ilarraza-Lomeli(MEXICO), Roberto Peidro (ARGENTINA)
08:30
Subacute effects of maximal exercise on heart rate variability in patients with chronic heart failure
P. Soares, P. Moreira, F. Neves, N. Rocha, A. Nobrega
08:45
Invasive exercise testing improves the early diagnosis of pulmonary arterial hypertension
R. Fowler, A. Maiorana, S. Jenkins, M. Thomas, E. Gabbay, G. O'Driscoll
09:00
Relationship of Exercise Heart Rate Responses to 10-Year Mortality in CHD
T. G. Allison, R. W. Squires, B. J. Johnson, F. H. Kuniyoshi, R. J. Thomas 09:15Circulatory responses to walking test of 50 m in coronary unit in unstable angina and acute myocardial
infarction of acute phase
C. Dias, A. Maiato, K. Baqueiro, A. Figueiredo, F. Rosa, J. Pitanga, L. Catão, A. Guimarães
09:30Monitoring myocardial infarction (diagnostic combination, prodromal period, behavioral characteristics)
using the WHO program "Registry of Acute Myocardial Infarction", “MONICA” during the period of 22 years
in Russia
V. Gafarov, A. Gafarova
09:45EUROASPIRE III: Lifestyle and risk factor management and use of drug therapies in coronary patients
from 22 countries in Europe.
K. Kotseva, C. Jennings, D. De Bacquer, G. De Backer, D. Wood
Tuesday, 20 May 2008
Feta l ca rd i o l o g y
Chairs: Pablo Marantz (ARGENTINA), Areias Carlos (PORTUGAL)
08:30
Volga - Ye llow P avillion - 0 8 :3 0 - 10: 00
Oral abstract Session
Histology of Umbilical Blood Vessels
J. Milei, H. Ruda Vega, R. Guerri Guttenberg, D. R. Grana, F. Azzato, M. Vazquez Blanco
08:43The severity of pulmonary regurgitation - what impact it may have on regional right ventricular function in
patients after Tetralogy of Fallot repair
E. Kowalik, M. Kowalski, M. Kusmierczyk, J. Rozanski, P. Hoffman
08:56Fetal ductal arteriosus flow velocities and right ventricular size are influenced by maternal ingestion of
polyphenol-rich common beverages
P. Zielinsky, J. Manica, A. Piccoli Jr., L. Nicoloso, R. Frajndlich, H. Menezes, A. Busato, T. Behrens, J. Huber, M. Silva
09:09 Maternal ingestion of herbal teas and grape juice during pregnancy may cause fetal ductal constriction
P. Zielinsky, A. Piccoli Jr., J. Manica, L. Nicoloso, H. Menezes, R. Frajndlich, A. Busato, L. Hagemann, M. Moraes
J. Silva
09:22An experimental study of the role of maternal ingestion of green tea, mate tea and grape juice as cause of
fetal ductal constriction
P. Zielinsky, J. Areias, A. Piccoli Jr., J. Manica, L. Nicoloso, H. Menezes, R. Frajndlich, M. Moraes, J. Silva, M. Allievi
09:35
Pulmonary venous flow and its relation with fetal respiratory movements
P. Zielinsky, K. Chemello, L. Nicoloso, M. Morais
09:48
Study of left atrium shortening fraction in fetuses of diabetic mothers
P. Zielinsky, S. Luchese, J. Manica, A. Piccoli Jr., L. Nicoloso, M. Leite, L. Hagemann, A. Busato, M. Moraes
Nov e l t r e a t m ent s f o r l ip ids dis o rde rs
Chairs: Mele Eduardo (ARGENTINA), Zampelas A (GREECE)
Tib e r - Ye llow P avillion - 0 8 :3 0 - 10: 00
Oral abstract Session
08:30Effectiveness of Trimetazidine treatment and Mediterranean-type diet in postinfarction overweight patients
with borderline serum cholesterol
K. G. Adamyan, A. V. Astvatsatryan, A. L. Chiningaryan
08:43A treatment algorithm for statin dose selection enables the majority of Latin-American patients with a range
of cardiovascular-risk profiles to reach LDL-C targets.
A. M. Valderrama, R. Vinueza, and The La-Atgoal Study Group
08:56Transfer of lipids to High Density Lipoprotein (HDL) in age groups and the effect of Coronary Artery Disease:
a study using an artificial nanoemulsion.
C. H. M Azevedo, A. C. Lo Prete, C. G. Puk, T. M. Seydell, F. Maniero, M. Wajngarten, J. Diament, R. C. Maranhao
09:09
Simultaneous transfer of lipids from an artificial model lipoprotein (LDE) to high-density lipoprotein.
A. C. Lo Prete, C. H. M. Azevedo, C. G. Puk, R. C. Maranhao
09:22Paradoxical and curvilinear relationship between components of metabolic syndrome, atherosclerosis, and
HDL-cholesterol in africans with type 2 diabetes mellitus: Proposition of metabolic syndrome definition for
B. Longo-Mbenza, J. B. Kasiam Lasi On’ki, A. Kasiam Lasi On’ki, N. Kangola Kabangu
09:35
Lipid transfer to the HDL fraction in patients with type 2 diabetes
T. M. Seydell, G. S. Feitosa-Filho, A. C. Lo Prete, F. Maniero, C. H. Azevedo, C. Alberto Silva, R. Cavalcante Maranhão
09:48Increased P-Selectin and Fibrinogen Levels After Maximal Stress Test Are Not Modified by a
High Dose Atorvastatin
D. Lindefjeld, M. Acevedo, G. Chamorro, E. Riedemann, D. Mezzano, C. Aranis, J. Oporto, O. Panes
Scientific Programme / 109
Tuesday, 20 May 2008
Gange s - Gr e e n P avillion - 0 8 :3 0- 10: 00
Oral abstract Session
Dr u g e l u t i n g s t e n t : E a r l y a n d late out c omes
Chairs: Omar Santaera (ARGENTINA), Costantino Costantini (BRAZIL)
08:30
Novel Drug Eluting Stent System with a Polymer Free, On-Site Stent Coating: Single Centre Experience
N. Sinha, S. Kumar, A. Kapoor, S. Tewari, H. Rai, N. Singh
08:43
Long term Follow-up of Bare Metal and Drug Eluting Stents in Coronary Angioplasty.
G. Lev, O. Mendiz, L. Valdivieso, F. Carlos, L. Villagra, P. Mollon, J. Scaglia
08:56
The Fate Of Coronary Artery Aneurysm Developed After Drug-eluting Stent Implantation
B. Hong, C. Ahn, Y. Yoon, P. Min, S. Rim, H. Kwon, D. Choi, Y. Jang, D. Jeon, J. Yang
09:09Long-term Outcome Following Primary Percutaneous Coronary Intervention with Drug-Eluting and
Bare Metal Stent in Patients with ST-Segment Elevation Myocardial Infarction
P. Thayssen, L. O. Jensen, M. Maeng, A. Kaltoft, H. Tilsted, M. Bottcher, K. E. Pedersen, L. Pedersen, S. O. Johnsen,
L. Thuesen
09:22
Can Disproportionality Analysis Play a Role in Monitoring Drug-Eluting Stent Safety?
H. Duggirala, X. Yang, R. Van Manen
09:35Treatment of bifurcation lesions with two drug eluted stents: Clinical follow up of "Crush" versus "T"
stenting techniques
I. Teplitsky, A. R. Assali, H. Vaknin Assa, E. Lev, D. Brosh, I. Ben-Dor, S. Fuchs, N. Shor, A. Battler, R. Kornowski
09:48Cost-effectiveness of the percutaneous treatment strategy of multivessel disease with Taxus stents in
comparison with bypass surgery 3 years after treatment
M. Gyongyosi, F. Leisch, R. Karnik, S. Harb, P. Siostrzonek, M. Heigert, G. Zenker, I. Lang, G. Christ, D. Glogar
Ech o st r e ss I
Chairs: Jorge Lax(ARGENTINA)
Mis s is s ippi - Ye llow P avillion - 0 8 :3 0- 10: 00
Oral abstract Session
08:30Prognostic Value of Exercise Stress Test and Pharmacological Myocardial Scintigraphy in Diabetic Women
Without Cardiac Symptom
P. Smanio, A. Thom, A. Carvalho, L. Mastrocolla, R. Meneghelo, S. Tebexreni, A. De Paola, L. Piegas
08:43Risk stratification of patients with chest pain suspected to be due to acute cardiac ischemia in the emergency
department: can rest myocardial perfusion imaging add value to the traditional risk stratification tools?
M. Ferreira, A. Ferrer-Antunes, V. Rodrigues, F. Santos, J. Lima, M. D. Cerqueira, L. A. Providência
08:56
Prevalence of myocardial ischemia in patients with syncope.
P. Smanio, J. Poeys, G. Monteiro, G. Moscardi, R. Teixeira, D. Moreira, A. Thom, L. Piegas
09:09Determinants of dipyridamole-induced hypotension in patients undergoing gated myocardial perfusion
single-photon emission computed tomography
A. De Lorenzo, R. S. L. Lima, M. P. Pellini, J. B. Pereira, L. M. B. Fonseca
09:22
Aortic stiffness is related to the extent of aortic structural damage detected by hybrid PET/CT
L. Joly, W. Djaballah, A. Kearney-Schwartz, A. Zervoudaki, P. Olivier, P. Jolivet, P. Y. Marie, A. Benetos
09:35Imaging of coronary artery fistulas by multidetector computed tomography: Is Multidetector computed
tomography sensitive?
F. Kacmaz, N. Isiksalan Ozbulbul, O. Alyan, O. Maden, A. D. Demir, R. Atak, A. R. Erbay, Y. Balbay, T. Olcer, E. Ilkay
09:48 Parameters associated with development of myocardial ischemia during mental stress test
J. Stepanovic, M. Ostojic, D. Lecic-Tosevski, O. Vukovic, A. Djordjevic-Dikic, I. Nedeljkovic, B. Beleslin, V. Giga,
I. Nedeljkovic, M. Nedeljkovic
Tuesday, 20 May 2008
Ech o s tre s s II
Chair: Shay Livschiz (ISRAEL)
Huang He - Ye llow P avillion - 0 8 :3 0 - 10: 00
Oral abstract Session
08:30Prevalence of ischemia in diabetic women with multiple risk factors. Comparison between myocardial
perfusion scintigraphy, exercise stress test and cardiopulmonary test in the assessment of severe coronary
artery disease
P. Smanio, C. Carvalho, A. Tebexreni, A. Thom, L. Mastrocolla, R. Meneghelo, A. Alves, L. Piegas
08:43Incremental Prognostic Value of Left Atrial Volume over Dobutamine Stress Echocardiography Results in
Patients with Known or Suspected Coronary Artery Disease
J. Tsutsui, P. Dourado, A. Elhendy, S. Falcão, A. Chagas, P. Daluz, J. Ramires, W. Mathias Jr.
08:56
New and faster protocol of stress echocardiography with dobutamine and atropine
L. Rocha Lopes, P. Cordeiro, O. Simoes, M. J. Loureiro, S. Almeida, C. Cotrim, M. Carrageta
09:09
Prognostic value of exercise echocardiography in diabetic patients
T. S. Aragão, J. L. M. Oliveira, F. D. Anjos-Andrade, E. O. Alves, A. C. Nascimento-Junior, T. J. S. Goes, A. D'Oliveira-Junior,
J. A. S. Barreto-Filho, A. C. S. Sousa
09:22Which is the target heart rate to achieve with dobutamine to consider sufficient an assessment of coronary
flow reserve. Is it a feasible test?
J. Lowenstein, E. Forte, A. Garcia, G. Peñaloza, A. Lescano, M. Amor, A. Panaro, C. Quiroz, O. Montaña, V. Darú
09:35Effects of myocardial viability assessed by strain stress echocardiography on diastolic function in Acute
Myocardial Infarction
W. J. Chung, M. S. Shin, E. O. Shim, W. C. Kang, S. H. Han, C. I. Moon, K. K. Koh, T. H. Ahn, I. S. Choi, E. K. Shin
09:48Mitral regurgitation and exercise capacity in heart failure patients with left ventricular systolic dysfunction
M. Trivi, J. Thierer, R. Guglielmone, A. Adriana, P. Huschnir, J. Marino, M. Sultán, V. Mezzalira, A. Hirshon Prado, R. Ronderos
Thame s - Ye llow P avillion - 0 8 :3 0- 10: 00
Oral abstract Session
Exp e r i e n c e s w it h high r is k p a tie n t s I
Chairs: José Gabay (ARGENTINA), Luis Guzman (UNITED STATES)
08:30
Nationwide Trends in the utilization Of Percutaneous Coronary Intervention (Pci) in the United States.
M. R. Movahed, M. Hashemzadeh, M. M. Jamal
08:43"Deep" Plasma Proteomic Assessment Reveals Increased Amyloidogenic Proteins in Patients With
Extensive Atherosclerosis
A. Wilson, A. Rafie, K. Beck, N. Balasubramanian, E. Fung, J. Olin, J. Cooke
08:56In-Hospital Mortality after Acute Ischemic Stroke in an Emerging Country. The Argentinian National Stroke
Registry (ReNACer)
L. A. Sposato, M. M. Esnaola, M. C. Zurru, J. J. Cirio, R. Zamora, O. Fustinoni, G. Saposnik
09:09Are there any Gender Differences in First-Ever Ischemic Strokes in Emerging Countries?. The Argentinian
National Stroke Registry (ReNACer) Experience
L. A. Sposato, M. M. Esnaola, M. C. Zurru, R. Zamora, O. Fustinoni, G. Saposnik
09:22
Effects of Carbamazepine on Spinal Cord Ischemia
M. Sirlak, S. Eryilmaz, B. Inan, L. Yazicioglu, E. Ozcinar, R. Akar, B. Kaya, Z. Egileten, R. Tasoz, U. Ozyurda
09:35
Early experience in mechanical cardiac support with Berlin heart as bridge to transplant in pediatrics
H. Vogelfang, G. Naiman, A. Villa, A. Charroqui, G. Moreno, L. Quiroga, G. Burlli, E. Carmona, D. Haag, M. De La Riba
09:48
Intraaortic Balloon Pump in High-Risk Cardiac Patients Undergoing Non-Cardiac Surgery
R. Levin, M. Degrange, R. Porcile, F. Salvagio, C. Del Mazo, A. Botbol, N. Blanco, E. Tanus
Scientific Programme / 111
Tuesday, 20 May 2008
R hine - Ye llow P avillion - 1 0 :3 0- 12: 00
Clinical Seminar
Ma n a g e m e n t o f p a tie n ts w it h s y ncope
Chairs: Dario Sobral (BRAZIL), Riccardo Cappato (ITALY)
10:30
Inappropriate sinus node tachycardia
Carlos A. Morillo (CANADA)
10:52
Management strategies
Rafael Rabinovich (ARGENTINA)
11:14
Syncope and falls in the elderly
Antonio Gonzalez Hermosillo(MEXICO)
Mis s ouri - Ye llow P avillion - 1 0 :3 0- 12: 00
Symposium
Wha t ’ s n e w i n he a r t f ail ur e?
Chairs: Jay Cohn (UNITED STATES), Shigetake Sasayama (JAPAN)
10:30
New pharmacotherapies for chronic heart failure
Philip A Poole-Wilson. (UNITED KINGDOM)
10:52
What is new with currents agents
Henry Krum (AUSTRALIA)
11:14
Cardiac resynchronization therapy
John Cleland (UNITED KINGDOM)
11:36
New pharmacotherapies for decompensated heart failure
Mihai Gheorghiade (UNITED STATES)
R io de la P lat a - R e d P avillion - 1 0 :3 0- 12: 00
Debate
Co n t r o v er s i a l i s s u e s r e g a rd i n g management and t reatment
of sy st o l i c h ear t f a il u r e
Chairs: Sergio Varini (ARGENTINA), Hori Masatsugu (JAPAN)
10:30
Statement 1:
Patients with systolic heart failure in the New York Heart Class Association II should be treated
with aldosterone antagonist
Pro: Willem Remme (NETHERLANDS)
Contra: José Luis López-Sendón (SPAIN)
11:15
Statement 2:
Patients with heart failure and LV ejection fraction < 25% and sinus rhythm should receive
anticoagulant therapy
Pro: Guillermo Torre Amione (UNITED STATES)
Contra: Barry Massie (UNITED STATES)
Tuesday, 20 May 2008
Huang He - Ye llow P avillion - 1 0 :3 0 - 12: 00
Symposium
Nuc l e a r c a r d io l o g y 2 00 8
Chairs: Alia Abdelfattah (EGYPT), Angel Sandrin (ARGENTINA)
10:30
Molecular imaging
Barry Zaret (UNITED STATES)
10:48
Utility of images of the evaluation of vulnerable asymptomatic patients
George Beller (UNITED STATES)
11:06
Pharmacological stress: New agents
Manuel Cerqueira (UNITED STATES)
11:24
Complementary techniques: Computed tomography and nuclear medicine
Ernest Garcia (UNITED STATES)
11:42
Coronary artery disease: Do women constitute a special group?
Joao Vitola (BRAZIL)
Euphrat e s - Ochre P avillion - 1 0 :3 0- 12: 00
Symposium
Up d a t e o n m i t r al r e g u r git a tion
Chairs: Marcia Barbosa(BRAZIL), Carlos Nojek (ARGENTINA)
10:30
Asymptomatic mitral regurgitation, intervene or wait?
TBD
10:52
Mitral valve reconstruction: What have we learned during the past 40 years?
David Adams(UNITED STATES)
11:14
Percutaneous repair of mitral regurgitation
William E. Cohn E. (UNITED STATES)
11:36
Three-dimensional echo evaluation of mitral regurgitation
Bernhard Mumm (GERMANY)
Gange s - Gr e e n P avillion - 1 0 :3 0- 12: 00
Clinical Seminar
Perc u t a n e o u s he a r t val ve int er v e nt ions :
The e n d o f v a l vu l a r o p e n he a r t s urge ry? - P art t wo
Chairs: Alejandro Palacios (ARGENTINA), Felipe Heusser Risopatró (CHILE)
10:30
Innovation in percutaneous mitral valve repair and replacement
Jose Condado (VENEZUELA)
10:52
Percutaneous pulmonary valve replacement: An update
Neil Wilson (UNITED KINGDOM)
11:14
Balloon mitral valve dilation for mitral stenosis disease from low income countries:
Has it replaced surgery forever?
Deborah Nercolini (BRAZIL)
11:36
Surgery vs. percutaneous procedures
A. A. Shafi Majumder (BANGLADESH)
Scientific Programme / 113
Tuesday, 20 May 2008
Me kong - Ochre P avillion - 1 0 :3 0- 12: 00
Clinical Seminar
Int e r v e n t i o n al tr eat m e n t o f acut e myocardial infarc t ion
Chairs: Fabio Sandoli De Brito (BRAZIL), Riccitelli Miguel (ARGENTINA)
10:30
Strategies to reduce door-to-balloon times
Daniel Berrocal(ARGENTINA)
10:52
Adjunctive drug treatment for primary PCI Dudek
Ricardo Lluberas (URUGUAY)
11:14
Multivessel disease management in ST-segment elevation myocardial infarction
Satyavan Sharma (INDIA)
11:36
Transfer for PCI: Controlled studies and the real world
P. Radke (GERMANY)
Nile - Ye llow P avillion - 1 0 :3 0- 12: 00
Symposium
Wo m e n a n d c o r onar y he a r t dis eas e
Chairs: Juan Justiniano Encina (BOLIVIA), Angeles Alonso Garcia (SPAIN)
10:30
Cardiovascular risk factors in women: Is there a real gender difference?
Nanette Wenger (UNITED STATES)
10:52
Diagnostic assessment of IHD in women
Noel Bairey Merz (UNITED STATES)
11:14
Therapeutic interventions in women: How can we improve outcomes?
Rose Marie Robertson (UNITED STATES)
11:36
Gender differences in angina and acute coronary
Acevedo Monica (CHILE)
Danub e - Gr e e n P avillion - 1 0 :3 0- 12: 00
Clinical Seminar
Late r e su l t s in Car d io va s c ul ar Int e rve nt ions
Chairs: Luis Guzman (UNITED STATES), Ramón Quesada (UNITED STATES)
10:30
Internal thoracic artery over 30 years of experience
Sabik III Joseph F (UNITED STATES)
11:00
Composite graph: Radial, gastroepiploic artery and SVG
Roque Cordoba (ARGENTINA)
11:30
Preservative surgery of the aortic valve: In hospital and long-term outcomes
Daniel Navia (ARGENTINA)
Tuesday, 20 May 2008
P ilcomayo - Ye llow P avillion - 1 0 :3 0- 12: 00
Symposium
The c l a ss e f f e c t d il em m a: Ar e a ll drugs wit hin a clas s cr e at e d e qual?
Chairs: Lerman Jorge (ARGENTINA), Luis Vidal (ARGENTINA)
10:30
Beta blockers
Corbalan Ramon (CHILE)
11:00
Nonsteroidal anti-inflammatory drugs
Frank Thomas Ruschitzka (SWITZERLAND)
11:30
Statins
Antonio Chagas (BRAZIL)
Volga - Ye llow P avillion - 1 0 :3 0 - 12: 00
Symposium
Perc u t a n e o u s p ul m o n a r y va l ve re place me nt
Chairs: Guillermo Kreutzer (ARGENTINA), Valmir Fontes (BRAZIL)
10:30
Opportunity of pulmonary valve replacement
Michael Landzberg (UNITED STATES)
10:52
Point of view of a surgeon
Andrés Schlichter (ARGENTINA)
11:14
Experience with Edwards valve
Ziyad Hijazi (UNITED STATES)
11:36
Results with Bonhoffer valve
Neil Wilson (UNITED KINGDOM)
Or inoco - Ochre P avillion - 1 0 :3 0- 12: 00
Symposium
Hyp e r t e n si o n and tar g et or g a n damage
Chairs: Luis Alcocer (MEXICO), Luis Molinary (PUERTO RICO)
10:30
Cognitive dysfunction and hypertension
Antonio Coca (SPAIN)
10:52
Specific cardiac complications
Richard Devereux (UNITED STATES)
11:14
The kidney’s role in hypertension
Luis Juncos (ARGENTINA)
11:36
Hypertension, inflammation and organ target damage
Oscar Carretero (UNITED STATES)
Scientific Programme / 115
Tuesday, 20 May 2008
Nige r - Gr e e n P avillion - 1 0 :3 0- 12: 00
Symposium
Ac u t e c o r o n a r y s yndr o m e in d ia b e t e s
Chairs: Mehta A. B (INDIA), Pomes Iparraguirre Horacio (ARGENTINA)
10:30
Diabetes and acute coronary syndromes: An overview
Jose Nicolau (BRAZIL)
10:52
Management of ACS in diabetics: An European perspective and lessons from the MIDAS registry
Marco Roffi (SWITZERLAND)
11:14
Diabetes and ACS in India: Magnitude of the disease burden and optimal pharmacotherapy
Shirish Hiremath (INDIA)
11:36
When perform surgical revascularization in patients with stable coronary artery disease?
Robert Califf (UNITED STATES)
P araná - Ochre P avillion - 1 0 :3 0- 12: 00
Symposium
Ca r d i o v a sc ul ar dis eas e pre vent ion in childre n
Chairs: Pilar Arnaiz (CHILE), Veronica Ines Volberg (ARGENTINA)
10:30
Prevention of cardiovascular diseases from childhood: The EDUCANDO Project
Rodolfo Daniel La Greca (ARGENTINA)
10:52
Excercise as a tool in prevention for children
Patricia Sangenis (ARGENTINA)
11:14
Pharmacologic treatment of hypertension in adolescents
Giuseppe Ambrosio (ITALY)
11:36
Cardiovascular risk factors in childhood: A growing international problem
Roya Kelishadi (ISLAMIC REPUBLIC OF IRAN)
Tigris - Ye llow P avillion - 1 0 :3 0- 12: 00
Symposium
Ac u t e h e a r t f ail ur e in t he em er g e ncy de part me nt
Chairs: Gines Sanz (SPAIN), Victor Mauro (ARGENTINA)
10:30
Biochemical diagnosis: How much better than clinical diagnosis?
Carlos Martinez-Sanchez (MEXICO)
10:52
Echocardiogram in acute heart failure: When to indicate it in the emergency department?
Pablo Oberti (ARGENTINA)
11:14
Heart failure units: Rationale for their implementation
Juan José Fuselli (ARGENTINA)
11:36
Nesiritide and levosimedan: Do they have any role in the emergency department?
Fernando Bacal (BRAZIL)
Tuesday, 20 May 2008
Se ine - Gr e e n P avillion - 1 0 :3 0 - 12: 00
Clinical Seminar
BMS a n d DES r e s t enos is : H ow do we t re at t he m in 2 0 0 8 ?
Chairs: Christopher Cates (UNITED STATES), Antonio Pocovi (ARGENTINA)
10:30
Critical assessment of the outcomes of in-stent restenosis
Expedito Ribeiro (BRAZIL)
10:52
High risk lesions for restenosis: Bifurcations, long lesions, small vessels, etc.
Spencer King III (UNITED STATES)
11:14
Different paterns and solutions for in-segment/stent restenosis for BMS and DES
Carlos Mendiz (ARGENTINA)
11:36
Are there any new devices for avoiding in-stent restenosis?
Mario Pieroni (ARGENTINA)
Tib e r - Ye llow P avillion - 1 0 :3 0 - 12: 00
Special Featured Joint Session
IS CP T h e G l o bal N ut r it io n Chal l e nge
Chairs: Scott Grundy (UNITED STATES), Palmira Pramparo (ARGENTINA)
10:30
Nutrition transition in the developing world
Barry Popkin (UNITED STATES)
10:52
Nutrition and health status in China
Zhao Dong (CHINA, PEOPLE’S REPUBLIC OF)
11:14
Nutrition and health status in Brazil
11:36
Nutrition and health status in Mexico
Thame s - Ye llow P avillion - 1 0 :3 0 - 12: 00
Special Featured Joint Session
IASC : H e a r t f a il u r e w it h pre s e r ve d s ys t olic funct ion
Chairs: Oscar Alvarado C (PERU), Maria Paniagua (PARAGUAY)
10:30
A new worldwide epidemic?
Wistremundo Dones (PUERTO RICO)
10:52
Pathophysiological mechanisms
Piñeiro Daniel (ARGENTINA)
11:14
How to make the diagnosis?
Miguel Quiñones (UNITED STATES)
11:36
How to treat it?
Diego Delgado (CANADA)
Scientific Programme / 117
Tuesday, 20 May 2008
Yangt z e - Ochre P avillion - 1 0 :3 0- 12: 00
Special Featured Joint Session
HRS & ISHNE: S u d d en c a r diac d eat h
Chairs: Oseroff Oscar (ARGENTINA), Branco Mautner (ARGENTINA)
10:30
High risk stratification for ICD implantation - clinical approach
Gioia Turitto (UNITED STATES)
10:52
High risk stratification for ICD implantation - non-invasive assessment
Nabil El-Sheriff(UNITED STATES)
11:14
ICD - primary prevention of SD
Luis Molina (MEXICO)
11:36
ICD indication for secondary prevention and genetic arrhytmic disorders
Carlos A. Morillo (CANADA)
Amaz on - Ye llow P avillion - 1 0 :3 0- 12: 00
South American Congress of Cardiology
Co n f e r e n c i a s
Pesidentes: Javier Bustamante (BOLIVIA), Eduardo Roura (ECUADOR)
10:30
De los ensayos clínicos a la práctica asistencial
Cagide Arturo (ARGENTINA)
11:15
Avances en el manejo de la enfermedad aórtica
Noedir Groppo Stolf (BRAZIL)
Volga - Ye llow P avillion - 1 4 :0 0- 15: 30
Symposium
Co n g e n i t a l h e ar t d i s e a s e i n co unt ries with limited r esou rc es
Chairs: Alberto Sciegata (ARGENTINA), Rodolfo Neirotti (SWITZERLAND)
14:00
Epidemiology and cost-effective practices for congenital heart disease in the developing world
Masood Sadiq (PAKISTAN)
14:22
Reality of Chagas Disease in 2008
Ademar Atik(BRAZIL)
14:44
Congenital cardiac surgery in the less privileged regions of the world
Anita Saxena (INDIA)
15:06
Congenital cardiac survey in Central America
Joaquín Barnoya (GUATEMALA)
Tuesday, 20 May 2008
R hine - Ye llow P avillion - 1 4 :0 0 - 15: 30
Clinical Seminar
Ris k st r a t i f i c a tion in ge n et ic dis orde rs : ICD or not ?
Chairs: Branco Mautner (ARGENTINA), Yunlong Xia (CHINA, PEOPLE’S REPUBLIC OF)
14:00
Genomic of sudden death: A new approach to risk stratification?
Peter Spooner (UNITED STATES)
14:22
Long QT Syndrome pathophysiological background
Gabriel Vanerio (URUGUAY)
14:44
ARVCs
Guy Fontaine (FRANCE)
15:06
Polymorphic ventricular tachycardia
Víctor Arregui (ARGENTINA)
R io de la P lat a - R e d P avillion - 1 4 :0 0- 15: 30
Debate
Guid i n g a n d o p t im iz in g t r e a tm ent of he art failure
Chairs: José Luis Barisani (ARGENTINA), V. Mareev (RUSSIAN FEDERATION)
14:00
Statement 1:
The medical treatment of heart failure should be guided and optimized with measurement of BNP levels
Pro: Henry Krum (AUSTRALIA)
Contra: Jay Cohn (UNITED STATES)
14:45
Statement 2:
The medical treatment of heart failure should be guided and optimize with echocardiogram parameters
Pro: Miguel Quiñones (UNITED STATES)
Contra: Marvin Konstam (UNITED STATES)
Nige r - Gr e e n P avillion - 1 4 :0 0- 15: 30
Symposium
Acu t e c o r o n ar y e vent s d u r ing n on-cardiac s urge ry
Chairs: Hernán Cohen Arazi (ARGENTINA), Edgar Pozo Valdivia (BOLIVIA)
14:00
Epidemiology of acute coronary events in non-cardiac surgery
Falconi Mariano (ARGENTINA)
14:22
How should we stratify patients before non-cardiac surgery?
Victor Sinisi (ARGENTINA)
14:44
Are scores really useful in cardiac risk assessment before non-cardiac surgery?
15:06
Prevention of acute coronary events in non-cardiac surgery: Revascularization or betablocker therapy?
Don Poldermans (NETHERLANDS)
Scientific Programme / 119
Tuesday, 20 May 2008
Gange s - Gr e e n P avillion - 1 4 :0 0- 15: 30
Clinical Seminar
Co m pl e x pa t i e n t s a n d c o mp l e x de cisions - Pa rt one
Chairs: Martínez Rios Marco A. (MEXICO), Miguel Rubio (ARGENTINA)
14:00
The left main trunk PCI, anatomy related strategies and outcomes
TBD
14:22
Elderly patients PCI: Clinical and anatomical risk factors
Christopher Cates (UNITED STATES)
14:44
Outcomes in sapheneous vein graft’s interventions: DES and BRS with/without distal protection
Roxana Mehran (UNITED STATES)
15:06
The patient with very low ejection fraction
Costantino Costantini (BRAZIL)
Euphrat e s - Ochre P avillion - 1 4 :0 0- 15: 30
Symposium
Cu rr e n t t o p ic s in inf e c tive e n d o cardit is
Chairs: Hector Delgado Osorio (PUERTO RICO), Peter Liu (CANADA)
14:00
World epidemiology of infective endocarditis/experience of ICE study
Adam Torbicki (POLAND)
14:22
Epidemiology, clinical characteristics and evolution of infective endocarditis in under-developed countries:
Results of the Latino-American registries (EIRA)
José Horacio Casabé (ARGENTINA)
14:44
New advances in prognostics stratification of patients with infective endocarditis
Miguel Gomez Sanchez (SPAIN)
15:06
Which should be the therapeutic approach of the multi-disciplinarian health team of a patient
with infective endocarditis in the new millennium?
Francisco Nacinovich (ARGENTINA)
Huang He - Ye llow P avillion - 1 4 :0 0- 15: 30
Symposium
End o t h e l i a l d y s f u nct i o n d e t ec tion w ith c old pr esso r test
and m y o c a r d ia l p e r f us io n
Chairs: Plastino Juan A. (ARGENTINA), Acevedo Monica (CHILE)
14:00
Prognostic impact of coronary vasodilator dysfunction
Dimitri Tousoulis (UNITED STATES)
14:22
Endothelial dysfunction on moderate risk patients
Perez Baliño Nestor (ARGENTINA)
14:44
PET utility on the analyses of the coronary vasomotion
Heinrich Schelbert (UNITED STATES)
15:06
Endothelia dysfuction treatment
Giuseppe Ambrosio (ITALY)
Tuesday, 20 May 2008
Danub e - Gr e e n P avillion - 1 4 :0 0- 15: 30
Symposium
Mitr a l v a l v e r e p air : W ha t is the be s t opt ion?
Chairs: Julio Palmaz (UNITED STATES), Alberto Domenech (ARGENTINA)
14:00
How to select patients for surgical mitral valve repair
Jaime Calderón Herrer (COLOMBIA)
14:22
In-hospital and long-term follow-up on surgical valve repair
David Adams(UNITED STATES)
14:44
When mitral valve repair is not possible: What prosthetic valve should be preferred and for which patient?
José Luis Navia (UNITED STATES)
15:06
Up-date on percutaneous mitral valve repair
Igor Palacios (UNITED STATES)
P araná - Ochre P avillion - 1 4 :0 0- 15: 30
Debate
Why a r e w e n o t b e tt er in pre vent ing cardiovas cular dis e as e s ?
Chairs: Shanthi Mendis (SWITZERLAND), Hernán Delmonte (ARGENTINA)
14:00
Statement 1:
It is the fault of the doctors that we are not better in preventing cardiovascular disease
Pro: Hassell Trevor (BARBADOS)
Contra: Zeljko Reiner (CROATIA)
14:45
Statement 2:
Is the general publics’ erroneous perception the reason why we are not better in preventing
cardiovascular disease?
Pro: Daniel W. Jones (UNITED STATES)
Contra: Ulrich Keil(GERMANY)
Thame s - Ye llow P avillion - 1 4 :0 0 - 15: 30
Symposium
Pro m o t i n g smoke -f r e e envir o n m e nt s
Chairs: Ana Tambussi (ARGENTINA), Federico Giachello (ARGENTINA)
14:00
Health impact of passive tobacco smoke: New evidence
Joaquín Barnoya (GUATEMALA)
14:22
Policy change for smoke-free environments in Latin America and the Caribbean
Beatriz Champagne (UNITED STATES)
14:44
Implementation of the framework convention on tobacco control
Eduardo Bianco (URUGUAY)
15:06
Counteracting the tobacco industry’s strategies
Ernesto Sebrie (UNITED STATES)
Scientific Programme / 121
Tuesday, 20 May 2008
Me kong - Ochre P avillion - 1 4 :0 0- 15: 30
Symposium
Non - i n v a si v e im a g in g f or t he d ia gnos is of myocardial is che mia:
Whi c h m e t h o d ?
Chairs: Kuschnir Paola (ARGENTINA), Wielgosz Andy (CANADA)
14:00
Nuclear medicine
Francisco Benítez (UNITED STATES)
14:22
Echocardiography
Walter Stoermann (ARGENTINA)
14:44
MRI and CT multi-slice
Mario Garcia (UNITED STATES)
15:06
Looking at the images: Why, when and which one?
Pérez De Arenaza Diego (ARGENTINA)
P ilcomayo - Ye llow P avillion - 1 4 :0 0- 15: 30
Symposium
Ca r d i o v a sc ul ar dr u g t her a p y in wome n
Chairs: César Serra (ARGENTINA), Pedro Lipszyc (ARGENTINA)
14:00
Treatement during pregnancy and post-partum
Manuel Vazquez-Blanco (ARGENTINA)
14:22
Reperfusion therapy
Jose Antonio Francisco Ramires (BRAZIL)
14:44
Hormone replacement therapy
Nanette Wenger (UNITED STATES)
15:06
Primary and secondary recommendations for Aspirin therapy in women
Smith Sidney (UNITED STATES)
Tigris - Ye llow P avillion - 1 4 :0 0- 15: 30
Symposium
Ac u t e c o r o n ar y s yn d r om e f r om pre -hos pit al t o t he e me rge ncy room
Chairs: Karl B. Kern (UNITED STATES), Alfredo Piombo (ARGENTINA)
14:00
Right ventricular myocardial infarction
Corbalan Ramon (CHILE)
14:22
Reducing the door-to-balloon time for myocardial infarction
Alia Abdelfattah (EGYPT)
14:44
Pre-hospital 12-lead EKG
Mario Lado (URUGUAY)
15:06
Antithrombotic therapy in pre-hospital and emergency room
Ernesto Paolasso (ARGENTINA)
Tuesday, 20 May 2008
Or inoco - Ochre P avillion - 1 4 :0 0 - 15: 30
Symposium
What a r e t h e s tr a te g ies in the m a nage me nt of mild hype rt e ns ion?
Chairs: Luis Acosta (VENEZUELA), Pablo Rodriguez (ARGENTINA)
14:00
Lifestyle modifications?
Celso Amodeo (ARGENTINA)
14:22
Anti-hypertensive drugs?
Alberto Zanchetti (ITALY)
14:44
Anti-platelets agents?
Luis Ruilope (SPAIN)
15:06
Lipid lowering agents?
Richard Devereux (UNITED STATES)
Se ine - Gr e e n P avillion - 1 4 :0 0- 15: 30
Clinical Seminar
Low e r l i m b i n t er vent io n s : S tand up and walk
Chairs: Miguel Chiape (ARGENTINA), Joseph F. Sabik III (UNITED STATES)
14:00 Patency vs clinical outcomes in complex infrapopliteal interventions: Does use of DES change the story?
Mariano Ferreira (ARGENTINA)
14:22 Percutaneuous treatment of total oclussions of SFA and iliac arteries: Long term follow-up
Fernando Cura (ARGENTINA)
14:44 Critical overview of endovascular treatment of aortic aneurysms
Patricio Zaefferer (ARGENTINA)
15:06 Long term results in superficial Femoral arteries stenting
Jorge Bluguerman (ARGENTINA)
Mis s ouri - Yello w Pavillion - 14:00-15:30
Special Featured Joint Session
AHA : C r i t ic a l i s s u e s a n d n e w s tr ategies to manage
pati e n t s w i t h c ar d io va s c ul ar dis e as e
Chairs: Gao Runlin (CHINA, PEOPLE’S REPUBLIC OF), Kumar Anil (INDIA)
14:00
New imaging strategies to assess cardiovascular risk
Fuster Valentin (UNITED STATES)
14:22
Critical issues in the new secondary prevention guidelines
Smith Sidney (UNITED STATES)
14:44
Evolving strategies for the treatment of hypertension - is it time to change the guidelines?
Daniel W. Jones (UNITED STATES)
15:06
New guidelines for the management of patients with valvular heart disease
Robert Bonow (UNITED STATES)
Scientific Programme / 123
Tuesday, 20 May 2008
Tib e r - Ye llow P avillion - 1 4 :0 0- 15: 30
Special Featured Joint Session
Inf l a m m a t i o n a n d Car d io va s c ular Dis e as e : Mult i-marke r appr oach
Chair: Conci Eduardo (ARGENTINA)
14:00
From inflammation biology to cardiovascular Biomarkers
Peter Libby (UNITED STATES)
14:22
Dyslipidemic risk factors which are clinically important
Tonkin Andrew (AUSTRALIA)
14:44
Adiponectin and Coronary Heart Disease
15:06
Brain natriurectic peptide as a marker of cardiovascular risk
Dimitri Tousoulis (UNITED STATES)
Yangt z e - Ochre P avillion - 1 4 :0 0- 15: 30
Special Featured Joint Session
ASN C : T h e bi g t r ial s on n u c l ear cardiology
Chairs: Barry Zaret (UNITED STATES), Néstor Alejandro Vita (ARGENTINA)
14:00
COURAGE Trial
Leslee Shaw (UNITED STATES)
14:22
INSPIRE Trial
John Mahmarian (UNITED STATES)
14:44
DIAD Trial
George Beller (UNITED STATES)
15:06
ADVANCE MPI
Manuel Cerqueira (UNITED STATES)
Mis s is s ippi - Ye llow P avillion - 1 4 :0 0- 15: 30
Special Featured Joint Session
Polí t i c a s d e S a l u d
Chairs: Graciela Ocaña (ARGENTINA), Perez Baliño Néstor Abel (ARGENTINA)
14:00
Políticas públicas en prevencíon cardiovascular: rol de los gobiernos provinciales
Oscar González (ARGENTINA)
14:22
Prevencíon cardiovascular en un sistema de atencíon primaria de la salud
Claudio Zin (ARGENTINA)
14:44
Políticas Públicas de Salud en la ciudad de Buenos Aires
Jorge Lemus(ARGENTINA)
15:06
Promocíon y programas de salud en la Argentina
Juan Carlos Nadalich (ARGENTINA)
Tuesday, 20 May 2008
Amaz on - Ye llow P avillion - 1 4 :0 0- 15: 30
South American Congress of Cardiology
Tr a t a m i e n t o ac t u a l de l a enf e r me dad coronaria cr ónica
Coordinadores: Patricia Rebaza (PERU), Edgar Pozo Valdivia (BOLIVIA)
14:00
Impacto del tratamiento médico en la enfermedad coronaria crónica
Sanhueza Patricio (CHILE)
14:15
¿Cuándo y cómo evaluar isquemia y viabilidad miocárdica?
Masoli Osvaldo (ARGENTINA)
14:30
¿Qué pacientes deben ser revascularizados?
Protasio Da Luz (BRAZIL)
14:45
Seleción de la estrategia de revascularización ¿Cuándo utilizar stent con drogas?
Ricardo Lluberas (URUGUAY)
Mis s ouri - Ye llow P avillion - 1 6 :0 0 - 17: 30
Symposium
Ade q u a t e m a n age m e n t o f c hr onic he art failure
Chairs: Miguel Quintana (PARAGUAY), Cuesta Silva Manuel (ARGENTINA)
16:00
Optimizing diuretic treatment in ambulatory patients
Barry Massie (UNITED STATES)
16:18
Frequent difficulties and mistakes with ACEI and beta blockers therapy
José Luis López-Sendón (SPAIN)
16:36
Careful Manage in patents with high comorbidity
Gilson Feitosa(BRAZIL)
16:54
Prevention of thromboembolic events
Ileana Piña (UNITED STATES)
17:12
How to implement a simple and effective disease programme in heart failure?
Grancelli Hugo (ARGENTINA)
Huang He - Ye llow P avillion - 1 6 :0 0- 17: 30
Symposium
Viabi l i t y i m a g in g
Chairs: Victor Balestrini (ARGENTINA), Gustavo Acosta (PARAGUAY)
16:00
Is dobutamine echo the best test?
Milind Desai (UNITED STATES)
16:18
Recent outcomes in Nuclear Cardiology
Francisco Benítez (UNITED STATES)
16:36
Is Pet the gold standard?
Heinrich Schelbert (UNITED STATES)
16:54
New kids on the block: Magnetic resonance
Masoli Osvaldo (ARGENTINA)
17:12
Is there room for spect nowadays?
George Beller (UNITED STATES)
Scientific Programme / 125
Tuesday, 20 May 2008
Or inoco - Ochre P avillion - 1 6 :0 0- 17: 30
Symposium
Ma n a g e m e n t o f p at ient s w ith hy pe rt e ns ion and comorb idit ie s
Chairs: Sverre E. Kjeldsen (NORWAY), Jaime Espinosa (PERU)
16:00
Heart failure and hypertension: Just an overload?
Jay Cohn (UNITED STATES)
16:22
Diabetes and hypertension
Antonio Coca (SPAIN)
16:44
Hypertension in the very elderly
Alberto Zanchetti (ITALY)
17:06
Microalbuminuria
Luis Ruilope (SPAIN)
Euphrat e s - Ochre P avillion - 1 6 :0 0- 17: 30
Clinical Seminar
Exe rci se i n v al vul ar he a r t dis eas e
Chairs: Mario Bey Lombana (PANAMA), Harry Acquatella (VENEZUELA)
16:00
Aortic stenosis
Roberto Peidro (ARGENTINA)
16:22
Aortic regurgitation
Daniel Areco (URUGUAY)
16:44
Mitral regurgitation
Jairo Pedraza (COLOMBIA)
17:06
Mitral stenosis
Pedro Gutierrez Fajardo (MEXICO)
P ilcomayo - Ye llow P avillion - 1 6 :0 0- 17: 30
Special Featured Joint Session
Rhe u m a t i c F e ver /R he u m at ic H eart Dis e as e
Chairs: Amoah Albert (GHANA), Aloyzio Achutti (BRAZIL)
16:00
It is still around?
Edward L. Kaplan (UNITED STATES)
16:18
Primary prevention and the ASAP Program in Africa
Mayosi Bongani (SOUTH AFRICA)
16:36
Pathogenesis of rheumatic heart disease
Luiza Guilherme (BRAZIL)
16:54
Rheumatic fever vaccines
Carapetis Jonathan (AUSTRALIA)
17:12
Rheumatic heart disease and its control in the Pacific
Andrew Steer (AUSTRALIA)
Tuesday, 20 May 2008
Yangt z e - Ochre P avillion - 1 6 :0 0 - 17: 30
Clinical Seminar
Und e r st a n d i ng hyp e r t r op hic c ardiomyopat hy
Chairs: Lastiri Hugo (ARGENTINA), Eduardo Moreyra (ARGENTINA)
16:00
HCM in children
Alday Luis (ARGENTINA)
16:22
Pathogenesis beyond gene mutations
Matsumori Akira (JAPAN)
16:44
Missense mutations and prognosis of hypertrophic cardiomyopathy
Lorenzo Montserrat (SPAIN)
17:06
Treatment approach
Peter Liu (CANADA)
Nige r - Gr e e n P avillion - 1 6 :0 0- 17: 30
Symposium
An in t e r n a t i o nal l o o k at c ar e f o r pat ie nt s wit h acut e coronary s yndro me
Chairs: Mauricio Cohen (UNITED STATES), Ricardo López Santi (ARGENTINA)
16:00
EUROPE
Juan Kaski (UNITED KINGDOM)
16:18
ASIA
16:36
LATIN AMERICA
Andres Orlandini (ARGENTINA)
16:54
USA
Leslee Shaw (UNITED STATES)
17:12
What did we learn from international registries?
P. Gabriel Steg (FRANCE)
Me kong - Ochre P avillion - 1 6 :0 0- 17: 30
Symposium
What sh o u l d b e t he a n tit hr om b ot ic t he rapy in acut e coronary s yndrome?
Chairs: Luis Mercado (BOLIVIA), P. Radke (GERMANY)
16:00
Should fondaparinux be the first choice in ACS?
Yusuf Salim (CANADA)
16:22
PCI in ACS: When to indicate and which antithrombotic agent should be used?
Enrique Fairman (ARGENTINA)
16:44
Low molecular heparin is the first choice
Robert Califf (UNITED STATES)
Scientific Programme / 127
Tuesday, 20 May 2008
P araná - Ochre P avillion - 1 6 :0 0- 17: 30
Symposium
Dia be t e s pr eve n tion
Chairs: Isaac Sinay (ARGENTINA), Shirish Hiremath (INDIA)
16:00
Interventions in diabetes prevention in Europe: Experiences from development of European guidelines
Marco Roffi (SWITZERLAND)
16:22
Diabetes prevention in Uruguay
Raul Pisabarro (URUGUAY)
16:44
Diabetes prevention programmes in China
Qing Qiao (FINLAND)
17:06
Diabetes prevention: A global strategy
Mehta A. B (INDIA)
Nile - Ye llow P avillion - 1 6 :0 0- 17: 30
Symposium
St re s s a n d d e pr e s s i o n : Ne w r i s k facto r s for c orona ry hea rt disease
Chairs: Bernardo Boskis (ARGENTINA), Adel Allam (EGYPT)
16:00
Psychosocial interventions in coronary heart disease
Matthew Burg (UNITED STATES)
16:18
Depression and cardiovascular disease
Acevedo Monica (CHILE)
16:36
Work stress and its impact on coronary artery disease
Noel Bairey Merz (UNITED STATES)
16:54
Myocardial ischaemia detection during mental stress: Is it prognostic?
Néstor Alejandro Vita (ARGENTINA)
17:12
Type D personality: a chronic risk factor in heart disease
Angelique Schiffer (NETHERLANDS)
R hine - Ye llow P avillion - 1 6 :0 0- 17: 30
Symposium
Hea l t h f r o m a ge n d er p er s p ec t iv e : Implicat ions for CVD
Chairs: Fernando De La Serna (ARGENTINA), Robert J. De Souza (SOUTH AFRICA)
16:00
A focus in gender
Nishtar Sania (PAKISTAN)
16:22
The implications for the PHC sector: Strengthening core competencies of PHC workers to deal
with CVD among women
Denise Eldemire Shearer (JAMAICA)
16:44
Policies that work: Examples from Canada
Wielgosz Andy (CANADA)
17:06
The WHO response
Shanthi Mendis (SWITZERLAND)
Tuesday, 20 May 2008
Volga - Ye llow P avillion - 1 6 :0 0 - 17: 30
Symposium
Pre v e n t i o n o f c ar d ia c dis eas e in childhood
Chairs: Alfonso Buendia-Hernandez (MEXICO), Alex Javois (UNITED STATES)
16:00
Childhood origins of vascular disease: New insights and future developments
Horacio Zylbersztejn (ARGENTINA)
16:22
Cardiovascular implications of childhood obesity
Michael Landzberg (UNITED STATES)
16:44
Metabolic Syndrome as risk factor in children
Irina Kovalskys(ARGENTINA)
17:06
Epidemiology of rheumatic fever
Anita Saxena (INDIA)
Danub e - Gr e e n P avillion - 1 6 :0 0- 17: 30
Debate
Cor o n a r y by p a s s s u r ge r y: Co n te mporary is s ue s
Chairs: Daniel Bracco (ARGENTINA), Expedito Ribeiro (BRAZIL)
16:00
Statement 1:
Extra-corporeal circulation in coronary surgery is preferred
Pro: Roberto Favaloro (ARGENTINA)
Contra: Enio Buffolo (BRAZIL)
16:45
Statement 2:
Patients with multiple vessel disease should have surgery
Pro: Manuel IrarrazAbal (CHILE)
Contra: Alfredo Rodriguez (ARGENTINA)
Tigris - Ye llow P avillion - 1 6 :0 0 - 17: 30
Symposium
Repe r f u si o n i n t he el de r l y: E vid ence vs . re al life
Chairs: Fernando Botto (ARGENTINA), M. Nahir (ISRAEL)
16:00
Reperfusion in developed countries
Xavier Bosch (SPAIN)
16:22
Reperfusion in the rest of the world
Álvaro Avezum (BRAZIL)
16:44
Comorbidity and reperfusion strategies
John Field (UNITED STATES)
17:06
Cardiac care after myocardial infarction
Mauricio Wajngarten (BRAZIL)
Scientific Programme / 129
Tuesday, 20 May 2008
Gange s - Gr e e n P avillion - 1 6 :0 0- 17: 30
Clinical Seminar
Ho w t o d e a l w ith P CI c om p l ic at i ons ?
Chairs: Gao Runlin (CHINA, PEOPLE’S REPUBLIC OF), Jorge Leguizamon (ARGENTINA)
16:00
PCI: Lethal or near lethal complications: Predictions and solutions
Grinfeld Liliana (ARGENTINA)
16:22
New antithrombotic strategies for avoiding stent thrombosis
Marcelo Casey (ARGENTINA)
16:44
Bleeding in PCI: How much of a problem?
Carlos Macaya (SPAIN)
17:06
Post-procedural renal failure: An unnecessary complication
Roxana Mehran (UNITED STATES)
R io de la P lat a - R e d P avillion - 1 6 :0 0- 17: 30
Symposium
Go Re d f o r Wom en: G oing g l o b al
Chairs: Zhao Dong (CHINA, PEOPLE’S REPUBLIC OF), Volqvartz Susanne (DENMARK)
16:00
Women and heart disease in Argentina
Florencia Rolandi (ARGENTINA)
16:18
Africa: The data gaps
Krisela Steyn (SOUTH AFRICA)
16:36
Go Red for Women in the USA
Nancy Brown (UNITED STATES)
16:54
Go Red for Women Singapore style
Sun Yee Ho (SINGAPORE)
17:12
Women & heart disease in low- and middle-income countries
Nishtar Sania (PAKISTAN)
Se ine - Gr e e n P avillion - 1 6 :0 0- 17: 30
Symposium
Str o k e a bo v e t he c ar o tids
Chairs: Omar Santaera (ARGENTINA), Chain Sergio (ARGENTINA)
16:00
Incidence, prevalence of ischemic and hemorrhagic strokes: Demographic and geographic differences
Sebastián Ameriso (ARGENTINA)
16:22
Therapeutic window: Diagnosis and management based on neuro-imaging, CT vs. MRI
Gilberto Gonzalez (UNITED STATES)
16:44
Medical treatment beyond aspirin and IV rtpa
Tonkin Andrew (AUSTRALIA)
17:06
Endovascular treatment in intracranial ischemic stroke
Fernando Vinuela (UNITED STATES)
Tuesday, 20 May 2008
Thame s - Ye llow P avillion - 1 6 :0 0 - 17: 30
Special Featured Joint Session
PCNA: The role of the nurse in preventive cardiology:
An a r e a o f l e ade r s hip
Chairs: Joanna Sikkema (UNITED STATES), Lira Maria Teresa (CHILE)
16:00
The role of the nurse on cardiovascular prevention programmes
Veronica Kramer (CHILE)
16:22
Secondary Prevention: Are we able to improve the results?
Catriona Jennings (UNITED KINGDOM)
16:44
Role of nursing in cardiac rehabilitation
Nancy Houston Miller (UNITED STATES)
17:06
Behavioral changes in cardiovascular diseases: Tools for success
Laura Hayman (UNITED STATES)
Amaz on - Ye llow P avillion - 1 6 :0 0 - 17: 30
South American Congress of Cardiology
Fac t o r e s d e r ies g o y a te r os c l er os is s ub clínica
Coordinadores: Mario Lado (URUGUAY), Santiago García Egüez (ECUADOR)
16:00
¿Es suficiente el score de Framinghan para establecer el riesgo cardiovascular?
Hernández Edson (VENEZUELA)
16:15
Aterosclerosis subclínica y riesgo cardiovascular. ¿Cómo evaluarla y como tratarla?
Antonio Chagas (BRAZIL)
16:30
Cambios en el estilo de vida: Beneficios clínicos y fallas en su implimentación
Victoria Chaparro Cristaldo (PARAGUAY)
16:45
¿Cómo detectar y como tratar el metabolismo anormal de la glucosa?
José Drago Silva (PERU)
17:00
Objetivos terapéuticos de los trastornos lipídicos en prevención primaria y secundaria
Rey Ricardo (ARGENTINA)
Scientific Programme / 131
Scientific programme by day and by time
Wednesday, 21 May 2008
Me kong - Ochre P avillion - 0 8 :3 0- 10: 00
Oral abstract session
Ant i p l a t e l e t s in P T CA
Chairs: Ricardo Lluberas (URUGUAY), Barrero Carlos (ARGENTINA)
08:30
Prognostic value of myocardial perfusion Gated SPECT after myocardial infarction
P. Pujol, G. Cuberas, G. De León, R. Falú, S. Aguadé-Bruix, J. Castell-Conesa, J. Candell-Riera
08:43 Can haemoglobin at admission predict short-term prognosis in acute coronary syndrome patients?
N. Antonio, S. Monteiro, C. Lourenco, S. Costa, R. Teixeira, F. Goncalves, P. Monteiro, L. Goncalves, M. Freitas,
L. A. Providencia
08:56Efficacy and Safety of Abciximab in Conjunction with Aspirin, Heparin and Clopidogrel in High Risk Indian
Patients Undergoing Percutaneous Coronary Intervention
N. Sinha, S. Kumar, K. Parikh, P. Chandra, A. Srinivas
09:09Safety and Efficacy of Bivalirudin in High-Risk Indian Patients Undergoing Percutaneous Coronary
Intervention: The Bivaflo® Registry
A. Seth, N. Sinha, K. Parikh, T. Patel, M. S. Hiremath, A. B. Mehta, P. Chandra, B. Pinto, K. K. Sethi, S. Kumar
09:22
Bleeding during warfarin therapy: an alert to concomitant diseases
P. L. Lavitola, G. Spina, F. Tarasoutchi, R. O. Sampaio, M. Grinberg
09:35Traditional cardiovascular risk factors in unselected patients with acute myocardial infarction – impact on
short-term mortality
Z. Monhart, V. Faltus, H. Grunfeldova, P. Jansky
09:48Interaction between inflammation, glucose plasma levels and left ventricular function in postmenopausal
women with coronary arterial disease
U. Rushentsova, Y. Ekimova
Ac u t e co r o n ar y s y n dr o m e s a n d P TCA
Chairs: P. Gabriel Steg (FRANCE), Hita Alejandro (ARGENTINA)
Tigris - Ye llow P avillion - 0 8 :3 0- 10: 00
Oral abstract session
08:30 Time to reperfusion and myocardial salvage achievement in Primary PCI
J. Szarfer, M. A. Riccitelli, A. Garcia Escudero, G. Gigena, B. Federico, A. Alonso, R. Sarmiento, R. Blanco, R. Neme,
L. Vidal
08:43
Brazilian Registry of Acute Coronary Syndromes
L. Piegas, H. Guimarães, A. Avezum, H. Reis, A. Muniz, E. Santos, M. Knobel, I. Santos, L. Ritt, J. Braga
08:56
Factors That Impact The Door-To-Electrocardiogram Time In Patients With Acute Myocardial Infarction
A. Correa, M. Makdisse, V. F. Oliveira, L. M. A. Forlenza, R. B. Magaldi, L. F. Lisboa, M. Vaidotas, M. Knobel, E. Knobel
09:09Patients undergoing rescue PCI with selective drug-eluting stent use can achieve similar mortalities to
primary PCI, and low rates of target vessel revascularisation
Q. Lo, V. Hsieh, N. Wouters, R. Van Der Vijver, D. Tobing, A. Hopkins, S. Lo, D. Leung, C. Juergens, J. French
09:22 ST segment resolution after a successful PTCA: clinical and angiographic associated factors
R. Blanco, J. Szarfer, M. A. Riccitelli, A. Garcia Escudero, S. Affatato, G. Gigena, F. Blanco, R. Sarmiento,
A. Rodriguez, L. Vidal
09:35
Predictors for lack of reperfusion after primary angioplasty in ST-elevation acute myocardial infarction
F. Cura, A. Garcia Escudero, M. Trivi, M. Albertal, J. Thierer, P. Perez Baliño, L. Padilla, J. Belardi
09:48
Prognosis of acute myocardial infarction in the elderly in Chile from 1993 to 2006
F. Lanas, J. C. Prieto, C. Nazzal, P. Seron, P. Campos, J. Bartolucci, R. Corvalan, Gemi Group
Wednesday, 21 May 2008
Wom e n a n d co r o n a r y d i s e a s e
Chairs: Masotti Mónica (SPAIN), Rodolfo Pizarro (ARGENTINA)
Se ine - Gr e e n P avillion - 0 8 :3 0- 10: 00
Oral abstract session
08:30Homocysteine lowering B-vitamin therapy improves coronary flow in patients with stable coronary artery
disease, a WENBIT substudy
Ø. Bleie, E. Strand, P. M. Ueland, S. E. Vollset, H. Refsum, J. Igland, J. E. Nordrehaug, O. Nygård
08:43Prognostic Value Of Myocardial Perfusion Defects With Cold Pressor Testing As An Indicator Of Endothelial
Dysfunction In Asymptomatic Moderate Risk Patients.Paradigma Multicenter Study
N. Perez Baliño, S. Traverso, L. Grynberg, M. Redruello, N. Maciel, C. Rapallo, D. Rosa, L. Vidal, J. Gagliardi, O. Masoli
08:56Atorvastatin Improved Endothelial Dysfunction To Supranormal Level After 9 Months Of Treatment In
Familial Hypercholesterolaemia Patients
A. Rapaee, H. Nawawi, K. Yusoff
09:09
Flow mediated vasodilation in women at risk for preeclampsia
F. A. Casas, H. A. Avaca, C. R. Majul, B. Lopez Ledesma, O. D. Manuale, G. M. Ferrari
09:22
Effects of Long-Term Estrogen Replacement Therapy in Postmenopausal Women with Coronary Risk Factors
R. Campisi, T. H. Schindler, J. O. Prior, X. L. Zhang, D. Dorsey, H. R. Schelbert
09:35Endothelial Dysfunction in dyslipidemia: pre and post-treatment assessment using 64-multislice PET/CT, C
Reactive Protein and Lipid Profile
E. Alexanderson, G. Alexanderson, L. García-Rojas, M. Rodríguez, P. A. Lamothe, J. A. Talayero, J. G. Juárez-Rojas,
H. Rodríguez-Zanella, J. Almada, A. Meave
09:48Ultrafiltration To Remove Inflammatory Mediators During Cardiopulmonary Bypass In Coronary Artery
Bypass Graft Surgery
O. Petrucci, N. Antunes, P. P. M. Oliveira, C. Kosour, M. H. S. L. Blotta, D. M. Braile, R. W. Vieira
Scientific Programme / 133
Wednesday, 21 May 2008
Nige r - Gr e e n P avillion - 0 8 :3 0- 10: 00
Oral abstract session
TC Sca n , a rr hytm ia s a n d or thos t at ic hypot e ns ion
Chairs: Dubner Sergio (ARGENTINA), Nabil El-Sheriff(UNITED STATES)
08:30Mutation screening of PKP2 gene in severe form of arrhythmogenic right ventricular cardiomyopathy in
Polish population
E.K. Wlodarska, G. Beffagna, O. Wozniak, E. Czarnowska, C. Basso, K. Pilichou, P. Hoffman, G. Thiene, G. A. Danieli,
A. Rampazzo
08:43Noncalcified Coronary Plaques Evaluated by 64 Slice Computed Tomography in Patients With Low Risk for
Coronary Artery Disease
A. Bayol, J. Vallejos, R. Peloso, J. Mazucco, R. Obregon, M. Romero, W. Harvey, R. Gonzalez, A. Zarza, J. Parras
08:56Diagnostic Accuracy of 64-Slice Computed Tomography To Identify Coronary Artery Disease. A Single Center
Comparison with Invasive Coronary Angiography
L. Lasave, E. Picabea, F. Kozak, A. Damonte, M. Rossi, C. Bonini, E. Arias, M. Gamen, A. Dauria, R. Villavicencio
09:09
Influence of paroxysm of atrial fibrillation on the left atrial and left ventricular functional parameters
L. Tunyan 09:22The significance of short time Poincare plot analysis in assessment of sudden cardiac death risk in patients
with alcoholic liver disease
B. M. Branislav Milovanovic, N. M. Nikola Milinic, M. K Mirjana Krotin, B. F. Branka Filipovic, V. B Vesna Bisenic
09:35
Association Between Orthostatic Hypotension And Results Of The Head-Up Tilt Table Testing
L. Smidt, M. Morais, J. Barbisan, C. Nicoletti, L. Biason, J. Paiva
09:48
Circulatory variables related to the clinical syndrome of Postural Orthostatic Hypotension
C. Podoleanu, R. Maggi, M. Brignole, D. Podoleanu, E. Carasca, K. Orban, I. Craciunescu, C. Ginghina
Wednesday, 21 May 2008
R hine - Ye llow P avillion - 0 8 :3 0 - 10: 00
Oral abstract session
ICD a n d p a c e make r s
Chairs: Luis Alcocer (MEXICO), Jorge Gonzalez ZUelgaray (ARGENTINA) 08:30 Clinical value of a simple RR interval holter monitoring as a predictor of life-threatening arrhythmias in
patients with defibrillator discharge.
M. Lewandowski, H. Szwed, I. Kowalik.
08:41
Identification of patients who benefit from implantable cardioverter defibrillators (ICDs) by combining the
genotypes for Angiotensinogen (AGT), Angiotensin-converting enzyme (ACE) and Angiotensin II type1
receptor (AT1R)
L. Woie, L. Wee, H. Vefring, J. T. Kvaløy, D. W. T. Nilsen.
08:52
on-pharmacological prevention of atrial fibrillation after off-pump CABG: temporary atrial external stimulation
N
F. Silva, P. Brofman, R. Milani, D. Précoma, M. Guimarães, L. Barbosa, A. Sartori, J. Augusto Souza.
09:03 T
he Successful Use of Extracorporeal Membrane Oxygenation and Drotrecogin alfa in Patients with Acute Life
Threatening Myocarditis
T. Tsai, S. Tsao, Y. Wu, J. Yu, K. Chan, K. Ueng, H. Wong, Y. Sun, S. Huang.
09:14 Effectiveness and Feasibility of a Transtelephonic Monitoring Program
A. Baranchuk, D. Campbell, K. Stuart, W. Hopman, J. McMillan, K. Aldworth-Gaumond, R. Witjes, D. Clark,
D. P. Redfearn, C. S. Simpson.
09:25 Biventricular Pacing Using Conventional Dual-Chamber Pacemakers in Patients with Permanent Atrial
Fibrillation and Heart Block
S. Pinski, B. Kuo, F. Arnaldo, M. Helguera.
09:36 Where Are The Left Ventricular Leads Really Implanted? A Study of 90 Consecutive Patients
C. D'Ivernois, J. Lesage, A. Lagrange, P. Blanc. 09:47 Antiarrhythmic effect of H1-histamine receptors blocker – Phencarol
O. N. Uchevatkina, L. M. Makarov, L. A. Balykova, V. N. Komolyatova, V. P. Balashov. Scientific Programme / 135
Wednesday, 21 May 2008
Euphrat e s - Ochre P avillion - 0 8 :3 0- 10: 00
Oral abstract session
Card i o m y opa t h i e s
Chairs: Eduardo Moreyra (ARGENTINA), Hector Delgado Osorio (PUERTO RICO)
08:30
Surgical treatment of primary dilated cardiomyopathy (the role of endomyocardial biopsy analysis)
M. Zorc, D. Petroviè, R. Zorc-Pleskoviè, A. Pleskoviè, N. Radovanoviæ
08:43New insight into the pathogenesis of the hypertrophic cardiomyopathy: benign tumour secreting
inappropriately high amount of BNP during stress
N. Nranyan 08:56Short and long term follow-up of patients with hypertrophic cardiomyopathy treated with percutaneous
alcohol septal myocardial ablation
L. A. Malek, M. Klopotowski, L. Chojnowska, M. Demkow, A. Witkowski, M. Dabrowski, B. Kusmierczyk, M. Konka,
R. Maczynska, W. Ruzyllo
09:09
Seven years follow-up of metoprolol for treatment of dilated cardiomyopathy
S. Xue 09:22Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy: Ultra-Low Dose of Alcohol (1 ml) is
Still Effective
J. Veselka, D. Zemánek, P. Tomašov, R. Duchoňová, K. Linhartová
09:35 Echocardiographic And Pathological Assessment Of Cardiac Myxomas: A 14-Year Retrospective Review.
T. F. Cianciulli, L. A. Cosarinsky, J. A. Lax, M. C. Saccheri, J. A. Gagliardi, H. J. Redruello, S. D. Llanos Dethinne,
S. Fandiño Lound, C. E. Parisi, L. A. Vidal
09:48Value of real-time three-dimensional echocardiography in patients with hypertrophic cardiomyopathy.
Comparison with two-dimensional echocardiography and magnetic resonance imaging.
L. Bicudo, J. Tsutsui, A. Shiozaki, C. Rochitte, E. Arteaga, C. Mady, W. Mathias
Mis s ouri - Ye llow P avillion - 0 8 :3 0- 10: 00 Oral abstract session
Kid n e y a n d he a r t f ail ur e
Chairs: Daniel Nul (ARGENTINA), Barry Massie (UNITED STATES) 08:30 Kidney-Heart Connection: Cardiac Fibrosis and Differential Ventricular Gene Profiles after One Kidney
Nephrectomy in the Absence of Heart Failure
F. L. Martin, A. Cataliotti, B. K. Huntley, G. E. Harders, H. H. Chen, J. C. Burnett.
08:45 Experimental Diabetic State Attenuated Left Ventricular Dysfunction after Myocardial Infarction
B. Rodrigues, A. Medeiros, G. Orsi Candido, K. Teodoro Rosa, R. Nitrosi De La Fuente, P. Chakur Brum,
K. De Angelis, M. C. Irigoyen.
09:00 Influence of glomerular filtration rate and age in the accuracy of Brain Natriuretic Peptide
B. Fabricio, L. Armini, J. Kezen, S. Gomes Jr., F. Alvim, P. P. Sampaio, I. Gotlib, J. Mansur.
09:15 High serum adiponectin as a marker of severity and bad prognosis in systolic heart failure
J. Thierer, A. Acosta, N. Vainstein, J. Marino, A. Hirchson Prado, M. Sultan, A. Francesia, M. Sutton, L. Boero, F. Brites.
09:30 Left atrial size and prognosis in patients with heart failure. An individual patient meta-analysis study of
longitudinal data (MeRGE Heart Failure)
A. Rossi, M. Quintana, P. L. Temporelli, G. Hillis, N. A. Marsan, D. Prior, C. Yu, K. Poppe, R. Doughty, G. Whalley.
09:45 C
omparison of prognostic value of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide
levels in patients with different functional classes of chronic systolic heart failure
A. B. Nargizyan, L. R. Tumasyan, K. G. Adamyan.
Wednesday, 21 May 2008
Hyp e rt e n s i o n a n d o t h e r ri s k f ac tor s
Chairs: Wistremundo Dones (PUERTO RICO)
Or inoco - Ochre P avillion - 0 8 :3 0 - 10: 00
Oral abstract session
08:30Cardiovascular autonomic control improvement induced by exercise training in an experimental model of
menopause associated with Dyslipidemia
M. Heeren, C. Mostarda, J. Paulini, K. Flues, L. De Souza, E. Moreira, M. C. Irigoyen, K. De Angelis
08:43
Impact of Age-related Elongation of the Aorta on Pulse Wave Velocity Measurement
J. Sugawara, K. Hayashi, T. Yokoi, H. Tanaka
08:56
Atrial Fibrillation And Isolated Systolic Hypertension: The Shep And Shep-X Study
T. Vagaonescu, A. C. Wilson, J. B. Kostis
09:09
The use of oscillometric blood pressure devices in children for fieldwork in resource poor settings
J. J. Miranda, S. Stanojevic, A. Bernabe-Ortiz, R. H. Gilman, L. Smeeth
09:22Rho Kinase Inhibition Reduces Blood Pressure And Activates The Vasodilator Pathway Of The Renin
Angiotensin System In The Aortic Wall Of Hypertensive Rats.
M. Ocaranza Jeraldino, P. Rivera, J. Jalil Milad
09:35Impact of combined hypertension and dyslipidemia on risk of coronary heart disease events in the elderly:
the Cardiovascular Health Study
N. D. Wong, V. A. Lopez, R. Tracy, D. Yanez, L. Kuller, G. Burke, C. Roberts, H. Solomon, B. Psaty
09:48
Heart Rate Recovery After Mental Stress Test Is Impaired In Healthy Relatives Of Hypertensive Patients
A. Nobrega, A. Coimbra, M. Magalhaes, R. Castro, P. Silva, S. Pedrosa
Nile - Ye llow P avillion - 0 8 :3 0- 10: 00
Oral abstract session
Hyp e r t e n si o n and s ub c l in ic a l at he ros cle ros is
Chairs: Alberto Lorenzatti (ARGENTINA), Protasio Da Luz (BRAZIL)
08:30
Cardiovascular Morbimortality in End Stage Renal Disease patients: Effect of Spironolactone
D. Gainza, S. Kunstmann, E. Marusic, A. Vukusich, L. Michea, C. Varela, D. Sepulveda, S. Bravo
08:43
Salt reduction in processed foods to reduce population sodium consumption
D. Ferrante, B. Linetzky, M. Virgolini, N. Apro
08:56Prevalence, and smoking behaviour among university students, and the impact of medical education in their
attitudes, towards tobacco control in Chile.
J. A. De Grazia, D. Faivovich, F. Falcón, R. Díaz, G. Yentzen, Maria Teresa Lira, S. Kunstmann
09:09Is there an association between impaired clock drawing test and hypertension in ambulatory communitydwelling elderly?
M. Schapira, M. Bellomo, J. Benchimol, M. Bechelli, S. Maggi, J. Pollan, M. Perazzoli, D. Seinhart, L. Cámera
09:22Impact of obesity and overweight on left ventricle mass, systolic and diastolic function in children and adolescents
I. Schusterova, J. Saligova, L. Potocnakova, M. Kuchta, I. Riecansky
09:35The Relationship of Adiponectin to C-Reactive Protein Levels, Anthropometric Parameters of Obesity and
Subclinical Atherosclerosis in Children
P. Arnaiz, M. Acevedo, S. Barja, M. Aglony, B. Guzman, B. Cassis, J. Carvajal, M. Moreno, X. Berrios
09:48The Impact of Age on the Identification of Pre-clinical Atherosclerosis by Screening Vascular Ultrasound
(WITHDRAWN)
J. Postley
Scientific Programme / 137
Wednesday, 21 May 2008
Mis s is s ippi - Ye llow P avillion - 0 8 :3 0- 10: 00
Oral abstract session
Exe rci se a n d a u tonom ic ne r vous s ys t e m
Chairs: José Spolidoro (ARGENTINA), Eduardo Rivas Estany (CUBA)
08:30 Strength And Flexibility Measurement In Patients In Phase II Cardiovascular Rehabilitation
S. Kerbage Soraya, Gallucci Emilce, Angelino Arnaldo, Brion Graciela, Morozovsky Veronica, Burgos Sebastian,
Diaz Lidia, Castañeda Luis, Roberto Peidro, Lirio Carlos
08:43Exercise-induced cardiopulmonary reflex increase is related to autonomic improvement in spontaneously
hypertensive rats
I. C. M. Silva, R. N. De La Fuente, K. Flues, C. Mostarda, K. De Angelis, M. C. Irigoyen
08:56
Carotid Chemoreceptors And Antihypertensive Agents
D. R. Grana, R. Guerri Guttenberg, N. Paglia, F. Azzato, J. E. Toblli, J. Milei
09:09An Integrative Evaluation Of Vascular Structure And Function In Patients With Essential Hypertension. Early
Detection Of Subclinical Vascular Disease.
P. Forcada, C. Kotliar, C. D´amico, J. Guerrieri, G. Millet, S. Obregon, O. Montaña, C. Schulte, A. Hita, D. Turri
09:22
Resistance arm exercise with vascular occlusion acutely improves recovery calf blood flow in older subjects
P. J. C. Vieira, G. R. Chiappa, C. N. Alves, R.S. Moraes, R. Stein, J. P. Ribeiro
09:35Effects of an acute inspiratory muscle training session on haemodynamic control of patients with heart failure
and inspiratory muscle weakness.
P. Mello, S. Borile, M. C. Irigoyen, G. M. Guerra, C. E. Negrão, MU P.B.Rondon, P. Dall´ago, E. Moacyr Krieger,
F. M. Consolim-Colombo
09:48Recovery Of Heart Rate Variability And Baroreflex Sensitivity After Maximal Exercise Is Correlated
To Exercise Capacity
A. Nobrega, P. Soares, K. Bousquet-Santos, L. Protasio, J. Figueiredo, E. Silva Junior, M. Souza
Yangt z e - Ochre P avillion - 0 8 :3 0- 10: 00
Oral abstract session
Soc i a l a n d em o tional f a c tor s in he art dis e as e
Chairs: Carlos Tajer (ARGENTINA), Angelique Schiffer (NETHERLANDS)
08:30Substantial Gaps in Myocardial Infarction Care and Outcomes Across Socioeconomic Groups
in the Contemporary Era of Evidence-Based Medicine
M. G. Cohen, G. M. Holmes, T. S. Carey, S. B. Greene, K. A. Selzman, C. Patterson
08:43
Burnout syndrome, perceived stress and depression in cardiology residents
S. Waldman, J. C. Lopez Diez, B. Linetzky, H. Cohen Arazi, S. Guinjoan, H. Grancelli
08:5610 years investigation of influence of depression on myocardial infarction risk in the population
of men of 25-64 years old in Russia: epidemiological views
V. Gafarov, E. Gromova, I. Gagulin, A. Gafarova
09:09
Association between Depression, Anxiety and Quality of Life In Post Acute Myocardial Infarction Patients
C. Lemos, C. Gottschall, L. Smidt
09:22
High Rates of Depression and Cardiovascular Risk Factors in Rural Mexico
L. A. Temming, K. A. Olson, C. R. Clover, B. D. Skinner, S. C. Clark, A. Krishnarao, S. M. Skinner, M. G. Cohen
09:35Effects of geographical area of residence & deprivation on access to coronary angiography and on mortality
after acute myocardial infarction in Quebec, Canada
C. B. Claudia Blais, D. H. Denis Hamel
09:48Alarming Prevalence of Metabolic Risk for Cardiovascular Diseases in a Physician Population of
Southern India
A. Mathavan, A. Chockalingam, S. Chockalingam, B. Bilchik, V. Saini
Wednesday, 21 May 2008
Cell t h er a py
Chairs: Jorge Trainini (ARGENTINA)
Tib e r - Ye llow P avillion - 0 8 :3 0- 10: 00
Oral abstract session
08:30 Mononuclear Stem Cells Implant In Chronic Ischemic Cardiomyopathy
J. C. Trainini, N. Lago, J. Bordone, J. C. Chachques, J. De Paz, O. Masoli, C. Collaud, A. Christen, J. C. Barisani,
J. Mouras
08:43Sustained clinical improvement after Autologous Bone Marrow Mononuclear Cell Transplantation (ABMMC)
in Humans With Severe Ischemic Heart Failure- Four years follow up
H. Dohmann, A. Haddad, R. C. Moreira, S. A. Silva, F. A. Tuche, J. A. Assad, R. Verney, C. M. Rutherford, A. S. Souza,
R. Borojevick
08:56 Mesothelial Cells Transplantation For Myocardial Vascularization And Regeneration
M. Cortes Morichetti, B. Bourahla, O. Meilhac, I. Elmadbouh, E. Chachques, A. Carpentier, J. B. Michel,
J. C. Chachques
09:09
Cellular Therapy In Cardiology: Analysis of Research at the Last 10 Years
G. Carvalho, A. Silva, P. Mota, P. Silva, L. Campos, D. Santoro, T. Guimarães, A. Câmara, R. Barreiro Filho, V. Lima
09:22
Bioartificial matrix and bone marrow stem cells in ischemic cardiomyopathy
J. Trainini, N. Lago, J. L. Barisani, A. Christen, J. Mouras, G. Ruiz Deza, M. Redruello, O. Masoli, S. Chada, J. Bordone
09:35Combining Granulocyte Colony-Stimulating Factor Treatment With Cellular Cardiomyoplasty induces
Myocardial Regeneration In Patients With Acute Or Chronic Ischaemic Heart Disease
J. Senior Sanchez, C. Saldarriaga, F. Cuellar, O. Velásquez, J. Gomez, J. Delgado, G. Blanco, C. Navas, F. Jaimes
09:48
Intracoronary Bone Marrow Stem Cell Transplantation: Feasibility, Safety, And Effect On Ventricular Function
And Myocardial Perfusion In Chronic Myocardial Infarction Patients. Recuperar Study.
L. Grynberg, N. Perez Baliño, M. Riccitelli, J. Dupont, R. Caccione, S. Traverso, M. Redruello, J. Szarfer, O. Masoli,
L. Vidal
Scientific Programme / 139
Wednesday, 21 May 2008
Danub e - Gr e e n P avillion - 0 8 :3 0- 10: 00
Oral abstract session
Exp e r i m e n t a l and c l in ic a l int erve nt ions wit h cardiovas cular ce lls
Chairs: Juan Carlos Chachques (FRANCE), Kwang Koh (KOREA, REPUBLIC OF)
08:30
Suppression of Cardiomyocyte Hypertrophy by Inhibition of the Ubiquitin-Proteasome System
K. Stangl, H. Dreger, M. Fechner, G. Baumann, V. Stangl, S. Meiners
08:43
rogressive Ventricular Remodeling Occurring After Alcohol Septal Ablation In Severely Symptomatic
P
Patients With Hypertrophic Obstructive Cardiomyopathy
Silvia Judith Fortunato De Cano, Manuel Nicolas Cano, Jairo Alves Pinheiro Jr., Vera Marcia Lopes Gimenes,
Creso Benedito Conceição Oliveira, Mercedes Maldonado Andrade, Amanda Moraes R. Sousa,
Jose Eduardo Mr Sousa, Adib Domingos Jatene
08:56
Physiologic cardiac hypertrophy : impact of its development upon a model of pathologic hypertrophy
I. Ennis, M. B. Nolly, O. A. Pinilla, C. D. Garciarena, V. B. Carranza, M. R. Piaggio, E. M. Escudero, H. E. Cingolani
09:09Time Course of Angiogenesis, Arteriogenesis and Peripheral Conductance After Plasmid VEGF Delivery in Rat
Model of Hind Limb Ischemia
S. Mishra, S. S. Chauhan, S. K. Maulik, R. Ray, S. Sharma, S. C. Manchanda, V. K. Bahl
09:22
ransendocardial Autologous Bone Marrow in Chronic Myocardial Infarction using a Helical Needle Catheter,
T
Two Year Follow-up in an Open-Label, Non-Randomized, Pilot Study (the TABMMI study)
L. M. De La Fuente, S. H. Stertzer, E. Peñaloza, J. Argentieri, J. Miano, B. Koziner, C. Bilos, L. Battaglia, J. Stertzer,
P. A. Altman
09:35Reduction of cardiac output: diagnosis of nursing in patients with cardiomyopathy wide undergone cell
therapy
A. Camara, A. Silva, D. Santoro, G. Carvalho, L. Campos, P. Silva, P. Mota, T. Guimarães, V. Lima, R. Barreiro Filho
09:48Cardiac 123I-MIBG Scintigraphy in a Chagasic Patient: Alterations induced by intracoronary injection of
autologous bone marrow mononuclear cells
L. M. B. Fonseca, S. S. Xavier, R. S. L. Lima, P. H. C. Castro, R. C. S. Goldenberg, M. C. Landermann, B. Gutfilen,
R. C. Pedrosa, A. Hasslocher-Moreno, A. C. Campos De Carvalho
Wednesday, 21 May 2008
Huang He - Yello w Pavillion - 08:30 -10:00
Oral abstract session
MR I a n d C T sc an
Chairs: Marcelo Goldstein (BELGIUM), Campanelli Hugo (ARGENTINA)
08:30
Evaluation of Pulmonary Vein anomalies by Cardiovascular Magnetic Resonance
A. Ithuralde, J. P. Gallo, J. Moltedo, C. Seara, P. Garcia De Lucis, C. Nojec, M. Ithuralde
08:43Detection of Myocardial Fibrosis by Cardiovascular Magnetic Resonance Imaging in Patients with Chagas’
Disease: Correlation with Clinical Presentation and Risk Stratification
M. Uellendahl, D. Sobral Filho, C. Ribeiro, S. Martins, W. Oliveira Jr., C. Medeiros, C. Rochitte
08:56
Diagnostic accuracy of 64-row Gadolinium-enhanced CT coronary angiography
P. Carrascosa, A. Deviggiano, C. Capuñay, M. Bettinotti, A. Goldsmit, J. Carrascosa, M. Garcia
09:09
Steep learning curve of exclusion significant coronary stenosis with DSCT coronary angiography assessment
T. Adla, J. Neuwirth, J. Veselka, R. Duchonova, L. Martinkovicova, V. Suchanek
09:22The ACTIVE Trial: Comparison of the Effects on Renal Function of Iomeprol-400 and Iodixanol-320 in Patients
with Chronic Kidney Disease Undergoing Abdominal Computed Tomography
C. M. Erley, H. S. Henrik S., S. K. Morcos, L. Grazioli, Z. Ni, L. Romano
09:35Multidetector CT coronary angiography: Importance of the previous appointment for the management of the
heart rate in our daily practice.
P. Carrascosa, A. Deviggiano, C. Capuñay, J. Carrascosa
09:48Clinical Characteristics and stress tests results of the patients derived to our centre for a CT coronary
angiography: The real world.
P. Carrascosa, A. Deviggiano, C. Capuñay, J. Carrascosa
P ilcomayo - Yello w Pavillion - 08:30-10:00
Oral abstract session
Inte r v e n t i o n s and c ar d ia c ul t r as ound
Chairs: Roxana Campisi (ARGENTINA), Sharaf Abd El Rahman Abd El Gawad Sharaf (EGYPT)
08:30
Myeloperoxidase, Subclinical Atherosclerosis, and Cardiovascular Disease Events
N. D. Wong, H. Gransar, J. Narula, L. J. Shaw, D. Polk, J. Moon, L. Miranda-Peats, D. S. Berman
08:43 Long-term results and factors influencing outcome of subclavian and innominate artery angioplasty
T. Przewlocki, A. Kablak-Ziembicka, P. Pieniazek, P. Musialek, A. Kozanecki, I. Stopa, A. Roslawiecka, D. Rzeznik,
K. Zmudka, W. Tracz
08:56
Anomalies In The Origin Of Coronary Artery In Chile. Frequency In 10.000 Consecutive Angiographies.
H. Ugalde, A. Ramirez, D. Ugalde, F. Ayala, S. Garcia, G. Dussaillant, A. Silva, E. Farias
09:09
Color Doppler Echocardiography Guided Transradial Coronary Interventions
S. Chugh, R. Kasliwal, N. Trehan
09:22Relationship between carotid intima-media thickness and atherosclerotic renal artery stenosis in
hypertensive patients.
S. Chain, H. Luciardi, G. Feldman, A. Breitgand, S. Berman, J. Ochoa, E. Escudero
09:35Endothelium dysfunction assessment with high-resolution ultrasound in patients with impaired left
ventricle function
O. Savenko, V. Vikentyev
09:48Kinking and coiling of the carotid arteries: Embryiogenic or acquired? A study by color Doppler
ultrasonography.
R. Beigelman, A. Izaguirre, M. Robles, D. R. Grana, G. Ambrosio, J. Milei
Scientific Programme / 141
Wednesday, 21 May 2008
Gange s - Gr e e n P avillion - 0 8 :3 0- 10: 00
Oral abstract session
Ins i d e t h e a r t er y , i n s i d e t h e pl aque
Chairs: Daniel Berrocal(ARGENTINA), Igor Palacios (UNITED STATES)
08:30Intravascular Ultrasound Assessment of Sirolimus-eluting or Paclitaxel-eluting Stent Expansion in
Diabetic Patients.
L. O. Jensen, M. Maeng, G. S. Mintz, E. H. Christiansen, K. N. Hansen, A. Galloe, H. Kelbaek, J. F. Lassen,
L. Thuesen, P. Thayssen
08:43
Safety and feasibility of same day discharge after Percutaneous Coronary Intervention using left radial access
S. Chugh, S. Chugh, R. Kasliwal, N. Trehan
08:56
Contrast-Induced Nephropathy (CIN) During PCI or Angiography in Patients at the Highest Risk
A. E. Moreyra, J. Reiner, C. Staniloae, S. K. Sharma, R. E. Katholi, R. J. Solomon
09:09
Are drug eluting stents an attractive strategy to treat the diffuse in-stent restenosis?
O. Carlevaro, S. Centeno, L. De Candido, H. Maffeo, R. Kevorkian
09:22
Effect of the Stent Design Properties on Restenosis in Stented Human Coronary Artery
V. Dehlaghi, S. Najarian, M. Tafazzoli-Shadpour, A. Rai
09:35The value of invasive functional parameters in prediction of restenosis in patients with previous
myocardial infarction
B. Beleslin, M. Ostojic, A. Djordjevic-Dikic, V. Vukcevic, S. Stojkovic, M. Nedeljkovic, D. Orlic, G Stankovic, V. Giga,
J. Stepanovic
09:48
Homocysteine lowering B-vitamin therapy and in-stent restenosis. A WENBIT sub study
Ø. Bleie, E. Strand, K. H. Løland, P. M. Ueland, S. E. Vollset, H. Refsum, M. Ebbing, J. E. Nordrehaug, O. Nygård
Volga - Y ellow Pavillion - 08:30-10:00
Oral abstract session
Co r o n a r y a n d non c o r onar y e n dovas cular t re at me nt II
Chairs: Carlos Mendiz (ARGENTINA), Alexander Abizaid (BRAZIL)
08:30
Biodegradable Synthetic Small Calibre Vascular Prostheses: Potential as Coronary Bypass Grafts (WITHDRAWN)
B. Walpoth, M. Cikirikcioglu, D. Mugnai, J. C. Tille, E. Pektok, A. Kalangos, G. Bowlin
08:43Impact of glycemic control on postoperative complications in type II diabetic patients undergoing elective
coronary bypass surgery.
M. Santos, D. Lowenstein, H. Sanabria, A. Ciccale Smit, R. Favaloro, E. Gabe
08:56Expiratory positive airway pressure associated with incentive spirometry reduces pulmonary complications
and improves functional capacity in patients undergoing coronary artery bypass graft surgery
P. Dall'Ago, M. P. Haefner, G. M. Ferreira, S. S. M. Barreto
09:09
Prognostic impact of early asymptomatic coronary graft stenosis or occlusion
A. De Lorenzo, M. S. Felix, C. C. Zeno, F. J. M. Pittela, A. S. C. Rocha
09:22
Early and late clinical outcomes after off pump are better than after on pump coronary surgery?
J. M. Vrancic, J. Thierer, F. Piccinini, G. Vaccarino, H. Raich, S. Florit, D. Navia
09:35
New Technology: Valvuloplasties with Biodegradable Rings
R. Neirotti, M. Cikirikcioglu, A. Kalangos
09:48 Midterm Outcomes After Aortic Valve Replacement With Homograft Implantation.
H. J. Redruello, T. F. Cianciulli, M. L. Talavera, J. A. Lax, M. C. Saccheri, R. Blanco, H. A. Prezioso, V. P. Picone,
O. A. Schwint, H. Vogelfang
Wednesday, 21 May 2008
Thame s - Yello w Pavillion - 08:30 -10:00
Ex pe ri e nc e s w i t h h i g h r i s k p a t i e nts II
Chairs: Carlos Macaya (SPAIN), Alejandro Palacios (ARGENTINA)
08:30
Percutaneous Left Ventricular Assist in Ischaemic Cardiac Arrest
V. Tuseth, M. Salem, R. Pettersen, S. Rotevatn, K. Grong, J. E. Nordrehaug
08:52
Open vs. Close Cells Stent Designs in Carotid Angioplasty.
G. Lev, O. Mendiz, L. Valdivieso, F. Carlos, L. Villagra, P. Mollon, J. Scaglia
09:14
Percutaneous Mitral Valvuloplasty during Pregnancy
H. M. Pham, H. L. Nguyen, Q. N. Nguyen, O. N. Pham, L. D. Do, V. L. Nguyen, K. G. Pham
09:36
Carotid artery stenting with neuroembolic cerebral protection filter vs endarterectomy . Long term follow-up.
B. Tedeschi, A. Tedeschi, B. Gonçalves, M. De Sena, R. Peixoto
P araná - Ochre P avillion - 0 8 :3 0- 10: 00
Adv a nc e s i n n u r s i n g t op ic s
Chairs: Amparo Peiró (SPAIN), José Antonio Boggiano (ARGENTINA)
08:30
Early transfer preparation for discharge patient from ICCU to a general ward.
Anna Lider, Sigalit Dayan, Miroslava Yardenova, Tatyana Gopshtein, Yafim Irgo
09:00 Six minute walking test in cardiac rehabilitation: factors related to performance.
M. Bustamante, V. Krämer, D. Guidi, A. Guajardo, F. Marques, F. Yañez, M. Acevedo
09:30“Does he live to take his medications or to fish?” Values, identity, and context as determinants of compliance
during heart failure
A. M. Clark, N. Freyberg, L. Strain, M. Chan, R. Tsuyuki, P. Armstrong, F. A. McAlister
P rev e n t i o n o f c ar d i o v a sc u l ar d isease
Chairs: Herman Schargrodsky (ARGENTINA), Denise Eldemire Shearer (JAMAICA)
Amaz on - 08:30-10:00
Oral abstract session
08:30Regional demonstration for sustained community based prevention of CVD: From North Karelia Project to
North Karelia Center of Public Health
V. Korpelainen, P. Puska
08:52Consumption of fruits and vegetables in adolescents of Porto Alegre, Southern Brazil: Association with age,
gender, and education
S. C. Fuchs, M. A. Rieth, L. B. Moreira, R. L. Henn, M. B. Moreira, P. Stoll, F. Ghizzoni, F. D. Fuchs
09:14EUROACTION: Do couples attending a hospital based multidisciplinary family cardiovascular prevention and
rehabilitation programme share the same smoking habits? Do they stop smoking together?
C. Jennings, T. Collier, A. Mead, J. Jones, A. Holden, S. Connolly, K. Kotseva, D. De Bacquer, G. De Backer, D. Wood
09:36Palpitations in menopausal women without structural heart disease: a cross sectional prospective study with
12 leads holter system recording
E. Sclarovsky
Scientific Programme / 143
Wednesday, 21 May 2008
R io de la P lat a - R e d P avillion - 0 8 :3 0- 10: 00
Oral abstract session
Pro g n o si s, M yoc ar d ia l inf arc tion and s t e nt s
Chairs: Riccitelli Miguel (Argentina), Karina Rey García (Cuba)
08:30Long-term prognosis in Mexican patients with silent myocardial ischemia: results of a cohort study with
10 years of follow-up
A. Unzueta, M. A. Villasis, G. Ordoñez, N. Zamorano, F. David
08:43Prognostic significance of N-terminal pro B-type natriuretic peptide in asymptomatic severe aortic
regurgitation: Incremental value over clinical and echocardiographic variables
R. Pizarro, P. Oberti, M. Falconi, F. Achilli, A. Arias, S. Tewell, J. Krauss, A. Cagide
08:56
Pseudo-aneurysm of VE - a complication of myocardial infarction
E. Marum, A. Soares, M. Amoedo, M. Patricio, M. Socorro, V. Cordeiro, R. Fitaroni, R. Russo, J. Buono, H. Abensur
09:09Patients with acute myocardial infarction receiving drug eluting stents have better survival compared
to patients receiving bare metal stents. A new jersey statewide database study
T. Vagaonescu, A. E. Moreyra, A. C. Wilson, N. M. Cosgrove, J. B. Kostis
09:22Significant differential metabolic effects of atorvastatin, atorvastatin combined with amlodipine, and
amlodipine therapy in hypertensive patients
K. Koh, M. Quon, S. Han, W. J. Chung, B. Oh, E. Shin
09:35
Low body mass index and body surface area are independently associated with aortic regurgitation
M. R. Movahed, A. Martinez, R. Ebrahimi
09:48Diagnostic usefulness and prognostic implications of tissue Doppler imaging and E/Vp ratio in patients
with aortic stenosis
P. Oberti, R. Pizarro, M. Falconi, F. Achilli, A. Arias, F. Sosa, L. Lucas, J. Krauss, A. Cagide
R hine - Yello w Pavillion - 10:30-12:00
Symposium
At r i a l f i b r i ll a t i o n : Fr o m p a t h o genesis to pr acti ce
Chairs: Rene Asenjo (CHILE), Enrique Retyk (ARGENTINA)
10:30
Mechanism of atrial fibrillation: From electrical to structural remodeling.
Johannes Brachmann (GERMANY)
10:52
Rate versus rhythm control: Still a matter of discussion?
Martinelli Martino (BRAZIL)
11:14
Old and new anti-arrhythmic drugs: Revised concepts
Ricardo Pesce (ARGENTINA)
11:36
Antithrombotic therapy: Revised guidelines
Ali Oto (TURKEY)
Wednesday, 21 May 2008
Mis s our - Yello w Pavillion - 10:30 -12:00
Symposium
Sudd e n d e a t h in hear t f a il u r e
Chairs: Iglesias Ricardo (ARGENTINA), Luis Molina (MEXICO)
10:30
Epidemiology of sudden death in heart failure
V. Mareev. (RUSSIAN FEDERATION)
10:52
Risk stratification for sudden death in heart failure
Adrian Baranchuk(CANADA)
11:14
ICD indications in primary prevention: The arrhythmia specialists’ vision
Sergio Pinski (UNITED STATES)
11:36
ICD indications in primary prevention: The clinical cardiologist specialists’ vision
Hernan Doval (ARGENTINA)
Yangt z e - Och r e Pavillion - 10:30 -12:00
Symposium
End o t h e l i a l fu n c tion a n d dys f u n ct ion: As s e s s me nt , t he rapy and out come
Chairs: Roberto César Esper (ARGENTINA), Luis Mercado (BOLIVIA)
10:30
Biomarkers in detection of endothelial function
Dimitri Tousoulis (UNITED STATES)
10:48
Methods for the non-invasive evaluation of endothelial function in humans.
Jorge Vilarino (ARGENTINA)
11:06
Detection of vulnerable plaque by coronary angioscopy
Kyoichi Mizuno (JAPAN)
11:24
Does correcting endothelialdysfunction make a difference?
Juan Kaski (UNITED KINGDOM)
11:42
Are inflammatory markers good cardiovascular risk
Peter Libby (UNITED STATES)
Or inoco - Ochre P avillion - 1 0 :3 0 - 12: 00
Debate
Mana g e m e n t o f pre -hyp e r t ens io n and me t ab olic s yndrome
Chairs: Leonardo Ribeiro (BRAZIL), Onen Churchill (BOTSWANA)
10:30
Statement 1:
Pre-hypertension should be treated with anti-hypertensive drugs
Pro: Gianfranco Parati (Milano, ITALY)
Contra: Dagnovar Aristizabal (COLOMBIA)
11:15
Statement 2:
Metabolic syndrome: A collection of risk factors or a true syndrome?
Pro: Wahida Karmally (New York, UNITED STATES)
Contra: Ricardo Horacio Rey (ARGENTINA)
Scientific Programme / 145
Wednesday, 21 May 2008
Euphrat e s - Ochre P avillion - 1 0 :3 0- 12: 00|
Symposium
Ma n a g e m e n t of a c u te p ul m o n a ry e mb olis m and pulmonary hype rt e ns io n
Chairs: Piñeiro Daniel (ARGENTINA), Corbalan Ramon (CHILE)
10:30
Current classification and diagnostic strategies
Adam Torbicki (POLAND)
10:52
Imaging and monitoring right ventricle function
Miguel Gomez Sanchez (SPAIN)
11:14
Present and future in the pulmonary hypertension treatment
Sergio Perrone (ARGENTINA)
11:36
Diagnostic strategy in acute pulmonary embolism
Jorge Ubaldini (ARGENTINA)
P aranA - Ochre P avillion - 1 0 :3 0- 12: 00
How-to & Workshop Session
Ho w t o a sse s s vent r ic ul ar dys y nchrony for R CT?
Chairs: Heinrich Schelbert (UNITED STATES), Ricardo Martellotto (ARGENTINA)
10:30
How to assess ventricular-dysynchrony?
Ronderos Ricardo (ARGENTINA)
11:15
How to optimise CRT?
John Gorcsan III (UNITED STATES)
Nile - Yello w Pavillion - 10:30-12:00
Symposium
Global risk factors for the development of coronary artery disease and stroke
Chairs: Santiago García Egüez (ECUADOR), Maranhão Mario (BRAZIL)
10:30
International prevalence, recognition and treatment of CV risk factors in out-patients with atherothrombosis
Deepak Bhatt (UNITED STATES)
11:00 Risk factors for the development of strokes in multiple populations
Gilberto Gonzalez (UNITED STATES)
11:30 Risk factors for heart disease globally: An up-date from the Inter-Heart Study
Yusuf Salim (CANADA)
Tigris - Ye llow P avillion - 1 0 :3 0- 12: 00
Symposium
The c h e st p ain c e n tr e: E vol ving conce pt
Chairs: M. Nahir (ISRAEL), Sergio Hauad (ARGENTINA)
10:30
New injury markers
Peter Libby (UNITED STATES)
10:52
The chest pain centre concept: Scientific rationale and clinical results
Hugo Ramos (ARGENTINA)
11:14
Exercise testing vs. images tests
Ezra Amsterdam (UNITED STATES)
11:36
What happens to patients who are descharged from the chest pain centre in the follow-up?
Muntaner Juan (ARGENTINA)
Wednesday, 21 May 2008
Gange s - Gr e e n P avillion - 1 0 :3 0- 12: 00
Debate
PCI i n c h r o n i c CHD ha s n o pro ven long-t e rm s afe t y and b e ne fit
Chairs: Roxana Mehran (UNITED STATES), José Antonio Rodríguez (CHILE)
10:30
Statement 1:
PCI in chronic CHD has no proven long-term safety and benefit
Pro: Yusuf Salim (CANADA
Contra: Igor Palacios (UNITED STATES)
11:15
Statement 2:
Conventional risk factors control is sufficient to prevent past intervention CVD progression
Pro: Spencer King III (UNITED STATES)
Contra: Robert Superko
Huang He - Ye llow P avillion - 1 0 :3 0 - 12: 00
Symposium
How t o u s e C T m u l t i s l ic e a n d m a gneti c r esonan ce in c linical pr acti ce?
Chairs: James Moon (UNITED KINGDOM), Ricardo Baeza (CHILE)
10:30
How to implement CT multislice in the emergency department to assess patients with chest pain?
Enrique Gurfinkel (ARGENTINA)
10:52
How to estimate cardiovascular risk using coronary CT multislice?
Andre Ricardo Valle (BRAZIL)
11:14
Cardiovascular magnetic resonance for assessing myocardial ischaemia and viability
Gustavo Avegliano (ARGENTINA)
11:36
Delayed enhancement imaging for evaluation of cardiomyopathy
Scott Flamm(UNITED STATES)
P ilcomayo - Ye llow P avillion - 1 0 :3 0- 12: 00
Symposium
Car d i o v a sc u l ar s a f e t y o f n o n - c ardiovas cular dr ugs
Chairs: Rothlin Rodolfo (ARGENTINA), Jeffrey Borer (UNITED STATES)
10:30
Anti-cancer therapies
Diego Rosso (ARGENTINA)
10:52
Erythropoietin
Henry Krum (AUSTRALIA)
11:14
Antipsychotics
Silvia Wikinski (ARGENTINA)
11:36
NSAIDs/Coxibs
Frank Thomas Ruschitzka (SWITZERLAND)
Scientific Programme / 147
Wednesday, 21 May 2008
Mis s is s ippi - Ye llow P avillion - 1 0 :3 0- 12: 00
Symposium
No v e l c e l l u la r m e c ha n is m s in c ardiac hype rt rophy and is chae mia
Chairs: Kwang Koh (KOREA, REPUBLIC OF)
10:30
NHE-I and myocardial hypertrophy
Ennis Irene (ARGENTINA)
10:52
Regulation of pHi in the heart
Richard Vaughan-Jones (UNITED KINGDOM)
11:14
PDE-5 inhibition and NHE-I
Néstor Gustavo Pérez (ARGENTINA)
11:36
UNREP effect
Paolo Tucci (BRAZIL)
Volga - Yello w Pavillion - 10:30-12:00
Symposium
Ad u l t co n g e n i t a l h e ar t d i s e a s e: H ot issues
Chairs: Patricia Frangini (CHILE), Capelli Horacio (ARGENTINA)
10:30
Asymtomatic Patients with ASD and Moderated/ Severe Pulmonary Hypertension
Alfonso Buendia-Hernandez (MEXICO)
10:52
Serious arrhythmia and sudden death after surgery
Jose Moltedo (ARGENTINA)
11:14 Mistakes and Disasters in Medical Care GUCH Patients
Jane Somerville (UNITED KINGDOM)
11:36
The perspective of patients
Michael Landzberg (UNITED STATES)
Thame s - Yello w Pavillion - 10:30-12:00
Symposium
Ad v a n c e d c o nc e p t s in cr itic al care nurs ing
Chairs: Nancy Houston Miller (UNITED STATES), Marcelo Alvarez (ARGENTINA)
10:30
Advantages and disadvantages of open critical care units
Nancy Bravo (ARGENTINA)
10:52
Prevalence of infections in patients post-cardiovascular surgery
Stella Maimone (ARGENTINA)
11:14
Contrapulsation balloon
Amparo Peiró (SPAIN)
11:36
Hemodynamic monitoring
Marcela Ferrada (CHILE)
Wednesday, 21 May 2008
Me kong - Ochre P avillion - 1 0 :3 0- 12: 00
Clinical Seminar
Man a g e m e n t of a c u te m yo c a r dial infarc t ion in t he 2 1 s t Ce nt ury
Chairs: Conci Eduardo (ARGENTINA), Eduardo Rivas Estany (CUBA)
10:30
Epidemiology of acute myocardial infarction in the 21st century: Is it changing?
Carlos Tajer (ARGENTINA)
10:52
Management of AMI in developing countries
Eduardo Morales Briceño (VENEZUELA)
11:14
Significance of Q-wave in myocardial infarction in the era of cardiac magnetic resonance imaging
Antoni Bayés De Luna (SPAIN)
11:36Multi-slice computed tomography after acute myocardial infarction: Can we use this technique to
establish prognosis?
Michael Lim (SINGAPORE)
Se ine - Gr e e n P avillion - 1 0 :3 0 - 12: 00
Symposium
M et a b o l ic s y n d r o m e i n y o u t h : Is it the beginning of the c ardiovas c ular
dise a se c o n t inuum ?
Chairs: Gabriel D. Waisman (ARGENTINA)
10:30
Bogalusa heart study
10:52
The Rio de Janeiro study
Brandao Ayrton (BRAZIL)
11:14
Risk score predictions of atherosclerotic lesions in young people: The PDAY study
Wistremundo Dones (PUERTO RICO)
11:36
How early does the cardiovascular disease continuum begin?
Mario Bey Lombana (PANAMA)
Danub e - Gr e e n P avillion - 1 0 :3 0- 12: 00
Symposium
Ca rd i o l o g y i n m i d d l e - a n d l o w - i ncome count ries
Chairs: Antonio Chagas (BRAZIL), Hassell Trevor (BARBADOS)
10:30
Prevention is better than cure
Nishtar Sania (PAKISTAN)
10:52
The research perspective
Reddy Srinath (INDIA)
11:14
Models of service delivery
Howard Spencer (BAHAMAS)
11:36
Economic impact of cardiology services
George A. Mensah (UNITED STATES)
Scientific Programme / 149
Wednesday, 21 May 2008
Amaz on - Y ellow Pavillion - 10:30-12:00
South American Congress of Cardiology
T om a d e d e ci s i o n e s e n v a l v u l o patías
Coordinadores: Plastino Juan A (ARGENTINA), Luis Moya (COLOMBIA)
10:30
¿Cirugía de la insuficiencia aórtica ¿Cuándo es demasiado precoz y cuándo demasiado tarde?
Juan Gonzalez Moreno (URUGUAY)
10:45
¿Cuándo intervenir la estenosis aórtica asintomática?
Octavio Aparicio (BOLIVIA)
11:00
La insuficiencia mitral severa con factibilidad de reparación. ¿Siempre es quirúrgica?
Gustavo Restrepo (COLOMBIA)
11:15
¿Cuándo operar la insuficiencia mitral funcional?
Zalaquett Ricardo (CHILE)
11:30
Procedimientos percutáneos de reparación y remplazo valvular
Jose Condado (VENEZUELA)
R hine - Yello w Pavillion - 14:00-15:30
Symposium
S ud d e n d e a t h
Chairs: Ladislao Endrei (ARGENTINA), María José Sancho Tello (SPAIN)
14:00
Sudden cardiac death, a changing problem
Ali Oto (TURKEY)
14:22
Role of pharmacological therapy to prevent sudden death
Jorge Garguichevich (ARGENTINA)
14:44
Role of ICD in primary prevention of sudden cardiac death
Luis Molina (MEXICO)
15:06 Role of the ICD in rare disorders
Andres Caeiro (ARGENTINA)
Danub e - Gr e e n P avillion - 1 4 :0 0- 15: 30
Symposium
To a bl a t e o r not t o ab l a te ? Cont rove rs ial is s ue s
Chairs: Pozzer Domingo (ARGENTINA), Sabine Ernst (UNITED KINGDOM)
14:00
To ablate or not to ablate in asymptomatic WPW
Riccardo Cappato (ITALY)
14:22
Should atrial flutter always be ablated?
Rolando Gonzalez (CHILE)
14:44
To ablate or not to ablate idiopathic ventricular tachycardia
Mauricio Scanavacca (BRAZIL)
15:06
Atrial tachycardia
Teruhisa Tanabe (JAPAN)
Wednesday, 21 May 2008
Mis s ouri - Ye llow P avillion - 1 4 :0 0 - 15: 30
Symposium
The c a r d i o r e n a l s yn d r om e in he a rt failure
Chairs: Roberto Colque (ARGENTINA), Barry Massie (UNITED STATES)
14:00 T
he cardiorenal syndrome: Pathophysiology of the crosstalk
Daniel Nul (ARGENTINA) 14:22 Prognosis in patients with chronic renal failure
Diego Delgado (CANADA) 14:44 Emerging therapies in acute heart failure
Mihai Gheorghiade (UNITED STATES) 15:06 Continuous ambulatory Ultrafiltrations in chronic heart disease
Victor Gura (UNITED STATES) Se ine - Gr een Pavillion - 14:00 -15:30
Symposium
Hae m o d y n a m i c s , hear t a n d hyp ert e ns ion
Chairs: Kuschnir Emilio (ARGENTINA), Eduardo Moreyra (ARGENTINA)
14:00
The role of collagen in the development of left ventricular dysfunction
Richard Devereux (UNITED STATES)
14:30
Hypertensive cardiopathy and coronary reserve. Is it always diminished?
Robert Califf (UNITED STATES)
15:00
Pulse wave velocity and prognosis
Gianfranco Parati (ITALY)
Mis s is s ippi - Ye llow P avillion - 1 4 :0 0 - 15: 30
Clinical Seminar
Con t e m p o r a r y f ac t o r s in c ar d io logy
Chairs: Horacio F. Cingolani F (ARGENTINA), Maranhão Mario (BRAZIL)
14:00
Up-date in the functions of natriuretic peptides
Adolfo De Bold (CANADA)
14:18
Vascular NADPH oxidases as drug targets for novel antioxidant strategies
Tj. Guzik (POLAND)
14:36
The growing role of inflammatory markers
Juan Kaski (UNITED KINGDOM)
14:54
The cellular pathophysiology of oxidative stress
Carlos Ferrario (UNITED STATES)
15:12
Apoptosis in myocardial ischaemia
Ricardo Gelpi (ARGENTINA)
Scientific Programme / 151
Wednesday, 21 May 2008
Nige r - Gr e e n P avillion - 1 4 :0 0- 15: 30
Clinical Seminar
Wo m e n a n d c a r diovas c u l a r d is e as e
Chairs: Romero Carlos (URUGUAY), Susana Zeffiro (ARGENTINA)
14:00
Explanation for the higher mortality in women
Noel Bairey Merz (UNITED STATES)
14:22
Clinical presentation and differences in pathophysiology of CAD in women
Judith Zilberman (ARGENTINA)
14:44
What is the best method for the non invasive investigation of CAD in my female patients?
Roxana Campisi (ARGENTINA)
15:06
Are there any differences in results from revascularization between genders?
Leslee Shaw (UNITED STATES)
Euphrat e s - Ochr e Pavillion - 14:00-15:30
Symposium
Cha g a s d i s e a s e
Chairs: Antonio Chagas (BRAZIL), Javier Bustamante (BOLIVIA)
14:00
Pathogenesis of chagas disease: Is there now a consensus?
José Antônio Marin-Neto (BRAZIL)
14:18
Chagas heart disease: Clinical work up at initial presentation and prognosis
Anis Rassi Jr. (BRAZIL)
14:36
Echocardiography approach for diagnosis and prognosis
Ricardo Migliore (ARGENTINA)
14:54
Periodic parasitemias in the development of Chagas’ cardiomyopathy
Oscar Salomone (ARGENTINA)
15:12
Antiparasitic treatments of chagas disease: An update
Arturo Arribada (CHILE)
Volga - Yello w Pavillion - 14:00-15:30
Symposium
Ma n a g e m e n t o f ob es ity today
Chairs: Norberto Pallavicini (ARGENTINA), Gerardo Uceda (ARGENTINA)
14:00
Obesity in the Americas
Luis Molinary (PUERTO RICO)
14:18
Which Diet Is Best for Obesity?
Jorge Braguinsky (ARGENTINA)
14:36
Exercise for the Management of Obesity
Palmira Pramparo (ARGENTINA)
14:54
Gastric bypass: patient selection and perioperative management
Claudio Zin (ARGENTINA)
15:12
Central obesity or viceral obesity?
Scott Grundy (UNITED STATES)
Wednesday, 21 May 2008
Me kong - Ochre P avillion - 1 4 :0 0- 15: 30
Symposium
Sca l i n g - u p sec ondar y preve n tion
Chairs: Eduardo Rivas Estany (CUBA), Álvaro Sosa Liprandi (ARGENTINA)
14:00
Lessons from prevention programs in Europe
David Wood (UNITED KINGDOM)
14:22
Secondary prevention in stroke
J. Fernandes (BRAZIL)
14:44
Field testing of fixed dose combinations
TBD
15:06
Gaps in secondary prevention and access to essential medicines
Reddy Srinath (INDIA)
Thame s - Ye llow P avillion - 1 4 :0 0 - 15: 30
Symposium
Rele v a n t n u r s in g t o p ic s
Chairs: Veronica Kramer (CHILE), Imelda Perdomo (ARGENTINA)
14:00
Evidences of nursing cares in cardiovascular surgery
Aina Lauga (ARGENTINA)
14:22
Advances in pre-hospitalization treatment of acute coronary syndromes with ST segment elevation
José Luis Araya (ARGENTINA)
14:44
Reaches and competences of nursing in catheter handling
Martín Toranzo (ARGENTINA)
15:06
Handling of cardiogenic shock in a public hospital emergency ward
Mabel Medina (ARGENTINA)
Nile - Ye llow P avillion - 1 4 :0 0 - 15: 30
How-to & Workshop Session
How t o r e a c h a n d m a in tain LDL b e low 7 0
in v e ry h i g h r i s k p a t i e n t s
Chairs: Francisco Fonseca(BRAZIL), Alberto Lorenzatti (ARGENTINA)
14:00
With mixed dyslipidemia
George Steiner (CANADA)
14:45
With severe hypercholesterolemia
Ada Cuevas (CHILE)
Scientific Programme / 153
Wednesday, 21 May 2008
Yangt z e - Ochre P avillion - 1 4 :0 0- 15: 30
Symposium
Str e ss e c h o c ar d io g r ap hy in d ifficult pat ie nt s
Chairs: Eduardo Escudero (ARGENTINA), Horacio Vazquez (URUGUAY)
14:00
Stress echo in patients with LBBB, atrial fibrillation or left ventricular hypertrophy
Manuel Pinto (CHILE)
14:22
Stress echo after heart transplant
Wilson Mathias (BRAZIL)
14:44
Stress echo for aortic valvulopathy
Gustavo Restrepo (COLOMBIA)
15:06
Assessment of coronary flow reserve during stress echo
Jorge A. Lowenstein (ARGENTINA)
P araná - Ochre P avillion - 1 4 :0 0- 15: 30
Clinical Seminar
Echo d o pp l e r a s the m a in t o o l in as s e s s ing le ft ve nt ricular funct ion
Chairs: Susan Acosta Castillo (BOLIVIA), Takeshi Nakatani (JAPAN)
14:00
Global and regional systolic function: The classic and the new
Miguel Quiñones (UNITED STATES)
14:22
Dyastolic ventricular function at rest and during exercise
Nelson Pizzano (URUGUAY)
14:44
Role of echodoppler in the diagnosis of heart failure
Mani Vannan (UNITED STATES)
15:06
Heart failure treatment based on the echocardiography findings
Bjoy Khandheria (UNITED STATES)
Gange s - Gr e e n P avillion - 1 4 :0 0- 15: 30
Clinical Seminar
New S t r a t e g ies f or P CI
Chairs: Ricardo Sarmiento (ARGENTINA), Jose Alejandro Martinez Sepulveda (CHILE)
14:00
Stents platforms, polymers and gene therapies: Where are we?
Igor Palacios (UNITED STATES)
14:22
New drugs for drug eluting stents
Alexander Abizaid (BRAZIL)
14:44
New approached for bifurcation lesions: One, two or dedicated stents?
Expedito Ribeiro (BRAZIL)
15:06
New non-stent devices
Jorge Belardi (ARGENTINA)
Wednesday, 21 May 2008
R io de la P lat a - R e d P avillion - 1 4 :0 0- 15: 30
Symposium
Pos t - g r a d u a te c a r diol ogy tr a in ing and re ce rt ificat ion
Chairs: Hector Luciardi (ARGENTINA), Abel Moreyra (UNITED STATES)
14:00
The training of cardiology in developing countries
Reddy Srinath (INDIA)
14:22
Sub-specialty training in cardiology
Günter Breithardt (GERMANY)
14:44
Promoting international medical education
Tudor Vagaonescu (UNITED STATES)
15:06
The training of a cardiac surgeon
Radu Deac (ROMANIA)
Or inoco - Ochre P avillion - 1 4 :0 0- 15: 30
Symposium
Man a g e m e n t of hyp e r t ens io n
Chairs: Fernando Manzur Jattin (COLOMBIA), Mayosi Bongani (SOUTH AFRICA)
14:00
ACE inhibition and ARB, mechanisms of cardiovascular and renal protection: Are they the same?
Oscar Carretero (UNITED STATES)
14:22
Benefits of hypertensive therapy beyond lowering blood pressure
Jorge Jalil (CHILE)
14:44
Diuretics: Are they the same?
Daniel Piskorz (ARGENTINA)
15:06
Choosing the right drug for the right patient or socio ethnic considerations in selection of hypertensive therapy
GuilleRmo Fabregues (ARGENTINA)
Huang He - Ye llow P avillion - 1 4 :0 0- 15: 30
Symposium
Tissu e d o pp l e r im aging: P r es ent and fut ure
Chairs: Jorge Cachero (ARGENTINA), Ricardo Castro (ARGENTINA)
14:00
Strain 2D non-doppler for quantifying regional ventricular function
Bjoy Khandheria (UNITED STATES)
14:22
Speckle tracking: A toy or a tool?
Carlos Eduardo Suaide Silva (BRAZIL)
14:44
Tissue doppler imaging: A new diagnostic and prognostic tool
Juan Carlos Plana (UNITED STATES)
15:06
Tissue doppler and strain rate during stress echo
Miguel Bustamante-Labarta (ARGENTINA)
Scientific Programme / 155
Wednesday, 21 May 2008
P ilcomayo - Ye llow P avillion - 1 4 :0 0- 15: 30
Symposium
Me d i c a l i n f o r m a tic s : App l ic a tions in cardiology
Chairs: Ortego Raul (ARGENTINA), Fernán Quirós (ARGENTINA)
14:00
Clinical decision support to improve cost and quality: Valve and practical use
Leslee Shaw (UNITED STATES)
14:18
Medical Informatics at Distance: Continuing Learning in Cardiology
Armando Pacher (ARGENTINA)
14:36
Tele electrocardiography in Chile: Impact on the national care system
Escobar Edgardo (CHILE)
14:54
Ambulatory blood pressure monitoring: Teletransmission: The Latin American experience
Jose Andres Octavio (VENEZUELA)
15:12
Knowledge Translation: from data to clinical practice
Alvaro Margoglis (URUGUAY)
Tib e r - Ye llow P avillion - 1 4 :0 0- 15: 30
Special Featured Joint Session
SM C : I n t e r v e n tional c ar d io l o g y in adult s wit h conge nit al he art dis e ase
Chairs: J. C. Linares-Casas (ARGENTINA), Carlos Zabal (MEXICO)
14:00
Patent ductus arteriosus in the adult. Interventional treatment versus surgical repair
Zabal Carlos (MEXICO)
14:22
Interventioan treatment of the coarctation of the aorta in adults
Alejandro Peirone (ARGENTINA)
14:44
Percutaneous closure with amplatzer device of atrial septal defects with pulmonary hypertension in adults
more than 40 years old
Alfonso Buendia-Hernandez (MEXICO)
15:06
Interventional cardiology in adults: State of the Art
Faella Horacio (ARGENTINA)
Amaz on - Ye llow P avillion - 1 4 :0 0- 15: 30
South American Congress of Cardiology
Fib r i l a c i ó n a u r ic ul ar . L o vie j o y lo nue vo.
Coordinadores: Dario Sobral (BRAZIL), Ronald Cuellar (BOLIVIA)
14:00
Activación neurohormonal e inflamación en la FA
Corbalan Ramon (CHILE)
14:15
¿Cómo diagnosticar y cómo tratar la FA intermitente?
Alberto Giniger (ARGENTINA)
14:30
¿Cómo optimizar el control del ritmo y la frecuencia?
Javier Galeano (PARAGUAY)
14:45
Prevención de la complicación embólica: ¿Cuándo y cómo?
René Vicuña Mariño (ECUADOR)
15:00
Ablación con radiofrecuencia como terapia de la FA
Rene Asenjo (CHILE)
Wednesday, 21 May 2008
Tigris - Ye llow P avillion - 1 4 :0 0 - 15: 30
South American Congress of Cardiology
Ava n c e s e n l a in s uf ic ie n c ia c ar d iaca aguda-de s compe ns ada
Coordinadores: Enrique Oropeza (BOLIVIA), Fernando Aguirre (ECUADOR)
14:00
Impacto de la descompensación en la evolución de la enfermedad
Juan Cimbaro Canella (ARGENTINA)
14:15
Asistencia respiratoria no invasiva en el manejo inicial
Solon Navarrete (COLOMBIA)
14:30
Estrategia actual del manejo farmacológico
Fabio Vilas-Boas (BRAZIL)
14:45
¿Cómo proteger la función renal?
Alberto Fernández (ARGENTINA)
Thame s - Ye llow P avillion - 1 6 :0 0- 17: 30
Symposium
Nur si n g i n c a r diovas c u l a r D is e a s e
Chairs: - Daniel Maggio (ARGENTINA), Virginia Argibay Pitlyk(SPAIN)
16:00
How can the Nursing Team work in the Prevent Coronary Risk Factors
Monica Soto Vertchert (ARGENTINA)
16:22
Academical Formation In Cardiovascular Nursing. What is the laboral status around the world?
Rosana Andreoli (ARGENTINA)
16:44
Cardiovascular Emergency: Importance of the Interrelation Doctor-Nurse in reducing Patients Morbimortality
Boggiano José Antonio (ARGENTINA)
17:06
Participation of Nurses in Bioethical Committees
Nancy Houston Miller (UNITED STATES)
Danub e - Gr e e n P avillion - 1 6 :0 0 - 17: 30
Clinical Seminar
Up -d a t e i n a bl a tion o f ve n tr ic u lar arrhyt hmias
Chairs: Ivan Mendoza (VENEZUELA), José Luis Serra (ARGENTINA)
16:00
Ventricular tachycardia: Epi- and endocardial approach
Adrian Baranchuk(CANADA)
16:22
Ventricular tachycardia ablation results
Teruhisa Tanabe (JAPAN)
16:44
Right & left ventricular outflow tract tachycardia
Sabine Ernst (UNITED KINGDOM)
17:06
Hemodynamically stable VT
Guy Fontaine (FRANCE)
Scientific Programme / 157
Wednesday, 21 May 2008
P araná - Ochre P avillion - 1 6 :0 0- 17: 30
Symposium
Growing practice of non-pharmacological treatment in congestive heart failure
Chairs: Barry Massie (UNITED STATES), Javier Marino (ARGENTINA)
16:00
Exercise I therapy: Application to mild to severe heart failure
Ileana Piña (UNITED STATES)
16:22
Treatment of heart failure patients with central sleep apnea syndrome by nasal oxygen
Shigetake Sasayama (JAPAN)
16:44
Waon Therapy : soothing warmth therapy
Chuwa Tei (JAPAN)
17:06
Device monitoring of heart failure
Cheuk-Man Yu (CHINA, PEOPLE’S REPUBLIC OF)
Mis s ouri - Ye llow P avillion - 1 6 :0 0- 17: 30
Clinical Seminar
Pro g n o st i c f a c tor s f o r hear t f a ilure in t he b e t ab locke r e ra:
Who m u st be l is te d f or he a r t t r ans plant
Chairs: Marcos Amuchastegui (ARGENTINA), Marcelo Montera (BRAZIL)
16:00
How to predict sudden death?
Guillermo Bortman (ARGENTINA)
16:22
Are scores useful in advance heart failure?
Nadine Clausell (BRAZIL)
16:44
Biomarkers for risk stratification
Eduardo Perna (ARGENTINA)
17:06
State of the art of VO2 max exercise test
Ileana Piña (UNITED STATES)
Euphrat e s - Ochre P avillion - 1 6 :0 0- 17: 30
Clinical Seminar
Myo c a r d i t i s a n d dil at ed c a r diomyopat hie s : How are t he y re lat e d?
Chairs: Hector Delgado Osorio (PUERTO RICO), Mitsuaki Isobe (JAPAN)
16:00
Difference in presentation timing of pregnancy-related heart failure
Karen Sliwa (SOUTH AFRICA)
16:30
Characterization of post part time cardiomyopathy
Carlos Dumont (ARGENTINA)
17:00
Pathogenesis of myocarditis
Peter Liu (CANADA)
Wednesday, 21 May 2008
Nige r - Gr e e n P avillion - 1 6 :0 0- 17: 30
Clinical Seminar
The h i g h - r i sk a s ym p t o m at ic p a tie nt wit h coronary art e ry dis e as e
Chairs: Tak-Fu Tse (CHINA, PEOPLE’S REPUBLIC OF), Zeljko Reiner (CROATIA)
16:00
Clinical characteristics of high-risk asymptomatic patients with coronary artery disease
Mele Eduardo (ARGENTINA)
16:22
Non-classical markers of risk in patients with asymptomatic coronary artery disease
T. Omland (NORWAY)
16:44
Optimal treatment of coronary heart disease to prevent heart failure
Diego Delgado (CANADA)
17:06
Dietary Lipids and Coronary Heart Disease
A. Zampelas (GREECE)
Volga - Ye llow P avillion - 1 6 :0 0 - 17: 30
Clinical Seminar
The c a r d i o v as c u l a r ha zar d s o f air pollut ion
Chairs: Ali Oto (TURKEY), Rose Marie Robertson (UNITED STATES)
16:00
The cardiovascular effect of air pollution: the AHA scientific statement
Smith Sidney (UNITED STATES)
16:22
The acute cardiovascular effects of air pollution
Hermes Ilarraza-Lomeli(MEXICO)
16:44
Mechanisms of cardiovascular disease induced by air pollution: Basic science studies
Shuchleib Rafael (MEXICO)
17:06
Mechanisms of cardiovascular disease induced by air pollution: Clinical science studies
David Newby (UNITED KINGDOM)
Nile - Ye llow P avillion - 1 6 :0 0- 17: 30
Symposium
Nut r i t i o n , d i e t a n d CVD pre vent io n
Chairs: Maranhão Mario (BRAZIL), Maria Inés Somoza (ARGENTINA)
16:00
Risk factors in the developing world
16:18
Healthy life style vs. medications in CVD prevention
Satyavan Sharma (INDIA)
16:36
Portofolio eating plan and antioxidants
Wahida Karmally (UNITED STATES)
16:54
Red wine: Experimental and clinical basis for its recomendations
Protasio Da Luz (BRAZIL)
Scientific Programme / 159
Wednesday, 21 May 2008
Me kong - Ochre P avillion - 1 6 :0 0- 17: 30
Clinical Seminar
Hyp e r g l y c e mia, in f l a m m a tion a n d coronary art e ry dis e as e :
New r e l a t i o n s hip s ?
Chairs: Jose Sala (ARGENTINA), Corbalan Ramon (CHILE)
16:00
Hyperglycemia as a risk factor in AMI: New insights
Jose Nicolau (BRAZIL)
16:30
Do biomarkers change pharmacological interventions in Stable Coronary Artery Disease?
Cagide Arturo (ARGENTINA)
17:00
The role of lipids in chronic coronary disease
Ada Cuevas (CHILE)
Mis s is s ippi - Ye llow P avillion - 1 6 :0 0- 17: 30
Symposium
Pre v e n t i o n o f c a r diovas c u l a r d is e as e in as ympt omat ic pat ie nt s
Chairs: Carlos Nijensohn (ARGENTINA), Alejandro Gómez Monroy (ARGENTINA)
16:00
The impact of policies to reduce salt consumption on cardiovascular health
Hassell Trevor (BARBADOS)
16:30
Experience in developing national policy frameworks for prevention and control of CVD
Herman Schargrodsky (ARGENTINA)
17:00
Cost effectiveness of cardiovascular prevention programmes
Shah Ebrahim (UNITED KINGDOM)
Gange s - Gr e e n P avillion - 1 6 :0 0- 17: 30
Clinical Seminar
Co m p l e x p a t ient s a n d c om p l e x de cis ions - P art t wo
Chairs:C. Vozzi (ARGENTINA), Miguel Ballarino(ARGENTINA)
16:00
When do gender differences exist in patients undergoing planned PCI?
Spencer King III (UNITED STATES)
16:22
When does a bifurcation lesion require more than one stent?
Costantino Costantini (BRAZIL)
16:44
An old concept a new approach. Autoretroperfusion of the coronary sinus in no-option patients
Jose Navia (ARGENTINA)
17:06
PCI in the diabetic patient: Outcomes for focal and diffuse disease
Alexander Abizaid (BRAZIL)
Wednesday, 21 May 2008
Huang He - Ye llow P avillion - 1 6 :0 0 - 17: 30
Symposium
Echo d o pp l e r in r e s ync hr o n is at i on e ra
Chairs: Jesus Vargas Baron (MEXICO), Amuchastegui Luis Maria (ARGENTINA)
16:00
Left ventricular dynamics in heart failure
Jeffrey Borer (UNITED STATES)
16:22
Myocardial?
Cheuk-Man Yu (CHINA, PEOPLE’S REPUBLIC OF)
16:44
Role of tissue doppler imaging in RCT
Eduardo Guevara (ARGENTINA)
17:06
Myocardial syndrome assessment by 3D
Bernhard Mumm (GERMANY)
Or inoco - Ochre P avillion - 1 6 :0 0 - 17: 30
Symposium
Hot t o p i c s i n hyp er te n s ion
Chairs: Jorge Jalil (CHILE), Fernando Peliche (ARGENTINA)
16:00
Home measurement of blood pressure: Does it work?
Gianfranco Parati (ITALY)
16:18
Obstructive sleep apnea: Where are we?
Luciano Drager (BRAZIL)
16:54
Silent white matter lesions, blood pressure variability and cognitive deterioration in elderly
hypertensive patients
Ramiro Sánchez (ARGENTINA)
17:12
Ambulatory blood pressure for all?
Mario Bendersky (ARGENTINA)
Tib e r - Ye llow P avillion - 1 6 :0 0- 17: 30
Special Featured Joint Session
SB C : C o r o n a r y Ar te r y D is e a s e 2 00 8
Chairs: Antonio Chagas (BRAZIL), Faella Horacio (ARGENTINA)
16:00
Clinical approaches for treatment: drugs vs lifestyle
Protasio Da Luz (BRAZIL)
16:22
The utility of inflammatory markers in the management of the disease
Enrique Gurfinkel (ARGENTINA)
16:44
Current views in PCI
Luiz Piva Mattos (BRAZIL)
17:06
The roll of surgical management
Kalil Renato Ak (BRAZIL)
Scientific Programme / 161
Wednesday, 21 May 2008
P ilcomayo - Ye llow P avillion - 1 6 :0 0- 17: 30
How-to & Workshop Session
ISC P : Upd a t e o n c urr e n t ca r d i o vasc ular r esea rch in USA and Eur ope
Chairs: Jay Cohn (UNITED STATES), Antoni Bayés De Luna (SPAIN)
16:00
Strategies toward advances in research: Perspective from the US National Heart Lung and Blood Institute
Marvin Konstam (UNITED STATES)
16:45
Most important clinical cardiovascular research in Europe
Angeles Alonso Garcia (SPAIN)
Amaz on - Ye llow P avillion - 1 6 :0 0- 17: 30
South American Congress of Cardiology
Nue v a s f r o n te r as e n l a hip e r t ens ión art e rial
Coordinadores: Claudia Anchique (COLOMBIA), Masao Sano (PARAGUAY)
16:00
La reducción de la presión arterial ¿es suficiente?
Felix Medina (PERU)
16:15
Hipertensión arterial en el anciano ¿Son distintos los objetivos y el tratamiento?
Fernando Manzur Jattin (COLOMBIA)
16:30
¿Cómo prevenir y tratar el daño de órgano blanco?
GuilleRmo Fabregues (ARGENTINA)
16:45
Objetivos terapéuticos en el paciente diabético
Espinoza Jaime (PERU)
17:00 Manejo de la hipertensión arterial en el paciente con insuficiencia renal
Hilton Chaves (BRAZIL)
PosterS AND ABSTRACTS
Poster Listing
P1Changing of monocyte chemoattractant protein-1 (MCP-1) in patients with type
2 diabetes mellitus and acute coronary syndrome
T. Golitsyna, T. Chazova, K. Zykov.
P3The presence of C allele for -765g>c common variant of cox-2 gene constitutes
a protector factor against coronary disease in Chilean individuals
L. A. Salazar, A. Hernandez, A. Cuevas, P. Jaramillo, C. Lanas, F. Lanas.
P4Tricuspid insufficiency does not increase early after permanent implantation
of pacemaker leads
N. Kucukarslan, A. Kirilmaz, E. Ulusoy, M. Yokusoglu, N. Gramatnikovski, E. Ozal, H. Tatar .
P5
Is allen test safe for radial artery graft in cabg surgery?
N. Kucukarslan, E. Ozal, E. Kuralay, M. Arslan, H. Tatar .
P6Two factors effecting the morbidity and mortality in surgery of vascular
injuries due to gunshot: Missed arterial injury, ignored vein repair
N. Kucukarslan, B. Oz, E. Ozal, V. Yildirim, M Sahin, H. Tatar .
P7Atherothrombotic risk factors correspond to the appearance of
internal inflammation and erythrocyte adhesiveness/aggregation
in the peripheral blood
I. Shapira, O. Rogowski, D. Zeltser, S. Berliner .
P8Low grade inflammation in individuals with the hypertriglyceridemic waist
phenotype. Another feature of this atherogenic dysmetabolism
I. Shapira, O. Rogowski, S. Toker, S. Melamed, A. Shirom, S. Berliner .
P9Liver enzymes and inflammation - sensitive biomarkers. Relevance for
apparently healthy individuals and those with atherothrombotic risk
I. Shapira, O. Rogowski, R. Oren, S. Berliner .
P10Effects of Efferent Sympathetic Nerve Stimulation on Ischemia-Induced
Ventricular Arrhythmias by Modulating Connexin43 Protein in Rats
X. R. Hu, H. Jiang, Z. B. Lu, H. Z. Wen, M. Ghias, D. D. Zhao, Q. Z. Tang, C. X. Huang.
P11Communication Devices Produce Electromagnetic Interference on ECG
machines: Does it really matter?
A. Baranchuk, J. Kang, C. Shaw, D. Campbell, H. Alanazi, W. Hopman, D. P. Redfearn, C. S. Simpson. Scientific Programme / 163
PosterS AND ABSTRACTS
Poster Listing
P12Prognosis of heart rate control on decompensated heart failure patients.
G. P. Aroutunov, Professor, A. G. Aroutunov, A. L. Volkova, N. A. Bylova.
P15Determination of Vascular Wall Shear Stress by High-Resolution Ultrasound
as a Method of Assessment of Endothelium-Dependent Vasodilatation in
Patients with Arterial Hypertension
A. Rekhviashvili, B. Tsinamdzgvrishvili, A. Tsiskaridze, M. Chkhetia, N. Archvadze, G. Labakhua .
P16Measurements in imaging: Are internal or external reference systems better
in detecting eary stage heart failure?
R. Asbot.
P17Quantitative electrocardiac parameters can predict impaired systolic heart
function
G. Simonyi, E. Szûcs, T. Bauernfeind, K. Szakolczai, J. R. Bedros, I. Préda, M. Medvegy.
P18
Endovascular therapy of chronic mesenteric ischaemia
A. Silva, R. Barros Wanderley, L. Carvalho Pereira, I. Kury Nunes, R. Luis Favero, L. Henrique Kanashiro.
P19Clinical Feasibility and angiographic follow-up of Endovascular Stent-Graft
for Type B Dissection (Stantford). Experience of a single center
A. Silva, R. Barros Wanderley, L. Carvalho Pereira, L. Henrique Kanashiro, R. Luis Favero, I. Abilio Kury Nunes.
P20Prevalence of Changes in Undiagnosed Glucose Intolerance According to Age
and Gender in Japanese Middle Aged Working People
H. Kawano, H. Soejima, H. Fujii, Y. Nagayoshi, Y. Tanaka, S. Nakayama, Y. Kinoshita, H. Ogawa.
P21Dehydroepiandrosterone Levels Vary According as Heart Failure Condition in
Patients with Idiopathic Dilated Cardiomyopathy
H. Kawano, Y. Nagayoshi, H. Soejima, Y. Tanaka, H. Yamabe, Y. Kinoshita, H. Ogawa.
P22Intermediate Outcome of Percutaneous Coronary Interventions for Single
Remaining Coronary Artery
S. Mishra, V. K. Bahl .
P23Frequency of diarrhoea as a predictor of elevated blood pressure
in children
J. J. Miranda, A. R. Davies, G. Davey Smith, L. Smeeth, L. Cabrera, R. H. Gilman, H. H. Garcia, Y. R. Ortega,
V. A. Cama.
P24
Is being an immigrant a risk factor for CVD in Australia?
J. Dassanayake, L. Gurrin, W. R. Payne, V. Sundararajan, S. C. Dharmage .
Poster Listing
P25Percutaneous femoral closure following thoracic aorta stent graft
placement: Preliminary results and 6 month follow up
P. Avanzas, M. Martin, I. Lozano, J. M. Llaneza, F. Vega, F. Fernandez, J. M. De La Hera, J. M. Vegas, J. M. Valle, C. Moris.
P26Predictive value of coronary artery stenoses and c-reactive protein levels in
patients with stable coronary artery disease
P. Avanzas, R. Arroyo-Espliguero, J. Quiles, J. C. Kaski.
P27
A/a’: A New Correlate of Left Ventricular End Diastolic Pressure?
R. A. Lawrance, I. Jadavji, W. T. Emery, J. B. Choy.
P28Univariable and Multivariable Correlates of E/e’: can we get closer to noninvasive left ventricular end-diastolic pressure estimation?
R. A. Lawrance, I. Jadavji, W. T. Emery, J. B. Choy.
P29Investigating the European Society of Cardiology Diastology Guidelines in a
Practical Scenario
W. T. Emery, I. Jadavji, J. B. Choy, R. A. Lawrance .
P30E/e’ Ratio Derived From Septal and Lateral Annuli and its Correlation With Left
Atrial Volume Index
W. T. Emery, I. Jadavji, R. A. Lawrance, J. B. Choy.
P31Echocardiographic Correlates of left atrial size: inter-relationships with
other diastolic measures.
I. Jadavji, W. T. Emery, R. A. Lawrance, I. Vondermuhl, J. B. Choy.
P32Discrepant Mitral Annular Doppler Velocities: Implications For The Assessment
Of Diastolic Function
W. T. Emery, I. Jadavji, R. A. Lawrance, J. B. Choy.
P33C-reactive protein correlates with left ventricular ejection fraction and
predicts functional status in patients with chronic stable angina
P. Avanzas, R. Arroyo-Espliguero, J. Quiles, J. C. Kaski.
P34The incidence of acute rheumatic fever in the world: a systematic review of
population-based studies
K. B. Tibazarwa, J. A. Volmink, B. M. Mayosi.
P35Patent ductus arteriosus closed with Nit-Occlud system: mid term follow-up.
R. E. Rios Mendez, R. Gamboa, F. P. Mollon, G. M. Arroyo, D. F. Gutierrez, D. M. Villa.
Scientific Programme / 165
Poster Listing
P39Effects of Taranabant, a Novel Cannabinoid 1 Receptor (CB-1R) Inverse Agonist,
on Weight Reduction in Obese Patients Over 12 Weeks
C. D. Gonzalez, N. Erondu, B. Gumbiner, B. Musser, K. Lu, R. A. Capece, S. Klein, E. Ravussin, J. M. Amatruda,
S. B. Heymsfield.
P40The prognostic value of NT-proBNP in patients with chronic coronary heart
disease but without clinically manifest heart failure.
O. Mayer Jr., J. Šimon, M. Galovcová, J. Bruthans, R. Cífková.
P41Cardiac performance in hypertensive versus physiological left ventricular
hypertrophy.
M. Deljanin Ilic, S. Ilic, V. Stoickov, L. Nikolic.
P42Changes of white blood cell count during stress echocardiography may
predict future coronary events.
S. Ilic, M. Deljanin Ilic, P. Milosavljevic, L. Nikolic.
P43Use of (all-blood) miniplegia versus crystalloid cardioplegia in an
experimental model of acute myocardial ischemia.
O. Petrucci, R. W. Vieira, M. R. Carmo, N. Antunes, P. P. M. Oliveira, D. M. Braile.
P45Echocardiography and adenosine test: non invasive method to detect patients
with reactive pulmonary hypertension.
R. Reinoso, H. Badiola Villa, R. Artigas Garcia, C. Lozano Girol.
P46How often does pressure recovery affect measurement of aortic valve
gradients by Doppler echocardiography in patients with aortic stenosis in
real-world clinical practice?
A. C. Parameswaran, D. Reisner, A. Amanullah.
P47Effect of beta blocker treatment on platelet nitric oxide synthase, cyclic
guanosine monophosphate and oxidative stress, in patients with heart failure
A. Shah, E. Gkaliagkousi, J. Decourcey, R. Buckley, J. Ritter, A. Ferro.
P48
The human serotonin 5-HT4a receptor
J. Neumann.
P49Effects of resistance stress on cardiac biochemical markers in power lifters
V. Pönitz, S. P. H. Hjortshoj, G. Espersen, J. Ravkilde.
Poster Listing
P50Clinical features of STEMI-patients with multivessel disease who develop
cardiogenic shock after primary percutaneous coronary intervention.
A. Dominguez-Rodriguez, M. J. Garcia-Gonzalez, S. Samimi-Fard, A. Sanchez-Grande, G. Yanes-Bowden,
I. Hernandez-Baldomero, P. Abreu-Gonzalez, F. Marrero-Rodriguez.
P51The Correlation Between Augmentation Index and Myocardial Ischemia of
Adenosine Stress Myocardial Scintigraphy
T. Morishima, T. Hatano, M. Aiga, M. Odaira, M. Nakayama, K. Takeishi, S. Fuse, T. Chikamori, K. Takazawa,
A. Yamashina.
P52A Prospective Randomized Trial of a Rapid Fibrinolytic Protocol for Left-sided
Prosthetic Valve Thrombosis (RAFT-PVT)
G. Karthikeyan, N. Mathew, R. S. Math, P. R. Bhimashankar, S. Singh, M. Kalaivani, V. K. Bahl.
P53Significance of brain natriuretic peptide in the prediction of secondary
morbidity and mortality in post-MI patients
A. Boskovic, L. Music.
P54Is there difference between daily and nightly heart rate variabilty
in patients with acute myocardial infarction
A. Boskovic, L. Music.
P55
Clinical efficacy of statins in smokers with coronary artery disease
A. Boskovic, L. Music, S. Dragnic.
P56Clinical efficacy of statins in secondary prevention in patients with coronary
artery disease depending on gender
A. Boskovic, L. Music.
P57
Cardioprotective Effect of Red Wine
A. Novakovic, L. J. Gojkovic Bukarica, D. Nezic, M. Peric.
P58Gender, age and clinical differences of Idiopathic, Hypertrophic and Atypical
complete left bundle branch block
S. Sclarovsky.
P59Electrical remodeling (ER) as is expressed in the electrocardiogram (ECG),
electrical remodeling phenotypes from Neonatal to Sexual maturation,
Gender differences.
S. Sclarovsky.
Scientific Programme / 167
Poster Listing
P60The accuracy of factors used in assessing the progression of expressed heart
failure symptoms
A. Chaitoff, H. Kominsky, V. Sumodi, K. Fagnilli, M. Hanna.
P62Impact of Diabetes on mortality of patients with heart failure with reduced
Left Ventricular function
A. Innasimuthu, G. Rao, B. Naronha, K. Ckarke.
P64Prognostic value of corrected QT interval and its correlation with cardiac
Troponin T in non - ST- elevation acute coronary syndrome
S. C. L. Llois Susana Claudia, F. L. G. Gadaleta Francisco Leonardo, V. A. S. Sinisi Víctor Alfredo, P. A. Avanzas Pablo,
J. C. K. Kaski, Juan Carlos.
P65Children who fulfil current recommendation for physical activity
are slimmer and have higher fitness level
M. Dencker, O. Thorsson, M. K. Karlsson, C. Linden, P. Wollmer, L. B. Andersen.
P66Body Fat, Abdominal fat and Body fat distribution related to Risk Factors for
Cardiovascular Disease in Young Children
M. Dencker, O. Thorsson, M. K. Karlsson, C. Linden, P. Wollmer, L. B. Andersen.
P68Epidemiological Aspects of the Burnout Syndrome in professional
cardiovascular nursing
J. Boggiano, R. Miret, D. Maggio, A. Bantar, I. Perdomo, M. Medina, M. Lavalle, E. Moya, N. Bravo,
H. Macazana Trucios.
P69Effect of early education on patient anxiety while waiting for cardiac
catheterization
J. Boggiano, A. Zichert, D. Maggio, H. Macazana Trucios, A. Incarbone, R. D´agosto, R. Dominguez, G. Bulacio,
N. Crozzoli, M. Bertoli.
P70Workplace stress factors perceived by the nurses, who work in those areas of
the hospital concerned with heart-lung transplants
J. Boggiano, R. Miret, D. Maggio, M. Medina, M. E. De La Antonia, N. Acuña, F. Rotemberg, D. Chaparro, C. Ortiz,
S. Castelar.
P71Corrected QT interval measurement in patients with non-ST elevation acute
coronary syndrome and t-wave abnormalities: Any additional clinical value?
F. L. Gadaleta, S. C. Llois, VA Sinisi, P. Avanzas, J. C. Kaski.
P72Scientific production spilt in symposiums of cardiovascular nursing in
Argentina
J. Boggiano, R. Miret.
Poster Listing
P73The virtual heart: art and science
J. Reynolds, C. Salazar, J. Vega, A. Castellanos.
P74Determinants of hospital length of stay in patients admitted with acute heart
failure.
R. Bagnati, P. Ledesma, N. Vulcano, S. Fernandez, C. Belziti .
P75Predictors of acute impairment in renal function in patients admitted with
acute decompensated heart failure.
P. Ledesma, R. Bagnati, N. Vulcano, S. Fernandez, C. Belziti .
P76Influence of atrial natriuretic peptide treatment on cardiovascular and renal
nitric oxide system in spontaneously hypertensive rats
M. A. Costa, D. Rodríguez Ierace, R. Elesgaray, M. F. Visintini Jaime, C. Caniffi, A. M. Balaszczuk, C. Arranz.
P77Most frequent symptoms and extension of coronary artery disease in women
with acute coronary syndromes
C. N. Crudo Norma, P. A. Alfredo Piombo, V. L. Luis Vidal.
P78Coronary artery calcification in elderly adults over 80 years old: does it have
any role in the pre-operation determination of ischemic heart disease?
Masahiro Tamashiro, Yuu Nomura, Toshiya Chinen, Atsushi Kakazu, Kageyuki Ohba, Naoya Maehira, Akira Kakazu,
Masanori Kakazu, Osamu Arasaki, Tetsuji Shinjo.
P81Early Outcomes of Direct Carotid Artery Stenting without Predilation in HighRisk Patients: Analysis of a Single-Center Registry
J. Veselka, D. Erná, P. Zimolová, M. Šramko, A. Tomek, M. Šrámek.
P84Relation of ischemia-modified albumin to ST-segment resolution after
reperfusion of acute myocardial infarction
A. Dominguez-Rodriguez, S. Samimi-Fard, P. Abreu-Gonzalez, M. J. Garcia-Gonzalez, J. C. Kaski.
P85Do diabetic patients with acute myocardial infarction treated with
thrombolytic therapy have a worse prognosis during long-term follow-up
B. Stefanovic, P. Mitrovic, Z. Vasiljevic, G. Matic, M. Radovanovic, N. Radovanovic, A. Karadzic, A. Milosevic,
G. Krljanac, M. Dragovic.
P86
Risk stratification in cardiac surgery: our experience
M. Silvero, G. Solari, L. Browne, D. Bergerot, R. Vallejo, E. Badino .
Scientific Programme / 169
Poster Listing
P87Low risk cardiovascular profile patients seems to have high risk
atherosclerotic plaques. Identification of atherosclerotic plaques in
asymptomatic patients with 64 channel MSCT.
A. Bayol, J. Vallejos, R. Obregon, M. Romero, R. Peloso, R. Gonzalez, W. Harvey, A. Zarza, J. Mazucco, J. Parras.
P88
Anterograde Utilization of Intraaortic Balloon Pump
R. Levin, M. Degrange, R. Porcile, F. Salvagio, N. Blanco, A. Botbol, C. Del Mazo, E. Tanus.
P89Relation between the VEGF Level and Myocard Ischemia in Patients with
Collateral Vessels and Single-Vessel Chronic Total Occlusion
F. Arican Ozluk, O. Badak, A. Sýsman, G. Capa Kaya, H. Bozkurt, S. Guneri .
P90Metabolic Syndrome Predicts Non-Elderly Onset in Patients with Acute
Myocardial Infarction
T. Saikawa, M. Hara, T. Takakura, T. Ooie, T. Iwao, S. Shigematsu.
P91Predictors of successful ASA reistance suppression using dose escalation
regimen in stable coronary artery disease patients.
M. Dominiak, T. Wcislo, A. Rozga, L. Figiel, J. Drozdz, M. Krzeminska - Pakula, J. Kasprzak.
P92Accuracy of myocardial contrast echocardiography in predicting early and
long-term outcome in patients with acute myocardial infarction
M. Olszowska, M. Kostkiewicz, P. Podolec, M. Hlawaty, T. Przewlocki, W. Tracz.
P93NT-proBNP measured on admission is well predictor early and long-term
outcome in patients with acute myocardial infarction after primary coronary
angioplasty.
M. Olszowska, M. Kostkiewicz, P. Podolec, M. Hlawaty, W. Tracz.
P94The impact of socioeconomic conditions on the evolution of chronic Chagas
disease.
R. Viotti, C. Vigliano, M. G. Alvarez, B. Lococo, M. Petti, G. Bertocchi, A. Armenti.
P95The effect of concomitant use of monopril and spironolactone in patients
with mild to moderate congestive heart failure
N. Krstic, M. Pavlovic, Z. Perisic, L. J. Radevic, M. Lazovic, S. Salinger, A. Stojkovic, D. Milic.
P96Carney’s syndrome: review and report of a case with five intracardiac
myxomas
M. Silvero, J Boullosa.
Poster Listing
P97Gated SPECT Myocardial imaging in patients with left bundle branch block:
comparison with stress echo coronary flow reserve
D. Sobic-Saranovic, S. Pavlovic, A. Djordjevic-Dikic, Z. Petrasinovic, N. Kozarevic, D. J. Saranovic,
M. Todorovic-Tirnanic, V. Artiko, V. Obradovic, M. Ostojic.
P99Value of Gated SPECT perfusion imaging in patients with previous myocardial
infarction and single vessel disease
D. Sobic-Saranovic, S. Pavlovic, B. Beleslin, M. Todorovic-Tirnanic, D. J. Saranovic, Z. Petrasinovic, V. Artiko,
V. Obradovic, B. Vujisic-Tesic, M. Ostojic.
P101
Ischemic Preconditioning in Elderly Patients with first STEMI.
M. Giorgi, R. Ahuad Guerrero, P. Schygiel, F. Sokn, H. Farras, M. Voos, J. Tronge .
P102Can we predict clopidogrel resistance after percutaneous intervention?
M. Dominiak, A. Rózga, T. Wcis£o, M. Krzemiñska- Paku£a, J. Kasprzak.
P103An increased right ventricular overload - how does it influence the tissue?
M. Kowalski, E. Kowalik, P. Hoffman.
P104ABO blood group distribution and major cardiovascular risk factors in
patients with myocardial infarction
I. Sari, O. Ozer, M. Sucu, V. Davutoglu, S. Gorgulu, M. Eren, M. Aksoy.
P105Clinical value of lead aVR in Acute Coronary Syndromes with non-ST segment
elevation
H. Juan Gallinari, H. Alviso De Vargas, E. Gonzalez Gonzalez, G. Boccuzzi, S. Colangelo, M. Minelli.
P106Morning peak in the circadian variation of myocardial infarction is not valid
for all nations: Afternoon predominance in Turkish population
I. Sari, V. Davutoglu, B. Erer, E. Tekbas, E. Ucer, O. Ozer, H. Uyarel, M. Eren, M. Sucu, M. Aksoy.
P107Analysis of timing events in Doppler ultrasound signals from the fetal heart
rate
J. Zietek, J. Jezewski, K. Horoba, A. Gacek, J. Wrobel.
P108Septadian Variation In The Occurrance of ST Elevation Myocardial Infarction In
Turkish population: Monday Syndrome
I. Sari, B. Erer, E. Tekbas, E. Ucer, H. Uyarel, V. Davutoglu, O. Ozer, M. Sucu, S. Soydinc, M. Aksoy.
P109
Antepartum evaluation of fetal cardiac performance
J. Zietek, A. Matonia, J. Sikora, K. Horoba, A. Gacek, J. Jezewski.
P110Left ventricular regional function in adults after aortic coarctation repair
M. Kowalski, E. Kowalik, K. Kotlinski, J. Rozanski, P. Hoffman.
Scientific Programme / 171
Poster Listing
P112Relationship between total and differential leukocyte counts and isolated
coronary artery ectasia
S. A. Kocaman, G. Taçoy, A. Sahinarslan, T. Timurkaynak, A. Çengel.
P113Short-term preoperative treatment with atorvastatin reduces
proinflammatory response and the risk of renal failure after
cardiopulmonary bypass in patients with diabetes type 2 operated due to
aortic valve disease-randomized, placebo controlled study
D. Zakrzewski, J. Janas, J. Stepinska.
P114Peak oxygen uptake is better than Oxygen Uptake Efficiency Slope in
quantifying cardiopulmonary functional reserve in patients with Metabolic
Syndrome
A. Casella-Filho, B. C. G. Nascimento, C. B. Casella, I. C. Trombetta, M. U. Rondon, F. Y. Cesena, D. Favaratto,
C. E. Negrao, P. L. Daluz, A. C. P. Chagas.
P115
Urbanization of Chagas Disease – A 17-year follow-up
F. Sosa.
P116Pharmacological effect at low dosis of Ezetimibe/Simvastatin combination
A. Kavata, B. Martire.
P117Association Between a Cell-Seeded Collagen Matrix and Cellular
Cardiomyoplasty for Myocardial Support and Regeneration
M. Cortes Morichetti, J. A. Genovese, E. Chachques, A. F. Carpentier, J. C. Chachques.
P118“Unoperated univentricular heart with normally related arteries and
pulmonary stenosis in a 47 year old woman”
J. V. G. N. Juvenal Vaz Guimarães Neto, T. M. G.Q. Tânia Maria Gonçalves Quintão, H. F. M. Helena Furtado
Martino, B. M. F. N. Betania De Freitas Nogueira, R. C. A. Roberta Chaves Araújo, G. P. T. Glenda Pataro Teixeira,
G. M. R. Gabriela Mendonça Rabello.
P119Cardiac tissue-reactive autoantibodies. Prevalence of anti-cardiac troponin-I
IgG in a BNP positive population.
M. Adamczyk, R. J. Brashear, P. G. Mattingly.
P120
Depression and heart disease - a cross cultural view
A. Nanhay, L. Villano.
P121Velocity vector imaging for assessment of mechanical dyssynchrony and its
comparison to color coded tissue Doppler imaging.
A. C. Parameswaran, T. P. Shah, A. Amanullah.
Poster Listing
P122Intraoperative coronary angiography – an approach to quality control
and logistic background for emergency simultaneous catheter-based
interventions during minimal invasive coronary bypass surgery
G. Friedrich, C. Kolbitsch, T. Schachner, N. Bonaros, S. Abbrederis, G. Laufer, O. Pachinger, J. Bonatti .
P123Metabolic syndrom by new IDF definition and mortality outcomes in patients
with manifest coronary heart disease.
O. Mayer, J. Šimon, M. Plášková, R. Cífková.
P124Intraoperative detection of porcelain aorta remains a challenging dilemma in
coronary artery bypass surgery
H. B. Bittner, R. R. Battellini, A. J. Rastan, F. W. Mohr.
P125Multislice Computer Tomographic Coronary Angiography for Preoperative Risk
Stratification in Patients undergoing Liver Transplantation
S. Abbrederis, G. Feuchtner, O. Pachinger, W. Vogel, E. Gassner, I. Graziadei, A. Mallouhi, G. Friedrich.
P126An Eight-Week, Multi-center, Randomized, Double-blind, Parallel Group study
Comparing The Efficacy and Safety of Amlodipine/Valsartan combination
therapy Versus Amlodipine Monotherapy in The Treatment of Stage 2
Hypertension
M. Destro, L. Satlin, A. Kandra, P. Brunel.
P127Value of first-line hypertension treatment with an amlodipine/valsartan
regimen for systolic blood pressure control: analyses in difficult-to-treat
populations
M. Destro, L. Satlin, A. Kandra, P. Brunel.
P128Efficacy and Safety of amlodipine/valsartan in Hispanic subjects with stage 2
hypertension
M. Destro, L. Satlin, A. Kandra, P. Brunel.
P129Tissue Doppler Imaging and Contrast Echocardiography: new methods in
diagnosing intracardiac structures.
M. Hlawaty, W. Tracz, M. Olszowska, M. Kostkiewicz, M. Pasowicz, P. Podolec.
P130Transient myocardial stunning syndrome: Prevalence and clinical features in
a population of a general hospital
L. Hamity, F. Ramello, A. Moyano, L. Marani, E. Moreyra, L. Alday.
P131
Lengthening of the Aorta with Advancing Age: MRI Study
H. Tanaka, K. Hayashi, T. Yokoi, J. Sugawara.
P132
Ischemic Cardiopathology in Cuban Women
S. Luis Mario Sollet Lopez, Laura Principe.
Scientific Programme / 173
Poster Listing
P133Anomalous Origin of the Left Coronary Artery from the Pulmonary Artery
(ALCAPA). Presentation of two cases.
L. M. Sollet Lopez, E. Selman Houssein, A. Naranjo, L. Principe, A. E. Gonzalez Morejon.
P134Assessment of Patients Operated on Complete Anomalous Drainage of
Pulmonary Veins According to the Cuban Program for Children’s Cardiac
Rehabilitation
S. Luis Mario Sollet Lopez, Francisco Carballes Garcia, Adel Glez Morejon, Laura Principe .
P135The Role of Abnormal Q Waves and ST-Segment Elevation as a Marker for
Disease Progression in Hypertrophic Cardiomyopathy
Maky Fabiola Furuki K., Hiroya Kawai, Katsuko Norisada, Mariko Okada, Kazuhiro Tatsumi, Toshiya Kataoka,
Tetsuari Onishi, Hidekazu Tanaka, Kenichi Hirata.
P136Heart rate, risk factors, metabolic syndrome and global cardiovascular risk
in a working population
M. A. Sánchez Chaparro, J. Román García, E. Calvo Bonacho, M. Cabrera Sierra, A. Fernández Meseguer,
M. Ruiz Moraga, J. C. Saínz Gutiérrez, C. Fernández-Labandera, A. García García, A. Gálvez Moraleda.
P137Evaluation of heart pumping function by dynamics of oxygen dept in
cardiopulmonary exercise test in patients with coronary artery disease.
S. V. Ivanov, Y. U. A. Izachik, A. B. Pestova, S. S. Ivanov, N. A. Grablina .
P138CT Cornary angiography - new perspectives of diagnostic of coronary artery
disease. Personal experiences
B. Cveticanin, M. Zorc.
P139 Isolated noncompaction is a biventricular disease
E. K. Wlodarska, O. Wozniak, B. Lubiszewska, M. Konka, D. Piotrowska-Kownacka, E. Walczak, K. Baranska,
W. Ruzyllo, P. Hoffman.
P140Presence and severity of cerebral white matter lesions associated with an
arterial hypertension
M. Tundybaeva, A. Jussipov.
P141Pregnancy in patients with prosthetic and homograft heart
valves - maternal and fetal outcome.
A. Lesniak-Sobelga, M. Kostkiewicz, W. Tracz.
P144Tissue Doppler post-systolic motion in patients with hypertensive heart
disease
A. Stevanovic, B. Vujisic-Tesic, M. Dekleva, L. J. Sevic.
Poster Listing
P145Influenza Vaccination Reduces the Frequency of Coronary Events in Patients
after Primary PCI
A. Ciszewski, Z. T. Bilinska, L. B. Brydak, M. Romanowska, C. Kepka, M. Kruk, W. Piotrowski, W. Ruzyllo.
P146Effect of fixed antihypertensive combinations on blood pressure, pulse wave
veloñity and glucose metabolism in hypertensive patients with metabolic
syndrome
S. Nedogoda, T. Chalabi, U. Brel, E. Podolskaya, G. Mazina, V. Tzoma, D. Zaremba.
P147Treatment of arterial hypertension with very-small doses of antibodies to
C-end fragment of àò1 receptors of angiotensin II.
S. Nedogoda, V. Petrov, O. Epstein, T. Chaliabi, U. Brel, N. Chepurina, G. Masina, A. Sabanov, S. Tarasov,
A. Kolosova .
P148EFFECT OF INDAPAMIDE SR VS HYDROCHLOROTHIAZIDE ON BLOOD PRESSURE, PULSE WAVE
VELOSITY AND GLUCOSE METABOLISM IN OBESE HYPERTENSIVE PATIENTS
S. Nedogoda, T. Chaliabi, U. Brel, E. Podolskaya, G. Mazina .
P149
EFFICACY OF ATORVASTATIN AT PATIENTS WITH METABOLIC SYNDROME
S. Nedogoda, V. Tsoma, T. Chaliabi, U. Brel, E. Podolskaya, G. Mazina .
P150THE EFFECT OF AN EDUCATIONAL INTERVENTION ON CARDIOVASCULAR RISK FACTORS IN
AN OVERWEIGHT ELDERLY POPULATION.
F. Santos, A. Neujahr, E. Veitenheimer, N. Schimidt, B. Santos, R. El-Kik, A. Gustavo.
P152
Normal E/Ea ratio values in healthy individuals according to age.
H. Deschle, G. Allende, A. Miranda, A. Lakowsky, D. Sanchez Luceros, J. Carbajales, R. Calviño.
P153Pediatric cardiovascular rehabilitation program: roll of the aquatic physical
therapy.
J. Bleiz, C. Serra, M. Venere, G. Guarraccino, G. Rocca, V. Assinnato, I. Souto, P. Campana, J. Rodriguez, S. Prates.
P154Systolic and Diastolic Left Ventricular Wall motion Dyssynchrony Assessed by
99mTc-sestamibi-Gated-SPECT in patient with hypertension
M. Ishikawa, A. Yamamoto, N. Takahashi, T. Shingo, J. Abe, K. Amitani, T. Yamaguchi, N. Kawaguchi, T. Uchida,
K. Munakata.
P155Impact Of Angiotensin II Receptor Brockade On Left Ventricular Dyssynchrony
In Hypertension
N. Takahashi, A. Yamamoto, M. Ishikawa, S. Tezuka, J. Abe, K. Amitani, T. Yamaguchi, N. Kawaguchi, T. Uchida,
K. Munakata.
P156Adherence of patients to the antihypertensive treatment in Georgian
population
D. Trapaidze, B. Tsinamdzgvrishvili, R. Tataradze, T. Abesadze, A. Rekhviashvili.
Scientific Programme / 175
Poster Listing
P157
Early and late results of total correction of tetralogy of Fallot
K. H. Hashemzadeh, S. H. Hashemzadeh, M. J. Dehdilani, M. Z. Dehdilani.
P158Acute effects of Peroxisome Proliferator Activated Receptor gamma (PPAR
gamma) Stimulation in macrophage cells and highly sensitivity
Creactive protein of Hypercholesterolemic Rabbits
A. Alessi, O. França Neto, C. Prim, P. R. Brofman, L. Noronha, L. Baroncini, D. B. Précoma.
P159
HYPERTENSION DETECTION IN CHILDREN IN SCHOOLARSHIP AGE
S. Lopez Cross, L. Dumas, D. Peroni, G. Valenzuela .
P160
Risk Factors For Inadequate Transesophageal Echocardiography
B. Flynn, J. Stanley, S. Wang, S. Lam, J. Meltzer, V. Moitra.
P161Release of calcitonin gene-related peptide from the jugular-nodose ganglion
complex in rats
T. Strecker, A. Dieterle, K. Messlinger, W. Neuhuber, M. Weyand, S. Koulchitsky.
P162Stenting of the Vena Cava Superior in a patient with a Total Artificial Heart
T. Strecker, M. Uder, R. Tandler, M. Weyand, M. Kondruweit.
P163Cardiac tumors – 37-year results, surgical experinence and outcome in our
heart surgery center
T. Strecker, J. Roesch, M. Weyand, M. Kondruweit.
P164Incidence of coronary artery disease in patients with tricuspid versus bicuspid
aortic stenosis
L. Cook, S. Burger, C. Harden.
P165One-Year Cardiovascular Event Rates in outpatients with slow upsloping ST
depression vs. horizontal or downsloping ST depression in Treadmill exercise
testing
L. Ferro, A. Contreras, P. Pogonza, E. Brenna, F. Urinovsky, R. Bagur, D. Morillo, L. M. Amuchastegui.
P166ASYNCHRONOUS HEMIDISC CLOSURE IN MECHANICAL BILEAFLET PROSTHESES WITH
NORMAL FUNCTION.
T. F. Cianciulli, M. A. Beck, J. A. Lax, M. C. Saccheri, G. E. Gigena, A. N. Dorelle, E. H. Fernandez, J. H. Leguizamon,
H. A. Prezioso, L. A. Vidal.
P167Detection of atherosclerosis in the brachiocephalic trunk: the missing piece of
the puzzle?
N. Moraes, R. Dias, J. Tsutsui, A. Uchida, M. Vieira, S. Oliveira, P. Da Luz, W. Mathias.
P168Is Easy-Access Preventive Medicine Necessary in a Social Healthcare System
A. Bader, M. Hochleitner.
Poster Listing
P169
Prone Imaging is An Effective Method of Attenuation Correction in
A. Salacata, J. Mills, S. Keavey .
P170Diabetic patients undergoing percutaneous coronary intervention using
drug-eluting stents: incidence and predictors of very late
(> 12 months) stent thrombosis
V. Voudris, P. Karyofillis, S. Thomopoulou, S. Patsilinakos, A. Manginas, C. Spargias, G. Pavlides, D. V. Cokkinos.
P171Long-term clinical outcome of patients with saphenous vein graft lesions
treated with drug-eluting stents ; comparison with patients treated with bare
metal stents
V. Voudris, S. Thomopoulou, P. Karyofillis, C. Kalianos, A. Manginas, G. Pavlides, C. Spargias, D. V. Cokkinos.
P172Seeking medical advice of patients with myocardial infarction in Russia
V. Gafarov, A. Gafarova.
P173Monitoring myocardial infarction (diagnostic combination, prodromal period,
behavioral characteristics) using the WHO
program “Registry of Acute Myocardial Infarction”, “MONICA”
during the period of 22 years in Russia
V. Gafarov, A. Gafarova.
P175 Eco-Cardiographic Ergometric Correlation of Patients
L. Sollet Lopez, A. Gonzalez Morejon, J. Ponce Vitar, E. Selman Houssein Sosa, R. Casanova Arsola,
C. Garcia Morejon, E. Fleitas.
P176 Eco-Cardiographic Ergometric Correlation of Patients
L. Sollet Lopez, A. Gonzalez Morejon, J. Ponce Vitar, E. Selman Houssein Sosa, R. Casanova Arsola,
C. Garcia Morejon, J. C. Ramiro Novoa, J. Ozores, E. Fleitas.
P177Correlación Eco cardiográfica-Ergo métrica de pacientes operados
de TGV a través de la técnica de Mustard.
L. Sollet Lopez, A. Glez Morejon, J. Ponce Vitar, E. Selman Houssein Sosa, R. Casanova Arzola, C. Garcia Morejon,
J. C. Ramiro Novoa, E. Fleitas.
P178
Risk Factors of Atherosclerosis in Children
H. Valdes Pino, L. Sollet Lopez, F. Carballes Garcia, E. Aguilera.
P179Factores de riesgos de aterosclerosis en poblacion infantil, area de salud
reparto Jesus Menendez, 2006
H. Valdes Pino, L. Sollet Lopez, F. Carballes Garcia, E. Aguilera.
Scientific Programme / 177
Poster Listing
P180OBESITY, PLASMA LIPID PROFILES AND METABOLIC SYNDROME AMONG APPARENTLY
HEALTHY ADULT NIGERIANS
M. Sani, K. Wahab, B. Yusuf, O. Johnson.
P181Correlation of ischemic wall motion abnormalities in stress echo with
observed morphologic pattern in twelve lead exercise electrocardiography.
N. G. Allende, R. Perez De La Hoz, E. Carrasco, G. Marambio, S. Carabajal, C. Vazquez, M. Russo.
P182VALVE REPLACEMENT WITH BILEAFLET HP-BIPLUS MECHANICAL PROSTHESES VERSUS
STANDARD PROSTHESES: LONG-TERM RESULTS.
T. F. Cianciulli, M. A. Beck, J. A. Lax, M. C. Saccheri, L. A. Cozarinsky, F. J. Gadea, A. N. Dorelle, R Guidoin,
H. A. Prezioso, L. A. Vidal.
P184Outcomes of Primary Percutaneous Coronary Intervention for Acute
ST-elevation Myocardial Infarction in patients aged over 80 years
I. Teplitsky, A. R. Assali, H. Vaknin Assa, E. Lev, D. Brosh, I. Ben-Dor, S. Fuchs, N. Shor, A. Battler, R. Kornowski.
P185The electrical remodeling in the senescent over 90 years old - Gender
differences and clinical aspects
S. Sclarovsky.
P186Level of knowledge of the impact of cardiovascular disease in women’s
mortality, in three population groups: ordinary women, nurses and medical
doctors in Santiago, Chile.
M. Fernandez, P. Arellano, V. Vera, P. Uriarte, M. Tobar, A. Abufhele.
P187
Noncompaction of the ventricular myocardium (NCVM)
A. De Dios, E. Flores, A. Olive, M. Pasquale, M. Vaccari, M. Vidal, M. Zampach, B. Zarlenga, R. Cayre.
P189Activated Factor XII and B-type natriuretic peptide, but not C-reactive protein,
are independent predictors of mortality following admission with suspected
myocardial infarction.
V. Pönitz, T. Brügger-Andersen, D. Pritchard, H. Grundt, H. Staines, D. T. W. Nilsen.
P190Activated Factor XII type A is an independent predictor of cardiovascular
outcome in coronary patients admitted with troponin T negative chest pain
V. Pönitz, T. Brugger-Andersen, D. Pritchard, H. Grundt, H. Staines, D. T. W. Nilsen.
P191
Mitral valve repair surgery
V. Bichara, J. Tazar, A. Araujo, R. De Rosa.
P192BODY COMPOSITION ANALYSIS WITH COMBINATED PHYSICAL TRAINING IN CORONARY
PATIENTS
M. Resnik, M. Ruffa, S. Taurozzi, L. Maggio, M. Perez Ruffa, E. Abad Monetti.
Poster Listing
P193Head to Head Comparison of Prognostic Value of Dobutamine and Adenosine
Real-Time Myocardial Contrast Echocardiography- Preliminary Results
A. Alves, I. Kowatsch, J. Tsutsui, A. Osório, L. César, J. Ramires, W. Mathias Jr.
P194THE IMPACT OF PREOPERATIVE ATRIAL FIBRILLATION IN PATIENTS UNDERGOING MITRAL
VALVE SURGERY: 15 YEARS OF EXPERIENCE OF A CARDIAC SURGERY SERVICE
R. Santa Ritta, M. Coutinho, E. Varella, F. Di Giovanni, K. Da Correggio, G. Longo, C. Fontana, S. Fadel.
P195
Nurse led heart Failure clinic is cost effective in New Zealand
I. Ternouth, B. Lindsay.
P196IS MULTI SLICE CT ANGIOGRAPHY ADEQUATE AS THE SOLE DIAGNOSTIC
CRITERIA TO PROCEED FOR CABG ?
H. Bedi, J. Gill, S. Bakshi.
P197SURGICAL TREATMENT OF CHRONIC SEVERE RIGHT VENTRICULAR CARDIOMYOPATHIES
M. Cortes Morichetti, J. L. Hebert, T. Lavergne, R. Frank, G. Fontaine, F. Hidden-Lucet, Y. Lecarpentier,
A. Carpentier, J. N. Fabiani, J. C. Chachques.
P198Late Complications After Drug-Eluting Stent Implantation in
“Real-World” Clinical Practice
D. R. Ramsdale, A. Rao, O. Asghar, K. A. Ramsdale, E. McKay.
P200Prevalence and Predictors of Carotid Versus Femoral Plaque by Screening
Vascular Ultrasound in Asymptomatic Adults
J. Postley, J. Gardin, A. Perez, M. Chan, N. D. Wong.
P201ROLE OF PATIENT EDUCATION IN EXERCISE ADHERENCE IN PATIENTS UNDERGOING
MYOCARDIAL REVASCULARIZATION
G. Giunta, D. Comtesse, H. Sanabria, A. Hershon, R. Mayer, L. Brandani, R. Romero, S. Di Yelsi, C. Commes,
S. Kerbage.
P202Retrieval, Repositioning, Unknotting, and Stripping of Intracardiac Catheters
and Foreign Bodies
J. Tisnado, D. J. Komorowski, M. K. Sydnor, D. A. Leung, J. Tisnado.
P206Renal function and evolution of Acute Coronary Sindrome. National Hospital
Arzobispo Loayza Lima-Peru
M. Carrion Chambilla, A. Hurtado Arestegui, C. Gutierrez Villafuerte, J. Pinto Concha.
P207
Survivin Expression in Cardiac Myxoma
P. H. Chu, S. M. Jung.
Scientific Programme / 179
Poster Listing
P209EFFECT OF LEVOSIMENDAN ON DIASTOLIC FUNCTIONS IN PATIENTS WITH HEART FAILURE
AND COEXISTING ATRIAL FIBRILLATION
O. C. Yontar, M. B. Yilmaz.
P210Elevated triglycerides/HDL ratio predicts extensive coronary artery disease in
Cyprus
C. Conkbayir, S. Kenan.
P211Short-term exercise training improves HDL functional characteristics in
patients with metabolic syndrome
A. Casella-Filho, V. M. Silva, C. B. Casella, I.C. Trombetta, F. Y. Cesena, B. C. G. Nascimento, C. E. Negrao,
R. C. Maranhao, P. L. Daluz, A. C. P. Chagas.
P213Prevalence of Rheumatic Heart Disease According to World Health
Organization Criteria for Sub-Clinical Valve Lesions
E. Marijon, D. S. Celermajer, B. Ferreira, A. O. Mocumbi, D. Sidi, X. Jouven.
P214ASSESSMENT OF QUALITY OF LIFE IN PATIENTS WITH DEPENDENT CAVOTRICUSPID ISTHMUS
FLUTTER
J. García-Seara, L. Martinez-Sande, F. Gude Sampedro, B. Cid Alvarez, R. Vidal Perez, F. Soto Loureiro,
J. Gonzalez Juanatey .
P216The effects of general demographic data on the initation and timing of
thrombolytic therapy among of STEMI patients
O. C. Yontar, A. Erdem, K. Yalta, M. B. Yilmaz, I. Tandogan.
P217Is There a Predictive Pattern of P-Wave Signal Averaged Electrocardiogram for
Arrhythmia Recurrence after Cardioversion of Persistent Atrial Fibrillation
C. Militaru, A. Giuca, O. Istratoaie, D. D. Ionescu.
P218Cardioprotective Effects of Zofenopril, Enalapril and Valsartan on
Doxorubicin Cardiotoxicity
E. Bozçali, D. B. Dedeoglu, O. Süzer, H. Karpuz.
P219PLASMA HOMOCYSTEINE LEVEL IN CARDIAC SYNDROME X AND ITS RELATION WITH DUKE
TREADMILL SCORE
T. Timurkaynak, S. Balcioglu, U. Arslan, S. A. Kocaman, A. Çengel.
P220Inflammation and Fibrinolytic Dysfunction in Impaired Glucose Tolerance.
H. L. Luciardi, S. Chain, S. G. Berman, G. Feldman, J. Muntaner, R. N, Herrera.
Poster Listing
P221ATP-binding cassette transporter G1 Promoter Variant Influences
to A Severity of Coronary Artery Disease
Y. Uehara, S. Furuyama, S. Abe, S. I. Miura, B. Zhang, K. Saku.
P222Layperson trainees improve their knowledge of resuscitation in BLS/AED
courses and their confidence in providing bystander CPR.
P. Cokkinos, N. Nikolaou, T. Papafanis, P. Strebelas, C. Hasikidis, A. Tasouli, D. Kontogianni, G. Gavrielatos,
T. Kapadohos, D. Chrysos.
P223Distribution, Awareness, Control and Benefits of Reduction of Blood Pressure
in Yerevan, Armenia
P. Zelveian, G. Podosyan, S. Barsamyan, A. Potosyan.
P224Prognostic value of surface Electrocardiogram (ECG) one-minute heart rate
variability (HRV)
J. Visperas, O. Bugarin, M. Somera, M. Ramirez, E. Caguioa, M. Yamamoto.
P225Is the cold pressor test useful in the pre-clinical stage of coronary heart
disease to predict events?
E. Pautasso, M. Koretzky, J. Aiub, C. Borrego, R. Foye, M. Boscaro, M. Battiston, F. De Cecco, J. Panini,
A. Marcon Del Point.
P226EXERCISE ECHOCARDIOGRAPHY WITH CONTRAST FOR THE EVALUATION OF PULMONARY
ARTERY SYSTOLIC PRESSURE. NEW METHOD.
L. Rocha Lopes, S. Almeida, R. Miranda, M. J. Loureiro, O. Simoes, P. Cordeiro, C. Cotrim, M. Carrageta.
P227Infectious endocarditis associated with permanent implantable electronic
devices (PIED): a prospective study. 18 months follow-up.
G. Pérez Baztarrica, F. Salvaggio, L. Gariglio, M. Cerón, F. Gonzalez, D. Calcines Huerta, H. Massetti, N. Blanco,
A. Botbol, R. Porcile.
P228Pulmonary embolism in infectious endocarditis associated with permanent
implantable electronic devices PIED: incidence and outcomes after
percutaneous extraction of catheters.
G. Pérez Baztarrica, F. Salvaggio, L. Gariglio, M. Nordaby, T. Soria, H. Cruz, F. Sanchez, N. Blanco, A. Botbol,
R. Porcile.
P229PREDICTORS OF HIGH HOSPITAL COSTS FOR ELDERLY PATIENTS WITH HEART FAILURE
M. Giorgi, M. Voos, R. Borracci, R. Ahuad, H. Farras, S. Balmaceda, M. Fanuele, J. Insua.
P230PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS OVER 80 YEARS OLD THROUGH
THE TRANSRADIAL ACCESS
G. Samaja, A. Rodriguez Saavedra, M. Koretzky, R. Costello.
Scientific Programme / 181
Poster Listing
P231
Transapical minimally invasive aortic valve implantation
T. Walther, R. Battellini, V. Falk, M. Borger, J. Kempfert, J. Fassl, Y. Rückert, A. Linke, G. Schuler, F. W. Mohr.
P232
Cardiac lead vegetations in rhythm devices - transvenous extraction
R. Battellini, A. Rastan, M. Uhlemann, N. Lachmann, M. Luduena, T. Walther, N. Doll, F. W. Mohr.
P233
Survival from cardiac arrest in a specialized hospital.
P. Cokkinos, E. Papadopoulou, A. Gkouziouta, V. Voudris, D. V. Cokkinos.
P234Non invasive assesment of coronary artery by pass grafts by VCT 64 multislice.
Comparison with conventional coronary angiography.
J. Bonelli, C. Cigalini.
P235Does Carvedilol Therapy Reduce QT Dispersion in Patients with Heart Failure ?
E. Tatli, T. Kurum, M. Aktoz, C. Gul, M. Buyuklu.
P236Effect of Carvedilol on P-Wave Duration and P-Wave Dispersion in Patients with
Systolic Heart Failure
E. Tatli, T. Kurum, M. Aktoz, M. Buyuklu, C. Gul, A. Barutcu.
P237
Non invasive coronary angiography with MSCT 64 slice
J. Bonelli, C. Cigalini, P. Pollono.
P238Clinical and echocardiographic assessment of patients with aortic valve
disease - maternal and fetal outcome
A. Lesniak-Sobelga, W. Tracz, M. Kostkiewicz.
P239Information poverty as a risk factor for cardiovascular disease: AshantiProCor Project to Increase CVD Knowledge and Practice Among Health Workers
C. Coleman, B. Bilchik.
P240Implementation measures secundary prevention CHD in Banja Luka
Region,Republic of Srpska,B&H
D. Vulic, S. Loncar, B. Vulic, D. Roganovic, M. Ostojic, J. Marinkovic.
P241Awareness, Treatment and Control of the Combination of Hypertension and
Hypercholesterolemia in a Primary Prevention Population in Chile
M. Acevedo, V. Krämer, R. Tagle, G. Chamorro, M. Fernandez, L. Orellana.
P243Does gender influence postprandial lipaemia in heterozygotes of familial
hypercholesterolaemia?
G. Kolovou, P. Cokkinos, S. Mavrogeni, G. Hatzigeorgiou, D. V. Cokkinos.
Poster Listing
P244
Coronary atherosclerosis in Western Siberia: north-south differences
V. Kuznetsov, I. Zyrianov, G. Kolunin, D. Krinochkin, L. Evlampieva, M. Bessonova, E. Gorbatenko.
P245ASYMPTOMATIC CAROTID ATHEROSCLEROSIS IN PATIENTS WITH CORONARIOPATHY:
PREVALENCE, PREDICTORS AND DIAGNOSIS
R. Marelli, J. Lopez Camelo, C. Geronés, C. Viscuso, A. Gomez Monroy, G. Godoy, M. Portis, F. Bourdin, I. Rifourcat,
R. Sanchez.
P246
ATHEROSCLEROSIS OF CAROTID ARTERIES AND CORONARY ARTERY DISEASE
P. Meszaros, N. Cemerlic-Adjic, K. Pavlovic, M. Maletin.
P247INTERLEUKIN-6 (IL-6): IS A MARKER FOR CARDIOVASCULAR DISEASE IN PATIENTS WITH
DIABETIC NEPHROPATHY
A. Silva, A. Baptista, P. Neves.
P248Prevalence of cardiovascular risk factors and metabolic syndrome in a
hospital hypertension unit
M. Irurita, C. Culebras, E. Bosch, R. Chirino, J. Irurita, L. Sanchez, L. Lopez Y Juan, B. Saiz, P. Rosique, R. Guerra.
P249Non-ischemic benefits may be independent of the LDL-lowering properties of
atorvastatin
J. C. Larosa, J. Shepherd, D. D. Waters, A. Breazna, D. Demicco.
P250Unravelling Hidden Renal Dysfunction. An unrecognized major problem.
M. Irurita, C. Culebras, E. Bosch, R. Chirino, J. Irurita, L. Suarez, B. Saiz, P. Rosique, R. Guerra, V. Nieto.
P251Pituitary-adrenal axis hormone adjustment following cardiac surgery
M. Irurita, C. Culebras, J. Velayo, J. Irurita, R. Chirino, L. Suarez, H. Marrero, B. Saiz, L. Lopez Y Juan, V. Nieto.
P252Determinant factors for temporary hormone changes in cardiac surgery
M. Irurita, C. Culebras, J. Velayo, J. Irurita, R. Chirino, L. Suarez, H. Marrero, B. Saiz, L. Lopez Y Juan, V. Nieto.
P253Plasmatic levels of apolipoprotein in young subjects without cardiovascular
disease. Effects of age, gender and body mass index.
D. A. Siniawski, W. M. Masson, P. Sorroche, J. Krauss, A. M. Cagide .
P254Achievement of Treatment Targets of Cardiovascular Risk Factors in a Pilot
Secondary Prevention Program In Chile
M. Acevedo, V. Krämer, G. Chamorro, G. Krogh, A. Muñoz, R. Corbalan.
P255ANTIPHOSPHOLIPID SYNDROME AND HYPERTENSIVE DISORDERS OF PREGNANCY
(preliminary results).
L. S. Voto, M. J. Mattioli, R. Zarate, G. N. Voto, B. E. Grand.
Scientific Programme / 183
Poster Listing
P256Elevated augmentation index but not hsCRP could be related to arterial
damage in patients with rheumatoid arthritis
A. Cypiene, A. Laucevicius, J. Dadoniene, A. Venalis, Z. Petrulioniene, M. Kovaite, J. Badariene, V. Dzenkeviciute,
L. Ryliskyte.
P257Autologous Bone-Marrow Mononuclear Cell Transplantation after Acute
Myocardial Infarction:Comparison of Two Delivery Techniques
H. Dohmann, S. A. Silva, R. C. Moreira, A. Haddad, F. A. Tuche, A. S. Souza, C. Peixoto, R. Verney, M. Amorin,
R. Borojevick .
P258IMPLEMENTATION OF EMERGENCY-BASED THROMBOLYSIS; AN ACHIEVABLE OPTION FOR
RURAL HOSPITALS IN DEVELOPING COUNTRIES.
S. Azarisman, H. Ngow, P. Melor, A. Jamalludin, A. Fauzi, S. Sapari, K. Khairi, S. Noorfaizan, M. Oteh.
P259COMPLIANCE WITH THE MALAYSIAN NATIONAL CLINICAL PRACTICE GUIDELINES ON THE
ADMINISTRATION OF THROMBOLYTIC AGENTS IN ACUTE ST-ELEVATION MYOCARDIAL
INFARCTION
S. Azarisman, H. Ngow, P. Melor, A. Jamalludin, A. Fauzi, S. Sapari, K. Khairi, S. Noorfaizan, M. Oteh.
P260RISK FACTOR PROFILE OF PATIENTS PRESENTING WITH ACUTE ST-ELEVATION MYOCARDIAL
INFARCTION TO A RURAL HOSPITAL IN MALAYSIA
S. Azarisman, H. Ngow, P. Melor, A. Jamalludin, A. Fauzi, S. Sapari, K. Khairi, S. Noorfaizan, M. Oteh.
P266SURGICAL THERAPY FOR ISCHEMIC HEART FAILURE: PREDICTORS OF MORTALITY AT LATE
FOLLOW-UP
I. Butkuviene, L. Ivaskeviciene, G. Nogiene, J. Zidanaviciute.
P267
ARTERIAL HYPERTENSION MULTICENTRIC STUDY IN TYPE 2 DIABETIC PATIENTS
M. L. Ruiz Morosini, E. Lopez Gonzalez, A. Garcia, A. Luongo, C. Gonzalez, G. Burlando, M. Ruiz .
P269
MYOCARDIAL PERFUSION SPECT WITH DOUBLE DRUG NEED.
V. Martire, D. Portillo, J. M. Dominguez, E. Pis Diez.
P270SPECT USEFULNESS IN PATIENTS WITH DOUBTFUL ERGOMETRY DUE TO
ST-T DEPRESSION
V. Martire, M. Cantos, M. Pilato, S. Pilato, C. Vietti, S. Vogogna.
P271INFLUENCE OF THE COLLATERAL CORONARY CIRCULATION IN THE MODEL
OF DOUBLE ERGOMETRIC STRESS TEST
V. Martire, A. Arrastia, S. Gonzalez, D. Portillo, J. M. Dominguez.
Poster Listing
P272Clinical outcomes in patient with idiopathic dilated cardiomyopathy or
coronary cardiomyopathy and an implantable cardoverter defibrillator.
Are they different?
R. Aguayo, S. Diangelo, W. De Andrade, E. Costa, L. Azocar, O. Macz, R. Ferreyra, I. Romero, J. Maloney, C. Muratore
P273PHARMACOLOGICAL EFFECTS OF INAMRINONE LACTATE IN PATIENTS WITH REVERSIBLE
PERFUSION DEFECTS INDUCED BY DIPYRIDAMOLE
V. Martire, D. Portillo, J. M. Dominguez, A. Kavata.
P274Implantable Cardioverter Defibrillator Therapy in Patients with Chronic
Chagas’ Cardiomyopathy: comparison with Ischemic Cardiomyopathy.
L. Aguinaga, C. Muratore, A. Malan, L. Batista, G. Maid, J. Escudero, M. Lanzotti, P. Chiale, J. Maloney .
P275Importance of Blood Flow and Calcification Degree in Results of Carotid
Artery Stenting
L. Martinez Riera, E. Trucco, M. J. Cabrera Ferreyra, F. Paoletti, H. Londero.
P276Cardiac Myocyte Injury Can Result in Elevated Levels of Choline in Plasma.
M. Adamczyk, R. J. Brashear, P. G. Mattingly.
P277Chest symptom classification is useful for identifying cardiac risk in diabetic
patients
H. Fukuda, M. Moroi, R. Nakazato, T. Furuhashi, K. Sugi.
P278DES, like BMS, do not influence systemic inflammatory status related with
inflammatory cells after PCI in stable angina pectoris
T. Timurkaynak, S. A. Kocaman, A. Sahinarslan, A. Cengel.
P279HOSPITALIZATION OF PATIENTS WITH HEART FAILURE. ROLE OF THE PRECIPITATING
FACTORS.
T. Livieratos, A. Tziovas, A. L. Patsilinakos, P. A. Koustas, F. O. Kontari, G. E. Fagogenis, G. E. Kordosis, A. T. Germanos.
P280CHARACTERISTICS, MANAGEMENT AND IN-HOSPITAL OUTCOMES OF PATIENTS WITH ACUTE
CORONARY SYNDROMES.
T. H. Livieratos, A. R. Tziovas, A. L. Patsilinakos, G. E. Fagogenis, F. O. Kontari, P. A. Koustas, G. E. Kordosis, A. T. Germanos.
P281The Effects of Nocturnal Dipping on Cardiovascular Outcome and Proteinuria
In Essential Hypertensive Patients
Y. Selcoki, B. Uz, N. Baybek, A. Akcay, B. Eryonucu.
P282Assessment of myocardial viability in chronic ischemic heart disease
evaluated by stress echocardiography with dobutamine and gated single
photon emission computed tomography (GSPECT)
M. Kostkiewicz, A. Lesniak-Sobelga, M. Olszowska, M. Hlawaty, P. Podolec, W. Tracz.
Scientific Programme / 185
Poster Listing
P283cardiopulmonary exercise testing in the estimation of the cardio respiratory
efficiency after cardiac rehabilitation in coronary patients
A. Stuto, G. Cosentino, A. Ambu, F. Raineri, G. Bottaro, G. Basile, B. Armaro.
P284Prevalence of Cardiac Events in Patients with Normal Perfusion
and Abnormal ST-T Segment During Dipyridamole Infusion
P. Smanio, L. Freitas, A. Feldman, A. Mota, C. Collet, F. Penhalves, R. Lopes, M. Oliveira, A. Thom, L. Piegas.
P285Five Year Results of the Treatment Strategy Based Upon the Fractional Flow
Reserve Measurements in Patients with Borderline Coronary Artery Lesions
U. Arslan, S. Balcioglu, S. A. Kocaman, T. Timurkaynak.
P286Aortic Sclerosis and Mitral Annular Calcification are Related with Increased
Risk Factors and Markers in Acute Coronary Syndrome
S. A. Kocaman, G. Taçoy, S. Türkoglu, S. Akinci, M. Erden, S. K. Açikgöz, A. Çengel.
P287Prevalence and Clinical Course of the End Stage Phase of Hypertrophic
Cardiomyopathy in Patients Referred to a Tertiary Care Center
A. Fernández, J. H. Casabé, R. R. Favaloro, M. Diez, L. Favaloro, C. Vigliano, E. Guevara, F. Landeta, J. Diaz, R. Laguens.
P288Relationship Between Frequency of Ventricular Tachyarrhythmia Episodes
and Functional Capacity in Patients Treated with Implantable Cardioverter
Defibrillator
A. Eksik, A. Akyol, T. Norgaz, S. Sakalli, N. Cakmak, H. Hasdemýr, A. Alper, O. Soylu, D. Oz, I. Erdinler .
P289Role of a family physician service in lipid control in patients
with coronary artery disease
O. Korzh, G. Kotchuev, S. Krasnokutskiy.
P290Torsade de Pointes: a cause of Morgagni-Adam-Stokes attacks
in patients with atrioventricular block.
D. Antonelli, E. Rosner, A. Shurman, N. A. Freedberg, Y. Turgeman.
P291Prognositc value of anemia in patients hospitalized for Acute Coronary
Syndrome
A. B. Cid Alvarez, E. Gonzalez Babarro, J. M. Garcia Acuña, A. Varela Román, P. Rigueiro Veloso, F. J. García Seara,
A. Virgos Lamela, R. Vidal Perez, A. Díaz Redondo, J. R. Gonzalez Juanatey.
P292Clinic features and prognosis of Acute Coronary Syndrome in
the elderly
A. B. Cid Alvarez, E. Gonzalez Babarro, J. M. Garcia Acuña, A. Varela Román, J. Garcia Seara, M. Gutierrez Feijoo,
R. Vidal Perez, J. L. Martinez Sande, A. Díaz Redondo, J. R. Gonzalez Juanatey.
Poster Listing
P293Clinical presentation and prognosis of Acute Coronary Syndrome
in women
A. B. Cid Alvarez, E. Gonzalez Babarro, M. Pedreira Perez, J. M. Garcia Acuña, M. Bastos Fernandez,
P. Mazon Ramos, I. Gomez Otero, R. Vidal Perez, A. Diaz Redondo, J. R. Gonzalez Juanatey.
P294Application of Devereux’s geometric model for the analysis of structure and
function in hypertensive patients.
D. Chejtman, S. Baratta, A. Hita, F. Tramontini, H. Fernandez, C. Kotliar, P. Forcada, D. Turri .
P296Serum myeloperoxidase level is associated with risk of major cardiovascular
events during hospitalization and extent of coronary artery disease in
patients with acute coronary syndromes
B. Karadag, B. Vatan, N. Karadag, I. Keles, Z. Ongen, V. A. Vural.
P297The prognostics significance of impaired glucose regulation in non-diabetic
patients with acute myocardial infarction
M. Ilic, I. Mrdovic, T. Jozic, R. Lasica, J. Perunicic, M. Asanin, M. Srdic, S. Stankovic, M. Matic, Z. Vasiljevic .
P298
Lead Intoxication in children: markers of endothelial damage.
G. Feldman, S. Chain, H. Luciardi, S. Berman, R. Feldman, N. Martínez Riera.
P299A Simplified Strategy for the Estimation of the Ventilatory Thresholds During
Ramp-Incremental Exercise
R. Stein, J. A. Neder.
P300Brachial-ankle Pulse Wave Velocity is a Marker of Coronary Heart Disease in
Subjects without, but not With, Metabolic Syndrome
H. Tomiyama, A. Yamashina .
P301Incidence of patients with isolated noncompaction of left ventricle - single
center experiences
A. Nikolic, L. J. Jovovic, S. Tomic, M. Vukovic, D. Nikolic.
P302Achieving Lipid Goals with Rosuvastatin compared to Simvastatin: DISCOVERY
BETA Study
T. Laks, E. Keba, M. Leiner, E. Merilind, M. Peterson, S. Reinmets, S. Väli, T. Sööt, K. Otter.
P303The disease of vasa vasorum in endarterectomy sequesters of coronary
arteries in patient with Chlamydia pneumoniae infection
M. Zorc, R. Zorc Pleskovic, A. Pleskovic, O. Vraspir Porenta, D. Petrovic, N. Radovanovic.
Scientific Programme / 187
Poster Listing
P304Chronic Chlamydia pneumoniae infection and morphology of atherosclerotic
process in diffuse and distal coronary artery disease
A. Pleskovic, R. Zorc Pleskovic, M. Zorc, O. Vraspir Porenta, D. Petrovic, N. Radovanovic.
P305PREDICTORS OF BLOOD PRESSURE NON-DIPPING PATTERN IN ACUTE CORONARY SYNDROME
A. Zamora, G. Vazquez, M. Vilaseca, J. M. Fernandez-Real, M. Crespo, A. Gibert, G. Paluzuie, S. Corali, D. Bron, J. Massa.
P306Intracoronary Autologous Bone Marrow Mononuclear Cell Transfer after
Large Anterior Acute Myocardial Infarction (AMI
M. A. Riccitelli, N. Perez Baliño, J. C. Dupont, J. Szarfer, F. Blanco, L. Grynberg, R. Cacchione, L. A. Vidal,
A. García Escudero, O. Masoli.
P307Coronary endothelial dysfunction is distinct in postmenopausal women with
chest pain in the absence of coronary artery disease
T. Ashikaga, H. Fujii, S. Niki, K. Ihara, N. Murai, S. Maeda, N. Yamawake, M. Nishizaki, Y. Kishi, M. Isobe.
P308PROGNOSTIC VALUE OF PULSE PRESSURE REGISTERED BY 24 HOURS AMBULATORY BLOOD
PRESSURE MONITORING IN ACUTE CORONARY SYNDROME
G. Vazquez, A. Zamora, M. Vilaseca, M. Crespo, A. Gibert, G. Paluzie, I. Caballe, V. Fernández, C. Campoamor, S. Coralli.
P309CORRELATION BETWEEN ACCESS TO INVASIVE CORONARY APPROACH AND COMORBIDITY
STATUS IN PATIENTS ADMITTED WITH ACUTE CORONARY SYNDROME IN A COMMUNITY
HOSPITAL
M. Vilaseca, G. Vazquez, A. Zamora, M. Crespo, A. Gibert, G. Paluzie, R. Cuenca, D. Bron, A. Rivera, R. Massa.
P310BLOOD PRESSURE VARIATION ACTIVITY/REST IS ASSOCIATED TO A POOR CARDIOVASCULAR
PROGNOSIS IN PATIENTS WITH ACUTE CORONARY SYNDROME
A. Zamora, G. Vazquez, M. Vilaseca, M. Crespo, A. Gibert, G. Paluzie, C. Campoamor, S. Coralli, D. Bron, A. Garcia-Flores.
P311
DEPRESSION AND QUALITY OF LIFE IN PATIENTS WITH HEART FAILURE.
M. Kowman, T. Sobow, I. Kloszewska, M. Dominiak, M. Klosinska, J. Drozdz.
P312Syncronous Carotid Artery Stenting and Cardiovascular Surgery. Long Term
Evolution
C. Fava, L. Valdivieso, G. Lev, L. Villagra, J. Scaglia, A. Mollon, O. Mendiz.
P313Effect of mean platelet volume on post-intervention coronary blood flow in
patients with chronic stable angina pectoris
H. Duygu, F. Ozerkan, U. Turk, B. Kirilmaz.
P314STATINS MIGHT IMPROVE CORONARY BLOOD FLOW AFTER PERCUTANEOUS CORONARY
INTERVENTION
H. Duygu, F. Ozerkan, U. Turk, C. Turkoglu.
Poster Listing
P315Latency Non Invasive Evaluation in Implantable Pacemaker Patients Potential
Use as Biosensor for Automatic Rate Responsive Pacemaker
D. Ortega, L. Barja, N. Mangani, F. Di Tomaso, A. Hita, D. Turri, M. Kenar.
P316
Parahisian Septal Stimulation. Indication Analysis. Results
D. Ortega, L. Barja, N. Mangani, E. V. Segura, A. Hita, C. Paladino, N. Paz, M. Kenar, D. Turri.
P317Cardiac Electrotonic Memory Induction after QRS Normalization by Parahisian
Pacing.
D. Ortega, L. Barja, N. Mangani, D. Turri, G. M. M Pellegrino, A. Hita, M. Kenar, C. Paladino, V. Kotowicz.
P318Effect of different right ventricular pacing places on left ventricular
electro-mechanical time.
D. Ortega, L. Barja, M. Amor, G. M. M. Pellegrino, N. Mangani, A. Hita, D. Turri, M. Kenar.
P319Uses of Tissue Doppler Imaging for Detection of Subclinical Left Ventricular
Dysfunction in Pre- Transplant Renal Hemodialysed Patients
C. Dizeo, M. Brito, G. Rey, P. Rossi.
P321Predictors for silent myocardial ischemia in diabetic patients with myocardial
perfusion ischemia
H. Fukuda, M. Moroi, R. Nakazato, T. Furuhashi, N. Joki, H. Hase.
P322Preoperative Use of Calcium Sensitizer Levosimendan Reduces Mortality
and Low Cardiac Output Syndrome in Patients with Aortic Stenosis and Left
Ventricular Dysfunction
R. Levin, M. Degrange, R. Porcile, F. Salvagio, C. Del Mazo, E. Tanus, N. Blanco, L. Botbol.
P323Screening for Primary Hyperaldosteronism in Essential Hypertensive Patients:
a Multicentric Study*
S. Lupi, S. Belli, D. Cornalo, S. Damilano, R. Gomez, M. Leal, M. Martinez, M. Nofal, G. Ruibal, E. Pardes.
P324ASYMPTOMATIC CAROTID ATHEROSCLEROSIS IN PATIENTS WITH SEVERE AORTIC VALVULAR
STENOSIS.
R. Marelli, L. Godoy, L. Geronés, N. Napoli, O. Pisano, C. Echeverria, M. Giacomo, V. Marasa, M. Geronés, O. Rastelli.
P325Determination of the Aldosterone/Plasma Renin Activity Ratio in a
Normotensive Population: a Multicentric Study*
E. Pardes, S. Belli, L. Contreras, L. Costa, R. Chervin, S. Damilano, C. Fenili, R. Gomez, M. Leal, S. Lupi.
P326
Key Role of Reactive Oxygen Species in the Anrep’s Phenomenon.
N. G. Pérez, L. P. Novaretto, H. E. Cingolani.
Scientific Programme / 189
Poster Listing
P327In the treatment of the acute myocardial infarction, the primary
percutaneous coronary intervention show us better in-hospital results than
the rescue percutaneous coronary intervention after thrombolisis.
M. Cantarelli, S. Gioppato, J. B. Guimarães, E. P. Ribeiro, J. Nardi, R. Gomes, T. Conforti, F. Pereda, R. Gonçalves,
H. Castello .
P328Are there differences in immediate results of percutaneous coronary
intervention between elderly population above and under 80 years old?
M. Cantarelli, S. Gioppato, J.B. Guimarães, E.P. Ribeiro, J. Nardi, R. Gomes, T. Conforti, F. Pereda, R. Gonçalves,
H. Castello .
P329Double chamber right ventricle: diagnosis and treatment. Presentation of two
cases
C. Viscuso, M. Giacomo, C. Echeverria, L. Cali, M. Antonetti, J. Como Birche, G. Basso, D. Herrera, O. Pisano,
R. Marelli .
P330
Quality Control ( QC ) in Anticoagulation Clinic
M. G Gonzalez Achaval, M. Hadad, A. Del Val, S. Ghione, S. Gomez, J. P. Sala.
P331
Therapeutic hypothermia after cardiac arrest
M. Petrovic, G. Panic, I. Srdanovic, T. Canji, A. Jovelic .
P332TETRALOGY OF FALLOT: A 1 YEAR OF EXPERIENCE AT THE HOSPITAL CARDIOLOGICO
INFANTIL LATINOAMERICANO “DR GILBERTO RODRIGUEZ OCHOA” CARACAS, VENEZUELA.
A. Galindo, J. Rengel, J. Figueira, S. Sanchez, A. Sanchez, J. Figueredo, N. Ysturiz, J. Iribarren, E. Parra, H. Mejias .
P333HOSPITAL CARDIOLOGICO INFANTIL LATINOAMERICANO “DR GILBERTO RODRIGUEZ OCHOA”
CARACAS; VENEZUELA. POST OPERATIVE EXPERIENCE OF VENTRICUALR SEPTAL DEFECT.
J. Figueira, J. Rengel, A. Galindo, S. Sanchez, J. Iribarren, A. Sanchez, C. Febres, M. Flores, H. Contreras, F. Emperador
P334ANOMALOUS ORIGIN OF THE LEFT CORONARY ARTERY FROM THE PULMONARY ARTERY
(ALCAPA) IN ADOLESCENT: PRESENTATION OF CLINICAL CASE.
J. Rengel, J. Figueira, A. Galindo, S. Sanchez, I. Donis, J. Figueredo, J. Gonzalez, F. Guerra, Y. Acosta, I. Tolj .
P335LONG TERM TIROFIBAN INFUSION BEFORE PCI IN PATIENTS WITH ANGIOGRAPHICALLY
MASSIVE INTRACORONARY THROMBUS
T. Timurkaynak, U. Arslan, S. Balcioglu, S. A. Kocaman, S. Türkoglu.
P336C- Reactive Protein and its relation with the ventricular mass,
in patients with chronic hemodialysis
I. Masuda.
Poster Listing
P339C- Reactive Protein and its relation with the ventricular mass, in patients with
chronic hemodialysis
Masuda Isabel, Ferrero Mónica, Hecker Susana, Ziella Juan Carlos, Marcozzi Amalia, Hansen Ana, Aguirre Gustavo,
Eduardo Escudero, Ciprés Miriam .
P341Early Detection of Right Ventricular Systolic Dysfunction at Tissue Level by
Isovolumic Myocardial Acceleration in Patients with COPD
Y. Tayyareci, C. P. Tastan, P. Bayazit, Y. Nisanci, A. Oncul, B. Umman, T. Goren, S. Umman, K. Adalet, Z. Bugra.
P342Management and immediate outcome of elderly patients with acute coronary:
A single center experience
V. Dias, S. Cabral, F. Soares, A. Luz, C. Gomes, F. Oliveira, L. Gomes .
P343
Invasive and anticoagulant threatment of coronary ectasia
V. Grigorov.
P344The Association Between Metabolic Syndrome and its Components and Heart
Failure in Patients Referred to a Primary Care Facility
F. Coelho, M. Moutinho, M. Rosa, V. Miranda, L. Tavares, E. Mesquita .
P345Effects of simvastatin on the transfer of lipids to high density lipoprotein in
coronary artery disease patients.
A. C. Lo Prete, C. H. Dina, C. H. M. Azevedo, T. M. Seydell, W. Hueb, R. C. Maranhao.
P346Bradykinin released during intense exercise inhibits the expression of gap
junction protein in trained mouse hearts.
G. C. Tiscornia, E. A. Garcia Gras.
P348THE EFFECTS OF THE CONTROLLED RESPIRATION ON THE AUTONOMIC MODULATION OF THE
HEART IN RESISTENT HIPERTENSION: THE IMPACT OF RENIN-ANGIOTENSIN-ALDOSTERONE
SYSTEM ON CARDIAC AUTONOMIC MODULATION (THE CURUMIM STUDY)
G. N. Gobbi, P. R. Benchimol-Barbosa, C. S. Miranda, A. F. P. Gondar, F. D. Vilela, F. V. Campos, J. Barbosa-Filho,
M. V. Barros, A. B. R. Lima, I. Cordovil.
P349HDL size and ability of acceptance cholesterol and other lipids in heart
transplantation patients with treatment
C. G. Puk, A. C. Lo Prete, E. A. Bocchi, C. H. Azevedo, S. Ayub, R. C. Maranhão.
P351
UTILITY OF A LOW-RISK SPECT TEST IN UNSTABLE ANGINA
Y. Castillo Costa, V. Mauro, A. Charask, R. Pérez, E. Fairman, L. Rodríguez, E. Barrionuevo, C. Barrero.
Scientific Programme / 191
Poster Listing
P352CARDIAC MIXOMAS: CLINICAL PRESENTATION, SURGICAL RESULTS AND LONG-TERM
FOLLOW UP OF 60 CASES.
E. Gonzalez, N. Pizzi, G. Caponi, J. Shiraishi, M. Varela Otero, Y. Arzani, L. Helman, R. Favaloro.
P353Compliacation of Cardiothoracic Surgery in the Peruvian National Heart
Institute
M. Condori.
P354Surgical Treatment of Acute Type A Aortic Dissections. Immediate and LongTerm Results.
R. Spampinato Torcivia, H. Cohen Arazi, H. Grancelli, W. Rodriguez, S. Waldman, M. Cáceres, M. Sellanes,
C. Pensa, C. Nojek.
P355Evaluation on the risk of target organ damage based on the genetic profile
of AGT 235MT, mineralocorticoid receptor GCC5GG4C and ACE I/D in subjects with
resistant hypertension
F. V. Campos, P. R. Benchimol-Barbosa, F. D. Vilela, C. S. Miranda, G. N. Gobbi, J. Barbosa-Filho, A. F. P. Gondar,
M. V. Barros, A. B. R. Lima, I. Cordovil.
P356Ventricular-Vascular coupling response and Left Ventricular Function
Parameters with the Ergo-metric stress
J. Tripolone, G. Santiago, M. Garcia.
P357
Right-sided Infective Endocarditis in Singapore
Y. Goh, P. Goh, H. Oh.
P358The effect of long-term beta-blocker treatment on endothelium-dependent
hemostasis in patients with chronic heart failure
E. V. Shlyakhto, K. A. Khmelnitskaya, M. Y. U. Sitnikova.
P359
NATURAL HISTORY OF RHEUMATIC MITRAL STENOSIS
M. Kilickap, B. Candemir, A. O. Ozdemir, S. Turhan, H. Ede, T. Altin, T. Sayin, G. Akgun, C. Erol.
P360Exercise diastolic left ventricular function in patients with coronary artery
disease
Y. U. A. Izachik, S. V. Ivanov, A. B. Pestova, N. A. Grablina, S. S. Ivanov.
P361Improvement in endothelial function with short-term exercise training and
without specific diet in patients with metabolic syndrome
A. Casella-Filho, S. R. Coimbra, C. B. Casella, I. C. Trombetta, F. Y Cesena, E. Cerqueira, D. Favarato, C. E. Negrao,
P. L. Daluz, A. C. P. Chagas.
Poster Listing
P363Mitral and aortic valve dysfunction in maintenance haemodialysis patients echocardiographic findings.
M. Hlawaty, M. Olszowska, W. Tracz, P. Podolec, M. Kostkiewicz, A. Liœniak-Sobelga, M. Pasowicz.
P364Medical advice to quit tobacco smoking as a cornerstone in cardiovascular
prevention. Reality or fiction.
G. Pérez Baztarrica, R. Alonso, H. Cruz, F. Sanchez, F. Ganzalez, M. Cerón, L. Gariglio, F. Salvaggio, R. Cherhousky,
R. Porcile.
P365
THE POLARISING SOLUTION IN THE TREATMENT OF ACUTE CORONARY SYNDROM
R. Matunovic, S. Rafajlovski, M. Rabrenovic, J. Samardzic, R. Spasic.
P367IMPORTANCE OF CARDIOSURGERY TREATEMENT IN PATIENTS WITH INFECTIVE
ENDOCARDITIS AND HEART FAILURE
R. Matunovic, Z. Mijailovic, D. Tavciovski, Z. Vucinic, Z. Davicevic, Z. Jovic, V. Begovic, J. Samardzic.
P368Resting Electrocardiographic Variables of Patients with Severe Coronary
Artery Disease Undergoing Coronary Artery Bypass Graft Surgery plus
Intramyocardial Bone Marrow Cell Injection: An One-Year Follow Up Study
M. S. Bittencourt, I. T. Schettert, C. J. Grupi, L. A. M. Cesar, J. E. Krieger, L. A. O. Dallan, S. A. Oliveira,
L. H. W. Gowdak.
P369Outcomes at Follow-Up of Patients who had Carotid Stenting Periprocedural
TIA or Minor Stroke Complications.
C. Fava, G. Lev, L. Valdivieso, L. Villagra, J. Scaglia, A. Mollon, O. Mendiz.
P370One Year Follow up of Ambulatory Electrocardiographic Variables of Patients
with Severe Coronary Artery Disease Undergoing Coronary Artery Bypass
Graft Surgery plus Intramyocardial Bone Marrow Cell Injection
M. S. Bittencourt, I. T. Schettert, C. J. Grupi, L. A. M. Cesar, J. E. Krieger, L. A. O. Dallan, S. A. Oliveira,
L. H. W. Gowdak.
P371Left Main Coronary Artery Disease is Correlated to the Clinical
Characteristics of Stable Coronary Artery Disease Patients. A Study Ajusted
to the Coronary Atherosclerotic Burden
A. L. V. Oliveira, M. S. Bittencourt, A. C. Pereira, L. A. M. Cesar, L. H. W. Gowdak.
P373Bisoprolol and perindopril combination in post infarction left ventricle
remodelling
K. G. Adamyan, A. V. Astvatsatryan, A. L. Chilingaryan .
P374
Cardiac resting metabolism: energetic cost of calcium withdrawal
P. Bonazzola, D. Takara.
Scientific Programme / 193
Poster Listing
P375Tissue Doppler Tricuspid Annular study with loading variations: clinical and
pronostical interest
G. Robles, M. Feissel, R. Khalaky, J. Badie, O. Ruyer, A. Grentzinger, J. P. Faller.
P376CAN WE USE THE QRS COMPLEX AXIS AS A ELECTROCARDIOGRAPHIC PREDICTOR OF
EFFICACY OF CARDIAC RESYNCHRONIZATION THERAPY?
J. García-Seara, B. Cid Alvarez, J. L. Martinez Sande, M. Bastos Fernandez, A. Varela Roman,
L. Grigorian Shamagian, P. Rigueiro Veloso, E. Gonzalez Babarro, J. R. Gonzalez-Juanatey.
P377INVERSE REMODELING AFTER DEPENDENT CAVOTRICUSPID ISTHMUS FLUTTER ABLATION
J. García-Seara, L. Martinez-Sande, B. Cid Alvarez, F. Soto Loureiro, R. Vidal Perez, M. Bastos Fernandez,
M. Gutierrez Feijoo, M. Vega Fernandez, J. R. Gonzalez Juanatey.
P378Echocardiographic assessment of early left diastolic dysfunction and
correlation with BNP serum levels estimation in patients without clinical
heart failure
K. Hristova, S. Milanov, I. Filibev.
P379ECHOCARDIOGRAPHIC REGIONAL RIGHT VENTRICULAR DYSFUNCTION IN PATIENTS WITH
ACUTE PULMONARY EMBOLISM
K. Hristova, S. Milanov, I. Filibev, D. Petrov.
P380THE RELATIONSHIP BETWEEN SERUM HBA1C LEVELS AND SEVERITY OF CORONARY
ARTERIAL DISEASE IN DIABETIC PATIENTS
O. C. Yontar, A. Erdem, M. B. Yilmaz, K. Yalta, I. Tandogan.
P381Entry – and exitblock as endpoints in segmental pulmonary vein isolation by
irrigated catheter ablation and the mesh mapper technique
A. Meissner, M. Von Bracht, M. Christ, P. Maagh, C. A. Perings, H. J. Trappe, G. Plehn.
P382
SCREENING PATIENTS FOR HYPERTENSION IN EMERGENCY DEPARTMENT
K. Hristova, S. Milanov, I. Filibev.
P383PREVENTION ON MORTALITY AND SUDDEN CARDIAC DEATH IN PATIENTS WITH
CARDIOVASCULAR DISEASES: EFFECT OF HIGHLY PURIFIED OMEGA – 3 FATTY ACID
(OMACOR).
K. Hristova, S. Milanov, I. Filibev.
P384Non-invasive assessment of arterial pulse pressure by using automatic
analysis of B-mode echographic images
S. Graf, R. Armentano.
Poster Listing
P385LONG - TERM EVOLUTION OF R WAVE AMPLITUDE IN PATIENTS WITH IMPLANTABLE
CARDIOVERTER DEFIBRILLATORS
MD Di Toro Dario, RCT Lopez Carlos, MD Hadid Claudio, MD Luis Vidal, MD Carlos Labadet.
P387STUDY OF THE DEGREE OF KNOWLEDGE THAT THE CARDIOLOGISTS IN THE CITY OF SÃO
PAULO BRAZIL HAVE ABOUT AN ENTITY WITH LOW PREVALENCE ASSOCIATED TO SUDDEN
CARDIAC DEATH: BRUGADA SYNDROME
A. R. Perez Riera, C. Ferreira, C. Ferreira Filho, E. Schapachnik, S. Dubner, A. H. Uchida, L. Zhang.
P388“SHARP-SUVED”… Proved Integrated Management with Indian Systems of
medicine for CAD (Coronary Artery Disease)
V. Marathe, S. Vaidya.
P389Right ventricular mechanic analysis and pulmonary distensibility during the
ergo-metric effort
J. Tripolone, G. Santiago, C. Rollan.
P390
New Left Ventricular Function Index. ¨Miocardic acceleration concept
J. Tripolone, G. Santiago, M. Salguero.
P391Asymptomatic Paroxistic Atrial Fibrillation.“The importance of
being silent”
J. Gant Lopez, F. Meiller, F. Deketele, A. Garcia Aguirre, A. Morales Lezica, M. Passauer, M. Cabo Fustaret,
G. Maid, C. Rivas.
P393Evaluation of Coronary Arterial Illness Risk Factors in Amazonians
Inhabitants of the Mutucal Island, City of Curuçá-Pará.
L. Freire, R. Freire, B. Faillace, M. Palmeira, M. Lemes, I. Faillace, H. Azevedo.
P394Presence of the Cardiovascular Risk Factors in Patients Attended in the
Cardiology Clinic of the University of the State of Pará.
L. Freire, R. Freire, B. Faillace, M. Palmeira, I. Faillace, M. Lemes, H. Azevedo.
P396RISK FACTORS FOR CORONARY EVENTS AND BASELINE DEMOGRAPHICS IN JAPANESE MEN.
J. Sasaki, K. Fukuyo, K. Shimomura.
P397Cardioprotective Effects of Nigella Sativa on Cyclosporine A-induced
Cardiotoxicity in Rats
Y. Selcoki, E. Uz, B. Uz, R. Bayrak, A. Kaya, F. H. Turgut, A. Karanfýl, S. Sahýn, N. Baybek, A. Akcay.
P398The Influence of the Beta-Adrenergic Agonists and Antagonists on T-wave
Alternans and late potential in Patients with Ventricular Tachyarrhythmia
N. Komiya, S. Fukae, S. Seto.
Scientific Programme / 195
Poster Listing
P399Effect of Carvedilol and Bisoprolol on parameters of quality of life in
patients with chronic heart failure
U. Kamilova, S. Shukurjanova, S. H. Jurayeva, R. Rahmonov, A. Kevorkov.
P400EFFECT OF BISOPROLOL AND CARVEDILOL ON PARAMETERS OF LEFT VENTRICLE
REMODELLING IN PATIENTS WITH POSTINFARCTION CARDIOSCLEROSIS
Z. Shoalimova, U. Kamilova, S. H. Jurayeva, A. Kevorkov, T. Aliyeva.
P401SUPERIORITY OF LEVOSIMENDAN OVER DOBUTAMINE IN LOW CARDIAC OUTPUT SYNDROME
AFTER AORTIC VALVE REPLACEMENT
R. Levin, M. Degrange, C. Del Mazo, R. Porcile, E. Tanus, N. Blanco, F. Salvagio, L. Botbol, V. Milman.
P402Long Time Prognostic Value of CK-MB Mass in Low-Risk Patients with Stable
Angina Scheduled for Cardiac Surgery
Kjell Vikenes, Knut S. Andersen, Tor Mellberg, Mikael Farstad, Jan Erik Nordrehaug.
P403EFFECT OF CARVEDILOL ON MYOCARDIAL PERFUSION IN PATIENTS WITH CHRONIC HEART
FAILURE
U. Kamilova, S. H. Jurayeva, T. Aliyeva, A. Kevorkov, B. Myasnik.
P405The combination of amlodipine 10mg and valsartan 160mg lowers blood
pressure effectively and safely in elderly hypertensive patients not
controlled by combination therapy with an ace inhibitor and a calcium
channel blocker
P. Trenkwalder, R. Schaetzl, E. Borbas, R. Handrock, S. Klebs.
P406Evaluation of Healthcare Provider Inertia in the Management of
Cardiovascular Disease (CVD) Risk Factors in Primary Care Settings in Cape
Town
K. Steyn, N. Levitt, M. N. Hill, C. Dennison, N. Peer, J. Fourie .
P407SHORT AND LONG-TERM OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION IN
PATIENTS WITHOUT KNOWN DIABETES AND ABNORMAL GLUCOSE REGULATION: CLINICAL
IMPLICATIONS
J. De La Hera, E. Hernández, J. Vegas, J. García-Ruiz, R. Suarez-Arias, I. Lozano, C. Fernández-Cimadevilla,
P. Avanzas, F. Alvarez, C Morís.
P408IMPACT OF UNKNOWN DIABETES DIAGNOSIS WITH ORAL GLUCOSE TOLERANCE TEST IN
CORONARY PATIENTS: IDENTIFICATION OF POSSIBLE IMPROVEMENTS IN SECONDARY
PREVENTION MEASURES
J. De La Hera, E. Hernández, J. Vegas, P. Avanzas, J. García-Ruiz, R. Suarez-Arias, F. Torres, D. Calvo, E. Delgado,
C. Morís.
Poster Listing
P409ORAL GLUCOSE TOLERANCE TEST PERFORMANCE AND MULTIDISCIPLINARY TEAM
APPROACH IMPROVE SECONDARY PREVENTION MEASURES IN NON-DIABETIC CORONARY
PATIENTS
J. De La Hera, E. Hernández, J. Vegas, R. Suarez-Arias, P. Avanzas, J. García-Ruiz, I. Lozano, A. Carro, E. Delgado,
C. Morís.
P410Poly(ADP-ribose) Polymerase (PARP) Inhibitor HO3089 Enhanced Post Ischemic
Myocardial Glucose Uptake Mostly By Activation Of AMP-activated Protein
Kinase (AMPK)
E. Bognar, G. Y. N. Kiss, Z. S. Sarszegi, E. Bartha, I. Solti, B. Sumegi, Z. Berente .
P412
SURGERY DEATH RATE PREDICTORS IN PATIENTS WITH SEVERE AORTIC STENOSIS
L. Gerones, L. Godoy, F. Bourdin, J. Como Birche, M. D’Aglio, F. Bravo, J. Aringoli, R. Martinez, P. Flaherty, R. Marelli.
P413Baseline characteristics in patients with Chagas Heart Disease Implanted
with a Defibrillator. Does the presence of a Ventricular Aneurysm make any
difference?
C. Hadid, C. Lopez, D. Di Toro, L. Vidal, C. Labadet.
P414PREVENTION OF RADIAL ARTERY SPASM IN CORONARY SURGERY WITH IN VITRO
OVER-DILATION
D. Guastavino, M. Nahin, G. Vizcarra, G. Cozzarin, S. Budelli, A. Zillo, D.R. Grana, J. Milei.
P415Time-course of regression of the protection conferred by simulated
high altitude on rat myocardium. I. Response to calcium and to hypoxia/
reoxygenation.
P. La Padula, L. Costa.
P416Clinical 2-year follow-up results in bifurcation lesions with sirolimus-eluting
stents and bare-metal stents.
T. Ashikaga, S. Niki, H. Fujii, K. Ihara, N. Murai, S. Maeda, N. Yamawake, M. Nishizaki, M. Isobe.
P417Time-course of regression of the protection conferred by simulated high
altitude on rat myocardium. II. Mitochondrial NOS activity and expression.
P. La Padula, J. Bustamante, A. Czerniczyniec, L. Costa.
P418Self-reported leisure-time physical activity predicts long-term survival in
patients with coronary heart disease
F. Apullan, M. Bourassa, J. C. Tardif, A. Fortier, M. Gayda, A. Nigam.
P419The Time of Cardioversion In Patients With Hyperthyroidism and
Atrial Fibrillation
H. Arý, E. Erdogan, V. Koca, T. Bozat .
Scientific Programme / 197
Poster Listing
P420Long-term outcome of the off-label use of paclitaxel-eluting stents: insights
from a cohort of 604 patients
X. Flores-Ríos, J. P. Abugattás-De Torres, R. Marzoa-Rivas, R. Campo-Pérez, G. Aldama-López, J. Salgado-Fernández,
R. Calviño-Santos, J. M. Vázquez-Rodríguez, N. Vázquez-González, A. Castro-Beiras.
P421THE COMBINATION OF AMLODIPINE 10 MG AND VALSARTAN 160 MG LOWERS BLOOD
PRESSURE EFFECTIVELY AND SAFELY IN HYPERTENSIVE PATIENTS NOT CONTROLLED BY
COMBINATION THERAPY WITH AN ACE INHIBITOR AND A CALCIUM CHANNEL BLOCKER
P. Trenkwalder, R. Schaetzl, E. Borbas, R. Handrock, S. Klebs.
P422THE COMBINATION OF AMLODIPINE 10 MG AND VALSARTAN 160 MG LOWERS BLOOD
PRESSURE EFFECTIVELY AND SAFELY IN OVERWEIGHT AND OBESE HYPERTENSIVE PATIENTS
NOT CONTROLLED BY COMBINATION THERAPY WITH AN ACE INHIBITOR AND A CALCIUM
CHANNEL BLOCKER
P. Trenkwalder, R. Schaetzl, E. Borbas, R. Handrock, S. Klebs.
P423THE COMBINATION OF AMLODIPINE 10 MG AND VALSARTAN 160 MG LOWERS BLOOD
PRESSURE EFFECTIVELY AND SAFELY IN HYPERTENSIVE PATIENTS WITH METABOLIC RISK
FACTORS NOT CONTROLLED BY COMBINATION THERAPY WITH AN ACE INHIBITOR AND A
CALCIUM CHANNEL BLOCKER
P. Trenkwalder, R. Schaetzl, E. Borbas, R. Handrock, S. Klebs.
P424Percutaneous Coronary Interventions in Octogenarians: Immediate and
Middle-Term Results
M. Centemero, O. Belzares, C. E. Soares, F. Maia, R. Staico, F. Feres, I. Pinto, L. A. Mattos, A. G. M. R. Sousa,
J. E. Sousa.
P426TYPE 2 DIABETES AND METABOLIC SYNDROME: LIPID TRANSFER FROM AN ARTIFICIAL
LIPIDIC NANOEMULSION TO HIGH DENSITY LIPOPROTEIN
V. M. Silva, C. G. C. Vinagre, M. P. Bertato, C. P. Oliveira, A. P. M. Chacra, R. C. Maranhão.
P427
ROSUVASTATIN AND AORTIC REMODELING IN NITRIC OXIDE DEFICIENT RATS
R. Neto-Ferreira, V. N. Rocha, L. S. R Reis, A. L. R Nascimento, C. A. Mandarim-De-Lacerda, J. J. Carvalho.
P428
Role Of Sildenafil In Eisenmenger Syndrome: A Pilot Study
N. Garg, U. Agrawal, N. Sinha .
P429EXERCISE TRAINING LEFT VENTRICULAR REMODELING IN MALES AND FEMALES RATS
V. B. Carranza, O. A. Pinilla, E. M. Escudero.
P430SHORT AND LONG TERM RESULTS OF PERCUTANEOUS CORONARY INTERVENTION IN
PATIENTS OLDER THAN 80 YEARS OLD
S. Bulur, S. Ordu, E. S. Albayrak, A. Kaya, S. Bulur, H. Ozhan, M. Yazici.
Poster Listing
P431Epidemiology in Rheumatic Valvular Disease Surgical Replacement in a
Developing Country.
Rogerio Brant Martins Chaves, Regina Maria De Aquino Xavier, Maria Cristina C. Kuschinir, Bernardo Rangel Tura,
Monica Moura De Vasconcellos, Vitor Manuel Pereira Azevedo, Carlos Alberto M. Magalhães, José Oscar Reis Brito,
Márcia Cristina C. M. Pinheiro, Clara Weksler.
P432SHORT AND LONG TERM FOLLOW-UP RESULTS OF PATIENTS WHO ARE IMPLANTED WITH
R-STENT: A SINGLE CENTER EXPERIENCE
S. Bulur, A. Kaya, S. Bulur, S. Ordu, H. Özhan, M. Yazici.
P433Mortality Among Patients Submitted to Valvular Surgical Procedures. Is there
any difference between rheumatic and degenerative valvular disease groups?
Rogerio Brant Martins Chaves, Regina Maria De Aquino Xavier, Maria Cristina C. Kuschinir, Bernardo Rangel Tura,
Monica Moura De Vasconcellos, Carlos Alberto M. Magalhães, Arn Migowski Rocha Dos Santos, Clara Weskler,
Vitor Manuel Pereira Azevedo, José Oscar Reis Brito.
P434Systemic vascular resistance measurement by echocardiography in
chronic congestive heart failure: a tool to optimize medical prescription
of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor
Blockers.
L. Florio, G. Vignolo, R. Centurión, J. Pouso.
P435Effect of cardiac arrest induced by cardioverter defibrillator (ICD) testing on
ischemia modified albumin (IMA).
L. Woie, Ø. Hetland, J. T. Kvaløy, D. W. T. Nilsen.
P436Epidemiological Profile of the Surgical Interventions in Valvular Diseases
in a Developing Country.
Rogerio Brant Martins Chaves, Regina Maria De Aquino Xavier, Maria Cristina C. Kuschinir, Bernardo Rangel Tura,
Mônica Moura De Vasconcellos, Vitor Manuel Pereira Azevedo, Arn Migowki Rocha Dos Santos, Clara Weskler,
Márcia Cristina C. M. Pinheiro, José Oscar Reis Brito.
P437Intracardiac electrocardiographic (EGM) morphology changes in patients with
implantable cardioverter defibrillator (ICD).
L. Woie, T. Eftestøl, J. T. Kvaløy, T. Aarsland, K. Tjelta, D. T. W. Nilsen.
P438The Prevalence of Hypertension and its Association with Body Weight Index in
Hungarian Policemen
G. Simonyi, J. R. Bedros, K. Szakolczai, M. Medvegy, T. Csatay, L. Halmy.
P439
The Effects of Vegetarian Diets on Chylomicron Metabolism
J. C. M. Vinagre, C. G. Vinagre, F. S. Pozzi, E. Slywitch, R. C. Maranhão.
Scientific Programme / 199
Poster Listing
P440Cortical renal volume measurements by using multi-detector row CT and its
relationship with primary hypertension
J. Vallejos, P. Carrascosa, C. Capuñay, A. Deviggiano, J. Carrascosa.
P441Left ventricle evaluation with 64-row Gadolinium enhanced cardiac CT.
P. Carrascosa, A. Deviggiano, C. Capuñay, J. Carrascosa, M. Garcia.
P442Multi-detector computed tomography feasibility´s in calculating the cortical
renal volume
J. Vallejos, P. Carrascosa, C. Capuñay, A. Deviggiano, J. Carrascosa.
P443Prevalence of myocardial bridging in 64-row MDCT coronary angiographic
studies.
P. Carrascosa, C. Capuñay, A. Deviggiano, J. Carrascosa, M. Garcia.
P444Risk Stratification in Non-ST Segment Acute Coronary Syndromes Based on
Acute and Chronic Risk Scores Derived From the European Guidelines
M. Dorobantu, A. G. Fruntelata, M. Stefuriac, M. Chiru, L. Platica, A. Crusitu, A. Scafa-Udriste.
P445Relationship between dietary intake of alcohol and some metabolic and
cardiovascular risk factors in healthy men
L. Vitek, M. Kalousova, B. Stankova, L. Novotny, P. Schreib, T. Zima, A. Zak.
P446Elderly patients with STEMI are suboptimally treated with reperfusion therapy
Z. Monhart, V. Faltus, H. Grunfeldova, P. Jansky.
P447Use of not evidence based treatments among elderly real world patients
hospitalized with acute heart failure.
A. Macchia, G. Ciambrone, N. Laffaye, J. Gambarte, S. Donato, N. Rizzo, F. Novo, C. Higa, P. Comignani.
P448ASSESSMENT OF CAROTID-RADIAL PULSE WAVE VELOCITY CHANGES AFTER INDUCED
ISCHEMIA
E. Rusak, O. Iavicoli, S. Vazquez, S. Robert, M. Duarte, J. Lerman, C. Bellido.
P449Brain Natriuretic Peptide Increases 24 Hours After Acute Myocardial Infarction
Irrespective of Reperfusion and Is a Marker of Early Left Ventricular
Remodeling
M. Dorobantu, R. Onut, A. Scafa-Udriste, D. Constantinescu, A. Alexandrescu, A. Vasile, E. Gainoiu, A. G. Fruntelata.
P450
Effect of repeated coronary angioplasty on QT dispersion
E. Z. Soliman, M. Abdel-Salam .
Poster Listing
P451Discrepancy between Troponins T and I in chronic hemodialysis patients
H. Trimarchi, M. Dicugno, M. Mongitore, M. Forrester, A. Toscano, F. Lombi, M. Vera, M. Alonso, H. Pereyra,
A. Muryan.
P452Correlation between chest pain and acute coronary syndrome diagnosis
M. Assad, A. Volschan, M. Diniz, LH. Fonseca, M. Santos, C. Stipp, A. Sa, E. Mesquita.
P453AGE-RELATED CHANGES IN MYOCARDIAL OXIDATIVE STRESS AND THE INTERVENTIONAL
EFFECT OF DHEA
M. H. V .M. Jacob, D. R. Janner, A. Belló-Klein, M. F. M. Ribeiro.
P454MORPHOLOGIC PATTERN OF LATE GADOLINIUM ENHANCEMENT IN TAKO-TSUBO SYNDROME.
“ANOTHER CLUE TO SOLVE THE ENIGMA”.
G. Avegliano, M. Huguet, P. Kuschnir, A. Panaro, F. Botto, G. Oller, D. Capdeferro, A. Frangi, R. Ronderos, M. Petit.
P455Delayment factors for medical assistance search in patients with chest pain
M. Assad, A. Volschan, M. Diniz, L. H. Fonseca, M. Santos, C. Stipp, A. K. Sá, E. Mesquita.
P456Acute effect of sildenafil citrate on pulse wave velocity in middle-aged
patients
M. Assad, A. Brandão, R. Pozzan, E. Magalhães, A. P. Brandão.
P457
BAROREFLEX FUNCTION ASSESSTMENT BY A NON-INVASIVE PRESSOR TEST
M. Duarte, D. R. Grana, C. A. Bellido, J. Milei.
P458
Exercise ventilatory response in diabetic patients
R. Peidro, D. Motta, A. Angelino, G. Brión, E. Navia, P. Diaz Uberti, R. Favaloro .
P459DEMOGRAPHIC CHARACTERISTICS OF OVER SIX HUNDRED RENAL ARTERIES INTERVENTIONS.
N. Schechtmann, Md. Facc, E. Polanco Md, S. Karas, Md. Facc.
P460Cardiac Magnetic Resonance Has Advantages Over 2D Echocardiography In
Assessment Of Mitral Stenosis Patients.
A. Rapaee, C. K. Liew, A. Y. Y. Fong, C. K Ang, H. B Liew, W. M Chin, B. S. P Chin, T. K Ong, K. H Sim.
P461Impairment of Endothelial Function In Newly Diagnosed Hypertensive and
Prehypertensives Patients
A. Rapaee, H. Nawawi, K. Yusoff.
P462Diagnostic and treatment algorithm for sustained ventricular tachycardia in
chronic Chagas disease
R. Viotti, C. Vigliano, M. G. Alvarez, B. Lococo, M. Petti, G. Bertocchi, A. Armenti, A. Sinisi.
Scientific Programme / 201
Poster Listing
P463
Furosemide induced cardiac alterations in thiamine-deprived rats
S. Cunha, J. C. Bastos, J. B. Salles, M. C. C. Silva, V. L. F. C. Bastos, C. A. Mandarim-De-Lacerda.
P464Risk stratification in asymptomatic severe mitral regurgitation: clinical,
biochemical and echocardiographic variables. Is it possible to determine
adverse clinical outcome?
R. Pizarro, P. Oberti, M. Falconi, F. Achilli, A. Arias, J. Krauss, A. Cagide.
P465Isolated coronary artery disease of the diagonal branch of the left anterior
descending artery
V. Kuznetsov, I. Bessonov, I. Zyrianov, G. Kolunin, D. Krinochkin, M. Semukhin, M. Bessonova, L. Frazin.
P466Association between polymorphisms of the Renin-Angiotensin System genes
and essential hypertension: a community-based study in Southern China
Y. Zhan, X. Jiang, H. Sheng, J. Li, P. Xun, Y. Cheng, J. Huang, H. Xiao.
P467Implementation and Results of a Comprehensive Cardiac Rehabilitation
Program in a Developing Country.
E Rivas Estany, J. Alvarez Gomez, J. Barrera Sarduy, S. Sixto Fernandez, L. Rodriguez Nande, C. Kesser Garcia.
P468Effect of PARP inhibition on young spontaneously hypertensive rat (SHR)
hearts
E. Bartha, R. Halmosi, I. Solti, E. Bognar, K. Kovacs, T. Habon, T. Kálai, B. Sumegi, K. Hideg, K. Toth.
P469Significance of determining troponin I levels in the evaluation of patients with
isolated form of aortic stenosis before and after aortic valve replacement
A. Nikolic, L. J. Jovovic, M. Vukovic, T. Babic, M. Balevic, V. Maravic, D. Brunner .
P470The effect of aortic valve replacement on B type BNP in patients with isolated
form of severe aortic stenosis and not impaired systolic function
A. Nikolic, L. J. Jovovic, M. Vukovic, T. Babic, M. Balevic, S. Tomic, D. Brunner.
P471Using of arterial graft (LIMA) in prediction of frequent occurrences of
pericardial effusion after CABG
A. Nikolic, S. Tomic, L. J. Jovovic, M. Vukovic, L. J. Trkulja, M. Zlatanovic, B. Djukanovic .
P472Prolactin inhibition improves clinical outcome in peripartum cardiomyopathy
patients presenting with subsequent pregnancy
O. Forster, D. Hilfiker-Kleiner, A. A. Ansari, J. B. Sundstrom, W. Tshani, A. Yip, A. Becker, K. Sliwa.
P473T-cell mediated autoimmune reaction in peripartum cardiomyopathy might be
reflected by activity of pro-inflammatory cytokines
O. Forster, A. A. Ansari, J. B. Sundstrom, W. Tshani, A. Becker, K. Sliwa.
Poster Listing
P478Time Course Pattern of Immunoglobulin M in HIV Positive and HIV Negative
Peripartum Cardiomyopathy Patients
O. Forster, A. A. Ansari, J. B. Sundstrom, W. Tshani, M. J. Nel, A. Becker, K. Sliwa.
P479acute coronary syndromes in black south african patients with human
immunodeficiency virus infection: the clinical and angiographic features
A. C. Becker, K. Sliwa, S. Stewart, E. Libhaber, A. R. Essop, M. R. Essop.
P480Heat shock proteins antibody level and associated disease in patients
undergoing cardiac operation.
V. Kecskemeti, A. Szebeni, Z. Prohaszka, I. Matko, Z. Szabolcs .
P481Circadian Rhythm and Risk Factors in Isolated Nocturnal Hypertension
G. Simonyi, R. J Bedros, M. Medvegy.
P482Prevalence of Sleep Related Breathing Disorders in Patients with Chronic Heart
failure and their Improvement with cardiac resynchronisation therapy
K. Seidl, M. Strauß, T. Kleemann, T. Becker.
P483Prevalence of Complete Electrical Pulmonary Vein Isolation Using
an Anatomically Guided Approach Assessed by a Novel High Density
Circumferential Mapping Catheter
K. Seidl, T. Becker, T. Kleemann, M. Strauß.
P484Interraction in changes of an endothelium status and clinical current in
patients with CHF on a background of therapy ACE inhibitors
M. Sitnikova, T. Maximova, C. Kchmelnitskaya.
P485Locally delivered Tetradecylthioacetic acid (TTA) reduces inflammation and
collagen formation after coronary balloon injury in a porcine model
R. P. Reidar Pettersen, M. S. Mohamed Salem, S. R. Svein Rotevatn, K. K. Karel Kuiper, T. L. Terje Larsen,
P. B Pavol Bohov, R. B Rolf Berge, J. E. N. Jan Erik Nordrehaug.
P486The Age-BNP Survival Model: Prediction of survival in old (>75 years) patients
with heart failure
E. Shlyakhto, M. Sitnikova, T. Lelyavina.
P487Interaction between the ACE polymorphism genes (insertion/deletion) and
the particular clinical features of congestive heart failure, structural and
functional indexes of the heart and mortality
M. Sitnikova, S. Ivanov, O. Krasnova, E. Shlyakhto.
Scientific Programme / 203
Poster Listing
P488IMPROVEMENT IN SIX-MINUTE WALK TEST PERFORMANCE AFTER A SINGLE DOSE OF
SILDENAFIL IN CHRONIC HEART FAILURE PATIENTS
J. Curotto Grasiosi, A. Paragano, M. Pelliza, D. Cordero, R. Machado, A. Abdala, G. Bertelle, R. Perez,
C. Magallanes, R. Esper.
P489SERUM MATRIX METALLOPROTEINASE-9/TISSUE INHIBITOR OF MATRIX
METALLOPROTEINASE-1 AND LEFT VENRICLE PERFORMANCE IN PATIENTS WITH AORTIC
STENOSIS
N. Goncharova, O. Moiseeva, G. Aleshina, E. Shlykhto.
P490HYPERTRIGLYCERIDEMIA: AN INDEPENDENT PREDICTOR STRONGLY CORRELATED WITH
OTHER CARDIOVASCULAR RISK FACTORS?
A. Paragano, J. Curotto Grasiosi, R. Machado, D. Cordero, A. Abdala, P. Merlo, J. Lopez Diez, D. Alasia,
C. Magallanes, R. Esper.
P491Right coronary artery morphology by 64-row MDCT in patients with left
dominant system.
P. Carrascosa, C. Capuñay, A. Deviggiano, E. Martin Lopez, J. Vallejos, J. Carrascosa.
P492Clinical perception of MS vs. Diagnosis according to ATPIII criterion. CARISMA
(Characterization and risk analysis of individuals with metabolic syndrome)
study group.
G. Cerezo, A. Vicario, N. Vainstein, E. Biasin, D. Ricon, D. Piskorz, I. Nocetti, C. Brommer, M. Miragaya.
P493
Estrogen-dependent gene expression in human cardiac tissue
G. Kararigas, E. Becher, V. Regitz-Zagrosek.
P494Dobutamine dynamic intraventricular gradient and hypertrophic
cardiomyopathy: morphologic and functional evaluation by cardiac magnetic
resonance
M. Ferreira, P. Donato, S. Monteiro, T. Pereira, R. Martins, F. Caseiro-Alves, L. A. Providência.
P495Cardiac magnetic resonance in the study of patients with a dynamic
intraventricular gradient during dobutamine stress echocardiography
M. Ferreira, P. Donato, S. Monteiro, R. Martins, F. Caseiro-Alves, L. A. Providência.
P496Tumor necrosis factor alpha, interleukin 1 and interleukin 1 receptor
antagonist polymorphisms in Mexican patients with myocardial infarction.
G. Vargas-Alarcón, J. M. Fragoso, J. M. Rodríguez-Pérez, N. Pérez-Hernández, D. Cruz-Robles, E. Chuquiure,
C. Martínez, Marco A. Martínez Ríos, P. A. Reyes.
P497Gender differences in presentation and prognosis in population with acute
chest pain suspected to be related with acute cardiac ischemia
M. Ferreira, V. Rodrigues, F. Santos, L. A. Providência.
Poster Listing
P498Sudden Cardiac Death and Defibrillators in Latin America. Primary and.
Secondary Prevention. Data from the ICD Registry Latin America.
R. Keegan, R. Eloy Pereyra, F. Colombo, W. Uribe, J. Cordero Cabra, C. Tentori, V. Moraes, K. Griffith, J. Maloney,
C. Muratore .
P499BENEFICIAL EFFECTS OF TRIMETAZIDINE, GIVEN BEFORE PERCUTANEOUS CORONARY
INTERVENTION, ON MYOCARIAL DAMAGE DURING THE PROCEDURE
A. Yilmaz, A. Erdem, K. Yalta, S. Sarikaya, M. B. Yilmaz, O. O. Turgut, I. Tandogan.
P500ABDOMINAL OBESITY: AN INDICATOR OF EXTENSIVE CORONARY ARTERIAL DISEASE IN
NSTEMI PATIENTS?
A. Erdem, O. C. Yontar, S. Sarikaya, A. Yilmaz, K. Yalta, M. B. Yilmaz, I. Tandogan.
P501EFFECTS OF CHRONIC WATER RESTRICTION ON CARDIOVASCULAR
M.P. Da Rosa, P. Arza, A. Fellet, M. Toscani, C. Arranz, M. A Costa, A. M Balaszczuk.
P502The Interleukin 1B –511 polymorphism is associated with the risk of developing
restenosis after coronary stenting in Mexican patients.
G. Vargas-Alarcon, E. Malpica-Miranda, J. M. Fragoso, H. Delgadillo-Rodríguez, J. M. Rodríguez-Pérez, C. GonzálezQuesada, N. Martínez-Rodríguez, M. A. Peña-Duque, Marco A. Martínez Ríos.
P503ENDOTHELIAL FUNCTION AND HORMONE REPLACEMENT WITH TIBOLONE IN MENOPAUSAL
WOMEN
J. Gomez-Mancebo, M. Navarrete, L. A. Sanchez, A. Pinzon.
P504Coronary artery bypass surgery in diabetes
E. Gabe, M. Santos, E. Dulbecco, J. Abud, H. Raffaelli, M. Rodriguez Acuña, A. Arnedo, F. Robles, R. Boughen,
R. R. Favaloro.
P505Relationship between inflammatory biomarkers, oxidative stress and
morpho-functional mitochondrial changes in experimental atherogenic model
M. C. Baez, M. Tarán, V. Campana, P. Pons, J. C. Simes, D. F. Comay, J. A. Palma, M. Moya.
P506HYPERTROPHIC CARDIOMYOPATHY AND PREGNANCY RELATED COMPLICATIONS.
F. Landeta, A. Fernandez, J. H. Casabe, F. Vaisbuj, C. Lopez, R. Coronel, R. Bianco, E. Guevara.
P507EFFECTS OF A COX-2 ANTAGANONIST ON VASCULAR INFLAMMATION ASSOCIATED
TO A MODEL OF METABOLIC SYNDROME
N. F. Renna, E. S. Gonzalez, M. C. Lama, R. M. Miatello.
P508Characteristics of Hypertrophic Cardiomyopathy in the elderly
J. H. Casabe, A. Fernandez, F. Landeta, G. Fava, F. Vaisbuj, R. Peidro, R. Laguens, R. R. Favaloro, C. Lopez,
E. Guevara.
Scientific Programme / 205
Poster Listing
P509Early and late outcome in patients with End Stage Renal Failure under chronic
dialysis undergoing cardiac valve surgery: mechanical versus biological
prosthetic valve
A. Hershson, M. Cabello, R. Coronel, G. Stampone, P. Roura, P. Raffaelle, J. Abud, E. Dulbecco, H. Raffaelli,
R. Favaloro.
P510Is there any difference at presentation in infantile dilated cardiomyopathy
regarding the age?
Vitor Manuel Pereira Azevedo, Marco Auré,lio Santos, Má,rcia Bueno Castier, Maria Cristina C. Kuschnir, José,
Geraldo De Castro Amino, Maria Ourinda Mesquita Cunha, Rogé,rio Brant Martins Chaves, Bernardo Rangel Tura,
Francisco M. Albanesi Filho, Regina Maria De Aquino Xavier.
P511Inappropriate ICD shocks: Incidence, predictors and prevention of recurrence.
COMPAS registry.
N. Galizio, S. Schanz, L. Medesani, P. Montoya, M. Ramirez, L. Soriano, G. Fava, R. Raña, H. Fraguas, J.L. Gonzalez.
P512Use of a Selective Beta-Blocker in Pediatric Patients with Long QT Syndrome
J. Moltedo, N. J Kertesz, M. S Abello, R. A Friedman, A. L Fenrich, B. C Cannon.
P513Radiofrequency ablation in patients with congenital heart disease
J. Moltedo, M. Abello, A. Ithuralde, C. Seara, H. Grancelli, M. Campos, N. Fernandez, S. Waldman, M. Ithuralde.
P514Predictor factors for death in coronary artery bypass surgery patients.
Which could be modified before surgery?
Renato Kaufman, Vitor Manuel Pereira Azevedo, Maria Cristina C. Kuschnir, José Geraldo De Castro Amino, Marco
Aurelio Santos, Rogério Brant Martins Chaves, Carlos Alberto Moreira Magalhã, Arn Migowski Rocha Dos Santos,
Bernardo Rangel Tura, Regina Maria De Aquino Xavier.
P515The relationship between serum lipids and quartiles of the omega-3 index
in a beef eating population in Argentina as compared to a fish eating ACS
population in Norway.
R. Leòn De La Fuente, H. Aarsetoey, P. Gallo, V. Pönitz, T. Aarsland, S. T. Nilsen, L. Woie, H. Staines, W. S. Harris,
D. W. T. Nilsen.
P517Early Arrhythmic Events and Quality of Life after Radiofrequency Catheter
Ablation of Atrial Fibrillation
T. Balabanski, V. Traykov, T. Shalganov, B. Dinov, M. Protich.
P518PREVALENCE OF PROLONGED QT INTERVAL IN LEFT VENTRICULAR HYPERTROPHY.
M. Orellana, P. Adriazola, F. Bello, P. Trejo, P. Gonzalez, E. Escobar.
P519Stepwise algorithm. Diagnostic accuracy of the supraventricular tachycardia
mechanism.
P. Montoya, J. L. Gonzalez, N. Galizio, G. Fava, S. Schanz, L. Medesani, L. Soriano, R. Raña, M. Ramirez.
Poster Listing
P520
THE EFECT OF SIMVASTATIN ON THE DECREASE OF INTIMOMEDIAL COMPLEX OF CAROTIDAL
ARTERIES IN PATIENTS WITH ARTERIAL HYPERTENSION
D. L. Lovic Dragan, B. L. Lovic Branko, M. L. Lovic Milan, D. D. J. Djordjevic Dragan, I.T. Tasic Ivan.
P522Aspirin resistance and cardiovascular events after Percutaneus Coronary
Intervention.
I. Santos-Rodriguez, I. Gonzalez-Mendia, C. Alonso-Buron, V. Ramirez-Castro, M. J. Ruiz-Olgado, M. L. Lopez,
M. Cascon-Bueno, J. Rodriguez-Collado, M. Diego-Dominguez, I. Alberca.
P523CARDIAC INVOLVEMENT IN SYSTEMIC SCLEROSIS
M. E. Isasi Capelo, E. S. Isasi Capelo.
P524
AGNETIC RESONANCE EVALUATION OF PULMONARY REGURGITATION
M
R. Parra, F. Heusser, G. Urcelay, P. Becker, E. Villanueva, J. Otero, C. Toledo, C. Garcia.
P526Early identification of preserved systolic function in acute decompensated
heart failure.
E. Fairman, V. Mauro, A. Charask, Y. Castillo Costa, L. Rodriguez, M. Ferrer, C. Barrero.
P527IMPLANTABLE CARDIOVERTER DEFIBRILLATOR IN HIGH RISK PATIENTS WITH HYPERTROPHIC
CARDIOMYOPATHY. FOLLOW-UP.
G. Fava, N. Galizio, J. L Gonzalez, H. Casabe, A. Fernandez, E. Guevara, L. Medesani, P. Montoya, S. Schanz,
F. Landeta.
P528The relationship between BNP and hsCRP and quartiles of the omega-3 index
in a beef eating ACS population in Argentina as compared to a coastal ACS
population in Norway.
R. Leòn De La Fuente, H. Aarsetoey, T. Brügger-Andersen, V. Pönitz, S. A. Dib Ashur, S. T. Nilsen, L. Woie,
H. Staines, W. S. Harris, D. W. T. Nilsen.
P529Assessment of Anemia and Renal Function in Patients with Heart Failure:
A Comparison of Patients with Left Ventricular Systolic Dysfunction Versus
Preserved Systolic Function
B. Sáenz, E. Barcellos, H. Villacorta, L. Costa Lima, . Soares, C. Wiefels, R. Steffen, A. Salles, E. Tinoco.
P530PROGNOSTIC UTILITY OF STRESS (99M)Tc-SESTAMIBI SPECT IN RISK STRATIFICATION OF
NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROMES
A. Dos Santos, C. Cortes, M. Daicz, J. Peirano, O. Cendoya, G. Marrero, I. Merlo, E. Duronto, E. Gurfinkel.
P531GRAVITATIONAL STRESS IN RAYNAUD’S PHENOMENON.
M.E. Isasi Capelo, E.S. Isasi Capelo.
Scientific Programme / 207
Poster Listing
P532
H eart rate recovery after a cardiovascular rehabilitation program
R. Peidro, P. Diaz Uberti, G. Brión, A. Angelino, E. Navia, D. Motta, F. Peidro, M. Santa María, R. Lowenstein,
R. Favaloro.
P533NON-PHARMACOLOGICAL PREVENTION OF ATRIAL FIBRILATTION AFTER OFF-PUMP CABG:
TEMPORARY ATRIAL EXTERNAL STIMULATION
F. Silva, P. Brofman, R. Milani, D. Précoma, M. Guimarães, L. Barbosa, A. Sartori, J. Augusto Souza.
P534Predicting Elevated C-Reactive Protein Levels by Body Mass Index and Waist
Circumference in Type 2 Diabetes Patients
A. C. Cordeiro, I. Castro, C. C. Gonzaga, M. G. Sousa, F. O. Borelli, O. Passarelli Jr., L. Lotaif, L. S. Piegas, C. Amodeo.
P535
octurnal blood pressure pattern in obese patient with and without sleep
N
apnea
G. Simonyi, J. R. Bedros, M. Medvegy.
P536Glutathione peroxidase, superoxide dismutase, TNF-alpha, CRP and VCAM-1 are
markers of metabolic syndrome
T. Francuz, J. Gminski, K. Siemianowicz, M. Goss, J. Kopec.
P537LDL-c, HDL-c and glucose optimization using phytonutrient combination
therapy in diabetes
I. Martinez, B. Horne, P. Verdegem.
P538Influence of myocardial ischemia and the number of obstructed coronaries at
major coronary events in patients submitted to medical treatment only.
T. Carvalho, M. Benetti, A. L. C. Hallal, A. J. Mansur.
P539Acute Coronary Sindromes without significant coronary lessions: clinical
profile and long term outcome.
C. Cabrera, D. Barranco, A. Spinelli, G. Vignolo, J. C. Hiriart.
P540Surgery for coarctation of the aorta in prematures weighting less than 1.900 kg.
R. De Rossi, E. Juaneda, G. Campos.
P541
D etecting subclinical alterations in early stages of Chagas’s disease
through Holter
D. S. Andres, I. M. Irurzun, M. M. Defeo, E. E. Mola, J. Mitelman, L. Gimenez, G. Ranchilio, P. Velazco, J. Armentano.
P542A new approach for percutaneous intervention of ostial right coronary
artery lesions. Feasibility of the Floating Wire Technique
G. Carvalho, V. Daher Vaz, J. M. Dias De Azeredo Bastos, S. Pontes Câmara, S. Rassi, A. Carvalho Leme Neto.
Poster Listing
P543Enhanced basal and exertional isometric diastolic function in resistance
training athletes
E. Fisman, Y. Adler, N. Koren-Morag, D. Tanne, E Lasry, A. Tenenbaum.
P544The atrial vulnerability parameters of lone atrial fibrillation patients with
subclinical hypothyroidism
N. Komiya, S. Seto, S. Fukae.
P545
I nsulin Resistance and Clustering of Cardiometabolic Risk Factors in Brazilian
Adolescents: Effect of Body Weight
I. C. Guimaraes, A. M. Almeida, R. Rocha, A. G. Bittencourt, A. Guimaraes.
P546COMPLEX AORTIC COARTATION ANGIOPLASTY WITH PTFE-COVERED BALLOON EXPANDABLE
STENT
M. Granja, L. Trentacoste, J. Damsky Barbosa, V. Lucini, M. Rivarola.
P547
A meta-analysis of trials of Omega-3 fatty acids supplementation in
cardiovascular diseases.
A. Macchia, R. Marchioli, R. Marfisi, H. Doval, S. Varini, D. Nul, H. Grancelli, P. D. Comignani, J. J. Fuselli, G. Tognoni.
P548Antibodies against Trypanosoma cruzi ribosomal P proteins induce apoptosis
on HL-1 cardiac cells.
G. Levy, M. J. Levin, K. Gomez.
P549CARDIAC REHABILITATION PROGRAM IN PEDIATRIC PATIENTS
P. Quiroga, Hermes Ilarraza-Lomel, M. D. Rius Suárez, I. Miranda, C. Zamora, A. Buendía.
P552DEFINITIVE HIS BUNDLE PACING IN PATIENTS WITH WIDE QRS
R. Barba, P. Moriña, J. Venegas, J. M. Fernández, M. Herrera.
P553Serum triglycerides may reflect the content of cellular omega-3 fatty acids
in CHD populations with a low intake of fish.
R. Leòn De La Fuente, P. Gallo, S. A. Dib Ashur, E. Lovaglio, A. Torino, S. T. Nilsen, L. Woie, H. Staines, W. S. Harris,
D. W. T. Nilsen.
P554RHEUMATIC HEART DISEASE DATABASE AS A FRAMEWORK TO CONSOLIDATE RHEUMATIC
FEVER SURVEILLANCE SYSTEM IN BRAZIL.
R. M. A. X. Regina Maria Aquino Xavier, M. C. C .K. Maria Cristina Caetno Kuschnir, V. M. P. A. Vitor Manuel Pereira
Azevedo, R. E. M Regina Elizabeth Muller, M. C. P. Márcia Cristina Pnheiro, B. R. T. Bernardo Rangel Tura,
D. V. Denizar Vianna, M. A. S. Marco Aurélio Santos, E. L. Eliane Lucas, M. F. P. L. Maria De Fátima Pereira Leite.
Scientific Programme / 209
Poster Listing
P555The strong relationship between age of patients but not polymorphisms of
genes encoding G-proteins system components and dominant vasodepressor
response to tilting in syncopal young and middle-aged patients
M. Lelonek, T. Pietrucha, M. Matyjaszczyk, J. H. Goch.
P556Primary Hypertension in Adolescents – Rio de Janeiro, Brazil
M. C. K. Maria Cristina Kuschnir, G. M. Gulnar Mendonça, R. M. A. X. Regina Maria Aquino Xavier,
R. E. M. Regina Elisabeth Muller, H. D. Henrique D‘abreu, A. M. Arn. Migowski, R. B. C. Rogério Brant Chaves,
M. C. P. Márcia Cristina Pinheiro, C. A. M. Carlos Alberto Magalhães, V. M.P. A. Vitor Manuel Pereira Azevedo.
P557Comparative value of NT-BNP and Tei index in the estimating of the severity of
congestive heart failure
J. Celutkiene, V. Grabauskiene, R. Steponeniene, J. Misiura, A. Laucevicius.
P558Non invasive diagnostic methods in controlling the effectiveness of
cardioprotective properties of creatinephosphate and agents on the base of
native DNA in young athletes
L. A. Balykova, L. M. Makarov, I. A. Markelova, I. A. Gorbunova, V. P. Balashov, S. A. Ivyanskij.
P559Predictors of abnormal heart rate response to dipyridamole in patients
undergoing myocardial perfusion SPECT
R. S. L Lima, A. De Lorenzo, M. P. Pellini, L. M. B. Fonseca.
P560Risk Model for cardiac surgery in Argentina: A Bedside Graphic Score.
V. Carosella, W. Rodriguez, M. Caceres, M. Sellanes, J. Bilbao, C. Cardenas, C. Pensa, H. Grancelli, C. Nojek.
P561Gender differences in the approach of coronary artery heart disease
J. Erriest, M. Cornelli, G. Vigo, V. Arregui, M. L. Plastino, L. Cartasegna, J. Camilletti.
P562Influence of chronic renal failure on the heart rate response to dipyridamole
of patients undergoing myocardial perfusion SPECT
A. De Lorenzo, R. S. L. Lima, M. P. Pellini, L. M. B. Fonseca.
P563Defibrillation Threshold in Patients of LABOR Registry
L. Jurado, C. Martinengo, A. Martín, F. Colosia, R. Samaniego, C. Garillo, E. Valero.
P564ICD Experience in a Latin American Pediatric Population
J. Scaglione, G. Fernandez, G. Maid, M. Senesi, R. Pesce, F. Dorticós, E. Valero, Icd-Labor Investigators.
P565Risk stratification in patients post-CABG using stress myocardial
perfusion SPECT
J. Erriest, A. Mele, V. Severicha, P. Kociubinski, J. Camilletti.
Poster Listing
P566
A non-linear HRV index used as an indirect measure of left ventricular
function
D. S. Andres, I. M. Irurzun, M. M. Defeo, E. E. Mola, J. Mitelman, L. Gimenez, C. De Luca, M. Marcia, P. Velazco.
P567Role of brain natriuretic peptide as a predictor of Right Ventricular
Dysfunction in patients with Pulmonary Embolism
B. Fabricio, K. Jose, S. Serafim, A. Flavio, P. P. Sampaio, N. Augusto, B. Alexandre, M. Joao.
P568Increase in the embedding dimension in electrocardiograms of adult and
pediatric patients with ventricular arrhythmia and congestive heart failure
D. S. Andres, I. M. Irurzun, M. M. Defeo, J. Bleiz, E. E. Mola, D. Perez Casal, J. Paul.
P569Arterial stiffness surrogates in black-African human immunodeficiency virusinfected patients
D. Lemogoum, C. Kouanfack, L. Van Bortel, M. Leeman, J. P. Degaute, P. H. Van De Borne.
P570
R elationship between plasmatic activity of type 1 plasminogen activator
inhibitor and the presence of risk factors in patients with type II diabetes.
N. Crespi, A. Scicolone, V. Sanchez, G. Scicolone.
P571Prevalence of hypertension and other cardiovascular risk factors in
postmenopausal women. Data from SEPHAR study.
M. Dorobantu, E. Badila, S. Ghiorghe, R. O. Darabont, G. Datcu, M. R. Luca.
P572
I nfluence of an adecuate zinc intake during fetal and posnatal and adult life
on arterial blood pressure and cardiovascular nitric oxide system
C. Arranz, A. Tomat, S. Finella, R. Elesgaray, L. Veiras, A. Balaszczuk, M. A. Costa.
P573Chronic Carbon Monoxide Exposure is Associated with Increased
Electrocardiographic P-wave and QT Dispersion
I. Sari, S. Zengin, O. Ozer, C. Yildirim, V. Davutoglu, M. Aksoy.
P574
ssociation of Changes in Oxidative and Proinflammatory States with Changes
A
in Vascular Function after a Lifestyle Modification Trial Among Obese
Adolescents
R. Kelishadi, M. Hashemi, N. Mohammadifard, S. Asgary, N. Khavarian.
P575Characteristics of Hypertrophic Cardiomyopathy in the elderly
J. H. Casabe, A. Fernandez, F. Landeta, G. Fava, F. Vaisbuj, R. Peidro, R. Laguens, R. R. Favaloro, C. Lopez,
E. Guevara.
P576Assessment of Right Ventricular Function in Inferior Myocardial Infarction by
Tei Index.
M. Barranco, R. Migliore, M. E. Adaniya, G. Miramont, F. Guerrero, H. Tamagusuku, A. Sinisi.
Scientific Programme / 211
Poster Listing
P577
NEW TRANSGENIC LINE FOR IN VIVO ASSESSMENT OF BONE-MARROW CELL HOMING TO
A
DAMAGED CARDIAC TISSUE
G. Barila, D. L. Altschuler, J. A. Genovese.
P579
I n-stent restenosis in coronary arteries evaluated with multislice computed
tomography of 64 channels
A. Bayol, J. Vallejos, R. Peloso, R. Obregon, M. Aguero, J. Baccaro, J. Mazucco, M. Romero, M. Vera, J. Parras.
P580
I mpact of a supervised exercise rehabilitation program on secondary
prevention goals after acute coronary syndromes.
I. B. Ignacio Batista, H. F. Horacio Fernandez, M. B. Mariano Berro, F. L. Federico Lipszyc, J. B. Jose Bonorino,
L. P. Luciano Pastori, S. B. Sergio Baratta, M. O. Martin O’Flaherty, G. I. Gilbert Iacometti, A. H. Alejandro Hita.
P581Value of electrophysiological testing and catheter ablation in children and
adolescents
A. Stefani, O. Perez Mayo, G. Costa, R. Speranza, D. Deluso, C. Zuloaga.
P582Cardiovascular Risk Factors in Rural Mexico: Results from the Proyecto
Puentes de Salud
K. A. Olson, L. A . Temming, C. R. Clover, T. D. Snyder, A. D. Nanney, I. JvNelligan, A. L. Rollins, B. D. Skinner,
P. Y. Frasier, M. G. Cohen.
P583
I nfluence of Emigration of Rural Mexicans to the United States and
Cardiovascular Risk Factors in Close Relatives who Remain in Mexico
C. R. Clover, L. A. Temming, K. A. Olson, S. M. Skinner, P. Y Frasier, D. Reuland, B. D. Skinner, A. Krishnarao,
M. G Cohen.
P590Correlation between serum high sensitivity CRP level and inhospital cardiac
events in the patients with unstable angina
H. Kazerani, A. Rai, V. Dehlaghi.
P593Analysis of Rate-Pressure Product In South Brazilian Population
K.C. Belli, T. Dipp, T.F. Panigas, C.F. Panigas, D.C. Bündchen, C.M. Richter, J.Z. Klafke, R. Killing, P.R.N. Viecili.
P596Analysis of Maximal Oxygen Consumption-VO2 max of a Brazilian Specific
Population
K. C. Belli, T. F. Panigas, T. Dipp, D. C. Bündchen, C. F. Paniga, C. M. Richter, J. Z. Klafke, M. A. Silva, J. L. C. Pippi,
P. R. N. Viecili.
P597
The role of clinical laboratory in high-risk for death groups selection using
classification tree analysis for infantile dilated cardiomyopathy.
Vitor Manuel Pereira Azevedo, Marco Aurélio Santos, Márcia Bueno Castier, Maria Cristina C. Kuschnir,
José Geraldo Castro Amino, Maria Ourinda M. Cunha, Rogério Brant Martins Chaves, Bernardo Rangel Tura,
Francisco M. Albanesi Filho, Regina Maria De Aquino Xavier.
Poster Listing
P598JOB STRESS AND ARTERIAL HYPERTENSION IN PREGNANCY
J. Marques Neto, S. A. G. Marques, M. S. Queroz, I. Fonseca, S. Moura, N. Oliveira, T. M. Araujo.
P599DILATED CARDIOMYOPATHIES: TREATMENT WITH STEM-CELLS : EXPERIENCE DURING
30 MONTHS.
O. T. Greco, J. L. B. Jacob, R. V. Ardito, M. R. Lago, A. Parro Junior, R. T. Takeda, F. V. Salis, L. P. Ruiz, M. A. Ruiz,
A. C. Abreu.
P600Intrahospital and long term clinic outcomes of coronary angioplasty with
drug eluting stent, in diabetic patients, compared with the no diabetic ones.
F. F.O. Fernando Fabian Ordonez, C. A. A. Carlos Alejandro Alvarez, A .C. Alberto Cristino,
C. A. I. Carlos Alvarez Iorio.
P601ACAP™CONFIRM: A NEW ALGORITHM BASED ON EVOKED-RESPONSE DETECTION FOR ATRIAL
CAPTURE CONTROL. A SHORT-TIME FOLLOW-UP STUDY
J. Olagüe, J. G. Martínez, J. J. García-Cuerrero, J. Fernández De La Concha, C. Llorente, F. Crespo, A. Ibañez,
M. J. Sancho-Tello, O. Sanz.
P602New ECG pattern in young patient with catecholaminergic polymorphic
ventricular tachycardia
L. Makarov, T. Kyryleva, S. Chuprova, V. Komoliatova.
P603
I ntrahospital and late outcomes a unique centre of treatment with
different kinds of drug eluting stents, in patients with “Off Label” coronary
angioplasty indication.
F. F. O. Fernando Fabian Ordonez, C. A. I. Carlos Alejandro Alvarez, A. C. Alberto Cristino, C. A. I. Carlos Alvarez Iorio.
P604Intrahospital and long term clinic outcomes of treatment with drug eluting
stent, in small vessel with “Off Label” coronary angioplasty indication.
F. F. O. Fernando Fabian Ordonez, C. A. A. Carlos Alejandro Alvarez, A. C. Alberto Cristino, C. A. I. Carlos Alvarez Iorio.
P607Hemodynamic Behavior In Different Periods Of Day In A Physical Exercise
Program Subjects
T. Dipp, D. C. Bündchen, T. F. Panigas, K. C. Belli, C. F. Panigas, C. M. Richter, A. M. R. Pereira, J. Z. Klafke, R. Killing,
P.R.N. Viecili.
P608Common Mental Disorders and Hypertension in adolescents –
Rio de Janeiro, Brazil
M. C. K. Maria Cristina Kuschnir, G. M. Gulnar Mendonça.
P609Prognostic significance of microalbuminuria in non-diabetic patients with
ST-segment elevation myocardial infarction.
A. Dominguez-Rodriguez, S. Samimi-Fard, M. J. Garcia-Gonzalez, G. Yanes-Bowden, A. Sanchez Grande-Flecha,
I. Hernandez-Baldomero, P. Abreu-Gonzalez, F. Marrero-Rodriguez, J. C. Kaski.
Scientific Programme / 213
Poster Listing
P610
orrelation Between Oxidative Stress, Endothelial Injury And Coagulation
C
Activation In Advanced Chronic Heart Failure
O. Korzh, S. Krasnokutskiy.
P611The Effect of Ambient Temperature Variability 0n Blood Pressure: Two Years of
Observation
T. F. Panigas, T. Dipp, C. M. Richter, D. C. Bündchen, J. L. C. Pippi, C. F. Panigas, Z. Klafke, K. C. Belli, P. R. N. Viecili.
P612Analysis of Cardiorespiratory Fitness in a Brazilian Specific Population
K. C. Belli, T. Dipp, T. F. Panigas, C. F. Panigas, C. M. Richter, D. C. Bündchen, J. Z. Klafke, P. R. N. Viecili.
P614
LEFT ATRIAL DOPPLER TISSUE IMAGING: CHANGES IN PATIENTS WITH CORONARY ARTERY
DISEASE.
C. Killinger, G. Cabrejos, M. Del Campo, M. Sun, D. Lozano, S. Ferradas, R. Rosental, G. Mohamed, S. Zymerman,
E. Beck.
P615
R eduction Of Exaggerated Exercise Blood Pressure Levels In Normotensive
Individuals After Physical Exercise Program.
C. M. Richter, C. F. Panigas, D.C. Bündchen, K. C. Belli, T. Dipp, T. F. Panigas, J. L. C. Pippi, J. Z. Klafke,
R. M. F. Sampedro, P. R. N. Viecili.
P616Alzheimer’s Type Dementia Versus Vascular Dementia in Hypertensive Patients
A. Vicario, C. D. Martinez, G. H. Cerezo.
P617SEVERE AORTIC STENOSIS AND NONCARDIAC SURGERY IN THE ELDERLY POPULATION.
D. De Mollein, C. Dominguez, G. Lopez Soutric, S. Robert, S. Berensztein, M. Vazquez Blanco, J. Lerman.
P618RELATION BETWEEN DIABETES, HEART RATE VARIABILITY AND LEFT VENTRICULAR
FUNCTION IN PATIENTS AFTER MYOCARDIAL INFARCTION
V. Stoickov, S. Ilic, M. Deljanin Ilic.
P619STUDY OF THE QUALITY OF LIFE (QOL) OF CORONARY PATIENTS, TREATIES WITH AND
WITHOUT CARDIAC REHABILITATION (CR).
A. Gómez Monroy, A. Amarilla, R. Gonzalez, D. Marelli, C. Herrera, S. Macin, N. Mijailovsky.
P620Contribution of the aVL lead in the electrocardiographic distinction between
AV Nodal Reentrant Tachycardia and AV Reentrant Tachycardia.
C. Hadid, D. Di Toro, C. Lopez, L. Vidal, C. Labadet.
P621CEREBROVASCULAR ACCIDENT PREVALENCE AND PREDICTORS IN MYOCARDIAL
REVASCULARIZATION SURGERY
R. Marelli, I. Rifourcat, E. Serrano, R. Lolo, J. Como Birche, C. Salomón, L. Ponce, M. David, A. Gomez Monroy, L. Mancini.
Poster Listing
P623Differences in cardiovascular mortality among men and women in the city of
Rio de Janeiro, Brazil, during the 1998 and 2002 FIFA Soccer World Cup
F. Braga, A. Bahia, J. Kezen, S. Gomes Jr., L. Armini, P. P. Sampaio, G. Oliveira, A. C. Neno, J. Mansur.
P624FREQUENCY OF COMMON VARIANTS OF ABCB1, CYP3A4 AND CYP3A5 GENES IN CHILEAN
SUBJECTS WITH PRIMARY HYPERCHOLESTEROMIA
A. Rosales, A. Pacheco, N. Saavedra, F. Lanas, L. A. Salazar.
P625Endothelial function: Relationship between coronary grafts and brachial
artery in patients of coronary artery bypass surgery.
V. Proto, C. Joo Turoni, R. Marañon, J. Salinas, J. Muntaner, M. Peral De Bruno.
P626FAMILY MYXOMATOSIS. PRESENTATION OF THREE CLINICAL CASES.
R. Marelli, A. Hauqui, M. Portis, D. Vazquez, C. Viscuso, C. Echeverria, V. Strada, J. Como Birche, F Hauqui,
N. Baungartner.
P627Secondary acute coronary syndromes in older people.
G. F. López Soutric, A. Brignoli, S. Swieszkowski, A. Lakowsky, V. Brito, J. M. Caparrós, R. Perez De La Hoz,
E. A. Sampó.
P628TAKAYASU DISEASE. PRESENTATION OF A CLINICAL CASE
R. Marelli, L. Bernardini, D. Braziunas, J. Di Siervi, C. Echeverria, C. Viscuso, N. Bangartner, R. Lagos, O. Pisano,
O. Rastelli.
P629ASSOCIATION BETWEEN BIRTH WEIGHT AND CARDIOVASCULAR RISK FACTORS
IN BRAZILIAN ADOLESCENTS
M. A. C. Sousa, I. C. Guimarães, C. Daltro, A. C. Guimarães.
P630Usefulness of the rapid test of NT-ProBNP and non-invasive haemodynamic
assessment with tissue Doppler for early diagnosis of decompensated heart
failure in a cardiovascular emergency room
E. Perna, E Garcia, O. Querencio, E. Villegas, P. Pozzer, G. Pereira Zini, R. Sanchez De Coll, W. Garcia, E. Fernandez,
J. Parras.
P631Comparing drug eluted with bare metal stents: Are we treating the same
patients in the same way?
F. Braga, L. Armini, J. Kezen, S. Gomes Jr., R. Guerreiro, A. Bahia, A. Neno, M. Batista, R. Villela, J. Mansur.
P632Transradial percutaneous coronary angiography and interventions
E. C. Eric J. Carro-Jiménez, H. Q. Humberto O. Quintana-Irazola, J. B. Jonathan Bonilla Díaz, C. A. Claudia Algaze, J.
D. R. Juan M. Del Río, J. C. Joaquín Crespo, J. O. José Ortiz Betancourt, E. R. Ernesto Ruiz, M. A. Michelle Arrieta, I.
P. Iris Parrilla Boria.
Scientific Programme / 215
Poster Listing
P633Conduct relation comparison betweent cardiac frequency and work load
during stress test on patients with cardiopathy
N. Pacheco, N. Ceron, J. Alonso, H. Ilarraza.
P634INCIDENCE OF CORONARY ARTERY STENT THROMBOSIS IN THE “REAL WORLD” EXPERIENCE
OF A UNIVERSITARY COLOMBIAN HOSPITAL
B. Lombo, C. Satizabal, I. Rendon, D. Sarmiento, C. Carvajal, J. Mor.
P635The relationship of left atrial size and stress echocardiography
S. Enar.
P636Effects of Amaranthus caudatus L. hydroalcoholic extract on new risk
factors of cardiovascular diseases and prevention of fatty streak formation
and comparing its effect with lovastatine
S. Asgary, N. Kabiri, H. Madani, P. Mahzoni, N. Jafari Dinani.
P637Effect of hydroalcoholic extracts of Jugulans Regia on blood sugar in
diabetes-induced rats
S. Asgary, P. Rahimi, H. Madani, P. Mahzouni, N. Jafari Dinani.
P638Dietary supplementation with Artemisia sieberi reduce atherosclerosis in
hypercholesterolemic rabbits
S. Asgary, N. Jafari Dinani, P. Mahzouni.
P639The Utility Rates of Integrated Treatment Strategies for CHD Secondary
Prevention among High Risk CHD Patients in China
D. Zhao, Q. Liu, M. Hunn, W. Wang, C. M. Yu, J. R. Zhu, J. Liu, S. Smith Jr.
P640Adipokines In Coronary Artery Disease And Heart Failure: Relationships With
Left Ventricle Hemodynamics And Cachexia
C. Antoniades, D. Tousoulis, A. Antonopoulos, A. Drolias, N. Koumallos, K. Marinou, K. Bakoyiannis, C. Tentolouris,
E. Vavouranakis, C. Stefanadis.
P641Genetic Polymorphism On Angiotensin Receptor Type 2, Modifies Plasma Levels Of
Acute Phase Proteins And Affects Cardiovascular Risk In Hypertensive Subjects
D. Tousoulis, N. Koumallos, C. Antoniades, A. Antonopoulos, D. Kardara, D. Mentzikof, C. Vasiliadou, C. Tentolouris,
E. Stefanadi, C. Stefanadis.
P642The Impact Of Acute Consumption Of Corn Oil, Liver Oil, Olive Oil Or Soya Oil On
Endothelial Function And Oxidative Stress Status, In Healthy Adults
C. Tentolouris, D. Tousoulis, N. Papageorgiou, C. Antoniades, A. Giolis, E. Stefanadi, C. Tsioufis, G. Bouras,
K. Marinou, C. Stefanadis.
Poster Listing
P643Oxidative Stress IS Not The Main Regulator Of Asymmetrical Dimethyl-Arginine
(ADMA) Synthesis In Experimental Homocysteinemia
C. Antoniades, D. Tousoulis, K. Marinou, G. Bouras, E. Stefanadi, C. Vasiliadou, C. Vlachopoulos, A. Antonopoulos,
C. Tentolouris, C. Stefanadis.
P644Gender differences in a population suspected of ischemic heart disease:
exercise response, perfusion abnormalities and prognosis
M. Ferreira, A. Ferrer-Antunes, J. Lima, L. A. Providência.
P645The Underlying Disease State As The Main Modifier Of The Relationship Between
Inflammatory Status And The Release Of sCD40L In Coronary Atherosclerosis
D. Tousoulis, C. Antoniades, C. Tentolouris, A. Nikolopoulou, K. Marinou, N. Koumallos, K. Koniari, C. Vasiliadou,
E. Stefanadi, C. Stefanadis.
P646Value of Myocardial Performance Index in Evaluation of Patients with
Hepatoesplenic Mansonic Schistosomiasis
V. T. Carvalho, M. M. Barbosa, L. C. S. Silva, J. R. Lambertucci.
P647Low-Dose Atorvastatin Treatment Suppresses Inflammatory And Thrombotic
Processes During Post- STEMI Period
C. Tentolouris, D. Tousoulis, C. Antoniades, V. Katsi, E Bosinakou, A. Antonopoulos, K. Marinou, P. Aggelopoulos,
E. Stefanadi, C. Stefanadis.
P648Homocysteine Variations Induce Endothelial Dysfunction By Activating
Endothelin-1 Pathway In Hypertensive Patients
D. Tousoulis, G. Bouras, C. Antoniades, K. Marinou, C. Tentolouris, C. Vasiliadou, A. Antonopoulos, E. Stefanadi,
P. Aggelopoulos, C. Stefanadis.
P649Role of Telemedicine for the Detection of ST-segment Elevation Acute
Myocardial Infarction
F. C. Cura, Fernando, R. L. Levi, Regina, L. V. Verruna, Leticia, A. S. Szyszko, Ariel, M. F. Farias, Marcelo,
F. O. Olejnik, Francisco, N. V. Navarro Victor, D. D. Drago, Daniel, J. E. Estrella, Javier.
P650PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH ATRIAL FIBRILLATION.
ANTITHROMBOTIC THERAPY AND BASELINE CLINICAL CHARACTERISTICS ANALYSIS.
J. M. Ruiz-Nodar, T. A. Brouzet, J. Hurtado, J. Valencia, J. R. Jimeno, J. Pineda, M. Valdés, F. Sogorb, G.Y.H. Lip,
F. Marín.
P651CASE REPORT: ASSOCIATION OF 2 VERY UNCOMMON PATHOLOGIES IN THE SAME PATIENT
C. Stringi, S. Pereiro Gonzalez, M. Masuelli, A. Bordenave, A. Crespo, G. Sumay, B. Nadinic, C. Poliserpi,
J. Modenesi, S Chekherdemian.
Scientific Programme / 217
Poster Listing
P652
V alue of TIMI risk Score for predicting mortality and major clinical events in
patients with STEMI that underwent Percutaneus Coronary Intervention on
admission to hospital.
I. Santos-Rodriguez, M. J. Ruiz-Olgado, V. Ramirez-Castro, J. Rodriguez-Collado, M. Cascon-Bueno, A. Perez-Bueno,
V. Leon-Arguero, I. Cruz-Gonzalez, F. Martin-Herrero, M. Diego-Dominguez.
P653Postgraduate and Systematic Distance Learning Experience in Cardiology
R. Ortego, A. Pacher, S. Berman, T. Bertuzzi, A. Carli, B. Kennel, R. Lombardo, S. Nanfara.
P654Expanded Clinical Indications for a Tissue Engineered Blood Vessel
L. M. De La Fuente, S. Garrido, A. Marini, J. Antonelli, A. Fiorillo, A. Kocher, I. Gasperovich, N. Dusserre, T. McAllister,
N. L’heureux.
P655Ambulatory Blood Pressure Monitoring In Hypertensive Offsprings
J. Knopfholz, A. Ribeiro Langowiski, E. Lima Junior, A. Reichert, M. Oliveira Nogueira, L. C. Guarita-Souza.
P656Continuous Activity in Telemedicine Focused on Teaching Cardiology
A. Pacher, R. Lombardo, R. Ortego, E. Schapachnik, S. Eskenazi, S. Nanfara, J. Sanagua, M. Heñin, S. Berman,
Pcvc Group.
P657ENDOTHELIAL FUNCTION IN RESPONSE TO ORAL LIPIDS AND POSTPRANDIAL LIPEMIA
Carlos I. Ponte N., O. Sanchez, R. Melendez, J. Isea-P, J. Feijoo, J. Gomez-M.
P658Are Lateral or Postero-Lateral Veins The Optimal Site to Implant Left Pacing
Leads? A study of 77 consecutive resynchronized patients
C. D’Ivernois, J. Lesage, A. Lagrange, P. Blanc.
P659Echocardiographic evaluation of myocardial contractility in hypertensive
left ventricular hypertrophy by a load-independent index
A. Tufare, E. Escudero.
P660Drug-eluting-stent-based percutaneous coronary intervention for treatment
of acute coronary syndrome with multivessel disease; Comparison of ‘culpritvessel-only’ and complete revascularization
B. Hong, H. Kim, S. Yoon, M. Kim, H. Moon, Y. Yoon, P. Min, S. Rim, H. Kwon.
P661Proarrhythmic effects of Flecainide during exercise stress test in coronary
artery disease detecting
K. G Adamyan, A. V. Astvatsatryan, A. L. Chilingaryan.
P662Antioxidant spectrum changes due to trimetazidine treatment in patients with
coronary artery disease and diabetes mellitus type 2. Experience in 44 patients
K. G. Adamyan, A. V. Astvatsatryan, A. L. Chilingaryan.
Poster Listing
P663Different Effect of DM and Other Cardiovascular Risk Factors on Circulating
Monocyte Count in Patients with Stable CAD
S. A. Kocaman, A. Sahinarslan, T. Timurkaynak.
P664Treatments and outcomes of acute myocardial infarction. A three year
experience in a progressive care unit.
M. Perez, C. Martinez Sagasta, E. Brunel, E. Soloaga, G. Medina, J. Bori, C. Smith, A. Palazzo, M. Veltri, J. Ubaldini.
P665Drug-eluting-stent-based percutaneous coronary intervention versus
coronary artery bypass surgery for treatment of patients with multivessel
coronary artery disease
B. Hong, H. Mun, N. Chon, M. Kim, C. Ahn, P. Min, Y. Yoon, S. Rim, H. Kwon.
P666LEFT VENTRICULAR ROTATION AND TORSION AFTER ANTERIOR AND INFERIOR MYOCARDIAL
INFARCTION.
M. Pinto.
P667Different levels than proposed in abdominal waist circumference on a
latinoamerican population
Carlos I. Ponte N., N. Vargas, I. Brajkovich, L. Machado-H, J. Isea-Pérez, J. Gómez.M, C. Mendoza.
P668SOLITARY PAPILLARY MUSCLE HYPERTROPHY CAN BE A PRECURSOR OF HYPERTROPHIC
CARDIOMYOPATHY
T. F. Cianciulli, M. C. Saccheri, A. M. Bermann, J. A. Lax, I. V. Konopka, R. S. Acunzo, H. J. Redruello, H. A. Prezioso,
M. V. Elizari, L. A. Vidal.
P669Acute Effects of Non Invasive Ventilation with Continuous Positive Airway
Pressure on Pulse Pressure in Chronic Heart Failure
M. Quintão, S. Chermont, N. N. Rocha, E. T. Mesquita, A. C. L. Da Nóbrega.
P670PERCUTANEOUS CORONARY INTERVENTIONS (PCI) FOR UNPROTECTED LEFT MAIN
CORONARY ARTERY (ULCMA)
M. Strozzi, D. Anic, B. Skoric.
P671Importante of reperfusion strategy and heart failure in the acute myocardial
infarction
S. M. Macin, E. R. Perna, P. Barrios, J. Parra Moreno, P. Pozzer, E. Villegas, G. Zini, P. Liva, J. Baccaro, J. R. Badaraco.
P672HEPATOPULMONARY SYNDROME AND HEMODYNAMIC RESPONSE ON THE LEFT SIZE
OF THE HEART
F. L. Weich Glogier, T. F. Cianciulli, J. Vilkas Anzorena, F. Spernanzoni, M. C. Saccheri, J. A. Lax, A. N. Dorelle,
H. A. Prezioso, L. A. Vidal, O. C. Imventarza.
Scientific Programme / 219
Poster Listing
P673Quality of life improvement in stable angina pectoris by combining physical
exercise and medical treatment
L. Matos, M. Lengyel, J. Szlavov, L. Pál.
P674Have adherence to guidelines in chronic coronary artery disease?
S. M Macin, J. Bono, H. Ramos, A. Romano, M. Balestra, G. Zapata, E. Hasbani, J. Mountaner, H. Luciardi.
P676DOPPLER TISSUE IMAGING IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
M. C. Saccheri, T. F. Cianciulli, S. E. Puga, I. V. Konopka, R. S. Acunzo, J. E. Guerra, D. F. Serans, H. A. Prezioso,
M. V. Elizari, L. A. Vidal.
P677
P OSITIVE CORRELATION BETWEEN WAIST CIRCUMFERENCE, HDL-CHOLESTEROL AND
TOTAL CHOLESTEROL IN CENTRAL AFRICANS WITH CONGESTIVE HEART FAILURE : REVERSE
EPIDEMIOLOGY AND U-RELATIONSHIP IN CARDIOVASCULAR RISK
B. Longo-Mbenza, H. F. Agongola Mambune, J. B. Kasiam On’Kin, E. Kintoki Vita, S. Mbungu Fuele,
J. Nkondi Nsenga, L. Mabwa, V. Nzuzi.
P678
eart rate variability after different cardiac surgery procedures and its
H
prognostic value
N. Lakusic, F. Baborski, J. Mirat, L. J. Pavelic, K. Fuckar, D. Cerovec, M. Majsec.
P679EARLY DETECTION OF MYOCARDIAL DAMAGE IN CHAGAS DISEASE.
T. F. Cianciulli, J. A. Lax, M. C. Saccheri, A. Papantoniou, R. J. Mendez, N. G. Prado, A. N. Dorelle, A. R. Riarte,
H. A. Prezioso, L. A. Vidal.
P680ASSOCIATION BETWEEN CORONARY HEART DISEASE, CERTAIN COMPONENTS OF METABOLIC
SYNDROME AND THE QTc INTERVAL IN HYPERTENSIVE CENTRAL AFRICANS
B. Longo-Mbenza, J. C. Manzala Kumbi, G. Milongo Dipa, A. Nge Okwe, S. Mbungu Fuele.
P681Evaluation of chest pain with BNP: Do we have a new tool?
F. Braga, L. Armine, P. P. Sampaio, A. Bahi, M. Simoes, J. Kezen, S. Gomes Jr., A. C. Neno, F. Alvim, J. Mansur.
P682Usefulness of Tissue Doppler Imaging alone and with Stress-Dobutamine
Echocardiography in cardiotransplanted patients.
F. S. Deketele, M. A. Morales Lezica, L. Ahualli, D. Radlovacky, V. Piccone, C. A. Rivas.
P684Prediction of echocardiography risk factors of thromboembolism using
D-dimmer in non-valvular atrial fibrillation
F. Braga, P. Medeiros, F. Brasil, F. Nogueira, A. Godomiczer, M. Spelta, A. C. Neno, R. Salomao, R. H. Lins, B. Hellmuth.
P685Evaluation of physicians´ knowledge on reperfusion therapy for acute
myocardial infarction in Argentina: a tool for quality improvement process.
R. Iglesias, F. Rolandi, F. Di Tommaso, I. Chaves, M. Strumminger, P. Stuzbach, A. Pocovi.
Poster Listing
P686Aortopulmonary fistula as an unusual complication in the follow-up of an
arterial switch operation (ASO) for Transposition of the Great Arteries.
B. Chiostri, I. Lugones, M. Grippo, J. L. Simon, A. J. Schlichter.
P687THE COMBINATION OF AMLODIPINE 5 MG AND VALSARTAN 160 MG LOWERS PULSE
PRESSURE EFFECTIVELY AND SAFELY IN ELDERLY AND NON-ELDERLY HYPERTENSIVE
PATIENTS NOT CONTROLLED BY MONOTHERAPY WITH CALCIUM CHANNEL BLOCKERS
J. Brachmann, R. Handrock, S. Klebs.
P688THE COMBINATION OF AMLODIPINE 5 MG AND VALSARTAN 160 MG LOWERS BLOOD
PRESSURE EFFECTIVELY AND SAFELY IN OVERWEIGHT AND OBESE HYPERTENSIVE PATIENTS
NOT CONTROLLED BY MONOTHERAPY WITH CALCIUM CHANNEL BLOCKERS
J. Brachmann, R. Handrock, S. Klebs.
P689Predictive value of preoperative BNP for adverse outcomes in Coronary Artery
Bypass Grafting
L. Valtuille, L. Gomez, F. Rolandi, A. Domenech, R. De Miguel, D. Perez De Arenaza, A. Cagide, J. L. Navarro Estrada.
P690LEFT ATRIAL APPENDAGE FUNCTION AND RISK OF THROMBOEMBOLISM IN MITRAL
STENOSIS IN SINUS RHYTHM
T. F Cianciulli, M. C. Saccheri, J. A. Lax, F. L. Weich Glogier, J. J. Cirio, R. A. Sarmiento, M. L. Talavera, D. A. Kyle,
O. Fustinoni (h), H. A. Prezioso.
P691
ody Image Analysis In Obeses, Overweight And Eutrophic Subjects
B
K. C. Guidini, P. M. Lese, K. C. Belli, A. C. Côrrea, D. C. Bündchen, T. Dipp, T. F. Panigas, C. M. Richter,
M.C. Romero, P. R. N. Viecili.
P692THE COMBINATION OF AMLODIPINE 5 MG AND VALSARTAN 160 MG LOWERS BLOOD
PRESSURE EFFECTIVELY AND SAFELY IN HYPERTENSIVE PATIENTS WITH METABOLIC RISK
FACTORS NOT CONTROLLED BY MONOTHERAPY WITH CALCIUM CHANNEL BLOCKERS
J. Brachmann, R. Handrock, S. Klebs.
P693Study of the Periodic Alimentary Compulsion in Individuals with Different
Anthropometrics Indexes
P. M. Lese, K. C. Guidini, K. C. Belli, C. M. Richter, A. C. Côrrea, D. C. Bündchen, T. Dipp, T. F. Panigas, M. C. Romero,
P. R. N. Viecili.
P694Progress of a Cardiac Transplantation Program in a Public Pediatric Hospital
in Argentina
H. Vogelfang, G. Naiman, A. Villa, M. Disanto, A. Charroqui, G. Moreno, R. Magliola, L. Quiroga, G. Burlli,
M. De La Riba.
Scientific Programme / 221
Poster Listing
P695CARDIOVERTER-DEFIBRILLATOR THERAPY AND ITS RELATION WITH SYSTOLIC AND
DIASTOLIC FUNCTION IN PATIENTS WITH CARDIOMYOPATHIES
C. Killinger, G. Ceconi, L. Shocron, M. Senesi, A. Cueto, M. Del Campo, C. Sun, G. Cabrejos, E. Beck,
A. Papadopoulos.
P696Clopidogrel response in acute coronary syndrome patients: Comparing
different loading doses
F. Braga, G. Lavall, R. Guerreiro, A. Godomiczer, M. Spleta, C. Segadaes, A. C. Neno, G. Gouvea, R. Villela, R. H. Lins.
P697
latelet Aggregation and Post Percutaneous Coronary Intervention
P
Myonecrosis.
F. Braga, E. Sophia, G. Lavall, R. Guerreiro, B. Zappa, R. Max, R. Villela, B. Hellmuth, P. Medeiros, R. H. Lins.
P698
BESITY IN A COHORT OF PUBLIC EMPLOYEES MEDICAL SERVICE OF MENDOZA O
ARGENTINA. Optimal Systematic Evaluation Program (OSEP STUDY) in Obesity
S. Mortaloni, O. Arrieta, S. Zizzias, L. Cammi, J . Alvarez, A. Añó, S. Depine, S. Gimenez.
P699
tructural and funtional alterations of cardiac and skeletal muscle
S
mitochondria in patients with congestive heart failure.
G. Guzman Mentesana, R. Cordoba, A. Baez, R. Dominguez, D. Comay, S. Lo Presti, W. Rivarola, P. Pons, R. Fretes,
P. Paglini.
P700Inflammation/Lipid Score may outperform TIMI score in acute myocardial
infarction treated by primary intervention.
J. Kasprzak, K. Kolodziej, M. Wraga, J. Z. Peruga, M. Krzeminska-Pakula.
P701
ontrast Enhancement Score: optimal parameter for predicting local and
C
global viability after myocardial infarction- a contrast echocardiographic
study.
J. Kasprzak, M. Ciesielczyk, J. Drozdz, M. Kurpesa, M. Kidawa, M. Krzeminska-Pakula.
P702Coronary flow reserve in infarct-related artery.is not altered by
Intracoronary administration of bone marrow stem cells.
J. Kasprzak, M. Plewka, P. Lipiec, K. Wierzbowska-Drabik, T. Robak, A. Korycka, T. Jezewski, J. Z. Peruga,
M. Krzeminska-Pakula.
P703EFFECTS OF WEIGHT LOSS AFTER GASTRIC BYPASS ON LEFT VENTRICULAR FUNCTION
ASSESSED BY TISSUE DOPPLER IMAGING
T. F. Cianciulli, A. M. Bermann, J. A. Lax, M. C. Saccheri, B. E. Linetzky, L. A. Morita, J. A. Gagliardi, A. N. Dorelle,
H. A. Prezioso, L. A. Vidal.
P704Economic Benefit of Physical Activity Program for Hypertensive Subjects:
Variation In Cost-Dose-Medication
T. Dipp, D. C. Bündchen, T. F. Panigas, K. C. Belli, C. F. Panigas, C. M. Richter, A. M. R. Pereira, E. G. Barbosa,
J. Z. Klafke, P. R. N. Viecili.
Poster Listing
P705Exercise-induced abnormal pulmonary arterial pressure response in young
athletes – normal physiology or precursor of endothelial damage?
T. Möller, K. Peersen, P. M. Fredriksen, H. Holmstrøm, E. Thaulow.
P706ECHOCARDIOGRAPHIC DETECTION OF RENAL CELL CARCINOMA EXTENDING FROM INFERIOR
VENA CAVA INTO RIGHT ATRIUM.
T. F. Cianciulli, M. C. Saccheri, J. A. Lax, L. A. Morita, H. J. Altube, J. F. Codone, M. T. Lioy Lupis, A. N. Dorelle,
H. A. Prezioso, L. A. Vidal.
P707Peripheral artery disease – still underestimated in diagnostic and
pharmacotherapy treatment
L. J. Banfic, M. Vrkic Kirhmajer, E. Fucak, I. Sakic.
P708Carotid artery stenting improves parameters of cerebrovascular
haemodynamics
D. Cerna, J. Veselka, P. Zimolova, P. Blasko, J. Fiedler, R. Duchonova, D. Zemanek, M. Maly, P. Hajek.
P709Moderate altitude conditions may cause hypoxia and abnormal pulmonary
arterial pressure response at rest and during exercise in patients with atrial
or ventricular septal defect
T. Möller, P. M. Fredriksen, H. Holmstrøm, J. Hallén, E. Thaulow.
P710Aspirin and Clopidogrel response in patients with acute coronary syndrome
F. Braga, G. Lavall, A. Sterque, F. Albuquerque, G. Gouvea, A. C. Neno, J. Kezen, R. Max, E. Sophia, B. Hellmuth.
P711
P arameters of right ventricular function in predicting exercise capacity as a
determinant of VO2max in patients with dilated cardiomyopathy
J. Vormbrock, G. Plehn, S. A. Machnick, C. Zuehlke, H. J. Trappe.
P712The Dose-Response Curve For Exercise And Blood Pressure: How Many Sessions
Are Needed?
D. C. Bündchen, T. F. Panigas, C. M. Richter, T. Dipp, C. F. Panigas, K. C. Belli, J. L. C. Pippi, J. Z. Klafke, T. Carvalho,
P. R. N. Viecili.
P713ASSESSMENT OF PLANIMETRIC MITRAL VALVE AREA IN PATIENTS WITH RHEUMATIC MITRAL
STENOSIS USING 16-ROW MULTIDETECTOR COMPUTED TOMOGRAPHY:COMPARISON WITH
TRANSTHORACIC TWO-DIMENTIONAL ECHOCARDIOGRAPHY
O. Ucar, M. Vural, Z. Cetin, S. Gokaslan, T. Gursoy, B. Demircelik, A. Selvi, S. Aydogdu.
P714
R adiation dose of dual-source CT is much higher compared to invasive
coronary angiography
R. Duchonova, T. Adla, J. Veselka, J. Neuwirth, L. Martinkovicova, V. Suchanek, P. Hajek, M. Maly, D. Zemanek,
P. Blasko.
Scientific Programme / 223
Poster Listing
P715Management of resistant hypertension by adding a low dose spironolactone
E. Badila, C. Tirziu, S. Ghiorghe, D. Bartos, M. Dorobantu.
P716INCREASED EXPRESSION OF THE HOMOLOGUE ANGIOTENSIN I CONVERTING ENZYME (ACE2)
INDUCED BY BOTH CANDESARTAN AND FASUDIL IN RATS WITH GENETICALLY HIGH LEVELS
OF ANGIOTENSIN II
M. Ocaranza Jeraldino, P. Rivera, J. Jalil Milad.
P717Ischemic or non-ischemic etiology influence on endothelial function in
patients with cardiac failure
E. Badila, S. Ghiorghe, C. Tirziu, D. Bartos, M. Dorobantu.
P718Risk factors for Trypanosoma cruzi infection reactivation in Chagas’ heart
transplant recipients.
T. Theodoropoulos, A. Silva, R. Bestetti.
P719Single centre experience in patients with left ventricular non-compaction:
clinical characteristics and evolution.
M. Diez, R. Fernandez, A. Fernandez, J. Casabe, G. Arroyo, E. Guevara, M. Tettamanti, R. Gamboa, C. Rodriguez
Correa, L. Favaloro.
P720Real-time three-dimensional echocardiographic left ventricular systolic
assessment: side-by-side comparison with cardiac computed tomography
M. L. C Vieira, C. H. Nomura, B. Tranchesi Jr., W. A. Oliveira, G. Naccarato, B. S. Serpa, R. B. D. Passos,
M. B. G. Funari, C. H. Fischer, S. S. Morhy.
P721The role of hemodynamic and non-hemodynamic factors of left ventricular
remodeling in patients with ankylosing spondylitis
D.A. Poddubnyy, A. P. Rebrov.
P722Prevalence and Relevance of Extreme Dipping Pattern of Blood Pressure
G. Simonyi, J. R. Bedros, M. Medvegy.
P723Morphological Study of Tachyarrhythmias: Typical Features on Cardiac MRI
P. Donato, B. Graça, M. J. Ferreira, F. Caseiro-Alves, L. A. Providência.
P724Incidence of cocaine use in patients under 45 years presenting to an emergency
department with adverse cardiovascular events
M. Colmenero, F. Manzano, A. Reina, R. Garcia, M. Rodriguez-Elvira, J. Roca.
P725Contribution of the diastolic wave to the evaluation of hypertensive subjects
F. C. Clara, Fernando, A. C. Casarini, Alfredo, A. T. Tufare, Ana, M. E. Echzu, María, A. S. Escandurra, Adriana,
G. M. Meschino, Gustavo, L. C. Clara, Laurencia.
Poster Listing
P726Long-term influence of cardiovascular risk factors in the development of
thromboembolic disease.
B. Roca, D. Bahamonde, M. Peris.
P727
M ass in the left atrium – A Challenger of Diagnosis
A. Soares, E. Marum, A. Silva, R. Russo, C. Chicanelli, H. Abensur.
P728Stress Doppler Echocardiography for Screening of Patients at Risk for
Pulmonary Arterial Hypertension
R. Maier, G. Kovacs, S. Scheidl, C. Hesse, W. Salmhofer, R. Stauber, M. Brodmann, E. Aberer, E. Gruenig,
H. Olschewski.
P729Coronary Angioplasty of Bifurcated Lesions
M. Albertal, F. Cura, L. Padilla, P. Perez Balino, A. Candiello, S. Jozami, J.. A. Belardi.
P730Nursing Diagnoses at Rio de Janeiro’s Chest Pain Unit
M. A. C. S Marluci Andrade Conceiçãostipp, K. B. A. Karla Biancha Silva De Andrade,
V. Z. M. Valéria Zadra De Mattos, A. P. B. P. Ana Paula Brito Pinheiro, M. F. M. Maria De Fátima Muino,
J. L. L. Josète Luzia Leite, R. S. S. Renata Silva Dos Santos, A. A. S. Alessandra Andrada De Souza,
N. M. C. Natália Machado Da Cunha.
P731Patch carotid endarterectomy. Follow up results in a selected group
J. Cors, C. Schulte, A. Hershson, G. Peltz, M. Nallar, H. Raffaelli.
P732
ANDOMIZED STUDY OF EVALUATION OF N-ACETYLCYSTEINE AND SODIUM BICARBONATE
R
IN THE PREVENTION OF CONTRAST-INDUCED NEPHROPATHY
A. Salvatierra Ruiz, G. Marchetti, A. Lagioia, M. Bodoira, D. Lavaggi, R. Ferreyra, A. Pocoví, A. Palacios,
P733Differential Trends in Use of Revascularization Procedures in Myocardial
Infarction Patients According to Socioeconomic Status
M. G. Cohen, G. M. Holmes, T. S. Carey, S. B. Greene, K. A. Selzman, S. C. Smith Jr., C. Patterson.
P734
I nflammation influences late prognosis of patients with STEMI treated with
primary PCI
M. Pyda, M. Lanocha, K. Korybalska, K. Ksiazek, S. Grajek, M. Lesiak, M. Grygier, A. Katarzynska, W. Skorupski,
J. Witowski.
P735A Comparison between Monophasic and Biphasic Multipulse Biowave® Pulses
during
E. Trendafilova, A. Alexandrov, E. Kostova, I. Toshev, A. Bankova, P. Tassovska, T. Andreeva, N. Gotcheva.
P736
ender differences in Left Main Artery Disease Assesed by Intravascular
G
Ultrasound
F. Kozak, L. Lasave, A. Abizaid, A. Damonte, M. Rossi, M. Gamen, F. Feres, E. Sousa, E. Picabea.
Scientific Programme / 225
Poster Listing
P737Need to reinforce the medical concern for smoking cessation. Results from a
survey.
J. Isea-Pérez, C. I. Ponte, B. Nuñez, J. L. Viloria, A. Reveron, J. Boscan, L. Hernandez, J. Pinto.
P738Importance of Thrombus Aspiration in intrahospital outcomes from Primary
Angioplasty
F. F. O. Fernando Fabian Ordonez, C.A.A. Carlos Alejandro Alvarez, A. C. Aberto Cristino, V. H. Veronica Heredia,
C. A. I. Carlos Alvarez Iorio.
P739Does thrombus aspiration with catheter export provide benefits to the
intrahospital outcomes of primary angioplasty?
F. F.O. Fernando Fabian Ordonez, C. A. A. Carlos Alejandro Alvarez, A. C. Alberto Cristino, V. H. Veronica Heredia,
C. A. I. Carlos Alvarez Iorio.
P741
M etabolic syndrome and Hepatic Transaminases Levels: Analysis of
33 Patients
J. Knopfholz, J. R. Faria Neto, A. Moser, B. A. Di Rico, G. Moreno Jardim, V. Bernardes, C. L. Pereira Da Cunha.
P743Circuit Weight Training and Cardiac Morphology: a Trial with Magnetic
Resonance Imaging
M. Camargo, R. Stein, J. Ribeiro, P. Schvartzman, M. Rizzatti, B. Schaan.
P744An Emergency Department Observation Unit protocol for Atrial Fibrillation:
Proceedings and Outcomes
M. D Tinetti Matias, M. D. Gonzalez Miguel, M. D. Castro Florencia, M. D. Costabel Juan Pablo,
M. D. Fernando Botto, M. D. Albina Gaston, M. D. Jorge Thierer, M. D. Alberto Giniger, M. D. Marcelo Trivi.
P745Superior Vena Cava to Pulmonary Artery Oxygen Gradient is a Function of
Coronary Sinus Oxygen Saturation
J. Giorgini, P. D Comignani, G. Ciambrone, S. Donato, J. Gambarte, C. Higa, A. Macchia, F. Novo.
P746
stimating achievable benefit from components of a comprehensive heart
E
disease prevention and treatment program
T. Kottke, D. Faith, C. Jordan.
P747Latino’s Attitudes and Preferences Regarding Treatment
of Hypertension
M. G. Cohen, B. L. Sleath, S. Blalock, A. R. Cerna, D. E. Bender.
P748Study of the arterial bypass in delayed postooperative of MR (miocardial
revascularization) through Multi-detector Row
CT Angiography
A. Tangari, G.S. Fernandes, C. A. Cattani, L. Fonseca, R. Castro, A. A. Santos, J. F. Baungratz, J. H. Vila,
J. C. Brigante, J. P. Silva.
Poster Listing
P749Mid -Term Follow up in a population who underwent Percutaneous Renal
Artery Stenting due to uncontrolled hypertension
C. Agatiello, H. Bassani Molinas, A. Pascua, D. Grinfeld, A. Fernandez, J. M. Gabay, C. Rojas Matas, D. Berrocal, L. Grinfeld.
P751Left Ventricular Function, Evaluated by Means of Myocardial Perfusion GatedSPECT Scintigraphy in a Population of Low Probability of Coronary Heart
Disease
F. Otero, A. Salvati, R. Geronazzo, V. Crosa, G. Casella, G. Bozovich, S. Traverso, R. Campisi.
P753Prevalence of Noonan Syndrome in adult patients with Primary Left
Ventricular Hypertrophy
G. Pereiro, I. Masuda, H. Cola, A. Graziano, O. Serraiocco, O. Cravero, A. Pasca, R. Hoffman, R. Savanti, A. Leon.
P755EFFECTS OF OVEREXPANSION ON STENTS’ RECOIL, SYMMETRIA-ASYMMETRIA AND
NEOINTIMAL HYPERPLASIA IN AORTAS OF HYPERCHOLESTEROLEMIC RABBITS
G. E. González, D. H. Berrocal, A. Fernández, L. Wilensky, C. Morales, L. Grinfeld, R. J. Gelpi.
P756What is the Prevalence of Anemia in ADHF?
S. M. Martins, C. Medeiros, F. M.Oliveira, R. Cantarelli, C. Sarteschi.
P757
BSENCE OF ASSOCIATION BETWEEN FACTOR XII 46C>T GENE POLYMORPHISM AND
A
CORONARY ARTERY DISEASE IN CHILEAN SUBJECTS
J. Caamaño, P. Jaramillo, C. Lanas, F. Lanas, L. A. Salazar.
P758Enzyme replacement therapy in Fabry’s Disease: Cardiac Analysis
A. Escobar, G. Ferrari, C. Kudrle, G. Doxastakis, O. Manuale, F. Casas, L. Dragonetti, S. Makhoul.
P759Rheumatic Carditis – still a challenge in Brazil!
R. E. Müller, B. R. Tura, S. M. Lamy, M. C. C. Kuschnir, C. Weksler, R. M. A. Xavier, M. J. L. M. Silva, F. F. Nascimento.
P760HEMORRHAGIC COMPLICATIONS OF COMBINED ANTIPLATELET AND ANTICOAGULANT
THERAPY IN ELECTIVE PCI PATIENTS
F. Baraona.
P761
U nawareness Of Presence For Cardiovascular Disease Risk Factors
In A Brazilian Regional Population
C. M. Richter, D. C. Bündchen, T. Dipp, K. C. Belli, T. F. Panigas, C. F. Panigas, J. Z. Klafke, M. A. Silva, P. R. N. Viecili.
P762Glycemic control in patients with type II diabetes mellitus after an acute
myocardial infarction – a randomized controlled pilot study comparing
glargine insulin plus regular insulin versus insulin pump therapy
C. Sampaio, D. Franco, F Eliaschewitz.
Scientific Programme / 227
Poster Listing
P763CLINICALS VARIABLES OF INTERRUPTION IN FOLLOWING OF HYPERTENSIVE PATIENTS
R. Altamirano, J. O. Ibañez, J. Kriskovich, R. Perez Rey, B.G. Rovai, C. Martinez, J. Gomez, S. Ibañez.
P764Blood pressure measurement according to the V Brazilian Hypertension
Guideline: does it make difference?
V. Guimarães Neto, S. Albuquerque, F. Souza, S. Lima, A. Feitosa, G. Falbo, D. Carvalho, J. Albuquerque.
P765Heart rate recovery after maximal exercise testing in healthy physically
active older women
O. Tairova, D. R. S. De Lorenzi, P. E. G. Carvalho, A. Scariot, G. Cavalli, J. M. Baumgarten.
P766
E ARLY VS LATE LOSARTAN EFFECTS ON POST-MYOCARDIAL INFARCTION VENTRICULAR
REMODELLING AND EARLY INFLAMMATORY INFILTRATE IN RABITS
G. E. González, L. Wilensky, L. Krieger, J. Palleiro, I. Seropian, M. Rodriguez, R. J. Gelpi, C. Morales.
P767Cardiovascular Events: 10 years of follow-up in a closed population
J. Tartaglione, G. Grazioli, M. Sarmiento, L. Goldstraj.
P768Fraction of the left Ventricle ejection And Auto Declared color
and polymorphism of the enzyme Gen Converser of Angiotensin in Heart Failure
B. Cavalieri.
P769Effect of remote ischemic posconditioning on endothelial function after one
period of sustained ischemia.
J. Álvarez- Gómez, Y. Coto Hernández, E. Roldos Cuza, L. Rodriguez Nandez, E. Rivas Stany, D. García Barreto.
P770
The post menopausal climacteric woman with hypertension: implications to
quality of life and functional capacity.
O. Tairova, D. R. S. De Lorenzi, P. E. G. Carvalho, G. Cavalli, A. Scariot.
P771ACUTE CORONARY SYNDROME IN THE VERY ELDERLY: DIFICULT DIAGNOSIS, LATE
DIAGNOSIS, LESS GUIDELINES APPLICATIONS AND WORSE PROGNOSIS.
A. Lichter, A. L. P. Ribeiro, H. P. M. Pena, M. A. M Andrade.
P772Ambulatory Blood Pressure (ABPM) in high risk patients. Improvement of 24 h
profile with intensive treatment
M. Baroni, C. Cruz, M. Gaute, SALA J, C. Balestrini, C. Serra, M. Bendersky.
P773Improvement of vascular risk factors management through a stroke
prevention program. Programa Integral General de ACV (PROTEGE-ACV)
M. Zurru, C. Alonzo, L. Brescacin, M. Romano, J. Rojas, MvPiaggio, M. Schneider, L. Camera, G. Waisman, E. Cristiano.
Poster Listing
P775ACUTE MYOCARDIAL INFARCTION IN A NON-PCI HOSPITAL
AC Alberto Caccavo, CAA Carlos Alejandro Alvarez, RU Rogelio Urizar, AMC Alicia Maria Carrique,
S. A. L. Sergio A. Lasdica, F. H. B. Facundo Horacio Bello, A. E. F. Adriana Elizabeth Ferrari.
P776Endothelial function in a model of systemic inflammation
R. A. Sarmiento, A. Capuccio, R. Solerno, M. Fenucci, A. Perrone, F. Exposito, A. Videla Lynch, L. Balletti,
A. Cherro, M. Larroude.
P777The CHADS 2 Score as predictor of stroke recurrence: gender comparison
M. Zurru, J. Rojas, M. Romano, L. Patrucco, E. Cristiano.
P779RIGHT VENTRICULAR HYPERTROPHY ALONE AS A NEW FORM OF PRESENTATION OF
HYPERTROPHIC CARDIOMYOPATHY.
M. C. Saccheri, T. F. Cianciulli, I. V. Konopka, R. S. Acunzo, R. J. Mendez, J. A. Gagliardi, L. A. Morita,
H. A. Prezioso, M. V. Elizari, L. A. Vidal.
P780CLINICAL SIGNIFICANCE OF TISSUE DOPPLER IMAGING IN PATIENTS WITH CHAGAS DISEASE.
T. F. Cianciulli, J. A. Lax, M. C. Saccheri, M. A. Beck, L. A. Morita, N. G. Prado, A. R. Riarte, A. N. Dorelle,
H. A. Prezioso, L. A. Vidal.
P781Left Ventricular Tachycardia in “Structurally Normal Hearts”:
In Search of the Lost Substrate.
J. Petriz, O. Souza, A. Casarsa, A. Serra, A. Glavan, L. Pereira, L. Mendonça, J. Moll.
P782High Sensitivity C - Reactive Protein and Asymptomatic Atherosclerosis
Evaluated for Endothelial Dysfunction and Carotid Intima Media Thickness
D. E. Lopez, G. Scianca, C. Sturgeon, D. Morisse, D. Avayu.
P783BETABLOCKERS IN ADMISSIONAL TREATMENT OF ACUTE HEART FAILURE: SECURITY AND
CLINICAL BENEFITS
M. Montera, S. Bernardez, M. Scofano, V. Barzilai, A. Volschan, E. Mesquita.
P784Nocturnal Blood Pressure (BP) In Patients With No Antihypertensive Treatment
M. Cruz, M. Baroni, J. Sala, C. Balestrini, C. Serra, M. Bendersky.
P785
A qualitative systematic review into helpseeking during heart failure :
Barriers and facilitators to prompt treatment
A. M. Clark, L. Svard, S. Heath, F. McAlister, J. Spiers.
P786Quality of Care: Acute Cardiac Failure Treatment in a Cardiac Failure Unit
M. Montera, S. Bernardez, V. Barzilai, A. Volshan, M. Scofano, E. Mesquita, A. Ribeiro.
P787Cost Evaluation of Acute Cardiac Failure Treatment in a Cardiac Failure Unit
M. Montera, S. Bernardez, I. Marques, E. Mesquita.
Scientific Programme / 229
Poster Listing
P788Impact of gender on coronary artery bypass results.Differences between men
and women.
E. Gabe, M. Santos, J. Abud, E. Dulbecco, H. Raffaelli, M. Rodriguez Acuña, A. Arnedo, F. Robles, R. Boughen,
R. R. Favaloro.
P789Coronary artery bypass surgry. Clinical risk predictors of in-hospital
mortality.
E. Gabe, M. Santos, E. Dulbecco, J. Abud, H. Raffaelli, M. Rodriguez Acuña, A. Arnedo, F. Robles, R. Boughen,
R. R. Favaloro.
P790Aspirin resistance recovers in the chronic phase of myocardial infarction
B. Skoric, D. Lovric, K. Narancic Skoric, J. Sertic, D. Milicic.
P792LV Remodelling Features in Athletes and Hypertensive Subjects
N. Sharashidze, Z Pagava, G Mamaladze, T Kishmareia, G Saatashvili.
P793Heart failure in population over 50 years in Bulgaria
M. Grigorov, J. Uzunangelov, A. Velkova, M. Tsekova, S. Djambazov, V. Bratanova, A. Bajkova.
P795Short-term effects of a low intensity physical activity
program on cardiometabolic profile of sedentary patients
with metabolic syndrome
C. M. Colombo, R. Macedo, A. M. Caporal, J. R. Faria Neto.
P796Centralization of Invasive Cardiac Care Results in Less Invasive Treatment in
Areas With Only Referral Hospitals
A. Hvelplund, J. N. Rasmussen, S. Rasmussen, S. Z. Abildstrøm, M. Madsen, S. Galatius, J. K. Madsen.
P797Characteristics and dynamics of resistance to antiplatelet drugs in
patients with acute myocardial infarction treated with standard doses of
acetylsalicylic acid and clopidogrel
D. Milicic, B. Skoric, D. Lovric, K. Narancic Skoric, J. Sertic.
P798Discriminating value of carotid intima-media thickness in pre- and
postmenopausal women with suspected coronary artery disease
A. Kablak-Ziembicka, T. Przewlocki, W. Tracz, P. Pieniazek, P. Musialek, A. Sokolowski, D. Rzeznik, R. Drwila.
P799Does Ambulatory Blood Pressure Predict Left Ventricular Diastolic
Dysfunction Independent of Conventional Blood Pressure in Groups
of African Descent?
E. Libhaber, C. Libhaber, O. H. Majane, M. J. Maseko, M. R. Essop, P. Sareli, G. R. Norton, A. J. Woodiwiss.
P800Atherosclerotic plaque instability may not be confined to coronary arteries
only, but may also involve other arterial districts.
A. Drzewiecka-Gerber, A. Rybicka-Musialik, J. Krauze, J. Myszor, M. Trusz-Gluza.
Poster Listing
P802Late gadolinium enhancement predicts all cause mortality in patients with
heart failure and systolic dysfunction of uncertain etiology
M. Nadal, A. Valle, J. Estornell, C. Soriano, N. Martinez, V. Jacas, A. Laynez, M Corbi, R. Paya, F. Ridocci-Soriano.
P803Corelation of Hyponatremia with short term (30 days) mortality among the
patients of acute ST elevation Myocardial Infarction.
Y. Varma, B. S. Yadav, T. Rajarajan, G. Singh, R. Gupta, R. K. Shrivastava, V. K. Sharma, R. S. Meena,
T. N. Dube, R. K. Jain.
P804Late gadolinium enhancement cardiovascular magnetic resonance is useful
to diferenciate left ventricular systolic dysfunction related to coronary
artery disease from dilated cardiomyopathy in patients with acute new onset
congestive heart failure.
A. Valle, M. Nadal, J. Estornell, C. Soriano, N. Martinez, A. Trigo, R. Romaguera, J. Perez, R. Paya, F. Ridocci-Soriano.
P805The Diabetes-Cardiovascular Risk Paradox: Results from a Finnish PopulationBased Prospective Study
N. C. Barengo, S. Katoh, V. Moltchanov, N. Tajima, J. O. Tuomilehto.
P806
E arly Surgical Management of Anatomically Complete Vascular Rings
T. Tsai, F. Chen, J. Yu.
P807
ICROALBUMINURIA- CARDIOMETABOLIC SYNDROME; INDEPENDENT MARKER OF
M
CARDIOVASCULAR RISK
V. Raos, T. Katic, O. Jaksic, B. Vitunjski-Englert, M. Raguz, J. Sikic-Vagic, M. Bergovec.
P808AUTOLOGOUS INTRAMYOCARDIAL TRANSPLANTATION OF BONE MARROW MONONUCLEAR
STEM-CELLS FOR DILATED CARDIOMYOPATHY – TECNIQUE AND EARLY RESULTS
R. Kalil, D. Ott, R. Sant’Anna, E. Dias, J. Fracasso, A. Cañedo, N. Nardi, J. Sant’Anna, P. Prates, I. Nesralla.
P809EFFECTS OF HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITORS IN
REDUCTION OF INFLAMMATORY RESPONSE TO CARDIOPULMONARY BYPASS
G. Teixeira, R. Kalil, P. Prates, J. Sant’Anna, L. Pellanda, A. Neto, I. Nesralla.
P810Correlation of femoral atherosclerosis and severity of CAD quantified by
Gensini score
M. Vrkic Kirhmajer, L. J. Banfic, M. Vojkoviæ, M. Strozzi, J. Bulum, K. Putarek, T. Simoncek.
P811LEFT VENTRICULAR TORSION DYNAMICS IN PATIENTS WITH FABRY’S DISEASE
Y. Zocalo, E. Guevara, D. Bia, A. Fernandez, J. Casabe, J. Politei, G. Cabrera, R. Armentano.
P812
The change in fractional flow reserve can predict lesion severity
and long term prognosis
S. A. Kocaman, A. Sahinarslan, T. Timurkaynak.
Scientific Programme / 231
Poster Listing
P813Prognostic value of left ventricular diastolic disfunction for adverse
cardiac events
A. Berger-Kucza, K. Wita, M. Turski, M. Trusz-Gluza.
P814
D eterminants of left early and late ventricular remodeling in patients with
acute MI treated with primary PCI
A. Berger-Kucza, W. Wróbel, M. Nowak, M. Trusz-Gluza.
P815
IOFIELD (Aura) scanning for preventive and primary investigation
B
of Heart patients and
S. Vaidya, V Marathe.
P816
Thrombus aspiration for microvascular protection in patients
with acute MI undergoing early primary PCI.
A. Berger-Kucza, M Lelek, K Wita, M Trusz-Gluza.
P817
I mpaired morning arterial distensibility adjustment in
hypertensive patients
D. Bia, S. Lluberas, Y. Zocalo, M. Zabalza, R. Armentano.
P818
P revalence of Metabolic Syndrome in adolescents of
Rio de Janeiro City, Brazil
D. G. Denise Giannini, M. S. Moysés Szklo, M. C. K. Maria Cristina Kuschnir.
P819
The impact of diffuse coronary artery disease on fractional
flow reserve
A. Sahinarslan, S. A. Kocaman, T. Timurkaynak.
P820Screening of Ischaemic Heart Disease in C hronic Arsenicosis Patients
S. Kole, R. Dutta, S. K. Roy, S. K. Biswas, A. Ghosh, A. Kundu, S. Gupta, B. Sarkar.
P821Cadillac risk score and regional perfusion score index
A. Berger-Kucza, M. Turski, K. Wita, M. Trusz-Gluza.
P822
Kissing Ballon Overexpansion in Provisional T-Stenting: Experiences
in a Bench Model
M. Zehetgruber, B. Pausa, B. Frey.
P823
A meliorating Morbidity and Abolishing Hospital Mortality Associated to Isolated
G. Gonzalez-Stawinski, L. Vargas, E. Nowicki, B. Lytle, J. Navia, G. Pettersson, L. Svensson, A. Gillinov, N. Smedira,
J. Sabik.
P825Women receive less invasive treatment after first acute myocardial infarction
A. Hvelplund, J. N. Rasmussen, S. Rasmussen, S. Z. Abildstrøm, M. Madsen, S. Galatius, J. K. Madsen.
Poster Listing
P826
P roximal neuroprotection as the system of choice in high risk carotid artery
stenting: Results from an academic center registry of 143 proximal– and 412
distal–neuroprotected CAS
P. Pieniazek, P. Musialek, A. Kablak-Ziembicka, L. Tekieli, T. Przewlocki, A. Lesniak-Sobelga, B. Biernacka, K. Zmudka,
W. Tracz.
P827
SYCHOLOGY IN THE CARDIAC TRANSPLANTATION PROGRAM
P
S. Bordignon, P. Ruschel, L. Lima, S. Wottrich, R. Machado, E. Vigueras, P. Cordeiro, V. Porto, S. Fonseca, I. Nesralla.
P828Early Myocardial Oxidative Stress Profile at 48h Post-Experimental Infarction
in Rats and the Effects of Cellular Therapy
A. M. V. Tavares, P. C. Schenkel, A. C. Taffarel, R. Dall’ Alba, G. Nicolaidis, G. Baldo, U. Matte, A. Belló-Klein,
L. E. Rohde, N. Clausell.
P829Heart rate recovery on the first minute in the six minutes walk test in patients
with chronic heart failure
S. Chermont, S. Lindemberg Malfacini, M. Pena Quintão, M. De Rossi, S Guilhon, M. M. Veloso, P. L. C. Teixeira,
S. Bernardez, A. C. Lucas Da Nobrega, E. T. Mesquita.
P830Chronic hepatitis C infection is associated with increased coronary artery
atherosclerozis defined by modified Reardon severity score
F. Kacmaz, O. Alyan, B. Deveci, O. Ozdemir, R. Astan, A. S. Celebi, E. Ilkay.
P831SOCIAL INDICATORS OF PATIENTS IN CARDIAC TRANSPLANTATION WAITING LIST ASSISTED
BY SOCIAL SERVICE OF IC/FUC
S. Bordignon, V. Porto, S. Fonseca, L. Lima, J. Vieira, P. Ruschel, P. Cordeiro, I. Nesralla.
P832
I mpact of angiotensin-converting enzyme inhibitor use on the incidence of
atrial fibrillation in the early postoperative period of elective cardiac surgery
F. R. França, R. J. Alves, R. N. Campos, R. B. Piveta, N. Kenji.
P833
I NCREASED S100B SERUM LEVELS IN DILATED CARDIOMYOPATHY PATIENTS
S. Bordignon, G. Mazzini, D. Schaf, E. Horowitz, F. Bacal, R. Bruch, C. Gonçalves, D. Souza, L. Portela.
P834Late results of endoventricular patch plasty repair in akinetic and dyskinetic
areas after acute myocardial infarction
S. Bordignon, P. Prates, A. Homsi-Neto, L. Lovato, G. Teixeira Filho, J. Sant’Anna, L. Yordi, R. Kalil, I. Nesralla.
P835The Effect ol Valsartan in Patients with Pulmonary Hypertension
L. Koldas, F. Ayan, G. Bozkurt, I. Basar.
P836THE ISCHEMIC RAT HEART RELEASES S100B
S. Bordignon, G. Mazzini, D. Schaf, A. Oliveira, C. Gonçalves, A. Belló-Klein, R. Bruch, G. Campos, D. Souza,
L. Portella.
Scientific Programme / 233
Poster Listing
P837Gene expression profiling in atrial fibrillation patients with structural heart
diseases.
M. Kharlap, L. Goryunova, A. Timofeeva, G. Smolyanova, G. Khaspekov, S. Dzemeshkevich, R. Akchurin, V. Ruskin,
S. Golitsyn, R. Beabealashvilli.
P838Angiographic Pulmonary Anatomy in Pulmonary Atresia with Ventricular
Septal Defect. A Useful Classification and Surgical Approach.
Marco Aurelio Santos, Vitor Manuel Pereira Azevedo, José Geraldo De Castro Amino, Maria Ourinda M. Da Cunha,
Rogério Brant Martins Chaves, Maria Cristina C. Kuschnir, Renato Kaufman, Bernardo Rangel Tura,
Regina Maria De Aquino Xavier.
P839Reflections on strategies of psychosocial rehabilitation of the transplant
patient, from my experience as a volunteer in a supportive house.
M. Machado, C. Garcez, M. Tatsch, S. Macin, L. Rosa, N. Antunes, A. Alvim, J. Souza.
P840Comparison of left ventricular ejection fraction evaluated by dual source CT
and two-dimensional echocardiography
R. Duchonova, K. Linhartova, L. Martinkovicova, T. Adla, J. Neuwirth, J. Veselka.
P842
E lective Electrical Cardioversion Protocol: Quality Indicator in
a Cardiac Emergency Department
K. Andrade, A. Pinheiro, A. Volschan, M. F. Muiño, V. Mattos, C. Almeida, G. Trancoso, S. Simas.
P843Acute Effects from Weaning of Mechanical Ventilation by Holter Analysis
G. A. Tinoco, M. P. Quintão, C. L. Oliveira, A. Torrão, J. C. Pereira, J. M. Linhares, L. N. De Barros, R. Tinoco,
E. T. Mesquita, S. Chermont.
P845
S ize of myocardial infarction but not transmurality is associated with lower
left ventricular ejection fraction and higher sphericity index
D. Perez De Arenaza, M. Pietrani, M. Falconi, P. Pollono, J. Moon, FvAbramzon, P. Oberti, L. Grinfeld,
R. Garcia-Monaco, A. Cagide.
P846PYRIDOSTIGMINE INCREASES BAROREFLEX SENSITIVITY AND IMPROVES AUTONOMIC
BALANCE AFTER MYOCARDIAL INFARCTION IN RATS
R. N. De La Fuente, I. C. M. Silva, L. E. De Souza, G. O. Candido, R. A. Sirvente, B. Rodrigues, E. M. Krieger,
S. Lacchini, M. C. Irigoyen.
P847Comparison between High resolution model and traditional Health System
model in an Outpatient Consultation Department of Cardiology. Experience
of 5 years
G. A. Cortez Quiroga, C. Rus Mansilla, M. M. Martinez Quesada, G. Lopez Moyano, M. Delgado Moreno,
E. Ruiz De Temiño De Andres, D. Sevilla Ruiz, M. Gavilan Perez, C. Recuerda Casado.
Poster Listing
P848Calcium-Dependent Tyrosine Kinase PYK2 Plays Crucial Role in Angiotensin IIBut Not Norepineprine-Mediated Activation of Rac/Superoxide Pathway That
Differentially Regulates Blood Pressure and Vasoconstriction
A. Matsui, M. Okigaki, A. Katsume, H. Yamada, H. Matsubara.
P849ENDOMYOCARDIAL FIBROSIS – MISSED DIAGNOSIS
V. Vaghela, K. Sliwa, R. Mvungi.
P850Critical aortic stenosis in infancy – how small can left ventricle be, and still
be adequate to support the circulation after an aortic valvotomy.
Marco Aurelio Santos, Vitor Manuel Pereira Azevedo, José Geraldo De Castro Amino, Maria Ourinda Mesquita
Cunha, Rogério Brant Martins Chaves, Renato Kaufman, Maria Cristina C. Kuschnir, Bernardo Rangel Tura,
Regina Maria De Aquino Xavier.
P853
C ardioprotective Action of Interleukin-1beta in Adaptation to Cardiac Pressure
Overload Stress by Activation of IGF-1/Akt Pathway
S. Honsho, S. Nishikawa, M. Okigaki, A. Matsui, H. Matsubara.
P855Effects of Carvedilol on Quality of Life and Clinical Outcomes in Elderly
patients with Chronic Heart Failure
N. Ganugrava, I. Jashi, B. Kobulia, R. Abashidze, G. Tabidze.
P857Adherence to selective criteria for the use of drug-eluting stents results in
low rates of target vessel revascularisation
J. Gohil, K. Kadappu, Q. Lo, D. Tobing, S. Lo, A. P. Hopkins, D. Leung, C. P. Juergens, J. K. French.
P858Assessment of Myocardial Dysfunction in Patients with non-ST Segment
Elevation Myocardial Infarction Using Serum B-type Natriuretic Peptide Level
B. Kim, B. Lee, C. Goh, Y. Byun, K. Rhee.
P859
C ost-effectiveness of 64- multislice slice coronary CT angiography at
emergency ward compared to standard management in low risk patients with
acute chest pain
D. Perez De Arenaza, M . Falconi, F. Abramzon, P. Pollono, A. Fernandez, PvOberti, LvGrinfeld, R. Garcia’Monaco,
J. Krauss, A Cagide.
P860
orrelation of heart rate with cardiovascular risk factors
C
A. Kalvelis, G. Bahs, I. Stukena, A. Lejnieks, U. Teibe.
P862
H uman aorta transcriptome profiles of different atherosclerotic lesions
types.
A. Timofeeva, L. Goryunova, G. Khaspekov, O. Ilyinskaya, V. Sirotkin, E. Tararak, R. Beabealashvilli.
Scientific Programme / 235
Poster Listing
P863The use of contrast in real-time and in bolus for quantification and
qualification of myocardial flow: comparison with Gated-SPECT and
angiography.
A. Camarozano, A. Soares, D. Bastos, A. Cantisano, C. Oliveira, EvSanson, L. H. Weitzel.
P864
ODULATION OF MONOCROTALINE INDUCED COR PULMONALE BY GRAPE JUICE
M
A. Belló-Klein, A. R. Lenhenbauer-Lüdke, R. Caron-Lienert, F. Mosele, T. R. Fernandes, W. Partata, M.F. Ribeiro.
P865Cost Effectiveness Analysis of Carotid Doppler Ultrasound Examinations in
Patients with Significant Left Main Coronary Artery Stenosis
A. L. V. Oliveira, M. S. Bittencourt, A. C. Pereira, L. A. M. Cesar, L. H. W. Gowdak.
P86699 Tc-SESTAMIBI DIPYRIDAMOLE MYOCARDIAL PERFUSION SINGLE-PROTON EMISSION
TOMOGRAPHY AND CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY SCANNING IN
DETECTION OF ALLOGRAFT CORONARY ARTERY DISEASE AFTER DEART TRANSPLANTTION
A. Tangari, G. S. Fernandes, C. A. M. Cattani, J. P. Silva, J. C. Brigante, L. Fonseca, J. A. Bottega.
P867Predictors of mortality from myocardial perfusion Gated-SPECT in patients
without previous myocardial infarction
P. Pujol, G. Cuberas, G. De León, R. Falú, S. Aguedé-Bruix, J. Castell-Conesa, J. Candell-Riera.
P868
V alsalva maneuver predicts exercise left ventricular outflow tract
obstruction in patients with hypertrophic cardiomiopathy
F. Vaisbuj, A. Fernandez, J. H. Casabe, M. Bustamante Labarta, G. Bozovich, F. Landeta, R. Peidro, G. Fava, E. Guevara.
P869
C ytokine network genes are associated with susceptibility to essential
hypertension in Tatars from Bashkortostan (Russia)
Y. R. Timasheva, T. R. Nasibullin, A. N. Zakirova, O. E. Mustafina.
P870CARDIOVASCULAR REHABILTACION POST CARDIAC TRANSPLANTATION
G. Brion, R. Peidro, A. Angelino, D. Motta, E. Navia, P. Diaz Uberti, F. Bethencourt, M. Diez, L. Favaloro, R. Favaloro.
P871
UTRITIONAL PROFILE OF PATIENTS IN THE WAITING LIST FOR HEART TRANSPLANTATION
N
S. Bordignon, P. Cordeiro, P. Borges, V. Porto, S. Fonseca, E. Horowitz, L. Lima, J. Vieira, P. Ruschel, I. Nesralla.
P872
ulse Oximetrie in Six Minutes Walk Test Associated With Exercise Tolerance in
P
Outpatients With Chronic Heart Failure
S. Chermont, S. Guilhon, M. P. Quintão, M. De Rossi, P. Teixeira, S. Lindemberg, S. Bernardez, D. A. Bastos, P. P. Soares, E. T. Mesquita.
P873Quantification of saved myocardium after primary angioplasty with
myocardial perfusion gated-SPECT. Preliminary results.
P. Pujol, G. De León, S. Aguadé-Bruix, B. García Del Blanco, S. Rossi, R. Falú, J. Figueras, J. Castell-Conesa,
J. Candell-Riera.
Poster Listing
P875Clinical characteristics of pain in men and women admitted to a chest pain unit
M. F. Larin, E. Ludueña Clos, C. Kudrle, G. M. Ferrari, H. Avaca, B. Lopez Ledesma, M. Gingins, EvBrunel,
J. D. Humphreys, O. Manuale.
P876EFFICACY AND SAFETY OF DRUG ELUTING STENTS FOR THE TREATMENT
OF DIFFUSE IN-STENT RESTENOSIS. INFLUENCE OF DIABETES ON LONG-TERM OUTCOME.
G. Schipani, F. Azzari, D. Chambre, A. Fernandez, E. Torresani, S. Brieva, R, Nauwerk, Horacio Pomes Iparraguirre,
C. Barrero, J. Leguizamon.
P877Energetics of ischemia-reperfusion in rat neonatal hearts: differences in Ca
homeostasis
A. E. Consolini, P. Bonazzola.
P878
P rofessional Divers with History of Decompression Sickness Have Much
More Higher Prevalence of Right to Left Shunt Than in Those without Such
Event and Reaveal Favourable Outcome during Mid-term Follow-up after the
Transcatheter Closure
J. Fiedler, T. Honìk, K. Linhartová, J. Veselka.
P879Sub-clinical miocarditis due to Dengue infection
J. Galeano, J. Ortellado, M. Paniagua, I. Lovera, C. Rodriguez.
P880Procalcitonin is a marker of infection after surgery for valvular heart
disease in a predominnatly rheumatic population.
G. Spina, F. Tarasoutchi, L.F. Moreira, R. O. Sampaio, F. Bertanha, V. M. Jonke, C. Strunz, M. Grinberg.
P881
ender differences of cardiovascular risk profile in Lithuania
G
S. Kutkiene, Z. Petrulioniene, J. Badariene, V. Dzenkeviciute.
P882Misclassification of Ischaemic Heart Disease Mortality in Brazil
A. R. N. Migowski Rocha Dos Santos, BERNARDO Rangel Tura, CARLOS Alberto Moreira Magalhães,
MÁRCIA Cristina C. Macedo Pinheiro, MARIA Cristina Kuschnir, REGINA Maria Aquino Xavier, ROGÉRIO Brant
Chaves, VITOR Manuel Pereira Azevedo.
P883Relation between patients baseline characteristic and pre-hospital treatment
and the occurrence of no-reflow after primary percutaneous intervention in
patients with pre-hospital diagnosis by means of ECG teletransmission
L. Malek, M. Karcz, P. Bekta, M. Klopotowski, M. Skwarek, M. Dabrowski, K. Kukula, A. Witkowski,. W Ruzyllo.
P884
A STUDY OF THE PERCEPTION OF THE HEART TRANSPLANTATION PATIENT THROUGH THE
FAMILY CARETAKER.
S. Bordignon, P. Ruschel, L. Lima, A. Souza, C. Thomas, C. Seelig, E. Vigueras, P. Cordeiro, S. Fonseca, I. Nesralla.
Scientific Programme / 237
Poster Listing
P885SPECT Myocardial Perfusion and Pulmonary Ventilation Perfusion Scintigraphy
for Differential Diagnosis between Coronary Artery Disease vs. Pulmonary
Embolism
P. Pujol, S. Valdivielso, G. De León, R. Falú, S. Aiguadé-Bruix, J. Castell-Conesa, J. Candell-Riera.
P886
I mpact of insulin resistance and nonalcoholic fatty liver disease on left
ventricular diastolic dysfunction in non-obese patients
G. Roytberg, O. Sharkhun, T. Ushakova, D. Sobolev, O. Platonova.
P887Multislice computed tomographic characteristics of coronary artery lesions
and pathophysiology insights to Tako-tsubo like left ventricular dysfunction
P. Avellana, C. Tajer, D. Santos, P. Carrascosa, A. Deviggiano, C. Capuñay, A. Pocoví, M. De Abreu, O. Santaera,
L. Antonietti.
P888Antihypertensive efficacy of the direct renin inhibitor aliskiren in patients
with diabetes, metabolic syndrome or obesity: a pooled analysis of 10
randomized trials
M. R. Weir, M. F. Prescott, C. Bush, V. Arora, D. L. Keefe.
P889Rhythm control strategy is not different of rate control strategy:
a long-term follow up cohort study
M. Falconi, P. Oberti, R. Pizarro, A. Arias, F. Achilli, D. Perez De Arenaza, G. Jaimovich, S. Quevedo, J. Krauss,
A. Cagide.
P890
V isceral fat in hypertensive and prehypertensive obese patients
G. Simonyi, J. R. Bedros, M. Medvegy, L. Halmy.
P891CARDIOVASCULAR REHABILITATION POST CARDIAC TRANSPLANTATION: FOLLOW UP AND
DROP OUT
G. Brion, R. Peidro, A. Angelino, D. Motta, E. Navia, P. Diaz Uberti, M. Diez, L. Favaloro, R. Favaloro.
P892
aternal Heart Disease and Pregnancy Outcome: A SingleM
V. Stangl, J. Schad, G. Gossing, A. Borges, G. Baumann, M. Laule, K. Stangl.
P893
LONG TERM FOLLOW-UP AFTER SURGICAL TREATMENT FOR IDIOPATHIC DILATATION OF THE
RIGHT ATRIUM
E. Mesquita, A. C. Rodrigues, V. Schubsky, H. Korkes, M. Barbero-Marcial, S. A. Oliveira, E. Lira, C. Fisher, M. Vieira,
S. Morhy.
P895Prognostic importance of weight loss in patients with heart failure and
different pre heart failure body mass
P. Rozentryt, J. U Nowak, S. Von Heahling, J. Sikora, A. John, U. Wilczek, L. Polonski, S. D Anker.
Poster Listing
P896ACE INHIBITION REVERTS CARDIAC DAMAGE IN EXPERIMENTAL DIABETES: ROLE OF
AUTONOMIC MODULATION
C. Malfitano, R. B. Wichi, K. Rosa, C. Mostarda, K. De Angelis, M. C. Irigoyen.
P897Successful Percutaneous Balloon Fenestration for Aortic Dissection
Presenting as Claudication
B. Kim, B. Lee, C. Goh.
P900The effect of living in the high plateau on cardiovascular system
G. A. Gamez Aldo, C. N. Cellino Natalia.
P901
P rimary Angioplasty in Patients Presenting Late After Onset of Chest Pain and
ST elevation Myocardial Infarction – KAMI registry
B. Kim, C. Goh, YvByun, M. H. Jeong, B. Lee.
P902
C ORRELATION BETWEEN PLASMA HOMOCYSTEINE, CARDIOVASCULAR RISK FACTORS AND
CARDIOVASCULAR DISEASE IN AN ADULT POPULATION FROM BUENOS AIRES.
L. Gariglio, O. Fridman, M. Potenzoni, D. Calcines, G. Perez Baztarrica, I. Bañes, L. Ferrero, J. Schnidt, A. Botbol,
R. Porcile.
P903QUICKOPT®: A NEW ALGORITHM FOR AUTOMATIC ATRIO-VENTRICULAR DELAY
OPTIMIZATION IN PACEMAKERS. A SHORT-TIME FOLLOW-UP STUDY
J. García Guerrero, J. Fernández De La Concha, J. Olagüe, M. J. Sancho-Tello, J. G. Martínez, A. Ibáñez, C. Llorente,
F. Crespo, O. Sanz.
P904
M RI in left ventricular non-compaction. Our experience in eleven patients.
C. A. Rivas, L. Dragonetti, F. Corbella, F. S. Deketele, M. A. Morales Lezica, L. Ahualli.
P905Permanent sinus rhythm is associated with less heart failure hospitalizations
in patients with history of atrial fibrillation
M. Falconi, P. Oberti, R. Pizarro, F. Sosa, L. Lucas, G. Maid, D. Perez De Arenaza, G. Jaimovich, J. Krauss, A. Cagide.
P906
I ncidence and characteristics of ischemic stroke in patients with atrial
fibrillation
M. Falconi, P. Oberti, R. Pizarro, G. Maid, D. Perez De Arenaza, S. Quevedo, A. Arias, F. Achilli, J. Krauss, A. Cagide.
P907The Effect of Telmisartan on Left Ventricular Mass And Renal Function
T. Huang, H. Ezumi, Y. Kobayashi.
P908
H omocysteine Levels and Methylentetrahydrofolate Reductase Gene Variant
(C677T) are Associated with Increased Risk of Hypertension in a Population of
the Buenos Aires City
R. P. Porcile, L Gariglio, V. Vanasco, M. Junco, M. Potenzoni, I. Bañes, O. Fridman.
Scientific Programme / 239
Poster Listing
P909
therogenic Index of Plasma as a Determinant of Oxidized LDL in Slovak NonA
CHD Subjects.
B. Vohnout, P. Blazicek, A. Dukat, G. Fodor, J. Lietava.
P910
S tem cells cardiac transplantation
F. Machado, E. Oliveira, F. Machado, V. Lisboa, B. Bessa, D. Gherardi, I. Pinto.
P911
THEROSCLEROTIC CAROTID PLAQUE IN PATIENTS WITH ACUTE CORONARY SYNDROME (ACS).
A
G. Zampi, F. Fini, G. Illuminati, C. Torromeo, F. Barilla, V. Paravati.
P912
R elation between pulse pressure and in-hospital mortality, 30-day
rehospitalization and combined events, in patients with decompensated heart
failure
R. Cantarelli, F. L. Cantarelli, F. M. F. Oliveira, C. A. Medeiros, C. Sarteschi, S. Martins Marinho.
P913
LONG-TERM OUTCOME OF CAROTID ARTERY STENTING WITH DISTAL EMBOLIC PROTECTION
G. Andersen, F. Azzari, S. Ludueña, D. Chambre, G. Schipani, A. Fernandez, S. Brieva, E. Torresani, H. Bertoni,
J. Leguizamon.
P915
I s stress and depression a prognostic risk factor in unstable angina patients?
N. Vita, A. Esquivel, D. Ostera, S. Bonetti, M. Gassmann, F. Diez.
P916Consistency of the results with a new percutaneous treatment for mitral
regurgitation and heart failure through the coronary sinus (CARILLON-CDI).
A. Ebner, S. Gallo, E. Alvarez, E. Silva, C. Oviedo.
P917
O lder patients with heart failure are at higher risk of hyperkalemia with
spironolactone: results from a heart failure programme
C. Belziti, N. Vensentini, N. Vulcano, S. Fernandez, D. Perez De Arenaza.
P920
G LOBAL MORTALITY ON PATIENTS WITH A PREVIOUS CARDIOVASCULAR EVENT AND
RELANTIOSHIP WITH CARDIOVASCULAR RISK FACTORS IN A COHORT OF PUBLIC EMPLOYEES
MEDICAL SERVICE MENDOZA ARGENTINA. OSEP STUDY (Optimal Systematic Evaluation
Program)
O. Arrieta, S. Mortaloni, S. Zizzias, A. Añó, J. Alvarez, S. Depine, L. Cammi, S. Gimenez.
P921Functional Capacity in Children with Congenital Heart Disease
C. Hossri, I. Jatene, G. Grecca, R. Meneghelo, H. Arakaki, A. Alves, B. Zaccara, S. Buglia, M. Tomazzi, J. Beutel.
P922CLINICAL AND METABOLIC CHARACTERIZATION OF METABOLIC SYNDROME IN CHILDREN
AND ADOLESCENTS IN ARGENTINA
C. Mazza, P. Evangelista, I. Kovalskys, A. Figueroa, P. Digon, S. Lopez, E. Scaiola, N. Perez, G. Dieuzeide.
Poster Listing
P923PROGNOSIS AND PREDICTORS OF LIFE THREATENING ARRHYTHMIAS IN PATIENTS WITH
ACUTE CORONARY SINDROMES
G. Maid, R. Perez Etchepare, F. Rolandi, J. Navarro Estrada, D. Perez De Arenaza, G. Elizalde, C. Moreno,
A. Cagide,
P924Left Main Coronary Artery angioplasty for stable angina and for acute
coronary syndromes. Acute results and long – term clinical outcome of 73
patients.
P. Tyczynski, A. Debski, Z. Chmielak, A. Witkowski, K. Cedro, J. Pregowski, W. Ruzyllo.
P925
F requency and distribution of depressive symptoms at a Cardiology
Consulting Room
J. Tripolone, G. Santiago, R Barin.
P927Blood pressure level, Lipids profile and cardiovascular risk factors in adults
Rwandan health volunteers.
Twagirumukiza Marc, Karagirwa Alphonse, Umutesi Hassina, Seminega Benoit, Musafiri Sanctus, Nkeramihigo
Emmanuel, Luc Van Bortel.
P928Cardiovascular Risk Reduction With Single-Pill Amlodipine/Atorvastatin in
Diverse Populations
R. Blank, S. Erdine, R. Feldman, P. Marques Da Silva, P. Chopra, H. Shi, R. A. Moller, M. Schou.
P929
OMPLEX CATHETERISM PROCEDURES IN A PUBLIC HOSPITAL IN ARGENTINA. FEASIBILITY
C
AND RESULTS
G. Feltes, M. De La Vega, A. Ittig, C. Leonardi, M. Giraudo, G. Pessah, L. Guzmán.
P931Higher aortic valve resistance at rest and in response stress in patients with
aortic valve sclerosis
M. Falconi, P. Oberti, R. Pizarro, A. Arias, L. Lucas, F. Sosa, M. Fernandez, D. Perez De Arenaza, J. Krauss, A. Cagide.
P932
hort Term Results of Repeat Valve Replacement - Predictive Factors Analysis
S
S. Beurtheret, H. Feier, V. Gariboldi, D. Grisoli, A. Riberi, A. Mouly-Bandini, D. Metras, F. Collart.
P934The Prognostic Value of Dypiridamol Stress Echocardiography in Women
B. Markman-Filho, M.C. Almeida, M. Markman, M. Moreno, C. Barros, A. Chaves, I. Labanca, M. F. Lobo, W. Souza,
S. Montenegro.
P935
R ole of adenosine testing in syncope of unknown origin
M. Sammartino, G Albina, R Laiño, A Giniger.
P936Ventriculoarterial Coupling in Severe Aortic Stenosis With Heart Failure
R. Migliore, M. Adaniya, M. Bruzzece, M. Barranco, G. Miramont, F. Guerrero, H. Tamagusuku, A. Sinisi.
Scientific Programme / 241
Poster Listing
P937Study of the depressive load on the cardiologic patient
J. Tripolone, G Santiago, J Gimenez, JM Tripolone.
P938Pulse wave velocity in normotensive adolescents
M. Bracho, E. Silva, G. Bermudez, J. Villasmil, S. Briceño, C. Esis, J. Chacon.
P939Histopathological Features of the Resected Left Atrial Appendage in
Paroxysmal Atrial Fibrillation in patients without Valvular Heart Disease
L. Antonietti, D. Santos, C. Tajer, M. Amat, A. Zapolanski, F. Mastrogiacomo, W. Astorino, E. Domenicchini, J. Lax.
P940Analysis of Clinical Characteristics and Head-up Tilt Test Responses in
Patients Suffering from Unexplained Syncope.
K. Alonso, J. Escobar Calderon, R. Sansalone, J. Armentano, L Ferrer, R. Aguero, M. Leonardi, Horacio Pomes
Iparraguirre.
P941
PITHELIOID HAEMANGIOENDOTHELIOMA OF THE AORTA
E
G. Feltes, M. Losano, N. Bustamante, G. Ghirardi, A Uribe, L. Guzmán.
P942
articularities of the Cardiovascular Risk in Old Women in an Urban Romanian
P
Community
D. Pop, D. Zdrenghea, A. Sitar-Tautu, M. Cebanu, D. Colcear, B. Borz.
P943
istopathologic Evaluation of Prophylactic Effects of Zofenopril, Enalapril
H
and Valsartan against Doxorubicin Cardiotoxicity in Rats
E. Bozcali, V. Karpuz, D. B. Dedeoglu, O. Suzer, H. Karpuz.
P944
requency of Incomplete Stent Apposition Assessed by StentBoost:
F
a Novel Angiographic Technique
A. Candiello, M. Albertal, F. Cura, L. Padilla, P. Perez Baliño, S. Jozami, J. Thierer, J. Belardi.
P945Acute aortic regurgitation due to spontaneous rupture of a fenestrated
cusp: report in six cases.
J. Goral, D. Avayu, J. Mitelman, D. Morisse, C. Froimovich, L. Rodas.
P946
A pplication of Health Informatics for Global Efforts: The Care of Adult
Congenital Heart Defects’ Surveillance
A. Krishnaswamy, G. Mensah, W. Book, M. McConnell, T. Lyle, A. Correa.
P947Bisoprolol favorably alters diastolic function and reduces NT-pro-BNP levels
in diastolic heart failure with restrictive transmitral flow pattern.
K. G. Adamyan, A. L. Chilingarian, A. V. Astvacatryan.
Poster Listing
P948EFFECTS OF SUPPLEMENTATION WITH SATURATED, MONOUNSATURATED OR
POLYUNSATURATED RICH-OILS ON FUNCTIONAL ASPECTS OF HIGH-DENSITY LIPOPROTEIN
(HDL) IN HAMSTERS.
F. Maniero, A. F. Padoveze, T. V. Oliveira, M. H. H. Santos, T. M. Seydell, M. L. Guzzo, C. H. Azevedo, R. C. Maranhão.
P949
ELATIONS OF QT INTERVALS WITH DIFFERENT DEFINITIONS AND COMPONENTS OF
R
METABOLIC SYNDROME IN
B. Longo-Mbenza, J. B Kasiam On’kin, J. C Manzala Kumbi, A. Nge Okwe, B. Buassa-Bu-Tsumbu, N. Kangola,
D. Vangu Ngoma, S. Mbungu Fuele, I. Longo Phemba.
P950The Effect of Homocysteine-lowering B-vitamin Intervention on Angiographic
Coronary Artery Disease May Be Adverse - A WENBIT Sub-Study
K. H. Løland, A. J. Blix, Ø. Bleie, E. Strand, P. M. Ueland, H. Refsum, M. Ebbing, J. E. Nordrehaug, O. K. Nygård.
P951Single and delayed defibrillation testing the day after first implantation of
cardioverter defibrillator: a reliable and safe strategy
H. Bader, N. Delarche, R. Lasserre, G. Flory, G. Estrade.
P952
Novel Coronary Heart Disease Risk Evaluation and Communication Program
A
Improves Modifiable Risk Factors and Understanding in Patients With
Hypertension: The Risk Evaluation And Communication Health Outcomes And
Utilization Trial (REACH OUT)
L. Erhardt, J. S. Benner, R. A. Moller, N. Rajicic, S. B. Cherry, Z. Gaciong, E. S. Johnson, M. C. J. M. Sturkenboom,
J. Garcia-Puig, X. Girerd.
P953TOBACCO CONSUMPTION AND PREVALENCY IN THE PERSONNEL OF A HOSPITAL
D. Morisse, D. Avayu, G. Lewy, J. Mitelman, J. Goral, C. Martorano, J. Gallo, C. Froimovich.
P954
O besity and Hypertension
Z. Brankovic.
P955HEALTH CAMPAIGN: A METHOD OF SCREENING AND EDUCATION IN CARDIOVASCULAR
HEALTH.
A. C. Santomauro Jr., M. R. Ugolini, L. Z. P. Oliveira, I. A. B. Bincoleto, F. M. B. Rossi, B. S. Santoro, E. R. Suarez,
C. Nagaoka, A. C. Santomauro, C. Ferreira.
P956
ROGNOSIS INFLUENCE OF LEISURE-TIME PHYSICAL ACTIVITY PRACTICE PRIOR TO
P
CORONARY ARTERY BYPASS GRAFT SURGERY
R. Nery, I. Mahmud, J. Barbisan, L. Smidt.
P957
ORRELATION BETWEEN EPIDMIOLOGICS FACTORS AND DIABETES MELLITUS IN PATIENTS
C
SUBMITTED TO MYOCARDIAL REVASCULARIZATION SURGERY
A. C. Santomauro Jr., L .Z. P. Oliveira, M. R. Ugolini, I. A. B. Bincoleto, C. Nagaoka, W. A. Amorim, J. Albuquerque,
A. C. Santomauro, A. T. Santomauro, F. Fraige Filho.
Scientific Programme / 243
Poster Listing
P958Secondary Prevention of Cardiac Sudden Death with Implantable CardioverterDefibrillator in Patients with Chronic Chagasic Cardiomiopathy and Preserved
Left Ventricular Function
P. R. Salvador, D. D Nascimento, S. A Fakhouri, A. S Fakhouri, A. C Silva, E. S Resende, C. S Melo, F. R De Fazzio,
F. H Silva, E. E Kanaan.
P959
P recise filtered-QRS limits tracking in signal-averaged electrocardiography:
Comparison between classical ESC vs. new derivative-based method
O. Nasario-Junior, P. R. Benchimol-Barbosa, J. Nadal, C. Miranda, G. N. Gobbi, F. P. Vilela, J. Barbosa-Filho,
I. Cordovil.
P960ELECTROCARDIOGRAPHIC ALTERATIONS OF PREVALENCE IN YOUNG SPORTMEN SOCCER
AMATEUR CATEGORY, CORRELATION WITH DOPPLER CARDIAC
I. Diaz, D. Avayu, D. Morisse, C. Seidler, J. Fuse, J. Goral, L. Rodas, A. Cardozo, A. Cler Pereyra, C. Froimovich.
P962
E xercise induced elevation of NT-pro-BNP is associated with subsequent
coronary events in men with negative stress-test.
K.G. Adamyan, A. L. Chilingarian, A. V. Astvatsatryan.
P963
RE CHANGES IN THE ARTERIAL WALL RESPONSIBLE FOR THE DECLINATION OF MENTAL
A
ACTIVITY IN LONGEVOUS INDIVIDUALS ?
E. Izcovich, A. Lescano, A. Izcovich, V. Daru, R. Izcovich, R. Ferreyra.
P964
ypertrophic cardiomyopathy: Case report
H
E. R. F. L Moraes, F. S. V. Jardim, G. T. Gama, F. L. Vieira, F. J. B. Silva Filho, D. R. Almeida.
P965
ssessment of Stent Expansion By a Novel Angiographic Technique: Stentboost
A
M. Albertal, A. Candiello, F. Cura, L. Padilla, P. Perez Baliño, S. Jozami, J. Thierer, J. Belardi.
P966Clinical Features of Patients Undergoing CABG who had Prior Percutaneus
Coronary Stenting.
A. Vizcarra Diaz, R. Marenchino, L. Diodato, V. Cesareo, A. Domenech, D. Bracco.
P968
A ssessment of left ventricle sublinical dysfunction and surgical outcome in
asymptomatic severe Mitral regurgitation. Study of Vector velocity Imaging
J. Moreno, M. A. Garcia, V. Celorrio, E. Perez, R. Pereira.
P969
B aseline plasma levels of nitrites/nitrates in patients with vasovagal syncope
G. A Ruiz, S. Sinigaglia, R. Hermes, R. Chirife, M. Capula, H. Grancelli, M. Nogues, M. C. Tentori.
P970
TUDY OF THE HEART RATE VARIABILITY IN TYPE 2 DIABETES MELLITUS
S
A. C. Santomauro Jr., C. Nagaoka, M. R. Ugolini, L. Z. P. Oliveira, I. A. B. Bincoleto, F. M. B. Rossi, B. S. Santoro,
W. A. Amorim, A. C. Santomauro, F. Fraige Filho.
Poster Listing
P971
The combination of different imaging techniques seems to be recommendable in
the quantification of pulmonary vein ostia sizes.
M. Christ, G. Plehn, M. Van Bracht, H. J. Trappe, A. Meissner.
P972Cardiotoxic effects of pentavalent antimony in guinea-pig leading to
arrhythmia and cardiomyopathy.
A. C. A Carvalho, L. F. Rodrigues-Jr., C. C. Lores, M. O. Masuda, A. C. C Carvalho, J. H. M. Nascimento.
P973
T-proBNP is not useful in early follow-up of heart transplant patients
N
D. Milicic, J. Ljubas, B. Pezo-Nikolic, B. Skoric.
P974
E valuation of the cardiopulmonary resuscitation teaching-learning by the
nursing team
L. A. B. N. Sampaio, A. M. K. Miyadahira.
P975Association between pravastatin and enalaprilat in the reversal of left
ventricular hypertrophy in rats induced by isoproterenol-preliminary results.
I. A. B. Bincoleto, A. C. Santomauro Jr., M. R. Ugolini, L. Z. P. Oliveira, A. Meneghini, C. Ferreira Filho, T. R. Theodoro,
E. R. Suarez, N. Murad, C. Ferreira.
P976
Takotsubo Syndrome: a cathecolamine cardiomyopathy
I. A. B. Bincoleto, A. C. Santomauro Jr., M. R. Ugolini, L. Z. P. Oliveira, F. M. B. Rossi, B. S. Santoro, J. F. Kelendjian,
R. Alessi, A. R. P. Rieira, C. Ferreira.
P977
P ercutaneous treatment of chronic total occlusion in routine clinical
practice
S. Jozami, M. Albertal, F. Cura, L. Padilla, A. Candiello, P. Perez Baliño, J. Thierer, J. Belardi.
P978CARDIOPULMONARY RESUSCITATION (CPR) IN THE POSTOPERATIVE ONE OF
CARDIOVASCULARY SURGERY: CHARACTERIZATION OF THE ACTIVITIES AND NECESSITIES OF
TRAINING EVIDENCED BY THE PROFESSIONALS OF NURSING.
L. A. B. N. Sampaio, A. M. K. Miyadahira, D. V. Correa.
P979TGF-B1 MEDIATES THE HYPERTROPHIC CARDIOMYOCYTE GROWTH INDUCED BY
ISOPROTERENOL IN RATS.
I. A. B. Bincoleto, A. C. Santomauro Jr., L. Z. P. Oliveira, M. R. Ugolini, C. Ferreira Filho, A. Meneghin I, T. R.
Theodoro, E. R. Suarez, N. Murad, C. Ferreira.
P980
C ardiac Peptides during Exercise in Heart Failure Patients
D. Zdrenghea, M. Ilea, D. Pop, D. Petrovai.
P981
ction of Memantine in the myocites of rats submitted to cold stress.
A
I. A. B. Bincoleto, A. C. Santomauro Jr., M. R. Ugolini, L. Z. P. Oliveira, C. Ferreira Filho, M. Ferriera, A. R. P. Rieira,
A. Meneghini, C. Ferreira, N. Murad.
Scientific Programme / 245
Poster Listing
P982
USPICION OF ACUTE CORONARY ILLNESS IN DIABETIC PATIENTS. CLINICAL
S
CHARACTERISTICS, TREATMENT AND EVOLUTION AT THIRTY DAYS
P. Gallo, S. Saravia Toledo, R. Leon De La Fuente, C. Laspiur, S. Araujo, A. Farah, F. Marconetto, H. Velez,
N. Barrientos.
P984
The influence of gastric bypass in the improvement of the Metabolic Syndrome
factors in the later post-operative (6 months)
I. A. B. Bincoleto, F. M. B. Rossi, A. C. Santomauro Jr., M. R. Ugolini, L. Z. P. Oliveira, W. A. Amorim, A. Serpa Neto,
R. B. F. Silva, M. Rossi, E. Z. Chehter.
P985
I s maximal exercise capacity related to ventricular dyssynchrony in
asymptomatic aortic stenosis?
M. Bustamante-Labarta, F. Vaisbuj, P. Roura, J. Casas, C. Lopez, M. Diaz, F. Salmo, C. Rodriguez-Correa,
G. Marambio, E. Guevara.
P986
C ardiac output monitoring in critical care: Influence of the height of the
headboard of the bed in the cardiac output and hemodynamics measurements.
V. S. Bulgarelli, L. A. B. N. Sampaio.
P987
I ncidence and risk factors of major bleeding in acute coronary syndrome
patients
A. Reina, F. Manzano, M. Colmenero, P. Castan, M. Rodriguez-Elvira.
P988
C LINICAL COURSE AND PROGNOSIS OF INFECTIVE ENDOCARDITIS IN THE ELDERLY
C. M. Cortés, R. J. San Miguel, P. Roura, C. Nagel, C. Salvatori, A. Arlia Ciommo, E. Dulbecco, J. Abud, R. R. Favaloro,
J. H. Casabe.
P989
D RUG TREATMENT OF HEART FAILURE PATIENTS IN A ROMANIAN GENERAL HOSPITAL
C. Talos, D. Zdrenghea, D. Pop.
P990
V entricular Tachyarrhythmias and the Impact of ICD Therapy in Patients with
Arrhythmogenic Right Ventricular Cardiomyopathy
F. Duru.
P991
USPICION OF ACUTE CORONARY DISEASE IN PATIENTS OVER 75 YEARS OLD. CLINICAL
S
CHARACTERISTICS, TREATMENT AND EVOLUTION AT THIRTY DAYS
P. Gallo, S. Saravia Toledo, R. Leon De La Fuente, S. Araujo, F. Wayar, C. Laspiur, F. Marconetto, C. Toldo, F. Rassi,
E. Aramburu.
P992
A ddition of Ivabradin further improves clinical status in patients with end
stage heart failure and intolerance to SS-blockers.
K. G. Adamyan, A. L. Chilingarian, A. V. Astvacatryan.
Poster Listing
P993
S hould Natriuretic Peptide (BNP) be considered for a marker of symptomatic
status in severe aortic stenosis patients?
M. Katz, G. Spina, F. Tarasoutchi, C. Strunz, R. O. Sampaio, M. Grinberg.
P994
I ntake of isoflavones-enriched soy product fermented with Enterococcus
faecium decrease total and non-HDL cholesterol levels in rats
D. C. U. Cavallini, E. A. Rossi, I. Z. Carlos, R. C. Vendramini, R. C Damaso, R. Bedani, G. F. Valdez.
P995
LIPOPROTEIN (a) CONCENTRATION IN THREE AFRO-AMERICAN POPULATIONS IN ZULIA
STATE, VENEZUELA
D. Aparicio, V. Bermúdez, E. Mengual, J. Faria, F. Finol, X. Guerra, D. Gotera, L. Acosta, E. Rojas, L. Sorell.
P996
symmetric and symmetric dimethylarginine are weaker predictors than
A
homocysteine of long-term mortality in both men and women with stable angina
G. Svingen, P. M. Ueland, Ø. Bleie, J. E. Nordrehaug, T. Folkestad, K. Kuiper, M. Ebbing, E. R. Pedersen, S. E. Vollset,
O. Nygård.
P997Does the frequency of syncope predict the response to Head-up tilt-table
testing in adolescents
R. Andalaft, D. Moreira, R. Habib, L. Moraes, K. Tukamoto, G. Bellini, V. Cerutti, R. Hams, D. Serrano,
C. Marques.
P998
Long Term Outcome Of Patients With Type B Aortic Dissection
D. Bracco, R. Marenchino, A Domenech, V. Cesareo, L. Diodato.
P999
B -Type Natriuretic Peptide and anemia, are they related?
R. A. F. Gomes, L. M. Sena, J. L. Ferreira, C. Sarteschi, S. M. Martins, A. D. M. Feitosa.
P1000 I ncidence of the cardiovascular risk factors in the patients of the Health
Campaign in Santo André, Brazil
A. C. Santomauro Jr., M. R. Ugolini, L. Z. P. Oliveira, I. A. B. Bincoleto, F. M. B. Rossi, B. S. Santoro, C. Nagaoka,
J. F. Kelendjian, E. R. Suarez, C. Ferreira.
P1001ASSESSMENT OF THE ANALGESIC EFFECTIVENESS OF GENERAL ANESTHESIA AND SPINAL
ANESTHESIA USING MORPHINE AND ROPIVACAINE IN PATIENTS SUBMITTED TO MIOCARDIAL
REVASCULARIZATION SURGERY
V. Pinheiro, R. Diniz, M. Ferreira, J. Costa, E. Pinheiro, M. Cascudo.
P1002SUSPICION OF ACUTE CORONARY DISEASE IN WOMEN, CLINICAL CHARACTERISTICS,
TREATMENT AND EVOLUTION AT THIRTY DAYS
R. Leon De La Fuente, S. Saravia Toledo, P. Gallo, S. Araujo, P. Kairuz, F. Wayar, N. Marquez, A. Lopez Facchin,
M. Geronimo.
Scientific Programme / 247
Poster Listing
P1003Ecologic methods for measuring health disparities attributed to
socioeconomic factors: risk of premature CVD mortality across geodemographic areas of Porto Alegre, Brazil
S. L. Bassanesi, M. I. R. Azambuja, A. C. Achutti.
P1004SUSPICION OF ACUTE CORONARY DISEASES, CLINICAL CHARACTERISTICS, TREATMENT AND
EVOLUTION AT THIRTY DAYS
R. Leon De La Fuente, S. Saravia Toledo, P. Gallo, C. Laspiur, S. Araujo, C. Flores Borja, A. Farah, J. Gomez, J. Zapata,
F. Rassi.
P1005Myocardial infarction : Strategy and results in hospitals with/without PCI
chance.
L. Herrera-Para, A. Reina-Toral, R. Diaz-Contreras, R. Lirola-Liebanas, G. Moratalla-Cecilia, F. Manzano-Manzano,
I. Slimobich, J. Benitez-Parejo, E. Aguayo-De Hoyos, J. C. Luque-Moscoso.
P1007PAINFUL PROCEDURES IN THE POST-OPERATORY OF CARDIAC SURGERY
V. Pinheiro, C. Pimenta.
P1008ADDITIVE VALUE OF TROPONINE T TO ADMISSION ELECTROCARDIOGRAM IN PATIENTS WITH
SUSPICION OF ACUTE CORONARY DISEASE
S. Saravia Toledo, P. Gallo, R. Leon De La Fuente, F. Marconetto, C. Laspiur, C. Rodriguez, G. Castillo,
F. Gomez Ortega, C. Swarzman.
P1009Cardiac I Troponin as a Predictor of Normal Coronary Arteries in Association
to Gender in Patients with Acute Coronary Syndrome without ST Segment
Elevation.
D. Di Nanno, L. Lopez, M. Consoli, C. Pasinato, A. Bordenave, J. Tartaglione, S. Chekherdemian.
P1010LONG TERM FOLLOW UP OF BIFURCATION LESIONS ANGIOPLASTY: OUR EXPERIENCE.
D. Grinfeld, D. Berrocal, G. Cugat, J. Gabay, C. Agatiello, P. Pollono, F. Fuertes, A. Fernandez, J. L. Parmisano, L. Grinfeld.
P1011Homeostasis model assessment (HOMA) as surrogate insulinization criteria in
patients with type 2 diabetes
F. Finol, V. Bermúdez, D. Aparicio, L. Acosta, R. Canelón, E. Rojas, E. Mengual, K. Acosta, R. Cano, M. Cabrera.
P1012The ratio of apolipoproteins ApoB/ApoA1 as a predictor of angiographic
progression of atherosclerosis in patients with coronary artery disease
A. J. Blix, K. H. Loland, O. Bleie, E. Strand, P. M. Ueland, H. Refsum, M. Ebbing, J. E. Nordrehaug, O. K. Nygard.
P1013Incremental shuttle walk test in the assessment of functional capacity in
chronic heart failure
C. Pulz, A. N. F. Alves, R. V. Z. Diniz, A.S. Tebexreni, A. C. C. Carvalho, A. A. V. De Paola, D. R. Almeida.
Poster Listing
P1014Antioxidant therapy improves left ventricular diastolic function
and alters remodeling in patients with postinfarction heart failure and
impaired renal function.
K. G. Adamyan, A. L. Chilingarian, A. V. Astvatsatryan.
P1015Low Frequency Power of Heart Rate Variability Associated With Baroreflex
Impairment in Myocardial Infarction in Rats
C. Mostarda, E. D. Moreira, B. Rodrigues, M. Vane, K. T. Rosa, E. M. Krieger, K. De Angelis, M. C. Irigoyen.
P1017Is carvedilol useful for symptomatic heart failure patients with chronic
cardiomyopathy due to a Chaga‘s disease?
R. V. Z. Diniz, R. F. M Viegas, J. M. L Amorim, A. S. Tebexreni, A. C. C. Carvalho, A. A. V. Paola, D. R. Almeida.
P1018Minimally-invasive cardiac surgical ablation (Wolf Mini-Maze) of Atrial
Fibrillation in patients without concomitant heart disease. Three years
follow up.
L. Antonietti, A. Zapolanski, D. Santos, F. Mastrogiacomo, A. Villamil, N. Gastaldello, J. Lax, C. Tajer.
P1020Heart Rate Variability Analysis in Patients with Congenital Generalized
Lipodystrophy (Berardinelli-Seip Syndrome)
C. Faria, D. Sobral-Filho, J. Brandão-Neto, A. Rego, S. Egito, F. Baracho.
P1022PLASMA LEVELS OF NITRIC OXIDE METABOLITES AND VASCULAR ENDOTHELIAL FUNCTION
IN MAJOR DEPRESSION SUBJECTS.
R. G Garcia, J. G. Zarruk-Serrano, W. Arenas-Borda, C. Barrera, E. Trillos, A. Pinzon, D. Quintero, C. Tomaz,
P. Lopez-Jaramillo.
P1024Orange Juice Synergistic Effects on GemfibrozilTreatment in High Fat Fed
Rabbits
M. Higuchi, J.J. Raposo, S. A. P. Palomino, M. H. H Santos, R. Ikegami, M. M Reis.
P1025B6 vitamers and long term mortality in patients with stable angina
E. R. Pedersen, M. Ebbing, O. Midttun, P.M. Ueland, S.E. Vollset, O. Bleie, H. Schartum-Hansen, J. E. Nordrehaug,
O. Nygard.
P1027Endothelium dysfunction as cardiovascular events risk factor in patients
with metabolic syndrome
O. Savenko, V. Vikentyev.
P1028Changes in multifractal parameters of heart rate fluctuations in correlation
with circadian differences of heart rate
R. Galaska, D. Makowiec, A. Dudkowska, A. Koprowski, M. Fijalkowski, A. Rynkiewicz.
Scientific Programme / 249
Poster Listing
P1030Molecular identification of T. cruzi lineages and populations in endstage Chagas heart disease patients undergoing heart transplantation:
predominance of lineage I
J. M. Burgos, M. Diez, C. Vigliano, M. Bisio, T. Duffy, L. Favaloro, R. Favaloro, M. J. Levin, A. G. Schijman.
P1032Percutaneous revascularization in elderly women. Do they have worst
prognosis?
M. Monteverde, H. Caballero, S. Liotta, E. Barrera, H. Fernandez, S. Berenztein, M. Vazques Blanco, E. Sampo,
J. Lerman.
P1034APICAL HYPERTROPHIC CARDIOMYOPATHY AND APICAL CALCIFIED THROMBUS:
A NEW COMPLICATION?.
M. C. Saccheri, T. F. Cianciulli, R. J. Mendez, I. V. Konopka, H. J. Redruello, G. E. Gigena, D. F. Serans, R. S. Acunzo,
H. A. Prezioso, L. A. Vidal.
P1035Role of theophylline (adenosine antagonist) or N-acetylcysteine alone and in
combination for prevention of contrast induced nephropathy
S. Kumar, N. Sinha, K. Chawla, A. Kapoor, S. Tewari, N. Prasad, S. Gambhir, S. Barai.
P1036Does the use of 600 mg Clopidogrel loading dose before percutaneous
coronary intervention in acute coronary syndromes increase the risk of
bleeding after the procedure?
R. Gusmao De Oliveira, A. Figueiredo, J. Petriz, A. Marques, M. Cardoso, A. Glavan, A. Brasileiro, B. Tura,
P. Resende.
P1038Bleeding complications in elderly patients with non-ST elevation acute
coronary syndromes: predictors and outcomes
C. Lourenço, R. Teixeira, A. Natália, S. Monteiro, S. Costa, F. Goncalves, P. Monteiro, L. Goncalves, M. Freitas,
L. A. Providencia.
P1039ACUTE CARDIAC INSUFFICIENCY SECONDARY TO VIRAL MYOCARDITIS: A CASE STUDY
C. L. Weksler, R. Alves, F. T. Oliveira, A. L. C. Marins, V. Z. Mattos, V. R. Souza.
P1041Maintenance of Venous Access as Indicator of Quality of Care for Nursing
A. L. C. Marins, R. Mourilhe Rocha, R. Esporcatte.
P1042THE IMPACT OF CORONARY ARTERY BYPASS GRAFT SURGERY IN THE ABANDON OF
SMOKING
R. Pietrobon, J. Barbisan, L. Smidt.
P1043MALE GENDER AND METABOLIC SYNDROME IN YOUNG INDIVIDUALS FOLLOWED-UP FOR A 17
YEARS-PERIOD. THE RIO DE JANEIRO STUDY
A. A. Brandao, M. E. C Magalhaes, E. G Campana, F. L Fonseca, O Pizzi, E. V Freitas, R Pozzan, A. P Brandao.
Poster Listing
P1045Anti-streptoccocal vaccination induces lowering of anti-oxLDL antiboties in
responding diabetic patients.
E. Rzewuska, M. Karynski, K. Jankowski, M. Puchta, A. Lipinska, P. Grzesiowski, D. Liszewska-Pfejfer, P. Pruszczyk.
P1047Is ankle-brachial index associated with ischemia on myocardial perfusion
scintigraphy in elderly patients?
L. Machado, P. Smanio, C. Ferreira, J. Borges, M. Castillo, A. Thom, L. Piegas.
P1048Prevalence of ‘responders’ and ‘non-responders’ to antiplatelet drugs
M. G. Gonzalez Achaval, S. Ghione, M. Hadad, S. Gomez, L. A. Del Val, C. Balestrini.
P1049Homocysteine and markers of immune activation as predictors
of mortality in stable angina patients
E. R. Pedersen, P. M. Ueland, S.E. Vollset, O. Midttun, G. Svingen, H. Schartum-Hansen, O. Bleie, M. Ebbing,
J. E. Nordrehaug, O. Nygard.
P1050PREVALENCE AND CHARACTERISTICS OF HIGH BLOOD PRESSURE AND ITS ASSOCIATION
TO CARDIOVASCULAR RISK FACTORS IN SOUTH SERBIA
I. Burazor, M. Burazor, N. Vukadinovic, B. Lovic, Z Burazor, G. Cvetanovic, N. Burazor.
P1051Tissue synchronization imaging in the localization of the accessory
atrioventricular pathways
M. Lanocha, A. Szyszka, K. Blaszyk, R. Ochotny, S. Grajek.
P1052Role Of Pentoxifylline (Non-Specific Anti-Cytokine Agent) On Left Ventricular
Ejection Fraction And Functional Class In Patients With Left Ventricular
Systolic Dysfunction
S. Kumar, N. Sinha, A. Kapoor, S. Tewari, G. S. Gill, V. Agarwal, R. N. Mishra.
P1053HIGH BLOOD PRESSURE IN A COHORT OF PEOPLE JOINT TO PUBLIC EMPLOYEES MEDICAL
SERVICE OF MENDOZA ARGENTINA
A. Añó, S. Mortaloni, O. Arrieta, S. Zizzias, L. Cammi, G. Vega, S. DepineY, S. Gimenez.
P1054A comparative study of Carotid Intima Media Thickness in Patient of End stage
renal disease patients on peritoneal dialysis
S. Kumar, N. Sinha, N. Prasad, K. Chawla, A. Kapoor, S. Tewari.
P1055Effects of flu vaccination of senior citizens (60+) on seasonal trends of
morbi-mortality in Brazilian hospitals.
M. I. Azambuja, S. L. Bassanesi.
P1056INTIMAL PROLIFERATION INDUCED BY PERIVASCULAR INFLAMMATION IN MICE:
COMPARISON BETWEEN FEMORAL AND CAROTID ARTERIES
S. Lacchini, L. F. Borges, J. P. F. Blini, B. S. Yasumura, J. E. Krieger.
Scientific Programme / 251
Poster Listing
P1058Impact of Body Mass Index in the Target Organs Damage in Patients with
Resistant Hypertension
M. Barros, A.B. Lima, C. A. S. Nascimento, J. R. M. Pereira, F. D. Vilela, V. Verri, P.R. Benchimol-Barbosa,
F. E. S. F. Cruz, I. Cordovil.
P1059Can the progression of endothelium dysfunction be a predictor
of cardiovascular events in patients with metabolic syndrome?
O. Savenko, V. Vikentyev.
P1060Myocardial infarction with angiographically normal coronary arteries in an
infant
A. Sardella, H. Vazquez, I. Abella, C. Viegas, I. Torres, M. Grippo, M. Cazalas, A. Goldsman, A. Slichter, C. Kreutzer.
P1061Clinical impact of prophylactic use of aprotinin in cardiac surgery.
S. Olival, B. Santos, R. Gomes, A. Rouge, L. Alves, M. Freitas, R. Vegni, W. Homena, J. O. R. Brito, O. N. Barbosa.
P1063Cardiogenic Shock without Acute Cardiac Syndrome: clinical profile of
patients, management strategies and prognosis.
I. Wojtkowska, M. Banaszewski, A. Konopka, M. Marona, J. Stepinska.
P1064Acute Heart Failure With Preserved Systolic Function in Acute Coronary
Syndrome Patients: clinical relevance and outcomes
C. Lourenço, R. Teixeira, S. Monteiro, N. António, S. Costa, F. Gonçalves, P. Monteiro, L. Gonçalves, M. Freitas,
L. Providência.
P1065Ambulatory blood-pressure monitoring in patients with severe aortic
regurgitation, before and after treatment with nifedipine
F. Gual-Capllonch, A. Evangelista, J. L. Tovar, T. Gonzalez-Alujas, M. Alvarez, P. Mahia, R. Aguilar, P. Tornos.
P1066The impact of Head-Up Tilt Test (HUT) with nitroglycerine (NTG) provocation on
chosen parameters of assessment in the healthy human subject circulation
K. Peczalski, P. Sionek, D. Wojciechowski.
P1068TYPE 2 DIABETICS WITH HIGH LEVELS OF C-REACTIVE PROTEIN PRESENT A REDUCTION OF
HEART RATE VARIABILITY
E. O. Fernandes, A. L. A. Branquinho, S. M. R. Castro, V. A. Leite, B. V. França, A.L.R.M. Freitas, L. C. Silva.
P1069ARTERIAL HYPERTENSION AND DYSLIPIDEMIA: COMPARISON AMONG ANAMNESIS AND THE
RESULTS GOT FROM DIGITAL SPHYGMOMANOMETER AND BIOCHEMICAL MEASUREMENT
FROM PERIPHERAL BLOOD
A. L. P. Arnaldo Lemos Porto, D. M. S. N. Douglas M. Silva Nascimento, J. P. H. R. João Paulo Hanel Rorato,
E. C. A. R. Eliane Consuelo A. Rabelo, C. C. P. Celmo Celeno Porto.
Poster Listing
P1070THE IMPACT OF NURSING CONSULTATION ON THE CONTROL OF INR
F. Silva, A. Camara, R. Filho, C. Barros, S. Figueiredo, T. Guimaraes, I. Santos, I. Oliveira, M. Bosa, R. Silva.
P1071Lower serum Fetuin-A levels are associated with aortic sclerosis in patients
with coronary artery disease and preserved renal function
K. Linhartova, J. Veselka, G. Sterbakova, O. Topolcan, R. Cerbak, J. Racek.
P1072SCIENTIFIC ANALYSIS OF PRODUCTION OF CARDIOVASCULAR NURSING UNDER THE
PREVENTION TERTIARY
A. Camara, C. Barros, D. Santoro, F. Silva, R. Barreiro Filho, R. Silva, S. Figueiredo, T. Guimarães, I. Santos,
L. Campos.
P1073Peri-stent Remodeling after Sirolimus-eluting or Paclitaxel-eluting Stent
Implantation in Diabetic Patients. A Randomized Serial Intravascular
Ultrasound Study.
L. O. Jensen, M. Maeng, P. Thayssen, E. H. Christiansen, K. N. Hansen, A. Galloe, H. Kelbaek, J. F. Lassen, L. Thuesen.
P1074The multidisciplinary team care to secondary prevention in a group with
resistant hypertension treated in a public institute of cardiology in Rio de
Janeiro, Brasil.
A. B. Lima, M. Barros, V. Verri, J. R. M. Pereira, C. A. S. Nascimento, F. D. Vilela, P. R. Benchhimol-Barbosa,
F. E. S. F. Cruz, I. Cordovil.
P1075The relationship between angiotensin converting enzyme gene polymorphism
and comorbidities in rural community patients with chronic heart failure.
H. Balieiro, E. T. Mesquita, T. L. Balieiro, S. R. Brito, R. B. Moreira, R. K. Osugue, S. B. Pereira, A. M. Domingos,
A. P. Moraes, G. Ribeiro.
P1076Successful treatment of endotension and aneurysm sac enlargement with
endovascular stent graft reinforcement.
M. Ferreira, R. La Mura, E. Ruslender, J. C. Parodi.
P1077METHIONINE PRODUCED AN IMPAIRMENT OF CARDIOVASCULAR AUTONOMIC MODULATION
IN RATS
G. O. Candido, R. H. Mendes, R. N. De La Fuente, C. Mostarda, I. C. M. Silva, L. Jorge, M. C. Irigoyen, K. Rigatto.
P1078IMPACT OF A MANAGED ACUTE MYOCARDIAL INFARCTION (AMI) PROTOCOL IN THE
PRESCRIPTION RATE OF ACE INHIBITORS OR ANGIOTENSIN RECEPTOR BLOCKER FOR
HOSPITALIZED PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND LEFT VENTRICULAR
SYSTOLIC DYSFUNCTION
M. R. P. Makdisse, A. Correa, S. Lagudis, S. S. Morhy, F. Bacal F, M. Knobel, C. H. Fischer, M. L. C. Vieira,
P. V. Pires, E. Knobel.
Scientific Programme / 253
Poster Listing
P1079Analysis of possible iPods interference with Pacemakers
M. Benassi, E. Valero, R. Pesce, L. Jurado.
P1081Contemporary management of carotid artery stenosis: carotid
endarterectomy is here to stay. Selection of the approach according to
patient surgical risk.
M. Ferreira, R. La Mura, E. Ruslender, J. C. Parodi.
P1082The resistant hypertension genotypes of the population resident in Rio de
Janeiro
F. D. Vilela, P. R. Benchimol-Barbosa, C. C. Zeno, A. B. Lima, M. Barros, F. V. Campos, C. S, Miranda, G. N. Gobbi,
J. Barbosa-Filho, I Cordovil.
P1083GLYCAEMIA AT ADMISSION ACCURATELY PREDICTS IN-HOSPITAL OUTCOME IN ACUTE
CORONARY SYNDROME PATIENTS
S. Monteiro, S. Costa, F. Goncalves, P. Monteiro, L. Goncalves, M. Freitas, L. A. Providencia.
P1084Usefulness of multislice computed tomography in the detection
of non-suspected coronary and myocardial diseases
M. Falconi, D. Perez De Arenaza, P. Oberti, P. Pollono, A. Fernandez, F. Abramzon, L. Grinfeld, R. Garcia Monaco,
J. Krauss, A. Cagide.
P1085ASSOCIATION BETWEEN PROGNOSTIC FACTORS IN SEVERE IDIOPATIC DILATED
CARDIOMYOPATHY AND FIBROSIS EVALUATED BY CARDIOVASCULAR MAGNETIC
RESONANCE
M. L. O. Mugnaini, D. B. Précoma, P. R. Schvartzman, L. A. Z. Moura, S. H. Barberato, G. Lemke, P. R. Brofman.
P1086Does symmetry of the aortic outflow velocity profile reflect contractile
function in coronary artery disease ? An automated analysis using
mathematical modelling
M. Cikes, H. Kalinic, A. Baltabaeva, S. Loncaric, C. Parsai, J. Separovic Hanzevacki, I. Cikes, G. Sutherland, B. Bijnens.
P1087Absence of electrocadiographic abnormalities in children infected with
Trypanosoma cruzi from a rural area of Argentina.
C. D. Lacunza, M. Gonzalez, A. Alberti, R. Cimino, V. Pereyra, R. Zacca, V. Orellana, M. A. Basombrío, J. Nasser,
P. Diosque.
P1088HEMODYNAMIC AND AUTONOMIC RESPONSES TO A MENTAL STRESS TEST AND
TO AN ISOMETRIC EXERCISE TEST IN OFFSPRING OF HYPERTENSIVE PARENTS.
J. V. Francica, M. V. Heeren, C. Mostarda, M. Sartori, M. Tubaldini, R. C. Araújo, M. C. Irigoyen, K. De Angelis.
P1089Population awareness on cardiovascular risk factors:
a developing country experience PrevenAção
A. Avezum, H. Guimarães, A. Brasileiro, P. Esteves, A. Neto, M. Bertolami, C. Serrano, L. Maia, A. Marco, F. Nobre.
Poster Listing
P1090264 DAYS ON BIVENTRICULAR MECHANICAL ASSISTANT SUPPORT
AS BRIDGE TO TRANSPLANTION IN A 31 MONTH OLD PATIENT
H. Vogelfang, G. Naiman, A. Villa, A. Charroqui, G. Moreno, R. Magliola, L. Quiroga, G. Burlli, D. Haag, M. De La Riba.
P1091NORMOTHERMIC CARDIOSURGERY. THE COMPARATIVE ANALYSIS
OF HEMODYNAMIC IN AORTO-CORONARY BYPASS SURGERY
R. S. Ovchinnikov, L. A. Bockeria, V. A. Lischouk, I. U. Sigaev, D. S. Gazizova, L. V. Sazukina, V. E. Volgushev.
P1092Hypertension Screening with a New Digital Blood Pressure Device Named
“Rastreometer”
A. D. M. Feitosa, V. R. Lafayette, L. B. N. C. Magalhaes, M. A. M. Gomes, R. D. Miranda.
P1093Latvian bifurcation lesion registry – IVUS results
A. Erglis, I. Kumsars, I. Narbute, D. Sondore, S. Jegere, A. Dombrovskis, A. Lismanis, I. Olina.
P1094Amplitude of in-hospital glycaemia variation: a new prognostic marker in
acute coronary syndromes?
S. Monteiro, N. Antonio, S. Costa, C. Negrier, R. Teixeira, F. Goncalves, P. Monteiro, L. Goncalves, M. Freitas,
L. A. Providencia.
P1095THE EFFECTS OF RESISTANCE EXERCISE ON PLASMA KINETICS OF AN ARTIFICIAL
NANOEMULSION THAT BINDS TO LOW-DENSITY LIPOPROTEIN RECEPTORS
J. L. Silva, C. G. Vinagre, A. T. Morikawa, R. C. Maranhao.
P1096Cardiac Magnetic Resonance in heterozygotes females with Anderson-Fabry
disease
L. Dragonetti, C. Rivas, F. Corbella, E. Eyheremendy, Adellfa.
P1097EXERCISE TRAINING INDUCED AUTONOMIC IMPROVEMENT WAS ASSOCIATED WITH
METABOLIC AND RENAL DYSFUNCTIONS ATTENUATION IN AN EXPERIMENTAL MODEL OF
METABOLIC SYNDROME AND MENOPAUSE.
K. Ponciano, J. Brito, I. Sanches, M. Heeren, M. C. Irigoyen, K. De Angelis.
P1098BODY MASS INDEX AND IN-HOSPITAL ACS OUTCOME:
THE MIDDLE IS THE PLACE TO BE!
S. Monteiro, S. Costa, F. Goncalves, P. Monteiro, L. Goncalves, M. Freitas, L. A. Providencia.
P1099Anaemia and renal failure – a deadly duet in Acute Coronary Syndromes
S. Monteiro, S. Costa, F. Goncalves, P. Monteiro, L. Goncalves, M. Freitas, L. A. Providencia.
P1100Using a fiber and phytonutrient combination therapy to control
hypercholesterolemia in an African American community
L. Njord, R. Njord, W. Cooper, P. J. E. Verdegem.
Scientific Programme / 255
Poster Listing
P1101CORONARY ACUTE SYNDROME IN PATIENTS ADMITTED TO THE EMERGENCY IN THE CENTRAL
HOSPYTAL OF THE SOCIAL INSTITUTE PREVISIÒN
F. Fernandez Chamorro, C. Saldivar, L. Fatecha, M. Centurión, J. Paredes, L. Bell, A. Villamayor, V. Marmol,
J. Gonzalez, S. Aguirre.
P1102Predictors and Clinical Relevance of Troponin Elevation following
percutaneous Aortic Valve Replacement
H. Jilaihawi, T. Spyt, E. Logtens, J. C. Laborde, D. Chin, J. Kovac.
P1103ENDOVASCULAR RECONSTRUCTION BY MEANS OF STENTS OF SYMPTOMATIC INTRACRANIAL
STENOSIS
P. Lylyk, C. Miranda, R. Ceratto, A. Ferrario, J. Vila, C. Ingino.
P1104Diabetes: a coronary artery disease equivalent revisited in acute coronary
syndrome patients
S. Monteiro, N. Antonio, S. Costa, C. Negrier, R. Teixeira, F. Goncalves, P. Monteiro, L. Goncalves,
M. Freitas, L. A. Providencia.
P1105Cardiac abnormalities in patients with HIV-related malignancies
in Sub-Saharan Africa
C. Onen.
P1106Angiopoietins mediate monocyte adhesion to endothelial cells
and have pro-inflammatory actions independent of VEGF
R. Potluri, T. Fujisawa, K. Chudasama, S. Ahmad, P. Hewett, M. Cudmore, A. Ahmed.
P1107HOW DO PARENTS AND RESPONSIBLE OF SCHOLARS DEAL WITH TONSILLITIS
AND RHEUMATIC FEVER IN RIO DE JANEIRO?
R. Müller, M. F. M. P. Leite, D. L. Sampaio, M. C. C. Kuschnir, M. J. L. M. Silva, A. S. Souza, R. Thurler, R. Bedim,
F. F. Nascimento, R. M. A. Xavier.
P1108Long-term (up to five years) Clinical Outcomes of On-label versus Off-label
Patients in the DESIRE (Drug Eluting Stents In the REal world) Registry
J. Costa Jr., A. Sousa, R. Costa, A. Costa, M. Cano, G. Maldonado, O. Berwanger, R. Pavanello, M. Barbosa,
J. Eduardo Sousa.
P1109Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of
extracellular signal-regulated kinases (ERK) 1/2 in rat heart in vivo.
J. F. Giani, M. M. Gironacci, M. C. Muñoz, D. Turyn, F. P. Dominici.
P1110MICROVASCULAR DIABETIC COMPLICATIONS ARE MORE PREVALENT IN INDIA COMPARED TO
MAURITIUS AND THE UK DUE TO POORER DIABETIC CONTROL
R. Potluri, Y. Purmah, N. Sewpaul, M. Dowlut.
Poster Listing
P1111Electrocardiographic patterns and coronariographic correlation in patients
with STEMI that underwent Percutaneous Coronary Intervention on admission
to hospital.
I. Santos-Rodriguez, M. J Ruiz-Olgado, V. Ramirez-Castro, J. Rodriguez-Collado, M. Cascon-Bueno, A. Perez-Bueno,
V. Leon-Arguero, I. Cruz-Gonzalez, F. Martin-Herrero, M. Diego-Dominguez.
P1113“ASSESSMENT OF ATRIAL SYSTOLE WITHIN THE FIRST 24 HOURS AFTER CARDIOVERSION IN
PATIENTS WITH ACUTE ATRIAL FIBRILLATION”
G. Rodriguez Botta, E. Escudero.
P1114Obesity as a predictor of mayor cardiovascular risk factors- Chilean
policemen cohort.
F. Vilchez, P. Varleta, B. Clericus, P. Salvo.
P1115Predictive Value of Cardiac I Troponin for High Risk Anatomy in Acute Coronary
Syndromes without ST Segment Elevation.
D. Di Nanno, L. Lopez, A. Torterola, A. Bordenave, M. Consoli, C. Pasinato, R. La Greca, S. Chekherdemian.
P1116Heart rate variation disturbance followed by right ventricle acute systolic
strain after pulmonary embolisms
M. Palinsky, J. Petrovicova, P. Mitro, M. Szakacs.
P1117EXCELLA First-in-Man STUDY : SAFETY AND EFFICACY OF ELIXIR NOVOLIMUS-ELUTING
STENT IN THE TREATMENT OF PATIENTS WITH DE NOVO CORONARY LESIONS
A. Abizaid, J. Costa Jr., R. Costa, F. Feres, D. Siqueira, P. Fitzgeral, R. Staico, D. Siqueira, A. Sousa, J. Eduardo Sousa.
P1118Association of alanine aminotransferase with cardiovascular risk factors in
40 years old subject from Slovak general population
B. Vohnout, J. Gasparovic, Z. Basistova, S. Wsolova, L. Fabryova, K. Raslova.
P1119Restenosis of Drug-eluting stents: a Currently Unsolved Issue?
J. Costa Jr., A. Sousa, R. Costa, A. Moreira, G. Maldonado, M. Cano, E. Romano, C. Jardim, C. Campo, J. Eduardo Sousa.
P1120Preliminary Results of the Hydroxyapatite Non-Polymer-Based SirolimusEluting Stent for the Treatment of Single De Novo Coronary Lesions – A FirstIn-Human Analysis of a Third Generation Drug-Eluting Stent (DES) System
A. Abizaid, J. Costa Jr., R. Costa, F. Feres, R. Graebin, R. Staico, L. Fernando Tanajura, A. Abizaid, A. Sousa,
J. Eduardo Sousa.
P1123The use of PICC in Infectious Endocarditis Treatment
P. Silva, A. Silva, C. Barros, G. Carvalho, L. Campos, P. Mota, P. Marinho, R. Barreiro Filho, R. Silva, T. Guimarães.
Scientific Programme / 257
Poster Listing
P1125Long-term results of drug-eluting stents for the treatment of saphenous
vein grafts: What we learned from the DESIRE-SVG (Drug-Eluting Stents In REal
world - Saphenous Vein Graft) Registry
J. Costa J., A. Sousa, A. Moreira, R. Costa, G. Maldonado, M. Cano, E. Egito, A. Cury, O. Berwanger, J. Eduardo Sousa.
P1126Tilt test in the investigation of exercise-induced syncope of unknown origin
A. Nobrega, R. Castro, A. Souza.
P1127Differential influences of high fat diet on cardiac remodeling from
normotensive and spontaneously hypertensive rats
S. A. Oliveira Júnior, A. P. Lima-Leopoldo, P. F. Martinez, D. H. S. Campos, M. M. Sugizaki, M. P. Okoshi, K. Okoshi,
C. R. Padovani, M. Dal Pai-Silva, A. C. Cicogna.
P1128Impact of Invasive Strategy in elderly patients presenting with
non-ST elevation acute coronary syndromes
C. Lourenço, R. Teixeira, N. António, S. Monteiro, S. Costa, F. Gonçalves, P. Monteiro, L. Gonçalves, M. Freitas,
L. A. Providência.
P1129NON ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROMES. ANTECEDENTS, CLINICAL
PRESENTATION AND PREDICTORS OF PROGNOSIS BY MULTIVARIATE ANALYSIS
H. Pomés Iparraguirre, G. Calderón, W. Santander, J. H. Leguizamón, O. Paredes, G. Kuhn, A. Arias Posada, L. Ferrer,
R. Aguero, G. Valeriano.
P1130Exercise antioxidant protective effect improves cardiovascular and renal
function in diabetic hypertensive rats
T. S. Cunha, R. H. Mendes, M. Bertagnolli, G. Cândido, J. P. Aguiar, K. Flues, K. De Angelis, F. K. Marcondes,
A. Belló-Klein, M. C. Irigoyen.
P1131Chronic Clopidogrel and Aspirin Therapy for Coronary Artery Disease: A 10 year
Clinical Follow-Up
S. Krishna, R. Suneja, P. C. Chabot, N. Kleiman.
P1132Role of M-mode septal to posterior wall motion delay as predictor
of response to cardiac resynchronization therapy
N. António, L. Coelho, S. Costa, H. Vieira, R. Martins, M. Ventura, J. Cristóvão, L. Elvas, L. Gonçalves,
L. A. Providência.
P1133Is an invasive strategy useful in women with non-ST acute coronary
syndrome?
R. Teixeira, C. Lourenço, N. Antonio, S. Monteiro, S. Costa, F. Gonçalves, P. Monteiro, L. Gonçalves, M. Freitas,
L. A. Providencia.
Poster Listing
P1134Very long-term clinical outcomes of a consecutive high-complexity population
treated with drug-eluting stents: Results of the DESIRE (Drug Eluting Stents
In the REal world) Registry
J. Costa Jr., A. Sousa, R. Costa, A. Moreira, M. Cano, G. Maldonado, C. Jardim, M. Helena Dib, C. Campos,
J. Eduardo Sousa.
P1135Vascular risk factors in perimenopausal female physicians in Argentina
H. Z. Zylbersztejn, Horacio, A. M. Mulassi, Andres, A. C. Cardone, Alberto, A. P. Picarel, Anibal, A. R. Robilotte
Analia, E. P. Pautasso, Enrique, S. K. Kusznier, Silvia, C. B. Belziti, Cesar.
P1136RISK OF HEMODIALYSIS AFTER HEART SURGERY
B. Santos, S. Olival, R. Gomes, A. Rouge, L. Alves, M. Freitas, R. Vegni, W. Homena, J. O. R. Brito, O. N. Barbosa.
P1137SYNCOPE WITH INJURY. DIAGNOSTIC AND OUTCOME
N. Galizio, L. Soriano, G. Fava, J. L. Gonzalez, L. Medesani, P. Montoya, S. Schanz, R. Ramon, H. Ramirez.
P1139Diagnosis of the Metabolic Syndrome and its Relation with Insulin Resistance.
G. Giunta, L. Cuniberti, C. Escarain, N. Pizzi, S. Lynch, A. Miranda, A. Christen, G. Yannarelli, R. Sanchez, H. Baglivo.
P1140C Reactive Protein and Cardiac I Troponin. Two Sides of the Same Medal?
D. Di Nanno, L. Lopez, M. Consoli, F. Petrolito, A. Costa, L. Saclietti, C. Pasinato, S. Chekherdemian.
P1141A new Strategy for Rheumatic Fever Prevention through Health Education –
PREFERE Program, Rio de Janeiro, Brazil
R. E. M. Regina Elizabeth Muller, M. C. K. Maria Cristina Kuschnir, B.R.T. Bernardo Rangel Tura,
R. M. A. X. Regina Maria Aquino Xavier, M. J. L. S. Maria José Lucas M. Da Silva, A. L. S. Ana Lucia Schilke,
F. F. N. Fabiana F. Nascimento, A. E. A. S. Anna Esther Araújo E Silva, A. B. L. Ana Beatriz Lima,
M. F. C. Marcia Fernanda De Carvalho.
P1142Angiographic and ultrasonographic comparison of Sirolimus and Novolimuseluting stents for the treatment of coronary lesions
J. Maia, J. Costa Jr., A. Abizaid, D. Chamie, F. Feres, R. Costa, R. Staico, D. Siqueira, A. Sousa, J. Eduardo Sousa.
P1144Mitochondrial ATP-Sensitive Potassium Channel Participation
in Spironolactone Preconditioning
C. C. Lores, L.F. Rodrigues Jr., A. C. A Carvalho, A. C. C. Carvalho, J. H. M. Nacimento.
P1145RESTRICTIVE CARDIOMYOPATHY: ETIOLOGIES AND OUTCOME IN A SINGLE CENTER
EXPERIENCE
V. Gregorietti, M. Peradejordi, A. Bertolotti, M. Diez, L. Favaloro, L. Talavera, C. Vigliano, R. Laguens, R. Favaloro.
P1146EQUIPLANARITY OF ECHOCARDIOGRAPHIC, SPECT AND CARDIAC MAGNETIC RESONANCE
IMAGING PLANES. TO WHAT EXTENT ARE THE AHA STATEMENTS FOR SEGMENTATION AND
NOMENCLATURE PRACTICABLE?
R. Asbot, K. Sugar, I. Balogh.
Scientific Programme / 259
Poster Listing
P1147THE GOOD SCORE´S QUALITY OF LIFE IS A MARKER FOR THE GOOD CONTROL
ON BLOOD PRESSURE IN HYPERTENSION PATIENT?
G. M. Guerra, E. O. Freitas, P. L. Silva, D. M. A. Giorgi, E. M. Krieger, H. F. Lopes.
P1148Relationship between ventricle-vascular coupling and the ventricular
function parameters. Concept of ventricle-vascular interaction.
J. Tripolone, G. Santiago, A. Schott, J. M. Tripolone.
P1149Racial Distribution Of Nitric Oxide Synthase Polymorphism In
A Multi-ethnical Population
E. Mesquita, S. Bernardez, O. Tardin, L. Pessoa, S. Chermont, T. Alves, H. Balieiro, L. Amorim, G. Ribeiro, M. Velloso.
P1152Atherothrombosis in acute coronary syndromes: one size does not fit all!
S. Monteiro, N. Antonio, S. Costa, R. Teixeira, C. Negrier, F. Goncalves, P. Monteiro, L. Goncalves, M. Freitas,
L. A. Providencia.
P1153STROKE AFTER CARDIOTHORACIC SURGERY: ANALYSIS OF ASSOCIATED FACTORS
S. Olival, B. Santos, R. Gomes, A. Rouge, L. Alves, M. Freitas, R. Vegni, W. Homena, J. O. R. Brito, O. N. Barbosa.
P1154Experience with covered stent implantation in congenital heart disease.
A. Peirone, A. Guevara, A. Spillmann, E. Juaneda, G. Pessah, G. Guglieri, E. Banille, L. Alday.
P1155MYOGENIC REGULATORY FACTORS EXPRESSION IN SKELETAL MUSCLE CHANGES DURING
VENTRICULAR DYSFUNCTION AND HEART FAILURE
P. F. Martinez, K. Okoshi, L. A. M. Zornoff, R. F. Carvalho, S. A. Oliveira Jr, D. H. S. Campos, A. R. R. Lima,
C. R. Nogueira, M. Dal Pai-Silva, M. P. Okoshi.
P1156Precompetitive assessment in young athletes
J. Kriskovich, R. Rasmussen, E. Villegas, G. Pereira Zini, M. Avila, M. De La Rosa, E. Tassano.
P1158emergency service: analysis of chest pain unity
J. Silveyra, P. Bayol, O. Querencio, E. Fernandez, S. Manzolillo, R. Zoni, J. Parras, J. Kriskovich, J. Escalante,
R. Peloso.
P1159Evaluation of Aortic Pathology by Cardiac Magnetic Resonance
A. Ithuralde, C. Seara, J. Moltedo, J. P. Gallo, C. Nojek, P. Garcia De Lucis, M . Garcia Nani, A. De Elizari, M. Ithuralde.
P1160NON ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROMES IN DIABETIC PATIENTS.
CLINICAL CHARACTERISTICS, THERAPEUTIC INTERVENTIONS AND INHOSPITAL OUTCOME
H Pomés Iparraguirre-, G Kuhn, G Calderón, W Santander, JH Leguizamón, O Paredes, R Aguero, L Ferrer,
J. Torres, A. Cejas.
Poster Listing
P1161Exercise testing assessment in active men and their relationship with smoking
J. Kriskovich, R. Rasmussen, E. Villegas, M. Avila, G. Pereira Zini, J. Sanagua, H. Martinez, E. Tassano.
P1163Family history of tobacco smoking and attitude towards the patient smoker in
female physicians of Argentina
H. Z. Zylbersztejn, Horacio, A. M. Mulassi, Andres, A. C. Cardone, Alberto, A. P. Picarel, Anibal, A. R. Robilotte,
Analia, E. P. Pautasso, Enrique, S. K. Kusznier, Silvia, C. B. Belziti, Cesar.
P1164Blood pressure control and prevalence of arterial hypertension in
adolescents of a rural population in Argentina. Vela Project.
Matias Tringler, Alejandro Diaz, Soledad Saravia, Maria Silvia Grenóvero.
P1165Analysis of Risk Factors for Cardiovascular Disease among Women in a city in
Argentina
M. Del Sueldo, Md, C. Serra, Md, Ph, G. Guerrero, Engineer, R. Rodrigo, Md. M. Carasa, Md. S. Castellino,
Md. V. Giovinni, Md. I. Vigil Torres, Md. D. Barra, Biochemist, J. Zilberman, Md.
P1166Anthropometric, Metabolic And Cardiorespiratory Profile Of Subjects Older
Than 60 Years-old In Brazil Southern Population
K. C. Belli, C. M. Richter, T. F. Panigas, D. C. Bündchen, T. Dipp, J. Z. Klafke, K. C. Guidini, C.F. Panigas, P. R. N. Viecili.
P1167Angiographic and ultrasonographic results of the SISC (Stent In Small
Coronaries) Registry
D. Chamie, J. Costa Jr., A. Abizaid, R. Costa, F. Feres, J. Maia, F. Devito, D. Siqueira, A. Sousa, J. Eduardo Sousa.
P1168Relationship Between Heart Rate Equations and Maximum Oxygen Consumption
for Exercise Program Prescription
J. L. C. Pippi, T. F. Panigas, T. Dipp, C. M. Richter, K. C. Belli, C. F. Panigas, D. C. Bündchen, J. Z. Klafke, P. R. N. Viecili.
P1169Rehabilitation in coronary patient: follow up
J. Kriskovich, R. Rasmussen, G. Amarilla, J. Vallejos, M. Avila, E. Villegas, J. Parra Moreno.
P1170Detection of coronary artery disease in asymptomatic patients with type
2 diabetes mellitus: Prevalence of perfusion defects detected by stress
technetium-99m sestamibi myocardial perfusion single-photon emission
computed tomography.
C. D. C Collaud Carlos, R. M. Redruello Marcela, B. J. Blanco Juan, P. O. Parysow Oscar, M. O. Masoli Osvaldo.
P1171Analysis of the reflective vasomotor carotid response to the
hyperventilation test. Comparative study between normal patients with risk
factors and patients with carotid atherosclerotic obstruccion
J. Tripolone, G. Santiago, J. M. Tripolone.
Scientific Programme / 261
Poster Listing
P1172Heart failure mortality in three brazilian states from 1999 to 2004: an analysis
it´s association with other conditions chosen as underlying cause of death.
E. Gaui, G. Oliveira, C. Klein.
P1173Long-Term Outcomes in Patients with Unstable Angina Evaluated
in a Chest Pain Unit
T. G. Allison, G. S. Reeder, P. A. Smars.
P1174PREDICTORS OF MEDIASTINITIS AFTER HEART SURGERY
S. Olival, B. Santos, R. Gomes, M. Santos, K. Senna, A. Rouge, M. Freitas, R. Vegni, J. O. R. Brito, O. N. Barbosa.
P1175Nutritional Profile in Outpatients With Chronic Heart Failure in a
Heart Failure Clinic
E. Britto, S. Chermont, E. T. Mesquita.
P1176The role of balloon static atrioseptostomy in inter atrial estabilization of
infants with complex congenital heart disease
L. Simões, P. R. Travancas, C. Lace, J. G. Athayde, W. Paiva, A. Inocenzi, M. Celente, F. Gurgel, A. H. Dorigo, C. C. Assef.
P1178VASCULAR EFFECTS OF CANDESARTAN AND TEMPOL IN A MODEL OF METABOLIC SYNDROME
N. F. Renna, E. S. Gonzalez, M. C. Lama, R. M. Miatello.
P1179Detection, awareness, counseling and control of hypertension in the US adult
age 18 years of more: A NHANES 1999-2004 study.
Sunil Kumar Agarwal, Samir Saba.
P1180Critical Pulmonary Valve Stenosis of the Neonate: Treatment With Balloon
Percutaneous Valvoplasty.(BPV)
L. Simões, C Lace, P. R. Travancas, P. S. Oliveira, F. Gurgel, W. Paiva, A. Inocenzi, M. Celente, J. G. Athayde,
A. H. Lago Dorigo.
P1181Aortopulmonary window—impact of associated lesions on natural history
and in the surgical results
L. Simões, C. Gangana, J. Caliani, C. C. Assef, R. Minardi, A. H. Lago Dorigo, P. R. Travancas, C. Lace, M. Celente, F. Gurgel.
P1182PERSPECTIVA DE GÉNERO EN TORNO A LA CARDIOPATÍA ISQUÉMICA Y LA SEXUALIDAD DE
LOS PACIENTES CORONARIOS.
I. Brevis.
P1183Angiotensin-(1-7) downregulates tyrosine hydroxylase through a proteasomedependent pathway
M. A. Lopez Verrilli, M. M. Gironacci.
Poster Listing
P1184Hospital Costs and Effects of Congenital Heart Surgery stratified with
Aristotle Score
E. Trindade, C. Tanamati, M. Barbero Marcial, R. Assad, M. Jatene, A. Riso, A. A. Lopes, L. Caneo, S. Fujii,
C. Yukiko Osato.
P1185Distribution of beta–adrenergic receptors polymorphisms in a Brazilian Heart
Failure Clinic.
S. Bernardez, O. Tardin, L. Pessoa, T. Alves, B. Cavaliere, R. Abdalah, S. Chermont, V. Navega, G. Ribeiro,
E. Mesquita.
P1186Ankle brachial index and its associated obesity criteria
T. Paes, D. Orlandi, F. Gazoni, H. Guimaraes, L. Vendrame, R. Lopes, A. C. Lopes.
P1188Dilated Cardiomyopathy Registry in Chronic Hemodialys Patients (REMIDIAL)
L. Gastaldi, M. Viso, C. Mascheroni, F. Acosta, D. Genova, A. Davila, S. Pezzotto, H. Lastiri, J. Beloscar.
P1189LIPOPROTEIN(a) PLASMATIC LEVELS AND LIPIDIC PROFILE ON INDIVIDUALS OF THE AÑÚ
TRIBE OF THE PAEZ MUNICIPALITY, ZULIA STATE, VENEZUELA
L. Acosta, A. Siciliano, V. Bermúdez, E. Mengual, D. Aparicio, R. Canelón, F. Finol, E. Rojas, J. Faría, L. Sorell.
P1190ENALAPRIL BUT NOT HYDRALAZINE INCREASES ENDOCARDIAL TRANSIENT OUTWARD
POTASSIUM CURRENT IN RAT CARDIOMIOCYTES
L. F. Rodrigues Jr., C. C. Lores, A. C. A. Carvalho, A. C. C. Carvalho, J. G. Mill, J. H. M. Nascimento.
P1191Incidence of depressive symptoms on the left ventricular function parameters
J. Tripolone, G. A. Santiago, J. M. Tripolone.
P1192WHICH IS THE LATE EVOLUTION OF SYMPTOMATIC PATIENTS WITH OBSTRUCTIVE
HYPERTROPHIC CARDIOMYOPATHY SUBMITTED TO ALCOHOL SEPTAL ABLATION?
MANUEL Nicolas Cano, SILVIA Judith Fortunato De Cano, ADRIANA C Moreira, RICARDO Pavanello,
JAIRO Alves Pinheiro Jr., AMANDA Gmr Sousa, JOSE Eduardo Mr Sousa, ADIB Domingos Jatene.
P1194Evaluation of anthropometric measures, clinical, nutritional and physical
activity level in subject with different levels of cardiovascular risk
A. P. Q. Mello, I.T. Silva, C. A. Sanibal, A. S. Timm, R. D. S. Filho, R. C. Maranhao, N. R. T. Damasceno.
P1195Does the type of stent influence in-hospital outcome in
acute coronary syndrome patients?
S. Costa, S. Monteiro, N. Antonio, C. Negrier, R. Teixeira, F. Goncalves, P. Monteiro, L. Goncalves, M. Freitas,
L. A. Providencia.
Scientific Programme / 263
Poster Listing
P1196WHICH IS THE BEST STRATEGY TO TREAT CONCOMITANT CAROTID
AND CORONARY ARTERY DISEASE?
MANUEL Nicolas Cano, ANDRÉS Sanchez Esteva, ANTONIO M. Kambara, FAUSTO Feres, ALEXANDRE Abizaid,
SAMUEL M. Martins, LEOPOLDO Soares Piegas, AMANDA Guerra Mr Sousa, JOSE Eduardo Mr Sousa,
ADIB Domingos Jatene.
P1197Noninvasive method for assessment of endothelial function based on
reflection index obtained with post-occlusive reactive hyperemia
A. S. F. Ferreira, Arthur De Sá, J. B. F. Barbosa Filho, José, I. C. Cordovil, Ivan, M. N. S. Souza, Marcio Nogueira.
P1198Atrial Fibrillation Analysis on the Absence of Cardiac Illness through the
Stroke Volume and Echocardiogram
J. Morais, T. Diogenes, J. Paes Jr.
P1199MAIN PULMONARY ARTERY PRESSURE WAVEFORM ANALYSIS: a time-domain approach
for complete hemodynamic evaluation during pulmonary hypertension.
J. Grignola, L. Devera, F. Ginés.
P1200THE EFFECTS OF THE BREATH CONTROLLED INCURSION ON THE BLOOD PRESSURE SYSTEM
IN SUBJECTS WITH RESISTENT HIPERTENSIVE TO THE TREATMENT: IMPACT OF AUTONOMIC
MODULATION ON RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
C. S. Miranda, P. R. Benchimol-Barbosa, G. N. Gobbi, J. Barbosa-Filho, M. V. Barros, A. B. R. Lima, F. Vilela,
F. V. Campos, I. Cordovil.
P1201The Volumetric Index of the Left Atrium is more Precise than the Limiar Measure
by the Echocardiogram
J. Morais, T. Diogenes, J. Paes Jr.
P1202Correlation between the average speed of mitral ring excursion by M-mode and
the conventional DP / DT of the mitral regurgitant flow valued by Doppler Echo
J. Tripolone, G. A. Santiago, J. M. Tripolone.
P1203Role of the cardiovascular magnetic resonance in patients with ventricular
arrhythmia of unknown cause
D. Perez De Arenaza, G. Maid, M. Falconi, M. Pietrani, P. Pollono, F. Abramzon, R. Perez-Etchepare,
R. Garcia Monaco, A. Cagide, G. Elizalde.
P1204Native Infective Endocarditis in 111 children: Changing Patterns
M. V. Lafuente, C. Villalba, G. Rossi, E. Lataza, H. Capelli.
P1205Analysis of DNA polymorphisms in the Endothelin-1 and Superoxide dismutaseMn genes and their relationship with the evolution of
the Chagasic Cardiomyopathy
O. Lassen, F. Quintiero, S. Tabares, J. Herrera, A. Garutti, G. Dotto, R. Sosa, R. Galerano, A. Sembaj.
Poster Listing
P1206CONTROL OF RISK FACTORS TREATMENT THROUGH CAROTID INTIMA-MEDIA THICKNESS
AND ENDOTHELIUM-DEPENDENT BRACHIAL ARTERY VASODILATATION FOR HIGH RISK
PATIENTS.
C. Ingino, M. Kura, R. Machado, A. Cherro, E. Ricardo, P. Lylyk.
P1207Evaluation of the Volumetric Index of the Left Atrium on Diabetics and
Hypertensive Patients
J. Morais, T. Diogenes, J. Paes Jr.
P1208PRELIMINARY REPORT AFTER A 7 YEAR FOLLOW-UP IN WOMEN WITH A HIGH RISK SCORE
EXERCISE TOLERANCE TEST AND A NORMAL CORONARY PERFUSION SPECT.
G. Llamas-Esperon, S. Varela-Ortiz, S. Sandoval-Navarrete, R. Munoz-Sandoval, M. L. Fuantos-Delgado,
U. Casas-Juarez, J. Albarran-Dominguez, A. Loera-Pinales, A. Zamora-Muciño.
P1209WAIST OBESITY - IMPORTANT RELATIONSHIP WITH METABOLIC SYNDROME
AND CARDIOVASCULAR EVENTS
I. A. B. Bincoleto, A. C. Santomauro Junior, M. R. Ugolini, L. Z. P. Oliveira, F. M. B. Rossi, C. Nagaoka, J. F.
Kelendjian, A. C. Santomauro, E. R. Suarez, C. Ferreira.
P1210CHARACTERISTICS, THERAPEUTIC INTERVENTIONS AND INHOSPITAL OUTCOME OF PATIENTS
WITH NON ST-ELEVATION ACUTE CORONARY SYNDROMES ACCORDING TO CLINICAL
PRESENTATION
H. Pomés Iparraguirre, W. Santander, G. Calderón, J. Torres, O. Paredes, M. Leonardi, D. Chambre, J. C. Olmos,
L. Ferrer, G. Guglieri.
P1211Reactive C Protein, Lipid and Anthropometric Profile in Adolescents with
Different Nutritional Status
L. B. Sanches, I. T. Silva, A. F. S. Paz, M. Fisberg, I. P. Cintra, A. P. Q. Mello, N. R. T. Damasceno.
P1212The Effect Of Campomanesia Xanthocarpa “Guabiroba” In Hypercholesterolemic
Subjects
J. Z. Klafke, T. F. Panigas, C. M. Richter, T. Dipp, K. C. Belli, D. C. Bündchen, M. A. Silva, J. C. H. Coracini, P. Bianchi,
P. R. N. Viecili.
P1213Coronary Fistula: treatment by hemodynamic techniques
L. Simões, C. Lace, F. Gurgel, P. R. Travancas, J. G. Athayde, C. C. Assef, M. Celente, A. H Lago Dorigo, W. Paiva,
M. S. Tagliari.
P1214Echocardiographic Evaluation of the Left Ventricular Hypertrophy in Patients
with Hypertension
A. Martinez, A. Esper, D. Holownia, J. Tazar.
Scientific Programme / 265
Poster Listing
P1215Evalution Of Blood Pressure Levels Among Indian Population Of The Upper Rio
Negro Basin
L. M. Rodrigues, O. E. Soares, T. Dipp, T. F. Panigas, C. F. Panigas, D. C. Bündchen, K. C. Belli, C. M. Richter,
P. R. N. Viecili.
P1216Relationship between depressive symptoms and self cerebral
flow regulation
J. Tripolone, G. A. Santiago, J. M. Tripolone.
P1217PREVALENCE OF PERIPHERAL ARTERIAL DISEASE OF LOWER EXTREMITIES, IN PATIENTS
WITH CORONARY DISEASE.
G. Llamas-Esperon, R. Muñoz-Sandoval, S. Sandoval-Navarrete, A. Zamora Muciño, M. L. Fuantos-Delgado,
U. T. Casas Juarez, J. Albarran-Dominguez, S. Varela Ortiz.
P1218Functional and Structural Alterations on Aortic Calcifications (AC)
J. Morais, T. Diogenes, J. Paes Jr.
P1219CARDIOPULMONARY AND METABOLIC EFFECTS IN PATIENTS SUBMITTED
TO A CARDIOPULMONARY AND METABOLIC REHABILITATION PROGRAM
C. A. Hossri, M. C. Thomazi, R. Ceolin, G. Shinzato, E. C. Souza, H. Arakaki.
P1220Electrocardiographical Evidences of Intra-coronary Autologous Stem
Cells Implantation: Intraventricular Electrical Transients Study by SignalAveraged Electrocardiogram
P. R. Benchimol-Barbosa, H. F. Martino, A. C. Campos-De-Carvalho, F. D. Vilela, C Miranda, R. N. Gobbi,
P. S. De Oliveira, L. H. Weitzel, J. Barbosa-Filho, I. Cordovil,.
P1221Reproducibility of reversible myocardial perfusion defects by cold pressor
test myocardial perfusion SPECT imaging.
O. Masoli, M. Redruello, N. Maciel, J. Gagliardi, S. Traverso, L. Grynberg, L. Vidal, N. Perez Baliño.
P1222Is the Rest Echocardiogram is enough to evaluate the contractile recovery
after CABG?
L. H. Weitzel, A. C. Camarozano, F. J. M. Pitella, C. A. S. Nascimento, L. Belem, A. S. C. Rocha.
P1223PERCUTANEOUS SEPTAL ABLATION WITH ABSORBABLE GELATIN SPONGE IN HYPERTROPHIC
OBSTRUCTIVE CARDIOMIOPATHY
G. Llamas-Esperon, S. Sandoval-Navarrete, R. Muñoz-Sandoval, A. Loera Pinales, S. Varela Ortiz,
E. Sandoval Rodriguez, M. L. Fuantos-Delgado, U. T. Casas Juarez, J. Albarran-Dominguez, A. Zamora Muciño.
P1224PREDICTION OF THE INTRAOPERATIVE IMPROVEMENT OF THE RIGHT VENTRICLE STROKE
WORK INDEX DURING PULMONARY ENDARTERECTOMY
A. Bertolotti, C. Gomez, J. Negroni, M. Diez, L. Favaloro, J. O. Caneva, R. Boughen, F. Klein, R. R. Favaloro.
Poster Listing
P1225Predictive Value of Carotid Intima-Media Thickness, Carotid Plaques and
Endothelium-Dependent Vasodilation for Vascular Events in High Risk Patients.
C. Ingino, M. Kura, R. Machado, A. Cherro, E. Ricardo, P. Lylyk.
P1226Heart failure in a public universitary hospital in Argentina. Characteristics of
population and causes of hospitalization.
V. Volberg, A. Pesantes, O. Grosso, J. Lerman, C. Berensztein, D. Pineiro.
P1227Non-invasive evaluation of local and regional biomechanical properties of
post-implanted arterial cryopreserved homografts
D. Bia, S. Laza, H. Perez, Y. Zocalo, D. Craiem, S. Lluberas, A. Esperon, I. Alvarez, R. Armentano.
P1228THE EFFECTS OF THE BREATH CONTROLLED INCURSIONS ON THE AUTONOMIC MODULATION
OF THE HEART IN SUBJECTS WITH RESISTENT HIPERTENSIVE TO THE TREATMENT: IMPACT
OF AUTONOMIC MODULATION ON RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (SRAA)
(CURUMIM STUDY II)
G. N. Gobbi, P. R. Benchimol-Barbosa, C. S. Miranda, F. D. Vilela, A. F. P. Gondar, J. Barbosa-Filho, M. V. Barros,
A. B. R. Lima, F. V. Campos, I. Cordovil.
P1229Is decrease of left ventricular ejection fraction after stress with normal
perfusion associated with cardiac events?
R. Berber, P. Nogueira, L. Ribeiro, D. Pareira, R. Lopes, F. Alves, M. Oliveira,. P Smanio.
P1230CLINICAL IMPLICATIONS OF ANEMIA IN HEART FAILURE PATIENTS
M. Descalzo, M. Diez, L. Favaloro, M. Perea, R. Ratto, D. Puente, J. Barra, M. Peradejordi, L Feldman.
P1231Analysis of the relationship of the presence of the resistance to the insulin
and diastolic dysfunction in senior.
R. F. M. Viégas, R. V. Z. Diniz, T. M. R. F. Viégas, A. M. R. R. Oliveira, A. C. Schimidt, D. R. Almeida.
P1232Socioeconomic status, Hospital Volume and Ischemic Stroke Mortality in
Canada
G. Saposnik, T. Jeerakathil, D. Selchen, V. Hachinski, M. K. Kapral.
P1233Aortic insufficiency and ventricular septal defect – Analysis of surgical
treatment
L. Simões, A. F. Malheiros, J. Caliani, L. C. Arongaus, F. Gurgel, F. Lino, J. A. T. Marinho, C. C. Assef, P. R. Travancas, W. Peixoto.
P1234Heart failure in a public universitary hospital in Argentina. Causes of acute
decompensation.
V. Volberg, A. Pesantes, O. Grosso, J. Lerman, C. Berensztein, D. Pineiro.
Scientific Programme / 267
Poster Listing
P1235Primary Percutaneous Coronary Intervention. A comparative analisys
according to Infarct localization in a General Hospital
MANUEL Nicolas Cano, DINALDO Cavalcanti Oliveira, ANDRÉS Sanches Esteva, SILVIA Judith Fortunato De Cano,
CLEBER Do Lago Mazzaro, EDUARDO Jaccoud, IGOR Alexander, MARIA Cristina Ferrari, PEDRO Augusto Abujamra,
FLAVIO Antonio De Oliveira Borelli.
P1236CLINICAL AND ECHOCARDIOGRAPHYCAL FOLLOW-UP AFTER ONE YEAR IN PATIENTS WHO
UNDERWENT MITRAL VALVULOPLASTY WITH DOUBLE-BALLOON TECHNIQUE FOR SEVERE
MITRAL STENOSIS
S. Sandoval-Navarrete, G. Llamas-Esperon, R. Muñoz-Sandoval, S. Varela Ortiz, A. Rosas Cabral, F. J. Serna Vela,
M. L. Fuantos Delgado, U. T. Casas Juarez, A. Zamora Muciño, J. Albarran Dominguez.
P1237The prevalence of risk factors for cardiovascular disease in university
hospital
T. Paes, D. Orlandi, F. Gazoni, H. Guimaraes, L. Vendrame, R. Lopes, A. C. Lopes.
P1238Ability of aortic atheromas to predict coronary and cerebral events.
H. Deschle, A. Salazar, M. Fernandez, R. Pissinis, P. Carrascosa, J. Carrascosa.
P1239Does Myocardial Perfusion Scintigraphy Help in the Definition of Therapy to
Assymptomatic Patients with Myocardial Ischemia?
C. Zukowski, R. Leite, C. Albertini, R. Kanthack, R. Lopes, M. Oliveira, FvAlves, P. Smanio.
P1240Obstetrical and clinical factors related to the mode of delivery in pregnant
women with heart disease
M. R. F. L. Bortolotto, M. Zugaib.
P1241ISCHEMIA ON RIGHT CORONARY TERRITORY DEMOSTRATED BY MYOCARDIAL PERFUSION
SPECT, CONDITIONED BY A UNIQUE LEFT CORONARY ARTERY, CORROBORATED BY
CORONARY CT SCAN AND CORONARY ANGIOGRAPHY
S. Sandoval-Navarrete, G. Llamas-Esperon, R. Muñoz-Sandoval, S. Varela Ortiz, A. Loera Pinales,
E. Sandoval Rodriguez, M. L. Fuantos Delgado, U. T. Casas Juarez, J. Albarran Dominguez.
P1242Fascicular Tachycardia in children and adolescents: Important aspects for
tachyarrhythmia aproach
R. Andalaft, D. Moreira, R. Habib, L. Moraes, K. Tukamoto, G. Bellini, R. Hams, V. Cerutti, A. Guimaraes, M. Juliano.
P1243BEHAVIOR OF THE ATRIOVENTRICULAR PRE-EXCITATION DURING AN EXERCISE TESTING
M. C. Thomazi, C. A. Hossri, N. Scarin, R. Meneghelo.
P1244LIPID PROFILE RESPONSE TO RESISTED PHYSICAL EXERCISE PROGRAM
IN TYPE 2 DIABETICS
E. Fernandes, A. L. A. Branquinho, S. M. R. Castro, V. A. Leite, B. V. França, A.L.R.M. Freitas, L. C. Silva.
Poster Listing
P1245Planimetric determination of left ventricular outflow tract: diagnostic
importance on prosthesis patient mismatch
E Castro, M. Cavazzi, A. Curcio, G. Converso, J. Quiroga, S. Chekerdemian.
P1246CASE FATALITY IN CORONARY ARTERY BYPASS GRAFT ALONG THE FIRST YEAR AFTER
HOSPITAL DISCHARGE IN RIO DE JANEIRO STATE, 1999 TO 2003
P. Godoy, N. A. Souza E Silva, G. M. M Oliveira, C. H Klein.
P1247Amiodarone as a good intervention for patients with heart failure and
ventricular arrhythmias
L. P. Leopoldo Piegas, A. A. Alvaro Avezum, A. G. Aloyra Guimaraes, I. S. Italo Santos, H. G. Hélio Guimaraes,
H. R. Helder Reis, E. S. Elizabeth Santos, A. M. A. Muniz.
P1248Absence Of Correlation Between The Anthropometric Variables And Blood
Pressure In Hypertensive Obese Subjects Submitted To An Exercise Physical
Program
C. F. Panigas, T. Dipp, T. F. Panigas, K. C. Belli, D. C. Bündchen, C. M. Richter, J. L.C. Pippi, P. R. N. Viecili.
P1249Influence of depressive symptoms on the parameters of left ventricular
function during ergometric test
J. Tripolone, G. A. Santiago, J. M. Tripolone, P. Zuliani, M. Salguero.
P1250CARDIAC HYPERTROPHY AND OXIDATIVE STRESS IN RATS TREATED WITH METHIONINE.
R. Sirvente, R. H. Mendes, G. O. Candido, C. Mostarda, L. Jorge, A. Belló-Klein, K. Rigatto, M. C. Irigoyen,.
P1251EFFECT OF CHRONIC ATORVASTATIN THERAPY IN THE MITOCHONDRIAL FUNCTION
P. Monteiro, P. Matafome, A. Reis, S. Monteiro, R. Seiça, L. Goncalves, L. A. Providencia.
P1252MYOCARDIAL PERFUSION SCINTIGRAPHY IN PATIENTS ASSESSED FOR RENAL
OR RENOPANCREATIC TRANSPLANTATION.
R. Ferrando, M. Lujambio, M. Kapitan, E. Moreira, J. Vilar, R. Hitateguy, C. Lecot, V. Selios, S. Miranda,
P. Marichal.
P1253CASE FATALITY IN PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTIES ALONG THE
FIRST YEAR AFTER HOSPITAL DISCHARGE IN RIO DE JANEIRO STATE, 1999 TO 2003
P. Godoy, G. M. M. Oliveira, N. A. Souza E Silva, C. H Klein.
P1254Primary Percutaneous Coronary Intervention during the acute fase of
Myocardial Infarction. Are there any differences in the late Evolution of
Elderly Vs Younger adult patients?
MANUEL Nicolas Cano, DINALDO Cavalcanti Oliveira, ANDRÉS Sanches Esteva, SILVIA Judith Fortunato De Cano,
CLEBER Lago Mazzaro, EDUARDO Jaccoud, IGOR Alexander, MARIA Cristina Ferrari, PEDRO Augusto Abujamra,
FLAVIO Antonio Oliveira Borelli.
Scientific Programme / 269
Poster Listing
P1255Risk stratification using myocardial perfusion SPECT in the assessment of
ischemic heart disease in symptomatic women.
M. Lujambio, R. Ferrando, J. Vilar, M. Kapitan, V. Selios, C. Lecot, R. Hitateguy, G. Lago, R. Lluberas, J. Gaudiano.
P1256Effect of Sleep Deprivation Partial of the Vascular reactivity
J.L. Dettoni, F. M. Consolim-Colombo, H. Moreno-Filho, M. C. Irigoyen, J. C. A. Ferreira-Filho, S. B. C. Souza,
S. Borile, L. F. Drager, E. M. Krieger, G. Lorenzi-Filho.
P1257Influence of PTCA on Mobilization of bone marrow-circulating progenitor
cells in peripheral blood
R. G. Turan, S. Yokus, M. Brehm, S. Steiner, T. Zeus, T. Bartsch, M. Koestering, C. M. Schannwell, B. E. Strauer.
P1258Valuation of the Excursion and Average Mitral Ring Speed as Left Ventricular
Systolic function indexes
J. Tripolone, G. A. Santiago, J. M. Tripolone.
P1259Optimization of Medical Therapy in African-American Patients with Heart
Failure Referred for Cardiac Resynchronization Therapy
M. Sardar, J. Shin, A. Kezerashvili, S. Maybaum, M. Galvao, K. Trivedi.
P1260INCIDENCE OF HOSTILITY IN SUBJECTS FOLLOWING A PROGRAM OF CARDIAC
REHABILITATION POST-MYOCARDIAL INFARCTION, PREDICTIVE FACTOR FOR POSSIBLE
RELAPSES
M. Alcocer, M. Rangel, E. Tirado, N. Pacheco, S. Leon, E. Castro, JvAlvarez De La Cadena, J. Rodriguez, E. Garcia,
D. Arroyo.
P1261Acute Effects of Acupuncture on Hemodynamics Variables in Outpatients With
Compensated Chronic Heart Failure
S. Chacon, S. Soares, M. Quintão, D. A. Bastos, L. Aragão, E. T. Mesquita, S. Chermont.
P1262Effect of Daily Versus Alternate Day Therapy With Simvastatin in Reducing
LDL-Cholesterol Among South Asian Cohort
M. Sardar, S. Nadeem, A. Omer, R. Siddiqui.
P1263CT Angiogram as Replacement Diagnostic Investigation for Angioplasty of
Coronary arteries
M. C. L Lim, C. De Larrazabal, T. W. Wong.
P1264Hospital mortality in acute STEMI in greater of 70 years
M. Correa, M. Lopez, R. Codutti, M. Sanjurjo.
P1265Long term results of balloon dilation of the mitral valve for pediatric typical
mitral valve stenosis.
A. Peirone, A. Guevara, A. Spillmann, B. Vega, E. Juaneda, E. Ruiz Lascano, E. Banille, L. Alday.
Poster Listing
P1266In-hospital management of decompensated heart failure: interaction among
NT-proBNP, renal function and diuretic response
M. L Coronel, P. L. Pozzer, G. A. Pereira Zini, R. P. Laurino, G. V. Lepore, C. R. Zoni, G. D. Olivera,
J. P. Cimbaro Canella, S. M. Macin, E Perna.
P1267Prevalence and treatment of the Arterial Hypertension in the city of Formosa
F. Sosa, C. Sosa, D. Hernandez.
P1268Finds of Miocardy Perfusion in diabetic asymptomatic patients without
previous AMI.
A. Pallares Farias, Abalsa Agustina, Joo Turoni Claudio, Rovaletti Federico, Castellanos Ramiro.
P1269PROGNOSTIC VALUE OF ADMISSION ECG IN NON-ST ELEVATION ACUTE CORONARY
SYNDROMES
H. Pomés Iparraguirre-, G Calderón, W. Santander, G. Guglieri, L. Ferrer, R. Aguero, O. Paredes, F. Brey, J. Torres,
G. Guthmann.
P1270Lack of late enhancement with gadolinium in non compaction cardiomyopathy
D. Perez De Arenaza, M. Falconi, M. Pietrani, P. Pollono, G. Maid, P. Oberti, C. Belziti, N. Vulcano, R. Garcia Monaco,
A. Cagide.
P1271Cardiovascular and electrocardiographic abnormalities observed in patients
undergoing chronic dialysis
P. Nasca.
P1272Regular and chronic use of statin prevents Atrial Fibrillation in the early
postoperative period of elective cardiac surgery
R. N. Campos, R. J. Alves, E. S. Hara, K. Nakiri.
P1273Significant percentage of patients using antihypertensive medication are not
presenting adequate levels of blood pressure in the twenty-four hours recording
R. N. Campos, R. J. Alves, T. Inada, E. Florido, K. Nakiri.
P1274Mortality in the STEMI according to the age. Experience in Cordis Institute of
the heart.
M. Correa, M. Sanjurjo, R. Codutti, M. Lopez.
P1275RISF FACTORS REDUCCION WITH IMPLEMENTATION OF NUTRICIONAL AND EXERCISE PROGRAM
M. Alcocer, A Nava, S. Leon, L. Robles, E. Castro, E. Tirado, E. Garcia, J. Alvarez De La Cadena, L. Mendoza, Y. Prior.
P1276Discrepancy between Perceived Obesity Status, Self-reported, and measured
BMI in the US population; and the strategies employed for weight loss or
maintenance: A NHANES 2003-2004 Study.
Ruchika Goel, Sunil Kumar Agarwal, Nikhil Gupta.
Scientific Programme / 271
Poster Listing
P1277Evaluation of diastolic function in the elderly: comparison of Echo Doppler
parameters in patients with and without hypertension.
N. Allende, H. Deschle, A. Lakowsky, A. Miranda, D. Sanchez Lucero, R. Calviño, J. Carabajales.
P1278Serum Levels of interleukins 1SS, 6, interleukin 2 Receptor and C Reactive
Protein for Diagnostic and Prognostic Evaluation in Unstable Angina.
J. Petriz, A. Brasileiro, D. Albuquerque, R. Abtibol, R. Gusmão, A. Figueiredo, P. Resende, N. Souza E Silva, J. Moll,
F. Albanesi.
P1279Percutaneous Left Ventricular Assist in Ischaemic Cardiac Arrest
V. Tuseth, M. Salem, R. Pettersen, K. Grong, J. E. Nordrehaug.
P1281ASSOCIATION OF CARDIOVASCULAR EVENTS WITH GLYCOSYLATED HAEMOGLOBIN IN
DIABETIC PATIENTS
P. Karki, R. K. Deo, S. K. Sharma, P. Acharya.
P1282Effects of Cilnidipine versus Atenolol on Left Ventricular Diastolic Function
and Hypertrophy in Essential Hypertension -CANDLE Trial
W. J Chung, B. C. Oh, E. O. Shim, M. S. Shin, W. C. Kang, C. I. Moon, S. H. Han, K. K. Koh, T. H. Ahn, E. K. Shin.
P12832-Dimensional strain echocardiographic assessment of myocardial function in
patients with myocardial bridge.
C. Kyoung Im, L. Dong Won, L. Hyeon Gook, K. Tae Ik.
P1284Comparison of Cardiac Structure and Function in Diabetes Mellitus with and
without Systemic Hypertension
C. Kyoung Im, K. Bohyun, L. Donwon, L. Hyeongook, K. Taeik.
P128510 - years investigation of influence of depression on myocardial infarction
risk at the population of men of 25-64 years in Russia: epidemiological views.
V. Gafarov, E. Gromova, I. Gagulin, A. Gafarova.
P1286OVERWEIGHT, OBESITY AND OTHER RISK FACTORS FOR ISCHEMIC HEART DISEASE IN 10 TO
18-YEAR OLD SCHOOLCHILDREN
S. Barbiero, L. Pellanda, C. Cesa, P. Campagnolo, F. Beltrami, C. Abrantes.
P1287TYPE OF STRESS FOR MYOCARDIUM PERFUSION STUDIES:
REVISION OF THE ADEQUACY OF INDICATIONS.
S. Armijo, B Morales, I Luksic, M Peña, J Jensen, P Canales.
P1288Seeking medical advice of patients with myocardial infarction
V. Gafarov, A. Gafarova.
Poster Listing
P1289NATIONWIDE TRENDS IN THE UTILIZATION OF MULTI VESSEL PERCUTANEOUS CORONARY
INTERVENTION (MPCI) IN THE UNITED STATES.
M. R. Movahed, M. Hashemzadeh, M. M. Jamal.
P1291In-vitro and in vivo pharmacodynamic properties of metoprolol
in fructose hypertensive rats
C. Höcht, C. Di Verniero, E. Silberman, M. Mayer, J. A. W. Opezzo, F. Bertera, C. AvTaira.
P1292Modification of some components of the cardiac beta-adrenergic system along
the experimental Trypanosoma cruzi infection.
M. S. Lo Presti, H. W. Rivarola, A. R. Fernández, J. E. Enders, G. Levin, D. F. Comay, P. A. Paglini-Oliva,.
P1293MOLECULAR BASIS OF FAMILIAL HYPERCHOLESTEROLEMIA IN URUGUAY
M. Stoll, P. Esperón, V. Raggio, M. Lorenzo.
P1294Aldosterone synthase C344T polymorphisms determine circadian arterial blood
pressure variation in resistant systemic arterial hypertension
P. R. Benchimol-Barbosa, A. D. Varanda-Rosario, M. Rollin-Ornelas, F. D. Vilela, C. Miranda, G. N. Gobbi,
J. Barbosa-Filho, I. Cordovil.
P1295Cardiovascular disease risk and anaemia in diabetes. What’s the association?
A. Silva, A. Baptista, A. Guedes, A. Cabrita, P. Neves.
P1297Tachycardia-induced cardiomyopathy by fascicular ventricular tachycardia
in a patient with left ventricular noncompaction/hypertrabeculation: A Case
Report
P. Pozzer, E. Perna, I. Reyes, L. Coronel, J. Silveyra, A. Bayol, R. Zoni, C. Babi.
P1298Prognostic value for CA125 antigen in newly diagnosed, advanced congestive
heart failure
K. Filipiak, A. Folga, M. Grabowski, S. Szmit, R. Glowczynska, A. Budaj, M. Marchel, A. Serafin, B. Przybysz, G Opolski.
P1299Electrocardiogram (ECG) in acute coronary syndromes - the specific ECG
features to predict total mortality
K. Filipiak, M. Grabowski, R. Glowczynska, A. Budaj, Z. Huczek, M. Marchel, A. Serafin, T. Imiela, F. Szymanski,
G. Opolski.
P1300The change in predicitive value of different electrocardiogram (ECG) features
in follow-up of acute coronary syndromes patients
K. Filipiak, M. Grabowski, R. Glowczynska, A. Budaj, A. Kaplon, B. Przybysz, A. Serafin, F. Szymanski, J. Olszewski,
G Opolski.
P1301LONG-TERM FOLLOW-UP OF PATIENTS WITH HEART FAILURE AND INDICATION FOR A
DEFIBRILLATOR FOR PRIMARY PREVENTION OF SUDDEN DEATH.
C. Hadid, P. Avellana, D. Di Toro, C. Fernandez Gomez, M. Visser, N. Prieto.
Scientific Programme / 273
Poster Listing
P1302INSULIN POTENTIATES THE CENTRAL PRESSOR RESPONSE TO ANGIOTENSIN II IN RATS
M. Mayer, C. Höcht, J. Giani, F. Dominici, E. Silberman, J. A. W. Oppezzo, M. Gironacci, C. Taira, B. Fernández,
A. M. Puyó.
P1303DISORDERS IN HEART RHYTHM AND DISTURBANCES IN INTRAVENTRICULAR CONDUCTION
SYSTEM IN HEART FAILURE
G. Vieyra, S. Folino, O. Agri, E. Pautasso, M. Koretzky, H. Bovero, J. Aiub, R. Montecchiesi.
P1304HEART FAILURE REGISTRY IN THE NORTHERN AREA OF GREATER BUENOS AIRES
G. Vieyra, E. Pautasso, S. Folino, O. Agri, M. Koretzky, E. Pardo, M. Rey, M. Chiozza.
P1305Can Dipyridamole act as a bridge for DES patients undergoing Non cardiac
Surgery Off Clopidogrel
A. Magd, H. Ragy, I. Attia, A. Zaki, N. Okasha.
P1306Is Platelet Aggregation Adequately Inhibited by Current Clopidogrel Dosing
Regimens?
A. Magd, M. Sawasany, A. Ramzy, S. Builtagy, A. Zaki, M. El Badry.
P1307Estimation of the level of knowledge and adherence to dietary guidelines
designed for hypertension treatment in a population of patients under
dialysis
I. M. Masuda, A. N. Aguirre , M. A. Marcozzi, F. M. Ferrero, Z. C. Ziella, H. A. Hansen , H. S. Hecker,
C. M. Ciprés, R. A. Ríos.
P1308EXERCISE STRESS ECHOCARDIOGRAPHY PRIOR TO DISCHARGE FROM A CHEST PAIN UNIT IN
PATIENTS WITH DIABETES MELLITUS
B. Lopez Ledesma, E. Ludueña Clos, H. Avaca, G. M. Ferrari, C. Kudrle, M. Gingins, M. F. Larin, P. Pieroni,
J. D. Humphreys, O. D. Manuale.
P1309AIR QUALITY AND RESPIRATORY AND CARDIOVASCULAR DISEASES IN A SOUTHERNS
BRAZILIAN CITY FROM 1997 TO 2006
E. O. Fernandes, R. Zumach, G. M. O. Fernandes, J. Müller, S. C. Faria.
P1310ATRIAL FIBRILLATION IN PATIENTS WITH AORTIC STENOSIS: CLINICAL SIGNIFICANCE OF
TISSUE INHIBITOR OF MATRIX METALLOPROTEINASE-1
N. Goncharova, O. Moiseeva, G. Aleshina, E. Shlykhto.
P1311Are there clinical and outcome differences in patients with aortic stenosis
treated with angiotensin converting-enzyme inhibitors?
P. Oberti, R. Pizarro, M. Falconi, F. Achilli, A. Arias, F. Sosa, L. Lucas, J. Krauss, A. Cagide.
P1312Kymogram - a new tool for the assessment of heart valve performance
M. Kondruweit, R. Cesnjevar, T. Wittenberg, S. Friedl, T. Strecker, M. Weyand.
Poster Listing
P1313Coffe consumption and atrial fibrillation
A. Mattioli, E. Tarabini Castellani, S. Bonatti, C. Miloro, D. Lodi, G. Mattioli.
P1314Pulmonary valvuloplasty in adults using the Inoue Balloon Catheter
H.M. Pham, H.L. Nguyen, Q.N Ngoc, H.M Nguyen, H.N Khong, V.L Nguyen, L.D Do, K.G. Pham.
P1315PHYSICAL AND SEDENTARY ACTIVITIES IN SOUTHERN BRAZILIAN TEENAGERS:
A POPULATION BASED CROSS-SECTIONAL STUDY
C. Cesa, A. Andreola, T. Santos, R. Petkowics, S. Barbiero, P. Campagnolo, F. Beltrami, E. Vigueras, L. Pellanda.
P1317Advantages of CT angiography in the planning and follow up of abdominal
aortic aneurysm
C Capuñay, P. Carrascosa, A. Deviggiano, E. Martin Lopez, J. Vallejos, J. Carrascosa.
P1318Multidetector CT features in the follow up of patients with endovascular
aortic aneurysm treatment
P. Carrascosa, C. Capuñay, A. Deviggiano, J. Vallejos, E. Martin Lopez, J. Carrascosa.
P1319CT features in pulmonary embolism. Impact of the Multidetector technology
C. Capuñay, P. Carrascosa, A. Deviggiano, E. Martin Lopez, J. Vallejos, J. Carrascosa.
P1320IVC-SCV Filters. A comprehensive review of the spectrum of complications.
J. Tisnado, M. K. Sydnor, D. J. Komorowski, D. A. Leung.
P1321CHEST PAIN UNITS: CLINICAL FEATURES OF THE PATIENTS
J. Ibañez, J. Muntaner, V. Mansilla, R. Corbalan.
P1322Idiopathic ventricular and atrial arrhythmias. Relationship with
developmental dismorphogenesis of their involved structures.
M. Elizari, S. Lupano, M. Ferreiro, M. Civetta, F. Lubenieki, S. Sicouri.
P1324PSEUDO INCOMPLETE RIGHT BUNDLE BRANCH BLOCK. ITS RELATIONSHIP WITH THE
EMBRYOLOGIC DEVELOPMENT OF THE RIGHT VENTRICULAR OUTFLOW TRACT.
M. Elizari, M. F. Lambardi, M. Ferreiro, R. S. Acunzo, P. A. Chiale, M. M. Civetta, R. R. Bonato.
P1326INTRAMYOCARDIAL OR INTRACORONARY CELL DELIVERY: WHICH IS THE BEST ROUTE FOR
CELL THERAPY IN IDIOPATHIC DILATED CARDIOMYOPATHY?
A. C. Campos De Carvalho, F. B. Muccillo, P. C. S. Costa, S. N. S. Arvelo, E. Assunção E Silva, P. S. Oliveira,
C. M. Gouvêa, C. T. Mesquita, H. F. Martino.
P1327Early prognosis of patients with valve prosthesis regurgitation immediately
after heart surgery.
R. O. Sampaio, F. C. S. Silva Jr., I. S. Oliveira, G. S. Spina, F. Tarasoutchi, M. Grinberg.
Scientific Programme / 275
Poster Listing
P1328The Trypanosoma cruzi infection with an isolate obtained from an endemic
area produces alterations in the complexes of the cardiac mitochondrial
respiratory chain
A. Baez, M. S. Lo Presti, H. W. Rivarola, G. Guzmán Mentesana, D. Comay, P. Paglini-Oliva.
P1329Effectiveness of different ablation methods for paroxysmal atrial
fibrillation in randomized study
D. Lebedev, E. Mikhaylov.
P1330P-wave analysis as a clue for optimization of paroxysmal atrial fibrillation
ablation
D. Lebedev, E. Mikhaylov.
P1331Misleading interpolated premature atrial contractions in patients with
paroxysmal atrial fibrillation: their mechanism and origination
E. Mikhaylov, D. Lebedev.
P1332Arial arrhythmias and their origination in patients with paroxysmal atrial
fibrillation according to ambulatory observation
E. Mikhaylov, D. Lebedev.
P1333Adventitial infectious agents in heart transplant accelerated graft coronary
atherosclerosis (AGCA)
N. V. Sambiase, M. L. Higuchi, M. M. Reis, E. Bocchi, N. Stolf.
P1334Serum Paraoxonase 1 Activity and Oxidative Markers of LDL in patients with
Cardiac Syndrome-X
M. Kayikcioglu, S. Saygi, E. Azarsiz, L. H. Can, H. Kultursay, E. Y. Sozmen.
P1335Does Myocardial Perfusion Scintigraphy Useful in the Detection
of Ischemia after Surgical Revascularization?
L. Cardenas, H. Herbas, R. Conti, Z. Fichino, A. Thom, R. Lopes, M. Oliveira, P. Smanio.
P1336COMBINATION OF GENETIC POLYMORPHISMS AND SMOKER STATUS IN HIGH RISK FAMILIES
M. Stoll, P. Esperón, V. Raggio, M. Lorenzo, M.C. Artucio, F. Kuster.
P1337Importance metabolic syndrome on hypertensive patients with left
ventricular hypertrophy – an 10 year follow-up study
I. Tasic, D. Djordjevic, G. Lazarevic, D. Mijalkovic, M. Lovic, D. Lovic, N. Miladinovic Tasic.
P1338 C
an Eustachian valve be a risk factor for pulmonary embolism?
I. Kurt.
Poster Listing
P1340 N
oninvasive assessment of coronary flow reserve after percutaneous
coronary intervention in patients with previous myocardial infarction:
Relation to functional recovery
A. Djordjevic-Dikic, M. Ostojic, B. Beleslin, J. Stepanovic, V. Giga, B. Vujisic-Tesic, I. Nedeljkovic, M. Nedeljkovic,
S. Stojkovic, Z. Petrasinovic.
P1341AN ANALYSIS OF LEFT ATRIAL EJECTION FRACTION IN THE DIFFERENT TYPES OF LEFT
VENTRICLE DIASTOLIC DYSFUNCTION
J. L. F. Jefferson Luís Vieira, T. V. B. Thaís Valenti Branchi, I. K. Ilmar Köhler, L. C. D. Luís Cláudio Danzmann,
M. R. T. Marco R. Torres.
P1342Clinical Outcome after multilesion percutaneous interventions: comparison
of a selective and non-selective use of drug-eluting stents
M. Albertal, F. Cura, L. T. Padilla, P. Perez Balino, A. Candiello, S. Jozami, J. A. Belardi.
P1343RESPONSES OF CORONARY FLOW IN POSTMENOPAUSAL WOMEN WITHOUT EVIDENCES OF
MYOCARDIAL ISCHEMIA EVALUATED BY TRANSESOPHAGEAL DOBUTAMINE-STRESS-ECHO:
A RANDOMIZED, DOUBLE BLIND, CROSSOVER CLINICAL ESSAY, WITH WASH OUT, DURING
HORMONE REPLACEMENT AND RALOX
M. R. T. Marco R. Torres, J. C. T. João Carlos Tress, T. C. D. E. Tereza Cristina Duque Estrada, L. S. C. Lilian S.
Costa, O. C. E. G. O. C. E. Gebara.
P1344Prevalence of Chagas Disease evaluated by 13 years in the Hospital San
Fernando of Buenos Aires
M. Galli, E. Alvarez, M. Boscaro, H. Deschle, M. Koretzky, J. Seresi, A. Rubinich.
P1345Lone Atrial Fibrillation : Comparation with Atrial Fibrillation with Heart
Disease. OFFICE FA Study
J. Gant Lopez, D. Di Toro, C. Muratore, J. Battista, A. Andina, A. Lucchini, C. Damico, R. Borracci.
P1346TiTAN2® (Hexacath, France), a titanium-NO coated stent: a drug-eluting-like
bare metal stent?
L. Van Casteren, P. Debruyne, B. Vankelecom, J. Roosen, E. Raymenants, S. De Ridder, L. Janssens.
P1347InCor-HCFMUSP’s Cardiovascular Emergency and Simulation Laboratory and
ACLS Courses
F. Marques, W. Nishizawa, M. Gonzalez, S. Timerman.
P1348Rationale for an Evidence-Based Intervention to Prevent Risk Factors for the
Development of Chronic Disease
C. Jordan, M. Slater, T. Kottke.
P1349Regression of cardiac lupus under immunosuppressive therapy.
E. Chammas, A. Hussein, A. Barbari, M. Abou Akl, O. Hamoui, L. Abouzahr.
Scientific Programme / 277
Poster Listing
P1350Multivessel coronary artery disease patients under medical therapy: A 10 year
observational study
E. Chammas, C. Elbacha, R. Kyrillos.
P1351TRADITIONAL RISK FACTORS ARE PREDICTIVE ON SEGMENTAL LOCALIZATION
OF CORONARY ARTERY DISEASE
G. Tacoy, S. Balcioglu, S. Akinci, G. Erdem, S. A. Kocaman, T. Timurkaynak, A. Cengel.
P1352Evolution of no culprit complex coronary lesions
R. Costantini, J. Telayna, F. Graziano.
P1353A Simple Echocardiographic Method for Left Ventricular Ejection Fraction
Calculation Specially Useful in Patients with Prior Myocardial Infarction
G. Liniado, J. Gagliardi, S. Schneck, S. Molteni.
P1354SUBACCUTE EFFECTS OF MAXIMAL EXERCISE ON ENDOTHELIAL FUNCTION
IN PATIENTS WITH CHRONIC HEART FAILURE
P. Moreira, P. Soares, F. Das Neves, N. Rocha, A. Nobrega.
P1355Predictors of left ventricular remodeling in patients after successful
primary percutaneous coronary intervention for acute myocardial
infarction: Long term follow-up
I. Nedeljkovic, B. Vujisic-Tesic, M. Ostojic, M. Petrovic, B. Beleslin, O. Petrovic, D. Zamaklar-Trifunovic,
A. Djordjevic-Dikic, V. Giga, J. Stepanovic.
P1356Prediction of acute coronary events by myocardial jeopardy score: Five years
follow-up patients with natural progression of coronary artery disease
I. Nedeljkovic, M. Ostojic, B. Beleslin, A. Djordjevic-Dikic, V. Giga, J. Stepanovic, M. Nedeljkovic, S. Stojkovic,
P. Mitrovic, B. Vujisic-Tesic.
P1357Infectious agents, MMP-9 and PPAR alpha are increased in the adventitia and
periadventital fat of aortic aneurysms
A. Roggerio, M. L. Higuchi, N. V. Sambiase, N. Stolf.
P1358Sleep-Disordered Breathing: Relation of treatment compliance and the
occurrence of cardiovascular disease in severe obstructive sleep apnea
patients.
J. Santos, B. Gonzales, J. Caneva, J. Oses, R. Boughen, F. Robles, E. Gabe.
P1359Costs and effects: Three-years follow-up of the InCor valve replacements
surgeries
E. Trindade, P. Pomerantzeff, M. Grinberg, C.M. Brandão, S. Fujii.
Poster Listing
P1360Echocardiographic Characteritics and Surgical Outcome of Mitral Valve
Disease In Marfan Syndrome
J. M Casas, C. E. Lopez, M. Segura, J. H. Casabe, P. Roura, H. Raffaelli, J. Abud, E. Dulbecco.
P1361SEVERE RHEUMATIC TRICUSPID REGURGITATION SEVERAL YEARS AFTER MITRAL VALVE
REPLACEMENT OR REPAIR
H. Silva, A. Bartolomé, V. Picone, C. A. Bruno.
P1362EMERGENCY DEPARTMENT PREDICTORS OF MORTALITY AND AORTIC INTERVENTION AMONG
PATIENTS WITH SYMPTOMATIC ABDOMINAL AORTIC ANEURYSM
M. P. Marturano, G. Procopio, R. Merbilháa, G. A. Ontiveros, E. Dulbecco, F. Klein, M. J. Fosco.
P1363CARDIOPULMONARY (VO2) EXERCISE TEST IN PATIENTS WITH ASYMPTOMATIC AND
SYMPTOMATIC SEVERE AORTIC STENOSIS
H. Silva, J. Ale, C. A. Bruno, A. Bartolomé, V. Picone.
P1365LONG-TERM OUTCOME IN PATIENTS WITH SYMPTOMATIC SEVERE AORTIC STENOSIS
H. Silva, A. Bartolomé, S. Belforte, V. Picone, C. A. Bruno.
P1366THE EFFECT OF BODY MASS INDEX ON BLOOD PRESSURE RESPONSE DURING EXERCISE
G. E. Yazici, G. Tacoy, B. Alibazoglu.
P1367 TIMI FRAME COUNT AND MYOCARDIAL BLUSH GRADE IN NORMAL CORONARY ARTERIES OF
PATIENTS
G. Tacoy, G. E. Yazici, S. A. Kocaman, M. Ozdemir, A. Cengel.
Note: For consistency, clarity and ease of interpretation, some abstract titles have had the font of their text amended and
minor spelling changes made.
Scientific Programme / 279
Industry satellite symposia and workshop activities
Programme at a glace – Satellite symposia table
PAVILLION
ROOM
Rio de
la Plata
SYMP
(IS)
Boehringer Ingelheim GmbH
ONTARGET: New Evidence
in Total Cardio & Vascular
Protection
Thames
SYMP
(IS)
Daiichi Sankyo Brazil
Blood pressure and beyond
- Ancillar effects by AT1 Receptor blockade
YELLOW
12.30 - 13.30 (INTERSESSION)
TUESDAY, 20 MAY, 2008
RED
MONDAY, 19 MAY, 2008
Danube
SYMP
(IS)
Astra Zeneca
Optimising Outcomes in Acute
Coronary Syndromes: Role of New
Approaches to Platelet Inhibition
Missouri
SYMP
(IS)
Bayer Schering Pharma AG
Targeting multiple risk factors to
optimise cardiovascular care
Nile
SYMP
(IS)
Pilcomayo
SYMP
(IS)
18.00 - 19.30 (EVENING SESSION)
Pfizer
GlaxoSmithKiline
A Remarkable Change in
SYMP Clinical evidence of fondaparinux in
Smoking Cessation: Approach
(IS) thrombosis: From VTE prevention to
and Treatment
acute coronary syndrome treatment
Novartis Pharma
SYMP
Emerging Data in the Treatment
(IS)
of Cardiovascular Disease
IFPMA
SYMP
Transparency around clinical trials and
(IS)
data: are we on the right trajectory?
SYMP
(IS)
Menarini International
Operations Luxembourg S.A.
From hypertension to heart
failure: the developing role of
vasodilating beta-blockers
SYMP
(IS)
Colgate
Oral Health-Cardiovascular
Health: Emerging Evidence of
the Relationship
WS
(IS)
Biotronik (12.45-13.30)
New Trends in Catheter
Ablation of Atrial Fibrillation
Mississippi
Solvay Pharmaceuticals GmbH
SYMP Retinopathy associated with prevalent
(IS) CHD in patients with T2D. What needs
to be done?
Tigris
Boehringer Ingelheim GmbH
SYMP
Acute Myocardial Infarction (IS) Reperfusion Strategies in Real Life and
their Potential Benefit for the Patient
Niger
Abbott Laboratories
SYMP
SYMP
Acute Heart Failure Treatment: Doing
(IS)
(IS)
what comes naturally?
American Heart Association
Strengthening the Chain
of Survival: From bench to
community
SYMP
(IS)
Merck Sharp & Dohme
ER Niacin/Laropiprant: A new
Paradigm in Comprehensive
Lipid Management
Ganges
Seine
12.30 - 13.30 (INTERSESSION)
Bayer Schering Pharma AG
SYMP Management of right ventricular
(IS) dysfunction in pulmonary arterial
hypertension
GlaxoSmithKline
Boston Scientific
SYMP
Drug Eluting Stent Technology: a
Diabetes, Cardiovascular
(IS)
breakthrough in PTCA patient outcome
disease and Thiazelidinediones
Tiber
GREEN
18.00 - 19.30 (EVENING SESSION)
Sanofi-aventis Latin America
SYMP
Intraabdominal Obesity and
SYMP
(IS) Cardiometabolic Risk Factors: present (IS)
and future
Arrhythmias
Sanofi-aventis
Reshaping the future in the
management of
atrial fibrillation
Janssen-Cilag Farmaceutica
SYMP
Building New Strategies in Acute
(IS)
Decompensated Heart Failure
Merck KGaA
Sanofi-aventis
The weight of the evidence: SYMP
SYMP
LMWHs Across the Spectrum of
(IS)
setting the standard with beta- (IS)
ACS: The Weight of the Evidence
blockade
Pharmacology
Heart failure / Left ventricular function
Basic science
Valvular disease / Pulmonary circulation / Myocardial-pericardial
Cardiac imaging / Computers
Ischemia/ Coronary artery disease
Acute cardiac care
Interventions / Peripheral circulation / Stroke
Paediatric / Congenital heart disease
Hypertension
Nursing / Technician
Exercise / Epidemiology / Prevention
Public policy / Advocacy initiatives
SYMP (IS) Symposium
WS (IS)
How-to and Workshop session
INDUSTRY SATELLITE SYMPOSIA AND WORKSHOP ACTIVITIES - INTERSESSION
Monday, 19 May 2008
Tigris - Ye llow P avillion - 1 2 :3 0 - 13: 30
Symposium (IS)
Boehringer Ingelheim GmbH
Acu t e M y o c ar d i a l In f arc t i o n - R e pe r fusion S t rategies in Real Life
and t h e i r Po t e n tial B ene f it f o r the P at ie nt
Chairs: Frans Van De Werf (BELGIUM), Rafael Diaz (ARGENTINA)
12:30
Thrombolysis: a treatment option for rural areas only?
Richard Arntz (GERMANY)
12:45
13:00
Fibrinolysis or Primary PCI: are we living up to the guidelines?
Rob Welsh (CANADA)
The benefits of gaining time in the treatment of STEMI patients
Freek Verheugt (NETHERLANDS)
13:15
Panel Discussion with an outlook to a new trial (STREAM)
Frans Van De Werf (BELGIUM) and Rafael Diaz (ARGENTINA)
Mis s ouri - Ye llow P avillion - 1 2 :3 0 - 13: 30
Symposium (IS)
Bayer Schering Pharma AG
Tar g e t i n g m ul t ip l e r is k f a c tor s t o opt imis e cardiovas cular care
Chairs: Smith Sidney (UNITED STATES), Alberto Villamil (ARGENTINA)
12:30
The unique formulation determines the benefits of nifedipine GITS
Peter A. Meredith (UNITED KINGDOM)
12:50
Nifedipine GITS - combining intervention and evidence to create a standard in cardiovascular care
Giuseppe Mancia (ITALY)
13:10
Low-dose ASA - from secondary to primary prevention
Smith Sidney (UNITED STATES)
Danub e - Gr e e n P avillion - 1 2 :3 0- 13: 30
Symposium (IS)
Astra Zeneca
Op t i m i si n g O u t c o m e s in Acut e Co ronary Syndrome s :
Role o f N e w Approac he s to P l at ele t Inhib it ion
Chairs: Nicolau José (BRAZIL), Deepak Bhatt (UNITED STATES)
12:30
Introduction
Nicolau José (BRAZIL), Deepak Bhatt (UNITED STATES)
12:40
Implications for Antiplatelet Therapy Post TRITON
Nicolau José (BRAZIL)
12:50
Bleeding Complications in Patients Receiving Oral Antiplatelet Therapy: Definitions, Prevalence, Consequences
Sunil V. Rao (UNITED STATES)
13:00
Novel Approaches to Platelet Inhibition: New Mechanisms
Hans Van Giezen (SWEDEN)
13:10
Novel Approaches to Platelet Inhibition: New Agents
Steen Husted (DENMARK)
13:20
Panel Discussion
Deepak Bhatt (UNITED STATES)
Scientific Programme / 281
INDUSTRY SATELLITE SYMPOSIA AND WORKSHOP ACTIVITIES - INTERSESSION
Monday, 19 May 2008
Mis s is s ippi - Ye llow P avillion - 1 2 :3 0- 13: 30
Symposium (IS)
Solvay Pharmaceuticals GmbH
Reti n o p a t h y as s oc iat ed w it h pr e vale nt CHD in pat ie nt s wit h T2 D.
Wha t n e e d s to b e done ?
Chairs: Alberto Zambon (ITALY), Anthony Keech (AUSTRALIA)
12:30
The eye microvascular complications and the vascular residual risk
Xavier Pintó (SPAIN)
12:50
FIELD; Macro- and Microvascular Benefits and the Metabolic Syndrome Profile
Anthony Keech (AUSTRALIA)
13:10
Role of Fibrates in Vascular Events Reduction in T2D Patients
Alberto Zambon (ITALY)
Nige r - Gr e e n P avillion - 1 2 :3 0- 13: 30
Symposium (IS)
Abbott Laboratories
Ac u t e H e a r t F a il u r e Tre a tm ent : Doing what come s nat urally?
Chairs: Sergio Perrone (ARGENTINA), Fabio Vilas-Boas (BRAZIL)
Welcome
Sergio Perrone (ARGENTINA)
ALARM-HF versus Euroheart II: What have we learnt?
Ferenc Follath(SWITZERLAND)
ALARM-HF: Factors which impact mortality
Fabio Vilas-Boas (BRAZIL)
Acute Heart Failure Hlobal Registry of Standard Treatment (ALARM-HF): Providing answers
Ferenc Follath(SWITZERLAND)
Q+A
Faculty
Se ine - Gr e e n P avillion - 1 2 :3 0- 13: 30
Symposium (IS)
Sanofi-aventis Latin America
Int r a a bd o m in a l O b es ity a n d Cardiome t ab olic R is k Fact ors :
Pre se n t a n d F ut u r e
Chair: Maria Ines Sosa Liprandi (ARGENTINA)
12:30
Reduction of Cardiometabolic Risk: is there room for improvement?
Richard W. Nesto (UNITED STATES)
13:00
ECS: New target for patients with multiple cardiometabolic risk factors
Rafael Maldonado (SPAIN)
INDUSTRY SATELLITE SYMPOSIA AND WORKSHOP ACTIVITIES - INTERSESSION
Monday, 19 May 2008
P ilcomayo - Ye llow P avillion - 1 2 :3 0- 13: 30
Symposium (IS)
International Federation of Pharmaceutical Manufacturers & Associations (Ifpma)
Tr a n sp a r e n c y ar o u n d c l in ic a l t rials and dat a:
Ar e w e o n t h e r ight t r aj e c tor y?
Chairs: Beat Widler (UNITED KINGDOM), Aurora Vila (ARGENTINA)
12:30
Setting the scene
Beat Widler (UNITED KINGDOM)
12:50
What does transparency mean for patients in Latin America
Aurora Vila (ARGENTINA)
13:10
Appropriate use and communication of public domain data - a case study on meta-analysis
Alexander Walker (UNITED STATES)
Nile - Ye llow P avillion - 1 2 :3 0- 13: 30
Symposium (IS)
Boston Scientific
Dr u g E l u t i n g S t ent T ec hnol ogy: A b re akt hrough in P TCA pat ie nt out com e
Chair: Jorge Belardi (ARGENTINA)
12:30
PTCA current indications. PTCA alternative or complementary to surgery / medical treatment?
Daniel Berrocal(ARGENTINA)
12:50
DES benefits. On and off label indications
Oscar Mendiz (ARGENTINA)
13:10
DES in the daily practice. The influence of the technique, clinical data support and the use of new
technology (IVUS) in the outcome.
Jorge Belardi (ARGENTINA)
Scientific Programme / 283
INDUSTRY SATELLITE SYMPOSIA AND WORKSHOP ACTIVITIES - EVENING SESSIONS
Monday, 19 May 2008
Tib e r - Ye llow P avillion - 1 8 :0 0- 19: 30
Symposium (IS)
Menarini International Operations Luxembourg S.A.
Fr o m h yperte n s i o n t o h e a r t f a i lur e: the develo p ing role of
va so d i l a t i n g b et a -b l oc ke r s
Chairs: Alberto Zanchetti (ITALY), Sanchez Ramiro (ARGENTINA)
18:00
Targets and benefits of blood pressure lowering
Brandão Ayrton (BRAZIL)
18:22
Beta-blockers in hypertension: do we know it all?
Gabriel D. Waisman (ARGENTINA)
18:44
CHF: from clinical trials to clinical pratice
Solon Navarrete (COLOMBIA)
19:06
The road ahead with nebivolol in the treatment of elederly CHF patients: clinical outcomes from SENIORS trial
Van Veldhuisen Dirk (NETHERLANDS)
R io de la P lat a - R e d P avillion - 1 8 :0 0- 19: 30
Symposium (IS)
Boehringer Ingelheim GmbH
ONTA RGET : N e w E vid enc e in T o tal Cardio & Vas cular P rot e ct ion
Chairs: Piegas Leopoldo (BRAZIL), Michael Böhm (GERMANY)
18:00
Blood pressure lowering or cardio & vascular protection - what to aim for?
Giuseppe Mancia (ITALY)
18:22
Cardio & vascular protection - the value of combining an ARB and an ACE-inhibitor
Thomas Unger (GERMANY)
18:44
The ONTARGET results
Rafael Diaz (ARGENTINA)
19:06
Translating ONTARGET into clinical practice
Michael Böhm (GERMANY)
Nige r - Gr e e n P avillion - 1 8 :0 0- 19: 30
Symposium (IS)
American Heart Association (AHA)
Str e n g t h e n i n g t he Cha in of S ur v ival: From b e nch t o communit y
Chairs: Timerman Sergio (BRAZIL), Robert O’connor (UNITED STATES)
18:00
ECC from bench to community to bench
Robert O’connor (UNITED STATES)
18:22
Progress and lessons learned from the «Take Heart America» project
Ed Racht (UNITED STATES)
18:44
International Perspective on the Strengthening the Chain of Survival
Timerman Sergio (BRAZIL)
19:06
A view from the future
Graham Nichol (UNITED STATES)
INDUSTRY SATELLITE SYMPOSIA AND WORKSHOP ACTIVITIES - EVENING SESSIONS
Monday, 19 May 2008
Se ine - Gr e e n P avillion - 1 8 :0 0 - 19: 30
Symposium (IS)
Sanofi-aventis
Res h a p i n g t h e f u tur e in t he m anage me nt of at rial fib rillat ion
Chairs: John Camm (UNITED KINGDOM), Marcelo Elizari (ARGENTINA)
18:00
Rationale for outcomes studies in atrial fibrillation
Gerald Nacarelli (UNITED STATES)
18:30
Impact of atrial fibrillation in the prognosis of cardiovascular disease
Marcelo Elizari (ARGENTINA)
19:00
ATHENA: a landmark study in atrial fibrillation
John Camm (UNITED KINGDOM)
Gange s - Gr e e n P avillion - 1 8 :0 0- 19: 30
Symposium (IS)
Merck Sharp and Dohme
ER N i a c i n / L a r o p iprant : A n ew P a r adigm in Compre he ns ive Lipid Manage men t
Chairs: Pedro Lipszyc (ARGENTINA), Ricardo Horacio Rey (ARGENTINA)
18:00
Epidemiology in Latin America
Ricardo Horacio Rey (ARGENTINA)
18:22
The need for Comprehensive Lipid Management
Anders G. Olsson (SWEDEN)
18:44
New Insights into Niacin Biology
Pedro Lipszyc (ARGENTINA)
19:06
Laropiprant: unlocking the Therapeutic Potential of Niacin
Moriguchi Emilio Hideyuki (BRAZIL)
Nile - Ye llow P avillion - 1 8 :0 0- 19: 30
Symposium (IS)
GlaxoSmithKline
Diab e t e s , C ar d i o v a sc u l a r d i s e a se and Thiazelidinediones
Chairs: Isaac Sinay (ARGENTINA), Juan Rosas (MEXICO)
18:00
Diabetes, Metabolic Syndrome & Cardiovascular disease
Álvaro Avezum (BRAZIL)
18:22
Rosiglitazone the most widely studied Oral Antidiabetic Medicine
Isaac Sinay (ARGENTINA)
18:44
Rosiglitazone FDA final statement
Juan Rosas (MEXICO)
19:06
Rosiglitazone Cardiovascular Profile
Nesto Richard W (UNITED STATES)
Scientific Programme / 285
INDUSTRY SATELLITE SYMPOSIA AND WORKSHOP ACTIVITIES - EVENING SESSIONS
Monday, 19 May 2008
Thame s - Ye llow P avillion - 1 8 :0 0- 19: 30
Symposium (IS)
Daiichi Sankyo Brazil
Blo o d pr e ssu r e a n d b eyond - A ncillar e ffe ct s b y AT 1 - R e ce pt or b lockad e
Chairs: Antonio Felipe Simão (BRAZIL), Antonio Chagas (BRAZIL)
18:00
HTN in the LA Region
Agustin Lara Esqueda (MEXICO)
18:22
RAAS and Drugs
Robson Santos (BRAZIL)
18:44
OLM Activity and figures
Arthur Ribeiro (BRAZIL)
19:06
Vascular Protection
Carlos Ferrario M. (ARGENTINA)
Danub e - Ye llow P avillion - 1 8 .0 0- 19. 30
Symposium/Workshop
St. Jude Medical
Fir st L a t i n A m e r ic an S ym p o s ium/Works hop on At rial Fib rillat ion
President: Oseroff Oscar (Argentina)
Chairs: Andrea Natale (UNITED STATES), Arruda Mauricio (UNITED STATES), Morillo Carlos (CANADA)
18:00Opening remarks on AF "The New Epidemic"AF mechanisms and the role of neural network: Implications on
current AF ablation strategies
John Camm (UNITED KINGDOM)
18:15
LA and PVs anatomy. The use of CT, MR and Echo to guide AF Ablation
Jose Carlos Pachon Mateos (BRAZIL), Mauricio Scanavacca (BRAZIL)
18:30
Current worldwide AF ablation approaches. Is image-guided remote navigation the future of AF ablation?
Andrea Natale (UNITED STATES)
18:45
Ablation of long-standing AF: Strategies beyond PV isolation. Future tools to minimize ablation collateral
Arruda Mauricio (UNITED STATES)
19:00
AF ablation "Guidelines and Clinical Trials "Are we ready for AF ablation as first line therapy"
Morillo Carlos (CANADA)
19:15Open discussion on: What to do in front of the Atrial Fibrillation patient, with the participation of the
Symposium Faculty and invited experts
INDUSTRY SATELLITE SYMPOSIA AND WORKSHOP ACTIVITIES - INTERSESSION
Tuesday, 20 May 2008
Tib e r - Ye llow P avillion - 1 2 :3 0- 13: 30
Symposium (IS)
Colgate
Or a l H e a l t h - C ard i o v a scu l ar He alth: E me rging Eviden c e of the Relationshi p
Chair: Nestor Lopez (CHILE)
12:30
The Oral Cavity and Chronic Inflammation: What is periodontal disease and how might it affect
cardiovascular health?
David Paquette (UNITED STATES)
12:45
The Global Epidemic of Cardiovascular Disease and Diabetes: What is the evidence of a relationship
between periodontal disease and CVD and Diabetes?
Smith Sidney (UNITED STATES)
13:00
Discussion: Can the recognition and treatment of periodontal disease make a difference in
cardiovascular outcomes?
David Paquette (UNITED STATES)
13:15
Discussion: What can a cardiologist do in his/her practice to assist in reducing the risk that
periodontal disease might contribute to a patient’s risk for CVD? What’s next for cardiology?
Smith Sidney (UNITED STATES)
Nile - Ye llow P avillion - 1 2 :3 0 - 13: 30
Symposium (IS)
Novartis Pharma
Eme r g i n g D a t a in the Tre a tm ent of Cardiovas cular Dis e as e
Chair: Alberto Villamil (ARGENTINA)
12:30
Welcome and Introduction: Understanding the Burden of Hypertension
Alberto Villamil (ARGENTINA)
12:45
A New Look at the Cardiovascular Continuum with Valsartan
Matthew Weir (UNITED STATES)
13:00
Amlodipine-Valsartan: Changing the Landscape of Blood Pressure Management
Kenneth Jamerson (UNITED STATES)
13:15
Evolution in Renin Suppression: the New Frontier
Matthew Weir (UNITED STATES)
Nige r - Gr e e n P avillion - 1 2 :4 5 - 13: 30
Workshop session (IS)
Biotronik
New Tre n d s i n Cat het er A b l a tion of At rial Fib rillat ion
12:45
Catheter ablation of atrial fibrillation: Where do we stand?
Dubner Sergio (ARGENTINA)
13:07
Catheter ablation of atrial fibrillation in patients with LV dysfunction
Johannes Brachmann (GERMANY)
Scientific Programme / 287
INDUSTRY SATELLITE SYMPOSIA AND WORKSHOP ACTIVITIES - INTERSESSION
Tuesday, 20 May 2008
Mis s ouri - Ye llow P avillion - 1 2 :3 0- 13: 30
Symposium (IS)
Bayer Schering Pharma AG
Ma n a g e m e n t of r ight ve n tr ic u l a r dys funct ion in
pulm o n a r y a r te r ial hyp e r t ens io n
Chairs: Miguel Gomez Sanchez (SPAIN), Sergio Perrone (ARGENTINA)
12:30
RV function in pulmonary hypertension
Sandrine Huez (BELGIUM)
12:45
How should we evaluate right ventricular function?
Adam Torbicki (POLAND)
13:00
Chronic adaptation of right ventricular function: Eisenmenger syndrome
Julio Sandoval (ARGENTINA)
13:15
Management of right ventricular dysfunction
Stephan Rosenkranz (GERMANY)
Se ine - Gr e e n P avillion - 1 2 :3 0- 13: 30
Symposium (IS)
Merck KGaA
The w e i g h t of the e vid enc e : S e tt ing t he s t andard wit h b e t a-b lockade
Chair: Norberto Vulcano (ARGENTINA)
12:30
Beta-blockade in chronic heart failure (CHF): past, presence and future of beta-blockers in CHF management
Cagide Arturo (ARGENTINA)
12:42
Beta-blockade in chronic heart failure (CHF): CIBIS III - expanding the frontier
Piotr Ponikowski (POLAND)
12:54
Cardioprotection in non-cardiac surgery (NCS):perioperative management in NCS - current status
Anai Durazzo (BRAZIL)
13:06
Cardioprotection in non-cardiac surgery (NCS): recent advances with beta-blockade in NCS
Don Poldermans (NETHERLANDS)
13:18
Closing remarks
Piotr Ponikowski (POLAND)
INDUSTRY SATELLITE SYMPOSIA AND WORKSHOP ACTIVITIES - EVENING SESSIONS
Tuesday, 20 May 2008
Se ine - Gr e e n P avillion - 1 8 :0 0 - 19: 30
Symposium (IS)
Sanofi-aventis
LMWH s Acro ss t he Spec t r um of A CS: The We ight of t he Evide nce
Chairs: José Luis López-Sendón (SPAIN), Grinfeld Liliana (ARGENTINA)
18:00
Differentiating anticoagulants: Do pharmacologic differences lead to differences in clinical outcomes?
Nicolau José (BRAZIL)
18:22
Defining adjunctive anticoagulants therapy in ACS
José Luis López-Sendón (SPAIN)
18:44
A decade of GRACE: The real world in STEMI and NSTE ACS
P. Gabriel Steg (FRANCE)
19:06
Panel discussion / Q & A
Grinfeld Liliana (ARGENTINA)
Gange s - Gr e e n P avillion - 1 8 :0 0- 19: 30
Symposium (IS)
Janssen-Cilag Farmaceutica
Buil d i n g N e w S t r at egie s in Acut e De compe ns at e d He art Failure
Chairs: Nadine Clausell (BRAZIL), Sergio Perrone (ARGENTINA)
18:00
Focus on Latin America: Unmet Needs in Acute Decompensated Heart Failure Management
Nadine Clausell (BRAZIL)
18:22
Current Treatment Options for Acute Decompensated Heart Failure
Uri Elkayam (UNITED STATES)
18:44
Nesiritide Therapy for the ADHF Patient
J. Thomas Heywood (UNITED STATES)
19:06 Case Presentation and Panel Discussion
Uri Elkayam (UNITED STATES), Panelists: Nadine Clausell (BRAZIL), Heywood J Thomas (UNITED STATES),
Sergio Perrone (ARGENTINA), Vilas-Boas Fábio (BRAZIL)
R io de la P lat a - R e d P avillion - 1 8 :0 0- 19: 30
Symposium (IS)
GlaxoSmithKline
Clin i c a l e v i d enc e of f o n d a p ar in u x in t hromb os is : From VTE pre ve nt ion
to a c u t e c o r onar y s yn d r om e tr eat me nt
Chairs: Rafael Diaz (ARGENTINA), Álvaro Avezum (BRAZIL)
18:00
VTE Prevention in Surgical Patients: Fondaparinux benefits over Enoxaparin
Alexander Turpie (CANADA)
18:22
Factor Xa Inhibition across the spectrum of ACS: Improved anti-thrombin treatment with
reduced bleeding risk
Yusuf Salim (CANADA)
18:44
Optimising Management of Acute coronary Syndromes from guidelines to clinical practice
Álvaro Avezum (BRAZIL)
19:06
Introduction to Fondapariniux Clinical Role
Rafael Diaz (ARGENTINA)
Scientific Programme / 289
INDEX
Authors
H. Aarsetoey.................................................... 75, 206-207
C. Aguilar-Salinas.......................................................... 108
M. Allievi....................................................................... 109
T. Aarsland............................................................ 199, 206
E. Aguilera.................................................................... 177
T. G. Allison........................................................... 108, 262
A. Abalovich.................................................................. 106
L. Aguinaga................................................................... 185
J. Almada...................................................................... 133
R. Abashidze................................................................. 235
S. Aguirre...................................................................... 256
C. Almeida............................................................ 234, 241
S. Abbrederis................................................................ 173
A. N. Aguirre................................................................. 274
D. R. Almeida..........................................244, 248-249, 267
A. Abdala...................................................................... 204
R. M. Ahmad................................................................... 73
S. Almeida............................................................ 111, 181
R. Abdalah.................................................................... 263
S. Ahmad...................................................................... 256
B. Almeida.................................................................... 102
M. Abdel-Salam............................................................ 200
A. Ahmed...................................................................... 256
A. M. Almeida............................................................... 209
J. Abe........................................................................... 175
S. Ahmed........................................................................ 73
M. C. Almeida............................................................... 241
S. Abe........................................................................... 181
C. Ahn................................................................... 110, 219
K. Alonso...................................................................... 242
I. Abella......................................................................... 252
T. H. Ahn............................................................... 111, 272
A. Alonso...................................................................... 132
M. S. Abello.................................................................. 206
R. Ahuad............................................................... 171, 181
M. Alonso..................................................................... 201
M. Abello...................................................................... 206
L. Ahualli............................................................... 220, 239
J. Alonso....................................................................... 216
H. Abensur............................................................ 144, 225
M. Aiga......................................................................... 167
R. Alonso...................................................................... 193
E. Aberer....................................................................... 225
S. Aiguadé-Bruix........................................................... 238
C. Alonso-Buron............................................................ 207
T. Abesadze.................................................................. 175
J. Aiub................................................................... 181, 274
C. Alonzo...................................................................... 228
S. Z. Abildstrøm.................................................... 230, 232
R. Akar.......................................................................... 111
A. Alper......................................................................... 186
L. Abouzahr................................................................... 277
A. Akcay................................................................ 185, 195
R. Altamirano................................................................ 228
F. Abramzon..................................................235, 254, 264
R. Akchurin................................................................... 234
W. Altarche-Xifró............................................................ 77
C. Abrantes................................................................... 272
C. Akel............................................................................ 73
T. Altin.......................................................................... 192
A. C. Abreu................................................................... 213
G. Akgun....................................................................... 192
P. A. Altman.................................................................. 140
P. Abreu-Gonzalez.........................................167, 169, 213
S. Akinci................................................................ 186, 278
D. L. Altschuler............................................................. 212
R. Abtibol...................................................................... 272
M. Aksoy.............................................................. 171, 211
H. J. Altube................................................................... 223
J. Abud.............................73, 107, 205-206, 230, 246, 279
M. Aktoz....................................................................... 182
I. Altun.......................................................................... 106
A. Abufhele................................................................... 178
A. Akyol........................................................................ 186
M. G. Alvarez........................................................ 170, 201
E. Acarturk.................................................................... 105
H. Alanazi...................................................................... 163
M. Alvarez..................................................................... 252
P. Acharya..................................................................... 272
D. Alasia........................................................................ 204
E. Alvarez.............................................................. 240, 277
F. Achilli..........................................144, 202, 238-239, 274
F. Albanesi.................................................................... 272
F. Alvarez...................................................................... 196
S. K. Açikgöz................................................................. 186
J. Albarran-Dominguez.......................................... 265-266
I. Alvarez....................................................................... 267
A. Acosta...........................................................74, 80, 136
E. S. Albayrak................................................................ 198
J. Alvarez.......................................107, 202, 222, 240, 271
F. Acosta....................................................................... 263
J. P. Albenque............................................................... 103
R. J. Alves............................................................. 233, 271
K. Acosta...................................................................... 248
I. Alberca....................................................................... 207
C. N. Alves.............................................................. 74, 138
Y. Acosta...................................................................... 190
M. Albertal........................71, 132, 225, 242, 244-245, 277
A. N. F. Alves................................................................ 248
N. Acuña....................................................................... 168
A. Alberti................................................................. 53, 254
L. Alves.......................................................... 252, 259-260
R. S. Acunzo...................................219-220, 229, 250, 275
C. Albertini.................................................................... 268
A. Alves.........................................................111, 179, 240
K. Adalet............................................................... 106, 191
C. Alberto.......................................................109, 213, 226
T. Alves................................................................. 260, 263
M. Adamczyk........................................................ 172, 185
G. Albina....................................................................... 241
F. Alves................................................................. 248, 267
K. G. Adamyan................................72, 103, 109, 136, 193,
F. Albuquerque............................................................. 223
E. O. Alves.................................................................... 111
......................................................218, 242, 244, 246, 249
D. Albuquerque............................................................. 272
R. Alves........................................................................ 250
M. E. Adaniya................................................................ 211
S. Albuquerque............................................................. 228
F. Alvim................................................................. 136, 220
T. Adla............................................................141, 223, 234
J. Albuquerque..................................................... 228, 243
A. Alvim........................................................................ 234
Y. Adler......................................................................... 209
M. Alcocer............................................................. 270-271
O. Alyan................................................................ 110, 233
A. Adriana..................................................................... 111
G. Aldama-López.......................................................... 198
A. Amanullah........................................................ 166, 172
P. Adriazola................................................................... 206
K. Aldworth-Gaumond.................................................. 135
A. Amarilla.................................................................... 214
S. Affatato..................................................................... 132
J. Ale............................................................................. 279
G. Amarilla.................................................................... 261
V. Agarwal.................................................................... 251
G. Aleshina........................................................... 204, 274
M. Amat........................................................................ 242
P. Aggelopoulos............................................................ 217
R. Alessi........................................................................ 245
J. M. Amatruda............................................................. 166
M. Aglony..................................................................... 137
A. Alessi.................................................................. 77, 176
J. Amatruda.................................................................... 75
U. Agrawal.................................................................... 198
G. Alexanderson........................................................... 133
G. Ambrosio.................................................................. 141
O. Agri.......................................................................... 274
B. Alexandre................................................................. 211
A. Ambu........................................................................ 186
S. Aguadé-Bruix.................................................... 132, 236
A. Alexandrescu............................................................ 200
D. Ametrano................................................................... 74
R. Aguayo..................................................................... 185
A. Alexandrov............................................................... 225
K. Amitani..................................................................... 175
S. Aguedé-Bruix............................................................ 236
A. Alfie.......................................................................... 102
M. Amoedo................................................................... 144
M. Aguero..................................................................... 212
B. Alibazoglu................................................................. 279
M. Amor............................................................... 111, 189
R. Aguero.........................................69, 242, 258, 260, 271
V. Aliperti........................................................................ 77
J. M. L. Amorim............................................................ 249
R. Agüero...................................................................... 103
T. Aliyeva...................................................................... 196
W. A. Amorim................................................ 243-244, 246
J. P. Aguiar.................................................................... 258
G. Allende............................................................. 175, 178
L. Amorim............................................................. 249, 260
R. Aguilar...................................................................... 252
N. Allende..................................................................... 272
M. Amorin..................................................................... 184
Authors
R. Andalaft............................................................ 247, 268
R. Armentano.........................................194, 231-232, 267
F. Ayan.......................................................................... 233
G. Andersen............................................................ 69, 240
A. Armenti............................................................ 170, 201
S. Aydogdu................................................................... 223
L. B. Andersen.............................................................. 168
S. Armijo....................................................................... 272
S. Ayub......................................................................... 191
A. Andina...................................................................... 277
L. Armine...................................................................... 220
M. I. R. Azambuja......................................................... 248
K. Andrade.................................................................... 234
L. Armini............................................................... 136, 215
I. Azar.............................................................................. 76
M. A. M. Andrade......................................................... 228
P. Armstrong................................................................ 143
S. Azarisman................................................................. 184
M. M. Andrade................................................................ 79
A. M. Arn Migowski...................................................... 210
E. Azarsiz...................................................................... 276
M. Andrade............................................................. 79, 228
P. Arnaiz........................................................................ 137
R. Azevedo..................................................................... 72
T. Andreeva.................................................................. 225
F. Arnaldo..................................................................... 135
H. Azevedo............................................109, 191, 195, 243
A. Andreola................................................................... 275
A. Arnedo.............................................................. 205, 230
C. H. M. Azevedo.............................................77, 109, 191
D. S. Andres.......................................................... 208, 211
L. C. Arongaus.............................................................. 267
L. Azocar....................................................................... 185
C. K. Ang....................................................................... 201
V. Arora......................................................................... 238
F. Azzari................................................................ 237, 240
P. Angelani...................................................................... 78
A. G. Aroutunov............................................................ 164
F. Azzato............................................................... 109, 138
A. Angelino.............................106-107, 201, 208, 236, 238
A. Arrastia..................................................................... 184
C. Babi.......................................................................... 273
D. Anic.......................................................................... 219
O. Arrieta...............................................107, 222, 240, 251
T. Babic......................................................................... 202
F. D. Anjos-Andrade...................................................... 111
G. Arroyo...................................................................... 224
F. Baborski.................................................................... 220
S. D. Anker.................................................................... 238
D. Arroyo...................................................................... 270
J. Baccaro............................................................. 212, 219
A. Añó....................................................107, 222, 240, 251
G. M. Arroyo........................................................... 76, 165
O. Badak....................................................................... 170
A. A. Ansari............................................................ 202-203
R. Arroyo-Espliguero..................................................... 165
J. R. Badaraco............................................................... 219
D. Antonelli................................................................... 186
U. Arslan........................................................180, 186, 190
J. Badariene.......................................................... 184, 237
H. Bader........................................................................ 243
J. Antonelli.................................................................... 218
M. Arslan...................................................................... 163
M. Antonetti................................................................. 190
E. Arteaga..................................................................... 136
A. Bader........................................................................ 176
D. Antoni......................................................................... 76
V. Artiko........................................................................ 171
J. Badie......................................................................... 194
C. Antoniades.................................................. 69, 216-217
M. C. Artucio................................................................. 276
Z. Badiei.......................................................................... 73
L. Antonietti...................................................238, 242, 249
G. P. Arutyunov........................................... 74-75, 104-105
E. Badila.........................................................106, 211, 224
N. Antonio............ 78-79, 101, 132, 255-256, 258, 260, 263
A. G. Arutyunov.............................................................. 74
E. Badino...................................................................... 169
N. António........................................................70, 252, 258
S. N. S. Arvelo............................................................... 275
H. Badiola Villa.............................................................. 166
A. Antonopoulos.............................................. 69, 216-217
H. Arý............................................................................ 197
S. H. Badruddin............................................................... 73
N. Antunes.....................................................133, 166, 234
P. Arza.......................................................................... 205
A. Baez................................................................. 222, 276
D. Aparicio..................................................... 247-248, 263
Y. Arzani........................................................................ 192
M. C. Baez.................................................................... 205
N. Apro......................................................................... 137
M. Asanin..................................................................... 187
R. Bagnati..................................................................... 169
F. Apullan...................................................................... 197
R. Asbot................................................................ 164, 259
R. Bagur........................................................................ 176
L. Aragão...................................................................... 270
S. Asgary.............................................................. 211, 216
D. Bahamonde.............................................................. 225
T. S. Aragão.................................................................. 111
O. Asghar...................................................................... 179
A. Bahi.......................................................................... 220
H. Arakaki............................................................. 240, 266
T. Ashikaga........................................................... 188, 197
A. Bahia........................................................................ 215
E. Aramburu.................................................................. 246
T. Asmann...................................................................... 72
V. K. Bahl.......................................................140, 164, 167
A. Arandjelovic................................................................ 71
N. Aspromonte............................................................... 70
G. Bahs......................................................................... 235
C. Aranis....................................................................... 109
M. Assad...................................................................... 201
A. Bajkova..................................................................... 230
R. L. Arantes................................................................. 101
R. Assad....................................................................... 263
K. Bakoyiannis........................................................ 69, 216
A. Araujo....................................................................... 178
J. A. Assad.................................................................... 139
S. Bakshi....................................................................... 179
S. Araujo................................................................ 246-248
A. R. Assali............................................................ 110, 178
T. Balabanski................................................................. 206
T. M. Araujo.................................................................. 213
C. Assef.........................................................262, 265, 267
J. M. Balaguer................................................................. 73
R. C. Araújo................................................................... 254
V. Assinnato.................................................................. 175
V. P. Balashov....................................................... 135, 210
R. C. Araújo................................................................... 254
R. Astan........................................................................ 233
N. Balasubramanian...................................................... 111
E. Arcani....................................................................... 106
W. Astorino................................................................... 242
A. M. Balaszczuk................................................... 169, 205
P. Arce............................................................................ 69
A. V. Astvacatryan................................................. 242, 246
Y. Balbay....................................................................... 110
N. Archvadze................................................................ 164
A. V. Astvatsatryan.......... 72, 103, 109, 193, 218, 244, 249
S. Balcioglu............................................180, 186, 190, 278
R. V. Ardito.................................................................... 213
R. Atak.......................................................................... 110
G. Baldo........................................................................ 233
J. Areias........................................................................ 109
J. G. Athayde........................................................ 262, 265
M. Balestra................................................................... 220
P. Arellano.................................................................... 178
I. Attia........................................................................... 274
A. Balestrini.................................................................. 102
W. Arenas-Borda.......................................................... 249
N. Augusto.................................................................... 211
C. Balestrini......................................78, 102, 228-229, 251
C. Argenta..................................................................... 108
H. A. Avaca................................................................... 133
M. Balevic..................................................................... 202
S. Argiró.......................................................................... 69
P. Avanzas..............................................165, 168, 196-197
H. Balieiro............................................................. 253, 260
E. Arias......................................................................... 134
D. Avayu...................................................80, 229, 242-244
T. L. Balieiro.................................................................. 253
A. Arias...........................144, 202, 238-239, 241, 258, 274
P. Avellana............................................................ 238, 273
S. K. Ball.......................................................................... 73
J. Aringoli...................................................................... 197
P. J. Avery....................................................................... 77
C. Ballantyne................................................................... 75
B. Armaro..................................................................... 186
M. Avila.................................................................. 260-261
A. E. Ballestrini................................................................ 71
J. Armentano........................................................ 208, 242
F. Ayala......................................................................... 141
L. Balletti....................................................................... 229
Index / 291
Authors
S. Balmaceda................................................................ 181
J. A. S. Barreto-Filho..................................................... 111
A. C. Becker.................................................................. 203
I. Balogh........................................................................ 259
N. Barrientos................................................................. 246
P. Becker...................................................................... 207
A. Baltabaeva................................................................ 254
E. Barrionuevo.............................................................. 191
K. Beckey........................................................................ 75
L. A. Balykova....................................................... 135, 210
P. Barrios.............................................................. 105, 219
R. Bedani...................................................................... 247
M. Banaszewski........................................................... 252
R. Barros Wanderley..................................................... 164
H. Bedi.......................................................................... 179
P. Bandosz.................................................................... 106
C. Barros........................................................241, 253, 257
R. Bedim....................................................................... 256
I. Bañes......................................................................... 239
M. V. Barros............................................191-192, 264, 267
J. R. Bedros...................................164, 199, 208, 224, 238
L. J. Banfic............................................................ 223, 231
M. Barros............................................................... 252-254
R. J. Bedros.................................................................. 203
N. Bangartner............................................................... 215
S. Barsamyan................................................................ 181
G. Beffagna................................................................... 134
E. Banille..........................................................76, 260, 270
E. Bartha............................................................... 197, 202
V. Begovic..................................................................... 193
A. Bankova.................................................................... 225
A. Bartolomé................................................................. 279
T. Behrens.................................................................... 109
A. Bantar....................................................................... 168
J. Bartolucci.................................................................. 132
R. Beigelman................................................................ 141
A. Baptista............................................................ 183, 273
D. Bartos....................................................................... 224
P. Bekta................................................................ 102, 237
K. Baqueiro................................................................... 108
T. Bartsch............................................................. 104, 270
J. A. Belardi......................................................71, 225, 277
F. Baracho..................................................................... 249
A. Barutcu..................................................................... 182
L. Belem....................................................................... 266
S. Barai......................................................................... 250
V. Barzilai...................................................................... 229
B. Beleslin.................................71, 110, 142, 171, 277-278
K. Baranska................................................................... 174
I. Basar.......................................................................... 233
S. Belforte..................................................................... 279
F. Baraona..................................................................... 227
G. Basile....................................................................... 186
L. Bell............................................................................ 256
R. Barba........................................................................ 209
Z. Basistova.................................................................. 257
N. Bellera........................................................................ 69
A. Barbari...................................................................... 277
M. A. Basombrío........................................................... 254
K. C. Belli..........212-214, 221-223, 227, 261, 265-266, 269
S. H. Barberato............................................................. 254
S. L. Bassanesi..................................................... 248, 251
S. Belli........................................................................... 189
M. Barbero Marcial....................................................... 263
H. Bassani Molinas....................................................... 227
K. C. Belli..........212-214, 221-223, 227, 261, 265-266, 269
M. Barbero-Marcial....................................................... 238
T. Bassani..................................................................... 106
C. Bellido.............................................................. 106, 200
E. Barbieri....................................................................... 72
S. L. Bassin............................................................... 75, 79
C. A. Bellido.................................................................. 201
G. F. Barbieri................................................................. 100
C. Basso....................................................................... 134
G. Bellini............................................................... 247, 268
S. Barbiero............................................................ 272, 275
G. Basso....................................................................... 190
F. Bello.......................................................................... 206
J. Barbisan.....................................................134, 243, 250
M. Bastos Fernandez............................................ 187, 194
A. Belló-Klein.................................201, 233, 236, 258, 269
L. Barbosa............................................................. 135, 208
J. C. Bastos................................................................... 202
M. Bellomo................................................................... 137
M. M. Barbosa........................................................ 74, 217
V. L. F. C. Bastos.......................................................... 202
R. Bellomo...................................................................... 80
M. Barbosa......................................................74, 217, 256
D. Bastos...................................................................... 236
J. Beloscar.................................................................... 263
T. Barbosa....................................................................... 76
L. Batista....................................................................... 185
F. Beltrami............................................................ 272, 275
E. G. Barbosa................................................................ 222
M. Batista..................................................................... 215
O. Belzares................................................................... 198
M. A. O. Barbosa............................................................ 76
G. Batsides..................................................................... 69
M. Benassi.................................................................... 254
O. N. Barbosa.........................................252, 259-260, 262
L. Battaglia.................................................................... 140
P. R. Benchhimol-Barbosa............................................ 253
J. Barbosa-Filho.......191-192, 244, 254, 264, 266-267, 273
R. Battellini........................................................... 173, 182
J. Benchimol................................................................. 137
E. Barcellos................................................................... 207
R. R. Battellini............................................................... 173
P. R. Benchimol-Barbosa.......................191-192, 244, 252,
N. C. Barengo............................................................... 231
J. Battista...................................................................... 277
.......................................................254, 264, 266-267, 273
G. Barila........................................................................ 212
M. Battiston.................................................................. 181
D. E. Bender................................................................. 226
F. Barilla........................................................................ 240
A. Battler............................................................... 110, 178
M. Benderski.................................................................. 74
R. Barin......................................................................... 241
T. Bauernfeind.............................................................. 164
I. Ben-Dor............................................................. 110, 178
J. L. Barisani................................................................. 139
G. Baumann.....................................................75, 140, 238
A. Benetos.................................................................... 110
J. C. Barisani................................................................. 139
J. M. Baumgarten......................................................... 228
M. Benetti..................................................................... 208
L. Barja.................................................................. 102, 189
N. Baungartner............................................................. 215
J. Benitez........................................................................ 70
L. D. Barja....................................................................... 78
J. F. Baungratz.............................................................. 226
J. Benitez-Parejo........................................................... 248
S. Barja......................................................................... 137
P. Bayazit...................................................................... 191
A. M. Benjo..................................................................... 77
L. Baroncini............................................................. 77, 176
N. Baybek............................................................. 185, 195
J. S. Benner.................................................................. 243
L. A. V. Baroncini............................................................ 77
M. Bayern..................................................................... 104
R. Berber................................................................ 79, 267
M. Baroni............................................................... 228-229
A. Bayol.................................................134, 170, 212, 273
C. Berensztein.............................................................. 267
J. Barra......................................................................... 267
P. Bayol......................................................................... 260
S. Berensztein.............................................................. 214
M. Barra.......................................................................... 77
R. Bayrak...................................................................... 195
Z. Berente..................................................................... 197
D. Barra......................................................................... 261
R. Beabealashvilli................................................... 234-235
S. Berenztein................................................................ 250
M. Barranco...............................................74, 79, 211, 241
M. Bechelli.................................................................... 137
A. Berez.......................................................................... 78
D. Barranco................................................................... 208
E. Becher...................................................................... 204
A. Berger-Kucza............................................................ 232
R. Barreiro Filho......................................139-140, 253, 257
M. A. Beck.....................................................176, 178, 229
D. Bergerot................................................................... 169
J. Barrera Sarduy.......................................................... 202
E. Beck..........................................................100, 214, 222
G. Berglund..................................................................... 75
C. Barrera...................................................................... 249
K. Beck......................................................................... 111
M. Bergovec................................................................. 231
E. Barrera...................................................................... 250
T. Becker...................................................................... 203
D. Berkowitz................................................................... 77
S. S. M. Barreto............................................................ 142
A. Becker............................................................... 202-203
S. Berliner..................................................................... 163
Authors
C. O. Berlowitz Fo......................................................... 102
H. B. Bittner.................................................................. 173
C. Borrego.................................................................... 181
S. Berman......................................................141, 187, 218
S. Blalock...................................................................... 226
M. R. F. L. Bortolotto.................................................... 268
D. S. Berman................................................................ 141
P. Blanc................................................................. 135, 218
A. Bortone.................................................................... 103
S. G. Berman................................................................ 180
N. Blanco.......................................111, 170, 181, 189, 196
B. Borz.......................................................................... 242
A. M. Bermann................................................80, 219, 222
F. Blanco.....................................................69-70, 132, 188
M. Bosa........................................................................ 253
G. Bermudez................................................................. 242
R. Blanco.........................................................70, 132, 142
J. Boscan...................................................................... 226
V. Bermúdez.................................................. 247-248, 263
P. Blanco....................................................................... 102
M. Boscaro........................................................... 181, 277
A. Bernabe-Ortiz........................................................... 137
G. Blanco...................................................................... 139
E. Bosch....................................................................... 183
V. Bernardes................................................................. 226
B. J. Blanco................................................................... 261
E. Bosinakou................................................................. 217
S. Bernardez..................................229, 233, 236, 260, 263
R. Blank........................................................................ 241
A. Boskovic................................................................... 167
D. Bernardez................................................................... 79
P. Blasko....................................................................... 223
A. Bossi........................................................................ 102
L. Bernardini................................................................. 215
K. Blaszyk..................................................................... 251
A. Botbol................................................111, 170, 181, 239
X. Berrios...................................................................... 137
P. Blazicek.................................................................... 240
L. Botbol............................................................... 189, 196
D. H. Berrocal............................................................... 227
Ø. Bleie..................................................133, 142, 243, 247
G. Bottaro..................................................................... 186
M. Bertagnolli............................................................... 258
J. Bleiz.................................................................. 175, 211
M. Bottcher............................................................ 79, 110
F. Bertanha................................................................... 237
J. P. F. Blini................................................................... 251
J. A. Bottega................................................................. 236
M. P. Bertato................................................................ 198
A. Blinowska................................................................... 80
R. Boughen............................................205, 230, 266, 278
G. Bertelle..................................................................... 204
A. J. Blix................................................................ 243, 248
J. Boullosa.................................................................... 170
F. Bertera...................................................................... 273
J. Bloch................................................................... 75, 103
B. Bourahla................................................................... 139
G. Bertocchi.......................................................... 170, 201
A. Bloigu......................................................................... 75
G. Bouras............................................................... 216-217
M. Bertolami................................................................. 254
M. H. S. L. Blotta.......................................................... 133
M. Bourassa................................................................. 197
M. Bertoli...................................................................... 168
I. Bluro............................................................................ 77
F. Bourdin............................................................. 183, 197
A. Bertolotti.......................................................... 259, 266
E. Bocchi....................................................................... 276
E. Bouskela..................................................................... 71
C. Bertoluci................................................................... 106
E. A. Bocchi.................................................................. 191
K. Bousquet-Santos...................................................... 138
H. Bertoni..................................................................... 240
G. Boccuzzi................................................................... 171
S. Boveda..................................................................... 103
T. Bertuzzi..................................................................... 218
A. Bochoeyer................................................................ 102
H. Bovero...................................................................... 274
O. Berwanger....................................................... 256, 258
L. A. Bockeria................................................................ 255
G. Bowlin...................................................................... 142
B. Bessa....................................................................... 240
M. Bodoira.................................................................... 225
T. Bozat......................................................................... 197
I. Bessonov................................................................... 202
L. Boero........................................................................ 136
E. Bozcali...................................................................... 242
M. Bessonova....................................................... 183, 202
G. Boerrigter................................................................. 108
E. Bozçali...................................................................... 180
R. Bestetti..................................................................... 224
J. Boggiano................................................................... 168
H. Bozkurt..................................................................... 170
F. Bethencourt.............................................................. 236
E. Bognar.............................................................. 197, 202
G. Bozkurt..................................................................... 233
A. Betriu.......................................................................... 69
K. Bohyun..................................................................... 272
G. Bozovich........................................................... 227, 236
M. Bettinotti................................................................. 141
N. Bonaros.................................................................... 173
M. Bracho..................................................................... 242
S. Beurtheret................................................................ 241
R. R. Bonato.................................................................. 275
F. Braga..................................................215, 220, 222-223
J. Beutel....................................................................... 240
J. Bonatti...................................................................... 173
J. Braga......................................................................... 132
P. R. Bhimashankar....................................................... 167
S. Bonatti...................................................................... 275
D. M. Braile........................................................... 133, 166
D. Bia............................................................. 231-232, 267
P. Bonazzola......................................................... 193, 237
I. Brajkovich.................................................................. 219
P. Bianchi...................................................................... 265
J. Bonelli....................................................................... 182
L. Brandani.................................................................... 179
R. Bianco.............................................................. 107, 205
S. Bonetti...................................................................... 240
A. A. Brandao................................................................ 250
E. Biasin........................................................................ 204
C. Bonini....................................................................... 134
A. P. Brandão................................................................ 201
L. Biason....................................................................... 134
J. Bono......................................................................... 220
J. Brandão-Neto............................................................ 249
V. Bichara...................................................................... 178
W. Book........................................................................ 242
B. F. Branka Filipovic..................................................... 134
L. Bicudo....................................................................... 136
E. Borbas.............................................................. 196, 198
Z. Brankovic.................................................................. 243
B. Biernacka............................................................ 78, 233
A. Bordenave.................................................217, 248, 257
R. J. Brashear....................................................... 172, 185
B. Bijnens..................................................................... 254
S. Bordignon.............................................77, 233, 236-237
F. Brasil......................................................................... 220
J. Bilbao...........................................................79, 102, 210
J. Bordone.................................................................... 139
A. Brasileiro...................................................250, 254, 272
B. Bilchik............................................................... 138, 182
F. O. Borelli............................................................. 80, 208
F. Bravo........................................................................ 197
Z. T. Bilinska.................................................................. 175
M. Borger..................................................................... 182
S. Bravo........................................................................ 137
C. Bilos......................................................................... 140
A. Borges...................................................................... 238
D. Braziunas.................................................................. 215
I. A. B. Bincoleto............................................ 243-247, 265
M. Borges....................................................................... 78
A. Breazna.................................................................... 183
C. Birka........................................................................... 77
P. Borges...................................................................... 236
M. Brehm............................................................. 104, 270
M. Bisio........................................................................ 250
J. Borges...................................................................... 251
A. Breitgand.................................................................. 141
S. K. Biswas.................................................................. 232
L. F. Borges.................................................................. 251
U. Brel........................................................................... 175
E. Bit Chacock................................................................. 70
J. Bori........................................................................... 219
E. Brenna...................................................................... 176
H. N. S. Bittencourt......................................................... 74
S. Borile................................................................ 138, 270
L. Brescacin.................................................................. 228
A. G. Bittencourt........................................................... 209
R. Borojevick......................................................... 139, 184
I. Brevis......................................................................... 262
M. S. Bittencourt.................................................. 193, 236
R. Borracci............................................................ 181, 277
F. Brey.......................................................................... 271
Index / 293
Authors
S. Briceño..................................................................... 242
G. Burlli..........................................................111, 221, 255
P. Campana.................................................................. 175
D. Brieger..................................................................... 100
J. C. Burnett.....................................................72, 108, 136
D. Campbell.......................................................... 135, 163
S. Brieva............................................................... 237, 240
C. Burnikoff..................................................................... 79
C. Campo...................................................................... 257
J. C. Brigante........................................................ 226, 236
S. Burtchaell......................................................... 103, 105
C. Campoamor.............................................................. 188
M. Brignole................................................................... 134
A. Busato...................................................................... 109
R. Campo-Pérez............................................................ 198
A. Brignoli..................................................................... 215
C. Bush......................................................................... 238
A. C. Campos De Carvalho.................................... 140, 275
M. Brinckmann............................................................... 77
N. Bustamante.............................................................. 242
R. N. Campos........................................................ 233, 271
G. Brion...................................................106-107, 236, 238
M. Bustamante................................................73, 143, 236
M. Campos................................................................... 206
G. Brión................................................................. 201, 208
I. Butkuviene................................................................. 184
G. Campos............................................................ 208, 233
F. Brites.............................................................74, 77, 136
M. Buyuklu................................................................... 182
D. H. S. Campos................................................... 258, 260
S. F. Brito Jr.................................................................. 102
N. A. Bylova.........................................74-75, 104-105, 164
L. Campos..............................................139-140, 253, 257
S. R. Brito...................................................................... 253
J. G. Byrne...................................................................... 73
P. Campos.................................................................... 132
V. Brito.......................................................................... 215
Y. Byun......................................................................... 235
C. Campos.....................................................140, 259, 275
J. O. R. Brito...........................................252, 259-260, 262
J. Caamaño................................................................... 227
F. V. Campos..................................191-192, 254, 264, 267
J. Brito.......................................................................... 255
I. Caballe....................................................................... 188
D. H. S. Campos................................................... 258, 260
M. Brito......................................................................... 189
H. Caballero.................................................................. 250
A. C. Campos-De-Carvalho........................................... 266
E. Britto......................................................................... 262
E. Caballero..................................................................... 75
L. H. Can....................................................................... 276
M. Brodmann................................................................ 225
M. Cabello.................................................................... 206
P. Canales..................................................................... 272
P. R. Brofman....................................................... 176, 254
S. Cabral....................................................................... 191
J. Candell-Riera..............................................132, 236, 238
C. Brommer.................................................................. 204
G. Cabrejos........................................................... 214, 222
B. Candemir.................................................................. 192
D. Bron......................................................................... 188
C. Cabrera..................................................................... 208
G. O. Candido................................................234, 253, 269
D. Brosh................................................................ 110, 178
L. Cabrera..................................................................... 164
G. Cândido.................................................................... 258
T. A. Brouzet................................................................. 217
M. Cabrera............................................................ 174, 248
A. Candiello...............................71, 225, 242, 244-245, 277
L. Browne..................................................................... 169
G. Cabrera..................................................................... 231
A. Cañedo..................................................................... 231
R. Bruch........................................................................ 233
A. Cabrita...................................................................... 273
R. Canelón............................................................ 248, 263
T. Brugger-Andersen.................................................... 178
R. Cacchione................................................................. 188
L. Caneo....................................................................... 263
T. Brügger-Andersen............................................ 178, 207
R. Caccione................................................................... 139
J. O. Caneva................................................................. 266
E. Brunel....................................................................... 219
M. Caceres................................................................... 210
C. Caniffi....................................................................... 169
P. Brunel....................................................................... 173
M. Cáceres................................................................... 192
T. Canji.......................................................................... 190
D. Brunner.................................................................... 202
M. Cadeiras.................................................................. 104
B. C. Cannon................................................................. 206
C. A. Bruno................................................................... 279
A. Cagide.................................77, 144, 202, 221, 234-235,
M. Cano................................................................. 256-259
J. Bruthans................................................................... 166
.......................................238-239, 241, 254, 264, 271, 274
R. Cano......................................................................... 248
M. Bruzzece............................................................ 74, 241
A. M. Cagide................................................................. 183
R. Cantarelli.......................................................... 227, 240
L. B. Brydak.................................................................. 175
E. Caguioa..................................................................... 181
F. L. Cantarelli............................................................... 240
B. Buassa-Bu-Tsumbu............................................ 78, 243
N. Cakmak.................................................................... 186
M. Cantarelli................................................................. 190
R. Buckley..................................................................... 166
D. Calcines............................................................ 181, 239
A. Cantisano................................................................. 236
A. Budaj........................................................................ 273
G. Calderon................................................................... 103
M. Cantos..................................................................... 184
S. Budelli....................................................................... 197
G. Calderón......................................69, 258, 260, 265, 271
C. Capano..................................................................... 107
A. Buendía.................................................................... 209
L. Cali............................................................................ 190
J. M. Caparrós.............................................................. 215
O. Bugarin..................................................................... 181
J. Caliani............................................................... 262, 267
D. Capdeferro......................................................... 79, 201
S. Buglia........................................................................ 240
A. Califano.................................................................... 104
R. A. Capece................................................................. 166
Z. Bugra................................................................ 106, 191
R. Calviño.............................................................. 175, 272
G. Caponi...................................................................... 192
S. Builtagy..................................................................... 274
R. Calviño-Santos.......................................................... 198
A. M. Caporal................................................................ 230
G. Bulacio..................................................................... 168
D. Calvo........................................................................ 196
A. Capuccio................................................................... 229
V. S. Bulgarelli............................................................... 246
V. A. Cama.................................................................... 164
M. Capula..................................................................... 244
J. Bulum....................................................................... 231
A. Camara............................................................. 140, 253
C. Capuñay....................................141, 200, 204, 238, 275
S. Bulur.................................................................. 198-199
A. Câmara..................................................................... 139
S. Carabajal................................................................... 178
D. C. Bündchen...............................212-214, 221-223, 227,
M. Camargo.................................................................. 226
J. Carabajales................................................................ 272
...............................................................261, 265-266, 269
A. Camarozano....................................................... 71, 236
M. Carasa..................................................................... 261
J. Buono....................................................................... 144
K. Camarozano................................................................ 71
E. Carasca..................................................................... 134
I. Burazor...................................................................... 251
A. C. Camarozano......................................................... 266
J. Carbajales................................................................. 175
M. Burazor.................................................................... 251
L. Camera..................................................................... 228
C. Cardenas.................................................................. 210
Z. Burazor..................................................................... 251
L. Cámera..................................................................... 137
L. Cardenas................................................................... 276
N. Burazor..................................................................... 251
J. Camilletti................................................................... 210
M. Cardoso................................................................... 250
S. Burger....................................................................... 176
L. Cammi...............................................107, 222, 240, 251
A. Cardozo.................................................................... 244
J. M. Burgos................................................................. 250
P. Campagnolo..................................................... 272, 275
T. S. Carey............................................................ 138, 225
G. Burke........................................................................ 137
V. Campana.................................................................. 205
O. Carlevaro.................................................................. 142
G. Burlando................................................................... 184
E. G. Campana.............................................................. 250
A. Carli.......................................................................... 218
Authors
F. Carlos...........................................................78, 110, 143
P. H. C. Castro.............................................................. 140
A. Chaitoff..................................................................... 168
I. Z. Carlos..................................................................... 247
S. M. R. Castro..................................................... 252, 268
T. Chalabi...................................................................... 175
M. R. Carmo................................................................. 166
A. Castro-Beiras............................................................ 198
T. Chaliabi..................................................................... 175
E. Carmona................................................................... 111
A. Cataliotti......................................................72, 108, 136
D. Chambre...................................................237, 240, 265
R. Caron-Lienert............................................................ 236
L. Catão........................................................................ 108
D. Chamie............................................................. 259, 261
V. Carosella................................................................... 210
C. A. M. Cattani............................................................ 236
E. Chammas.......................................................... 277-278
A. F. Carpentier............................................................. 172
B. Cavaliere................................................................... 263
G. Chamorro.................................................. 109, 182-183
M. Carrageta......................................................... 111, 181
B. Cavalieri.................................................................... 228
H. C. Champion............................................................... 77
V. B. Carranza..................................................77, 140, 198
G. Cavalli....................................................................... 228
K. Chan......................................................................... 135
E. Carrasco................................................................... 178
D. C. U. Cavallini........................................................... 247
M. Chan...........................................................73, 143, 179
P. Carrascosa.........................141, 200, 204, 238, 268, 275
M. Cavazzi.................................................................... 269
P. Chandra.................................................................... 132
J. Carrascosa.................................141, 200, 204, 268, 275
R. Cayre........................................................................ 178
D. Chaparro................................................................... 168
A. Carro......................................................................... 197
M. Cazalas.............................................................. 76, 252
A. Charalambous............................................................ 77
S. Carson........................................................................ 74
M. Cebanu.................................................................... 242
A. Charask...............................................69, 100, 191, 207
L. Cartasegna................................................................ 210
G. Ceconi...................................................................... 222
A. Charroqui...................................................111, 221, 255
C. Carvajal..................................................................... 216
K. Cedro........................................................................ 241
S. S. Chauhan............................................................... 140
J. Carvajal..................................................................... 137
A. Cejas........................................................................ 260
I. Chaves....................................................................... 220
A. C. A. Carvalho............................................245, 259, 263
A. S. Celebi................................................................... 233
H. Chaves..................................................................... 108
A. C. C. Carvalho.............................245, 248-249, 259, 263
M. Celente............................................................ 262, 265
A. Chaves..................................................................... 241
D. Carvalho................................................................... 228
D. S. Celermajer............................................................ 180
A. Chávez........................................................................ 76
R. F. Carvalho................................................................ 260
A. Celestini..................................................................... 76
K. Chawla............................................................... 250-251
G. Carvalho.....................................139-140, 208, 228, 257
V. Celorrio..................................................................... 244
M. Chazan....................................................................... 74
A. C. A Carvalho.............................................245, 259, 263
J. Celutkiene................................................................. 210
T. Chazova.................................................................... 163
T. Carvalho.....................................................208, 217, 223
N. Cemerlic-Adjic.......................................................... 183
E. Z. Chehter................................................................. 246
P. E. G. Carvalho........................................................... 228
M. Cenanovic................................................................ 105
D. Chejtman.....................................................79, 106, 187
A. Carvalho....................................110, 208, 245, 259, 263
O. Cendoya................................................................... 207
S. Chekerdemian.......................................................... 269
C. Carvalho.............................111, 245, 248-249, 259, 263
A. Cengel....................................................... 185, 278-279
S. Chekherdemian.................................217, 248, 257, 259
J. J. Carvalho................................................................ 198
A. Çengel.......................................................172, 180, 186
M. G. Chelu................................................................... 103
V. T. Carvalho................................................................ 217
M. Centemero.............................................................. 198
K. Chemello.................................................................. 109
H. Casabe........................ 73, 205, 207, 211, 236, 246, 279
S. Centeno.................................................................... 142
F. Chen......................................................................... 231
J. Casabe.............................................................. 224, 231
R. Centurión.................................................................. 199
M. Chen........................................................................ 107
A. C. Casarini................................................................ 224
M. Centurión................................................................. 256
H. H. Chen.......................................................72, 108, 136
A. Casarsa..................................................................... 229
R. Ceolin....................................................................... 266
Y. Cheng....................................................................... 202
J. Casas........................................................................ 246
R. Ceratto............................................................... 78, 256
N. Chepurina................................................................. 175
F. Casas........................................................................ 227
R. Cerbak...................................................................... 253
R. Cherhousky.............................................................. 193
J. M. Casas................................................................... 279
G. H. Cerezo................................................................. 214
S. Chermont............219, 233-234, 236, 260, 262-263, 270
F. A. Casas.................................................................... 133
A. R. Cerna.................................................................... 226
Z. A. Chernaya................................................. 74, 104-105
U. Casas-Juarez............................................................ 265
D. Cerna........................................................................ 223
T. K. Chernyavskaya......................................... 74, 104-105
M. Cascon-Bueno..........................................207, 218, 257
D. Černá......................................................................... 169
A. Cherro.......................................................229, 265, 267
M. Cascudo.................................................................. 247
N. Ceron....................................................................... 216
S. B. Cherry................................................................... 243
F. Caseiro-Alves.................................................... 204, 224
M. Cerón............................................................... 181, 193
R. Chervin..................................................................... 189
C. B. Casella...................................................172, 180, 192
D. Cerovec.................................................................... 220
P. A. Chiale................................................................... 275
G. Casella...................................................................... 227
E. Cerqueira.................................................................. 192
G. R. Chiappa.......................................................... 74, 138
A. Casella-Filho..............................................172, 180, 192
V. Cerutti............................................................... 247, 268
C. Chicanelli.................................................................. 225
B. Cassis....................................................................... 137
C. Cesa................................................................. 272, 275
T. Chikamori.................................................................. 167
P. Castan...................................................................... 246
L. A. M. Cesar................................................101, 193, 236
A. L. Chilingarian....................................242, 244, 246, 249
S. Castelar.................................................................... 168
L. César........................................................................ 179
A. L. Chilingaryan.....................................72, 103, 193, 218
A. Castellanos............................................................... 169
V. Cesareo............................................................ 244, 247
D. Chin.................................................................... 73, 256
J. Castell-Conesa...........................................132, 236, 238
F. Y. Cesena...................................................172, 180, 192
W. M. Chin.................................................................... 201
S. Castellino.................................................................. 261
R. Cesnjevar................................................................. 274
B. S. P. Chin.................................................................. 201
H. Castello.................................................................... 190
Z. Cetin......................................................................... 223
B. Chiostri..................................................................... 221
G. Castillo..................................................................... 248
P. C. Chabot.................................................................. 258
M. Chiozza.................................................................... 274
V. Castillo...................................................................... 106
E. Chachques........................................................ 139, 172
R. Chirife....................................................................... 244
M. Castillo..................................................................... 251
J. Chacon...................................................................... 242
R. Chirino...................................................................... 183
R. Castro........................................137, 226, 252, 258, 268
S. Chacon..................................................................... 270
M. Chiru........................................................................ 200
I. Castro........................................................................ 208
A. P. M. Chacra............................................................. 198
M. Chkhetia.................................................................. 164
D. Castro..........................................................75, 107, 226
S. Chada....................................................................... 139
Z. Chmielak................................................................... 241
E. Castro................................................................ 269-271
A. C. P. Chagas..............................................172, 180, 192
A. Chockalingam........................................................... 138
Index / 295
Authors
S. Chockalingam........................................................... 138
S. R. Coimbra................................................................ 192
L. C. L. Correia........................................................ 72, 107
D. Choi.......................................................................... 110
A. Coimbra.................................................................... 137
J. Cors.......................................................................... 225
I. S. Choi....................................................................... 111
P. Cokkinos............................................................ 181-182
C. Cortes....................................................................... 207
L. Chojnowska.............................................................. 136
D. V. Cokkinos...................................................... 177, 182
C. M. Cortés................................................................. 246
N. Chon......................................................................... 219
H. Cola.......................................................................... 227
R. Corvalan................................................................... 132
P. Chopra.............................................................. 108, 241
S. Colangelo.................................................................. 171
L. A. Cosarinsky............................................................ 136
J. B Choy...................................................................... 165
D. Colcear..................................................................... 242
G. Cosentino................................................................. 186
M. Christ........................................................103, 194, 245
C. Coleman................................................................... 182
N. M. Cosgrove............................................................. 144
G. Christ........................................................................ 110
F. Collart....................................................................... 241
A. Costa...................................72, 169, 205, 211, 256, 259
A. Christen............................................................ 139, 259
C. Collaud............................................................. 139, 261
G. Costa................................................................ 102, 212
E. H. Christiansen............................................71, 142, 253
C. Collet........................................................................ 186
E. Costa........................................................................ 185
D. Chrysos.................................................................... 181
T. Collier...........................................................73, 107, 143
S. Costa...............................70, 78-79, 101, 132, 250, 252,
P. H. Chu....................................................................... 179
M. Colmenero....................................................... 224, 246
.......................................254-256, 258, 260, 263, 275, 277
K. Chudasama............................................................... 256
F. Colombo................................................................... 205
L. Costa.........................................................189, 197, 207
J. Chudek...................................................................... 101
C. M. Colombo.............................................................. 230
R. Costa......................................................... 256-259, 261
S. Chugh................................................................ 141-142
F. Colosia...................................................................... 210
J. Costa...................................................247, 256-259, 261
W. J. Chung........................................75-77, 111, 144, 272
D. Comay.............................................................. 222, 276
M. A. Costa....................................................169, 205, 211
S. Chuprova.................................................................. 213
N. Combes.................................................................... 103
P. C. S. Costa................................................................ 275
E. Chuquiure................................................................. 204
P. Comignani................................................................ 200
J. Costa Jr...............................................256-257, 259, 261
G. Ciambrone...................................................72, 200, 226
C. Commes................................................................... 179
R. Costantini................................................................. 278
T. F. Cianciulli.....................................79-80, 136, 142, 176,
D. Comtesse................................................................. 179
R. Costello............................................................ 102, 181
.......................................................178, 219-223, 229, 250
M. Condori.................................................................... 192
L. C. Costello-Boerrigter............................................... 108
L. Cicco........................................................................... 73
T. Conforti..................................................................... 190
C. Cotrim.............................................................. 111, 181
F. T. Cichelero............................................................... 106
M. Conforto.................................................................. 100
M. Coutinho.................................................................. 179
A. C. Cicogna................................................................ 258
C. Conkbayir................................................................. 180
L. A. Cozarinsky............................................................ 178
A. B. Cid Alvarez.................................................... 186-187
S. Connolly.......................................................73, 107, 143
G. Cozzarin.................................................................... 197
M. Ciesielczyk............................................................... 222
M. Consoli.....................................................248, 257, 259
I. Craciunescu............................................................... 134
R. Cífková............................................................. 166, 173
F. M. Consolim-Colombo...................................... 138, 270
D. Craiem...................................................................... 267
C. Cigalini...................................................................... 182
A. E. Consolini............................................................... 237
O. Cravero.................................................................... 227
M. Cikes....................................................................... 254
D. Constantinescu........................................................ 200
N. Crespi....................................................................... 211
I. Cikes.......................................................................... 254
R. Conti......................................................................... 276
A. Crespo...................................................................... 217
M. Cikirikcioglu............................................................. 142
A. Contreras.................................................................. 176
F. Crespo.............................................................. 213, 239
L. Cimerman................................................................... 80
L. Contreras.................................................................. 189
M. Crespo..................................................................... 188
R. Cimino...................................................................... 254
H. Contreras................................................................. 190
A. Cribier......................................................................... 78
H. E. Cingolani...................................................... 140, 189
G. Converso.................................................................. 269
E. Cristiano............................................................ 228-229
I. P. Cintra..................................................................... 265
L. Cook......................................................................... 176
J. Cristóvão................................................................... 258
M. Ciprés...................................................................... 274
J. Cooke........................................................................ 111
V. Crosa........................................................................ 227
J. J. Cirio............................................................... 111, 221
W. Cooper.................................................................... 255
N. Crozzoli..................................................................... 168
M. Cisterna................................................................... 107
J. C. H. Coracini............................................................ 265
C. N. Crudo Norma....................................................... 169
M. Ciszewski................................................................ 102
S. Corali........................................................................ 188
A. Crusitu...................................................................... 200
A. Ciszewski................................................................. 175
S. Coralli........................................................................ 188
H. Cruz.................................................................. 181, 193
L. Citta.......................................................................... 102
F. Corbella............................................................. 239, 255
C. Cruz.......................................................................... 228
N. Citta.......................................................................... 102
M. Corbi........................................................................ 231
M. Cruz......................................................................... 229
M. M. Civetta................................................................ 275
P. Cordeiro................................77, 111, 181, 233, 236-237
F. E. S. F. Cruz....................................................... 252-253
K. Ckarke...................................................................... 168
V. Cordeiro.................................................................... 144
I. Cruz-Gonzalez.................................................... 218, 257
D. Clark......................................................................... 135
A. C. Cordeiro......................................................... 80, 208
D. Cruz-Robles.............................................................. 204
A. M. Clark............................................................ 143, 229
D. Cordero.................................................................... 204
T. Csatay....................................................................... 199
S. C. Clark..................................................................... 138
I. Cordovil..........191-192, 244, 252-254, 264, 266-267, 273
G. Cuberas............................................................ 132, 236
N. C. D. Clementino........................................................ 74
D. Cornalo..................................................................... 189
M. Cudmore................................................................. 256
I. P. Clements............................................................... 105
M. Cornelli.................................................................... 210
F. Cuellar....................................................................... 139
B. Clericus.................................................................... 257
M. L. Coronel...................................................70, 105, 271
R. Cuenca..................................................................... 188
C. R. Clover........................................................... 138, 212
R. Coronel.............................................................. 205-206
A. Cueto........................................................................ 222
M. R. Cobain................................................................... 73
L. Coronel................................................70, 105, 271, 273
A. Cuevas..................................................................... 163
J. F. Codone.................................................................. 223
A. Correa................................................102, 132, 242, 253
H. Cuezo......................................................................... 78
R. Codutti............................................................... 270-271
A. G. Correa.................................................................. 102
G. Cugat........................................................................ 248
L. Coelho...................................................................... 258
M. Correa............................................................... 270-271
C. Culebras................................................................... 183
F. Coelho...................................................................... 191
D. V. Correa.................................................................. 245
S. Cunha............................................................... 202, 258
A. C. Côrrea.................................................................. 221
T. S. Cunha................................................................... 258
M. G. Cohen...........................................138, 212, 225-226
Authors
L. Cuniberti................................................................... 259
D. De Backer................................................................. 107
N. Delarche................................................................... 243
F. Cura..............................71, 132, 225, 242, 244-245, 277
D. De Bacquer..........................................73, 107-108, 143
H. Delgadillo-Rodríguez................................................ 205
C. Curato......................................................................... 77
G. De Bacquer.............................................................. 107
M. Delgado Moreno...................................................... 234
A. Curcio....................................................................... 269
L. N. De Barros............................................................. 234
D. Delgado...................................................................... 74
A. Cury.................................................................... 79, 258
L. De Candido............................................................... 142
E. Delgado............................................................. 196-197
G. Cvetanovic............................................................... 251
F. De Cecco.................................................................. 181
J. Delgado..................................................................... 139
B. Cveticanin................................................................. 174
A. De Dios..................................................................... 178
M. Deljanin Ilic...................................................... 166, 214
A. Cypiene.................................................................... 184
A. De Elizari................................................................... 260
R. Della Pasqua............................................................... 72
F. Cyrino......................................................................... 71
U. De Faire...................................................................... 75
D. Deluso.............................................................. 102, 212
E. Czarnowska.............................................................. 134
F. R. De Fazzio.............................................................. 244
D. Demicco................................................................... 183
A. Czerniczyniec........................................................... 197
J. A. De Grazia.............................................................. 137
A. D. Demir................................................................... 110
R. D´agosto................................................................... 168
M. De La Vega.............................................................. 241
B. Demircelik................................................................ 223
C. D´amico.................................................................... 138
J. De La Hera......................................................... 196-197
M. Demkow................................................... 101-102, 136
L. D’angelo................................................................... 106
M. De La Riba................................................111, 221, 255
M. Dencker................................................................... 168
K. Da Correggio............................................................. 179
R. N. De La Fuente..................................76, 138, 234, 253
M. C. Deng................................................................... 104
P. Da Luz....................................................................... 176
M. De La Rosa.............................................................. 260
D. H. Denis Hamel........................................................ 138
M. P. Da Rosa............................................................... 205
M. E. De La Antonia...................................................... 168
D. V. Denizar Vianna..................................................... 209
M. Da Cunha................................................................. 234
L. M. De La Fuente............................................... 140, 218
C. Dennison.................................................................. 196
M. Dabrowski................................................102, 136, 237
R. N. De La Fuente..................................76, 138, 234, 253
R. K. Deo....................................................................... 272
J. Dadoniene................................................................. 184
C. De Larrazabal............................................................ 270
S. Depine.......................................................107, 222, 240
M. D’Aglio..................................................................... 197
G. De León.....................................................132, 236, 238
M. Descalzo.................................................................. 267
R. B. D’Agostino............................................................. 73
J. J. G. De Lima............................................................ 101
H. Deschle.............................................175, 268, 272, 277
V. Daher Vaz................................................................. 208
D. R. S. De Lorenzi........................................................ 228
P. Dessen............................................................... 75, 103
I. Dahlbom...................................................................... 75
A. De Lorenzo................................................110, 142, 210
M. Destro..................................................................... 173
M. Daicz........................................................................ 207
C. De Luca.................................................................... 211
J. L. Dettoni.................................................................. 270
M. Dal Pai-Silva..................................................... 258, 260
R. De Miguel................................................................. 221
A. Dettorre.................................................................... 103
R. Dall’ Alba.................................................................. 233
D. De Mollein................................................................ 214
B. Deveci...................................................................... 233
P. Dall´ago........................................................74, 138, 142
L. De Noronha................................................................. 77
L. Devera...................................................................... 264
P. Dall’Ago.......................................................74, 138, 142
P. S. De Oliveira............................................................ 266
A. Deviggiano................................141, 200, 204, 238, 275
L. A. O. Dallan............................................................... 193
A. De Paola................................................................... 110
F. Devito....................................................................... 261
C. Daltro........................................................................ 215
A. V. De Paola......................................................... 72, 248
S. C. Dharmage............................................................. 164
P. Daluz......................................................................... 111
F. J. De Paula................................................................ 101
G. Di Gesaro................................................................. 106
N. R. T. Damasceno.............................................. 263, 265
J. De Paz....................................................................... 139
F. Di Giovanni................................................................ 179
R. C. Damaso................................................................ 247
S. De Ridder.................................................................. 277
D. Di Nanno...................................................248, 257, 259
C. Damico..................................................................... 277
R. De Rosa.................................................................... 178
B. A. Di Rico.................................................................. 226
S. Damilano.................................................................. 189
M. De Rossi.......................................................... 233, 236
J. Di Siervi..................................................................... 215
J. Damsky Barbosa....................................................... 209
R. De Rossi............................................................. 76, 208
G. Di Tano....................................................................... 70
L. D’Angelo................................................................... 106
T. De Santo..................................................................... 72
F. Di Tomaso................................................................. 189
G. A. Danieli.................................................................. 134
M. De Sena................................................................... 143
F. Di Tommaso............................................................. 220
R. O. Darabont...................................................... 106, 211
L. De Souza................................................................... 137
D. Di Toro...............................................197, 214, 273, 277
V. Daru.......................................................................... 244
C. De Zuloaga............................................................... 102
C. Di Verniero................................................................ 273
V. Darú.......................................................................... 111
P. Debruyne.................................................................. 277
S. Di Yelsi...................................................................... 179
F. Das Neves................................................................ 278
A. Debski.............................................................. 102, 241
J. Diament.................................................................... 109
J. Dassanayake............................................................. 164
J. Decourcey................................................................. 166
S. Diangelo................................................................... 185
G. Datcu........................................................................ 211
D. B. Dedeoglu..................................................... 180, 242
J. M. Dias De Azeredo Bastos...................................... 208
A. Dauria....................................................................... 134
R. Dedrick..................................................................... 104
C. Dias.......................................................................... 108
G. Davey Smith............................................................. 164
M. M. Defeo......................................................... 208, 211
V. Dias.......................................................................... 191
E. Dias.......................................................................... 231
Z. Davicevic.................................................................. 193
J. P. Degaute................................................................ 211
F. David......................................................................... 144
M. Degrange..........................................111, 170, 189, 196
R. Dias.......................................................................... 176
M. David....................................................................... 214
J. A. Degrazia................................................................ 107
P. Diaz Uberti..........................106-107, 201, 208, 236, 238
A. R. Davies.................................................................. 164
V. Dehlaghi........................................................... 142, 212
I. Diaz...................................................................... 80, 244
A. Davila........................................................................ 263
F. Deketele................................................................... 195
M. Diaz......................................................................... 246
V. Davutoglu......................................................... 171, 211
M. Dekleva................................................................... 174
C. Diaz...................................................................... 73, 75
M. De Abreu....................................................70, 100, 238
M. Del Campo....................................................... 214, 222
A. Díaz Redondo........................................................... 186
W. De Andrade............................................................. 185
C. Del Mazo...........................................111, 170, 189, 196
R. Díaz.......................................................................... 137
K. De Angelis................................74, 76-77, 136-138, 239,
M. Del Sueldo......................................................... 78, 261
R. Diaz-Contreras.......................................................... 248
...............................................................249, 254-255, 258
L. A. Del Val.................................................................. 251
S. A. Dib Ashur..................................................... 207, 209
G. De Backer.............................................73, 107-108, 143
A. Del Val.............................................................. 190, 251
M. Dicugno................................................................... 201
Index / 297
Authors
M. Diego-Dominguez.....................................207, 218, 257
L. Dragonetti..................................................227, 239, 255
L. Enciso....................................................................... 102
A. Dieterle..................................................................... 176
M. Dragovic.................................................................. 169
J. E. Enders................................................................... 273
G. Dieuzeide................................................................. 240
H. Dreger...................................................................... 140
O. Epstein..................................................................... 175
F. Diez................................................................... 105, 240
A. Drolias...................................................................... 216
A. R. Erbay.................................................................... 110
M. Diez........... 106, 186, 224, 236, 238, 250, 259, 266-267
J. Drozdz........................................................170, 188, 222
P. Erceg.................................................................. 74, 105
P. Digon........................................................................ 240
R. Drwila....................................................................... 230
A. Erdem........................................................180, 194, 205
M. Dikic.......................................................................... 71
A. Drzewiecka-Gerber................................................... 230
G. Erdem...................................................................... 278
C. H. Dina...................................................................... 191
M. Duarte.............................................................. 200-201
M. Erden....................................................................... 186
A. Dini............................................................................. 71
D. Duarte........................................................................ 79
S. Erdine............................................................... 108, 241
R. V. Z. Diniz.................................................. 248-249, 267
T. N. Dube............................................................. 108, 231
I. Erdinler...................................................................... 186
R. Diniz......................................................................... 247
R. Duchonova................................................141, 223, 234
E. Erdogan.................................................................... 197
M. Diniz........................................................................ 201
R. Duchoňová................................................................ 136
M. Eren......................................................................... 171
B. Dinov........................................................................ 206
A. Dudkowska.............................................................. 249
B. Erer........................................................................... 171
L. Diodato............................................................. 244, 247
T. Duffy......................................................................... 250
A. Erglis........................................................................ 255
T. Diogenes........................................................... 264-266
H. Duggirala.................................................................. 110
L. Erhardt...................................................................... 243
P. Diosque.................................................................... 254
A. Dukat........................................................................ 240
C. M. Erley.................................................................... 141
T. Dipp..............212-214, 221-223, 227, 261, 265-266, 269
E. Dulbecco......................73, 107, 205-206, 230, 246, 279
Z. Eroglu......................................................................... 77
M. Disanto.................................................................... 221
L. Dumas...................................................................... 176
C. Erol........................................................................... 192
F. Ditomaso.................................................................. 102
H. Duplain............................................................... 75, 103
N. Erondu................................................................ 75, 166
C. D’Ivernois......................................................... 135, 218
J. Dupont...................................................................... 139
J. Erriest....................................................................... 210
C. Dizeo........................................................................ 189
E. Duronto............................................................ 100, 207
S. Eryilmaz.................................................................... 111
W. Djaballah.................................................................. 110
F. Duru.......................................................................... 246
B. Eryonucu.................................................................. 185
S. Djambazov................................................................ 230
G. Dussaillant................................................................ 141
J. Escalante.................................................................. 260
D. Djordjevic................................................................. 276
N. Dusserre.................................................................. 218
A. S. Escandurra........................................................... 224
A. Djordjevic-Dikic...........................110, 142, 171, 277-278
R. Dutta........................................................................ 232
C. Escarain.................................................................... 259
B. Djukanovic................................................................ 202
H. Duygu....................................................................... 188
A. Escobar.............................................................. 72, 227
L. D. Do................................................................. 143, 275
S. Dzemeshkevich........................................................ 234
J. Escudero................................................................... 185
D. Dobrev..................................................................... 103
V. Dzenkeviciute................................................... 184, 237
E. M. Escudero................................................77, 140, 198
H. Dohmann......................................................... 139, 184
Z. Dzielinska.................................................................. 101
C. Esis........................................................................... 242
N. Doll........................................................................... 182
S. S. Eagle....................................................................... 73
S. Eskenazi................................................................... 218
A. Dombrovskis............................................................ 255
K. A. Eagle.................................................................... 100
M. M. Esnaola......................................................... 78, 111
E. Domenicchini............................................................ 242
M. Ebbing.......................................142, 243, 247-249, 251
A. Esper........................................................................ 265
A. M. Domingos............................................................ 253
A. Ebner........................................................................ 240
A. Esperon.................................................................... 267
R. Dominguez....................................................... 168, 222
R. Ebrahimi................................................................... 144
P. Esperón............................................................ 273, 276
C. Dominguez............................................................... 214
C. Echeverria................................................. 189-190, 215
G. Espersen.................................................................. 166
A. Dominguez-Rodriguez...............................167, 169, 213
H. Ede........................................................................... 192
R. Esporcatte................................................................ 250
M. Dominiak.................................................. 170-171, 188
T. Eftestøl..................................................................... 199
A. Esquivel.................................................................... 240
F. Dominici.................................................................... 274
Z. Egileten..................................................................... 111
A. R. Essop................................................................... 203
S. Donato.........................................................72, 200, 226
E. Egito......................................................................... 258
M. R. Essop.......................................................... 203, 230
P. Donato.............................................................. 204, 224
E. T. Egito....................................................................... 76
J. P. Esteves........................................................... 72, 107
L. Dong Won................................................................. 272
S. Egito......................................................................... 249
P. Esteves........................................................72, 107, 254
I. Donis......................................................................... 190
Y. Ekimova.................................................................... 132
J. Estornell.................................................................... 231
L. Donwon.................................................................... 272
A. Eksik......................................................................... 186
G. Estrade..................................................................... 243
J. P. Donzeau................................................................ 103
C. Elbacha..................................................................... 278
S. J. Eum........................................................................ 79
A. N. Dorelle.........79-80, 176, 178, 219-220, 222-223, 229
R. Elesgaray.......................................................... 169, 211
A. Evangelista............................................................... 252
A. H. Dorigo.................................................................. 262
A. Elhendy.................................................................... 111
P. Evangelista............................................................... 240
M. Dorobantu........................................106, 200, 211, 224
F. Eliaschewitz.............................................................. 227
L. Evlampieva............................................................... 183
D. Dorsey...................................................................... 133
G. Elizalde............................................................. 241, 264
F. Exposito.................................................................... 229
F. Dorticós.................................................................... 210
A. Elizalde....................................................................... 77
E. Eyheremendy........................................................... 255
A. Dos Santos............................................................... 207
M. V. Elizari.................................................... 219-220, 229
H. Ezumi....................................................................... 239
G. Dotto........................................................................ 264
R. El-Kik........................................................................ 175
J. N. Fabiani.................................................................. 179
R. Doughty.................................................................... 136
S. Ellovitch.................................................................... 102
B. Fabricio............................................................. 136, 211
P. Dourado.................................................................... 111
I. Elmadbouh................................................................. 139
L. Fabryova................................................................... 257
H. Doval...........................................................70, 100, 209
H. Eltchaninoff................................................................ 78
G. Facin......................................................................... 100
M. Dowlut..................................................................... 256
L. Elvas......................................................................... 258
S. Fadel......................................................................... 179
G. Doxastakis................................................................ 227
W. T. Emery.................................................................. 165
K. Fagnilli...................................................................... 168
S. Dragnic..................................................................... 167
F. Emperador................................................................ 190
G. E. Fagogenis............................................................. 185
D. D. Drago................................................................... 217
S. Enar.......................................................................... 216
B. Faillace..................................................................... 195
Authors
I. Faillace....................................................................... 195
E. O. Fernandes.................................................... 252, 274
A. Ferro......................................................................... 166
D. Faith......................................................................... 226
T. R. Fernandes............................................................. 236
M. Fervenza.................................................................... 72
D. Faivovich.................................................................. 137
E. Fernandes................................................................. 268
G. Feuchtner................................................................. 173
S. A. Fakhouri................................................................ 244
G. S. Fernandes.................................................... 226, 236
Z. Fichino...................................................................... 276
A. S. Fakhouri................................................................ 244
G. M. O. Fernandes...................................................... 274
J. Fiedler............................................................... 223, 237
G. Falbo........................................................................ 228
F. Fernandez Chamorro................................................ 256
J. Figal.......................................................................... 107
S. Falcão....................................................................... 111
C. Fernandez Gomez.................................................... 273
L. Figiel......................................................................... 170
F. Falcón....................................................................... 137
N. Fernandez................................................................ 206
J. Figueira..................................................................... 190
V. Falk........................................................................... 182
G. Fernandez................................................................ 210
A. Figueiredo.................................................108, 250, 272
J. P. Faller..................................................................... 194
E. Fernandez......................................................... 215, 260
J. Figueiredo................................................................. 138
V. Faltus...........................................................72, 132, 200
S. Fernandez......................................................... 169, 240
S. Figueiredo................................................................. 253
R. Falú............................................................132, 236, 238
M. Fernandez.........................................178, 182, 241, 268
J. Figueras.................................................................... 236
R. Falú,...........................................................132, 236, 238
A. Fernandez.........................102, 205, 207, 211, 224, 227,
J. Figueredo.................................................................. 190
S. Fandiño............................................................... 70, 136
...............................................231, 235-237, 240, 248, 254
A. Figueroa................................................................... 240
M. Fanuele.................................................................... 181
R. Fernandez................................................................. 224
M. Fijalkowski............................................................... 249
A. Farah................................................................ 246, 248
H. Fernandez...........................................79, 176, 187, 250
R. D. S. Filho................................................................. 263
S. C. Faria...................................................................... 274
F. Fernandez......................................................... 165, 256
R. Filho.......................................................................... 253
C. Faria.................................................................. 249, 274
E. H. Fernandez............................................................ 176
I. Filibev........................................................................ 194
J. Faría.......................................................................... 263
J. Fernández De La Concha.................................. 213, 239
K. Filipiak....................................................................... 273
E. Farias........................................................................ 141
A. Fernández Meseguer............................................... 174
S. Finella....................................................................... 211
M. F. Farias................................................................... 217
J. M. Fernández............................................................ 209
F. Fini............................................................................ 240
M. Farnier....................................................................... 75
A. Fernández..................................................174, 186, 227
F. Finol........................................................... 247-248, 263
M. Farrall......................................................................... 77
A. R. Fernández............................................................ 273
A. Fiorillo....................................................................... 218
H. Farras............................................................... 171, 181
C. Fernández................................................................... 69
M. Fisberg.................................................................... 265
J. Fassl.................................................................... 73, 182
V. Fernández................................................................. 188
C. H. Fischer....................................................79, 224, 253
L. Fatecha..................................................................... 256
B. Fernández................................................................. 274
C. Fisher....................................................................... 238
A. Fauzi......................................................................... 184
C. Fernández-Cimadevilla............................................. 196
E. Fisman...................................................................... 209
G. Fava............................................205-207, 211, 236, 259
C. Fernández-Labandera............................................... 174
R. Fitaroni..................................................................... 144
C. Fava.............................................................78, 188, 193
J. M. Fernandez-Real.................................................... 188
P. Fitzgeral.................................................................... 257
L. Favaloro...... 106, 186, 224, 236, 238, 250, 259, 266-267
F. L. Fernando Lanas.................................................... 102
G. Fitzgerald.................................................................. 100
R. R. Favaloro.........................186, 205, 211, 230, 246, 266
L. Fernando Tanajura.................................................... 257
P. Flaherty..................................................................... 197
D. Favarato................................................................... 192
S. Ferradas.................................................................... 214
A. Flavio........................................................................ 211
D. Favaratto.................................................................. 172
R. Ferrando............................................................ 269-270
E. Fleck................................................................... 75, 107
G. Fazio......................................................................... 106
D. Ferrante.................................................................... 137
E. Fleitas....................................................................... 177
C. Febres...................................................................... 190
G. M. Ferrari...................................................133, 237, 274
P. Flondor..................................................................... 106
M. Fechner................................................................... 140
G. Ferrari....................................................................... 227
C. Flores Borja.............................................................. 248
R. A. Fedato.................................................................... 75
A. Ferrario............................................................... 78, 256
E. Flores........................................................................ 178
F. L. Federico Lipszyc................................................... 212
C. Ferreira Filho..................................................... 195, 245
D. Flores....................................................................... 107
B. Federico................................................................... 132
J. L. Ferreira.................................................................. 247
M. Flores...................................................................... 190
H. Feier......................................................................... 241
B. Ferreira..................................................................... 180
X. Flores-Ríos................................................................ 198
J. Feijoo........................................................................ 218
C. Ferreira..............................195, 243, 245, 247, 251, 265
J. Floridia........................................................................ 78
M. Feissel..................................................................... 194
M. Ferreira......................110, 142, 204, 217, 247, 253-254
E. Florido....................................................................... 271
A. D. M. Feitosa.................................................... 247, 255
G. M. Ferreira................................................................ 142
L. Florio......................................................................... 199
A. Feitosa...................................................................... 228
A. L. Ferreira................................................................. 106
S. Florit......................................................................... 142
G. S. Feitosa-Filho......................................................... 109
M. A. P. Ferreira............................................................ 108
G. Flory......................................................................... 243
L. Feldman.................................................................... 267
M. J. Ferreira................................................................ 224
K. Flues................................................76-77, 137-138, 258
G. Feldman....................................................141, 180, 187
J. C. A. Ferreira-Filho.................................................... 270
B. Flynn......................................................................... 176
R. Feldman........................................................... 187, 241
M. Ferreiro.................................................................... 275
G. Fodor........................................................................ 240
A. Feldman................................................................... 186
C. R. Ferreiro................................................................... 76
A. Fogel.......................................................................... 76
M. S. Felix..................................................................... 142
L. Ferrer........................... 69, 103, 242, 258, 260, 265, 271
A. Folga......................................................................... 273
A. Fellet........................................................................ 205
M. Ferrer................................................................. 69, 207
S. Folino........................................................................ 274
G. Feltes................................................................ 241-242
A. Ferrer-Antunes................................................. 110, 217
T. Folkestad.................................................................. 247
H. Feng........................................................................... 73
F. M. Ferrero................................................................. 274
A. Y. Y. Fong................................................................. 201
C. Fenili......................................................................... 189
L. Ferrero...................................................................... 239
F. L. Fonseca................................................................ 250
A. L. Fenrich.................................................................. 206
M. Ferrero..................................................................... 274
S. Fonseca................................................77, 233, 236-237
M. Fenucci.................................................................... 229
R. Ferreyra.............................................102, 185, 225, 244
I. Fonseca..................................................................... 213
F. Feres..........................................198, 225, 257, 259, 261
M. Ferriera.................................................................... 245
L. M. B. Fonseca............................................110, 140, 210
E. L. Ferlin............................................................... 74, 106
L. Ferro......................................................................... 176
L. Fonseca.....................................................226, 236, 250
Index / 299
Authors
L. H. Fonseca................................................................ 201
E. Fucak........................................................................ 223
E. A. Garcia Gras........................................................... 191
C. Fontana.................................................................... 179
S. Fuchs................................................................ 110, 178
M. A. Garcia.................................................................. 244
P. Forcada......................................................106, 138, 187
F. D. Fuchs.......................................................76, 106, 143
E. Garcia........................................................ 215, 270-271
L. M. A. Forlenza................................................... 102, 132
S. C. Fuchs.......................................................76, 106, 143
W. Garcia...................................................................... 215
M. Forrester.................................................................. 201
F. C. Fuchs.............................................................. 76, 106
R. G. Garcia................................................................... 249
O. Forster.............................................................. 202-203
K. Fuckar....................................................................... 220
R. Garcia........................................224, 235, 254, 264, 271
R. Y. Forte..................................................................... 100
F. Fuertes..................................................................... 248
A. Garcia................................111, 132, 184, 191, 195, 244
E. Forte................................................................. 100, 111
S. Fujii................................................................... 263, 278
M. Garcia................................141, 186-187, 192, 200, 260
A. Fortier....................................................................... 197
H. Fujii............................................................164, 188, 197
C. Garcia............................................................... 177, 207
M. J. Fosco......................................................73, 100, 279
T. Fujisawa.................................................................... 256
S. Garcia....................................................................... 141
J. Fourie........................................................................ 196
S. Fukae................................................................ 195, 209
H. H. Garcia................................................................... 164
R. Fowler...................................................................... 108
H. Fukuda........................................................70, 185, 189
A. García..........................................................69, 174, 188
R. Foye......................................................................... 181
K. Fukuyo...................................................................... 195
J. J. García-Cuerrero..................................................... 213
J. Fracasso.................................................................... 231
M. B. G. Funari.............................................................. 224
A. Garcia-Flores............................................................ 188
J. M. Fragoso......................................................... 204-205
E. Fung......................................................................... 111
M. J. Garcia-Gonzalez....................................167, 169, 213
H. Fraguas.................................................................... 206
T. Furuhashi.....................................................70, 185, 189
R. Garcia’Monaco..................................235, 254, 264, 271
F. Fraige Filho........................................................ 243-244
S. Furuyama.................................................................. 181
J. Garcia-Puig................................................................ 243
R. Frajndlich.................................................................. 109
J. Fuse.................................................................... 80, 244
C. D. Garciarena............................................................ 140
O. França Neto.............................................................. 176
S. Fuse.......................................................................... 167
L. García-Rojas.............................................................. 133
O. R. França Neto........................................................... 77
J. Fuselli................................................................ 102, 209
J. García-Ruiz......................................................... 196-197
F. R. França................................................................... 233
O. Fustinoni.......................................................... 111, 221
J. García-Seara...................................................... 180, 194
O. França................................................................ 77, 176
O. Fustoni....................................................................... 78
J. Gardin................................................................. 73, 179
B. V. França........................................................... 252, 268
J. Gabay........................................................................ 248
N. Garg......................................................................... 198
A. Francesia............................................................ 74, 136
E. Gabbay..................................................................... 108
V. Gariboldi................................................................... 241
J. V. Francica................................................................. 254
E. Gabe..................................................142, 205, 230, 278
L. Gariglio.......................................................181, 193, 239
D. Franco...................................................................... 227
A. Gacek....................................................................... 171
C. Garillo....................................................................... 210
L. François...................................................................... 78
Z. Gaciong..................................................................... 243
S. Garrido...................................................................... 218
T. Francuz..................................................................... 208
F. L. Gadaleta................................................................ 168
A. Garutti...................................................................... 264
A. Frangi................................................................. 79, 201
F. J. Gadea.................................................................... 178
J. Gasparovic................................................................ 257
R. Frank........................................................................ 179
V. Gafarov..............................................108, 138, 177, 272
I. Gasperovich............................................................... 218
P. Y. Frasier................................................................... 212
A. Gafarova............................................108, 138, 177, 272
M. Gassmann............................................................... 240
L. Frazin........................................................................ 202
J. Gagliardi...............................70, 100, 102, 133, 266, 278
E. Gassner.................................................................... 173
P. M. Fredriksen................................................... 103, 223
I. Gagulin............................................................... 138, 272
N. Gastaldello............................................................... 249
N. A. Freedberg............................................................ 186
E. Gainoiu..................................................................... 200
L. Gastaldi..................................................................... 263
B. Freedman................................................................. 100
D. Gainza.........................................................75, 107, 137
J. Gaudiano................................................................... 270
L. Freire........................................................................ 195
M. Gaito.......................................................................... 69
E. Gaui.................................................................. 106, 262
R. Freire........................................................................ 195
R. Galaska..................................................................... 249
M. Gaute....................................................................... 228
E. O. Freitas.................................................................. 260
S. Galatius............................................................. 230, 232
G. Gavrielatos............................................................... 181
J. Freitas......................................................................... 72
R. Galerano................................................................... 264
M. Gayda...................................................................... 197
M. Freitas....................................70, 78-79, 101, 132, 250,
A. Galindo..................................................................... 190
D. S. Gazizova............................................................... 255
.................................252, 254-256, 258-260, 262-263, 268
M. Galli......................................................................... 277
F. Gazoni............................................................... 263, 268
E. V. Freitas................................................................... 250
S. Gallo......................................................................... 240
O. C. E. Gebara............................................................. 277
A. L. R. M. Freitas................................................. 252, 268
P. Gallo...................................141, 206, 209, 246-248, 260
S. Geidel....................................................................... 103
L. Freitas....................................................................... 186
J. Gallo.......................................................................... 243
R. J. Gelpi.............................................................. 227-228
X. Freixa.......................................................................... 69
J. P. Gallo.............................................................. 141, 260
D. Genova..................................................................... 263
J. French....................................................................... 132
A. Galloe..........................................................71, 142, 253
J. A. Genovese..................................................... 172, 212
R. Fretes....................................................................... 222
M. Galovcová................................................................ 166
A. T. Germanos............................................................. 185
B. Frey.......................................................................... 232
M. Galvao..................................................................... 270
T. Gerntholtz................................................................. 107
N. Freyberg................................................................... 143
G. T. Gama.................................................................... 244
R. Geronazzo................................................................ 227
O. Fridman.................................................................... 239
J. Gambarte.....................................................72, 200, 226
L. Gerones.................................................................... 197
S. Friedl......................................................................... 274
S. Gambhir.................................................................... 250
L. Geronés.................................................................... 189
R. A. Friedman.............................................................. 206
R. Gamboa.......................................................76, 165, 224
M. Geronés................................................................... 189
G. Friedrich................................................................... 173
M. Gamen............................................................. 134, 225
C. Geronés.................................................................... 183
C. Froimovich................................................... 80, 242-244
C. Gangana................................................................... 262
M. Geronimo................................................................ 247
J. Frostegård................................................................... 75
I. Gantz........................................................................... 75
H. Ghandehari................................................................. 79
A. G. Fruntelata............................................................. 200
N. Ganugrava................................................................ 235
D. Gherardi................................................................... 240
M. L. Fuantos Delgado................................................. 268
F. Ganzalez................................................................... 193
M. Ghias....................................................................... 163
M. L. Fuantos-Delgado.......................................... 265-266
C. Garcez...................................................................... 234
S. Ghione.............................................................. 190, 251
Authors
S. Ghiorghe....................................................106, 211, 224
S. Golitsyn.................................................................... 234
N. Gotcheva.................................................................. 225
G. Ghirardi..................................................................... 242
T. Golitsyna................................................................... 163
D. Gotera...................................................................... 247
F. Ghizzoni.................................................................... 143
A. M. Gomes........................................................ 100, 255
I. Gotlib......................................................................... 136
A. Ghosh....................................................................... 232
R. Gomes........................................190, 252, 259-260, 262
C. Gottschall................................................................. 138
M. Giacomo........................................................... 189-190
I. Gomes....................................................................... 102
G. Gouvea.............................................................. 222-223
J. Giani.......................................................................... 274
G. B. Gomes................................................................... 75
C. M. Gouvêa................................................................ 275
E. Giardina.............................................................. 75, 107
M. A. M. Gomes........................................................... 255
L. H. W. Gowdak...........................................101, 193, 236
A. Gibert....................................................................... 188
C. Gomes...................................................................... 191
V. Grabauskiene............................................................ 210
V. Giga....................................................110, 142, 277-278
L. Gomes...................................................................... 191
N. A. Grablina........................................................ 174, 192
G. Gigena................................................................ 69, 132
R. A. F. Gomes............................................................. 247
M. Grabowski............................................................... 273
G. S. Gill........................................................................ 251
S. Gomes Jr...................................................136, 215, 220
B. Graça........................................................................ 224
J. Gill............................................................................. 179
J. Gomez.................................................71, 139, 228, 248
R. Graebin..................................................................... 257
A. Gillinov...................................................................... 232
C. Gomez................................................................ 73, 266
S. Graf........................................................................... 194
R. H. Gilman.......................................................... 137, 164
K. Gomez...................................................................... 209
S. Grajek............................................................... 225, 251
V. M. L. Gimenes............................................................ 79
S. Gomez.............................................................. 190, 251
N. Gramatnikovski........................................................ 163
L. Gimenez........................................................... 208, 211
L. Gomez...................................................................... 221
D. R. Grana............................106, 109, 138, 141, 197, 201
J. Gimenez.................................................................... 242
R. Gomez.............................................................. 106, 189
B. E. Grand.................................................................... 183
S. Gimenez............................................107, 222, 240, 251
J. Gómez...................................................................... 219
H. Gransar..................................................................... 141
F. Ginés........................................................................ 264
J. Gomez-Mancebo...................................................... 205
I. Graziadei.................................................................... 173
C. Ginghina................................................................... 134
F. Goncalves....... 70, 79, 101, 132, 250, 254-256, 260, 263
A. Graziano................................................................... 227
M. Gingins............................................................ 237, 274
L. Gonçalves..............................................70, 78, 252, 258
F. Graziano.................................................................... 278
A. Giolis........................................................................ 216
F. Gonçalves....................................................78, 252, 258
G. Grazioli..................................................................... 228
S. Gioppato................................................................... 190
C. Gonçalves................................................................. 233
L. Grazioli...................................................................... 141
D. M. A. Giorgi.............................................................. 260
R. Gonçalves........................................................... 76, 190
G. Grecca...................................................................... 240
J. Giorgini...................................................................... 226
B. Gonçalves................................................................. 143
A. Greco.......................................................................... 79
V. Giovinni..................................................................... 261
N. Goncharova...................................................... 204, 274
O. T. Greco................................................................... 213
M. Giraudo.................................................................... 241
A. F. P. Gondar............................................... 191-192, 267
J. P. Greelish................................................................... 73
X. Girerd........................................................................ 243
H. Gonna............................................................... 103, 105
S. B. Greene......................................................... 138, 225
M. Gironacci..................................................256, 262, 274
C. C. Gonzaga......................................................... 80, 208
S. B. Greene......................................................... 138, 225
M. M. Gironacci.................................................... 256, 262
B. Gonzales................................................................... 278
V. Gregorietti................................................................ 259
P. Gitelman..................................................................... 70
D. Gonzales.................................................................... 77
A. Grentzinger............................................................... 194
A. Giuca........................................................................ 180
P. Gonzalez................................................................... 206
K. Griffith...................................................................... 205
G. Giunta........................................................107, 179, 259
R. Gonzalez.............................134, 170, 186-187, 194, 214
J. Grignola..................................................................... 264
E. Gkaliagkousi............................................................. 166
J. L. Gonzalez................................................. 206-207, 259
M. Grigorov................................................................... 230
A. Gkouziouta............................................................... 182
C. D. Gonzalez.............................................................. 166
V. Grigorov.................................................................... 191
A. Glavan.............................................................. 229, 250
F. Gonzalez................................................................... 181
M. Grinberg...................................132, 237, 247, 275, 278
G. Gleim.......................................................................... 75
E. Gonzalez.............................171, 174, 186-187, 192, 194
D. Grinfeld............................................................ 227, 248
D. Glogar............................................................... 100, 110
E. S. Gonzalez....................................................... 205, 262
M. Grippo.............................................................. 221, 252
R. Glowczynska............................................................ 273
J. Gonzalez....................................................180, 190, 256
D. Grisoli....................................................................... 241
J. Gminski..................................................................... 208
S. Gonzalez....................................................184, 205, 262
E. Gromova........................................................... 138, 272
R. N. Gobbi................................................................... 266
C. Gonzalez................................................................... 184
K. Grong................................................................ 143, 272
G. N. Gobbi.....................191-192, 244, 254, 264, 267, 273
G. E. González........................................................ 227-228
H. Grönlund.................................................................... 75
J. H. Goch..................................................................... 210
G. E. González........................................................ 227-228
P. Grosse........................................................................ 78
A. Godomiczer...................................................... 220, 222
T. Gonzalez-Alujas......................................................... 252
O. Grosso..................................................................... 267
L. Godoy............................................................... 189, 197
J. R. Gonzalez-Juanatey................................................ 194
E. Gruenig..................................................................... 225
P. Godoy....................................................................... 269
I. Gonzalez-Mendia....................................................... 207
S. Grujic........................................................................ 105
G. Godoy....................................................................... 183
C. González-Quesada.................................................... 205
H. Grundt................................................................ 75, 178
T. J. S. Goes................................................................. 111
G. Gonzalez-Stawinski.................................................. 232
H. Grunfeldova.................................................72, 132, 200
C. Goh................................................................... 235, 239
M. Good........................................................................ 103
C. J. Grupi..................................................................... 193
Y. Goh........................................................................... 192
J. Goral............................................................ 80, 242-244
M. Grygier..................................................................... 225
P. Goh........................................................................... 192
E. Gorbatenko............................................................... 183
L. Grynberg............................................133, 139, 188, 266
J. Gohil.......................................................................... 235
I. A. Gorbunova............................................................. 210
A. Grzesiak...................................................................... 77
S. Gokaslan................................................................... 223
J. M. Gore..................................................................... 100
P. Grzesiowski.............................................................. 251
R. J. Goldberg............................................................... 100
T. Goren........................................................................ 191
A. Guajardo................................................................... 143
R. C. S. Goldenberg...................................................... 140
S. Gorgulu..................................................................... 171
F. Gual-Capllonch.......................................................... 252
A. Goldsman................................................................. 252
L. Goryunova......................................................... 234-235
L. C. Guarita-Souza....................................................... 218
A. Goldsmit................................................................... 141
M. Goss........................................................................ 208
G. Guarraccino.............................................................. 175
L. Goldstraj................................................................... 228
G. Gossing.................................................................... 238
D. Guastavino............................................................... 197
Index / 301
Authors
A. Guedes..................................................................... 273
V. Hachinski.................................................................. 267
G. Heper......................................................................... 72
F. Guerloy..................................................................... 100
M. Hadad.............................................................. 190, 251
H. Herbas...................................................................... 276
R. Guerra...................................................................... 183
A. Haddad............................................................. 139, 184
R. Hermes.................................................................... 244
G. M. Guerra......................................................... 138, 260
C. Hadid.........................................................197, 214, 273
L. Hernandez................................................................ 226
X. Guerra....................................................................... 247
M. P. Haefner............................................................... 142
D. Hernandez................................................................ 271
F. Guerra....................................................................... 190
L. Hagemann................................................................ 109
A. Hernandez................................................................ 163
J. E. Guerra............................................................. 80, 220
P. Hajek........................................................................ 223
E. Hernández......................................................... 196-197
G. M. Guerra......................................................... 138, 260
A. Halabe...................................................................... 107
I. Hernandez-Baldomero....................................... 167, 213
R. Guerreiro.......................................................... 215, 222
A. L. C. Hallal................................................................ 208
M. Herrera.................................................................... 209
F. Guerrero......................................................74, 211, 241
J. Hallén........................................................................ 223
J. Herrera...................................................................... 264
P. Guerrero................................................................... 106
R. Halmosi.................................................................... 202
C. Herrera..................................................................... 214
J. Guerrieri.................................................................... 138
L. Halmy............................................................... 199, 238
D. Herrera..................................................................... 190
E. Guevara....... 73, 186, 205, 207, 211, 224, 231, 236, 246
L. Hamity...................................................................... 173
R. N. Herrera................................................................. 180
A. Guevara............................................................ 260, 270
O. Hamoui.................................................................... 277
L. Herrera-Para.............................................................. 248
R. Guglielmone....................................................... 80, 111
R. Hams................................................................ 247, 268
A. Hershon.................................................................... 179
G. Guglieri......................................................260, 265, 271
S. Han................................................................ 75-77, 144
A. Hershson.......................................................... 206, 225
D. Guidi......................................................................... 143
R. Handrock...........................................106, 196, 198, 221
C. Hesse....................................................................... 225
K. C. Guidini.......................................................... 221, 261
M. Hanna...................................................................... 168
Ø. Hetland.................................................................... 199
R. Guidoin..................................................................... 178
K. N. Hansen....................................................71, 142, 253
F. Heusser.................................................................... 207
S. Guilhon............................................................. 233, 236
A. Hansen..................................................................... 274
P. Hewett..................................................................... 256
A. Guimaraes........................................................ 209, 268
M. Hara......................................................................... 170
S. Heymsfield................................................................. 75
T. Guimaraes................................................................ 253
E. S. Hara...................................................................... 271
F. Hidden-Lucet............................................................ 179
M. Guimarães....................................................... 135, 208
S. Harb.......................................................................... 110
K. Hideg........................................................................ 202
T. Guimarães..........................................139-140, 253, 257
C. Harden...................................................................... 176
C. Higa.....................................................72, 102, 200, 226
J. B. Guimarães............................................................ 190
G. E. Harders.......................................................... 72, 136
M. Higuchi.................................................................... 249
H. Guimarães........................................................ 132, 254
J. M. Hare....................................................................... 77
D. Hilfiker-Kleiner.......................................................... 202
A. Guimarães................................................................ 108
W. S. Harris...............................................75, 206-207, 209
M. N Hill........................................................................ 196
I. C. Guimarães............................................................. 215
W. Harvey............................................................. 134, 170
G. Hillis......................................................................... 136
A. C. Guimarães............................................................ 215
C. Hasdemir.................................................................... 77
M. S. Hiremath............................................................. 132
R. Guindy...................................................................... 108
H. Hasdemýr................................................................. 186
J. C. Hiriart.................................................................... 208
S. Guinjoan................................................................... 138
H. Hase......................................................................... 189
A. Hita......................................79, 102, 106, 138, 187, 189
C. Gul............................................................................ 182
M. Hashemi.................................................................. 211
R. Hitateguy........................................................... 269-270
R. Guleria...................................................................... 103
M. Hashemzadeh......................72, 79, 102, 106, 111, 273
S. P. H. Hjortshoj.......................................................... 166
G. M. Gulnar Mendonça....................................... 210, 213
K. H. Hashemzadeh...................................................... 176
M. Hlawaty............................................170, 173, 185, 193
B. Gumbiner................................................................. 166
S. H. Hashemzadeh...................................................... 176
M. Hochleitner.............................................................. 176
C. Gun............................................................................. 79
C. Hasikidis................................................................... 181
C. Höcht................................................................. 273-274
S. Guneri....................................................................... 170
A. Hasslocher-Moreno.................................................. 140
D. O. Hodge.................................................................. 105
S. Gupta........................................................................ 232
T. Hatano...................................................................... 167
S. J. Hoff......................................................................... 73
R. Gupta................................................................ 108, 231
G. Hatzigeorgiou........................................................... 182
P. Hoffman............................................109, 134, 171, 174
E. P. Gurfinkel............................................................... 100
A. Hauqui...................................................................... 215
R. Hoffman................................................................... 227
F. Gurgel........................................................262, 265, 267
F. Hauqui...................................................................... 215
A. Holden.........................................................73, 107, 143
L. Gurrin........................................................................ 164
K. Hayashi............................................................. 137, 173
R. Holloway.......................................................... 103, 105
T. Gursoy...................................................................... 223
S. Heath........................................................................ 229
G. M. Holmes....................................................... 138, 225
M. Gus.......................................................................... 106
J. L. Hebert................................................................... 179
G. M. Holmes....................................................... 138, 225
R. Gusmão.................................................................... 272
T. G. Heck....................................................................... 74
H. Holmstrøm....................................................... 103, 223
F. Gustafsson............................................................... 104
S. Hecker...................................................................... 274
D. Holownia.................................................................. 265
A. Gustavo.................................................................... 175
B. Hedblad...................................................................... 75
W. Homena................................................... 252, 259-260
B. Gutfilen..................................................................... 140
M. Heeren.......................................................77, 137, 255
A. Homsi-Neto.............................................................. 233
G. Guthman.................................................................... 69
M. Heigert.................................................................... 110
B. Hong.......................................................... 110, 218-219
G. Guthmann................................................................ 271
M. Helguera.................................................................. 135
T. Honìk........................................................................ 237
D. F. Gutierrez......................................................... 76, 165
B. Hellmuth.................................................... 220, 222-223
S. Honsho..................................................................... 235
L. A. Guzman.................................................................. 74
L. Helman..................................................................... 192
A. Hopkins.................................................................... 132
B. Guzman.................................................................... 137
R. Hemetsberger.......................................................... 100
W. Hopman.......................................................... 135, 163
M. L. Guzzo................................................................... 243
M. Heñin....................................................................... 218
B. Horne....................................................................... 208
M. Gyongyosi....................................................... 100, 110
R. L. Henn............................................................... 76, 143
K. Horoba...................................................................... 171
D. Haag................................................................. 111, 255
R. Henquin.................................................................... 104
E. Horowitz.................................................77-78, 233, 236
R. Habib................................................................ 247, 268
H. S. Henrik................................................................... 141
C. Hossri....................................................................... 240
T. Habon....................................................................... 202
H. D. Henrique D`abreu................................................ 210
J. Hou............................................................................. 73
Authors
L. Howes...................................................................... 108
M. Isa............................................................................ 102
H. Jiang......................................................................... 163
H. Hreybe..................................................................... 101
M. E. Isasi Capelo......................................................... 207
X. Jiang......................................................................... 202
K. Hristova.................................................................... 194
J. Isea-P........................................................................ 218
H. Jilaihawi............................................................. 73, 256
V. Hsieh........................................................................ 132
J. Isea-Pérez......................................................... 219, 226
M. Jiménez..................................................................... 69
X. R. Hu......................................................................... 163
M. Ishikawa.................................................................. 175
J. R. Jimeno.................................................................. 217
C. X. Huang................................................................... 163
O. Istratoaie.................................................................. 180
M. Joao......................................................................... 211
S. Huang....................................................................... 135
A. Ithuralde....................................................141, 206, 260
N. Jochmann.................................................................. 75
T. Huang....................................................................... 239
A. Ittig........................................................................... 241
S. Joekes........................................................................ 78
J. Huang....................................................................... 202
S. Ivanov........................................................174, 192, 203
A. John......................................................................... 238
J. Huber........................................................................ 109
L. Ivaskeviciene............................................................ 184
S. O. Johnsen............................................................... 110
Z. Huczek...................................................................... 273
S. A. Ivyanskij................................................................ 210
S. P. Johnsen.................................................................. 79
W. Hueb....................................................................... 191
T. Iwao.......................................................................... 170
B. J. Johnson................................................................ 108
M. Huguet.............................................................. 79, 201
Y. U. A. Izachik...................................................... 174, 192
E. S. Johnson................................................................ 243
J. D. Humphreys................................................... 237, 274
A. Izaguirre.................................................................... 141
O. Johnson................................................................... 178
M. Hunn........................................................................ 216
E. Izcovich..................................................................... 244
A. O. Johnson-Levonas................................................... 75
B. K. Huntley........................................................... 72, 136
A. Izcovich.................................................................... 244
N. Joki........................................................................... 189
J. Hurtado..................................................................... 217
R. Izcovich.................................................................... 244
P. Jolivet....................................................................... 110
P. Huschnir................................................................... 111
V. Jacas........................................................................ 231
L. Joly........................................................................... 110
A. Hussain...................................................................... 69
S. Jacob........................................................................ 103
J. Jones...........................................................73, 107, 143
A. Hussein.................................................................... 277
J. L. B. Jacob................................................................ 213
J. L. Jones.................................................................... 107
A. Hvelplund......................................................... 230, 232
M. H. V. M. Jacob......................................................... 201
V. M. Jonke................................................................... 237
L. Hyeongook............................................................... 272
I. Jadavji........................................................................ 165
C. Jordan.............................................................. 226, 277
G. Iacometti.................................................................. 106
F. Jahan.......................................................................... 73
L. Jorge............................................................74, 253, 269
L. E. Ianhez................................................................... 101
F. Jaimes...................................................................... 139
K. Jose.......................................................................... 211
O. Iavicoli...................................................................... 200
G. Jaimovich.......................................................... 238-239
G. Joseph....................................................................... 77
A. Ibañez....................................................................... 213
R. K. Jain............................................................... 108, 231
X. Jouven...................................................................... 180
J. Ibañez....................................................................... 275
O. Jaksic....................................................................... 231
A. Jovelic...................................................................... 190
S. Ibañez....................................................................... 228
M. M. Jamal...............................72, 79, 102, 106, 111, 273
Z. Jovic......................................................................... 193
A. Ibáñez....................................................................... 239
A. Jamalludin................................................................ 184
L. J. Jovovic.......................................................... 187, 202
J. Igland........................................................................ 133
M. A. James......................................................... 103, 105
S. Jozami..................................71, 225, 242, 244-245, 277
D. Iglesias....................................................................... 77
K. D. James.................................................................. 108
T. Jozic.......................................................................... 187
M. Ignjatovic................................................................. 105
J. Janas......................................................................... 172
J. G. Juárez-Rojas......................................................... 133
K. Ihara.................................................................. 188, 197
Y. Jang.......................................................................... 110
C. Juergens.................................................................. 132
R. Ikegami..................................................................... 249
K. Jankowski................................................................. 251
M. Juliano..................................................................... 268
H. Ilarraza...................................................................... 216
D. R. Janner.................................................................. 201
M. Junco....................................................................... 239
M. Ildizli.......................................................................... 77
P. Jansky.........................................................72, 132, 200
S. M. Jung.................................................................... 179
M. Ilea........................................................................... 245
L. Janssens................................................................... 277
L. Jurado............................................................... 210, 254
S. Ilic..................................................................... 166, 214
A. Januszewicz............................................................. 101
S. H. Jurayeva............................................................... 196
M. Ilic............................................................................ 187
P. Jaramillo........................................................... 163, 227
A. Jussipov................................................................... 174
E. Ilkay.................................................................. 110, 233
C. Jardim.............................................................. 257, 259
N. Kabiri........................................................................ 216
G. Illuminati................................................................... 240
F. S. V. Jardim............................................................... 244
A. Kablak-Ziembicka............. 76, 78, 80, 101, 141, 230, 233
O. Ilyinskaya................................................................. 235
M. R. Järvelin.................................................................. 75
F. Kacmaz............................................................. 110, 233
T. Imiela........................................................................ 273
I. Jashi.......................................................................... 235
K. Kadappu.................................................................... 235
O. C. Imventarza..................................................... 79, 219
I. Jatene.................................................................. 76, 240
J. Kado.......................................................................... 103
T. Inada......................................................................... 271
M. Jatene..................................................................... 263
J. Kadziela..................................................................... 102
B. Inan.......................................................................... 111
P. Y. Jayet..................................................................... 103
L. I. Kafarskaya............................................ 74-75, 104-105
A. Incarbone................................................................. 168
T. Jeerakathil................................................................ 267
P. Kairuz........................................................................ 247
C. Ingino..................................................78, 256, 265, 267
S. Jegere...................................................................... 255
L. Kaklamanis.................................................................. 77
A. Innasimuthu............................................................. 168
M. Jelinek..................................................................... 100
T. Kálai.......................................................................... 202
A. Inocenzi.................................................................... 262
S. Jenkins..................................................................... 108
M. Kalaivani.................................................................. 167
J. Insua......................................................................... 181
A. J. W. Jenney............................................................ 103
A. Kalangos................................................................... 142
D. D. Ionescu................................................................ 180
C. S. Jennings............................................................... 107
C. Kalianos.................................................................... 177
J. Iribarren..................................................................... 190
L. O. Jensen......................................71, 79, 110, 142, 253
R. Kalil................................................................... 231, 233
M. C. Irigoyen.......................74, 76-77, 136-138, 234, 239,
J. Jensen...................................................................... 272
H. Kalinic....................................................................... 254
................................................249, 253-255, 258, 269-270
D. Jeon......................................................................... 110
M. Kalousova................................................................ 200
M. Irurita....................................................................... 183
M. H. Jeong.................................................................. 239
A. Kaltoft................................................................. 79, 110
J. Irurita......................................................................... 183
T. Jezewski................................................................... 222
A. Kalvelis..................................................................... 235
I. M. Irurzun.......................................................... 208, 211
J. Jezewski................................................................... 171
S. Kamal-Bahl.................................................................. 79
Index / 303
Authors
U. Kamilova................................................................... 196
I. Keles.......................................................................... 187
A. Kocher...................................................................... 218
E. E. Kanaan.................................................................. 244
J. Kempfert................................................................... 182
P. Kociubinski............................................................... 210
A. Kandra...................................................................... 173
S. Kenan....................................................................... 180
M. Koestering....................................................... 104, 270
J. Kang.......................................................................... 163
M. Kenar............................................................... 102, 189
K. Koh.................................................75-77, 111, 144, 272
W. C. Kang............................................................ 111, 272
N. Kenji......................................................................... 233
N. V. Kokosadze.............................................................. 74
N. Kangola............................................................ 109, 243
B. Kennel...................................................................... 218
C. Kolbitsch................................................................... 173
R. Kanthack................................................................... 268
B. M. Kennelly.............................................................. 100
L. Koldas....................................................................... 233
T. Kapadohos................................................................ 181
C. Kepka....................................................................... 175
S. Kole.......................................................................... 232
M. Kapitan............................................................. 269-270
S. Kerbage.....................................................107, 138, 179
K. Kolodziej................................................................... 222
A. Kaplon...................................................................... 273
N. J. Kertesz................................................................. 206
A. Kolosova................................................................... 175
A. Kapoor....................................................... 110, 250-251
R. Kevorkian.................................................................. 142
G. Kolovou.................................................................... 182
M. K. Kapral.................................................................. 267
A. Kevorkov.................................................................. 196
G. Kolunin............................................................. 183, 202
B. Karadag.................................................................... 187
J. Kezen.................................................136, 215, 220, 223
H. Kominsky................................................................. 168
N. Karadag.................................................................... 187
A. Kezerashvili.............................................................. 270
N. Komiya............................................................. 195, 209
A. Karadzic.................................................................... 169
K. Khairi......................................................................... 184
V. Komoliatova.............................................................. 213
A. Karanfýl.................................................................... 195
R. Khalaky..................................................................... 194
V. N. Komolyatova........................................................ 135
G. Kararigas.................................................................. 204
M. Kharlap.................................................................... 234
D. J. Komorowski................................................. 179, 275
S. Karas......................................................................... 201
G. Khaspekov......................................................... 234-235
M. Kondruweit...................................................... 176, 274
M. Karcz................................................................ 102, 237
N. Khavarian.................................................................. 211
K. Koniari....................................................................... 217
D. Kardara..................................................................... 216
K. A. Khmelnitskaya...................................................... 192
M. Konka.............................................................. 136, 174
P. Karki.......................................................................... 272
H. N. Khong.................................................................. 275
A. Konopka................................................................... 252
M. K. Karlsson............................................................... 168
R. Kiamco....................................................................... 69
I. V. Konopka...........................................219-220, 229, 250
R. Karnik....................................................................... 110
M. Kidawa..................................................................... 222
F. O. Kontari.................................................................. 185
N. A. Karoli.................................................................... 103
M. Kilickap.................................................................... 192
D. Kontogianni.............................................................. 181
H. Karpuz.............................................................. 180, 242
R. Killing................................................................. 212-213
G. Kopec....................................................................... 101
V. Karpuz....................................................................... 242
C. Killinger............................................................. 214, 222
J. Kopec........................................................................ 208
G. Karthikeyan.............................................................. 167
B. Kim................................................................... 235, 239
S. Kopecky.................................................................... 107
M. Karynski................................................................... 251
H. Kim........................................................................... 218
C. Kopp......................................................................... 100
P. Karyofillis.................................................................. 177
M. Kim................................................................... 218-219
A. Koprowski................................................................ 249
E. Kaschina..................................................................... 77
H. S. Kim......................................................................... 79
G. E. Kordosis............................................................... 185
J. C. Kaski...............................................165, 168-169, 213
Y. Kinoshita................................................................... 164
N. Koren-Morag............................................................ 209
R. Kasliwal............................................................. 141-142
A. Kirilmaz..................................................................... 163
M. Koretzky...................................................181, 274, 277
J. Kasprzak..................................................... 170-171, 222
B. Kirilmaz..................................................................... 188
H. Korkes...................................................................... 238
A. Katarzynska.............................................................. 225
S. Kiserud....................................................................... 75
M. E. Korkmaz................................................................ 72
R. E. Katholi.................................................................. 142
Y. Kishi.......................................................................... 188
R. Kornowski........................................................ 110, 178
T. Katic.......................................................................... 231
T. Kishmareia................................................................ 230
V. Korpelainen............................................................... 143
S. Katoh........................................................................ 231
G. Y. N. Kiss.................................................................. 197
M. I. Korsunskaya........................................................... 74
V. Katsi.......................................................................... 217
J. Z. Klafke.......................212-214, 222-223, 227, 261, 265
K. Korybalska................................................................ 225
A. Katsume................................................................... 235
S. Klebs..................................................106, 196, 198, 221
A. Korycka..................................................................... 222
M. Katz......................................................................... 247
T. Kleemann.................................................................. 203
O. Korzh................................................................ 186, 214
A. Kavata............................................................... 172, 185
N. Kleiman.................................................................... 258
C. Kosour...................................................................... 133
N. Kawaguchi................................................................ 175
S. Klein.......................................................................... 166
J. Kostic.......................................................................... 71
H. Kawano.................................................................... 164
F. Klein.............................................................73, 266, 279
J. B. Kostis............................................................ 137, 144
A. Kaya........................................................... 195, 198-199
C. Klein................................................................. 106, 262
M. Kostkiewicz......... 76, 101, 170, 173-174, 182, 185, 193
B. Kaya.......................................................................... 111
C. H. Klein..................................................................... 269
E. Kostova..................................................................... 225
M. Kayikcioglu........................................................ 77, 276
M. Klopotowski..................................................... 136, 237
G. Kotchuev.................................................................. 186
H. Kazerani.................................................................... 212
M. Klosinska................................................................. 188
C. Kotliar........................................................106, 138, 187
K. Kazmi.......................................................................... 73
I. Kloszewska................................................................ 188
K. Kotlinski.................................................................... 171
C. Kchmelnitskaya........................................................ 203
M. Knobel......................................................102, 132, 253
V. Kotowicz................................................................... 189
A. Kearney-Schwartz.................................................... 110
E. Knobel.......................................................102, 132, 253
K. Kotseva.................................................73, 107-108, 143
S. Keavey...................................................................... 177
J. Knopfholz.......................................................... 218, 226
T. Kottke............................................................... 226, 277
B. Keavney...................................................................... 77
Y. Kobayashi................................................................. 239
C. Kouanfack................................................................. 211
E. Keba......................................................................... 187
B. Kobulia...................................................................... 235
S. Koulchitsky............................................................... 176
V. Kecskemeti............................................................... 203
M. Koc.......................................................................... 105
N. Koumallos................................................... 69, 216-217
D. L. Keefe.................................................................... 238
V. Koca.......................................................................... 197
A. P. Kourounakis............................................................ 77
R. Keegan..................................................................... 205
S. A. Kocaman...............................172, 180, 185-186, 190,
P. N. Kourounakis........................................................... 77
H. Kelbaek.......................................................71, 142, 253
........................................................219, 231-232, 278-279
P. A. Koustas................................................................ 185
J. F. Kelendjian...............................................245, 247, 265
E. Koch..................................................................... 73, 75
J. Kovac.................................................................. 73, 256
Authors
K. Kovacs...................................................................... 202
F. Kuster....................................................................... 276
E. Lataza....................................................................... 264
G. Kovacs...................................................................... 225
S. Kutkiene................................................................... 237
F. Latif........................................................................... 104
M. Kovaite.................................................................... 184
W. Kuzmicz..................................................................... 80
F. Latiff......................................................................... 104
I. Kowalik...................................................................... 135
V. Kuznetsov......................................................... 183, 202
G. Laufer....................................................................... 173
E. Kowalik............................................................. 109, 171
J. T. Kvaløy............................................................ 135, 199
M. Laule.................................................................. 75, 238
M. Kowalski.......................................................... 109, 171
H. Kwon......................................................... 110, 218-219
R. P. Laurino................................................................. 271
I. Kowatsch................................................................... 179
D. A. Kyle...................................................................... 221
D. Lavaggi..................................................................... 225
M. Kowman.................................................................. 188
R. Kyrillos...................................................................... 278
G. Lavall................................................................. 222-223
F. Kozak................................................................ 134, 225
T. Kyryleva.................................................................... 213
M. Lavalle..................................................................... 168
A. Kozanecki..............................................76, 80, 101, 141
N. L’heureux................................................................. 218
T. Lavergne................................................................... 179
N. Kozarevic.................................................................. 171
G. Labakhua.................................................................. 164
P. L. Lavitola................................................................. 132
B. Koziner..................................................................... 140
I. Labanca..................................................................... 241
R. A. Lawrance............................................................. 165
V. Krämer....................................................... 143, 182-183
J. C. Laborde........................................................... 73, 256
J. Lax.................................................................... 242, 249
S. Krasnokutskiy................................................... 186, 214
S. Lacchini............................................................ 234, 251
A. Laynez...................................................................... 231
O. Krasnova.................................................................. 203
C. Lace.................................................................. 262, 265
S. Laza.......................................................................... 267
J. Krauze....................................................................... 230
N. Lachmann................................................................ 182
G. Lazarevic.................................................................. 276
C. Kreutzer.............................................................. 76, 252
C. D. Lacunza................................................................ 254
M. Lazovic.................................................................... 170
E. M. Krieger..................................101, 234, 249, 260, 270
V. R. Lafayette.............................................................. 255
O. Lazzarín...................................................................... 76
L. Krieger...................................................................... 228
N. Laffaye..................................................................... 200
V. Le............................................................................... 79
J. E. Krieger.......................................................... 193, 251
M. V. Lafuente.............................................................. 264
M. Leacche..................................................................... 73
E. Krieger.............................................................. 193, 251
A. Lagioia...................................................................... 225
M. Leal.......................................................................... 189
D. Krinochkin........................................................ 183, 202
N. Lago......................................................................... 139
D. Lebedev................................................................... 276
S. Krishna...................................................................... 258
M. R. Lago.................................................................... 213
Y. Lecarpentier............................................................. 179
A. Krishnarao........................................................ 138, 212
G. Lago......................................................................... 270
D. Lecic-Tosevski.......................................................... 110
A. Krishnaswamy.......................................................... 242
R. Lagos........................................................................ 215
C. Lecot................................................................. 269-270
J. Kriskovich................................................... 228, 260-261
A. Lagrange.......................................................... 135, 218
P. Ledesma................................................................... 169
G. Krljanac..................................................................... 169
S. Lagudis..................................................................... 253
B. Lee................................................................... 235, 239
G. Krogh........................................................................ 183
R. Laguens.............................................186, 205, 211, 259
E. J. Lee.......................................................................... 79
N. Krstic........................................................................ 170
R. Laiño......................................................................... 241
M. Leeman................................................................... 211
M. Kruk......................................................................... 175
J. Laitinen....................................................................... 75
J. H. Leguizamon.......................................................... 176
H. Kruklis...................................................................... 100
A. Lakowsky..................................................175, 215, 272
J. H. Leguizamón.......................................................... 258
M. Krzeminska-Pakula.................................................. 222
T. Laks.......................................................................... 187
M. Leiner...................................................................... 187
K. Ksiazek..................................................................... 225
N. Lakusic..................................................................... 220
F. Leisch....................................................................... 110
M. Kuchta..................................................................... 137
P. Lal............................................................................. 104
M. F. M. P. Leite........................................................... 256
A. Kuchwaha................................................................. 108
S. Lam.......................................................................... 176
R. Leite......................................................................... 268
K. H. Kuck..................................................................... 103
M. C. Lama........................................................... 205, 262
M. Leite........................................................................ 109
N. Kucukarslan.............................................................. 163
M. F. Lambardi.............................................................. 275
V. A. Leite............................................................. 252, 268
C. Kudrle........................................................227, 237, 274
J. R. Lambertucci.......................................................... 217
A. Lejnieks.................................................................... 235
G. Kuhn................................................................. 258, 260
P. A. Lamothe............................................................... 133
M. Lelek........................................................................ 232
K. Kuiper....................................................................... 247
S. M. Lamy................................................................... 227
M. Lelonek.................................................................... 210
K. Kukula............................................................... 102, 237
F. Lanas.................................................132, 163, 215, 227
T. Lelyavina................................................................... 203
L. Kuller......................................................................... 137
C. Lanas................................................................ 163, 227
M. Lemes..................................................................... 195
H. Kultursay............................................................ 77, 276
M. C. Landermann........................................................ 140
G. Lemke...................................................................... 254
S. Kumar.................................................110, 132, 250-251
F. Landeta......................................186, 205, 207, 211, 236
C. Lemos...................................................................... 138
I. Kumsars..................................................................... 255
I. Lang........................................................................... 110
M. Lengyel.................................................................... 220
A. Kundu....................................................................... 232
M. Lanocha........................................................... 225, 251
A. R. Lenhenbauer-Lüdke............................................. 236
F. Kuniyoshi.................................................................. 107
M. Lanzotti.................................................................... 185
A. Leon......................................................................... 227
S. Kunstmann..................................................75, 107, 137
M. F. Larin............................................................. 237, 274
S. Leon.................................................................. 270-271
B. Kuo........................................................................... 135
J. C. Larosa................................................................... 183
M. Leonardi...................................................103, 242, 265
M. Kura................................................................. 265, 267
M. Larroude.................................................................. 229
C. Leonardi................................................................... 241
E. Kuralay...................................................................... 163
L. Lasave.............................................................. 134, 225
V. Leon-Arguero.................................................... 218, 257
M. Kurpesa................................................................... 222
R. Lasica....................................................................... 187
G. V. Lepore.................................................................. 271
I. Kurt............................................................................ 276
C. Laspiur.............................................................. 246, 248
J. Lesage.............................................................. 135, 218
T. Kurum....................................................................... 182
E. Lasry......................................................................... 209
A. Lescano............................................................ 111, 244
I. Kury Nunes................................................................ 164
M. Lass......................................................................... 103
P. M. Lese.................................................................... 221
P. Kuschnir......................................................... 79-80, 201
O. Lassen..................................................................... 264
M. Lesiak...................................................................... 225
B. Kusmierczyk............................................................. 136
J. F. Lassen................................................71, 79, 142, 253
A. Lesniak-Sobelga..........................78, 174, 182, 185, 233
M. Kusmierczyk............................................................ 109
R. Lasserre................................................................... 243
D. Leung............................................................... 132, 235
Index / 305
Authors
E. Lev.................................................................... 110, 178
T. Livieratos.................................................................. 185
L. Lovato....................................................................... 233
G. Lev..............................................78, 110, 143, 188, 193
T. H. Livieratos.............................................................. 185
I. Lovera........................................................................ 237
M. J. Levin............................................................ 209, 250
J. Ljubas............................................................... 104, 245
D. L. Lovic Dragan........................................................ 207
G. Levin........................................................................ 273
G. Llamas-Esperon........................................ 265-266, 268
B. Lovic......................................................................... 251
N. Levitt........................................................................ 196
J. M. Llaneza................................................................. 165
M. Lovic........................................................................ 276
G. Levy......................................................................... 209
S. C. Llois...................................................................... 168
D. Lovic......................................................................... 276
M. Lewandowski...............................................76, 80, 135
C. Llorente............................................................ 213, 239
D. Lovric....................................................................... 230
G. Lewy........................................................................ 243
J. Lloveras...................................................................... 79
D. Lowenstein.............................................................. 142
C. Lezon.......................................................................... 77
S. Lluberas............................................................ 232, 267
R. Lowenstein.............................................................. 208
Q. Li................................................................................ 73
R. Lluberas.................................................................... 270
J. Lowenstein............................................................... 111
J. Li......................................................................... 77, 202
A. C. Lo Prete....................................................... 109, 191
I. Lozano........................................................ 165, 196-197
E. Libhaber............................................................ 203, 230
Q. Lo..................................................................... 132, 235
D. Lozano...................................................................... 214
C. Libhaber................................................................... 230
S. Lo..............................................132, 222, 235, 273, 276
Z. B. Lu......................................................................... 163
A. Lichter...................................................................... 228
M. F. Lobo.................................................................... 241
K. Lu............................................................................. 166
J. Lietava...................................................................... 240
B. Lococo.............................................................. 170, 201
F. Lubenieki.................................................................. 275
C. K. Liew..................................................................... 201
D. Lodi.......................................................................... 275
B. Lubiszewska............................................................. 174
H. B. Liew..................................................................... 201
A. Loera-Pinales............................................................ 265
M. R. Luca.................................................................... 211
G. Ligorio........................................................................ 72
E. Logtens.............................................................. 73, 256
L. Lucas.................................................144, 239, 241, 274
W. K. Lim...................................................................... 104
K. H. Loland.................................................................. 248
A. Lucchini.................................................................... 277
M. C. L. Lim.................................................................. 270
K. H. Løland.......................................................... 142, 243
S. Luchese.................................................................... 109
A. R. R. Lima................................................................. 260
R. Lolo.......................................................................... 214
H. Luciardi......................................................141, 187, 220
J. Lima.................................................................. 110, 217
R. Lombardo................................................................. 218
V. Lucini........................................................................ 209
A. B. R. Lima...........................................191-192, 264, 267
F. Lombi........................................................................ 201
M. Luduena.................................................................. 182
S. Lima.......................................................................... 228
B. Lombo...................................................................... 216
S. Ludueña.................................................................... 240
A. B. Lima.............................................................. 252-254
S. Loncar....................................................................... 182
I. Lugones............................................................... 76, 221
L. Lima..............................77, 110, 140, 210, 233, 236-237
S. Loncaric.................................................................... 254
L. Luis........................................................................... 169
R. S. L. Lima..................................................110, 140, 210
G. Longo....................................................................... 179
M. Lujambio........................................................... 269-270
V. Lima................................................................... 139-140
B. Longo-Mbenza..............................76, 78, 109, 220, 243
I. Luksic........................................................................ 272
A. P. Lima-Leopoldo...................................................... 258
R. Lopes.........................................186, 263, 267-268, 276
A. Luongo..................................................................... 184
D. Lindefjeld................................................................. 109
A. C. Lopes........................................................... 263, 268
S. Lupano...................................................................... 275
S. Lindemberg...................................................... 233, 236
A. A. Lopes................................................................... 263
S. Lupi........................................................................... 189
C. Linden...................................................................... 168
H. F. Lopes................................................................... 260
J. C. Luque-Moscoso.................................................... 248
B. Lindsay..................................................................... 179
M. A. Lopez Verrilli........................................................ 262
A. Luz............................................................................ 191
B. Linetzky............................................................. 137-138
C. Lopez........................... 73, 138, 197, 205, 211, 214, 246
T. Lyle........................................................................... 242
J. M. Linhares............................................................... 234
M. L. Lopez................................................................... 207
S. Lynch........................................................................ 259
K. Linhartova......................................................... 234, 253
L. Lopez.........................................183, 207, 248, 257, 259
B. Lytle......................................................................... 232
K. Linhartová......................................................... 136, 237
M. Lopez................................................................ 270-271
P. Maagh.............................................................. 103, 194
G. Liniado...................................................................... 278
V. A. Lopez.................................................................... 137
L. Mabwa...................................................................... 220
A. Linke................................................................... 73, 182
V. Lopez.......................................................................... 75
A. Macedo...................................................................... 72
F. Lino........................................................................... 267
S. Lopez................................................................ 176, 240
R. Macedo.................................................................... 230
R. H. Lins.............................................................. 220, 222
C. E. Lopez.................................................................... 279
R. Machado...........................................204, 233, 265, 267
A. Liœniak-Sobelga....................................................... 193
D. E. Lopez................................................................... 229
P. Machado..................................................................... 78
S. Liotta........................................................................ 250
J. Lopez................................................................ 183, 204
M. Machado................................................................. 234
M. T. Lioy Lupis............................................................ 223
E. Lopez.........................................................184, 229, 279
F. Machado................................................................... 240
G. Y. H. Lip.................................................................... 217
G. F. López Soutric....................................................... 215
L. Machado................................................................... 251
P. Lipiec........................................................................ 222
A. López........................................................................ 107
L. Machado-H............................................................... 219
A. Lipinska.................................................................... 251
P. Lopez-Jaramillo......................................................... 249
S. A. Machnick.............................................................. 223
E. Lira............................................................................ 238
F. López-Jiménez.......................................................... 107
A. Maciag........................................................................ 76
R. Lirola-Liebanas......................................................... 248
M. Lorenz....................................................................... 75
N. Maciel.............................................................. 133, 266
V. Lisboa....................................................................... 240
G. Lorenzi-Filho............................................................. 270
S. M. Macin..............................................70, 219-220, 271
L. F. Lisboa................................................................... 132
M. Lorenzo........................................................... 273, 276
S. Macin................................................................ 214, 234
V. A. Lischouk............................................................... 255
C. C. Lores.....................................................245, 259, 263
O. Macz........................................................................ 185
A. Lismanis................................................................... 255
M. Losano..................................................................... 242
R. Maczynska............................................................... 136
D. Liszewska-Pfejfer..................................................... 251
L. Lotaif................................................................... 80, 208
H. Madani..................................................................... 216
N. Liu.............................................................................. 75
M. J. Loureiro....................................................... 111, 181
O. Maden...................................................................... 110
Q. Liu............................................................................ 216
C. Lourenco.....................................................79, 101, 132
M. Madsen........................................................... 230, 232
J. Liu............................................................................. 216
C. Lourenço.......................................70, 78, 250, 252, 258
J. K. Madsen......................................................... 230, 232
P. Liva........................................................................... 219
E. Lovaglio.............................................................. 75, 209
C. Mady........................................................................ 136
Authors
S. Maeda.............................................................. 188, 197
A. J. Mansur................................................................. 208
J. Martinez.............................................................. 74, 108
M. Maeng..........................................71, 79, 110, 142, 253
J. Manterola.................................................................... 78
F. Martinez...............................................74, 108, 258, 260
H. Maffeo..................................................................... 142
O. Manuale........................................................... 227, 237
R. Martinez................................................................... 197
R. B. Magaldi................................................................ 132
O. D. Manuale....................................................... 133, 274
A. Martinez........................................................... 144, 265
M. Magalhaes............................................................... 137
F. Manzano........................................................... 224, 246
L. Martinez..................................................... 185-186, 194
M. E. C. Magalhaes...................................................... 250
S. Manzolillo................................................................. 260
C. Martinez........................................................... 219, 228
L. B. N. C. Magalhaes................................................... 255
G. Marambio......................................................... 178, 246
M. Martinez.......................................................... 189, 234
E. Magalhães................................................................ 201
R. C. Maranhao..............................109, 180, 191, 255, 263
C. D. Martinez............................................................... 214
M. A. Magalhães........................................................... 102
L. Marani....................................................................... 173
I. Martinez..................................................................... 208
C. Magallanes............................................................... 204
R. Marañon................................................................... 215
N. Martinez................................................................... 231
A. Magd........................................................................ 274
V. Marasa...................................................................... 189
H. Martinez................................................................... 261
R. Maggi....................................................................... 134
V. Marathe............................................................ 195, 232
P. F. Martinez........................................................ 258, 260
S. Maggi....................................................................... 137
V. Maravic..................................................................... 202
J. G. Martínez....................................................... 213, 239
L. Maggio...................................................................... 178
C. C. Marboe................................................................. 104
C. Martínez................................................................... 204
A. P. Maggioni.............................................................. 103
M. Marchel................................................................... 273
N. Martínez-Rodríguez.................................................. 205
R. Magliola............................................................ 221, 255
G. Marchetti.................................................................. 225
L. Martinez-Sande................................................. 180, 194
P. Mahia........................................................................ 252
R. Marchioli................................................................... 209
F. Martin-Herrero.................................................. 218, 257
I. Mahmud.................................................................... 243
M. Marcia..................................................................... 211
L. Martinkovicova..........................................141, 223, 234
P. Mahzoni.................................................................... 216
A. Marco....................................................................... 254
H. F. Martino......................................................... 266, 275
P. Mahzouni.................................................................. 216
M. S. Marcolino.............................................................. 74
R. Martins............................................................. 204, 258
J. Maia.................................................................. 259, 261
F. K. Marcondes............................................................ 258
S. M. Martins........................................................ 227, 247
F. Maia.......................................................................... 198
F. Marconetto....................................................... 246, 248
V. M. Martins................................................................ 106
L. Maia.......................................................................... 254
M. A. Marcozzi.............................................................. 274
S. Martins............................................................. 141, 240
A. Maiato...................................................................... 108
R. Marelli.................................183, 189-190, 197, 214-215
V. Martire............................................................... 184-185
G. Maid.......................... 185, 195, 210, 239, 241, 264, 271
D. Marelli...................................................................... 214
B. Martire...................................................................... 172
R. Maier........................................................................ 225
R. Marenchino...................................................... 244, 247
C. Martorano................................................................. 243
A. Maiorana.................................................................. 108
R. Marfisi...................................................................... 209
M. P. Marturano...............................................73, 100, 279
O. H. Majane................................................................. 230
L. Mari.................................................................... 78, 102
E. Marum.............................................................. 144, 225
M. Majsec..................................................................... 220
J. Mariani................................................................ 78, 100
E. Marusic..................................................................... 137
C. R. Majul.................................................................... 133
P. Marichal.................................................................... 269
R. Marzoa-Rivas............................................................ 198
L. Makarov.................................................................... 213
P. Y. Marie.................................................................... 110
C. Mascheroni.............................................................. 263
M. Makdisse......................................................... 102, 132
E. Marijon............................................................. 103, 180
M. J. Maseko................................................................ 230
S. Makhoul.................................................................... 227
F. Marín........................................................................ 217
G. Masina..................................................................... 175
D. Makowiec................................................................ 249
P. Marinho.................................................................... 257
M. Masotti...................................................................... 69
M. Makowiecka-Ciesla................................................. 101
J. A. T. Marinho............................................................ 267
R. Massa....................................................................... 188
A. Malan....................................................................... 185
A. Marini....................................................................... 218
J. Massa....................................................................... 188
G. Maldonado........................................................ 256-259
J. Marinkovic................................................................ 182
J. Massaro...................................................................... 73
L. Malek........................................................................ 237
K. Marinou....................................................... 69, 216-217
H. Massetti................................................................... 181
M. Maletin.................................................................... 183
A. L. C. Marins.............................................................. 250
W. M. Masson.............................................................. 183
C. Malfitano.................................................................. 239
I. A. Markelova.............................................................. 210
L. Mastrocolla........................................................ 110-111
A. F Malheiros............................................................... 267
M. Markman................................................................. 241
F. Mastrogiacomo................................................. 242, 249
A. Mallouhi.................................................................... 173
B. Markman-Filho......................................................... 241
M. O. Masuda............................................................... 245
J. Maloney............................................................ 185, 205
V. Marmol..................................................................... 256
I. Masuda.............................................................. 190, 227
E. Malpica-Miranda....................................................... 205
M. Marona.................................................................... 252
M. Masuelli................................................................... 217
M. Maly........................................................................ 223
E. Marques..................................................................... 72
P. Matafome......................................................... 100, 269
G. Mamaladze............................................................... 230
C. Marques................................................................... 247
R. S. Math..................................................................... 167
S. C. Manchanda........................................................... 140
I. Marques.................................................................... 229
A. Mathavan................................................................. 138
D. M. Mancini............................................................... 104
A. Marques................................................................... 250
N. Mathew.................................................................... 167
L. Mancini..................................................................... 214
S. A. G. Marques.......................................................... 213
W. Mathias Jr....................................................... 111, 179
C. A. Mandarim-De-Lacerda.................................. 198, 202
N. Marquez................................................................... 247
C. Mathieu.............................................................. 75, 103
N. Mangani......................................................78, 102, 189
H. Marrero.................................................................... 183
G. Matic...........................................................74, 105, 169
A. Manginas.................................................................. 177
G. Marrero.................................................................... 207
M. Matic....................................................................... 187
J. Manica...................................................................... 109
F. Marrero-Rodriguez............................................ 167, 213
I. Matko........................................................................ 203
F. Maniero............................................................ 109, 243
N. A. Marsan................................................................. 136
A. Matonia.................................................................... 171
V. G. Manolopoulos........................................................ 77
M. Martin...................................................................... 165
L. Matos....................................................................... 220
L. Manriquez............................................................. 73, 75
F. L. Martin......................................................72, 108, 136
H. Matsubara................................................................ 235
V. Mansilla.................................................................... 275
A. Martín....................................................................... 210
A. Matsui...................................................................... 235
J. Mansur...............................................136, 208, 215, 220
C. Martinengo............................................................... 210
U. Matte....................................................................... 233
Index / 307
Authors
P. G. Mattingly...................................................... 172, 185
C. Mendoza.......................................................... 107, 219
L. Miranda-Peats........................................................... 141
A. Mattioli..................................................................... 275
L. Mendoza................................................................... 271
J. Mirat......................................................................... 220
G. Mattioli..................................................................... 275
R. Meneghelo.........................................110-111, 240, 268
R. Miret......................................................................... 168
M. J. Mattioli................................................................. 183
A. Meneghin I............................................................... 245
R. N. Mishra.................................................................. 251
V. Mattos...................................................................... 234
H. Menezes.................................................................. 109
S. Mishra.............................................................. 140, 164
L. A. Mattos.................................................................. 198
E. Mengual.................................................... 247-248, 263
J. Misiura...................................................................... 210
V. Z. Mattos.................................................................. 250
D. Mentzikof................................................................. 216
P. Mitro......................................................................... 257
R. Matunovic................................................................ 193
R. Merbilhaa................................................................. 102
P. Mitrovic...............................................74, 105, 169, 278
M. Matyjaszczyk........................................................... 210
E. Merilind.................................................................... 187
S. I. Miura..................................................................... 181
S. K. Maulik................................................................... 140
P. Merlo........................................................................ 204
A. M. K. Miyadahira...................................................... 245
S. Mavrogeni................................................................ 182
I. Merlo......................................................................... 207
S. Möbius-Winkler.......................................................... 73
R. Max................................................................... 222-223
A. Mesples..................................................................... 80
A. O. Mocumbi............................................................. 180
T. Maximova................................................................. 203
E. Mesquita...........................191, 201, 229, 238, 260, 263
J. Modenesi.................................................................. 217
S. Maybaum................................................................. 270
E. T. Mesquita.................219, 233-234, 236, 253, 262, 270
P. Moffa.......................................................................... 72
O. Mayer............................................................... 166, 173
K. Messlinger................................................................ 176
G. Mohamed................................................................. 214
R. Mayer....................................................................... 179
P. Meszaros.................................................................. 183
N. Mohammadifard....................................................... 211
M. Mayer............................................................... 273-274
D. Metras...................................................................... 241
A. Mohan...................................................................... 103
O. Mayer Jr................................................................... 166
V. Mezzalira.......................................................74, 80, 111
J. Mohan......................................................................... 79
G. Mazina...................................................................... 175
D. Mezzano................................................................... 109
F. Mohr........................................................................... 73
J. Mazucco....................................................134, 170, 212
J. Miano........................................................................ 140
O. Moiseeva......................................................... 204, 274
C. Mazza....................................................................... 240
R. M. Miatello....................................................... 205, 262
V. Moitra....................................................................... 176
G. Mazzini..................................................................... 233
V. Micevski................................................................... 104
E. E. Mola............................................................. 208, 211
P. Mbuilu........................................................................ 78
L. Michea...................................................................... 137
J. C. Molina............................................................. 75, 107
F. McAlister.................................................................. 229
J. B. Michel................................................................... 139
J. Moll................................................................... 229, 272
T. McAllister................................................................. 218
O. Midttun............................................................ 249, 251
R. A. Moller....................................................108, 241, 243
M. McConnell............................................................... 242
Z. Mijailovic................................................................... 193
T. Möller............................................................... 103, 223
N. McHado..................................................................... 74
N. Mijailovsky............................................................... 214
P. Mollon...........................................76, 78, 110, 143, 165
E. McKay...................................................................... 179
D. Mijalkovic................................................................. 276
A. Mollon.............................................................. 188, 193
J. McMillan................................................................... 135
E. Mikhaylov................................................................. 276
F. P. Mollon............................................................. 76, 165
A. Mead...........................................................73, 107, 143
R. Milani................................................................ 135, 208
G. Molon......................................................................... 72
A. Meave...................................................................... 133
L. Milani.......................................................................... 70
V. Moltchanov............................................................... 231
P. Medeiros.......................................................... 220, 222
S. Milanov..................................................................... 194
S. Molteni..................................................................... 278
A. Medeiros.......................................................... 136, 240
D. Milic......................................................................... 170
H. Mon............................................................................ 76
C. Medeiros.......................................................... 141, 227
D. Milicic........................................................104, 230, 245
M. Mongitore................................................................ 201
L. Medesani................................................... 206-207, 259
C. Militaru..................................................................... 180
Z. Monhart.......................................................72, 132, 200
M. Medina.................................................................... 168
J. G. Mill........................................................................ 263
A. Monney.............................................................. 75, 103
G. Medina..................................................................... 219
G. Millet........................................................................ 138
O. Montaña........................................................... 111, 138
M. Medvegy..........................164, 199, 203, 208, 224, 238
M. Milli............................................................................ 70
S. Monte....................................................................... 103
R. S. Meena.......................................................... 108, 231
J. Mills.......................................................................... 177
R. Montecchiesi............................................................ 274
A. Mehra......................................................................... 69
V. Milman..................................................................... 196
S. Monteiro...........................70, 78-79, 100-101, 132, 204,
A. B. Mehta................................................................... 132
C. Miloro....................................................................... 275
............................... 250, 252, 254-256, 258, 260, 263, 269
O. Meilhac.................................................................... 139
P. Milosavljevic............................................................. 166
P. Monteiro...........................70, 78-79, 100-101, 132, 250,
F. Meiller....................................................................... 195
A. Milosevic.................................................................. 169
S. Meiners.................................................................... 140
P. Min............................................................ 110, 218-219
A. Meissner...................................................103, 194, 245
R. Minardi..................................................................... 262
H. Mejias...................................................................... 190
M. Minelli...................................................................... 171
S. Melamed.................................................................. 163
G. S. Mintz.................................................................... 142
A. Mele......................................................................... 210
M. Miragaya.................................................................. 204
R. Melendez................................................................. 218
G. Miramont....................................................74, 211, 241
P. Mello........................................................................ 138
C. Miranda.......................................78, 244, 256, 266, 273
A. P. Q. Mello....................................................... 263, 265
V. Miranda.................................................................... 191
C. S. Melo..................................................................... 244
R. Miranda.................................................................... 181
P. Melor........................................................................ 184
C. S. Miranda..................................191-192, 254, 264, 267
J. Meltzer...................................................................... 176
I. Miranda...................................................................... 209
R. H. Mendes.................................................253, 258, 269
A. Miranda.....................................................175, 259, 272
R. J. Mendez..................................................220, 229, 250
S. Miranda..............................191-192, 254, 264, 267, 269
O. A. Mendiz................................................................... 76
R. D. Miranda................................................................ 255
L. Mendonça................................................................. 229
J. J. Miranda......................................................... 137, 164
.......................................252, 254-256, 258, 260, 263, 269
G. Monteiro.................................................................. 110
S. Montenegro.............................................................. 241
I. Montero..................................................................... 107
A. Montero-Gómez....................................................... 107
C. Montes....................................................................... 76
M. Monteverde............................................................. 250
P. Montoya.................................................... 206-207, 259
H. Moon........................................................................ 218
C. I. Moon............................................................. 111, 272
J. Moon................................................................ 141, 234
J. Mor........................................................................... 216
L. Moraes......................................................244, 247, 268
V. Moraes..................................................................... 205
A. P. Moraes................................................................. 253
R. S. Moraes......................................................... 106, 138
Authors
N. Moraes..................................................................... 176
M. S. Moysés Szklo...................................................... 232
A. B. Nargizyan............................................................. 136
M. Moraes.................................................................... 109
I. Mrdovic...................................................................... 187
B. Naronha.................................................................... 168
E. R. F. L. Moraes......................................................... 244
F. B. Muccillo................................................................ 275
J. Narula........................................................................ 141
J. Morais................................................................ 264-266
D. Mugnai..................................................................... 142
O. Nasario-Junior.......................................................... 244
M. Morais............................................................. 109, 134
M. L. O. Mugnaini......................................................... 254
P. Nasca........................................................................ 271
M. A. Morales Lezica............................................ 220, 239
M. F. Muiño.................................................................. 234
D. D. Nascimento......................................................... 244
C. Morales............................................................. 227-228
E. K. Mulholland............................................................ 103
F. F. Nascimento................................................... 227, 256
B. Morales.................................................................... 272
R. E. Müller................................................................... 227
C. A. S. Nascimento....................................... 252-253, 266
G. Moratalla-Cecilia....................................................... 248
R. Müller....................................................................... 256
B. C. G. Nascimento............................................. 172, 180
S. K. Morcos................................................................. 141
M. A. Müller.................................................................. 106
J. H. M. Nascimento............................................. 245, 263
G. Moré.......................................................................... 74
J. Müller........................................................................ 274
A. L. R Nascimento....................................................... 198
D. Moreira...................................76-77, 110, 247, 249, 268
H. Mun.......................................................................... 219
C. Nascimento.............................................................. 102
E. D. Moreira...................................................... 76-77, 249
K. Munakata.................................................................. 175
F. Nascimento...............................................227, 256, 259
R. B. Moreira................................................................. 253
A. Muniz............................................................... 132, 269
T. R. Nasibullin.............................................................. 236
L. F. Moreira................................................................. 237
A. Muñoz...................................................................... 183
J. Nasser....................................................................... 254
P. Moreira............................................................. 108, 278
M. C. Muñoz................................................................. 256
A. Natália...................................................................... 250
A. Moreira.............................................................. 257-259
R. Munoz-Sandoval....................................................... 265
R. Nauwerk................................................................... 237
L. B. Moreira....................................................76, 106, 143
N. Murad....................................................................... 245
A. Nava......................................................................... 271
M. B. Moreira........................................................ 106, 143
N. Murai................................................................ 188, 197
M. Navarrete................................................................. 205
C. M. Moreira................................................................ 106
C. Muratore...................................................185, 205, 277
V. Navarro..................................................................... 217
E. Moreira............................................................. 137, 269
P. Murray........................................................................ 73
C. Navas....................................................................... 139
L. Moreira..................................................................... 108
A. Muryan..................................................................... 201
V. Navega..................................................................... 263
R. C. Moreira......................................................... 139, 184
A. Musacchio.................................................................. 78
D. Navia........................................................................ 142
J. Moreno..................................................................... 244
P. Musialek........................................78, 80, 141, 230, 233
E. Navia...................................106-107, 201, 208, 236, 238
C. Moreno..................................................................... 241
L. Music........................................................................ 167
H. Nawawi............................................................ 133, 201
M. Moreno.......................................................75, 137, 241
B. Musser............................................................... 75, 166
J. Nayee.......................................................................... 75
G. Moreno.............................................111, 221, 226, 255
O. E. Mustafina............................................................. 236
C. Nazzal....................................................................... 132
H. Moreno-Filho............................................................ 270
R. Mvungi..................................................................... 235
I. Nedeljkovic................................................. 110, 277-278
A. Moreyra...................................................................... 69
B. Myasnik.................................................................... 196
M. Nedeljkovic..................................71, 110, 142, 277-278
A. E. Moreyra........................................................ 142, 144
J. Myszor...................................................................... 230
J. A. Neder.................................................................... 187
S. Morhy..................................................79, 224, 238, 253
G. Naccarato........................................................... 79, 224
S. Nedogoda................................................................. 175
A. T. Morikawa.............................................................. 255
J. H. M. Nacimento....................................................... 259
C. E. Negrao...................................................172, 180, 192
D. Morillo...................................................................... 176
J. Nadal......................................................................... 244
C. E. Negrão.................................................................. 138
P. Moriña...................................................................... 209
M. Nadal....................................................................... 231
C. Negrier...............................................255-256, 260, 263
C. Moris........................................................................ 165
S. Nadeem.................................................................... 270
J. Negroni..................................................................... 266
C. Morís................................................................. 196-197
B. Nadinic..................................................................... 217
M. J. Nel....................................................................... 203
T. Morishima................................................................. 167
C. Nagaoka.............................................243-244, 247, 265
K. Nelson........................................................................ 78
D. Morisse................................................80, 229, 242-244
Y. Nagayoshi................................................................. 164
R. Neme................................................................. 69, 132
L. A. Morita.................................................... 222-223, 229
C. Nagel........................................................................ 246
A. Neno......................................................................... 215
M. Moroi..........................................................70, 185, 189
M. Nahin....................................................................... 197
R. Nery.......................................................................... 243
S. Mortaloni...........................................107, 222, 240, 251
G. Naiman......................................................111, 221, 255
I. Nesralla..........................................77, 231, 233, 236-237
G. Moscardi.................................................................. 110
S. Najarian..................................................................... 142
A. Neto................................................................. 231, 254
F. Mosele...................................................................... 236
J. Najjar......................................................................... 103
R. Neto-Ferreira............................................................ 198
A. Moser....................................................................... 226
Y. Naka......................................................................... 104
W. Neuhuber................................................................ 176
C. Mostarda..........76-77, 137-138, 239, 249, 253-254, 269
S. Nakayama................................................................. 164
A. Neujahr..................................................................... 175
P. Mota.......................................................... 139-140, 257
M. Nakayama................................................................ 167
J. Neumann.................................................................. 166
A. Mota......................................................................... 186
R. Nakazato......................................................70, 185, 189
J. Neuwirth....................................................141, 223, 234
D. Motta.................................106-107, 201, 208, 236, 238
K. Nakiri........................................................................ 271
F. Neves................................................................. 76, 108
A. Mouly-Bandini.......................................................... 241
M. Nallar....................................................................... 225
P. Neves............................................................... 183, 273
J. Mountaner................................................................ 220
S. Nanfara..................................................................... 218
J. L. Neyeloff................................................................ 106
S. Moura....................................................................... 213
A. Nanhay..................................................................... 172
D. Nezic........................................................................ 167
L. A. Z. Moura............................................................... 254
A. D. Nanney................................................................. 212
Q. N. Ngoc.................................................................... 275
J. Mouras...................................................................... 139
N. Napoli....................................................................... 189
H. Ngow....................................................................... 184
M. Moutinho................................................................. 191
R. Narang...................................................................... 103
H. L. Nguyen......................................................... 143, 275
M. R. Movahed.................. 72, 79, 102, 106, 111, 144, 273
A. Naranjo..................................................................... 174
Q. N. Nguyen................................................................ 143
M. Moya....................................................................... 205
I. Narbute...................................................................... 255
V. L. Nguyen......................................................... 143, 275
E. Moya........................................................................ 168
J. Nardi......................................................................... 190
H. M. Nguyen............................................................... 275
A. Moyano.................................................................... 173
N. Nardi......................................................................... 231
Z. Ni.............................................................................. 141
Index / 309
Authors
P. Nicod.......................................................................... 75
V. Obradovic................................................................. 171
H. Olschewski.............................................................. 225
G. Nicolaidis.................................................................. 233
R. Obregon....................................................134, 170, 212
K. A. Olson............................................................ 138, 212
C. Nicoletti.................................................................... 134
S. Obregon........................................................... 106, 138
J. Olszewski................................................................. 273
L. Nicoloso.................................................................... 109
M. Ocaranza....................................................77, 137, 224
M. Olszowska........................................170, 173, 185, 193
V. Nieto......................................................................... 183
J. Ochoa....................................................................... 141
M. Olteanu.................................................................... 106
A. Nigam....................................................................... 197
R. Ochotny.................................................................... 251
A. Omer........................................................................ 270
S. Niki................................................................... 188, 197
M. Odaira...................................................................... 167
A. Oncul................................................................ 106, 191
N. Nikolaou................................................................... 181
G. O’Driscoll................................................................. 108
T. K. Ong....................................................................... 201
L. Nikolic....................................................................... 166
H. Ogawa...................................................................... 164
Z. Ongen....................................................................... 187
A. Nikolic............................................................... 187, 202
H. Oh............................................................................ 192
G. A. Ontiveros..................................................... 100, 279
D. Nikolic...................................................................... 187
B. Oh................................................................. 75-77, 144
R. Onut......................................................................... 200
A. Nikolopoulou............................................................ 217
N. Okasha..................................................................... 274
T. Ooie.......................................................................... 170
D. T. W. Nilsen...................................................... 178, 199
M. Okigaki.................................................................... 235
J. A. W. Opezzo............................................................ 273
S. T. Nilsen................................................75, 206-207, 209
K. Okoshi.............................................................. 258, 260
G. Opolski..................................................................... 273
Y. Nisanci.............................................................. 106, 191
M. P. Okoshi......................................................... 258, 260
J. Oporto....................................................................... 109
S. Nishikawa................................................................. 235
J. Olagüe.............................................................. 213, 239
K. Orban........................................................................ 134
M. Nishizaki.......................................................... 188, 197
T. Olcer......................................................................... 110
G. Ordoñez................................................................... 144
W. Nishizawa................................................................ 277
F. O. Olejnik.................................................................. 217
S. Ordu.................................................................. 198-199
L. Njord......................................................................... 255
J. Olin........................................................................... 111
M. Orellana................................................................... 206
R. Njord......................................................................... 255
I. Olina.......................................................................... 255
V. Orellana.................................................................... 254
F. Nobre........................................................................ 254
S. Olival...................................................252, 259-260, 262
L. Orellana.................................................................... 182
A. Nobrega................................76, 108, 137-138, 258, 278
A. Olive......................................................................... 178
R. Oren......................................................................... 163
I. Nocetti....................................................................... 204
S. A. Oliveira Júnior...................................................... 258
D. Orlandi.............................................................. 263, 268
R. Noe............................................................................. 71
A. M. R. R. Oliveira....................................................... 267
D. Orlic.................................................................... 71, 142
M. Nofal........................................................................ 189
A. Oliveira........................ 79, 193, 224, 233, 238, 258, 260
D. Ortega.............................................................. 102, 189
G. Nogiene.................................................................... 184
F. M. F. Oliveira............................................................ 240
D. F. Ortega.................................................................... 78
F. Nogueira................................................................... 220
I. S. Oliveira................................................................... 275
F. Ortega......................................................................... 78
C. R. Nogueira............................................................... 260
L. Z. P. Oliveira............................................... 243-247, 265
Y. R. Ortega.................................................................. 164
P. Nogueira............................................................. 79, 267
P. P. M. Oliveira.................................................... 133, 166
R. Ortego...................................................................... 218
M. Nogues.................................................................... 244
V. Oliveira..............................................102, 193, 236, 243
J. Ortellado................................................................... 237
C. Nojec........................................................................ 141
G. Oliveira......................................................106, 215, 262
C. Ortiz.......................................................................... 168
M. B. Nolly.................................................................... 140
T. V. Oliveira.................................................................. 243
L. Ose............................................................................. 75
C. H. Nomura................................................................ 224
C. P. Oliveira................................................................. 198
J. Oses......................................................................... 278
S. Noorfaizan................................................................ 184
N. Oliveira..................................................................... 213
A. Osório....................................................................... 179
M. Nordaby................................................................... 181
F. Oliveira.......................................................132, 191, 240
D. Ostera...................................................................... 240
J. E. Nordrehaug......133, 142-143, 243, 247-249, 251, 272
S. A. Oliveira..........................................193, 238, 258, 260
J. Ostermeyer............................................................... 103
T. Norgaz...................................................................... 186
P. S. Oliveira......................................................... 262, 275
M. Ostojic........... 71, 74, 105, 110, 142, 171, 182, 277-278
L. Noronha.................................................................... 176
E. Oliveira..................................................................... 240
R. K. Osugue................................................................. 253
G. R. Norton.................................................................. 230
M. Oliveira...... 111, 133, 166, 186, 218, 227, 267-269, 276
M. Oteh........................................................................ 184
A. Novakovic................................................................. 167
C. Oliveira..................................................................... 236
F. Otero........................................................................ 227
L. P. Novaretto.............................................................. 189
J. L. M. Oliveira............................................................. 111
J. Otero......................................................................... 207
F. Novo............................................................72, 200, 226
S. Oliveira......................................................176, 262, 275
D. Ott............................................................................ 231
G. Novo......................................................................... 106
F. T. Oliveira.................................................................. 250
G. Ottaviano.................................................................. 106
S. Novo......................................................................... 106
I. Oliveira....................................................................... 253
K. Otter......................................................................... 187
L. Novotny.................................................................... 200
S. A. Oliveira Jr............................................................. 260
R. S. Ovchinnikov.......................................................... 255
M. Nowak..................................................................... 232
W. Oliveira Jr................................................................ 141
C. Oviedo...................................................................... 240
J. U. Nowak.................................................................. 238
W. A. Oliveira.......................................................... 79, 224
D. Oz............................................................................. 186
E. Nowicki..................................................................... 232
S. A. Oliveira..........................................193, 238, 258, 260
B. Oz............................................................................. 163
N. Nranyan.................................................................... 136
V. F. Oliveira.................................................................. 132
E. Ozal.......................................................................... 163
L. Ntyintyane................................................................ 107
C. L. Oliveira................................................................. 234
E. Ozcinar..................................................................... 111
R. B. Nunes..................................................................... 74
A. L. V. Oliveira..................................................... 193, 236
A. O. Ozdemir............................................................... 192
M. C. P. Nunes............................................................... 74
F. M. Oliveira................................................................ 227
O. Ozdemir........................................................... 192, 233
B. Nuñez....................................................................... 226
P. S. Oliveira......................................................... 262, 275
M. Ozdemir................................................................... 279
B. Nuta.......................................................................... 103
G. D. Olivera................................................................. 271
O. Ozer................................................................. 171, 211
O. Nygard............................................................. 249, 251
P. Olivier....................................................................... 110
F. Ozerkan.................................................................... 188
O. Nygård......................................................133, 142, 247
G. Oller......................................................................... 201
H. Ozhan....................................................................... 198
D. Nyhan......................................................................... 77
J. Ollitrault...................................................................... 80
H. Özhan....................................................................... 199
V. Nzuzi......................................................................... 220
J. C. Olmos............................................................. 69, 265
J. Ozores...................................................................... 177
Authors
U. Ozyurda.................................................................... 111
E. Parra......................................................................... 190
C. Pellegrini................................................................... 100
G. Pacheco............................................................. 78, 102
R. Parra......................................................................... 207
G. M. M. Pellegrino..........................................78, 102, 189
N. Pacheco........................................................... 216, 270
J. Parras.........................................134, 170, 212, 215, 260
M. P. Pellini........................................................... 110, 210
A. Pacheco.................................................................... 215
C. Parsai........................................................................ 254
M. Pelliza...................................................................... 204
O. Pachinger................................................................. 173
W. Partata..................................................................... 236
R. Peloso...............................................134, 170, 212, 260
L. Padilla.........................................132, 225, 242, 244-245
O. Parysow................................................................... 261
G. Peltz......................................................................... 225
C. R. Padovani............................................................... 258
A. Pasca........................................................................ 227
H. P. M. Pena................................................................ 228
A. F. Padoveze.............................................................. 243
A. Pascua...................................................................... 227
M. Peña........................................................................ 272
T. Paes.................................................................. 263, 268
C. Pasinato.....................................................248, 257, 259
M. A. Peña-Duque........................................................ 205
J. Paes Jr............................................................... 264-266
M. Pasowicz..................................................101, 173, 193
E. Peñaloza................................................................... 140
Z. Pagava...................................................................... 230
M. Pasquale.................................................................. 178
G. Peñaloza................................................................... 111
N. Paglia........................................................................ 138
O. Passarelli Jr........................................................ 80, 208
F. Penhalves................................................................. 186
P. Paglini....................................................................... 222
M. Passauer.................................................................. 195
C. Pensa............................................................... 192, 210
P. Paglini-Oliva.............................................................. 276
R. B. D. Passos............................................................. 224
M. Peradejordi...................................................... 259, 267
J. Paiva......................................................................... 134
T. Patel.......................................................................... 132
M. Perazzoli.................................................................. 137
W. Paiva................................................................ 262, 265
M. Patricio.................................................................... 144
I. Perdomo.................................................................... 168
L. Pál............................................................................. 220
L. Patrucco.................................................................... 229
M. Perea....................................................................... 267
C. Paladino.................................................................... 189
A. L. Patsilinakos........................................................... 185
F. Pereda...................................................................... 190
C. Palaniswamy............................................................ 103
S. Patsilinakos............................................................... 177
L. Pereira.............................................................. 226, 229
A. Palazzo..................................................................... 219
C. Patterson.......................................................... 138, 225
R. Pereira.......................................................213, 222, 244
P. Palazzolo................................................................... 106
J. Paul........................................................................... 211
S. B. Pereira.................................................................. 253
M. Palinsky................................................................... 257
J. Paulini.......................................................74, 76-77, 137
A. M. R. Pereira.................................................... 213, 222
J. Palleiro...................................................................... 228
B. Pausa........................................................................ 232
J. R. M. Pereira...................................................... 252-253
J. A. Palma.................................................................... 205
E. Pautasso........................................................... 181, 274
J. B. Pereira.................................................................. 110
M. Palmeira.................................................................. 195
R. Pavanello.................................................................. 256
T. Pereira...................................................................... 204
T. Palomero.................................................................. 104
L. J. Pavelic................................................................... 220
A. C. Pereira.......................................................... 193, 236
S. A. P. Palomino.......................................................... 249
G. Pavlides.................................................................... 177
G. Pereiro...................................................................... 227
G. Paluzie...................................................................... 188
M. Pavlovic................................................................... 170
V. Pereyra..................................................................... 254
G. Paluzuie.................................................................... 188
K. Pavlovic.................................................................... 183
H. Pereyra..................................................................... 201
A. Panaro.............................................................. 111, 201
S. Pavlovic.................................................................... 171
E. Perez........................................................................ 244
O. Panes....................................................................... 109
N. Pavo......................................................................... 100
R. Perez.................................178, 195, 204, 215, 228, 241
G. Panic........................................................................ 190
I. Pavo Jr....................................................................... 100
H. Perez........................................................................ 267
C. F. Paniga................................................................... 212
R. Paya.......................................................................... 231
A. Perez.............................................................73, 75, 179
T. F. Panigas.....212-214, 221-223, 227, 261, 265-266, 269
W. R. Payne.................................................................. 164
N. Perez.........................................133, 139, 188, 240, 266
C. F. Panigas............212-214, 222-223, 227, 261, 266, 269
S. Payzin......................................................................... 77
J. Perez......................................................................... 231
J. Panini........................................................................ 181
N. Paz........................................................................... 189
M. Perez............................................................... 178, 219
A. A. V. Paola................................................................ 249
A. F. S. Paz.................................................................... 265
R. Pérez........................................................................ 191
F. Paoletti...................................................................... 185
K. Peczalski................................................................... 252
A. Perez-Bueno..................................................... 218, 257
J. F. Paolini...................................................................... 75
E. R. Pedersen...............................................247, 249, 251
R. Perez-Etchepare....................................................... 264
A. Papadopoulos........................................................... 222
K. E. Pedersen.............................................................. 110
N. Pérez-Hernández...................................................... 204
E. Papadopoulou........................................................... 182
L. Pedersen............................................................ 79, 110
M. Peric........................................................................ 167
T. Papafanis.................................................................. 181
E. R. Pedersen...............................................247, 249, 251
M. Perin........................................................................ 102
N. Papageorgiou........................................................... 216
S. F. Pedra...................................................................... 76
C. A. Perings......................................................... 103, 194
A. Papantoniou............................................................. 220
S. Pedrosa.................................................................... 137
M. Peris........................................................................ 225
A. Paragano.................................................................. 204
R. C. Pedrosa................................................................ 140
Z. Perisic....................................................................... 170
A. C. Parameswaran............................................. 166, 172
N. Peer.......................................................................... 196
E. Perna...........................................70, 105, 215, 271, 273
V. Paravati..................................................................... 240
K. Peersen............................................................ 103, 223
D. Peroni....................................................................... 176
E. Pardes...................................................................... 189
J. Pei............................................................................... 73
A. Perrone..................................................................... 229
E. Pardo........................................................................ 274
F. Peidro....................................................................... 208
B. Pertiné........................................................................ 80
O. Paredes.......................................69, 258, 260, 265, 271
J. Peirano...................................................................... 207
J. Z. Peruga................................................................... 222
J. Paredes..................................................................... 256
L. Peixoto........................................................................ 72
J. Perunicic................................................................... 187
M. Paredes............................................................... 73, 75
R. Peixoto..................................................................... 143
A. Pesantes.................................................................. 267
D. Pareira...................................................................... 267
W. Peixoto.................................................................... 267
C. Pesce......................................................................... 77
K. Parikh........................................................................ 132
C. Peixoto..................................................................... 184
G. Pessah............................................................. 241, 260
C. Parisi........................................................................... 70
N. Pejcic........................................................................ 105
L. Pessoa.............................................................. 260, 263
C. E. Parisi..................................................................... 136
E. Pektok...................................................................... 142
A. B. Pestova........................................................ 174, 192
J. L. Parmisano............................................................. 248
L. Pellanda.....................................................231, 272, 275
M. Peterson.................................................................. 187
J. C. Parodi............................................................. 253-254
F. Pellegrini................................................................... 103
M. Petit................................................................... 79, 201
Index / 311
Authors
R. Petkowics................................................................. 275
S. Pipitone.................................................................... 106
V. Porto............................................................77, 233, 236
Ö. Petnehazy................................................................ 100
J. L. C. Pippi...................................212, 214, 223, 261, 269
A. Posa......................................................................... 100
M. R. Petracek................................................................ 73
M. Piraino..................................................................... 100
J. Postley.........................................................73, 137, 179
Z. Petrasi....................................................................... 100
P. V. Pires..................................................................... 253
M. Potenzoni................................................................ 239
Z. Petrasinovic...................................................... 171, 277
J. Pirkola......................................................................... 75
S. Potic......................................................................... 105
J. Petriz..........................................................229, 250, 272
O. Pisano....................................................... 189-190, 215
R. Potluri....................................................................... 256
F. Petrolito.................................................................... 259
D. Pisano........................................................................ 79
L. Potocnakova............................................................. 137
D. Petrov....................................................................... 194
A. Pisarevsky................................................................ 106
A. Potosyan.................................................................. 181
V. Petrov....................................................................... 175
R. Pissinis..................................................................... 268
J. Pouso........................................................................ 199
D. Petrovai.................................................................... 245
J. Pitanga...................................................................... 108
A. Pouta.......................................................................... 75
M. Petrovic........................................................... 190, 278
F. J. M. Pitella............................................................... 266
C. Poy........................................................................... 105
D. Petrovic............................................................. 187-188
B. Pitt............................................................................ 108
R. Pozzan.............................................................. 201, 250
O. Petrovic.................................................................... 278
F. J. M. Pittela............................................................... 142
P. Pozzer........................................................215, 219, 273
J. Petrovicova............................................................... 257
R. B. Piveta................................................................... 233
P. L. Pozzer................................................................... 271
D. Petroviè.................................................................... 136
O. Pizzi.......................................................................... 250
F. S. Pozzi..................................................................... 199
O. Petrucci............................................................ 133, 166
M. Plášková.................................................................. 173
N. G. Prado........................................................... 220, 229
Z. Petrulioniene..................................................... 184, 237
M. L. Plastino................................................................ 210
N. Prasad............................................................... 250-251
R. Pettersen.......................................................... 143, 272
J. Plate............................................................................ 69
P. Prates............................................................... 231, 233
E. Pettersen.................................................................. 103
L. Platica....................................................................... 200
S. Prates....................................................................... 175
G. Pettersson................................................................ 232
O. Platonova................................................................. 238
P. Pratesi........................................................................ 79
M. Petti................................................................. 170, 201
G. Plehn.................................................103, 194, 223, 245
D. Précoma......................................................77, 135, 208
B. Pezo-Nikolic...................................................... 104, 245
A. Pleskovic........................................................... 187-188
I. Préda......................................................................... 164
S. Pezzotto.................................................................... 263
A. Pleskoviè.................................................................. 136
J. Pregowski................................................................. 241
A. Pfeferman................................................................ 102
M. Plewka..................................................................... 222
A. Prejbisz..................................................................... 101
L. Pfister....................................................................... 100
J. Poch............................................................................ 79
M. F. Prescott............................................................... 238
H. M. Pham........................................................... 143, 275
A. Pocoví............................................................... 225, 238
H. A. Prezioso...... 79-80, 142, 176, 178, 219-223, 229, 250
O. N. Pham................................................................... 143
Y. A. Pocrovskiy............................................................ 105
J. C. Prieto.................................................................... 132
K. G. Pham............................................................ 143, 275
D. A. Poddubnyy................................................... 103, 224
N. Prieto........................................................................ 273
E. Picabea............................................................. 134, 225
C. Podoleanu................................................................ 134
C. Prim.................................................................... 77, 176
F. Piccinini..................................................................... 142
D. Podoleanu................................................................ 134
C. R. Prim........................................................................ 77
A. Piccoli Jr................................................................... 109
P. Podolec..............................................170, 173, 185, 193
L. Principe..................................................................... 174
V. Piccone..................................................................... 220
E. Podolskaya............................................................... 175
D. Prior.......................................................................... 136
R. Picon........................................................................ 106
G. Podosyan................................................................. 181
J. O. Prior...................................................................... 133
V. Picone....................................................................... 279
J. Poeys........................................................................ 110
Y. Prior.................................................................. 107, 271
L. S. Piegas............................................................. 80, 208
P. Pogonza.................................................................... 176
D. Pritchard................................................................... 178
P. Pieniazek.......................................78, 80, 141, 230, 233
Y. A. Pokrovskiy.............................................................. 74
G. F. Procopio............................................................... 100
P. Pieroni...................................................................... 274
E. Polanco..................................................................... 201
G. Procopio............................................................. 73, 279
M. Pietrani.....................................................234, 264, 271
N. Polat......................................................................... 106
Z. Prohaszka................................................................. 203
R. Pietrobon.................................................................. 250
C. Poliserpi.................................................................... 217
L. Protasio..................................................................... 138
T. Pietrucha................................................................... 210
J. Politei........................................................................ 231
M. Protich..................................................................... 206
M. Pilan........................................................................... 73
D. Polk.......................................................................... 141
V. Proto......................................................................... 215
M. Pilato....................................................................... 184
J. Pollan........................................................................ 137
L. A. Providencia.........................78-79, 100-101, 132, 250,
S. Pilato......................................................................... 184
P. Pollono........................182, 234-235, 248, 254, 264, 271
...............................................254-256, 258, 260, 263, 269
K. Pilichou..................................................................... 134
L. Polonski.................................................................... 238
L. Providência......................................................... 70, 252
C. Pimenta.................................................................... 248
P. Pomerantzeff............................................................ 278
P. Pruszczyk.................................................................. 251
J. Pineda....................................................................... 217
L. Ponce........................................................................ 214
T. Przewlocki............... 76, 78, 80, 101, 141, 170, 230, 233
D. Pineiro...................................................................... 267
K. Ponciano................................................................... 255
A. Przybylski............................................................. 76, 80
A. Pinheiro.................................................................... 234
V. Pönitz..................................................166, 178, 206-207
B. Przybysz................................................................... 273
V. Pinheiro............................................................. 247-248
P. Pons................................................................. 205, 222
B. Psaty........................................................................ 137
E. Pinheiro.................................................................... 247
C. I. Ponte..................................................................... 226
M. Puchta..................................................................... 251
J. Pinheiro Jr................................................................... 79
D. Pop............................................................ 242, 245-246
D. Puente...................................................................... 267
O. A. Pinilla......................................................77, 140, 198
S. Popovic..................................................................... 105
S. E. Puga..................................................................... 220
B. Pinto......................................................................... 132
K. Poppe....................................................................... 136
P. Pujol...........................................................132, 236, 238
I. Pinto.................................................................. 198, 240
R. P. Porcile.................................................................. 239
C. G. Puk............................................................... 109, 191
J. Pinto.................................................................. 179, 226
L. Portela...................................................................... 233
C. Pulz........................................................................... 248
A. Pinzon............................................................... 205, 249
L. Portella...................................................................... 233
Y. Purmah..................................................................... 256
D. Piotrowska-Kownacka.............................................. 174
D. Portillo............................................................... 184-185
K. Putarek..................................................................... 231
W. Piotrowski............................................................... 175
M. Portis............................................................... 183, 215
A. M. Puyó.................................................................... 274
Authors
M. Pyda........................................................................ 225
G. Rao........................................................................... 168
M. F. Ribeiro................................................................. 236
O. Querencio........................................................ 215, 260
V. Raos......................................................................... 231
A. L. P. Ribeiro........................................................ 74, 228
M. S. Queroz................................................................. 213
A. Rapaee............................................................. 133, 201
A. Ribeiro.............................................................. 218, 229
S. Quevedo............................................................ 238-239
C. Rapallo...................................................................... 133
G. Ribeiro.......................................................253, 260, 263
J. Quiles........................................................................ 165
J. J. Raposo.................................................................. 249
E. P. Ribeiro.................................................................. 190
M. Quintão............................................................ 219, 270
K. Raslova..................................................................... 257
J. Ribeiro....................................................................... 226
M. P. Quintão........................................................ 234, 236
J. N. Rasmussen................................................... 230, 232
L. Ribeiro................................................................ 79, 267
D. Quintero................................................................... 249
R. Rasmussen....................................................... 260-261
M. F. M. Ribeiro............................................................ 201
F. Quintiero................................................................... 264
S. Rasmussen....................................................... 230, 232
M. Ribeiro..................................................................... 201
C. Quiroga..................................................................... 102
S. Rassi......................................................................... 208
C. Ribeiro...................................................................... 141
L. Quiroga......................................................111, 221, 255
F. Rassi................................................................. 246, 248
A. Riberi........................................................................ 241
P. Quiroga............................................................. 107, 209
A. Rastan...................................................................... 182
R. Ricardo....................................................................... 77
J. Quiroga..................................................................... 269
A. J. Rastan................................................................... 173
E. Ricardo............................................................. 265, 267
C. Quiroz....................................................................... 111
O. Rastelli............................................................. 189, 215
M. Riccitelli............................................................. 70, 139
M. Quon............................................................ 75-77, 144
R. Ratto......................................................................... 267
C. M. Richter.....212-214, 221-223, 227, 261, 265-266, 269
M. Rabrenovic.............................................................. 193
J. Ravkilde.................................................................... 166
D. Ricon........................................................................ 204
J. Racek........................................................................ 253
E. Ravussin................................................................... 166
F. Ridocci-Soriano......................................................... 231
L. J. Radevic................................................................. 170
R. Ray........................................................................... 140
I. Riecansky.................................................................. 137
D. Radlovacky............................................................... 220
E. Raymenants............................................................. 277
E. Riedemann............................................................... 109
N. Radovanoviæ............................................................ 136
A. P. Rebrov.......................................................... 103, 224
A. R. P. Rieira................................................................ 245
M. Radovanovic...............................................74, 105, 169
C. Recuerda Casado..................................................... 234
A. Riera........................................................................... 72
N. Radovanovic.................................74, 105, 169, 187-188
D. P. Redfearn...................................................... 135, 163
M. A. Rieth.................................................................... 143
S. Rafajlovski................................................................ 193
H. J. Redruello.......................................136, 142, 219, 250
I. Rifourcat............................................................ 183, 214
P. Raffaelle................................................................... 206
M. Redruello..........................................133, 139, 261, 266
K. Rigatto.............................................................. 253, 269
H. Raffaelli........................73, 107, 205-206, 225, 230, 279
G. S. Reeder................................................................. 262
A. Righetti....................................................................... 78
A. Rafie......................................................................... 111
H. Refsum.............................................133, 142, 243, 248
P. Rigueiro Veloso................................................. 186, 194
V. Raggio.............................................................. 273, 276
V. Regitz-Zagrosek........................................................ 204
S. Rim............................................................ 110, 218-219
M. Raguz...................................................................... 231
A. Rego......................................................................... 249
S. J. Rim......................................................................... 79
H. Ragy......................................................................... 274
A. Reichert.................................................................... 218
R. E. Rios Mendez.................................................. 76, 165
P. Rahimi...................................................................... 216
R. P. Reidar Pettersen.................................................. 203
A. Ríos.......................................................................... 274
R. Rahmonov................................................................ 196
A. Reina...........................................................70, 224, 246
A. V. Risnenko................................................................ 74
A. Rai.................................................................... 142, 212
A. Reina-Toral............................................................... 248
A. Riso.......................................................................... 263
H. Rai............................................................................ 110
J. Reiner....................................................................... 142
L. Ritt............................................................................ 132
H. Raich........................................................................ 142
S. Reinmets.................................................................. 187
J. Ritter......................................................................... 166
F. Raineri....................................................................... 186
R. Reinoso.................................................................... 166
W. Rivarola....................................................222, 273, 276
T. Rajarajan................................................................... 231
A. Reis.................................................................. 100, 269
H. W. Rivarola....................................................... 273, 276
D. Rajic................................................................... 74, 105
H. Reis.......................................................................... 132
M. Rivarola.................................................................... 209
N. Rajicic....................................................................... 243
M. M. Reis............................................................ 249, 276
E. Rivas Stany............................................................... 228
S. Ramamurthy............................................................. 103
L. S. R Reis................................................................... 198
C. Rivas................................................................. 195, 255
F. Ramello..................................................................... 173
D. Reisner..................................................................... 166
C. A. Rivas............................................................ 220, 239
J. Ramires............................................................. 111, 179
A. Rekhviashvili..................................................... 164, 175
A. Rivera....................................................................... 188
M. Ramirez........................................................... 181, 206
I. Rendon...................................................................... 216
P. Rivera..........................................................77, 137, 224
H. Ramirez.................................................................... 259
J. Rengel....................................................................... 190
M. Rizzatti..................................................................... 226
A. Ramirez.................................................................... 141
N. F. Renna........................................................... 205, 262
N. Rizzo......................................................................... 200
V. Ramirez-Castro..........................................207, 218, 257
E. S. Resende............................................................... 244
Y. Ro............................................................................. 108
J. C. Ramiro Novoa....................................................... 177
P. Resende........................................................... 250, 272
T. Robak........................................................................ 222
R. C. Ramon Corbalan................................................... 102
M. Resnik..................................................................... 178
S. Robert............................................................... 200, 214
R. Ramon...................................................................... 259
D. Reuland.................................................................... 212
C. Roberts..................................................................... 137
R. Ramos........................................................................ 79
A. Reveron.................................................................... 226
F. Robles........................................................205, 230, 278
A. Rampazzo................................................................. 134
M. Rey.......................................................................... 274
L. Robles....................................................................... 271
K. A. Ramsdale............................................................. 179
G. Rey........................................................................... 189
G. Robles...................................................................... 194
D. R. Ramsdale............................................................. 179
I. Reyes......................................................................... 273
M. Robles..................................................................... 141
A. Ramzy...................................................................... 274
P. A. Reyes................................................................... 204
B. Roca......................................................................... 225
R. Raña......................................................................... 206
J. Reynolds................................................................... 169
J. Roca.......................................................................... 224
G. Ranchilio................................................................... 208
K. Rhee......................................................................... 235
G. Rocca....................................................................... 175
C. Rando......................................................................... 71
A. R. Riarte............................................................ 220, 229
L. Rocha Lopes..................................................... 111, 181
M. Rangel..................................................................... 270
A. Ribeiro Langowiski................................................... 218
R. Rocha....................................................................... 209
A. Rao........................................................................... 179
J. P. Ribeiro......................................................74, 106, 138
N. Rocha..........................................76, 108, 198, 219, 278
Index / 313
Authors
A. Ruiz.................................................................. 213, 244
M. S. Rocha............................................................ 72, 107
R. Romero.............................................................. 78, 179
A. S. C. Rocha....................................................... 142, 266
T. Romero................................................................. 73, 75
J. M. Ruiz-Nodar........................................................... 217
V. N. Rocha................................................................... 198
M. C. Romero............................................................... 221
M. J. Ruiz-Olgado..........................................207, 218, 257
C. Rochitte............................................................ 136, 141
M. U. Rondon............................................................... 172
A. Ruokonen................................................................... 75
L. Rodas...........................................................80, 242, 244
J. Roosen...................................................................... 277
C. Rus Mansilla............................................................. 234
R. Rodrigo..................................................................... 261
M. Rosa........................................................................ 191
E. Rusak........................................................................ 200
L. F. Rodrigues Jr.................................................. 259, 263
K. Rosa................................................................... 74, 239
P. Ruschel...................................................... 233, 236-237
L. F. Rodrigues Jr.................................................. 259, 263
K. T. Rosa...................................................................... 249
P. Ruschell...................................................................... 77
B. Rodrigues............................................74, 136, 234, 249
D. Rosa......................................................................... 133
U. Rushentsova............................................................ 132
L. M. Rodrigues............................................................ 266
F. Rosa.......................................................................... 108
V. Ruskin....................................................................... 234
A. C. Rodrigues............................................................. 238
L. Rosa.......................................................................... 234
E. Ruslender.......................................................... 253-254
V. Rodrigues......................................................... 110, 204
G. Rosadiez..................................................................... 77
R. Russo............................................................... 144, 225
M. Rodriguez Acuña............................................. 205, 230
A. Rosales..................................................................... 215
M. Russo...................................................................... 178
G. Rodriguez Botta........................................................ 257
A. Rosas Cabral............................................................. 268
C. M. Rutherford........................................................... 139
C. Rodriguez Correa................................................ 73, 224
B. T. Roseguini................................................................ 74
O. Ruyer....................................................................... 194
L. Rodriguez Nande...................................................... 202
R. Rosental................................................................... 214
W. Ruzyllo........................101-102, 136, 174-175, 237, 241
L. Rodriguez Nandez..................................................... 228
P. Rosique.................................................................... 183
A. Rybicka-Musialik....................................................... 230
A. Rodriguez Saavedra.................................................. 181
A. Roslawiecka....................................................... 76, 141
L. Ryliskyte................................................................... 184
L. Rodriguez.............................................69, 202, 207, 228
E. Rosner...................................................................... 186
A. Rynkiewicz............................................................... 249
C. Rodriguez............................................73, 224, 237, 248
H. Ross........................................................................... 74
E. Rzewuska................................................................. 251
A. Rodriguez......................................................... 132, 181
H. J. Ross..................................................................... 104
D. Rzeznik........................................................76, 141, 230
M. Rodriguez.................................................205, 228, 230
J. Ross.......................................................................... 104
A. Sa............................................................................. 201
W. Rodriguez........................................................ 192, 210
M. Rossi........................................................134, 225, 246
A. K. Sá......................................................................... 201
J. Rodriguez.......................................................... 175, 270
A. Rossi................................................................ 136, 247
G. Saatashvili................................................................ 230
D. Rodríguez Ierace...................................................... 169
G. Rossi........................................................................ 264
L. Saavedra................................................................... 107
M. Rodríguez................................................................ 133
F. M. B. Rossi................................................ 243-247, 265
N. Saavedra.................................................................. 215
L. Rodríguez.................................................................. 191
S. Rossi......................................................................... 236
A. Sabanov.................................................................... 175
J. Rodriguez-Collado......................................207, 218, 257
R. Rossi.......................................................................... 78
J. Sabik......................................................................... 232
C. Rodriguez-Correa...................................................... 246
E. A. Rossi.................................................................... 247
M. C. Saccheri...................................79-80, 136, 142, 176,
M. Rodriguez-Elvira............................................... 224, 246
N. Rossi.......................................................................... 76
.......................................................178, 219-223, 229, 250
J. M. Rodríguez-Pérez............................................ 204-205
P. Rossi......................................................................... 189
L. Saclietti..................................................................... 259
H. Rodríguez-Zanella..................................................... 133
L. Rosso.......................................................................... 77
B. Sáenz........................................................................ 207
J. Roesch...................................................................... 176
F. Rotemberg................................................................ 168
D. Y. Sahin.................................................................... 105
D. Roganovic................................................................ 182
S. Rotevatn................................................................... 143
M. Sahin....................................................................... 163
A. Roggerio................................................................... 278
A. Rouge.................................................252, 259-260, 262
A. Sahinarslan.................................172, 185, 219, 231-232
O. Rogowski................................................................. 163
P. Roura...................................................73, 206, 246, 279
S. Sahýn........................................................................ 195
L. E. Rohde................................................................... 233
B. G. Rovai.................................................................... 228
T. Saikawa.................................................................... 170
C. Rojas Matas........................................................ 78, 227
S. K Roy........................................................................ 232
V. Saini.......................................................................... 138
J. Rojas.................................................................. 228-229
G. Roytberg.................................................................. 238
B. Saiz........................................................................... 183
E. Rojas.......................................................... 247-248, 263
J. Rozanski............................................................ 109, 171
S. Sakalli....................................................................... 186
E. Roldos Cuza.............................................................. 228
P. Rozentryt.................................................................. 238
I. Sakic.......................................................................... 223
R. B. Rolf Berge............................................................ 203
A. Rozga....................................................................... 170
K. Saku.......................................................................... 181
C. Rollan....................................................................... 195
A. Rózga....................................................................... 171
J. P. Sala....................................................................... 190
M. Rollin-Ornelas.......................................................... 273
A. Rubinich................................................................... 277
A. Salacata.................................................................... 177
A. L. Rollins................................................................... 212
P. Rubis........................................................................ 101
H. Salazar........................................................................ 69
R. Romaguera............................................................... 231
Y. Rückert..................................................................... 182
L. A. Salazar...................................................163, 215, 227
C. Roman.................................................................. 73, 75
H. Ruda Vega................................................................ 109
A. Salazar...............................................163, 215, 227, 268
M. I. Roman.................................................................... 76
M. Ruffa........................................................................ 178
C. Salazar...................................................................... 169
J. Román García............................................................ 174
G. Ruibal....................................................................... 189
C. Saldarriaga................................................................ 139
A. Romano.................................................................... 220
E. Ruiz De Temiño De Andres...................................... 234
C. Saldivar..................................................................... 256
E. Romano.................................................................... 257
G. Ruiz Deza................................................................. 139
M. Salem.............................................................. 143, 272
M. Romano............................................................ 228-229
E. Ruiz Lascano............................................................. 270
A. Sales........................................................................... 76
E. R. Romano.................................................................. 76
M. Ruiz Moraga............................................................ 174
J. Salgado-Fernández.................................................... 198
L. Romano.................................................................... 141
M. L. Ruiz Morosini....................................................... 184
M. Salguero.......................................................... 195, 269
M. Romanowska.......................................................... 175
E. Ruiz................................................................... 234, 270
J. Saligova..................................................................... 137
L. Romeo........................................................................ 70
G. A. Ruiz...................................................................... 244
J. Salinas....................................................................... 215
M. Romero............................................103, 134, 170, 212
L. P. Ruiz....................................................................... 213
S. Salinger..................................................................... 170
I. Romero...................................................................... 185
M. Ruiz................................................................. 174, 184
F. V. Salis...................................................................... 213
Authors
F. Saliva.......................................................................... 74
G. A. Santiago..................................263-264, 266, 269-270
J. Schad........................................................................ 238
A. Salles........................................................................ 207
A. C. Santomauro........................................... 243-247, 265
R. Schaetzl............................................................ 196, 198
J. B. Salles.................................................................... 202
A. T. Santomauro.......................................................... 243
D. Schaf........................................................................ 233
W. Salmhofer................................................................ 225
A. C. Santomauro Jr............................................... 243-247
C. M. Schannwell.................................................. 104, 270
F. Salmo.................................................................. 73, 246
B. S. Santoro.................................................. 243-245, 247
S. Schanz....................................................... 206-207, 259
R. Salomao................................................................... 220
D. Santoro...................................................... 139-140, 253
E. Schapachnik..................................................... 195, 218
C. Salomón................................................................... 214
D. Santos.......................................................238, 242, 249
M. Schapira................................................................... 137
P. R. Salvador................................................................ 244
E. Santos...................................................................... 132
H. Schartum-Hansen............................................ 249, 251
F. Salvaggio.......................................................... 181, 193
I. Santos................................................................ 132, 253
N. Schechtmann........................................................... 201
F. Salvagio.............................................111, 170, 189, 196
M. Santos......................................142, 201, 205, 230, 262
S. Scheidl...................................................................... 225
C. Salvatori.............................................................. 73, 246
B. Santos........................................175, 252, 259-260, 262
P. C. Schenkel............................................................... 233
P. Salvo......................................................................... 257
T. Santos....................................................................... 275
U. Scherrer............................................................. 75, 103
S. Salzberg...................................................................... 70
F. Santos........................................................110, 175, 204
I. T. Schettert................................................................ 193
G. Samaja..................................................................... 181
M. H. H. Santos.................................................... 243, 249
A. G. Schijman.............................................................. 250
R. Samaniego............................................................... 210
J. Santos....................................................................... 278
A. C. Schimidt............................................................... 267
J. Samardzic................................................................. 193
A. A. Santos.................................................................. 226
N. Schimidt................................................................... 175
N. V. Sambiase..................................................... 276, 278
I. Santos-Rodriguez........................................207, 218, 257
T. H. Schindler.............................................................. 133
S. Samimi-Fard..............................................167, 169, 213
O. Sanz................................................................. 213, 239
G. Schipani............................................................ 237, 240
S. Samir........................................................................ 101
S. Sapari........................................................................ 184
J. A. Schirger................................................................ 108
M. Sammartino............................................................. 241
G. Saposnik......................................................78, 111, 267
A. J. Schlichter........................................................ 76, 221
P. P. Sampaio.........................................136, 211, 215, 220
D. J. Saranovic.............................................................. 171
S. Schneck.................................................................... 278
R. O. Sampaio........................................132, 237, 247, 275
S. Saravia............................................................... 246-248
M. Schneider................................................................ 228
D. L. Sampaio............................................................... 256
M. Sardar...................................................................... 270
C. Schneider................................................................. 106
C. Sampaio................................................................... 227
A. Sardella............................................................... 76, 252
J. Schnidt...................................................................... 239
R. M. F. Sampedro........................................................ 214
P. Sareli......................................................................... 230
A. Schott....................................................................... 260
F. Sampedro................................................................. 214
I. Sari..................................................................... 171, 211
M. Schou.............................................................. 108, 241
E. A. Sampó.................................................................. 215
S. Sarikaya.................................................................... 205
I. M. Schou................................................................... 108
H. Sanabria........................................................... 142, 179
R. Sarjanovich................................................................. 74
P. Schreib..................................................................... 200
J. Sanagua............................................................ 218, 261
B. Sarkar....................................................................... 232
V. Schubsky.................................................................. 238
P. Sanches...................................................................... 72
R. A. Sarmiento..........................................70, 80, 221, 229
G. Schuler............................................................... 73, 182
L. B. Sanches................................................................ 265
R. Sarmiento....................................................69, 102, 132
C. Schulte............................................................. 138, 225
I. Sanches..................................................................... 255
D. Sarmiento................................................................. 216
R. Schumiachkin............................................................. 76
F. Sanchez............................................................ 181, 193
M. Sarmiento................................................................ 228
I. Schusterova............................................................... 137
O. Sanchez................................................................... 218
Z. S. Sarszegi................................................................ 197
P. Schvartzman............................................................. 226
R. Sanchez.....................................................183, 215, 259
C. Sarteschi...................................................227, 240, 247
M. Schwab............................................................. 75, 103
V. Sanchez.................................................................... 211
A. Sartori............................................................... 135, 208
O. A. Schwint................................................................ 142
L. Sanchez.................................................................... 183
C. Sartori................................................................. 75, 103
P. Schygiel.................................................................... 171
S. Sanchez.................................................................... 190
M. Sartori...................................................................... 254
R. Sciacca............................................................... 75, 107
A. Sanchez.....................................................190, 205, 213
J. Sasaki........................................................................ 195
G. Scianca..................................................................... 229
L. A. Sanchez................................................................ 205
C. Satizabal................................................................... 216
A. Scicolone.................................................................. 211
M. A. Sánchez Chaparro............................................... 174
L. Satlin......................................................................... 173
G. Scicolone.................................................................. 211
A. Sanchez-Grande....................................................... 167
R. Savanti...................................................................... 227
S. Sclarovsky.................................................102, 167, 178
M. J. Sancho-Tello................................................ 213, 239
N. A. Savelov.................................................................. 74
E. Sclarovsky.......................................................... 72, 143
A. Sancineti................................................................... 103
O. Savenko....................................................141, 249, 252
M. Scofano................................................................... 229
M. Sancineti.................................................................. 103
M. Sawasany................................................................ 274
C. G. Scott.................................................................... 105
S. Sandoval-Navarrete................................... 265-266, 268
S. Saygi......................................................................... 276
E. Scrivano...................................................................... 78
M. Sani......................................................................... 178
B. Saygi........................................................................... 77
C. Seara.........................................................141, 206, 260
C. A. Sanibal.................................................................. 263
T. Sayin......................................................................... 192
C. Seelig....................................................................... 237
M. Sanjurjo............................................................ 270-271
L. V. Sazukina................................................................ 255
C. Segadaes.................................................................. 222
R. Sankaranarayanan............................................ 103, 105
A. Scafa-Udriste............................................................ 200
E. V. Segura.................................................................. 189
R. Sansalone................................................................. 242
J. Scaglia..........................................78, 110, 143, 188, 193
M. Segura..................................................................... 279
M. Santa....................................................................... 208
J. Scaglione.................................................................. 210
R. Seiça................................................................. 100, 269
R. Santa........................................................................ 179
E. Scaiola...................................................................... 240
K. Seidl.......................................................................... 203
W. Santander...................................69, 258, 260, 265, 271
N. Scarin....................................................................... 268
C. Seidler................................................................ 80, 244
P. Santander................................................................... 69
A. Scariot...................................................................... 228
D. Seinhart.................................................................... 137
J. Sant’Anna......................................................... 231, 233
G. B. Scaro...................................................................... 74
D. Selchen.................................................................... 267
R. Sant’Anna................................................................. 231
B. Schaan...................................................................... 226
Y. Selcoki.............................................................. 185, 195
G. Santiago..............................192, 195, 241-242, 260-261
T. Schachner................................................................. 173
V. Selios................................................................. 269-270
Index / 315
Authors
M. Sellanes........................................................... 192, 210
A. Shirom...................................................................... 163
J. L. Simon.............................................................. 76, 221
A. Selvi.......................................................................... 223
E. Shlyakhto.................................................................. 203
J. Šimon................................................................ 166, 173
K. A. Selzman........................................................ 138, 225
E. Shlykhto............................................................ 204, 274
T. Simoncek.................................................................. 231
A. Sembaj..................................................................... 264
Z. Shoalimova............................................................... 196
G. Simonyi.............................164, 199, 203, 208, 224, 238
M. Semukhin................................................................ 202
L. Shocron.................................................................... 222
C. S. Simpson....................................................... 135, 163
O. Sen........................................................................... 105
N. Shor.................................................................. 110, 178
S. Singh........................................................................ 167
L. M. Sena.................................................................... 247
A. A. Shoukas................................................................. 77
G. Singh................................................................ 108, 231
M. Senesi............................................................. 210, 222
R. K. Shrivastava................................................... 108, 231
N. Singh........................................................................ 110
K. Senna....................................................................... 262
S. Shukurjanova............................................................ 196
I. Singla......................................................................... 101
D. Sepulveda................................................................ 137
A. Shurman................................................................... 186
N. Sinha..........................................110, 132, 198, 250-251
S. Serafim..................................................................... 211
A. Siciliano.................................................................... 263
A. Sinha........................................................................ 104
A. Serafin...................................................................... 273
S. Sicouri....................................................................... 275
D. A. Siniawski.............................................................. 183
S. Sinigaglia.................................................................. 244
D. F. Serans.......................................................... 220, 250
R. Siddiqui..................................................................... 270
J. Seresi........................................................................ 277
D. Sidi........................................................................... 180
A. Sinisi..............................................74, 79, 201, 211, 241
P. Seron........................................................................ 132
K. Siemianowicz........................................................... 208
P. Sionek....................................................................... 252
I. Seropian..................................................................... 228
I. U. Sigaev.................................................................... 255
P. Siostrzonek............................................................... 110
B. S. Serpa.................................................................... 224
J. Sikic-Vagic................................................................. 231
D. Siqueira.....................................................257, 259, 261
A. Serra......................................................................... 229
J. Sikora................................................................ 171, 238
A. Siqueira-Filho.............................................................. 71
S. Serra........................................................................... 76
E. Silberman.......................................................... 273-274
M. Sirlak........................................................................ 111
O. Serraiocco................................................................ 227
F. J. B. Silva Filho.......................................................... 244
V. Sirotkin..................................................................... 235
D. Serrano..................................................................... 247
E. Silva........................... 138, 240, 242, 259, 269, 272, 275
R. Sirvente.................................................................... 269
E. Serrano..................................................................... 214
J. Silva...............................................................72, 78, 109
A. Sitar-Tautu................................................................ 242
C. Serrano..................................................................... 254
F. Silva...................................................135, 208, 246, 253
M. Sitnikova.................................................................. 203
J. Sertic......................................................................... 230
A. C. Silva...................................................................... 244
B. Sjöberg....................................................................... 75
A. Seth.......................................................................... 132
F. H. Silva...................................................................... 244
D. Skapura.................................................................... 103
K. K. Sethi..................................................................... 132
M. C. C. Silva................................................................ 202
B. D. Skinner......................................................... 138, 212
S. Seto.................................................................. 195, 209
H. Silva.................................................................. 244, 279
S. M. Skinner........................................................ 138, 212
V. Severicha.................................................................. 210
P. Silva....................................137, 139-140, 226, 236, 257
B. Skoric................................................104, 219, 230, 245
L. J. Sevic..................................................................... 174
A. Silva....................................139-141, 164, 183-184, 212,
W. Skorupski................................................................ 225
N. Sewpaul................................................................... 256
...............................................224-225, 227, 257, 265, 273
M. Skwarek.......................................................... 102, 237
T. M. Seydell..................................................109, 191, 243
R. Silva.................................................................. 253, 257
M. Slater....................................................................... 277
A. Shah......................................................................... 166
M. J. L. M. Silva.................................................... 227, 256
B. L. Sleath................................................................... 226
T. P. Shah...................................................................... 172
L. C. S. Silva.................................................................. 217
J. Sleigh.......................................................................... 71
T. Shalganov................................................................. 206
I. T. Silva............................................................... 263, 265
A. Slichter..................................................................... 252
I. Shapira....................................................................... 163
M. A. Silva......................................................212, 227, 265
I. Slimobich............................................................. 70, 248
N. Sharashidze.............................................................. 230
B. Silva.................................................................... 76, 244
E. Slywitch.................................................................... 199
O. Sharkhun.................................................................. 238
I. C. M. Silva.............................................76, 138, 234, 253
P. Smanio........................110-111, 186, 251, 267-268, 276
V. K. Sharma......................................................... 108, 231
V. M. Silva............................................................. 180, 198
P. A. Smars................................................................... 262
S. K. Sharma......................................................... 142, 272
R. B. F. Silva.................................................................. 246
N. Smedira.................................................................... 232
S. Sharma..................................................................... 140
S. A. Silva.............................................................. 139, 184
L. Smeeth............................................................. 137, 164
C. Shaw........................................................................ 163
J. P. Silva.............................................................. 226, 236
L. Smidt.................................................134, 138, 243, 250
M. Silva...................................76, 109, 138, 180, 198, 227,
C. Smith.............................................................4, 219, 225
L. J. Shaw..................................................................... 141
C. Shekhar...................................................................... 79
H. Sheng....................................................................... 202
J. Shepherd.................................................................. 183
H. Shi............................................................................ 241
S. Shigematsu.............................................................. 170
L. S. Shigueoka............................................................... 75
E. O. Shim............................................................. 111, 272
K. Shimomura............................................................... 195
J. Shin........................................................................... 270
E. Shin............................................................... 75-77, 144
M. S. Shin............................................................. 111, 272
E. K. Shin.............................................................. 111, 272
T. Shingo....................................................................... 175
G. Shinzato................................................................... 266
A. Shiozaki.................................................................... 136
J. Shiraishi.................................................................... 192
...............................................................234, 252-253, 256
F. C. S Silva Jr............................................................... 275
I. C. M. Silva.............................................76, 138, 234, 253
C. Silva...................................................202, 244, 252, 268
J. L. Silva....................................................................... 255
P. L. Silva...................................................................... 260
V. M. Silva............................................................. 180, 198
J. P. Silva.............................................................. 226, 236
M. Silvero.............................................................. 169-170
J. Silveyra............................................................. 260, 273
K. H. Sim....................................................................... 201
S. Simas........................................................................ 234
J. C. Simes.................................................................... 205
M. Simoes.................................................................... 220
O. Simoes............................................................. 111, 181
L. Simões.......................................................262, 265, 267
G. Smolyanova.............................................................. 234
T. D. Snyder.................................................................. 212
P. Soares.........................................76, 108, 138, 236, 278
S. Soares...................................................................... 270
A. Soares.......................................................144, 225, 236
C. E. Soares.................................................................. 198
O. E. Soares.................................................................. 266
F. Soares....................................................................... 191
P. P. Soares.................................................................. 236
D. Sobic-Saranovic........................................................ 171
D. Sobolev.................................................................... 238
T. Sobow...................................................................... 188
D. Sobral-Filho.............................................................. 249
M. Socorro.................................................................... 144
H. Soejima.................................................................... 164
F. Sogorb...................................................................... 217
Authors
A. Sokolowski....................................................... 101, 230
T. Spyt.................................................................... 73, 256
M. Strumminger........................................................... 220
G. Solari........................................................................ 169
R. Squires..................................................................... 107
C. Strunz............................................................... 237, 247
R. Solerno..................................................................... 229
M. Šrámek.................................................................... 169
K. Stuart........................................................................ 135
E. Z. Soliman................................................................. 200
M. Šramko.................................................................... 169
I. Stukena...................................................................... 235
E. Soloaga..................................................................... 219
I. Srdanovic................................................................... 190
C. Sturgeon................................................................... 229
R. J. Solomon............................................................... 142
M. Srdic........................................................................ 187
A. Sturich........................................................................ 76
H. Solomon................................................................... 137
A. Srinivas..................................................................... 132
M. C. J. M. Sturkenboom............................................. 243
I. Solti.................................................................... 197, 202
R. Staico........................................................198, 257, 259
A. Stuto......................................................................... 186
M. Somera.................................................................... 181
H. Staines.........................................75, 178, 206-207, 209
P. Stuzbach................................................................... 220
D. Sondore.................................................................... 255
G. Stampone................................................................. 206
J. Su................................................................................ 75
S. Sood......................................................................... 103
V. Stangl................................................................. 75, 140
L. Suarez....................................................................... 183
T. Sööt.......................................................................... 187
K. Stangl..........................................................75, 140, 238
E. R. Suarez...........................................243, 245, 247, 265
E. Sophia................................................................ 222-223
C. Staniloae................................................................... 142
R. Suarez-Arias...................................................... 196-197
L. Sorell................................................................. 247, 263
B. Stankova................................................................... 200
V. Suchanek.......................................................... 141, 223
T. Soria.......................................................................... 181
S. Stankovic.................................................................. 187
M. Sucu........................................................................ 171
L. Soriano.............................................................. 206, 259
G. Stankovic............................................................ 71, 142
K. Sugar........................................................................ 259
C. Soriano..................................................................... 231
J. Stanley...................................................................... 176
J. Sugawara.......................................................... 137, 173
P. Sorroche................................................................... 183
S. Stanojevic................................................................. 137
K. Sugi.................................................................... 70, 185
F. Sosa...................................144, 172, 239, 241, 271, 274
R. Stauber..................................................................... 225
M. M. Sugizaki.............................................................. 258
E. Sosa.......................................................................... 102
A. C. Steer.................................................................... 103
M. Sultan...................................................................... 136
R. Sosa......................................................................... 264
E. Stefanadi..................................................... 69, 216-217
M. Sultán................................................................ 80, 111
C. Sosa......................................................................... 271
C. Stefanadis................................................... 69, 216-217
G. Sumay...................................................................... 217
J. E. Sousa.............................................................. 76, 198
A. Stefani.............................................................. 102, 212
B. Sumegi............................................................. 197, 202
E. Sousa...........................................................76, 198, 225
B. Stefanovic...................................................74, 105, 169
V. Sumodi..................................................................... 168
A. Sousa........................................................ 256-259, 261
R. Steffen..................................................................... 207
Y. Sun........................................................................... 135
A. G. M. R. Sousa......................................................... 198
M. Stefuriac.................................................................. 200
C. Sun........................................................................... 222
J. E. Sousa.............................................................. 76, 198
R. Stein............................................74, 106, 138, 187, 226
M. Sun.......................................................................... 214
M. G. Sousa............................................................ 80, 208
S. Steiner.............................................................. 104, 270
V. Sundararajan............................................................. 164
A. C. S Sousa................................................................ 111
S. Steiner-Boker............................................................ 100
J. B. Sundstrom..................................................... 202-203
M. A. C. Sousa.............................................................. 215
V. Stelet.......................................................................... 76
R. Suneja...................................................................... 258
I. Souto......................................................................... 175
J. Stepanovic..........................................110, 142, 277-278
A. Sunil......................................................................... 101
N. A. Souza E. Silva....................................................... 269
J. Stepinska.......................................................... 172, 252
S. Suryawanshi............................................................... 75
O. Souza....................................................................... 229
R. Steponeniene........................................................... 210
L. Sutera....................................................................... 106
A. Souza.........................................................237, 258, 269
G. Sterbakova............................................................... 253
G. Sutherland................................................................ 254
D. Souza....................................................................... 233
M. Sterlinski.................................................................... 76
M. Sutton................................................................ 74, 136
A. S. Souza.....................................................139, 184, 256
A. Sterque..................................................................... 223
O. Suzer........................................................................ 242
S. B. C. Souza............................................................... 270
J. Stertzer..................................................................... 140
O. Süzer........................................................................ 180
F. Souza........................................................................ 228
S. H. Stertzer................................................................ 140
L. Svard......................................................................... 229
M. Souza....................................................................... 138
A. Stevanovic................................................................ 174
L. Svensson.................................................................. 232
E. C. Souza.................................................................... 266
S. Stewart............................................................. 107, 203
G. Svingen............................................................ 247, 251
J. Souza........................................................................ 234
C. Stipp......................................................................... 201
C. Swarzman................................................................ 248
L. C. B. Souza................................................................. 76
V. Stoickov............................................................ 166, 214
S. Swieszkowski........................................................... 215
W. Souza...................................................................... 241
S. Stojkovic...............................................71, 142, 277-278
M. K. Sydnor......................................................... 179, 275
V. R. Souza.................................................................... 250
A. Stojkovic................................................................... 170
P. Syska.......................................................................... 76
S. Soydinc..................................................................... 171
N. Stolf.................................................................. 276, 278
A. Sýsman.................................................................... 170
O. Soylu........................................................................ 186
M. Stoll................................................................. 273, 276
Z. Szabolcs.................................................................... 203
E. Y. Sozmen.......................................................... 77, 276
P. Stoll.......................................................................... 143
M. Szakacs................................................................... 257
C. Spargias.................................................................... 177
T. Stompor.................................................................... 101
K. Szakolczai......................................................... 164, 199
R. Spasic....................................................................... 193
I. Stopa................................................................... 80, 141
J. Szarfer..................................................69, 132, 139, 188
M. Spelta...................................................................... 220
V. Strada....................................................................... 215
A. Szebeni..................................................................... 203
R. Speranza........................................................... 102, 212
L. Strain........................................................................ 143
J. Szlavov...................................................................... 220
F. Spernanzoni........................................................ 79, 219
E. Strand................................................133, 142, 243, 248
S. Szmit........................................................................ 273
J. Spiers........................................................................ 229
B. E. Strauer.......................................................... 104, 270
E. Szûcs........................................................................ 164
A. Spillmann.......................................................... 260, 270
M. Strauß...................................................................... 203
H. Szwed...........................................................76, 80, 135
G. Spina.........................................................132, 237, 247
P. Strebelas.................................................................. 181
F. Szymanski................................................................. 273
A. Spinelli...................................................................... 208
T. Strecker............................................................ 176, 274
A. Szyszka..................................................................... 251
M. Spleta...................................................................... 222
C. Stringi....................................................................... 217
E. Tabak........................................................................ 104
L. A. Sposato.......................................................... 78, 111
M. Strozzi.............................................................. 219, 231
S. Tabares..................................................................... 264
Index / 317
Authors
G. Tabidze..................................................................... 235
A. Taylor.................................................................... 73, 75
K. Tjelta......................................................................... 199
G. Tacoy................................................................. 278-279
Y. Tayyareci.......................................................... 106, 191
M. Tobar....................................................................... 178
G. Taçoy................................................................ 172, 186
J. Tazar................................................................. 178, 265
D. Tobing.............................................................. 132, 235
K. Taeik......................................................................... 272
A. S. Tebexreni...................................................... 248-249
J. E. Toblli..................................................................... 138
M. Tafazzoli-Shadpour.................................................. 142
A. Tedeschi................................................................... 143
C. Tobon......................................................................... 79
A. C. Taffarel................................................................. 233
B. Tedeschi................................................................... 143
M. Todorovic-Tirnanic................................................... 171
R. Tagle......................................................................... 182
U. Teibe........................................................................ 235
S. Toker........................................................................ 163
M. S. Tagliari................................................................. 265
R. Teixeira....................................70, 78-79, 101, 110, 132,
C. Toldo........................................................................ 246
C. Taira.......................................................................... 274
.......................................250, 252, 255-256, 258, 260, 263
C. Toledo...................................................................... 207
O. Tairova..................................................................... 228
P. Teixeira..................................................................... 236
I. Tolj............................................................................. 190
N. Tajima....................................................................... 231
G. Teixeira............................................................. 231, 233
J. F. Tolsa...................................................................... 103
N. Takahashi................................................................. 175
E. Tekbas...................................................................... 171
D. Tomar......................................................................... 79
T. Takakura................................................................... 170
L. Tekieli................................................................. 78, 233
P. Tomašov................................................................... 136
D. Takara....................................................................... 193
J. Telayna...................................................................... 278
A. Tomat....................................................................... 211
K. Takazawa.................................................................. 167
L. A. Temming...................................................... 138, 212
C. Tomaz....................................................................... 249
R. T. Takeda.................................................................. 213
P. L. Temporelli............................................................. 136
M. Tomazzi................................................................... 240
K. Takeishi.................................................................... 167
A. Tenenbaum.............................................................. 209
A. Tomek...................................................................... 169
L. Talavera.....................................................142, 221, 259
C. Tentolouris.................................................. 69, 216-217
S. Tomic................................................................ 187, 202
M. L. Talavera....................................................... 142, 221
M. C. Tentori................................................................. 244
H. Tomiyama................................................................ 187
J. A. Talayero................................................................ 133
C. Tentori.............................................................. 205, 244
M. Tonetto...................................................................... 74
C. Talos......................................................................... 246
I. Teplitsky............................................................ 110, 178
O. Topolcan.................................................................. 253
H. Tamagusuku..........................................74, 79, 211, 241
I. Ternouth.............................................................. 71, 179
A. Torino....................................................................... 209
G. Tamashiro.................................................................. 71
C. Terzic........................................................................ 107
P. Tornos...................................................................... 252
A. Tamashiro................................................................... 71
M. Tettamanti............................................................... 224
A. Torrão....................................................................... 234
T. Tammelin.................................................................... 75
S. Tewari........................................................ 110, 250-251
I. Torres........................................................................ 252
Y. Tanaka...................................................................... 164
S. Tewell....................................................................... 144
J. Torres.........................................................260, 265, 271
H. Tanaka.............................................................. 137, 173
S. Tezuka...................................................................... 175
F. Torres....................................................................... 196
C. Tanamati................................................................... 263
E. Thaulow............................................................ 103, 223
E. Torresani........................................................... 237, 240
R. Tandler..................................................................... 176
P. Thayssen.......................................71, 79, 110, 142, 253
C. Torromeo.................................................................. 240
I. Tandogan....................................................180, 194, 205
T. R. Theodoro.............................................................. 245
A. Tors............................................................................ 72
Q. Z. Tang..................................................................... 163
T. Theodoropoulos........................................................ 224
A. Torterola................................................................... 257
A. Tangari.............................................................. 226, 236
G. Thiene...................................................................... 134
M. Toscani.................................................................... 205
D. Tanne....................................................................... 209
A. Thom..........................................110-111, 186, 251, 276
A. Toscano.................................................................... 201
E. Tanus.................................................111, 170, 189, 196
M. Thomas................................................................... 108
I. Toshev....................................................................... 225
P. Tapanainen................................................................. 75
R. Thomas.................................................................... 107
K. Toth.......................................................................... 202
M. Tarán....................................................................... 205
C. Thomas.................................................................... 237
J. L. Tovar..................................................................... 252
E. Tararak...................................................................... 235
M. C. Thomazi....................................................... 266, 268
R. Tracy......................................................................... 137
F. Tarasoutchi........................................132, 237, 247, 275
S. Thomopoulou........................................................... 177
W. Tracz......................................76, 78, 80, 101, 141, 170,
S. Tarasov..................................................................... 175
S. Thompson-Bell........................................................... 75
.......................................173-174, 182, 185, 193, 230, 233
J. C. Tardif..................................................................... 197
O. Thorsson.................................................................. 168
J. Trainini...................................................................... 139
O. Tardin............................................................... 260, 263
L. Thuesen.........................................71, 79, 110, 142, 253
J. C. Trainini.................................................................. 139
J. Tartaglione........................................................ 228, 248
R. Thurler...................................................................... 256
F. Tramontini................................................................. 187
I. Tasic.......................................................................... 276
K. Tibazarwa................................................................. 107
B. Tranchesi Jr.............................................................. 224
A. Tasouli...................................................................... 181
C. Tibbatts...................................................................... 71
G. Trancoso.................................................................. 234
R. Tasoz........................................................................ 111
J. C. Tille....................................................................... 142
D. Trapaidze.................................................................. 175
E. Tassano............................................................. 260-261
H. Tilsted................................................................ 79, 110
H. J. Trappe...........................................103, 194, 223, 245
P. Tassovska................................................................. 225
Y. R. Timasheva............................................................ 236
P. R. Travancas..............................................262, 265, 267
C. P. Tastan................................................................... 191
A. S. Timm.................................................................... 263
S. Traverso.............................................133, 139, 227, 266
H. Tatar......................................................................... 163
M. Timm......................................................................... 77
V. Traykov..................................................................... 206
R. Tataradze.................................................................. 175
A. Timofeeva......................................................... 234-235
N. Trehan............................................................... 141-142
E. Tatli........................................................................... 182
T. Timurkaynak.172, 180, 185-186, 190, 219, 231-232, 278
P. Trejo......................................................................... 206
M. Tatsch...................................................................... 234
E. Tinoco....................................................................... 207
E. Trendafilova.............................................................. 225
S. Taurozzi.................................................................... 178
R. Tinoco....................................................................... 234
P. Trenkwalder...................................................... 196, 198
A. Tavares....................................................................... 74
G. A. Tinoco.................................................................. 234
L. Trentacoste............................................................... 209
L. Tavares..................................................................... 191
E. Tirado................................................................. 270-271
M. Trevisan................................................................... 100
A. M. V. Tavares........................................................... 233
C. Tirziu......................................................................... 224
A. Trigo......................................................................... 231
D. Tavciovski................................................................. 193
G. C. Tiscornia............................................................... 191
E. Trillos........................................................................ 249
A. Tavridou...................................................................... 77
J. Tisnado............................................................. 179, 275
H. Trimarchi.................................................................. 201
Authors
E. Trindade............................................................ 263, 278
D. Ugalde...................................................................... 141
D. Vangu Ngoma................................................76, 78, 243
J. Tripolone.............................192, 195, 241-242, 260-261,
M. R. Ugolini.................................................. 243-247, 265
B. Vankelecom.............................................................. 277
........................................................263-264, 266, 269-270
M. Uhlemann................................................................ 182
A. D. Varanda-Rosario................................................... 273
K. Trivedi....................................................................... 270
E. Ulusoy...................................................................... 163
S. Varela Ortiz....................................................... 266, 268
L. J. Trkulja.................................................................... 202
R. Umakanthan............................................................... 73
M. Varela Otero............................................................ 192
I. C. Trombetta...............................................172, 180, 192
B. Umman............................................................ 106, 191
A. Varela Roman........................................................... 194
C. Tron............................................................................ 78
S. Umman..................................................................... 191
J. S. Varela.................................................................... 106
J. Tronge....................................................................... 171
D. Umpierre.................................................................. 106
C. Varela......................................................................